Citrus Sinensis ID: 020102
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X8C5 | 748 | Wall-associated receptor | yes | no | 0.930 | 0.411 | 0.575 | 1e-106 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.930 | 0.388 | 0.574 | 1e-105 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.939 | 0.408 | 0.564 | 1e-104 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.882 | 0.388 | 0.590 | 1e-103 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.885 | 0.371 | 0.587 | 1e-102 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.918 | 0.397 | 0.566 | 1e-101 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.882 | 0.4 | 0.574 | 1e-101 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.930 | 0.421 | 0.563 | 1e-100 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.936 | 0.403 | 0.568 | 1e-100 | |
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.867 | 0.365 | 0.578 | 1e-99 |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 386 bits (992), Expect = e-106, Method: Compositional matrix adjust.
Identities = 194/337 (57%), Positives = 256/337 (75%), Gaps = 29/337 (8%)
Query: 2 LLRIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVN 61
L + ++K+R I++++ FF++NGG+LL+Q L +G+V + ++FSS EL+KAT++FN N
Sbjct: 362 LYKFVQKRRKLIRMRK-FFRRNGGMLLKQQLARKEGNV-EMSRIFSSHELEKATDNFNKN 419
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCC 98
R+LGQGGQGTVYKGM DGRI+AVK+SK N VKLLGCC
Sbjct: 420 RVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCC 479
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
LETEVP+LVYEF+ NG L + LHD ++ ++ +TWE+RL IA E+AGAL+YLHSAAS PI
Sbjct: 480 LETEVPVLVYEFVPNGDLCKRLHD--ESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPI 537
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 218
YHRDIK+TNILLDER RAKV+DFGTS+ + +DQTH+TT++ GTFGY+DPEY QSS+ T+K
Sbjct: 538 YHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEK 597
Query: 219 SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKK 278
SDVYSFGVVLVELLTG+KP S+ S+EN LAA+FV ++++NR+ DI+DD++
Sbjct: 598 SDVYSFGVVLVELLTGEKP--SSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNM 655
Query: 279 NQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
+Q+M+ ANLA RCL+ GKKRP M EVS+EL IR S
Sbjct: 656 DQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (981), Expect = e-105, Method: Compositional matrix adjust.
Identities = 193/336 (57%), Positives = 252/336 (75%), Gaps = 28/336 (8%)
Query: 1 MLLRIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNV 60
+L + I+K+R + K+ FFK+NGGLLLQQ L S G ++++ +FSS+EL+KAT +F+
Sbjct: 392 LLYKFIKKQR-KLNQKKKFFKRNGGLLLQQQLISTVG-MVEKTIVFSSRELEKATENFSS 449
Query: 61 NRILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGC 97
NRILGQGGQGTVYKGM DGRI+AVKKSK N VKLLGC
Sbjct: 450 NRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGC 509
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
CLET+VP+LVYEFI NG L++HLHD ++ TW +RLRIA ++AGAL+YLHS+ASSP
Sbjct: 510 CLETKVPVLVYEFIPNGNLFEHLHDEF-DENIMATWNIRLRIAIDIAGALSYLHSSASSP 568
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD 217
IYHRD+KSTNI+LDE+YRAKV+DFGTS+ + +D TH+TT + GT GY+DPEY QSSQ TD
Sbjct: 569 IYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTD 628
Query: 218 KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGK 277
KSDVYSFGVVLVEL+TG+K I + SQEN +LA YF+ +M++N+L+DI+D ++
Sbjct: 629 KSDVYSFGVVLVELITGEKSI--SFLRSQENRTLATYFILAMKENKLFDIIDARIRDGCM 686
Query: 278 KNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
+Q+ A A +A +CL+L G+KRP+M EVSMEL+ IR
Sbjct: 687 LSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 378 bits (971), Expect = e-104, Method: Compositional matrix adjust.
Identities = 192/340 (56%), Positives = 250/340 (73%), Gaps = 29/340 (8%)
Query: 2 LLRIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVN 61
L + I+K+R +++ FF++NGG+LL+Q L +G+V + K+FSS EL+KAT++FN N
Sbjct: 370 LYKFIKKQRRSSRMRV-FFRRNGGMLLKQQLARKEGNV-EMSKIFSSNELEKATDNFNTN 427
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCC 98
R+LGQGGQGTVYKGM DGRI+AVK+SK N VKLLGCC
Sbjct: 428 RVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCC 487
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
LETEVP+LVYEF+ NG L + L D ++ +TWE+RL IA E+AGAL+YLHSAAS PI
Sbjct: 488 LETEVPVLVYEFVPNGDLCKRLRDECD--DYIMTWEVRLHIAIEIAGALSYLHSAASFPI 545
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 218
YHRDIK+TNILLDE+Y+ KV+DFGTS+ + +DQTH+TT++ GTFGY+DPEY QSS+ TDK
Sbjct: 546 YHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDK 605
Query: 219 SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKK 278
SDVYSFGVVLVEL+TGK P S+ S+EN AA+FV ++++NR DI+D+++
Sbjct: 606 SDVYSFGVVLVELITGKNP--SSRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDECNL 663
Query: 279 NQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318
+Q+MA A LA+RCL+ GKKRP M EVS+EL IR SS K
Sbjct: 664 DQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSYK 703
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (963), Expect = e-103, Method: Compositional matrix adjust.
Identities = 189/320 (59%), Positives = 240/320 (75%), Gaps = 28/320 (8%)
Query: 19 FFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMRE 78
FFK+NGGLLL+Q L + G+V K+FSSKEL+KAT++FN+NR+LGQGGQGTVYKGM
Sbjct: 383 FFKRNGGLLLKQQLTTRGGNV-QSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLV 441
Query: 79 DGRIIAVKKSK-----------------------NAVKLLGCCLETEVPLLVYEFISNGT 115
DGRI+AVK+SK N VKL+GCCLETEVP+LVYE I NG
Sbjct: 442 DGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGD 501
Query: 116 LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175
L++ LH + ++ +TW++RLRI+ E+AGALAYLHSAAS+P+YHRD+K+TNILLDE+YR
Sbjct: 502 LFKRLHH--DSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYR 559
Query: 176 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 235
AKV+DFGTS+ I +DQTH+TT + GTFGYLDPEY Q+SQ TDKSDVYSFGVVLVEL+TG+
Sbjct: 560 AKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGE 619
Query: 236 KPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLN 295
KP FS +EN L ++F +M++NR+ DI+D ++ + Q++A A LA RCL L
Sbjct: 620 KP-FSVMR-PEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLK 677
Query: 296 GKKRPTMEEVSMELNGIRGS 315
GKKRP M EVS+EL IR S
Sbjct: 678 GKKRPNMREVSVELERIRSS 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 373 bits (957), Expect = e-102, Method: Compositional matrix adjust.
Identities = 188/320 (58%), Positives = 237/320 (74%), Gaps = 27/320 (8%)
Query: 19 FFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMRE 78
FFK+NGGLLLQQ LN+ G+V ++ ++FSS+EL+KAT++F+ +RILGQGGQGTVYKGM
Sbjct: 413 FFKRNGGLLLQQQLNTNKGNV-EKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLV 471
Query: 79 DGRIIAVKKSK-----------------------NAVKLLGCCLETEVPLLVYEFISNGT 115
DGR +AVKKSK + VKLLGCCLETEVP LVYEFI NG
Sbjct: 472 DGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGN 531
Query: 116 LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175
L+QH+H+ ++ ++ TW MRLRIA ++AGAL+YLHSAASSPIYHRDIKSTNILLDE+YR
Sbjct: 532 LFQHIHE--ESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYR 589
Query: 176 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 235
KV+DFGTS+ + +D TH TT I GT GY+DPEY+ SSQ TDKSDVYSFGVVLVEL+TG+
Sbjct: 590 TKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGE 649
Query: 236 KPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLN 295
KP+ + N SQE LA +F +M++NR ++I+D ++ K Q+MA ANLA RCL+
Sbjct: 650 KPVITVSN-SQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSK 708
Query: 296 GKKRPTMEEVSMELNGIRGS 315
GKKRP M +V +L I S
Sbjct: 709 GKKRPCMRKVFTDLEKILAS 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (949), Expect = e-101, Method: Compositional matrix adjust.
Identities = 188/332 (56%), Positives = 240/332 (72%), Gaps = 28/332 (8%)
Query: 4 RIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRI 63
+++RK+RM + K FFK+NGGLLLQQ LN+ G V ++ KLFSS+EL+KAT++FN NR+
Sbjct: 402 KLLRKRRMTNR-KRKFFKRNGGLLLQQQLNTTQGRV-EKTKLFSSRELEKATDNFNDNRV 459
Query: 64 LGQGGQGTVYKGMREDGRIIAVKKS-----------------------KNAVKLLGCCLE 100
+GQGGQGTVYKGM DGR +AVKKS ++ VKLLGCCLE
Sbjct: 460 IGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLE 519
Query: 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYH 160
TEVP+LVYEFI NG L+QHLH+ ++ W +R+RIA +++GA +YLH+AA SPIYH
Sbjct: 520 TEVPILVYEFIPNGNLFQHLHEEFD--DYTALWGVRMRIAVDISGAFSYLHTAACSPIYH 577
Query: 161 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSD 220
RDIKSTNILLDE+YRAKV+DFGTS+ +++D TH TT I GT GY+DPEY+ SS T+KSD
Sbjct: 578 RDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSD 637
Query: 221 VYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQ 280
VYSFGVVLVEL+TG+KP+ + T QE LA YF +MR+NRL++I+D ++ K Q
Sbjct: 638 VYSFGVVLVELITGEKPVITLSET-QEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQ 696
Query: 281 IMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
++A ANLA RCL GK RP M EVS L I
Sbjct: 697 VIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 367 bits (942), Expect = e-101, Method: Compositional matrix adjust.
Identities = 185/322 (57%), Positives = 239/322 (74%), Gaps = 30/322 (9%)
Query: 19 FFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMRE 78
FFK+NGGLLL+Q L + DGSV + K+FSS+EL+KAT++F+++R+LGQGGQGTVYK M
Sbjct: 390 FFKRNGGLLLKQQLTTKDGSV-EMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRMLV 448
Query: 79 DGRIIAVKKSK-----------------------NAVKLLGCCLETEVPLLVYEFISNGT 115
DG I+AVK+SK N VKLLGCCLETEVP+LVYE+I NG
Sbjct: 449 DGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGD 508
Query: 116 LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175
L++ LHD + ++ +TWE+RLRIA E+AGAL+Y+HSAAS PI+HRDIK+TNILLDE+YR
Sbjct: 509 LFKRLHD--EYDDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYR 566
Query: 176 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 235
AK++DFGTS+ +A DQTH+TT + GTFGY+DPEY SSQ T KSDVYSFGVVLVEL+TG+
Sbjct: 567 AKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGE 626
Query: 236 KPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLN 295
KP+ S+E + LA YF+ +M++NR DI+D ++ K Q+MA A LA RCL+
Sbjct: 627 KPMSRV--RSEEGIGLATYFLEAMKENRAVDIIDIRIKDESK--QVMAVAKLARRCLNRK 682
Query: 296 GKKRPTMEEVSMELNGIRGSSR 317
G KRP M EVS++L IR S +
Sbjct: 683 GNKRPNMREVSIKLERIRSSPK 704
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (936), Expect = e-100, Method: Compositional matrix adjust.
Identities = 190/337 (56%), Positives = 249/337 (73%), Gaps = 29/337 (8%)
Query: 2 LLRIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVN 61
L ++I+K+R +I + FFK+NGGLLL+Q L + DG+V + K+FSSKEL KAT++F+++
Sbjct: 375 LFKLIKKRR-NINRSKKFFKRNGGLLLKQQLTTKDGNV-EMSKIFSSKELRKATDNFSID 432
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCC 98
R+LGQGGQGTVYKGM DG I+AVK+SK N VKLLGCC
Sbjct: 433 RVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCC 492
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
LETEVP+LVYE+I NG L++ LHD ++ ++ +TWE+RLRIA E+AGAL Y+HSAAS PI
Sbjct: 493 LETEVPILVYEYIPNGDLFKRLHD--ESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPI 550
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 218
+HRDIK+TNILLDE+YRAKV+DFGTS+ + +DQTH+TT + GTFGY+DPEY SSQ T K
Sbjct: 551 FHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHK 610
Query: 219 SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKK 278
SDVYSFGVVLVEL+TG+KP+ S+E LA +F+ +M++NR+ DI+D ++ K
Sbjct: 611 SDVYSFGVVLVELITGEKPLSRV--RSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKL 668
Query: 279 NQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
Q+MA A LA +CL+ GK RP M+EVS EL IR S
Sbjct: 669 EQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (932), Expect = e-100, Method: Compositional matrix adjust.
Identities = 192/338 (56%), Positives = 249/338 (73%), Gaps = 28/338 (8%)
Query: 2 LLRIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVN 61
L + IR++R + K+ FFK+NGGLLLQQ L + +G+V D ++F+S+EL+KAT +F++
Sbjct: 379 LYKFIRRQRR-LNQKKKFFKRNGGLLLQQQLTTTEGNV-DSTRVFNSRELEKATENFSLT 436
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCC 98
RILG+GGQGTVYKGM DGRI+AVKKSK N VKLLGCC
Sbjct: 437 RILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCC 496
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
LET+VP+LVYEFI NG L++HLHD + TWE+RLRIA ++AGAL+YLHSAASSPI
Sbjct: 497 LETDVPILVYEFIPNGNLFEHLHDDSDDYTM-TTWEVRLRIAVDIAGALSYLHSAASSPI 555
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 218
YHRDIKSTNI+LDE++RAKV+DFGTS+ + +D TH+TT + GT GY+DPEY QSSQ TDK
Sbjct: 556 YHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDK 615
Query: 219 SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKK 278
SDVYSFGVVL EL+TG+K + + SQE +LA YF +M++NRL DI+D ++ K
Sbjct: 616 SDVYSFGVVLAELITGEKSV--SFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKL 673
Query: 279 NQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
NQ+ A A +A +CL++ G+KRP+M +VSMEL IR S
Sbjct: 674 NQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYS 711
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 363 bits (931), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 181/313 (57%), Positives = 229/313 (73%), Gaps = 26/313 (8%)
Query: 23 NGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRI 82
NGGLLLQQ LN+ G V+++ ++F+SKEL+KAT +F+ NR+LG GGQGTVYKGM DGR
Sbjct: 410 NGGLLLQQELNTRQG-VVEKARIFTSKELEKATENFSENRVLGHGGQGTVYKGMLVDGRT 468
Query: 83 IAVKKSK-----------------------NAVKLLGCCLETEVPLLVYEFISNGTLYQH 119
+AVKKSK + VKLLGCCLETEVP+LVYEFI NG L++H
Sbjct: 469 VAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKH 528
Query: 120 LHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179
+H+ + ++ + W MRLRIA ++AGAL+YLHSAASSPIYHRDIKSTNILLDE+YRAKVA
Sbjct: 529 IHEE-EADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVA 587
Query: 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
DFGTS+ + +DQTH TT I GT GY+DPEY++SSQ T+KSDVYSFGV+L EL+TG KP+
Sbjct: 588 DFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVI 647
Query: 240 SAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKR 299
NT QE ++LA +F +M++ RL DI+D ++ K Q+MA ANLA +CL G+ R
Sbjct: 648 MVQNT-QEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNR 706
Query: 300 PTMEEVSMELNGI 312
P M EV EL I
Sbjct: 707 PNMREVFTELERI 719
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | ||||||
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.927 | 0.743 | 0.654 | 1e-120 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.924 | 0.352 | 0.655 | 1e-120 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.903 | 0.363 | 0.669 | 1e-120 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.930 | 0.443 | 0.643 | 1e-119 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.948 | 0.462 | 0.637 | 1e-118 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.921 | 0.419 | 0.645 | 1e-117 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.924 | 0.426 | 0.637 | 1e-117 | |
| 224075946 | 729 | predicted protein [Populus trichocarpa] | 0.918 | 0.417 | 0.651 | 1e-117 | |
| 297734146 | 1029 | unnamed protein product [Vitis vinifera] | 0.924 | 0.297 | 0.637 | 1e-116 | |
| 224075820 | 626 | predicted protein [Populus trichocarpa] | 0.915 | 0.484 | 0.645 | 1e-115 |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1128), Expect = e-120, Method: Compositional matrix adjust.
Identities = 220/336 (65%), Positives = 270/336 (80%), Gaps = 29/336 (8%)
Query: 1 MLLRIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNV 60
+L R+++++R IK KE FK+NGGLLL+Q L+S +G+V D+ KLF+SKEL+KAT+ +N
Sbjct: 28 LLYRVLKRRR-KIKHKEKCFKRNGGLLLEQQLSSSEGNV-DKTKLFTSKELEKATDRYNE 85
Query: 61 NRILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGC 97
NR++GQGGQGTVYKGM DGRI+AVKK K N VKLLGC
Sbjct: 86 NRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGKLEQFINEVVILSQINHRNVVKLLGC 145
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
CLE EVPLLVYE+I NGTL +H+HD QN+EFP+TW+MRL+IATEVAGAL+YLHSAAS P
Sbjct: 146 CLEIEVPLLVYEYIPNGTLSEHIHD--QNEEFPITWKMRLQIATEVAGALSYLHSAASIP 203
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD 217
IYHRDIKSTNILLD++YRAKVADFGTSK +A+DQTH+TTK+QGTFGYLDPEY QSSQ T+
Sbjct: 204 IYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTKVQGTFGYLDPEYFQSSQFTE 263
Query: 218 KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGK 277
KSDVYSFG+VL+ELLTGKKPI S G S E SLA+YF+ SM+++RL D+LD +V+K G+
Sbjct: 264 KSDVYSFGIVLIELLTGKKPILSIG--SGEGKSLASYFIMSMKEDRLSDLLDARVVKEGR 321
Query: 278 KNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
K +I A A LA+RC++LNGKKRPTM EV+MEL IR
Sbjct: 322 KEEINAIAFLAKRCINLNGKKRPTMMEVAMELERIR 357
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1127), Expect = e-120, Method: Compositional matrix adjust.
Identities = 219/334 (65%), Positives = 263/334 (78%), Gaps = 28/334 (8%)
Query: 3 LRIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNR 62
L I+ K+R IK KE F +NGGLLL+Q L+S +G+ ID+ KLF+SKEL+KAT+ +N NR
Sbjct: 319 LYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGN-IDKTKLFTSKELEKATDRYNENR 377
Query: 63 ILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCL 99
++GQGG+GTVYKGM DGRI+AVKK K N VKLLGCCL
Sbjct: 378 VIGQGGEGTVYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCL 437
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
ETEVPLLVYEFI NGTL +H+H QN+EFP+TWE+RLRIATEVAGAL+YLHSAAS PIY
Sbjct: 438 ETEVPLLVYEFIPNGTLSEHIHG--QNEEFPITWEIRLRIATEVAGALSYLHSAASVPIY 495
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRDIKSTNILLD++YRAKVADFG SKF+A+DQTH+TT++QGTFGYLDPEY QSSQ T+KS
Sbjct: 496 HRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKS 555
Query: 220 DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKN 279
DVYSFG+VL+ELLTGKKPI S S+E SLA+YF+ SM ++RL D+LD QV+K +K
Sbjct: 556 DVYSFGIVLIELLTGKKPILSTA--SEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKE 613
Query: 280 QIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
+I A A LA RC++LNGKKRPTM EV+MEL IR
Sbjct: 614 EINAIAFLARRCINLNGKKRPTMMEVAMELERIR 647
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1121), Expect = e-120, Method: Compositional matrix adjust.
Identities = 219/327 (66%), Positives = 260/327 (79%), Gaps = 28/327 (8%)
Query: 6 IRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILG 65
+ K+R IK KE FK+NGGLLL+Q L+S +G+V D+ KLF+SKEL+KAT+ +N NR++G
Sbjct: 478 VLKRRQKIKYKEKCFKRNGGLLLEQQLSSSEGNV-DKTKLFTSKELEKATDRYNENRVIG 536
Query: 66 QGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCLETE 102
QGGQGTVYKGM DGRI+AVKK K N VKLLGCCLET
Sbjct: 537 QGGQGTVYKGMLMDGRIVAVKKLKIVGDGKVEQFINEVVILSQINHRNVVKLLGCCLETA 596
Query: 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162
VPLLVYEFI NGTL +H+HD QN+EFP+TWEMRLRIA EVAGAL+YLHSAAS PIYHRD
Sbjct: 597 VPLLVYEFIPNGTLSEHIHD--QNEEFPITWEMRLRIAIEVAGALSYLHSAASIPIYHRD 654
Query: 163 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 222
IKSTNILLD++YRAKVADFGTSK +A+DQTH+TT++QGTFGYLDPEY QSSQ T+KSDVY
Sbjct: 655 IKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVY 714
Query: 223 SFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM 282
SFG+VL+ELLTGKKPI S S+E SLA+YF+ SM ++RL D+LD QV+K GKK +I
Sbjct: 715 SFGIVLIELLTGKKPILSTA--SEEGKSLASYFILSMNEDRLSDLLDAQVVKEGKKEEIN 772
Query: 283 AFANLAERCLDLNGKKRPTMEEVSMEL 309
A A LA RC++LNGKKRPTM EV+MEL
Sbjct: 773 AIAFLARRCINLNGKKRPTMMEVAMEL 799
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 435 bits (1118), Expect = e-119, Method: Compositional matrix adjust.
Identities = 217/337 (64%), Positives = 271/337 (80%), Gaps = 29/337 (8%)
Query: 2 LLRIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVN 61
L +II+++R +KLK+ FFK+NGGLLL+Q L+S + + +++ K+F+SKEL+KAT+ ++ N
Sbjct: 346 LYKIIKRRRA-MKLKQNFFKRNGGLLLEQQLSSTE-NYVEQTKVFTSKELEKATDDYHTN 403
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCC 98
RILGQGGQGTVYKGM DGR++A+KKSK N VKL+GCC
Sbjct: 404 RILGQGGQGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINEVVILSQINHRNVVKLIGCC 463
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
LETEVPLLVYEFI NGTLYQ++H+ N+EFP+TWEMRLRIATEVAGALAYLH+AAS PI
Sbjct: 464 LETEVPLLVYEFIPNGTLYQYIHN--PNEEFPVTWEMRLRIATEVAGALAYLHAAASMPI 521
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 218
YHRDIKS+NILLDE+YRAKVADFGTSK I++DQTHVTT++QGTFGYLDPEY QSSQ T+K
Sbjct: 522 YHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQFTEK 581
Query: 219 SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKK 278
SDVYSFGVVLVELLTG+KPI S S E SLA YF+ +M ++RL++ILD +V+K G +
Sbjct: 582 SDVYSFGVVLVELLTGQKPISSY--RSVEERSLATYFLMTMEESRLFEILDARVLKEGGR 639
Query: 279 NQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
+I+A A LAE+CL+LNGKKRP M+ V++EL GIR S
Sbjct: 640 EEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSS 676
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1103), Expect = e-118, Method: Compositional matrix adjust.
Identities = 218/342 (63%), Positives = 260/342 (76%), Gaps = 28/342 (8%)
Query: 3 LRIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNR 62
L I K+R IK KE F +NGGLLL+Q L+S +G+ ID+ KLF+SKEL+KAT+ +N NR
Sbjct: 304 LYIXLKRRKKIKYKEKCFNRNGGLLLEQQLSSSEGN-IDKTKLFTSKELEKATDRYNENR 362
Query: 63 ILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCL 99
++GQG QGT YKGM DGRI+AVKK K N VKLLGCCL
Sbjct: 363 VIGQGXQGTXYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCL 422
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
ETEVPLLVYEFI NGTL +H+H QN+EFP+TWEMRLRIATEV GAL+YLHS AS PIY
Sbjct: 423 ETEVPLLVYEFIPNGTLSEHIHG--QNEEFPITWEMRLRIATEVXGALSYLHSXASIPIY 480
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRDIKSTNILLB++YRAKVADFG SKF+A+DQTH+TT++QGTFGYLDPEY QSSQ T+KS
Sbjct: 481 HRDIKSTNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKS 540
Query: 220 DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKN 279
DVYSFG+VL+ELLTGKKPI S S+E SLA+YF+ SM ++RL D+LD QV+K +K
Sbjct: 541 DVYSFGIVLIELLTGKKPILSIA--SEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKE 598
Query: 280 QIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRA 321
+I A A LA RC++LNGKKRPTM EV+MEL IR RA
Sbjct: 599 EINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFRA 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1100), Expect = e-117, Method: Compositional matrix adjust.
Identities = 215/333 (64%), Positives = 264/333 (79%), Gaps = 28/333 (8%)
Query: 6 IRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILG 65
I K+R KLK+ FFK+NGGLLL+Q L+S + S +++ K+F+SKEL+KAT++++ +RILG
Sbjct: 344 IIKRRRATKLKQKFFKRNGGLLLEQQLSSTE-SHVEQTKVFTSKELEKATDNYHTSRILG 402
Query: 66 QGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCLETE 102
QGGQGTVYKGM DGR++A+KKSK N VKL GCCLETE
Sbjct: 403 QGGQGTVYKGMLTDGRVVAIKKSKLVDEDKLDQFINEVVILSQINHRNVVKLTGCCLETE 462
Query: 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162
VPLLVYEFI NGTL+Q++ + N+EFP+TWEMRLRIATEVAGALAYLHSAAS PIYHRD
Sbjct: 463 VPLLVYEFIPNGTLFQYIQN--PNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRD 520
Query: 163 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 222
IKS+NILLDE+YRAKVADFGTSK IA++QTHVTT +QGTFGYLDPEY QSSQ T+KSDVY
Sbjct: 521 IKSSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVY 580
Query: 223 SFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM 282
SFGVVLVELLTG+KPI S S E SLA YF+ +M +NRL++ILD +V+K G + +I+
Sbjct: 581 SFGVVLVELLTGQKPISSL--RSVEERSLATYFLMTMEENRLFEILDARVLKEGGREEII 638
Query: 283 AFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
A A +AE+CL+LNGKKRP M+ V++EL GIR S
Sbjct: 639 AMAKMAEKCLNLNGKKRPKMKTVAIELEGIRSS 671
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1099), Expect = e-117, Method: Compositional matrix adjust.
Identities = 213/334 (63%), Positives = 265/334 (79%), Gaps = 28/334 (8%)
Query: 6 IRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILG 65
+ +K++DI++K+ FFK+NGGLLLQQ ++S D ++ K+F+S EL+KAT++FN NRILG
Sbjct: 336 VVRKQLDIRVKKRFFKRNGGLLLQQQISS-DKIAFEKTKIFTSDELEKATDNFNKNRILG 394
Query: 66 QGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCLETE 102
QGGQGTVYKGM DGRI+AVKKSK N V +LGCCLETE
Sbjct: 395 QGGQGTVYKGMLNDGRIVAVKKSKIVDENQLEHFINEIVILSQINHRNVVGILGCCLETE 454
Query: 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162
VPLLVYEFISNGTL+Q +HD QN EFPL+WEMRLRIA EV+GAL+YLHSA S PIYHRD
Sbjct: 455 VPLLVYEFISNGTLFQLIHD--QNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRD 512
Query: 163 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 222
IKSTNILLD++Y+AKV+DFGTS+ I++DQTH+TT +QGTFGYLDPEY QSSQ T+KSDVY
Sbjct: 513 IKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVY 572
Query: 223 SFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM 282
SFGVVLVELLTG+KPI S S E SLA +F+ S++++RL+DILD +V+K G+K IM
Sbjct: 573 SFGVVLVELLTGQKPISST--RSPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIM 630
Query: 283 AFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
FA LA RCL+LNG+KRPTM+EV+ E++ IR S+
Sbjct: 631 TFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVSA 664
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075946|ref|XP_002304841.1| predicted protein [Populus trichocarpa] gi|222842273|gb|EEE79820.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1094), Expect = e-117, Method: Compositional matrix adjust.
Identities = 215/330 (65%), Positives = 259/330 (78%), Gaps = 26/330 (7%)
Query: 6 IRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILG 65
+ KKR +I+LK FFK+NGGLLLQQ L+S GSV + K+F+SKEL+ AT+ FN NRILG
Sbjct: 343 LAKKRKNIELKRKFFKRNGGLLLQQQLSSNHGSV-QKTKIFTSKELETATDRFNENRILG 401
Query: 66 QGGQGTVYKGMREDGRIIAVKKS-----------------------KNAVKLLGCCLETE 102
QGGQGTVYKGM EDGRI+AVK+S +N VKL GCCLETE
Sbjct: 402 QGGQGTVYKGMLEDGRIVAVKRSTIVGEEKLEEFINEVVILSQINHRNVVKLFGCCLETE 461
Query: 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162
VPLLVYEFISNG L+Q+LH+ QN++F L+WEMRL+IA EVAGAL+YLHSAAS PIYHRD
Sbjct: 462 VPLLVYEFISNGNLFQYLHNFYQNEDFILSWEMRLQIAIEVAGALSYLHSAASIPIYHRD 521
Query: 163 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 222
IKS NILLD++YRAKV+DFG+S+ +A+DQTH+TT +QGTFGYLDPEY QSSQ TDKSDVY
Sbjct: 522 IKSANILLDDKYRAKVSDFGSSRSMAIDQTHLTTNVQGTFGYLDPEYFQSSQFTDKSDVY 581
Query: 223 SFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM 282
SFGVVLVELL+GKKPI S+ TSQE SLA +F+ M +NRL+DILD QV + + +IM
Sbjct: 582 SFGVVLVELLSGKKPIISS--TSQETRSLATHFIVLMEENRLFDILDVQVKEDCLEEEIM 639
Query: 283 AFANLAERCLDLNGKKRPTMEEVSMELNGI 312
A ANLA+RCL+++ K RPTM+EVS EL I
Sbjct: 640 AVANLAKRCLNVSRKHRPTMKEVSAELERI 669
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 213/334 (63%), Positives = 265/334 (79%), Gaps = 28/334 (8%)
Query: 6 IRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILG 65
+ +K++DI++K+ FFK+NGGLLLQQ ++S D ++ K+F+S EL+KAT++FN NRILG
Sbjct: 216 VVRKQLDIRVKKRFFKRNGGLLLQQQISS-DKIAFEKTKIFTSDELEKATDNFNKNRILG 274
Query: 66 QGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCLETE 102
QGGQGTVYKGM DGRI+AVKKSK N V +LGCCLETE
Sbjct: 275 QGGQGTVYKGMLNDGRIVAVKKSKIVDENQLEHFINEIVILSQINHRNVVGILGCCLETE 334
Query: 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162
VPLLVYEFISNGTL+Q +HD QN EFPL+WEMRLRIA EV+GAL+YLHSA S PIYHRD
Sbjct: 335 VPLLVYEFISNGTLFQLIHD--QNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRD 392
Query: 163 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 222
IKSTNILLD++Y+AKV+DFGTS+ I++DQTH+TT +QGTFGYLDPEY QSSQ T+KSDVY
Sbjct: 393 IKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVY 452
Query: 223 SFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM 282
SFGVVLVELLTG+KPI S S E SLA +F+ S++++RL+DILD +V+K G+K IM
Sbjct: 453 SFGVVLVELLTGQKPISST--RSPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIM 510
Query: 283 AFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
FA LA RCL+LNG+KRPTM+EV+ E++ IR S+
Sbjct: 511 TFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVSA 544
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075820|ref|XP_002335844.1| predicted protein [Populus trichocarpa] gi|222835559|gb|EEE73994.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1081), Expect = e-115, Method: Compositional matrix adjust.
Identities = 215/333 (64%), Positives = 259/333 (77%), Gaps = 30/333 (9%)
Query: 4 RIIRKKRMDIKLKEGFFKQNGGLLLQQMLNSYDGSV-IDRCKLFSSKELDKATNHFNVNR 62
++ ++KR + KLK+ +FK+NGGLLLQ+ L+S G V +++ K+F SKELDKAT+H+NVNR
Sbjct: 300 KVFKRKRSE-KLKKKYFKRNGGLLLQEQLSS--GEVNVEKIKMFPSKELDKATDHYNVNR 356
Query: 63 ILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCL 99
LGQGGQGTVYKGM DG+I+AVKKSK N VKLLGCCL
Sbjct: 357 TLGQGGQGTVYKGMLADGKIVAVKKSKVIDEGNLRQFINEVVLLSQINHRNVVKLLGCCL 416
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
ETEVPLLVYEFI NGTL+Q LHD N+EFPLTWEMRLRIA EVAGAL YLHSAAS PI+
Sbjct: 417 ETEVPLLVYEFIPNGTLFQFLHD--PNEEFPLTWEMRLRIAAEVAGALFYLHSAASLPIF 474
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRDIKSTNILLDE+YRAKVADFGTS+ +++DQTHVTT +QGTFGYLDPEY QSSQ TDKS
Sbjct: 475 HRDIKSTNILLDEKYRAKVADFGTSRSVSIDQTHVTTLVQGTFGYLDPEYFQSSQFTDKS 534
Query: 220 DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKN 279
DVYSFGVVLVELLTG+K I S + ++ SLA YF+ +M N L+DILD QV+K G++
Sbjct: 535 DVYSFGVVLVELLTGQKAI-SFTRSEEQGRSLATYFIMAMESNCLFDILDPQVVKQGERE 593
Query: 280 QIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
+++ A+LA CL LNGK+RPTM+EV+M L I
Sbjct: 594 EVLMVASLARSCLRLNGKERPTMKEVTMVLERI 626
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | ||||||
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.694 | 0.307 | 0.623 | 1.6e-94 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.673 | 0.296 | 0.616 | 1.8e-93 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.691 | 0.289 | 0.603 | 1e-92 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.673 | 0.305 | 0.607 | 7e-92 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.697 | 0.300 | 0.597 | 1.1e-91 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.697 | 0.293 | 0.602 | 4.9e-91 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.691 | 0.291 | 0.597 | 2.7e-90 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.691 | 0.288 | 0.601 | 3e-89 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.688 | 0.298 | 0.584 | 2.1e-88 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.679 | 0.312 | 0.578 | 3.1e-87 |
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 756 (271.2 bits), Expect = 1.6e-94, Sum P(2) = 1.6e-94
Identities = 146/234 (62%), Positives = 188/234 (80%)
Query: 82 IIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
++A +N VKLLGCCLETEVP+LVYEF+ NG L + LHD ++ ++ +TWE+RL IA
Sbjct: 463 VLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHD--ESDDYTMTWEVRLHIAI 520
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
E+AGAL+YLHSAAS PIYHRDIK+TNILLDER RAKV+DFGTS+ + +DQTH+TT++ GT
Sbjct: 521 EIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGT 580
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
FGY+DPEY QSS+ T+KSDVYSFGVVLVELLTG+KP S+ S+EN LAA+FV ++++
Sbjct: 581 FGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKP--SSRVRSEENRGLAAHFVEAVKE 638
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
NR+ DI+DD++ +Q+M+ ANLA RCL+ GKKRP M EVS+EL IR S
Sbjct: 639 NRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 732 (262.7 bits), Expect = 1.8e-93, Sum P(2) = 1.8e-93
Identities = 140/227 (61%), Positives = 180/227 (79%)
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
+N VKL+GCCLETEVP+LVYE I NG L++ LH + ++ +TW++RLRI+ E+AGALA
Sbjct: 475 RNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHH--DSDDYTMTWDVRLRISVEIAGALA 532
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
YLHSAAS+P+YHRD+K+TNILLDE+YRAKV+DFGTS+ I +DQTH+TT + GTFGYLDPE
Sbjct: 533 YLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPE 592
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
Y Q+SQ TDKSDVYSFGVVLVEL+TG+KP FS +EN L ++F +M++NR+ DI+
Sbjct: 593 YFQTSQFTDKSDVYSFGVVLVELITGEKP-FSVMRP-EENRGLVSHFNEAMKQNRVLDIV 650
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
D ++ + Q++A A LA RCL L GKKRP M EVS+EL IR S
Sbjct: 651 DSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 1.0e-92, Sum P(2) = 1.0e-92
Identities = 140/232 (60%), Positives = 184/232 (79%)
Query: 82 IIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
I++ +N VKLLGCCLET+VP+LVYEFI NG L++HLHD ++ TW +RLRIA
Sbjct: 494 ILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEF-DENIMATWNIRLRIAI 552
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
++AGAL+YLHS+ASSPIYHRD+KSTNI+LDE+YRAKV+DFGTS+ + +D TH+TT + GT
Sbjct: 553 DIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGT 612
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
GY+DPEY QSSQ TDKSDVYSFGVVLVEL+TG+K I SQEN +LA YF+ +M++
Sbjct: 613 VGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFL--RSQENRTLATYFILAMKE 670
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
N+L+DI+D ++ +Q+ A A +A +CL+L G+KRP+M EVSMEL+ IR
Sbjct: 671 NKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 7.0e-92, Sum P(2) = 7.0e-92
Identities = 138/227 (60%), Positives = 178/227 (78%)
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
+N VKLLGCCLETEVP+LVYE+I NG L++ LHD ++ ++ +TWE+RLRIA E+AGAL
Sbjct: 483 RNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHD--ESDDYTMTWEVRLRIAIEIAGALT 540
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
Y+HSAAS PI+HRDIK+TNILLDE+YRAKV+DFGTS+ + +DQTH+TT + GTFGY+DPE
Sbjct: 541 YMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPE 600
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
Y SSQ T KSDVYSFGVVLVEL+TG+KP+ S+E LA +F+ +M++NR+ DI+
Sbjct: 601 YFLSSQYTHKSDVYSFGVVLVELITGEKPLSRV--RSEEGRGLATHFLEAMKENRVIDII 658
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
D ++ K Q+MA A LA +CL+ GK RP M+EVS EL IR S
Sbjct: 659 DIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 731 (262.4 bits), Expect = 1.1e-91, Sum P(2) = 1.1e-91
Identities = 141/236 (59%), Positives = 184/236 (77%)
Query: 82 IIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLT-WEMRLRIA 140
I++ +N VKLLGCCLET+VP+LVYEFI NG L++HLHD + ++ +T WE+RLRIA
Sbjct: 480 ILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHD--DSDDYTMTTWEVRLRIA 537
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
++AGAL+YLHSAASSPIYHRDIKSTNI+LDE++RAKV+DFGTS+ + +D TH+TT + G
Sbjct: 538 VDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSG 597
Query: 201 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
T GY+DPEY QSSQ TDKSDVYSFGVVL EL+TG+K + SQE +LA YF +M+
Sbjct: 598 TVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFL--RSQEYRTLATYFTLAMK 655
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
+NRL DI+D ++ K NQ+ A A +A +CL++ G+KRP+M +VSMEL IR S
Sbjct: 656 ENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYS 711
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 4.9e-91, Sum P(2) = 4.9e-91
Identities = 141/234 (60%), Positives = 179/234 (76%)
Query: 82 IIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
I++ ++ VKLLGCCLETEVP LVYEFI NG L+QH+H+ ++ ++ TW MRLRIA
Sbjct: 498 ILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHE--ESDDYTKTWGMRLRIAV 555
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
++AGAL+YLHSAASSPIYHRDIKSTNILLDE+YR KV+DFGTS+ + +D TH TT I GT
Sbjct: 556 DIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGT 615
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
GY+DPEY+ SSQ TDKSDVYSFGVVLVEL+TG+KP+ + N SQE LA +F +M++
Sbjct: 616 VGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSN-SQEIRGLADHFRVAMKE 674
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
NR ++I+D ++ K Q+MA ANLA RCL+ GKKRP M +V +L I S
Sbjct: 675 NRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 719 (258.2 bits), Expect = 2.7e-90, Sum P(2) = 2.7e-90
Identities = 138/231 (59%), Positives = 177/231 (76%)
Query: 82 IIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
I++ ++ VKLLGCCLETEVP+LVYEFI NG L++H+H+ + ++ + W MRLRIA
Sbjct: 491 ILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEE-EADDYTMIWGMRLRIAV 549
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
++AGAL+YLHSAASSPIYHRDIKSTNILLDE+YRAKVADFGTS+ + +DQTH TT I GT
Sbjct: 550 DIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGT 609
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
GY+DPEY++SSQ T+KSDVYSFGV+L EL+TG KP+ NT QE ++LA +F +M++
Sbjct: 610 VGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNT-QEIIALAEHFRVAMKE 668
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
RL DI+D ++ K Q+MA ANLA +CL G+ RP M EV EL I
Sbjct: 669 RRLSDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERI 719
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 721 (258.9 bits), Expect = 3.0e-89, Sum P(2) = 3.0e-89
Identities = 139/231 (60%), Positives = 178/231 (77%)
Query: 82 IIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
I++ ++ VKLLGCCLETEVP+LVYEFI NG L++H+H+ ++ ++ + W MRLRIA
Sbjct: 500 ILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEE-ESDDYTMLWGMRLRIAV 558
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
++AGAL+YLHS+ASSPIYHRDIKSTNILLDE+YRAKVADFGTS+ + +DQTH TT I GT
Sbjct: 559 DIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGT 618
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
GY+DPEY+QSSQ T+KSDVYSFGV+L EL+TG KP+ NT QE V+LA +F +M++
Sbjct: 619 VGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNT-QEIVALAEHFRVAMKE 677
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
RL DI+D ++ K Q+MA A +A +CL GKKRP M EV EL I
Sbjct: 678 KRLTDIIDARIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERI 728
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 695 (249.7 bits), Expect = 2.1e-88, Sum P(2) = 2.1e-88
Identities = 135/231 (58%), Positives = 173/231 (74%)
Query: 82 IIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
I++ ++ VKLLGCCLETEVP+LVYEFI NG L+QHLH+ ++ W +R+RIA
Sbjct: 501 ILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFD--DYTALWGVRMRIAV 558
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
+++GA +YLH+AA SPIYHRDIKSTNILLDE+YRAKV+DFGTS+ +++D TH TT I GT
Sbjct: 559 DISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGT 618
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
GY+DPEY+ SS T+KSDVYSFGVVLVEL+TG+KP+ + T QE LA YF +MR+
Sbjct: 619 VGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSET-QEITGLADYFRLAMRE 677
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
NRL++I+D ++ K Q++A ANLA RCL GK RP M EVS L I
Sbjct: 678 NRLFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 689 (247.6 bits), Expect = 3.1e-87, Sum P(2) = 3.1e-87
Identities = 133/230 (57%), Positives = 178/230 (77%)
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
+N VK+LGCCLETEVP+LVYEFI N L+ HLH+ +++FP++WE+RL IA EVA AL+
Sbjct: 444 RNVVKILGCCLETEVPILVYEFIPNRNLFDHLHN--PSEDFPMSWEVRLCIACEVADALS 501
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
YLHSA S PIYHRD+KSTNILLDE++RAKV+DFG S+ +A+D TH+TT +QGT GY+DPE
Sbjct: 502 YLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPE 561
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
Y QS+ T KSDVYSFGV+L+ELLTG+KP+ QE L AYF+ +MR +RL++IL
Sbjct: 562 YLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRR--QEVRMLGAYFLEAMRNDRLHEIL 619
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318
D ++ + + +++A A LA RCL LN + RPTM +V +EL+ ++ S RK
Sbjct: 620 DARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQ-SKRK 668
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 331 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.003 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.004 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.004 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.004 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-44
Identities = 83/275 (30%), Positives = 117/275 (42%), Gaps = 48/275 (17%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NA 91
+ + R LG G GTVYK + G+I+AVK K N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
V+L+ + + LV E+ G L+ +L + PL+ + +IA ++ L YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEYLH 115
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
S I HRD+K NILLDE K+ADFG +K + + +TT GT Y+ PE
Sbjct: 116 SNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLL 171
Query: 212 SSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270
K DV+S GV+L ELLTGK P Q L +
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ----LQLIRRILGPPLEFDEPKWS 227
Query: 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ K L ++CL+ + KRPT EE+
Sbjct: 228 SGSEEAKD--------LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 1e-41
Identities = 64/195 (32%), Positives = 90/195 (46%), Gaps = 35/195 (17%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK------------------------KSKNAVKLLGCC 98
LG+GG GTVY ++ G+ +A+K N VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
+ LV E+ G+L L + E L+ + LRI ++ L YLH S+ I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQILEGLEYLH---SNGI 113
Query: 159 YHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQLT 216
HRD+K NILLD + K+ADFG SK + + I GT Y+ PE +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 217 DKSDVYSFGVVLVEL 231
+KSD++S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 70/273 (25%), Positives = 105/273 (38%), Gaps = 50/273 (18%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVKK------------------------SKNAV 92
+ + LG+G G VY ++ G+++A+K N V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
+L + + LV E+ G L+ L R + ++ AL YLHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSE--DEARFYLRQILSALEYLHS 115
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
I HRD+K NILLDE K+ADFG ++ +D T GT Y+ PE
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272
D++S GV+L ELLTG KP F + E + K + +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTG-KPPFPGDDQLLE-------LFKKIGKPKPPFPPPEWD 222
Query: 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ +L + L + +KR T EE
Sbjct: 223 IS-------PEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-36
Identities = 70/283 (24%), Positives = 113/283 (39%), Gaps = 71/283 (25%)
Query: 61 NRILGQGGQGTVYKGM----REDGRI-IAVKKSK------------------------NA 91
+ LG+G G VYKG ++ +AVK K N
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
VKLLG C E E +V E++ G L L+ L+ L A ++A + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDL----LSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
S HRD+ + N L+ E K++DFG S+ + D + + ++ PE +
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 212 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270
+ T KSDV+SFGV+L E+ T G++P Y + ++
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP----------------Y----------PGMSNE 210
Query: 271 QVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTMEEV 305
+V++ K + +L +C + + RPT E+
Sbjct: 211 EVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 70/283 (24%)
Query: 61 NRILGQGGQGTVYKG---MREDGRII--AVKKSK------------------------NA 91
+ LG+G G VYKG + DG+ + AVK K N
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
VKLLG C E E ++V E++ G L +L N+ L+ L A ++A + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK---NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
S HRD+ + N L+ E K++DFG S+ + D + + ++ PE +
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 212 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270
+ T KSDV+SFGV+L E+ T G++P Y + +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP----------------Y----------PGMSNA 211
Query: 271 QVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTMEEV 305
+V++ KK + L +C + + RPT E+
Sbjct: 212 EVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-35
Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 55/273 (20%)
Query: 62 RILGQGGQGTVYKGM-REDGRIIAVK-------------------------KSKNAVKLL 95
+LG+G G+VY + ++ G ++AVK + N V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 96 GCCL-ETEVPLLVY-EFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHS 152
G E + L ++ E++S G+L L + + P E +R ++ LAYLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLP---EPVIRKYTRQILEGLAYLHS 119
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLDPEYHQ 211
I HRDIK NIL+D K+ADFG +K + ++ T ++GT ++ PE +
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 212 SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271
+ +D++S G ++E+ TGK P GN +AA + +I +
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALY-KIGSSGEPPEIPEHL 229
Query: 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ F +CL + KKRPT +E
Sbjct: 230 SEEA------KDF---LRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 73/291 (25%)
Query: 62 RILGQGGQGTVYKGMREDG----RIIAVKKSK------------------------NAVK 93
+ LG+G G VYKG + +AVK K N V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFP----LTWEMRLRIATEVAGALAY 149
LLG C E E LV E++ G L +L P L+ + L A ++A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDP 207
L S HRD+ + N L+ E K++DFG S+ + D + G ++ P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRWMAP 176
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266
E + T KSDV+SFGV+L E+ T G P Y
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----------------Y----------PG 210
Query: 267 ILDDQVMKLGKKNQIMAF--------ANLAERCLDLNGKKRPTMEEVSMEL 309
+ +++V++ +K + L C L+ + RPT E+ L
Sbjct: 211 LSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 76/290 (26%)
Query: 61 NRILGQGGQGTVYKG-----MREDGRIIAVKKSK------------------------NA 91
+ LG+G G VYKG +AVK K N
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
V+LLG C + E +V E++ G L L + LT + L++A ++A + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE 119
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG---YLDPE 208
S HRD+ + N L+ E K++DFG S+ I D + G ++ PE
Sbjct: 120 S---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPE 174
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267
+ + T KSDV+SFGV+L E+ T G++P +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQP--------------------------YPGM 208
Query: 268 LDDQVMKLGKKNQIMAF--------ANLAERCLDLNGKKRPTMEEVSMEL 309
+++V++L + + L +C + + RPT E+ +L
Sbjct: 209 SNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 75/269 (27%), Positives = 109/269 (40%), Gaps = 57/269 (21%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK-----------------------KSKNAVKLLGCCL 99
+G+GG G VYK + G+ +A+K K N VK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT---EVAGALAYLHSAASS 156
+ + +V EF S G+L L NQ + IA E+ L YLHS
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKST--NQTLTESQ-----IAYVCKELLKGLEYLHSNG-- 118
Query: 157 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 216
I HRDIK+ NILL K+ DFG S ++ T + GT ++ PE
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 217 DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276
K+D++S G+ +EL GK P + M+ L+ I + L
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSE---------------LPPMK--ALFKIATNGPPGLR 218
Query: 277 KKNQIMA-FANLAERCLDLNGKKRPTMEE 304
+ F + ++CL N +KRPT E+
Sbjct: 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 1e-27
Identities = 72/272 (26%), Positives = 106/272 (38%), Gaps = 53/272 (19%)
Query: 62 RILGQGGQGTVYKGMR-EDGRIIAVKK-------------SKNAVKLLGCC--------- 98
+ +G+G G VY R DG++ +K+ + N VK+L
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 99 ---LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
E +V E+ G L Q + + + + P E L ++ AL YLHS
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGK-PFPEEQILDWFVQLCLALKYLHSRK- 123
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 215
I HRDIK NI L K+ DFG SK ++ T + GT YL PE Q+
Sbjct: 124 --ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPY 180
Query: 216 TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK--NRLYDILDDQVM 273
KSD++S G VL EL T K P F + + K Y + Q
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP-FEG--ENLLEL---------ALKILKGQYPPIPSQYS 228
Query: 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
NL L + ++RP++ ++
Sbjct: 229 S--------ELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 75/277 (27%), Positives = 109/277 (39%), Gaps = 53/277 (19%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK------------NAVKLLGCCLETE 102
+ ++LGQG G VYK + G+I A+KK +K L E
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTL---RSCE 57
Query: 103 VPLLV--YE-FISNGTLY--------QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
P +V Y F G + L D L+ + + IA ++ L YLH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH 116
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI----AMDQTHVTTKIQGTFGYLDP 207
+ I HRDIK +N+L++ + K+ADFG SK + T V GT Y+ P
Sbjct: 117 TKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSP 169
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267
E Q + +D++S G+ L+E GK P G S L + I
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF--FEL------------MQAI 215
Query: 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
D L + F + CL + KKRP+ E
Sbjct: 216 CDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 101 bits (251), Expect = 3e-24
Identities = 70/284 (24%), Positives = 103/284 (36%), Gaps = 49/284 (17%)
Query: 57 HFNVNRILGQGGQGTVYKGMREDGRIIAVKK---------------------------SK 89
+ + R LG+G G VY D +++A+K
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N VKL + LV E++ G+L L + + L I ++ AL Y
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE--ALFILAQILSALEY 116
Query: 150 LHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMDQTHV-----TTKIQGTFG 203
LHS I HRDIK NILLD K+ DFG +K + + + GT G
Sbjct: 117 LHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 204 YLDPEYHQSSQL---TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
Y+ PE L + SD++S G+ L ELLTG P F S
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP-FEGEKNSSATSQTLKII----- 227
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
L + + A ++L ++ L + K R +
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 9e-24
Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 55/275 (20%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK-------------------------KSKN 90
++ + ++G+G G VYKG+ E G +A+K K N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAY 149
VK +G ++ ++ E+ NG+L Q + + FP E + + +V LAY
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK---KFGPFP---ESLVAVYVYQVLQGLAY 114
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
LH + HRDIK+ NIL + K+ADFG + + D + + GT ++ PE
Sbjct: 115 LHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEV 170
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269
+ S + SD++S G ++ELLTG P + +AA L+ I+
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAA----------LFRIVQ 213
Query: 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
D L + + +C + RPT ++
Sbjct: 214 DDHPPL-PEGISPELKDFLMQCFQKDPNLRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 75/269 (27%), Positives = 116/269 (43%), Gaps = 51/269 (18%)
Query: 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVKK-------------------------SKNA 91
F + +G+G G V+K +R+ D R+ A+K+ S
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
++ L+ +V E+ NG L++ L + PL + R ++ LA+LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAHLH 118
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
S I HRDIKS N+ LD K+ D G +K ++ D T+ I GT YL PE +
Sbjct: 119 S---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCE 174
Query: 212 SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271
+KSDV++ GVVL E TGK P F A N +L + K I+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHP-FDANN----QGAL-------ILK-----IIRGV 217
Query: 272 VMKLGKKNQIMAFANLAERCLDLNGKKRP 300
+ + A L ++CL + ++RP
Sbjct: 218 FPPVSQMYS-QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-23
Identities = 74/273 (27%), Positives = 112/273 (41%), Gaps = 55/273 (20%)
Query: 64 LGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGC 97
+G G G VY + + G ++AVK K N VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
+ E + E+ S GTL + L E + ++ LAYLHS
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDE-----HVIRVYTLQLLEGLAYLHSHG--- 119
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG---YLDPEYHQSSQ 214
I HRDIK NI LD K+ DFG + + + T + ++Q G Y+ PE +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 215 LTDK---SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271
+D++S G V++E+ TGK+P +S +N + V + K + D Q
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP-WSE----LDNEFQIMFHVGAGHKPPIPD--SLQ 232
Query: 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ GK + +RCL+ + KKRPT E
Sbjct: 233 LSPEGK--------DFLDRCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 72/282 (25%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVK---------------------KSKNAVKLL 95
F++ LG+G G+VYK + +E G+++A+K S VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 96 GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA---LAYLHS 152
G + +V E+ G++ D ++ LT E IA + L YLHS
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSV----SDIMKITNKTLTEE---EIAAILYQTLKGLEYLHS 117
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
+ HRDIK+ NILL+E +AK+ADFG S + T I GT ++ PE Q
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQE 173
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272
+K+D++S G+ +E+ GK P +H MR
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSD---------------IHPMR-----------A 207
Query: 273 MKLGKKNQIMAFANLAE----------RCLDLNGKKRPTMEE 304
+ + ++ + +CL + ++RP+ +
Sbjct: 208 IFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 7e-22
Identities = 71/303 (23%), Positives = 108/303 (35%), Gaps = 78/303 (25%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---------------------------K 87
+ F +I+G+G TV +E + A+K
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 88 SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
+KL + E V E+ NG L Q++ + + + T R A E+ AL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCT---RF-YAAEILLAL 115
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-------- 199
YLHS I HRD+K NILLD+ K+ DFGT+K + + + + K
Sbjct: 116 EYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 200 -----------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248
GT Y+ PE SD+++ G ++ ++LTGK P F N
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP-FRGSNE---- 227
Query: 249 VSLAAYFVHSMRKNRLYDILD--DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVS 306
Y Y K +L E+ L L+ + R + E
Sbjct: 228 -----YLTFQKILKLEYSFPPNFPPDAK-----------DLIEKLLVLDPQDRLGVNEGY 271
Query: 307 MEL 309
EL
Sbjct: 272 DEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 54/281 (19%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK----------------------NAVK 93
+ +G+G G V G G+ +AVK K N V+
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
LLG L+ +V E+++ G+L +L R + +T +L A +V + YL
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV---ITLAQQLGFALDVCEGMEYLEE- 120
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
HRD+ + N+L+ E AKV+DFG +K + Q ++ T PE +
Sbjct: 121 --KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREK 174
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY--DILDDQ 271
+ + KSDV+SFG++L E I+S G + L H + R+ + +
Sbjct: 175 KFSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPE 227
Query: 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
V K+ K C +L+ KRPT +++ +L I
Sbjct: 228 VYKVMKD------------CWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 56/230 (24%)
Query: 62 RILGQGGQGTVYKG------MREDGRIIAVKKSK------------------------NA 91
R LG+G G V+ G D ++AVK K N
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHL--HDR-------LQNQEFPLTWEMRLRIATE 142
VK G C E + P++V+E++ +G L + L H + LT L+IA +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---KIQ 199
+A + YL AS HRD+ + N L+ K+ DFG S+ + TT ++
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVG 181
Query: 200 GT----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNT 244
G ++ PE + T +SDV+SFGVVL E+ T GK+P + N
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-21
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK-------KSKNA-------------------VKLLG 96
LG+G G V ++ G++ A+K + VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 97 CCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
+TE L LV E+ G L+ HL ++E + E A E+ AL YLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL-----SKEGRFSEERARFYAAEIVLALEYLHSLG- 113
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 215
I +RD+K NILLD K+ DFG +K ++ + + T GT YL PE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGY 170
Query: 216 TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
D +S GV+L E+LTGK P F A + +
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPP-FYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-20
Identities = 73/271 (26%), Positives = 116/271 (42%), Gaps = 53/271 (19%)
Query: 62 RILGQG--GQGTVYKGMREDGRIIAVKK-------------------------SKNAVKL 94
R+LG+G G+ T+Y+ ED ++ K+ N +
Sbjct: 6 RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
++ L+ E+ + GTLY + + + Q F EM L ++ A++Y+H A
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQ-KGQLFE--EEMVLWYLFQIVSAVSYIHKAG 121
Query: 155 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 214
I HRDIK+ NI L + K+ DFG SK + + + T + GT Y+ PE Q +
Sbjct: 122 ---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVK 177
Query: 215 LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274
KSD+++ G VL ELLT K+ F A N V + ++ N Y +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKR-TFDATNPLNLVVKI-------VQGN--YTPVVSVYSS 227
Query: 275 LGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+L L + +KRPT +EV
Sbjct: 228 --------ELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 64/274 (23%), Positives = 107/274 (39%), Gaps = 49/274 (17%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK----------------------SKNA 91
+ +G+G G VYK R G+ +A+KK N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
V L + +V E++ G+L D + + + EV L YLH
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLT----DIITQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
S + HRDIKS NILL + K+ADFG + + +++ + + GT ++ PE +
Sbjct: 134 SQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIK 189
Query: 212 SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271
K D++S G++ +E+ G+ P Y + L+ I
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPP----------------YLREPPLR-ALFLITTKG 232
Query: 272 VMKLGKKNQIMA-FANLAERCLDLNGKKRPTMEE 304
+ L + F + +CL + +KRP+ EE
Sbjct: 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 36/209 (17%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKKSKNA----------------------VKLLGCCLET 101
+G G G V+ G + R +A+K + V+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHR 161
LV+EF+ +G L D L+ Q + E L + +V +AYL S+ + HR
Sbjct: 72 SPICLVFEFMEHGCL----SDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 162 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 221
D+ + N L+ E KV+DFG ++F+ DQ +T + + PE S+ + KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 222 YSFGVVLVELLTGKKPIFSAGNTSQENVS 250
+SFGV++ E +FS G T EN S
Sbjct: 185 WSFGVLMWE-------VFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 74/293 (25%), Positives = 118/293 (40%), Gaps = 59/293 (20%)
Query: 58 FNVNRILGQGGQGTVYKGM--REDGRI--IAVKKSK------------------------ 89
+ +ILG+G G+V +G ++DG +AVK K
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 90 -NAVKLLGCCLETE------VPLLVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRIAT 141
N +KL+G C E P+++ F+ +G L+ L + RL L + L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QG 200
++A + YL ++ HRD+ + N +L E VADFG SK I + +I +
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 201 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSM 259
++ E T KSDV++FGV + E+ T G+ P N + Y H
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD-----YLRHGN 232
Query: 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
R + D LD + +M C + K RPT ++ L I
Sbjct: 233 RLKQPEDCLD-------ELYDLMYS------CWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-20
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 63 ILGQGGQGTVYKGMREDGRIIAVK-----------------------------KSKNAVK 93
+LG+G GTVY G+ G++IAVK K N V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
LG CL+ + EF+ G++ L N+ PL + + ++ +AYLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAYLH-- 119
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT-----TKIQGTFGYLDPE 208
++ + HRDIK N++L K+ DFG ++ +A H T + GT ++ PE
Sbjct: 120 -NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 240
S KSD++S G + E+ TGK P+ S
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 72/271 (26%), Positives = 115/271 (42%), Gaps = 56/271 (20%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK------------------------KSKNAVKLLGCC 98
LG G G V K + R G+I+AVK S V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 99 L-ETEVPLLVYEFISNGTLYQHLHDRLQNQ--EFPLTWEMRLRIATEVAGALAYLHSAAS 155
++ + + E++ G+L + L +Q + E L +IA V L YLH
Sbjct: 69 YNNGDISICM-EYMDGGSLDKIL-KEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK 121
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYHQSS 213
I HRD+K +NIL++ R + K+ DFG S + ++ +T V GT Y+ PE Q +
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGN 174
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
+ KSD++S G+ L+EL TG+ P + L Y I+++
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY------------IVNEPPP 222
Query: 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+L F + CL + ++RP+ +E
Sbjct: 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-19
Identities = 70/269 (26%), Positives = 111/269 (41%), Gaps = 45/269 (16%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKKS----------KNAVKLLGCCLETEVPLLV------ 107
LG G G+V K + KK K ++ L E P +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 108 ---------YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
EF+ G+L DR+ + P+ E+ +IA V L YL++ I
Sbjct: 73 LNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYHQSSQLT 216
HRDIK +NIL++ R + K+ DFG S + ++ T V GT Y+ PE Q + T
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYT 180
Query: 217 DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276
KSDV+S G+ ++EL GK P + + L I+ + +L
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL------DLLQQIVQEPPPRLP 234
Query: 277 KKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + CL + +RPT +++
Sbjct: 235 SSDFPEDLRDFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 21/231 (9%)
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
N VKL+G C + L++E+I L + L + L+WE R +IA +A AL
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALR 794
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
+LH S + ++ I++D + + + D + Y+ PE
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPE 848
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
++ +T+KSD+Y FG++L+ELLTGK P + V A Y + D+
Sbjct: 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY----CYSDCHLDMW 904
Query: 269 DDQVMK---LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
D ++ +N+I+ NLA C + RP +V L SS
Sbjct: 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 61/209 (29%), Positives = 85/209 (40%), Gaps = 39/209 (18%)
Query: 57 HFNVNRILGQGGQGTVYKGMRED------------GRIIAVKKSKNAVKLLGCCLETEVP 104
HF + R++G+G G V + D + + +N + E P
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 105 LLV---YEF------------ISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALA 148
LV Y F + G L HL Q +F E +++ E+ AL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFS---EEQVKFWICEIVLALE 114
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
YLHS I HRDIK NILLDE+ + DF + + D +TT GT GY+ PE
Sbjct: 115 YLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
+ D +S GV E L GK+P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-19
Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 37/209 (17%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK----------------------NAVK 93
+ R LG G G V+ G +AVK K V+
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
L C E E +V E++S G+L L + L + +A ++A +AYL S
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK---LRLPQLVDMAAQIAEGMAYLESR 122
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFGYLDPEY 209
HRD+ + NIL+ E K+ADFG ++ I D+ K I+ T PE
Sbjct: 123 N---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 210 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
+ T KSDV+SFG++L E++T G+ P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-19
Identities = 68/279 (24%), Positives = 107/279 (38%), Gaps = 61/279 (21%)
Query: 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSK-------------NAVKLL-------- 95
F V + LG+G G+VYK R D + A+K+ N +++L
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 96 ---------GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
G L +V E+ G L + + R + + + + RI ++
Sbjct: 62 ISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKR-KKKRKLIPEQEIWRIFIQLLRG 115
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L LH I HRD+KS NILL K+ D G SK + + T+I GT Y+
Sbjct: 116 LQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPHYMA 169
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266
PE + + KSD++S G +L E+ T P F A + Y V + +
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPP-FEARSMQDLR-----YKVQRGKYPPIPP 223
Query: 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
I + N L + K RP +++
Sbjct: 224 IYSQDL------------QNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 30/197 (15%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKKSK----------------------NAVKLLGCCLET 101
LG G G V+ G +A+K + N V+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHR 161
+V E+++NG L +L + ++ L E L + ++V A+ YL S HR
Sbjct: 72 RPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 162 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 221
D+ + N L+ E KV+DFG ++++ DQ + + + PE S+ + KSDV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 222 YSFGVVLVELLT-GKKP 237
+SFGV++ E+ + GK P
Sbjct: 185 WSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-18
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 29/199 (14%)
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKKSK----------------------NAVKLLGCCL 99
R LG G G V++G+ + +AVK K ++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
E +V E + G+L ++L L + +A +VA +AYL +
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAYLEAQN---YI 125
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRD+ + N+L+ E KVADFG ++ I D + + PE ++ + KS
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 220 DVYSFGVVLVELLT-GKKP 237
DV+SFG++L E++T G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-18
Identities = 51/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 77 REDGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQ---------HLHDRLQNQ 127
+ + ++ V + ++ V+ G C E L+V+E++ +G L + + ++
Sbjct: 55 QREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114
Query: 128 EF-PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186
LT L IA+++A + YL AS HRD+ + N L+ + K+ DFG S+
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171
Query: 187 I-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNT 244
I + D V + ++ PE + T +SD++SFGVVL E+ T GK+P + NT
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-18
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 47/213 (22%)
Query: 60 VNRILGQGGQGTVYKG-MREDGR---IIAVKKSK------------------------NA 91
+ +++G G G V +G ++ G+ +A+K K N
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
++L G ++ +++ E++ NG+L + L R + +F T + + +A + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKF--TVGQLVGMLRGIASGMKYL- 122
Query: 152 SAASSPIY-HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-----IQGTFGYL 205
S Y HRD+ + NIL++ KV+DFG S+ + + TTK I+ T
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT---- 175
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + T SDV+SFG+V+ E+++ G++P
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 90 NAVKLLGCCLETE------VPLLVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRIATE 142
N ++L+G CL+T P+++ F+ +G L+ L + RL + L +M ++ T+
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGT 201
+A + YL +S HRD+ + N +L+E VADFG SK I + +I +
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMR 260
++ E T KSDV+SFGV + E+ T G+ P EN + Y R
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLRQGNR 232
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
+ D LD +L C LN K RP+ E + EL
Sbjct: 233 LKQPPDCLD-------------GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 31/194 (15%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK----------------------KSKNAVKLLGCCLE 100
LG G G VY+G+ ++ +AVK K N V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 101 TEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
E P ++ EF++ G L +L + + + L +AT+++ A+ YL
Sbjct: 74 -EPPFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRD+ + N L+ E + KVADFG S+ + D + + PE ++ + KS
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 220 DVYSFGVVLVELLT 233
DV++FGV+L E+ T
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 50/272 (18%)
Query: 63 ILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLG 96
+G+G GTV K R DG+I+ K K N V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 97 CCL--ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH--S 152
+ + +V E+ G L Q L + + + + E RI T++ AL H S
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
+ + HRD+K NI LD K+ DFG +K + D + T + GT Y+ PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272
+KSD++S G ++ EL P F+A N + LA+ + + R+ ++
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPP-FTARN----QLQLASK-IKEGKFRRIPYRYSSEL 238
Query: 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
N+++ L+++ KRP+ EE
Sbjct: 239 ------NEVIKS------MLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 42/206 (20%)
Query: 62 RILGQGGQGTVYKGMRE-----DGRIIAVKK------------------------SKNAV 92
+ LG+G G V + G +AVK +N V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 93 KLLGCCLET--EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
K G C + L+ E++ +G+L D LQ + + L ++++ + YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSL----RDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDP 207
S HRD+ + NIL++ K++DFG +K + D+ + K G F Y P
Sbjct: 126 GSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP 181
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLT 233
E ++S+ + SDV+SFGV L EL T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-17
Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 62 RILGQGGQGTVYKG------------------------------MREDGRIIAVKKSKNA 91
++LG G GTVYKG + E ++A +
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDE-AYVMASVDHPHV 71
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLH---DRLQNQEFPLTWEMRLRIATEVAGALA 148
V+LLG CL + L+ + + G L ++ D + +Q L W ++A ++
Sbjct: 72 VRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYL-LNW------CVQIAKGMS 123
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT-FGYLDP 207
YL + HRD+ + N+L+ K+ DFG +K + +D+ + ++
Sbjct: 124 YLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
E T KSDV+S+GV + EL+T G KP
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-17
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 58/296 (19%)
Query: 62 RILGQGGQGTVYK-GMREDGRIIAVK------------------------KSKNAVKLLG 96
LG+G G+V K ++ G I A+K KS VK G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 97 CCL---ETEVPLLVYEFISNGTLYQHLHDRLQNQ-----EFPLTWEMRLRIATEVAGALA 148
L + + + + E+ G+L ++ +++ + E L +IA V L+
Sbjct: 67 AFLDESSSSIGIAM-EYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGLS 119
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFI-AMDQTHVTTKIQGTFGYLD 206
YLHS I HRDIK +NILL + + K+ DFG S + + ++ T GT Y+
Sbjct: 120 YLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMA 171
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266
PE Q + SDV+S G+ L+E+ + P G + L +Y V +M L D
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKD 230
Query: 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAM 322
+ + F + ++CL+ + +RPT ++ +E I+ +KK M
Sbjct: 231 EPGNGI------KWSEEFKDFIKQCLEKDPTRRPTPWDM-LEHPWIKAQMKKKVNM 279
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-17
Identities = 70/294 (23%), Positives = 103/294 (35%), Gaps = 79/294 (26%)
Query: 56 NHFNVNRILGQGGQGTVYKGMRED-GRIIAVKK------------------------SKN 90
+ + + ++G G VY + +A+K+ N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT---EVAGAL 147
VK + + LV ++S G+L + IAT EV L
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-----EAIIATVLKEVLKGL 115
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA--MDQTHVTTK-IQGTFGY 204
YLHS HRDIK+ NILL E K+ADFG S +A D+T K GT +
Sbjct: 116 EYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 205 LDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKP-------------IFSAGNTSQENVS 250
+ PE Q K+D++SFG+ +EL TG P + + + +
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232
Query: 251 LAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
Y K +F + CL + KRPT EE
Sbjct: 233 YKKY---------------------SK-----SFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 39/208 (18%)
Query: 62 RILGQGGQGTVYKG--MREDGRII--AVKK------------------------SKNAVK 93
R++G+G G VY G + DG+ I AVK N +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 94 LLGCCLETE-VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
LLG CL +E PL+V ++ +G L + N T + + +VA + YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP----TVKDLIGFGLQVAKGMEYL-- 114
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGTFGYLDPEY 209
AS HRD+ + N +LDE + KVADFG ++ I H T + ++ E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKP 237
Q+ + T KSDV+SFGV+L EL+T P
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 58 FNVNRILGQGGQGTVYKGMREDGRIIAVK--KSKNAVK---------------------L 94
F + R LG G G V++G+ ++ +A+K KS + +K L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
C E ++ E + G+L L + L + +A +VA +AYL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYLEE-- 122
Query: 155 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD-QTHVTTKIQGTFGYLDPEYHQSS 213
HRD+ + NIL+ E KVADFG ++ I D KI + + PE
Sbjct: 123 -QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179
Query: 214 QLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQE 247
+ KSDV+SFG++L E+ T G+ P G + E
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPY--PGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (192), Expect = 3e-16
Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 37/204 (18%)
Query: 63 ILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLLG 96
LG+G G VYK ++ G I+A+KK + N VKLL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 97 CCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASS 156
LV+E+ L L + PL+ + I ++ LAY HS
Sbjct: 66 VIHTERKLYLVFEY-----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR-- 118
Query: 157 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 216
I HRD+K NIL++ K+ADFG ++ + T ++ T Y PE S+
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176
Query: 217 DKS-DVYSFGVVLVELLTGKKPIF 239
+ D++S G + E++TG KP+F
Sbjct: 177 STAVDIWSVGCIFAEMITG-KPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 41/208 (19%)
Query: 62 RILGQGGQGTVYKGMRED-GRIIAVKK---------SKNAVKLLGC-------------- 97
++LGQG G VY D GR +AVK+ +K V L C
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 98 ----CLETEVPLLVY-EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
CL + L ++ E++ G++ L LT + + ++ + YLHS
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLDPEY 209
+ I HRDIK NIL D K+ DFG SK I T + + + GT ++ PE
Sbjct: 123 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEV 178
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKP 237
K+DV+S G +VE+LT K P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 46/213 (21%)
Query: 63 ILGQGGQGTVYKGMR-EDGRIIAVKK--------------------------------SK 89
++G G G+VY GM G ++AVK+ +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N V+ LG L+ + + E++ G++ L + E L +I L Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILK----GLNY 121
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-----IQGTFGY 204
LH+ I HRDIK NIL+D + K++DFG SK + + T +QG+ +
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
+ PE + + T K+D++S G ++VE+LTGK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 69/270 (25%), Positives = 109/270 (40%), Gaps = 60/270 (22%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK---KSKNAVKLLGCCLETEVPLLVYE---------- 109
+G G G VYK ++ G ++AVK ++ N + ++ +V L ++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 110 FISN----------GTLYQHLHDRLQNQEFPLTWEMRL-RIATEVAGALAYL---HSAAS 155
FI++ T L R+Q P E L ++ + AL YL H
Sbjct: 83 FITDSDVFICMELMSTCLDKLLKRIQ-GPIP---EDILGKMTVAIVKALHYLKEKHG--- 135
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 215
+ HRD+K +NILLD K+ DFG S + + T+ G Y+ PE
Sbjct: 136 --VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDP 191
Query: 216 TDK----SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271
K +DV+S G+ LVEL TG+ P ++ V L IL ++
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPY--KNCKTEFEV--------------LTKILQEE 235
Query: 272 VMKL-GKKNQIMAFANLAERCLDLNGKKRP 300
L + F + + CL + +KRP
Sbjct: 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 71/286 (24%), Positives = 113/286 (39%), Gaps = 70/286 (24%)
Query: 63 ILGQGGQGTVYKGMRED-GRIIAVKK---------------------------------S 88
++G+G G VY + G ++AVK+
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 89 KNAVKLLGCCLETEVPLLVY-EFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAG 145
N V+ LG TE L ++ E++ G++ L + R + Q + +V
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ-------LVRFFTEQVLE 119
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK----FIAMDQTHVTTKIQGT 201
LAYLHS I HRD+K+ N+L+D K++DFG SK DQ +QG+
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMSMQGS 173
Query: 202 FGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259
++ PE S + K D++S G V++E+ G++P S E A + + +
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP------WSDEEAIAAMFKLGNK 227
Query: 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
R I D M L + C +N RPT E+
Sbjct: 228 RSAP--PIPPDVSMNLSP-----VALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 70/290 (24%), Positives = 116/290 (40%), Gaps = 71/290 (24%)
Query: 61 NRILGQGGQGTVYKGM---REDGRI-IAVKKSKNA------------------------V 92
R +G+G G VY+G+ E+ +I +AVK KN V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 93 KLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
KL+G TE P+ +V E G L +L N+ L + + +++ ALAYL
Sbjct: 71 KLIGVI--TENPVWIVMELAPLGELRSYLQ---VNKY-SLDLASLILYSYQLSTALAYLE 124
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
S HRDI + N+L+ K+ DFG S+++ + + +K + ++ PE
Sbjct: 125 SKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 212 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270
+ T SDV+ FGV + E+L G KP N +D
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-------------------------ND 216
Query: 271 QVMKLGKKNQI-------MAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
+ ++ ++ +L +C + KRP E+ +L+ I
Sbjct: 217 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-16
Identities = 67/211 (31%), Positives = 93/211 (44%), Gaps = 40/211 (18%)
Query: 62 RILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKL-------------------------- 94
R+LG+G G V ++E GR+ AVK K V L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 95 LGCCLET-EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHS 152
L CC +T + V EF++ G L H+ +++ F E R R A E+ AL +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFD---EARARFYAAEITSALMFLHD 114
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
I +RD+K N+LLD K+ADFG K + T+ GT Y+ PE Q
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
D ++ GV+L E+L G P F A N
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAP-FEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 70/257 (27%), Positives = 105/257 (40%), Gaps = 43/257 (16%)
Query: 58 FNVNRILGQGGQGTVY----KGMREDGRIIAVKKSKNAVKL------------------- 94
F + R+LG G G V+ G + G++ A+K K A +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 95 --------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
L +T+ L L+ ++++ G L+ HL+ R + F + E+R+ IA E+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR---EHFTES-EVRVYIA-EIVL 116
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
AL +LH I +RDIK NILLD + DFG SK ++ GT Y+
Sbjct: 117 ALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 206 DPEY--HQSSQLTDKSDVYSFGVVLVELLTGKKPI-FSAGNTSQENVSLAAYFVHSMRKN 262
PE S D +S GV+ ELLTG P SQ +S
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK 233
Query: 263 RLYDILDDQVMKLGKKN 279
+ D + KL +K+
Sbjct: 234 TMSAEARDFIQKLLEKD 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 60 VNRILGQGGQGTVYKGM------REDGRIIAVKKSKNA---------------------- 91
+ R LG+G G V+ +D ++AVK K+A
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 92 -VKLLGCCLETEVPLLVYEFISNGTLYQHLHDR-----LQNQEFP---LTWEMRLRIATE 142
VK G C+E + ++V+E++ +G L + L L + LT L IA +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGT 201
+A + YL AS HRD+ + N L+ E K+ DFG S+ + + D V
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGN 243
++ PE + T +SDV+S GVVL E+ T GK+P + N
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 75/276 (27%), Positives = 114/276 (41%), Gaps = 63/276 (22%)
Query: 62 RILGQGGQGTVYKGM-REDGRIIAVKKSK----------------------------NAV 92
+LG G G+VY+G+ +DG AVK+ N V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 93 KLLGCCLETEVPLLVY-EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATE-VAGALAYL 150
+ LG E + L ++ E + G+L + L +++ E +R+ T + L YL
Sbjct: 66 QYLGTEREED-NLYIFLELVPGGSLAKLL------KKYGSFPEPVIRLYTRQILLGLEYL 118
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLDPEY 209
H HRDIK NIL+D K+ADFG +K + K +G+ ++ PE
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEV 172
Query: 210 -HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
Q +D++S G ++E+ TGK P +S E V AA F R L I
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPP-WSQ----LEGV--AAVF-KIGRSKELPPIP 224
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
D + K+ I+ +CL + RPT E
Sbjct: 225 DH--LSDEAKDFIL-------KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 74 KGMREDGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHL------------- 120
K + + ++ + ++ VK G C + + ++V+E++ +G L + L
Sbjct: 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 121 HDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180
R E L+ L IA+++A + YL AS HRD+ + N L+ K+ D
Sbjct: 112 QPRQAKGELGLS--QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGD 166
Query: 181 FGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPI 238
FG S+ + + D V ++ PE + T +SDV+SFGV+L E+ T GK+P
Sbjct: 167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
Query: 239 FSAGNT 244
F NT
Sbjct: 227 FQLSNT 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 46/223 (20%)
Query: 64 LGQGGQGTVYKG------------------------------MREDGRIIAVKKSKNAVK 93
LG+G G VYKG R++ +++ + N V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMR-----------LRIATE 142
LLG C + + +++E++++G L++ L + + L IA +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGT 201
+A + YL +S HRD+ + N L+ E K++DFG S+ I + D V +K
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGN 243
++ PE + T +SD++SFGVVL E+ + G +P + N
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 53/245 (21%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRI-IAVK---------------------- 86
E + + +LG+G G VY ++ IA+K
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 87 -KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDR---LQNQEFPLTWEMRLRIATE 142
K +N V+ LG E + E + G+L L + L++ E + + + +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----Q 116
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQG 200
+ L YLH + I HRDIK N+L++ Y K++DFGTSK +A T G
Sbjct: 117 ILEGLKYLHD---NQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLA-GINPCTETFTG 171
Query: 201 TFGYLDPEYHQSSQLTDK--------SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252
T Y+ PE + DK +D++S G +VE+ TGK P G +
Sbjct: 172 TLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 253 AYFVH 257
+ +H
Sbjct: 226 MFKIH 230
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 43 CKLFSSKELDKATNHFNVN---------RILGQGGQGTVYKGMREDGRIIAVKKSKNAVK 93
C+ ++ + N N ++L + ++ +I++ N +
Sbjct: 24 CEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDR------LQNQEFPLTWEMRLRIATEVAGAL 147
LLG C ++ E++ NG L Q L L L++ L +AT++A +
Sbjct: 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGM 143
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT----FG 203
YL S HRD+ + N L+ + Y K+ADFG S+ + + ++QG
Sbjct: 144 RYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---YSSDYYRVQGRAPLPIR 197
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
++ E + T KSDV++FGV L E+LT
Sbjct: 198 WMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-15
Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 12/175 (6%)
Query: 67 GGQGTVYKGMREDGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQN 126
Q V + +R++ R++A + +++LG E L E+++ G++ L
Sbjct: 41 SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAF 100
Query: 127 QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSK 185
+E + + ++ L+YLH + I HRD+K N+L+D R ++ADFG +
Sbjct: 101 KE-----AVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152
Query: 186 FIAMDQT---HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
+A T ++ GT ++ PE + Q DV+S G V++E+ T K P
Sbjct: 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 70/240 (29%), Positives = 106/240 (44%), Gaps = 62/240 (25%)
Query: 33 NSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK----K 87
+S GS K S EL++ VNRI G G GTVYK + R GR+ A+K
Sbjct: 60 SSASGSAPSAAKSLS--ELER------VNRI-GSGAGGTVYKVIHRPTGRLYALKVIYGN 110
Query: 88 SKNAVKLLGCCLETEV------PLLV---------------YEFISNGTLY-QHLHDRLQ 125
++ V+ C E E+ P +V EF+ G+L H+ D
Sbjct: 111 HEDTVRR-QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF 169
Query: 126 NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185
+ +A ++ +AYLH I HRDIK +N+L++ K+ADFG S+
Sbjct: 170 LAD----------VARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSR 216
Query: 186 FIA--MDQTHVTTKIQGTFGYLDPEYHQSSQLTD------KSDVYSFGVVLVELLTGKKP 237
+A MD + + GT Y+ PE ++ L D++S GV ++E G+ P
Sbjct: 217 ILAQTMDPCNSSV---GTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 70/293 (23%)
Query: 62 RILGQGGQGTVYKGMR------EDGRIIAVKKSK------------------------NA 91
R +GQG G V++ E ++AVK K N
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQE-----------------FPLTWE 134
VKLLG C + L++E+++ G L + L R + PL+
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 135 MRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 193
+L IA +VA +AYL + HRD+ + N L+ E K+ADFG S+ I + D
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLA 252
+ ++ PE ++ T +SDV+++GVVL E+ + G +P + + E V
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---EEV--- 241
Query: 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+Y + D V+ N + NL C RP+ +
Sbjct: 242 -----------IYYVRDGNVLSC-PDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-15
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHL----HDRLQNQEFPLTWEMRLRIATEVA 144
KN V+LLG C E E ++ E+ G L Q L + + PL+ + ++ + T++A
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
+ +L +++ HRD+ + N L+ + KV+ SK + + + +
Sbjct: 128 LGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYF---VHSMR 260
L PE Q + KSDV+SFGV++ E+ T G+ P + + N A V
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGC 244
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309
+RLY ++ RC +N K RP+ E+ L
Sbjct: 245 PSRLYKLM--------------------TRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 46/149 (30%), Positives = 62/149 (41%), Gaps = 17/149 (11%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165
LV E++ G L L L ++ E+ AL YLHS I HRD+K
Sbjct: 70 LVMEYLPGGDLASLLE-----NVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKP 121
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQTHV-------TTKIQGTFGYLDPEYHQSSQLTDK 218
NIL+D K+ DFG SK + + +I GT Y+ PE +
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT 181
Query: 219 SDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
D +S G +L E L G P G T +E
Sbjct: 182 VDWWSLGCILYEFLVGIPPFH--GETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 8e-15
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 41/209 (19%)
Query: 62 RILGQGGQGTVYKGM-------REDGRIIAVK------------------------KSKN 90
R LGQG G VY+G+ + R+ A+K +
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRV-AIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEF-----PLTWEMRLRIATEVAG 145
V+LLG + L+V E ++ G L +L R E P T + +++A E+A
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGY 204
+AYL A+ HRD+ + N ++ E K+ DFG ++ I D K +
Sbjct: 131 GMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
+ PE + T KSDV+SFGVVL E+ T
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-15
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKKSK------------------------NAVKLLGC 97
+G+G G VYKG+ + +AVK + N VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
C++ + +V E + G+L L + ++ LT + L+++ + A + YL S
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL----RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC-- 114
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSSQLT 216
HRD+ + N L+ E K++DFG S+ V+ + Q + PE + T
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 217 DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS 250
+SDV+S+G++L E FS G+T +S
Sbjct: 174 SESDVWSYGILLWE-------TFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 8/153 (5%)
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
V+L G C + + +V EF+ NG L +L R Q + L+ +M L + +V + YL
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGK---LSKDMLLSMCQDVCEGMEYLE 117
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
+ HRD+ + N L+ KV+DFG ++++ D+ ++ + + PE
Sbjct: 118 R---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN 174
Query: 212 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGN 243
S+ + KSDV+SFGV++ E+ T GK P N
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 38/205 (18%)
Query: 57 HFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------KSKNAVKLL 95
+ I+G+G G V +G G+ +AVK KN V+LL
Sbjct: 7 KLTLGEIIGEGEFGAVLQG-EYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLL 65
Query: 96 GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
G L + +V E +S G L L R ++ L+ + +VA + YL S
Sbjct: 66 GVILHNGL-YIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES--- 118
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTTKIQGTFGYLDPEYHQSS 213
+ HRD+ + NIL+ E AKV+DFG ++ + +D + + K + PE +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHK 172
Query: 214 QLTDKSDVYSFGVVLVELLT-GKKP 237
+ + KSDV+S+GV+L E+ + G+ P
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 28/190 (14%)
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFI-AMDQTHVT 195
+I+ V L YL I HRD+K +NIL++ R K+ DFG S + I +M + V
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 159
Query: 196 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI---------------FS 240
GT Y+ PE Q + T +SD++S G+ LVE+ G+ PI S
Sbjct: 160 ----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVS 215
Query: 241 AGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM----KLGKKNQIMAFANLAERCLDLNG 296
G + + ++ + S R ++++LD V KL F + ++CL N
Sbjct: 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNP 275
Query: 297 KKRPTMEEVS 306
K+R ++E++
Sbjct: 276 KERADLKELT 285
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 78 EDGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHD---RLQNQEFPLTWE 134
E+ +++ + V+L G C + +V E++SNG L +L + R Q +
Sbjct: 48 EEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL----- 102
Query: 135 MRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194
L + +V +AYL S HRD+ + N L+D++ KV+DFG S+++ D+
Sbjct: 103 --LEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157
Query: 195 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
+ + + PE S+ + KSDV++FGV++ E+ + GK P
Sbjct: 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 54/212 (25%)
Query: 64 LGQGGQGTVYKG--MREDGRII--AVK------------------------KSKNAVKLL 95
LG G G+V KG + + G+ + AVK V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 96 GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFP----LTWEMRLRIATEVAGALAYLH 151
G C E +LV E G L ++L + +E P A +VA +AYL
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYL---KKRREIPVSDLKEL------AHQVAMGMAYLE 112
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPE- 208
S HRD+ + N+LL R++AK++DFG S+ + + G + + PE
Sbjct: 113 S---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 209 --YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
Y + S KSDV+S+GV L E + G KP
Sbjct: 170 INYGKFSS---KSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 51/158 (32%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 81 RIIAVKKSKNAVKLLGCCLETEVPLL-VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
R++A+ + L C +T+ L V EF++ G L H+ D+ + + T+
Sbjct: 47 RVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----Y 101
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
A E+ L +LHS I +RD+K N++LD K+ADFG K +T
Sbjct: 102 AAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FC 157
Query: 200 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
GT Y+ PE Q + T D +SFGV+L E+L G+ P
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 40/275 (14%)
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLH 121
++L + + + + + ++ + +KL G C + LL+ E+ G+L L
Sbjct: 36 KMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLR 95
Query: 122 DRLQ-------------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162
+ + E LT + A +++ + YL A + HRD
Sbjct: 96 ESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRD 152
Query: 163 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDV 221
+ + N+L+ E + K++DFG S+ + + ++V +K + ++ E T +SDV
Sbjct: 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDV 212
Query: 222 YSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQI 281
+SFGV+L E++T L + RL+++L +N
Sbjct: 213 WSFGVLLWEIVT-----------------LGGNPYPGIAPERLFNLLKTGYRMERPENCS 255
Query: 282 MAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
NL C KRPT ++S EL + S
Sbjct: 256 EEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 87 KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
K N+++ GC L LV E+ D L+ + PL + IA GA
Sbjct: 83 KHPNSIEYKGCYLREHTAWLVMEYCLGSA-----SDLLEVHKKPL---QEVEIAAITHGA 134
Query: 147 L---AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
L AYLHS + HRDIK+ NILL E + K+ADFG++ + + V GT
Sbjct: 135 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPY 186
Query: 204 YLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
++ PE Q K DV+S G+ +EL K P+F+ S
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------- 232
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
LY I ++ L F N + CL + RPT EE+
Sbjct: 233 ---LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 48/146 (32%), Positives = 69/146 (47%), Gaps = 14/146 (9%)
Query: 95 LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHS 152
L C +T+ L V E+++ G L H+ ++ F E R R A E+ L +LH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFD---EPRARFYAAEIVLGLQFLHE 114
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLDPEYHQ 211
I +RD+K N+LLD K+ADFG K I T T+ GT Y+ PE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILS 169
Query: 212 SSQLTDKSDVYSFGVVLVELLTGKKP 237
D ++ GV+L E+L G+ P
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N ++L G L T ++V E G+L L F ++ A ++A + Y
Sbjct: 57 NLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKD-ALGHFLIS--TLCDYAVQIANGMRY 112
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT--FGYLDP 207
L S HRD+ + NILL + K+ DFG + + ++ H + F + P
Sbjct: 113 LES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
E ++ + SDV+ FGV L E+ T G++P
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 77/293 (26%), Positives = 113/293 (38%), Gaps = 64/293 (21%)
Query: 51 LDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK----------------------- 86
L T F + ++G+G G VYK ++ G+++A+K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 87 KSKNAVKLLGCCLETEVPL------LVYEFISNGT---LYQHLHDRLQNQEFPLTWEMRL 137
N G ++ P LV E G+ L + L + + L E
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK----RLKEEWIA 116
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197
I E LAYLH + + HRDIK NILL + K+ DFG S + T
Sbjct: 117 YILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 198 IQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252
I GT ++ PE + D +SDV+S G+ +EL GK P+
Sbjct: 174 I-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD------------ 220
Query: 253 AYFVHSMRKNRLYDILDDQVMKL-GKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+H MR L+ I + L +N F + CL N ++RP MEE
Sbjct: 221 ---MHPMRA--LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 11/141 (7%)
Query: 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASSPIY 159
TE V +F++ G L+ HL + + FP E R R A E+A AL YLHS I
Sbjct: 68 TEKLYFVLDFVNGGELFFHLQ---RERSFP---EPRARFYAAEIASALGYLHSIN---IV 118
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
+RD+K NILLD + + DFG K + Q+ TT GT YL PE + +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 220 DVYSFGVVLVELLTGKKPIFS 240
D + G VL E+L G P +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYC 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 36/204 (17%)
Query: 64 LGQGGQGTVYK-GMREDGRIIAVKK-------------------------SKNAVKLLGC 97
+G+G G V+K RE G +A+KK VKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
+LV E++ + L + L+++E PL + +AY+H+
Sbjct: 68 FPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--- 119
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD 217
I HRD+K N+L+ K+ADFG ++ + ++ + + T Y PE ++ D
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 218 KS-DVYSFGVVLVELLTGKKPIFS 240
D+++ G + ELL G P+F
Sbjct: 180 PGVDLWAVGCIFAELLNG-SPLFP 202
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 4e-14
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 39/214 (18%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NA 91
+ V + LG G G+VY +E G ++A+KK K N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLR-IATEVAGALAYL 150
VKL E + V+E++ G LYQ + DR + + F E +R I ++ LA++
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDR-KGKPFS---ESVIRSIIYQILQGLAHI 115
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-Y 209
H +HRD+K N+L+ K+ADFG ++ I + T + T Y PE
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEIL 170
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
+S+ + D+++ G ++ EL T +P+F +
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTL-RPLFPGSS 203
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-14
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 85 VKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDR-----------LQNQEFPLTW 133
+ K KN + LLG C + +V E+ ++G L L R + E LT
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQT 192
+ + A +VA + +L AS HRD+ + N+L+ E + K+ADFG ++ I +D
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
TT + ++ PE T +SDV+SFGV+L E+ T
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-14
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 59/298 (19%)
Query: 57 HFNVNRILGQGGQGTV----YKGMRED-GRIIAVKK-----------------------S 88
H + LG+G G+V Y ++++ G ++AVKK
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64
Query: 89 KNAVKLLGCCLETEVP--LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
N VK G C LV E++ G+L D LQ L L A+++
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSL----RDYLQKHRERLDHRKLLLYASQICKG 120
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFG 203
+ YL S HRD+ + NIL++ R K+ DFG +K + D+ + + G F
Sbjct: 121 MEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263
Y PE S+ + SDV+SFGVVL EL T S ++ S A F+ M ++
Sbjct: 178 YA-PESLTESKFSVASDVWSFGVVLYELFT----------YSDKSCSPPAEFMRMMGNDK 226
Query: 264 LYDILDDQVMKLGKKNQ--------IMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
++ +++L K N + + C + + +RP+ E+++++ IR
Sbjct: 227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 70/294 (23%), Positives = 110/294 (37%), Gaps = 67/294 (22%)
Query: 62 RILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLL 95
+G+G G VYK + G ++A+KK N V+L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 96 GCCLETEVP--LLVYEFISNGTLYQHLHDR---LQNQEFPLTWEMRLRIATEVAGALAYL 150
+V+E++ HD L + E T ++ L YL
Sbjct: 65 EIVTSKGKGSIYMVFEYMD--------HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-Y 209
HS I HRDIK +NIL++ K+ADFG ++ + T T Y PE
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE------------------NVSL 251
+++ + D++S G +L EL G KPIF G+T E VS
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLG-KPIF-QGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 252 AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+F + K L + K + +L ++ L L+ KKR + ++
Sbjct: 232 LPWFENLKPKKPYKRRLREFF----KHLIDPSALDLLDKLLTLDPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-14
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 40/205 (19%)
Query: 64 LGQGGQGTVYKG---MREDGRIIAVKKSKNA-------------------------VKLL 95
LG G GTV KG M++ + +AVK KN V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 96 GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
G C E E +LV E G L + L E +T + +V+ + YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLEE--- 113
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYHQSS 213
+ HRD+ + N+LL ++ AK++DFG SK + D+ + K G + + PE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 214 QLTDKSDVYSFGVVLVELLT-GKKP 237
+ + KSDV+SFGV++ E + G+KP
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 68/297 (22%), Positives = 124/297 (41%), Gaps = 57/297 (19%)
Query: 63 ILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKL 94
++G+G G VY+G GR++A+K + N K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
G L+ ++ E+ G++ R + P+ + I EV AL Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVIIREVLVALKYIHKV- 120
Query: 155 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 214
+ HRDIK+ NIL+ K+ DFG + + + + +T + GT ++ PE +
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177
Query: 215 LTD-KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
D K+D++S G+ + E+ TG P S + A + + RL D +++
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPY------SDVDAFRAMMLIPKSKPPRLEDNGYSKLL 231
Query: 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAMFSKIIKRL 330
+ + +A CLD K+R + EE+ + I+ S+ ++ ++I R
Sbjct: 232 R-----EFVAA------CLDEEPKERLSAEELL-KSKWIKAHSKTPVSILKELISRY 276
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 70/219 (31%), Positives = 103/219 (47%), Gaps = 40/219 (18%)
Query: 62 RILGQGGQGTVY---KGMRED-GRIIAVK-------------KSKNAVKLLGCCLETEVP 104
++LGQG G V+ K D G++ A+K ++K +L E P
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL---AEVNHP 58
Query: 105 LLV---YEFISNGTLY--------QHLHDRLQNQEFPLTWE-MRLRIATEVAGALAYLHS 152
+V Y F + G LY L RL ++E T E ++ +A E+A AL +LHS
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELALALDHLHS 116
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
I +RD+K NILLDE K+ DFG SK ++D GT Y+ PE
Sbjct: 117 LG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL 251
T +D +SFGV++ E+LTG P G +E +++
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPF--QGKDRKETMTM 209
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 69/275 (25%), Positives = 111/275 (40%), Gaps = 70/275 (25%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK------------------------KSKNAVKLLGCC 98
+G+G G VYK + + +++A+K +S K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT---EVAGALAYLHSAAS 155
L+ ++ E+ G+ D L+ + T+ IA EV L YLH
Sbjct: 69 LKGSKLWIIMEYCGGGSCL----DLLKPGKLDETY-----IAFILREVLLGLEYLHEEGK 119
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 215
HRDIK+ NILL E K+ADFG S + + T + GT ++ PE + S
Sbjct: 120 ---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGY 175
Query: 216 TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR------KNRLYDILD 269
+K+D++S G+ +EL G+ P L+ H MR KN +
Sbjct: 176 DEKADIWSLGITAIELAKGEPP-------------LSDL--HPMRVLFLIPKNNPPSLEG 220
Query: 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
++ K K + CL+ + K+RP+ +E
Sbjct: 221 NKFSKPFK--------DFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 71/272 (26%), Positives = 104/272 (38%), Gaps = 57/272 (20%)
Query: 64 LGQGGQGTVYKG-MREDGRIIAVK-----------------------KSKNAVKLLGCCL 99
+G G G VYK G ++A+K + N V G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
+ +V E+ G+L D Q PL+ + E LAYLH +
Sbjct: 71 RRDKLWIVMEYCGGGSL----QDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKI 123
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ---GTFGYLDPEYHQSSQLT 216
HRDIK NILL E K+ADFG S + T K + GT ++ PE +
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 217 D---KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
K D+++ G+ +EL + P+F +H MR L +
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFD---------------LHPMRALFLISKSNFPPP 224
Query: 274 KLGKKNQ-IMAFANLAERCLDLNGKKRPTMEE 304
KL K + F + ++CL + KKRPT +
Sbjct: 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 61/209 (29%), Positives = 85/209 (40%), Gaps = 46/209 (22%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK----------------------KSKNA---VKLLGC 97
+G+G GTV K + + G I+AVK +S + VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 98 CLETEVPLLVYEF--ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
+ E IS Y+++++ P E+ +IA AL YL
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEV-LKSVIP--EEILGKIAVATVKALNYLKEELK 128
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKF----IAMDQTHVTTKIQGTFGYLDPEYHQ 211
I HRD+K +NILLD K+ DFG S IA T+ G Y+ PE
Sbjct: 129 --IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA------KTRDAGCRPYMAPERID 180
Query: 212 SSQLTD---KSDVYSFGVVLVELLTGKKP 237
S +SDV+S G+ L E+ TGK P
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 50/266 (18%)
Query: 64 LGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCL 99
+GQG GTVY + G+ +A+K K N V L L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
+ +V E+++ G+L + + E + R E AL +LHS + +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCR-----ECLQALEFLHS---NQVI 137
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRDIKS NILL K+ DFG I +Q+ +T + GT ++ PE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 220 DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKN 279
D++S G++ +E++ G+ P + EN A Y + + L +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTPELQ----------NPEK 240
Query: 280 QIMAFANLAERCLDLNGKKRPTMEEV 305
F + RCL+++ +KR + +E+
Sbjct: 241 LSAIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 67/298 (22%)
Query: 58 FNVNRILGQGGQGTVYKGM--REDGRI--IAVKKSK------------------------ 89
F + R+LG+G G+V + EDG +AVK K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 90 -NAVKLLGCCLETE------VPLLVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRIAT 141
N +KL+G L + +P+++ F+ +G L+ L R+ + F L + +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
++A + YL +S HRD+ + N +L+E VADFG SK I + QG
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR----QGC 173
Query: 202 FGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYF 255
L ++ L D SDV++FGV + E++T G+ P AG EN + Y
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY--AG---VENSEIYNYL 228
Query: 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
+ R + D L+D L +C K RP+ + + +L I
Sbjct: 229 IKGNRLKQPPDCLED-------------VYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-13
Identities = 45/135 (33%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165
LV E++ G L+ HL ++ FP A +V AL YLHS I +RD+K
Sbjct: 78 LVMEYVPGGELFSHLR---KSGRFPEPVARFY--AAQVVLALEYLHSLD---IVYRDLKP 129
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG 225
N+LLD K+ DFG +K + +T+ + GT YL PE S D ++ G
Sbjct: 130 ENLLLDSDGYIKITDFGFAKRVK-GRTYT---LCGTPEYLAPEIILSKGYGKAVDWWALG 185
Query: 226 VVLVELLTGKKPIFS 240
+++ E+L G P F
Sbjct: 186 ILIYEMLAGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 48 SKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSKNAVKLLGCCLETEVPLLV 107
K++D A ++L + +V M + I+ + V+++G C E E +LV
Sbjct: 20 KKQIDVAI------KVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLV 72
Query: 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTN 167
E S G L + L ++ +T + + +V+ + YL HRD+ + N
Sbjct: 73 MEMASGGPL----NKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARN 125
Query: 168 ILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYHQSSQLTDKSDVYSFG 225
+LL ++ AK++DFG SK + D ++ + G + + PE + + +SDV+S+G
Sbjct: 126 VLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 185
Query: 226 VVLVELLT-GKKP 237
+ + E + G+KP
Sbjct: 186 ITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 10/144 (6%)
Query: 95 LGCCLETEVPLL-VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
L C +T+ L V E+++ G L H+ + E + A E+ L +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-----YAAEIICGLQFLHKK 115
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
I +RD+K N+LLD+ K+ADFG K M+ + GT Y+ PE +
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 214 QLTDKSDVYSFGVVLVELLTGKKP 237
+ + D +SFGV+L E+L G+ P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 89 KNAVKLLGCCLET--EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
+N VK GCC E + L+ E++ G+L +L + L L A ++
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEG 119
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFG 203
+AYLHS HRD+ + N+LLD K+ DFG +K + + + G F
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263
Y E + ++ + SDV+SFGV L ELLT S +E + M R
Sbjct: 177 YA-VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ---GQMTVVR 232
Query: 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTME 303
L ++L+ + KN L + C + K RPT
Sbjct: 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 47/153 (30%), Positives = 84/153 (54%), Gaps = 12/153 (7%)
Query: 87 KSKNAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
+ N V+LLG +E + L +V E+++ G+L +L R ++ L + L+ + +V
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCE 113
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
A+ YL + + HRD+ + N+L+ E AKV+DFG +K + Q ++ T
Sbjct: 114 AMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---- 166
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + + + KSDV+SFG++L E+ + G+ P
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 81 RIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFP-------LTW 133
+I++ K+ N ++LLG C+ + ++ E++ NG L Q L R F ++
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193
L +A ++A + YL AS HRD+ + N L+ Y K+ADFG S+ + +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 194 VTTKIQG----TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
+IQG ++ E + T SDV++FGV L E+ T
Sbjct: 186 ---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N V LLG C L++ E+ G L L + +E LT E L + +VA +A+
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT----FGYL 205
L AS HRD+ + N+LL K+ DFG ++ I D +V ++G ++
Sbjct: 157 L---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPVKWM 210
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265
PE + T +SDV+S+G++L E IFS G+ + + + F Y
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWE-------IFSLGSNPYPGMPVDSKF---------Y 254
Query: 266 DILDDQVMKLGKKNQIMAFA-----NLAERCLDLNGKKRPTMEEVS 306
++ + G + A ++ + C D + KRPT +++
Sbjct: 255 KLIKE-----GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 65/224 (29%), Positives = 91/224 (40%), Gaps = 39/224 (17%)
Query: 87 KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
+ N ++ GC L LV E+ D L+ + PL + IA GA
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSA-----SDILEVHKKPL---QEVEIAAICHGA 124
Query: 147 L---AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
L AYLHS HRDIK+ NILL E K+ADFG++ ++ + V GT
Sbjct: 125 LQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPY 176
Query: 204 YLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
++ PE Q K DV+S G+ +EL K P+F+ S
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------- 222
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
LY I + L + F N + CL + RP+ EE
Sbjct: 223 ---LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-13
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 62 RILGQGGQGTVY------------------KGMREDGRIIAVKKSKNAVKLLG------- 96
R++G+G G V+ + M +D R+ A + +KLL
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERL-AAQNECQVLKLLSHPNIIEY 64
Query: 97 --CCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
LE + ++V E+ GTL +++ R N + L ++ AL ++H+
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLD--EDTILHFFVQILLALHHVHTKL 121
Query: 155 SSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
I HRD+K+ NILLD+ K+ DFG SK ++ T + GT Y+ PE +
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGK 176
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
KSD+++ G VL EL + K+ F A N
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRA-FEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 81 RIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHL-HDRLQNQEFP--------- 130
+I++ K N ++LLG C++ + ++ E++ NG L Q L L ++E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 131 ----LTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK- 185
+++ L +A ++A + YL +S HRD+ + N L+ E K+ADFG S+
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 232
A D + + ++ E + T SDV++FGV L E+L
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 99 LETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASS 156
+TE L L+ +++S G ++ HL+ R F E +R + E+ AL +LH
Sbjct: 74 FQTEAKLHLILDYVSGGEMFTHLYQR---DNFS---EDEVRFYSGEIILALEHLHKLG-- 125
Query: 157 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 216
I +RDIK NILLD + DFG SK ++ T GT Y+ PE +
Sbjct: 126 -IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184
Query: 217 DKS-DVYSFGVVLVELLTGKKPIFSAGN-TSQENVS 250
K+ D +S G+++ ELLTG P G +Q VS
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 17/138 (12%)
Query: 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKST 166
V+E++ TL + L L R+ +V ALA H+ I HRD+K
Sbjct: 57 VFEYVPGRTL----REVLAADG-ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQ 108
Query: 167 NILL---DERYRAKVADFGTSKFI----AMDQTHVT--TKIQGTFGYLDPEYHQSSQLTD 217
NI++ R AKV DFG + D +T T++ GT Y PE + +T
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 218 KSDVYSFGVVLVELLTGK 235
SD+Y++G++ +E LTG+
Sbjct: 169 NSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 50/136 (36%), Positives = 72/136 (52%), Gaps = 13/136 (9%)
Query: 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASSPIYHRDIKS 165
V ++++ G L+ HL + + FP E R R A E+A AL YLHS I +RD+K
Sbjct: 74 VLDYVNGGELFFHLQ---RERSFP---EPRARFYAAEIASALGYLHSLN---IIYRDLKP 124
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSF 224
NILLD + + DFG K ++ + T+ GT YL PE + Q D++ D +
Sbjct: 125 ENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRTVDWWCL 182
Query: 225 GVVLVELLTGKKPIFS 240
G VL E+L G P +S
Sbjct: 183 GAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 49/212 (23%)
Query: 62 RILGQGGQGTVYKG-----------------MRE------------DGRIIAVKKSKNAV 92
++LG G GTVYKG +RE + ++A S
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLH---DRLQNQEFPLTWEMRLRIATEVAGALAY 149
+LLG CL + V L V + + G L ++ DR+ +Q+ L W ++A ++Y
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNW------CVQIAKGMSY 124
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---KIQGTFGYLD 206
L + HRD+ + N+L+ K+ DFG ++ + +D+T K+ + L+
Sbjct: 125 LEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
H+ + T +SDV+S+GV + EL+T G KP
Sbjct: 182 SILHR--RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 85 VKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRL-----------QNQEFPLTW 133
+ K KN + LLG C + ++ E+ S G L ++L R Q E L++
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQT 192
+ + A +VA + YL AS HRD+ + N+L+ E K+ADFG ++ I +D
Sbjct: 140 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
TT + ++ PE T +SDV+SFGV+L E+ T G P
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-13
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQH---LHDRLQNQEFPLTWEMRLRIATEVAGA 146
N V+ LE + +V + I L +H L ++ Q W + +++ A
Sbjct: 70 NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL----A 125
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L YLH I HRD+ NI+L E + + DFG +K T + GT Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266
PE ++ +K+DV++FG +L ++ T + P +S +SLA V +Y+
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIV-----EAVYE 231
Query: 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVS 306
L + + ++ + + CL + + RP + +VS
Sbjct: 232 PLPEGMY-----SEDVTD--VITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 9e-13
Identities = 64/225 (28%), Positives = 92/225 (40%), Gaps = 39/225 (17%)
Query: 87 KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
K N ++ GC L+ LV E+ D L+ + PL + IA GA
Sbjct: 79 KHPNTIEYKGCYLKEHTAWLVMEYCLGSA-----SDLLEVHKKPL---QEVEIAAITHGA 130
Query: 147 L---AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
L AYLHS + HRDIK+ NILL E + K+ADFG++ + + V GT
Sbjct: 131 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPY 182
Query: 204 YLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
++ PE Q K DV+S G+ +EL K P+F+ S
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------- 228
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
LY I + L +F + CL ++RP E+
Sbjct: 229 ---LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 29/197 (14%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKK----------SKNAVKLLGCCLETEVPLLVY---EF 110
LG G G V K + +I +K ++ L E P +V F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 111 ISNGTL---YQHLH----DRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDI 163
S+G + +H+ D++ + + E+ +++ V LAYL I HRD+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDV 130
Query: 164 KSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 221
K +NIL++ R K+ DFG S + +M + V GT Y+ PE Q + + +SD+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDI 185
Query: 222 YSFGVVLVELLTGKKPI 238
+S G+ LVEL G+ PI
Sbjct: 186 WSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 48/204 (23%)
Query: 63 ILGQGGQGTVYKGMR-EDGRIIAVKK---------SKNAVKLLGCCLETEVPLLV----- 107
ILG G GTVYK RI+AVK K + L + + P ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 108 ----------YEFISNGTL--YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
EF+ G+L Y+ + + + RIA V L YL S
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG-----------RIAVAVVKGLTYLWSLK- 115
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYHQSS 213
I HRD+K +N+L++ R + K+ DFG S + ++ +T+V GT Y+ PE
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGE 168
Query: 214 QLTDKSDVYSFGVVLVELLTGKKP 237
Q SDV+S G+ +EL G+ P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 73/248 (29%), Positives = 104/248 (41%), Gaps = 45/248 (18%)
Query: 31 MLNSYDGSVIDRCKLFSSK-ELDKAT-----NHFNVNRILGQGGQGTV-YKGMREDGRII 83
M+ S D + C+ F D+AT + ++R+LG G GTV DG
Sbjct: 1 MMASGDAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPF 60
Query: 84 AVK---------KSKNAVKLLGCCL----------------------ETEVPL--LVYEF 110
AVK KN + CCL V + LV ++
Sbjct: 61 AVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDY 120
Query: 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL 170
+ G L Q + R + E L + +V A+ ++HS + HRDIKS NILL
Sbjct: 121 ANAGDLRQEIKSRAKTNRTFREHEAGL-LFIQVLLAVHHVHS---KHMIHRDIKSANILL 176
Query: 171 DERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLV 229
K+ DFG SK + A V GT Y+ PE + + K+D++S GV+L
Sbjct: 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLY 236
Query: 230 ELLTGKKP 237
ELLT K+P
Sbjct: 237 ELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 41 DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSKNAVKLLGCCLE 100
D KL++ K L KAT + Q + T + R + +++ + + L +
Sbjct: 26 DSGKLYAMKVLKKAT--------IVQKAKTTEHT--RTERQVLEHIRQSPFLVTLHYAFQ 75
Query: 101 TEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
T+ L L+ ++I+ G L+ HL R + +E E+++ E+ AL +LH I
Sbjct: 76 TDTKLHLILDYINGGELFTHLSQRERFKEQ----EVQIYSG-EIVLALEHLHKLG---II 127
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DK 218
+RDIK NILLD + DFG SK D+ GT Y+ P+ + DK
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDK 187
Query: 219 S-DVYSFGVVLVELLTGKKPIFSAGN-TSQENVS 250
+ D +S GV++ ELLTG P G SQ +S
Sbjct: 188 AVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 81 RIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMR---- 136
+I++ K N ++LL C+ ++ ++ E++ NG L Q L R + QE ++
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL-SRHEPQEAAEKADVVTISY 129
Query: 137 ---LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193
+ +AT++A + YL +S HRD+ + N L+ + Y K+ADFG S+ + +
Sbjct: 130 STLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 194 VTTKIQG----TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
+IQG ++ E + T SDV++FGV L E+LT
Sbjct: 187 ---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 85 VKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHL-----------HDRLQNQEFPLTW 133
+ K KN + LLG C + ++ E+ S G L ++L +D + + +T+
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQT 192
+ + +VA + YL AS HRD+ + N+L+ E K+ADFG ++ + +D
Sbjct: 137 KDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193
Query: 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
TT + ++ PE T +SDV+SFGV++ E+ T G P
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 58/217 (26%), Positives = 84/217 (38%), Gaps = 46/217 (21%)
Query: 62 RILGQGGQGTVYKG------------------MREDGR------------IIAVKKSKNA 91
R LG G G VY+G + E I++ +N
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHL-HDR-LQNQEFPLTWEMRLRIATEVAGALAY 149
V+L+G E ++ E ++ G L L +R + LT + L A +VA Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 150 LHSAASSPIYHRDIKSTNILLDER---YRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYL 205
L HRDI + N LL + AK+ADFG ++ I + ++
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAG 242
PE T K+DV+SFGV+L E IFS G
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWE-------IFSLG 218
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 55/165 (33%), Positives = 78/165 (47%), Gaps = 13/165 (7%)
Query: 81 RIIAVKKSKNAVKLLGCCLETEVPLL-VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
RI+A+ + L CC +T+ L V E+++ G L Q Q E R R
Sbjct: 47 RILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLM------FQIQRSRKFDEPRSRF 100
Query: 140 -ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 198
A EV AL +LH + +RD+K NILLD K+ADFG K + TT
Sbjct: 101 YAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTF 156
Query: 199 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
GT Y+ PE Q + D ++ GV++ E++ G+ P F A N
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP-FEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 30/197 (15%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKKSKNAVKLLGCCLE--------------------TEV 103
LG G G V+ G +AVK K LE +E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 104 PL-LVYEFISNGTLYQHLHD-RLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHR 161
P+ +V E++S G+L L D + + P +M A +VA +AY+ HR
Sbjct: 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM----AAQVAAGMAYIERMN---YIHR 126
Query: 162 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 221
D++S NIL+ + K+ADFG ++ I ++ + + PE + T KSDV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 222 YSFGVVLVELLT-GKKP 237
+SFG++L EL+T G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 41/138 (29%), Positives = 72/138 (52%), Gaps = 8/138 (5%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165
+V E+ G L Q + + + + FP + L+ ++ + ++H + HRDIKS
Sbjct: 75 IVMEYCDGGDLMQKIKLQ-RGKLFP--EDTILQWFVQMCLGVQHIHEKR---VLHRDIKS 128
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG 225
NI L + + K+ DFG+++ + + T + GT Y+ PE ++ +KSD++S G
Sbjct: 129 KNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLG 187
Query: 226 VVLVELLTGKKPIFSAGN 243
+L EL T K P F A +
Sbjct: 188 CILYELCTLKHP-FQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 37/203 (18%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLLGC 97
+G+G G VYK + G I+A+KK K N +KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
LV+EF+ LY+ + DR + L + ++ LA+ HS
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQLT 216
I HRD+K N+L++ K+ADFG ++ T + T Y PE +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177
Query: 217 DKSDVYSFGVVLVELLTGKKPIF 239
D++S G + ELL+ +P+F
Sbjct: 178 TPVDIWSVGCIFAELLSR-RPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 69/273 (25%), Positives = 110/273 (40%), Gaps = 52/273 (19%)
Query: 63 ILGQGGQGTVYKGMREDGRIIAVKKSK------------------------NAVKLLGCC 98
+LG+G G V+KG +D +AVK K N VKL+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
+ + +V E + G L R + E L + ++ A + A +AYL S
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL--RKKKDE--LKTKQLVKFALDAAAGMAYLESKNC--- 114
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSSQLTD 217
HRD+ + N L+ E K++DFG S+ D + ++ + Q + PE + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 218 KSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276
+SDV+S+G++L E + G P N Y + +K D V K
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQK------CPDDVYK-- 225
Query: 277 KKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309
+ +RC D + RP E+ EL
Sbjct: 226 ----------VMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 85 VKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLH-----------DRLQNQEFPLTW 133
+ K KN + LLG C + ++ E+ S G L ++L D + E LT+
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQT 192
+ + A +VA + YL AS HRD+ + N+L+ E K+ADFG ++ + +D
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
TT + ++ PE T +SDV+SFGV+L E+ T G P
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-12
Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 52/267 (19%)
Query: 64 LGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCL 99
+GQG GTVY M G+ +A++ K+ N V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
+ +V E+++ G+L + + ++ + E AL +LHS + +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHS---NQVI 138
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRDIKS NILL K+ DFG I +Q+ + + GT ++ PE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 220 DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKN 279
D++S G++ +E++ G+ P + EN A LY I + +L
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLN------ENPLRA-----------LYLIATNGTPELQNPE 240
Query: 280 QIMA-FANLAERCLDLNGKKRPTMEEV 305
++ A F + RCLD++ +KR + +E+
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 60/189 (31%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASSPIYHRDIK 164
V ++I+ G L+ HL Q E R R A E+A AL YLHS I +RD+K
Sbjct: 73 FVLDYINGGELFYHL------QRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLK 123
Query: 165 STNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSF 224
NILLD + + DFG K ++ T+ GT YL PE D +
Sbjct: 124 PENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182
Query: 225 GVVLVELLTGKKPIFSAG------NTSQENVSLAAYFVHSMRKNRLYDILD-DQVMKLGK 277
G VL E+L G P +S N + + L +S R + L +L D+ +LG
Sbjct: 183 GAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR-HLLEGLLQKDRTKRLGA 241
Query: 278 KNQIMAFAN 286
K+ M N
Sbjct: 242 KDDFMEIKN 250
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 39/208 (18%)
Query: 62 RILGQGGQGTVYKG------------------------MRE------DGRIIAVKKSKNA 91
R LGQG G VY+G MRE + ++ +
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQE-----FPLTWEMRLRIATEVAGA 146
V+LLG + + L++ E ++ G L +L E P + + +++A E+A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYL 205
+AYL++ + HRD+ + N ++ E + K+ DFG ++ I D K ++
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLT 233
PE + T SDV+SFGVVL E+ T
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 40/220 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGR---IIAVKKSK---------------------- 89
+H +++G G G V++G+ + GR +A+K K
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 90 --NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEF-PLTWEMRLRIATEVAGA 146
N ++L G + + +++ E++ NG L ++L D + EF LR +A
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLR---GIAAG 119
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD--QTHVTTKIQGTFGY 204
+ YL + HRD+ + NIL++ KV+DFG S+ + D T+ T+ + +
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGN 243
PE + T SDV+SFG+V+ E+++ G++P + N
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 71/248 (28%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 78 EDGRIIAVKKSKNAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMR 136
E+ I+A S V+L C + + L +V E++ G L + + N + P W
Sbjct: 92 EERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLV----NLMSNYDVPEKWAKF 146
Query: 137 LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---H 193
EV AL +HS + HRD+K N+LLD+ K+ADFGT + MD+T
Sbjct: 147 Y--TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVR 199
Query: 194 VTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV 249
T + GT Y+ PE +S + D +S GV L E+L G P ++
Sbjct: 200 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-------- 250
Query: 250 SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNG----KKRPTMEEV 305
SL + M + +D + KN I AF E L NG K+ P +
Sbjct: 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
Query: 306 SMELNGIR 313
+ IR
Sbjct: 311 QWNWDNIR 318
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 30/197 (15%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKKSK-------------NAVKLLG--------CCLETE 102
LG G G V+ G +A+K K N +K L + E
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 103 VPLLVYEFISNGTLYQHLHDRLQNQE-FPLTWEMRLRIATEVAGALAYLHSAASSPIYHR 161
++ E++ NG+L D L+ E LT + +A ++A +A++ HR
Sbjct: 74 PIYIITEYMENGSLV----DFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHR 126
Query: 162 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 221
D+++ NIL+ E K+ADFG ++ I ++ + + PE T KSDV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 222 YSFGVVLVELLT-GKKP 237
+SFG++L E++T G+ P
Sbjct: 187 WSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 85 VKKSKNAVKLLGCCLETEVPLLV-YEFISNGTLYQHLHDR-----------LQNQEFPLT 132
+ K KN + LLG C + E PL V E+ + G L + L R + E L+
Sbjct: 74 IGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 133 WEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQ 191
++ + A +VA + YL S HRD+ + N+L+ E K+ADFG ++ + +D
Sbjct: 133 FKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
T+ + ++ PE T +SDV+SFG+++ E+ T G P
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 62 RILGQGGQGTVYKGM-----------------------------REDGRIIAVKKSKNAV 92
++LG G GTVYKG+ ++ I+A + V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQN--QEFPLTWEMRLRIATEVAGALAYL 150
+LLG CL + L V + + +G L ++H+ N + L W ++A + YL
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLDPEY 209
+ HRD+ + N+L+ K+ DFG ++ + D+ + ++ E
Sbjct: 126 EERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 210 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
+ T +SDV+S+GV + EL+T G KP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 8/139 (5%)
Query: 101 TEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
+E P+ +V E++S G+L L + L + +A ++A +AY+
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMN---YV 124
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRD+++ NIL+ E KVADFG ++ I ++ + + PE + T KS
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 220 DVYSFGVVLVELLT-GKKP 237
DV+SFG++L EL T G+ P
Sbjct: 185 DVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 46/138 (33%), Positives = 63/138 (45%), Gaps = 11/138 (7%)
Query: 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNI 168
E+ G L+ L DR E + R IA V A YLH+ I +RD+K N+
Sbjct: 73 EYCLGGELWTILRDRGLFDE----YTARFYIAC-VVLAFEYLHNRG---IIYRDLKPENL 124
Query: 169 LLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVL 228
LLD K+ DFG +K + Q T GT Y+ PE + D +S G++L
Sbjct: 125 LLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 229 VELLTGKKPIFSAGNTSQ 246
ELLTG+ P F +
Sbjct: 183 YELLTGRPP-FGEDDEDP 199
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 58/206 (28%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA-------------VKLLGCCLET 101
N + V ++G+G G V K + G I+A+KK K + VK+L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 102 EVPLLVYEFISNGTLY-------QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
+ L F G LY + L + L+ L + ++ A+AY HS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS-- 118
Query: 155 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 214
I HRDIK NIL+ E K+ DFG ++ + T T Y PE
Sbjct: 119 -HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 215 LTDKS-DVYSFGVVLVELLTGKKPIF 239
K DV++ G ++ ELL G +P+F
Sbjct: 178 NYGKPVDVWAIGCIMAELLDG-EPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 31/235 (13%)
Query: 58 FNVNRILGQGGQGTVY--KGMREDGRIIAVKK-------------SKNAVKLLGCCLETE 102
+ + + +G+G G +Y K + D +K+ SK V LL
Sbjct: 2 YEIIKKIGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 103 VPLLVYEFISNGTLY--------QHLHDRLQNQEFPLTWEMR-LRIATEVAGALAYLHSA 153
+ F NG L+ L R+ Q L E + L +++ L ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD- 119
Query: 154 ASSPIYHRDIKSTNILLDERYR-AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
I HRDIKS NI L + AK+ DFG ++ + D + GT YL PE Q+
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQN 176
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267
+K+D++S G VL EL T K P F N Q + + + + N D+
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKICQGYFAPISPNFSRDL 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 48/189 (25%), Positives = 94/189 (49%), Gaps = 19/189 (10%)
Query: 77 REDGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMR 136
+++ ++A N V LLG + + +++E+++ G L++ L R + + + +
Sbjct: 55 QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114
Query: 137 ------------LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184
L IA ++A + YL +S H+D+ + NIL+ E+ K++D G S
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLS 171
Query: 185 KFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAG 242
+ I + D V K ++ PE + + SD++SFGVVL E+ + G +P + G
Sbjct: 172 REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY--G 229
Query: 243 NTSQENVSL 251
++QE + +
Sbjct: 230 FSNQEVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 48/145 (33%), Positives = 67/145 (46%), Gaps = 13/145 (8%)
Query: 95 LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHS 152
L C +TE + V E+ + G L H+H + F E R A V L YLH
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDV----FS---EPRAVFYAACVVLGLQYLHE 119
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
+ I +RD+K N+LLD K+ADFG K M T+ GT +L PE
Sbjct: 120 ---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTE 175
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKP 237
+ T D + GV++ E+L G+ P
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 44/218 (20%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK------------------------ 89
T +NRI G+G G VY+ G I+A+KK +
Sbjct: 7 TEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 90 -NAVKLL----GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144
N V+L G L++ LV E+ Q L L N P + + ++
Sbjct: 66 PNIVELKEVVVGKHLDS--IFLVMEYCE-----QDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
L YLH + I HRD+K +N+LL ++ K+ADFG ++ + +T K+ T Y
Sbjct: 119 RGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWY 174
Query: 205 LDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSA 241
PE + D+++ G +L ELL KP+
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-12
Identities = 36/103 (34%), Positives = 46/103 (44%), Gaps = 9/103 (8%)
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
EV + LH I HRDIK N+L+D+ K+ DFG S+ ++ K
Sbjct: 103 IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFV 154
Query: 200 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAG 242
GT YL PE SD +S G V+ E L G P F A
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP-FHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 58/189 (30%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASSPIYHRDIK 164
V ++++ G L+ HL Q E R R A EVA A+ YLHS I +RD+K
Sbjct: 73 FVLDYVNGGELFFHL------QRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLK 123
Query: 165 STNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSF 224
NILLD + + DFG K ++ T+ GT YL PE + D +
Sbjct: 124 PENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL 182
Query: 225 GVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSMRKNRLYDIL-----DDQVMKLGK 277
G VL E+L G P +S + SQ +N+ + + D+L DQ +LG
Sbjct: 183 GAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGA 241
Query: 278 KNQIMAFAN 286
K + N
Sbjct: 242 KADFLEIKN 250
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 48/149 (32%), Positives = 79/149 (53%), Gaps = 11/149 (7%)
Query: 89 KNAVKLLGCCLET--EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
+N VK G C E L+ EF+ +G+L ++L R +N+ + + +L+ A ++
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNK---INLKQQLKYAVQICKG 121
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGY 204
+ YL S HRD+ + N+L++ ++ K+ DFG +K I D+ + T K + +
Sbjct: 122 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
PE S+ SDV+SFGV L ELLT
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 10/151 (6%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N V++ L E ++ EF+ G L + + L E + V AL Y
Sbjct: 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDIV------SQTRLNEEQIATVCESVLQALCY 132
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
LHS + HRDIKS +ILL R K++DFG I+ D + + GT ++ PE
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEV 188
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 240
+ + D++S G++++E++ G+ P FS
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 63/221 (28%), Positives = 89/221 (40%), Gaps = 39/221 (17%)
Query: 87 KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
+ N ++ GC L LV E+ D L+ + PL + IA GA
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSA-----SDLLEVHKKPL---QEVEIAAVTHGA 124
Query: 147 L---AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
L AYLHS + HRD+K+ NILL E K+ DFG++ +A V GT
Sbjct: 125 LQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPY 176
Query: 204 YLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
++ PE Q K DV+S G+ +EL K P+F+ S
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------- 222
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT 301
LY I ++ L + F N + CL + RPT
Sbjct: 223 ---LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 46/136 (33%), Positives = 69/136 (50%), Gaps = 16/136 (11%)
Query: 106 LVYEFISNGTLYQHLHD--RLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDI 163
++ E++ G L+ +L + R N L A+E+ AL YLHS I +RD+
Sbjct: 78 MLMEYVPGGELFSYLRNSGRFSNS-------TGLFYASEIVCALEYLHSKE---IVYRDL 127
Query: 164 KSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYS 223
K NILLD+ K+ DFG +K + D+T + GT YL PE QS D ++
Sbjct: 128 KPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLAPEVIQSKGHNKAVDWWA 183
Query: 224 FGVVLVELLTGKKPIF 239
G+++ E+L G P F
Sbjct: 184 LGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 55/291 (18%)
Query: 64 LGQGGQGTVYKGMREDGR-IIAVK------------------------KSKNAVKLLGCC 98
+G+G G VYKG+ + ++A+K S + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
L+ ++ E++ G+ L + PL I E+ L YLHS
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 218
HRDIK+ N+LL E+ K+ADFG + + Q T + GT ++ PE + S K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 219 SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKK 278
+D++S G+ +EL G+ P +H MR L+ I + L +
Sbjct: 182 ADIWSLGITAIELAKGEPPNSD---------------LHPMRV--LFLIPKNSPPTLEGQ 224
Query: 279 NQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAMFSKIIKR 329
F E CL+ + + RPT +E+ R + KK + +++I R
Sbjct: 225 YS-KPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT--KKTSFLTELIDR 272
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK------------------------ 89
+F + + +G+G VYK + DGR++A+KK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 90 --NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
N +K L +E +V E G L + + Q+ + + ++ AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
++HS I HRDIK N+ + K+ D G +F + T + + GT Y+ P
Sbjct: 120 EHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
E + KSD++S G +L E+ + P +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 30/197 (15%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKKSKNAVKLLGCCLETE-----------VPL------- 105
LGQG G V+ G +A+K K + L+ VPL
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 106 ---LVYEFISNGTLYQHLHD-RLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHR 161
+V EF+ G+L L + + + P +M A ++A +AY+ HR
Sbjct: 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM----AAQIADGMAYIERMN---YIHR 126
Query: 162 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 221
D+++ NIL+ + K+ADFG ++ I ++ + + PE + T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 222 YSFGVVLVELLT-GKKP 237
+SFG++L EL+T G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 63/199 (31%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165
+V E++ G L + + N + P W R A EV AL +HS HRD+K
Sbjct: 120 MVMEYMPGGDLV----NLMSNYDIPEKWA-RFYTA-EVVLALDAIHSMG---FIHRDVKP 170
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQT---HVTTKIQGTFGYLDPEYHQS----SQLTDK 218
N+LLD+ K+ADFGT + MD T + GT Y+ PE +S +
Sbjct: 171 DNMLLDKSGHLKLADFGTC--MKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRE 227
Query: 219 SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM-RKNRLYDILDDQVMKLGK 277
D +S GV L E+L G P ++ SL + M KN L DD +
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSKIMDHKNSL-TFPDDIEISKQA 278
Query: 278 KNQIMAFANLAERCLDLNG 296
K+ I AF E L NG
Sbjct: 279 KDLICAFLTDREVRLGRNG 297
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 33/233 (14%)
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKKSK----------------------NAVKLLGCCL 99
+ LG G G V+ G + +AVK K V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQE-FPLTWEMRLRIATEVAGALAYLHSAASSPI 158
+ E ++ E+++ G+L D L++ E + + + ++A +AY+
Sbjct: 72 KEEPIYIITEYMAKGSLL----DFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNY 124
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 218
HRD+++ N+L+ E K+ADFG ++ I ++ + + PE T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 219 SDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRK--NRLYDIL 268
SDV+SFG++L E++T GK P N+ + Y + M + LYDI+
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-11
Identities = 72/283 (25%), Positives = 110/283 (38%), Gaps = 59/283 (20%)
Query: 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVK 93
F + ++G G G VYKG + G++ A+K +N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 94 LLGCCLETEVP------LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
G ++ P LV EF G++ + + N L E I E+ L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT---LKEEWIAYICREILRGL 124
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
++LH + HRDIK N+LL E K+ DFG S + T I GT ++ P
Sbjct: 125 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 180
Query: 208 EYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262
E + D KSD++S G+ +E+ G P+ +H MR
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD---------------MHPMRA- 224
Query: 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
L+ I + +L K F + E CL N +RPT E++
Sbjct: 225 -LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 43/215 (20%)
Query: 57 HFNVNRILGQGGQGTVYKGMRED-GRIIAVK------------KSKNA------------ 91
++ + ++LG+G G VY D GR +AVK K NA
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 92 ----VKLLGCCLE-TEVPLLVY-EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
V+ GC + E L ++ E++ G++ D+L+ LT + R ++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI----KDQLKAYG-ALTENVTRRYTRQILQ 117
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGTF 202
++YLHS + I HRDIK NIL D K+ DFG SK I M T + + + GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTP 173
Query: 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
++ PE K+DV+S +VE+LT K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 1e-11
Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 52/267 (19%)
Query: 64 LGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCL 99
+GQG GTVY + G+ +A+K K+ N V L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
+ +V E+++ G+L + + ++ + E AL +LHS + +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALDFLHS---NQVI 137
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRDIKS NILL K+ DFG I +Q+ +T + GT ++ PE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 220 DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKN 279
D++S G++ +E++ G+ P + EN A LY I + +L
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLN------ENPLRA-----------LYLIATNGTPELQNPE 239
Query: 280 QIMA-FANLAERCLDLNGKKRPTMEEV 305
++ A F + RCL+++ +R + +E+
Sbjct: 240 RLSAVFRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 29/197 (14%)
Query: 137 LRIAT---EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193
+IAT E+ L YLHS HRDIK+ N+LL E+ K+ADFG + + Q
Sbjct: 101 FQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157
Query: 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA 253
T + GT ++ PE Q S K+D++S G+ +EL G+ P N+
Sbjct: 158 RNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP-----NSD-------- 203
Query: 254 YFVHSMRKNRLYDILDDQVMKL-GKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
+H MR L+ I + L G+ ++ F + CL+ + RPT +E+ +
Sbjct: 204 --MHPMRV--LFLIPKNNPPTLTGEFSK--PFKEFIDACLNKDPSFRPTAKELLKHKFIV 257
Query: 313 RGSSRKKRAMFSKIIKR 329
+ + KK + +++I R
Sbjct: 258 KNA--KKTSYLTELIDR 272
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 36/184 (19%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTH---VTTKIQGT 201
AL Y+HS + HRD+K +NILL+ R K+ADFG ++ ++ +++ V T T
Sbjct: 119 ALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 202 FGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNT--------------SQ 246
Y PE S K D++S G +L E+L G KP+F +T S
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 247 ENV-SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFAN-----LAERCLDLNGKKRP 300
E++ S+ + F +M L + L ++++ A+ L ++ L N KR
Sbjct: 235 EDIESIKSPFAATM----LDSLPSRPRKPL---DELLPKASDDALDLLKKLLVFNPNKRL 287
Query: 301 TMEE 304
T EE
Sbjct: 288 TAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 73/298 (24%), Positives = 123/298 (41%), Gaps = 63/298 (21%)
Query: 57 HFNVNRILGQGGQGTVYKGMRED-GRIIAVKKSKNA-------------VKLLGC----- 97
+ + + +G G G V + + GR +A+KK N +KLL
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 98 ---CLETEVPLLVYEFISNGTLY--QHLHD----RLQNQEFPLTWEMRLRIATEVAGALA 148
L+ P +F +Y L + ++ PLT + ++ L
Sbjct: 61 IIGLLDILRPPSPEDF---NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-------HVTTKIQGT 201
YLHSA + HRD+K +NIL++ K+ DFG ++ + D+ +V T+
Sbjct: 118 YLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW--- 171
Query: 202 FGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
Y PE SS K+ D++S G + ELLT KP+F G + ++L + +
Sbjct: 172 --YRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPLF-PGRDYIDQLNLIVEVLGTPS 227
Query: 261 KNRLYDILDDQVMK----LGKK-----NQIMAFAN-----LAERCLDLNGKKRPTMEE 304
+ L I ++ L KK +++ A+ L E+ L + KKR T +E
Sbjct: 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 24/172 (13%)
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197
+IA + AL YLHS S + HRD+K +N+L++ + K+ DFG S ++ +D T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTID 163
Query: 198 IQGTFGYLDPEY---HQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA 253
G Y+ PE + + D KSDV+S G+ ++EL TG+ P S Q+
Sbjct: 164 A-GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ------ 216
Query: 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
L ++++ +L + F + +CL N K+RP E+
Sbjct: 217 ----------LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 64/273 (23%), Positives = 109/273 (39%), Gaps = 52/273 (19%)
Query: 64 LGQGGQGTVYKG-MREDGRIIAVKKSK------------------------NAVKLLGCC 98
+G+G G V+ G +R D +AVK + N V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
+ + +V E + G L + + L + +++ A + YL S
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSSQLT 216
HRD+ + N L+ E+ K++DFG S+ D + +T Q + PE + +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 217 DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276
+SDV+SFG++L E FS G N+S + + ++ V
Sbjct: 175 SESDVWSFGILLWE-------AFSLGAVPYANLS----------NQQTREAIEQGVRLPC 217
Query: 277 KKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309
+ A L ERC + + +RP+ V EL
Sbjct: 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 57/213 (26%), Positives = 82/213 (38%), Gaps = 54/213 (25%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK----------------------------NAVKL 94
LG+G VYK +E GRI+A+KK K N + L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLT------W-EMRLRIATEVAGAL 147
L LV+EF+ L + + D+ LT + M LR L
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDK----SIVLTPADIKSYMLMTLR-------GL 115
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
YLHS + I HRD+K N+L+ K+ADFG ++ +T ++ T Y P
Sbjct: 116 EYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171
Query: 208 E-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
E + D++S G + ELL P
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLR-VPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 63/218 (28%), Positives = 90/218 (41%), Gaps = 53/218 (24%)
Query: 60 VNRILGQGGQGTVYKGM-REDGRIIAVKKSK----------------------------N 90
+ I G+G GTVYK GR +A+KK + N
Sbjct: 4 LAEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 91 AVKLLGCC----LETEVPL-LVYEFISNGTLYQHLHDRLQNQEFP-LTWEMRLRIATEVA 144
V+LL C + E+ L LV+E + Q L L P L E + ++
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTTKIQGTF 202
+ +LHS I HRD+K NIL+ + K+ADFG ++ M T V T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV----TL 170
Query: 203 GYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
Y PE QSS T D++S G + EL ++P+F
Sbjct: 171 WYRAPEVLLQSSYAT-PVDMWSVGCIFAELFR-RRPLF 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 46/207 (22%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKK-----------------------SKNAVKLLGCCL 99
+G+G G V + GR +AVKK N V++ L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 100 ETEVPLLVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRIAT---EVAGALAYLHSAAS 155
+ +V EF+ G L + H R+ ++ IAT V AL++LH+
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQ----------IATVCLAVLKALSFLHAQG- 135
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 213
+ HRDIKS +ILL R K++DFG F A V + + GT ++ PE
Sbjct: 136 --VIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFS 240
+ D++S G++++E++ G+ P F+
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 9/103 (8%)
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVT 195
+++ V L YL I HRD+K +NIL++ R K+ DFG S + +M + V
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163
Query: 196 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 238
GT Y+ PE Q + + +SD++S G+ LVE+ G+ PI
Sbjct: 164 ----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 59 NVNRILGQGGQGTVYKGMRED---GRI---IAVKKSKNA--------------------- 91
+ R LGQG G VY+G D G +AVK +
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 92 ---VKLLGCCLETEVPLLVYEFISNGTLYQHLH----DRLQNQEFPL-TWEMRLRIATEV 143
V+LLG + + L+V E +++G L +L + N P T + +++A E+
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTF 202
A +AYL++ HRD+ + N ++ + K+ DFG ++ I D K
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
++ PE + T SD++SFGVVL E+ +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 49/216 (22%)
Query: 58 FNVNRILGQGGQGTVYKGM----REDGRI-IAVKKSKNAV-------------------- 92
F ++LG G GTVYKG+ E +I +A+K+ + A
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 93 ----KLLGCCLETEVPLLVYEFISNGTLYQHLH---DRLQNQEFPLTWEMRLRIATEVAG 145
+LLG CL + V L + + + G L ++ D + +Q L W ++A
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNW------CVQIAK 120
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---KIQGTF 202
+ YL + HRD+ + N+L+ K+ DFG +K + D+ K+ +
Sbjct: 121 GMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
L+ H+ T +SDV+S+GV + EL+T G KP
Sbjct: 178 MALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 87 KSKNAVKLLGCCLETEVPL----LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATE 142
S N +K+ G ++ L L+ E+ + G L + L ++E L+++ +L +A +
Sbjct: 76 DSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKEKDLSFKTKLDMAID 130
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 202
L L+ + P ++++ S + L+ E Y+ K+ G K ++ K
Sbjct: 131 CCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNVNFM 184
Query: 203 GYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
Y + S+ T K D+YS GVVL E+ TGK P EN++
Sbjct: 185 VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF--------ENLTTKE------- 229
Query: 261 KNRLYD--ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+YD I + +KL + + E C + KRP ++E+
Sbjct: 230 ---IYDLIINKNNSLKLPLDCPLE-IKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 43/215 (20%)
Query: 57 HFNVNRILGQGGQGTVYKGMRED-GRIIAVK------------KSKNA------------ 91
++ + ++LGQG G VY D GR +AVK K NA
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 92 ----VKLLGCCLET-EVPLLVY-EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
V+ GC + E L ++ E + G++ D+L++ LT + + ++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI----KDQLKSYG-ALTENVTRKYTRQILE 117
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGTF 202
++YLHS + I HRDIK NIL D K+ DFG SK I + T + + + GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTP 173
Query: 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
++ PE K+D++S G +VE+LT K P
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 21/142 (14%)
Query: 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY-----LHSAASSPIY 159
LL+ E+ S G L + + RL+ L G L Y L S +
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKE---------HLPFQEYEVGLLFYQIVLALDEVHSRKMM 191
Query: 160 HRDIKSTNILLDERYRAKVADFGTSK----FIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 215
HRD+KS NI L K+ DFG SK +++D V + GT YL PE + +
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRY 248
Query: 216 TDKSDVYSFGVVLVELLTGKKP 237
+ K+D++S GV+L ELLT +P
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 40/110 (36%), Positives = 57/110 (51%), Gaps = 7/110 (6%)
Query: 131 LTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FI 187
LT + + ++ ++YLHS + I HRDIK NIL D K+ DFG SK I
Sbjct: 103 LTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159
Query: 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
M T + + + GT ++ PE K+DV+S G +VE+LT K P
Sbjct: 160 CMSGTGIRS-VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 81 RIIAVKKSKNAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
R++A+ + L C +T L V E+++ G L H+ Q +
Sbjct: 52 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPHAVFY 106
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-I 198
A E+A L +LHS I +RD+K N++LD K+ADFG K TT+
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTF 161
Query: 199 QGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 237
GT Y+ PE + Q KS D ++FGV+L E+L G+ P
Sbjct: 162 CGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 45/134 (33%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165
+ EF+ G L+ HL + FP ++ E+ A YLHS I +RD+K
Sbjct: 95 FLLEFVVGGELFTHLR---KAGRFPN--DVAKFYHAELVLAFEYLHSKD---IIYRDLKP 146
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG 225
N+LLD + KV DFG +K + T + GT YL PE QS D ++ G
Sbjct: 147 ENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMG 202
Query: 226 VVLVELLTGKKPIF 239
V+L E + G P F
Sbjct: 203 VLLYEFIAGYPPFF 216
|
Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 73/270 (27%), Positives = 100/270 (37%), Gaps = 52/270 (19%)
Query: 64 LGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCL 99
+G G G VYK G + AVK K N V G L
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
E + E+ G+L H E + + R E LAYLHS
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGK---M 128
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE---YHQSSQLT 216
HRDIK NILL + K+ADFG + I + I GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 217 DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276
D+++ G+ +EL + P+F +H MR L + Q KL
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFD---------------LHPMRALFLMSKSNFQPPKLK 232
Query: 277 KKNQ-IMAFANLAERCLDLNGKKRPTMEEV 305
K + F N + L N KKRPT E +
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 81 RIIAVKKSKNAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
R++A+ + L C +T L V E+++ G L + + +E +
Sbjct: 52 RVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE-----PHAVFY 106
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-I 198
A E+A L +LHS I +RD+K N++LD K+ADFG K D VTTK
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTF 161
Query: 199 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
GT Y+ PE D ++FGV+L E+L G+ P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 64/215 (29%), Positives = 89/215 (41%), Gaps = 43/215 (20%)
Query: 64 LGQGGQGTVYKGMRED-GRIIAVKK-SKNAV-------------KLLGCCLETEVPL--- 105
+G+G G VY+ ++D RI A+K SK + +L L E P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 106 ------------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHS 152
LV +++S G L+ HL + F E R + E+ AL +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGRFS---EDRAKFYIAELVLALEHLHK 114
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQ 211
I +RD+K NILLD + DFG SK + T GT YL PE
Sbjct: 115 ---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 212 SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
T D +S GV++ E+ G P F A +T Q
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSP-FYAEDTQQ 204
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-10
Identities = 62/266 (23%), Positives = 113/266 (42%), Gaps = 50/266 (18%)
Query: 64 LGQGGQGTVYKGMRED-GRIIAVK-----------------------KSKNAVKLLGCCL 99
+GQG GTV+ + G+ +A+K K+ N V L L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
+ +V E+++ G+L + + ++ + E AL +LH+ + +
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEA------QIAAVCRECLQALEFLHA---NQVI 137
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRDIKS N+LL K+ DFG I +Q+ +T + GT ++ PE K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 220 DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKN 279
D++S G++ +E++ G+ P + EN A Y + + L + +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTPELQN----------PEK 240
Query: 280 QIMAFANLAERCLDLNGKKRPTMEEV 305
F + RCL+++ +KR + +E+
Sbjct: 241 LSPIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 64/223 (28%), Positives = 90/223 (40%), Gaps = 21/223 (9%)
Query: 78 EDGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRL 137
E+ I+A S V+L + +V E++ G L + + N + P W R
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV----NLMSNYDVPEKWA-RF 146
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197
A EV AL +HS HRD+K N+LLD+ K+ADFGT + +
Sbjct: 147 YTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 198 IQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA 253
GT Y+ PE +S + D +S GV L E+L G P ++ SL
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVG 254
Query: 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNG 296
+ M DD + KN I AF E L NG
Sbjct: 255 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG 297
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 14/141 (9%)
Query: 106 LVYEFISNGTLYQHLHDR---LQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162
+V ++ G LY+ ++ + L ++ L W +++ +A L ++H I HRD
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHD---RKILHRD 126
Query: 163 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 222
IKS NI L + K+ DFG ++ + T I GT YL PE ++ +KSD++
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNKSDIW 185
Query: 223 SFGVVLVELLTGKKPIFSAGN 243
+ G VL E+ T K F AGN
Sbjct: 186 ALGCVLYEMCTLKHA-FEAGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 40/204 (19%)
Query: 64 LGQGGQGTV-YKGMREDGRIIAVKK-----------------------SKNAVKLLGCCL 99
+G+G G V ++ G+++AVKK +N V++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 100 ETEVPLLVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
+ +V EF+ G L + H R+ ++ + V AL+ LH+ +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLHAQG---V 137
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSSQLT 216
HRDIKS +ILL R K++DFG F A V + + GT ++ PE
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 217 DKSDVYSFGVVLVELLTGKKPIFS 240
+ D++S G++++E++ G+ P F+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 107 VYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASSPIYHRDIK 164
V E+ + G L+ HL +R+ +++ R R E+ AL YLHS + +RD+K
Sbjct: 73 VMEYANGGELFFHLSRERVFSED-------RARFYGAEIVSALGYLHSCD---VVYRDLK 122
Query: 165 STNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSF 224
N++LD+ K+ DFG K D + T GT YL PE + + D +
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 225 GVVLVELLTGKKPIFS 240
GVV+ E++ G+ P ++
Sbjct: 182 GVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 35/199 (17%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK------------------------KSKNAVKLLGCC 98
+G+G G V+KG+ +++A+K S K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
L+ ++ E++ G+ L + PL I E+ L YLHS
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 218
HRDIK+ N+LL E K+ADFG + + Q T + GT ++ PE + S K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 181
Query: 219 SDVYSFGVVLVELLTGKKP 237
+D++S G+ +EL G+ P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 57/204 (27%), Positives = 85/204 (41%), Gaps = 37/204 (18%)
Query: 62 RILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKLLG------------------------ 96
++LG+G G V+ ++ + A+K K V L+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 97 --CCLETEVPLL-VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
C +T+ L V E+++ G L H+ +F L A E+ L +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFY--AAEIICGLQFLHSK 115
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
I +RD+K NILLD K+ADFG K + T GT Y+ PE
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQ 171
Query: 214 QLTDKSDVYSFGVVLVELLTGKKP 237
+ D +SFGV+L E+L G+ P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 70/256 (27%), Positives = 108/256 (42%), Gaps = 57/256 (22%)
Query: 62 RILGQGGQGTVYKGMREDG----RIIAVKKSKNA---------------------VKL-- 94
++LG+GG G V++ + G +I A+K K A VK
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 95 ---LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
L +T L L+ E++S G L+ HL +E + +E++ AL +L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLE-----REGIFMEDTACFYLSEISLALEHL 116
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 210
H I +RD+K NILLD + K+ DFG K ++ + VT GT Y+ PE
Sbjct: 117 HQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 211 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE-------NVSLAAYFVHSMRKNR 263
S D +S G ++ ++LTG P F+A N + ++L Y R
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPP-FTAENRKKTIDKILKGKLNLPPYLTPEAR--- 228
Query: 264 LYDILDDQVMKLGKKN 279
D + KL K+N
Sbjct: 229 ------DLLKKLLKRN 238
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 47/134 (35%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165
LV FI+ G L+ HL + F L+ R A E+ AL LH + +RD+K
Sbjct: 70 LVLAFINGGELFHHLQ---REGRFDLS-RARFYTA-ELLCALENLHKFN---VIYRDLKP 121
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG 225
NILLD + + DFG K + M T GT YL PE T D ++ G
Sbjct: 122 ENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180
Query: 226 VVLVELLTGKKPIF 239
V+L E+LTG P +
Sbjct: 181 VLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 59/244 (24%), Positives = 89/244 (36%), Gaps = 64/244 (26%)
Query: 58 FNVNRILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKLLGC---CLETE----------- 102
F V +++G+G G V+ ++ G++ A+K + + + + E
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 103 -VPL-----------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
V L LV E++ G L L + FP R IA E+ AL +
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK---DVFPEET-ARFYIA-ELVLALDSV 117
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-------------------FIAMDQ 191
H HRDIK NIL+D K+ADFG K F
Sbjct: 118 HKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 192 THVTTKIQ---------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAG 242
Q GT Y+ PE + + + D +S GV+L E+L G P F +
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP-FYSD 233
Query: 243 NTSQ 246
+
Sbjct: 234 TLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 46/208 (22%)
Query: 63 ILGQGGQGTVYKGMRED-GRIIAVK-------KSK-------NAVKLLGCCLETEVPLLV 107
I+G+GG G VY + D G++ A+K K K N +L + P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 108 ---YEF------------ISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
Y F ++ G L+ HL H E MR A E+ L ++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE------MRF-YAAEIILGLEHM 113
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 210
H+ + +RD+K NILLDE +++D G + + + H + GT GY+ PE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 211 QSSQLTDKS-DVYSFGVVLVELLTGKKP 237
Q D S D +S G +L +LL G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 37/204 (18%)
Query: 63 ILGQGGQGTVYK-GMREDGRIIAVKK-------------------------SKNAVKLLG 96
++G+G G V K +E G+I+A+KK +N V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 97 CCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASS 156
+ LV+EF+ + L D L+ L + ++ + + HS
Sbjct: 68 VFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHS---H 119
Query: 157 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 216
I HRDIK NIL+ + K+ DFG ++ +A V T T Y PE
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKY 178
Query: 217 DKS-DVYSFGVVLVELLTGKKPIF 239
++ D+++ G ++ E+LTG +P+F
Sbjct: 179 GRAVDIWAVGCLVTEMLTG-EPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 64/216 (29%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 62 RILGQGGQGTVYKGMRED------GRI-IAVK------------------------KSKN 90
LG G G VY+G D G I +AVK N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHD-RLQNQEFP-LTWEMRLRIATEVAGALA 148
VKLLG CL E ++ E + G L +L D R++ P LT + L I +VA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 149 YLHSAASSPIYHRDIKSTNILLDE-----RYRAKVADFGTSKFI-AMDQTHVTTKIQGTF 202
YL HRD+ + N L+ E K+ DFG ++ I D +
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
++ PE + T +SDV+SFGV++ E+LT G++P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 42/206 (20%)
Query: 63 ILGQGGQGTVYKGMRED-GRIIAVK---KSKNAVK-----------LLGCCLETEVPLLV 107
I+G+GG G VY + D G++ A+K K + +K +L + P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 108 ---YEF------------ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
Y F ++ G L+ HL Q+ F EMR ATE+ L ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLS---QHGVFSEK-EMRF-YATEIILGLEHMHN 115
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
+ +RD+K NILLDE +++D G + + + H + GT GY+ PE Q
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 213 SQLTDKS-DVYSFGVVLVELLTGKKP 237
D S D +S G +L +LL G P
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 43/159 (27%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N + L G ++ +++ EF+ NG L L R + +F + + + +A + Y
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVI--QLVGMLRGIAAGMKY 121
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--VTTKIQGTFG--YL 205
L + HRD+ + NIL++ KV+DFG S+F+ D + T+ + G +
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGN 243
PE + T SDV+S+G+V+ E+++ G++P + N
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 3e-10
Identities = 43/131 (32%), Positives = 60/131 (45%), Gaps = 25/131 (19%)
Query: 139 IATEVAGALAYLHSAASSP----IYHRDIKSTNILLDERYR-----------------AK 177
I ++ ALAY H+ P + HRD+K NI L R AK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 178 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY--HQSSQLTDKSDVYSFGVVLVELLTGK 235
+ DFG SK I ++ + GT Y PE H++ DKSD+++ G ++ EL +GK
Sbjct: 183 IGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 236 KPIFSAGNTSQ 246
P A N SQ
Sbjct: 241 TPFHKANNFSQ 251
|
Length = 1021 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 51/231 (22%), Positives = 87/231 (37%), Gaps = 53/231 (22%)
Query: 57 HFNVNRILGQGGQGTVY-------------KGMRED--------------GRIIAVKKSK 89
+++ R++G+GG G VY K +RED +I A
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMR------LRIATEV 143
V + C + + +I TL L Q + + L I ++
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH---------- 193
+ Y+HS + HRD+K NILL + D+G + F +++
Sbjct: 123 CATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 194 -------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
+ KI GT Y+ PE ++ +D+Y+ GV+L ++LT P
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 13/137 (9%)
Query: 106 LVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASSPIYHRDI 163
V E+++ G L+ HL +R+ +++ R R E+ AL YLHS I +RD+
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSED-------RTRFYGAEIVSALDYLHSGK---IVYRDL 121
Query: 164 KSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYS 223
K N++LD+ K+ DFG K D + T GT YL PE + + D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 224 FGVVLVELLTGKKPIFS 240
GVV+ E++ G+ P ++
Sbjct: 181 LGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 9/135 (6%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165
V E+ + G L+ HL ++E T E E+ AL YLHS + +RDIK
Sbjct: 72 FVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKL 123
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG 225
N++LD+ K+ DFG K D + T GT YL PE + + D + G
Sbjct: 124 ENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 226 VVLVELLTGKKPIFS 240
VV+ E++ G+ P ++
Sbjct: 183 VVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 81 RIIAVKKSKNAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
R++A++ + L C +T L V E+++ G L H+ + +E +
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE-----PQAVFY 106
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-I 198
A E++ L +LH I +RD+K N++LD K+ADFG K +D VTT+
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTF 161
Query: 199 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
GT Y+ PE D +++GV+L E+L G+ P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 71/283 (25%), Positives = 108/283 (38%), Gaps = 59/283 (20%)
Query: 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVK 93
F + ++G G G VYKG + G++ A+K +N
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 94 LLGCCLETEVP------LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
G ++ P LV EF G++ L + W I E+ L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
A+LH+ + HRDIK N+LL E K+ DFG S + T I GT ++ P
Sbjct: 135 AHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190
Query: 208 EYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262
E + D +SD++S G+ +E+ G P+ +H MR
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD---------------MHPMRA- 234
Query: 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
L+ I + KL K F + E CL N RP+ E++
Sbjct: 235 -LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 39/185 (21%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT---TKIQGTF 202
AL Y+H+A ++HRD+K NIL + + K+ DFG ++ +A + T T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATR 170
Query: 203 GYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSA--------------GNTSQ 246
Y PE S S+ T D++S G + E+LTG KP+F G S
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 247 ENVSL-----AAYFVHSMRKNRLYDILDDQVMKLGKK--NQIMAFANLAERCLDLNGKKR 299
E +S A ++ SMRK Q + +K N L ER L + K R
Sbjct: 230 ETISRVRNEKARRYLSSMRKK--------QPVPFSQKFPNADPLALRLLERLLAFDPKDR 281
Query: 300 PTMEE 304
PT EE
Sbjct: 282 PTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 95 LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHS 152
L C +TE L V EF+S G L H+ + ++ P E R + E++ AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQ---RQRKLP---EEHARFYSAEISLALNFLHE 114
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
I +RD+K N+LLD K+ D+G K + T+ GT Y+ PE +
Sbjct: 115 RG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKP--IFSAGNTSQEN 248
D ++ GV++ E++ G+ P I + +N
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 61/238 (25%), Positives = 92/238 (38%), Gaps = 46/238 (19%)
Query: 87 KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
N ++ LG C+E+ LLV EF G L +L ++ R+A EVA
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--Y 204
L +LH A H D+ N L K+ D+G + + + TK +
Sbjct: 113 LLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRW 168
Query: 205 LDPEYHQSSQ-------LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVH 257
L PE + T KS+++S GV + EL T + + S E V
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP--DLSDEQV-------- 218
Query: 258 SMRKNRLYDILDDQVMKLGKKN----------QIMAFANLAERCLDLNGKKRPTMEEV 305
L ++ +Q +KL K ++M F C L+ + RPT EEV
Sbjct: 219 ------LKQVVREQDIKLPKPQLDLKYSDRWYEVMQF------CW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 12/172 (6%)
Query: 95 LGCCLETEVPLL-VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHS 152
L C +TE L V E+++ G L H+ + ++ P E R + E++ AL YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP---EEHARFYSAEISLALNYLHE 114
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
I +RD+K N+LLD K+ D+G K + T+ GT Y+ PE +
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264
D ++ GV++ E++ G+ P G++ + + Y + + ++
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 12/137 (8%)
Query: 106 LVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASSPIYHRDI 163
V E+ + G L+ HL +R+ +++ R R E+ AL YLHS + + +RD+
Sbjct: 72 FVMEYANGGELFFHLSRERVFSED-------RARFYGAEIVSALDYLHSEKN--VVYRDL 122
Query: 164 KSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYS 223
K N++LD+ K+ DFG K D + T GT YL PE + + D +
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 181
Query: 224 FGVVLVELLTGKKPIFS 240
GVV+ E++ G+ P ++
Sbjct: 182 LGVVMYEMMCGRLPFYN 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 57 HFNVNRILGQGGQGTV----YKGMREDGRIIAVKKSKNA-------------VKLLG--- 96
+ + + LGQG G V + +A+KK N +KLL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAE-TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 97 ------CCLETEVPLLVYEFISNGT-LYQHLHDRLQNQ----EFPLTWEMRLRIATEVAG 145
C + ++ V+ N LY+ L + +Q PLT ++
Sbjct: 60 GHKNITCLYDMDI---VFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TF 202
L Y+HSA + HRD+K N+L++ K+ DFG ++ + + + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 203 GYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 239
Y PE S Q K+ DV+S G +L ELL G+KP+F
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM--DQTHVTTKIQGTFG 203
L Y+HSA + HRD+K +N+LL+ K+ DFG ++ D T T+ T
Sbjct: 118 GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 204 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 239
Y PE +S+ K+ D++S G +L E+L+ +P+F
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 89 KNAVKLLGCCLE-TEVPLLVYEFISNGTLYQHLHD-RLQNQEFPLTWEMR--LRIATEVA 144
+N + +L C+E E P ++Y +++ G L L RL P + + +A ++A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFG 203
++YLH + H+DI + N ++DE + K+ D S+ MD +
Sbjct: 128 CGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
++ E + + + SDV+SFGV+L EL+T G+ P
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 95 LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHS 152
L C +T L LV E+++ G L H+ + ++ P E R A E+ AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQ---RQRKLP---EEHARFYAAEICIALNFLHE 114
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
I +RD+K N+LLD K+ D+G K + T+ GT Y+ PE +
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRG 170
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKP 237
+ D ++ GV++ E++ G+ P
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT---EVAG 145
+N V + L + +V EF+ G L + N+E +IAT V
Sbjct: 79 ENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---------QIATVCLSVLR 129
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFG 203
AL+YLH+ + HRDIKS +ILL R K++DFG F A V + + GT
Sbjct: 130 ALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLVGTPY 183
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263
++ PE + D++S G++++E++ G+ P F+ + +MR R
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------------LQAMR--R 229
Query: 264 LYDILDDQVMKLGKKNQIM-AFANLAERCLDLNGKKRPTMEEVSMELNG 311
+ D L +V K + ++ F LDL + P+ + EL
Sbjct: 230 IRDNLPPRVKDSHKVSSVLRGF-------LDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 5/128 (3%)
Query: 120 LHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179
L+ L + PL + L I ++ L YLH+ I HRD+K+ NI +++ + +
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIG 199
Query: 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
D G ++F + + + GT PE + K+D++S G+VL E+L IF
Sbjct: 200 DLGAAQFPVVAPAFL--GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257
Query: 240 SAGNTSQE 247
++ E
Sbjct: 258 EDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 35/219 (15%)
Query: 56 NHFNVNRILGQGGQGTVYKGMRED--GRIIAVKKSKNAVKLLG---CCLETE-------- 102
F+V ++G+G G V + +RE G I A+K K +V L E E
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 103 ---VPLLVYEFISNGTLY--------QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
+P L Y F LY L L E +M E+ A+ +H
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
HRDIK N+L+D K+ADFG++ + ++ + GT Y+ PE
Sbjct: 120 QMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 212 SSQLTDKS------DVYSFGVVLVELLTGKKPIFSAGNT 244
+ K D +S GV+ E++ G+ P F G +
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-FHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 60/205 (29%), Positives = 83/205 (40%), Gaps = 41/205 (20%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK-----------------------KSKNAVKLLGCCL 99
LG G G VYK +E G A K K N V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLR-IATEVAGALAYLHSAASSPI 158
++ EF G L + L E LT E ++R + ++ AL +LHS +
Sbjct: 73 YENKLWILIEFCDGGAL-DSIMLEL---ERGLT-EPQIRYVCRQMLEALNFLHS---HKV 124
Query: 159 YHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD 217
HRD+K+ NILL K+ADFG S K + Q T GT ++ PE D
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKD 182
Query: 218 -----KSDVYSFGVVLVELLTGKKP 237
K+D++S G+ L+EL + P
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 40/117 (34%), Positives = 52/117 (44%), Gaps = 4/117 (3%)
Query: 130 PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFIA 188
PL E + I + ALAYLH I HRD+K+ NI LDE A + DFG + K A
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245
T GT PE K+D++S G+VL E+ +F S
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 58 FNVNRILGQGGQGTVYK-GMREDGRIIAVKK-SKNAVKL--------------------- 94
F R+LG+GG G V +R G++ A KK K +K
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 95 ---LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMR-LRIATEVAGALAY 149
L ET+ L LV ++ G L H+++ + N F E R + A E+ L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFD---EERAVFYAAEITCGLED 117
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
LH I +RD+K NILLD+ +++D G + I +T + ++ GT GY+ PE
Sbjct: 118 LHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEV 172
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKP 237
++ + T D + G ++ E++ GK P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 50/170 (29%), Positives = 74/170 (43%), Gaps = 33/170 (19%)
Query: 97 CCLETEVPL-LVYEFISNG---TLYQHLHDRLQNQEFPLTWEM-RLRIATEVAGALAYLH 151
C ET+ L +V E++ G TL +++ L +M R+ A E AL YLH
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNIG--------ALPVDMARMYFA-ETVLALEYLH 118
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT--------------HVTTK 197
+ I HRD+K N+L+ K+ DFG SK M T + +
Sbjct: 119 NYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 198 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
+ GT Y+ PE D ++ G++L E L G P F G+T +E
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF--GDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 75/298 (25%), Positives = 112/298 (37%), Gaps = 69/298 (23%)
Query: 56 NHFNVNRILGQGGQGTVYK------GMREDGRIIAVKK---------------------- 87
N ++G+G G V K G+R D I +K+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 88 SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFP-----------LTWEMR 136
N + LLG C L E+ +G L L + P L+ +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 137 LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196
L A +VA + YL + HRD+ + NIL+ E Y AK+ADFG S+ Q
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 179
Query: 197 KIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254
K G ++ E S T SDV+S+GV+L E I S G T ++ A
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE-------IVSLGGTPYCGMTCAEL 232
Query: 255 FVHSMRKNRLYDIL--DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310
+ + RL L DD+V +L +C +RP+ ++ + LN
Sbjct: 233 YEKLPQGYRLEKPLNCDDEVY------------DLMRQCWREKPYERPSFAQILVSLN 278
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 37/148 (25%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
V+LLG C + L V + G+L H+ + L + L ++A + YL
Sbjct: 72 VRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS----LDPQRLLNWCVQIAKGMYYLE 126
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYH 210
+ HR++ + NILL ++ADFG + + D+ + ++ + ++ E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 211 QSSQLTDKSDVYSFGVVLVELLT-GKKP 237
+ T +SDV+S+GV + E+++ G +P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 39/140 (27%), Positives = 71/140 (50%), Gaps = 10/140 (7%)
Query: 101 TEVPL-LVYEFISNGTLYQHLH-DRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
T+ P+ ++ EF++ G+L L D Q P + + ++A +A++
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP----KLIDFSAQIAEGMAFIEQ---RNY 123
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 218
HRD+++ NIL+ K+ADFG ++ I ++ + + PE T K
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 219 SDVYSFGVVLVELLT-GKKP 237
SDV+SFG++L+E++T G+ P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 44 KLFSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSKNAVKLLGCCLETEV 103
KL++ K+L+K R+ + G Y+G + RI+A S+ V L +T+
Sbjct: 19 KLYACKKLNK-------KRLKKRKG----YEGAMVEKRILAKVHSRFIVSL-AYAFQTKT 66
Query: 104 PL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMR-LRIATEVAGALAYLHSAASSPIYHR 161
L LV ++ G L H+++ ++E P E R ++ L +LH I +R
Sbjct: 67 DLCLVMTIMNGGDLRYHIYN--VDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYR 121
Query: 162 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 221
D+K N+LLD +++D G + + Q+ T GT G++ PE Q + D
Sbjct: 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDFSVDY 180
Query: 222 YSFGVVLVELLTGKKPIFSAG 242
++ GV L E++ + P + G
Sbjct: 181 FALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L Y+HSA + HRD+K +NIL++E K+ DFG ++ Q T T Y
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRA 173
Query: 207 PEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIF 239
PE + Q D + D++S G + E+L G KP+F
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 37/208 (17%)
Query: 58 FNVNRILGQGGQGTVYK-GMREDGRIIAVKK-SKNAVKL--------------------- 94
F R+LG+GG G V +R G++ A KK K +K
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 95 ---LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMR-LRIATEVAGALAY 149
L ET+ L LV ++ G L H++ + F E R + A E+ L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFE---EGRAVFYAAEICCGLED 117
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
LH I +RD+K NILLD+ +++D G + + QT + ++ GT GY+ PE
Sbjct: 118 LHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEV 172
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKP 237
++ + T D ++ G +L E++ G+ P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N + L G +++ ++V E++ NG+L L R + +F T + + +A + Y
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQF--TVIQLVGMLRGIASGMKY 121
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDP 207
L + HRD+ + NIL++ KV+DFG S+ + D T G + P
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGN 243
E + T SDV+S+G+V+ E+++ G++P + N
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 44 KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKLLGCCLETE 102
K+++ K+LDK R+ + G + + E + I K S + L ET+
Sbjct: 19 KMYACKKLDK-------KRLKKRKG----EQMALNE--KKILEKVSSRFIVSLAYAFETK 65
Query: 103 VPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASSPIYH 160
L LV ++ G L H++ N P E R A ++ L +LH I +
Sbjct: 66 DDLCLVMTLMNGGDLKYHIY----NVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVY 118
Query: 161 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSD 220
RD+K N+LLD+ +++D G + + + GT GY+ PE Q D
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 221 VYSFGVVLVELLTGKKPIFSAGNTSQEN 248
++ G L E++ G+ P F E
Sbjct: 177 WFALGCTLYEMIAGRSP-FRQRKEKVEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 72/276 (26%), Positives = 104/276 (37%), Gaps = 52/276 (18%)
Query: 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVK 93
F + + +G G G VYK G + A+K K N V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
G L + + EF G+L H PL+ ++ E L YLHS
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYH-----VTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE---YH 210
HRDIK NILL + K+ADFG S I + I GT ++ PE
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVE 181
Query: 211 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270
+ D+++ G+ +EL + P+F +H MR L +
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFD---------------LHPMRALFLMTKSNF 226
Query: 271 QVMKLGKKNQ-IMAFANLAERCLDLNGKKRPTMEEV 305
Q KL K + +F + + L N KKRPT E++
Sbjct: 227 QPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 5/98 (5%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L Y H HRDIK +NILL+ + + K+ADFG ++ +++ T T Y
Sbjct: 129 LNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 207 PEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGN 243
PE + + DV+S G +L EL T KKPIF A
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 26/185 (14%)
Query: 130 PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189
PL + LR +++VA + +L AS HRD+ + N+LL + AK+ DFG ++ I
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 190 DQTHVTTKIQGT----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245
D +V ++G ++ PE T +SDV+S+G++L E IFS G +
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE-------IFSLGKSP 314
Query: 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + F + M K R Y + + IM + C +L +RPT ++
Sbjct: 315 YPGILVNSKF-YKMVK-RGYQ-MSRPDFAPPEIYSIM------KMCWNLEPTERPTFSQI 365
Query: 306 SMELN 310
S +
Sbjct: 366 SQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 49/222 (22%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK----------------------------NAVKL 94
+G G GTVYK G +A+K + N V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 95 LGCCL------ETEVPLLVYEFISNGTLYQHLHDRLQNQEFP-LTWEMRLRIATEVAGAL 147
+ C ET+V L V+E + Q L L P L E + + L
Sbjct: 68 MDVCATSRTDRETKVTL-VFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
+LH+ + I HRD+K NIL+ + K+ADFG ++ + T + T Y P
Sbjct: 122 DFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAP 176
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV 249
E S D++S G + E+ +KP+F GN+ + +
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF-CGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 45/228 (19%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYK-GMREDGRIIAVK--------------------- 86
+ L T+ + + +G+G G VYK ++DG + AVK
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS 74
Query: 87 --KSKNAVKLLGCCLETEVPL-----LVYEFISNGT---LYQHLHDRLQNQEFPLTWEMR 136
N VK G + + + LV E + G+ L + L Q + +
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM----- 129
Query: 137 LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196
I+ + GAL L ++ I HRD+K NILL K+ DFG S + + T
Sbjct: 130 --ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 197 KIQGTFGYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIF 239
+ GT ++ PE Q D S DV+S G+ +EL G P+F
Sbjct: 188 SV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 130 PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189
PLT E + + +VA + +L AS HRD+ + NILL E K+ DFG ++ I
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 190 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248
D +V + ++ PE T +SDV+SFGV+L E IFS G +
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE-------IFSLGASPYPG 279
Query: 249 VSLAAYFVHSMR 260
V + F ++
Sbjct: 280 VQINEEFCQRLK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 41/180 (22%), Positives = 83/180 (46%), Gaps = 31/180 (17%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTFG 203
L Y+HSA + HRD+K +N+L++E ++ DFG ++ ++ + + T+ T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 204 YLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY-------- 254
Y PE S + T D++S G + E+L G++ +F G + L
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP-GKNYVHQLKLILSVLGSPSEE 234
Query: 255 FVHSMRKNRLYDILDDQVMKLGKK-----NQIMAFA-----NLAERCLDLNGKKRPTMEE 304
++ + +R+ + + L +K ++I A +L + L + ++R T+E+
Sbjct: 235 VLNRIGSDRVRKYIQN----LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L YLHSA I HRDIK N+L++ K+ DFG ++ D++ T+ T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 207 PEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
PE S+ T D++S G + ELL G++ +F A + Q+
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELL-GRRILFQAQSPIQQ 213
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 50/174 (28%), Positives = 73/174 (41%), Gaps = 18/174 (10%)
Query: 68 GQGTVYKGMR---EDGRI---IAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLH 121
Q + KG+R E R I N V L + + LV + G L+ H+
Sbjct: 18 QQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77
Query: 122 DRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181
L E E R A E+ AL LH I RD+ NILLD+R ++ F
Sbjct: 78 KFLNIPE-----ECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYF 129
Query: 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 235
++ ++ + ++ Y PE S+ T+ D +S G +L ELLTGK
Sbjct: 130 S--RWSEVEDSCDGEAVENM--YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 23/102 (22%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGY 204
L Y+HSA I HRD+K +NI ++E K+ DFG ++ + T +V T+ Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 181
Query: 205 LDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
PE Y+Q+ D++S G ++ ELLTG K +F
Sbjct: 182 RAPEIMLNWMHYNQT------VDIWSVGCIMAELLTG-KTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 37/208 (17%)
Query: 58 FNVNRILGQGGQGTVYK-GMREDGRIIAVKK-SKNAVK---------------------- 93
F R+LG+GG G V +R G++ A KK K +K
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 94 --LLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMR-LRIATEVAGALAY 149
L ET+ L LV ++ G L H+++ + N F E R + A E+ L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFD---EQRAIFYAAELCCGLED 117
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
L I +RD+K NILLD+R +++D G + I +T V ++ GT GY+ PE
Sbjct: 118 LQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEV 172
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKP 237
+ + T D + G ++ E++ G+ P
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMR-LRIATEVAGALAYLHSAASSPIYHRDIK 164
+V F G LY +L+ Q+ L E + + ++A AL YLH I HRD+K
Sbjct: 77 IVMGFCEGGDLYH----KLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLK 129
Query: 165 STNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSF 224
+ N+ L KV D G ++ + +Q + + + GT Y+ PE + KSDV++
Sbjct: 130 TQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWAL 188
Query: 225 GVVLVELLTGK 235
G + E+ T K
Sbjct: 189 GCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 62 RILGQGGQGT---VYKGM-REDGRIIAVKKSKNAVKLLGCCLE-TEVPLL---------- 106
+ILG+ G+GT V K R+ G+ A+K K K L E+ L
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 107 -----VYEFISNGTLY-------QHLHDRLQNQEFPLTWEMRLR-IATEVAGALAYLHSA 153
+++ G L +L++ ++ ++ PL E R++ ++ +L ++H
Sbjct: 62 RLIEVLFD-RKTGRLALVFELMDMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMHR- 118
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
+ I+HRDIK NIL+ + K+ADFG+ + I + T+ T Y PE
Sbjct: 119 --NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYISTRWYRAPE----C 169
Query: 214 QLTD-----KSDVYSFGVVLVELLTGKKPIFSAGN 243
LTD K D+++ G V E+L+ P+F N
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTN 203
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHD-----------RLQNQEFPLTWEMRLR 138
N + LLG C + E+ G L L + LT + L+
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 198
A++VA + YL + HRD+ + N+L+ E +K+ADFG S+ ++ +V K
Sbjct: 124 FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKT 176
Query: 199 QGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
G ++ E S T KSDV+SFGV+L E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 5e-08
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 20/157 (12%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHD-----------RLQNQEFPLTWEMRLR 138
N + LLG C L E+ +G L L + L+ + L
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 198
A +VA + YL + HRD+ + NIL+ E Y AK+ADFG S+ + +V K
Sbjct: 117 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKT 169
Query: 199 QGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
G ++ E S T SDV+S+GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLLGC 97
+G+G G VYKG ++ G+I+A+KK + N V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT-EVAGALAYLHSAASS 156
++ L++EF+S L ++L + Q ++ ++ + + HS
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDA---ELVKSYLYQILQGILFCHSRR-- 121
Query: 157 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL- 215
+ HRD+K N+L+D + K+ADFG ++ + V T T Y PE S
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 216 TDKSDVYSFGVVLVELLTGKKPIF 239
+ D++S G + E+ T KKP+F
Sbjct: 180 STPVDIWSIGTIFAEMAT-KKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHL-HDRLQNQEFP--LTWEMRLRIATEVAGA 146
N +K L +E +V E G L Q + + + Q + P W+ +++ + A
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----A 118
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+ ++HS + HRDIK N+ + K+ D G +F + +T + GT Y+
Sbjct: 119 VEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 240
PE + KSD++S G +L E+ + P +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 38/213 (17%)
Query: 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVKKSK-------------------------- 89
+F + + +G+G VY+ DG +A+KK +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHL-HDRLQNQEFP--LTWEMRLRIATEVAGA 146
N +K +E +V E G L + + H + Q + P W+ +++ + A
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS----A 118
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L ++HS + HRDIK N+ + K+ D G +F + +T + GT Y+
Sbjct: 119 LEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
PE + KSD++S G +L E+ + P +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 5/103 (4%)
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 202
+A + +HS HRDIK N+LLD ++ADFG+ + D T ++ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 203 GYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFS 240
Y+ PE Q+ + + D +S GV + E+L G+ P ++
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 52/184 (28%), Positives = 79/184 (42%), Gaps = 26/184 (14%)
Query: 130 PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189
PLT E + + +VA + +L AS HRD+ + NILL E K+ DFG ++ I
Sbjct: 169 PLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225
Query: 190 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248
D +V + ++ PE T +SDV+SFGV+L E IFS G +
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE-------IFSLGASPYPG 278
Query: 249 VSLAAYFVHSMRKN---RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
V + F +++ R + ++ IM C N + RPT E+
Sbjct: 279 VQIDEEFCRRLKEGTRMRAPEYATPEIY------SIML------DCWHNNPEDRPTFSEL 326
Query: 306 SMEL 309
L
Sbjct: 327 VEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 26/186 (13%)
Query: 124 LQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183
L+ E L E L + +VA +++L AS HRD+ + NILL K+ DFG
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGL 260
Query: 184 SKFIAMDQTHVTTKIQGT----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
++ I D +V ++G ++ PE + T +SDV+S+G++L E IF
Sbjct: 261 ARDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE-------IF 310
Query: 240 SAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKR 299
S G++ + + + F Y ++ + L + ++ + C D + KR
Sbjct: 311 SLGSSPYPGMPVDSKF---------YKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKR 361
Query: 300 PTMEEV 305
PT +++
Sbjct: 362 PTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 42/140 (30%), Positives = 62/140 (44%), Gaps = 26/140 (18%)
Query: 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIK 164
+L+ ++I +G L+ D L+ + E++ I ++ AL LH I H DIK
Sbjct: 85 VLIMDYIKDGDLF----DLLKKEGKLSEAEVKK-IIRQLVEALNDLHKHN---IIHNDIK 136
Query: 165 STNILLDE-RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTD 217
N+L D + R + D+G K I + GT Y PE Y S
Sbjct: 137 LENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIKGHNYDVSF---- 187
Query: 218 KSDVYSFGVVLVELLTGKKP 237
D ++ GV+ ELLTGK P
Sbjct: 188 --DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 27/74 (36%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD 217
I HRD+K+ NI L K+ DFG S+ + M + T GT Y+ PE +
Sbjct: 127 ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQGYDS 184
Query: 218 KSDVYSFGVVLVEL 231
KSD++S G +L E+
Sbjct: 185 KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 18/143 (12%)
Query: 106 LVYEFISNG---TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162
LV ++ G TL DRL ++ + + IA + L Y+H RD
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLP-EDMARFYLAEMVIAIDSVHQLHYVH---------RD 127
Query: 163 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTD 217
IK NIL+D ++ADFG+ + D T ++ GT Y+ PE Q+ +
Sbjct: 128 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGP 187
Query: 218 KSDVYSFGVVLVELLTGKKPIFS 240
+ D +S GV + E+L G+ P ++
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 11/133 (8%)
Query: 130 PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189
LT E + + +VA + +L AS HRD+ + NILL E K+ DFG ++ I
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 190 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248
D +V + ++ PE T +SDV+SFGV+L E IFS G +
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPG 284
Query: 249 VSLAAYFVHSMRK 261
V + F +++
Sbjct: 285 VKIDEEFCRRLKE 297
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 62/226 (27%), Positives = 89/226 (39%), Gaps = 55/226 (24%)
Query: 56 NHFNVNRILGQGGQGTVYKGMRED-GRIIAVK--------------------------KS 88
F + +GQGG G V+ ++D G I+A+K KS
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNG---TLYQH---LHDRLQNQEFPLTWEMRLRIATE 142
+ VKLL + E L E++ G TL + L + R +A E
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED----------HARFYMA-E 109
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGT 201
+ A+ LH HRD+K N L+D K+ DFG SK + + V G+
Sbjct: 110 MFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GS 161
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
Y+ PE + D +S G +L E L G P FS G+T E
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP-FS-GSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 56/213 (26%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK-------------------------KSKNAVKLLGC 97
+G+G GTV+K RE I+A+K K KN V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 98 CLETEVPLLVYEFIS----------NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
+ LV+E+ NG + + Q L+ L
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLK-------GL 112
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
A+ HS + HRD+K N+L+++ K+ADFG ++ + + ++ T Y P
Sbjct: 113 AFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPP 168
Query: 208 EYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 239
+ ++L S D++S G + EL +P+F
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 35/207 (16%)
Query: 58 FNVNRILGQGGQGTVYK-GMREDGRIIAVKK-SKNAVKL--------------------- 94
F R+LG+GG G V +R G++ A K+ K +K
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 95 ---LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
L ET+ L LV ++ G L H+++ + N F E L A E+ L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGF--EEERALFYAAEILCGLEDL 118
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 210
H +RD+K NILLD+ +++D G + + + + GT GY+ PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVL 173
Query: 211 QSSQLTDKSDVYSFGVVLVELLTGKKP 237
+ + T D + G ++ E++ G+ P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 31/119 (26%), Positives = 57/119 (47%), Gaps = 5/119 (4%)
Query: 116 LYQHLHDR-LQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY 174
LY ++D ++ PL + R I ++ A+ Y+H + HRDIK NI L+
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDG 304
Query: 175 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 233
+ + DFGT+ ++ GT PE + +D++S G++L+++L+
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQ 214
HRDIK N+LLD+ ++ADFG+ + D T + GT Y+ PE Q+ +
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 215 LTDKSDVYSFGVVLVELLTGKKPIFS 240
+ D +S GV + E+L G+ P ++
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 57/222 (25%)
Query: 54 ATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFIS 112
AT++ N+ + LG+G TVYKG+ R +G+++ A+K++ E VP + I
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLV-------ALKVISMKTEEGVP---FTAIR 52
Query: 113 NGTLYQH--------LHDRLQNQEFPLTWEMRLRIATEVAG------------------- 145
+L + LHD + +E LT+ + T++A
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKE-TLTFVFEY-MHTDLAQYMIQHPGGLHPYNVRLFMF 110
Query: 146 ----ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQG 200
LAY+H I HRD+K N+L+ K+ADFG ++ ++ QT+ + +
Sbjct: 111 QLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-- 165
Query: 201 TFGYLDPEYHQSSQLTDKS---DVYSFGVVLVELLTGKKPIF 239
T Y P+ + TD S D++ G + +E+L G +P F
Sbjct: 166 TLWYRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 36/229 (15%)
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
K+ V G C+ + ++V E++ G+L +L + ++W +L +A ++A AL
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISW--KLEVAKQLAWALH 114
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD-- 206
+L + H ++ + N+LL R + G FI + ++ + L+
Sbjct: 115 FLEDKG---LTHGNVCAKNVLL---IREEDRKTGNPPFIKLSDPGISITVLPKEILLERI 168
Query: 207 ----PE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
PE L+ +D +SFG L E IFS G+ L+A S +K
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWE-------IFSGGDK-----PLSAL--DSQKK 214
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310
+ Y+ D + K ++ ANL +C+D RP+ + +LN
Sbjct: 215 LQFYE--DRHQLPAPKWTEL---ANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 56/209 (26%), Positives = 79/209 (37%), Gaps = 49/209 (23%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKK------------------------SKNAVKLLGCCL 99
LG G G VYK ++ ++A K N VKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
++ EF + G + + E PLT + + AL YLH + I
Sbjct: 73 YENNLWILIEFCAGGAV----DAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ------GTFGYLDPEYHQSS 213
HRD+K+ NIL K+ADFG S T IQ GT ++ PE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS-------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 214 QLTD-----KSDVYSFGVVLVELLTGKKP 237
D K+DV+S G+ L+E+ + P
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 50/218 (22%)
Query: 64 LGQGGQGTVYKG--MREDGRIIAVKKSK----------------------------NAVK 93
+G+G G V+K ++ GR +A+K+ + N V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 94 LLGCCL------ETEVPLLVYEFISNGTLYQHLHDRLQNQEFP-LTWEMRLRIATEVAGA 146
L C ET++ L V+E + Q L L P + E + ++
Sbjct: 69 LFDVCTVSRTDRETKLTL-VFEHVD-----QDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L +LHS + HRD+K NIL+ + K+ADFG ++ + T + T Y
Sbjct: 123 LDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRA 177
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244
PE S D++S G + E+ +KP+F G++
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR-GSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L Y+HSA + HRD+K +N+LL+ K+ DFG ++ ++ T+ T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRA 176
Query: 207 PE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
PE S+ T DV+S G + ELL G+KP+F
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 62/240 (25%), Positives = 101/240 (42%), Gaps = 40/240 (16%)
Query: 87 KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRL--RIATEVA 144
+ N ++ LG C E LLV EF G L +L R + +T + R+A E+A
Sbjct: 53 QHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQRMACEIA 110
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-------FIAMDQTHVTTK 197
L +LH + H D+ N LL K+ D+G S ++ DQ V
Sbjct: 111 LGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--P 165
Query: 198 IQGTFGYLDPEYHQSSQLTDK---SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254
++ L E H + + D+ S+V+S GV + EL F G+ Y
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL-------FELGSQP--------Y 210
Query: 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFAN----LAERCLDLNGKKRPTMEEVSMELN 310
S + Y + + Q +KL K + ++ + + C L ++RP+ EEV + L+
Sbjct: 211 RHLSDEQVLTYTVREQQ-LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 45/207 (21%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK--KSKNA---------VKLLGCCLETEVPLLVYEFI 111
LG G G VYK +E G + A K ++K+ +++L C + L+ F
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 112 SNGTLYQHLH--------------DR-LQNQEFPLTWEMRLRIATEVAGALAYLHSAASS 156
+G L+ + DR L + + I ++ AL YLHS
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------ICRQMLEALQYLHSMK-- 130
Query: 157 PIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 215
I HRD+K+ N+LL K+ADFG S K + Q GT ++ PE +
Sbjct: 131 -IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCETM 187
Query: 216 TD-----KSDVYSFGVVLVELLTGKKP 237
D K+D++S G+ L+E+ + P
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 15/143 (10%)
Query: 122 DRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181
D L N+ L++ + + +VA + +L AS HRD+ + N+L+ E K+ DF
Sbjct: 227 DTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDF 283
Query: 182 GTSKFIAMDQTHVTTKIQGTF---GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 238
G ++ I D +++ TF ++ PE ++ T SDV+SFG++L E I
Sbjct: 284 GLARDIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE-------I 334
Query: 239 FSAGNTSQENVSLAAYFVHSMRK 261
F+ G T + + F +++++
Sbjct: 335 FTLGGTPYPELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 58/224 (25%), Positives = 89/224 (39%), Gaps = 58/224 (25%)
Query: 63 ILGQGGQGT---VYKGMR---EDGRIIAVKKSK--------------------------N 90
I G G+GT VYK R +DG+ A+KK K N
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN 63
Query: 91 AVKLLGCCLETEVPL--LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
V L+ LE L++++ + L+Q + Q + + M + ++ +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 149 YLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTS-KFIAMDQTHVT-TKIQGTF 202
YLHS + + HRD+K NIL+ ER K+ D G + F A + + T
Sbjct: 123 YLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 203 GYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
Y PE Y T D+++ G + ELLT +PIF
Sbjct: 180 WYRAPELLLGARHY------TKAIDIWAIGCIFAELLT-LEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 35/229 (15%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRL-RIATEVAGALA 148
N ++ LG C+E LLV+E+ G L +L + + + L R+A E+A +
Sbjct: 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYL--SQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGYLD 206
++H H D+ N L KV D+G + ++ T +L
Sbjct: 114 HMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLA 169
Query: 207 PE----YHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259
PE +H +++ T S+V++ GV L EL +S + S V
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS--HLSDREV---------- 217
Query: 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLD---LNGKKRPTMEEV 305
L ++ DQ +KL K + ++ L L+ +KR T EEV
Sbjct: 218 ----LNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 12/149 (8%)
Query: 106 LVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIK 164
+V EFI T+++++ H N PL + ++L + ++ ALAY+HS I HRD+K
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPL-FLVKL-YSYQLCRALAYIHSKF---ICHRDLK 197
Query: 165 STNILLDER-YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH-QSSQLTDKSDVY 222
N+L+D + K+ DFG++K + Q V+ I F Y PE ++ T D++
Sbjct: 198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPELMLGATNYTTHIDLW 255
Query: 223 SFGVVLVELLTGKKPIFSAGNTSQENVSL 251
S G ++ E++ G PIFS ++ + V +
Sbjct: 256 SLGCIIAEMILG-YPIFSGQSSVDQLVRI 283
|
Length = 440 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 9e-07
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
+A+LH + I HRD+K++N+LL+ R K+ DFG ++ T++ T Y
Sbjct: 118 GVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYR 173
Query: 206 DPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
PE + + + D++S G + ELLT KKP+F
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 51/218 (23%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK------------------------KSKNAVKLLGCC 98
LG+G TVYKG R G I+A+K K +N V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 99 LETEVPL-LVYEFISNG-TLYQHLH------DRLQNQEFPLTWEMRLRIATEVAGALAYL 150
+ TE L LV+E++ Y H D + F T+++ L+ +A+
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSF--TYQL-LK-------GIAFC 116
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 210
H + + HRD+K N+L+++R K+ADFG ++ + + ++ T Y P+
Sbjct: 117 HE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVL 172
Query: 211 QSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQE 247
S+ S D++S G ++ E++TG +P+F G +++
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITG-RPLF-PGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 59/231 (25%), Positives = 82/231 (35%), Gaps = 54/231 (23%)
Query: 54 ATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK------------------------- 87
+ + LG+G G VYK + GR++A+KK
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 88 SKNAVKLLGCCLE-----TEVPLLVYEFISNGTLYQHLHDR---LQNQEFPLTWEMRLRI 139
N V L+ +E VY T Y HD L+N LT
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMV----TPYMD-HDLSGLLENPSVKLTESQIKCY 120
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG----------TSKFIAM 189
++ + YLH I HRDIK+ NIL+D + K+ADFG K
Sbjct: 121 MLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 190 DQTHVTTKIQGTFGYLDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
T T + T Y PE + T D++ G V E+ T +PI
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 68/289 (23%), Positives = 111/289 (38%), Gaps = 63/289 (21%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK-----------------------KSKN 90
++ + + +G+G G V+K + +++G AVK N
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 91 AVKLLGCCLETEVP-----LLVYEFISNGT---LYQHLHDRLQNQEFPLTWEMRLRIATE 142
VK G + +V LV E + G+ L + R + E P+ IA
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-------IAYI 129
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 202
+ AL L + HRD+K NILL K+ DFG S + + T + GT
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTP 188
Query: 203 GYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVH 257
++ PE Q D + DV+S G+ +EL G P+ +H
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD---------------LH 233
Query: 258 SMRKNRLYDILDDQVMKLGKKNQIMA-FANLAERCLDLNGKKRPTMEEV 305
MR L+ I + L + F + +CL + +KRPT+ ++
Sbjct: 234 PMRA--LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 38/132 (28%), Positives = 57/132 (43%), Gaps = 8/132 (6%)
Query: 116 LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175
LY +L RL+ PL +A ++ A+ Y+H I HRDIK+ N+L++
Sbjct: 246 LYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPED 298
Query: 176 AKVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG 234
+ DFG + F T I GT PE T D++S G+V+ E
Sbjct: 299 ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVH 358
Query: 235 KKPIFSAGNTSQ 246
+FSA +
Sbjct: 359 TASLFSASRGDE 370
|
Length = 461 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 37/200 (18%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKK-------------------------SKNAVKLLGC 97
+G+G G VYK + G ++A+KK N VKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 98 CLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASS 156
+ TE L LV+EF+ + L + + D PL + ++ LA+ HS
Sbjct: 68 -IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLP--LIKSYLFQLLQGLAFCHS---H 119
Query: 157 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL- 215
+ HRD+K N+L++ K+ADFG ++ + T ++ T Y PE +
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYY 178
Query: 216 TDKSDVYSFGVVLVELLTGK 235
+ D++S G + E++T +
Sbjct: 179 STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 56 NHFNVNRILGQGGQGTVYK-GMREDGRIIAVKKSKNA-------------VKLLGCCLET 101
N F V ++G+G G V K +E I+A+KK K++ +K+L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY-----LHSAASS 156
+ L F G LY + + ++ L EM + E + Y +H +
Sbjct: 61 NIVELKEAFRRRGKLYL-VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 157 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 216
I HRDIK N+L+ K+ DFG ++ ++ T+ T Y PE +
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 217 DKSDVYSFGVVLVELLTGKKPIF 239
D++S G +L EL G +P+F
Sbjct: 180 KAVDMWSVGCILGELSDG-QPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 34/155 (21%), Positives = 68/155 (43%), Gaps = 8/155 (5%)
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N V+L G ++V E++SNG L L+ E L + + +A + Y
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGAL----DSFLRKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
L + H+ + + +L++ K++ F + + + T + + PE
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 210 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGN 243
Q + SDV+SFG+V+ E+++ G++P +
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 34/203 (16%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK---NAVKLLGCCLETEV------PLLV--Y-EF 110
LG+G G+VYK + R G +A+K+ + + K +E ++ P +V Y F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 111 ISNGTLYQHLH-------DRL--QNQEFPLTWEMRL-RIATEVAGALAYLHSAASSPIYH 160
G +Y + D+L E L RI V L +L + I H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIH 126
Query: 161 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD--- 217
RD+K TN+L++ + K+ DFG S + + T I G Y+ PE +S
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNI-GCQSYMAPERIKSGGPNQNPT 183
Query: 218 ---KSDVYSFGVVLVELLTGKKP 237
+SDV+S G+ ++E+ G+ P
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
V L G + LV EF+ G + L +N+ FP ++ A ++ YL
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPN--DVGCFYAAQIVLIFEYLQ 148
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
S I +RD+K N+LLD+ K+ DFG +K + T + GT Y+ PE
Sbjct: 149 SLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILL 201
Query: 212 SSQLTDKSDVYSFGVVLVELLTGKKPIFS 240
+ +D ++ G+ + E+L G P ++
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVGCPPFYA 230
|
Length = 340 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 31/103 (30%), Positives = 44/103 (42%), Gaps = 3/103 (2%)
Query: 137 LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196
L I V A+ YLH + I HRDIK+ NI ++ + DFG + F +
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
GT PE D++S G+VL E+ T +F
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284
|
Length = 391 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 36/204 (17%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLLGC 97
+G+G G VYK + G I+A+KK + N V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
LV+EF+ + L +++ D L + ++ +AY HS
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYM-DSSP--LTGLDPPLIKSYLYQLLQGIAYCHS---HR 119
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQLT 216
+ HRD+K N+L+D K+ADFG ++ + T ++ T Y PE S Q +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYS 178
Query: 217 DKSDVYSFGVVLVELLTGKKPIFS 240
D++S G + E++ ++P+F
Sbjct: 179 TPVDIWSIGCIFAEMVN-RRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 33/132 (25%), Positives = 65/132 (49%), Gaps = 8/132 (6%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165
LV ++ G L H+++ E L E + + ++ + +LHS I +RD+K
Sbjct: 70 LVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKP 123
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG 225
N+LLD++ +++D G + + + T+ GT GY+ PE + + D ++ G
Sbjct: 124 ENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMG 181
Query: 226 VVLVELLTGKKP 237
+ E++ G+ P
Sbjct: 182 CSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 40/211 (18%)
Query: 63 ILGQGGQGTVYKGM-REDGRIIAVKKSK-------------NAVKLLGCCLETE--VPLL 106
+G+G G VYK + G+++A+KK++ + LL E+ V LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 107 ----------------VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
V+E++ + L + + + PL + ++ +A+
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 151 HSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE- 208
H + HRD+K N+L+D ++ K+AD G + ++ T +I T Y PE
Sbjct: 127 HKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEV 182
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
S+ + D++S G + E+ K+P+F
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSR-KQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 37/126 (29%), Positives = 61/126 (48%), Gaps = 9/126 (7%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQG--TFG 203
L Y+HSA + HRD+K N+ ++ E K+ DFG ++ + +H +G T
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 204 YLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262
Y P + T D+++ G + E+LTG KP+F AG E + L V +R+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLF-AGAHELEQMQLILESVPVVREE 241
Query: 263 RLYDIL 268
++L
Sbjct: 242 DRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 22/102 (21%)
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQG 200
++ L Y+HSA I HRD+K +N+ ++E K+ DFG ++ + T +V T+
Sbjct: 128 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 181
Query: 201 TFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGK 235
Y PE Y+Q+ D++S G ++ ELLTG+
Sbjct: 182 --WYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 15/111 (13%)
Query: 137 LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196
L +VA + +L AS HRD+ + N+LL + K+ DFG ++ I D +V+
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 197 KIQGTF---GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244
TF ++ PE + T SDV+S+G++L E IFS G T
Sbjct: 297 G--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE-------IFSLGGT 338
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 42/193 (21%), Positives = 95/193 (49%), Gaps = 22/193 (11%)
Query: 76 MREDGRIIAVKKSK----NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPL 131
+RE+ + A+ +S+ N V LLG + + +++ + S+ L++ L R + +
Sbjct: 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS 110
Query: 132 TWEMR-----------LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180
T + + + I T++A + +L +S + H+D+ + N+L+ ++ K++D
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISD 167
Query: 181 FGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPI 238
G + + A D + ++ PE + + SD++S+GVVL E+ + G +P
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
Query: 239 FSAGNTSQENVSL 251
G ++Q+ + +
Sbjct: 228 --CGYSNQDVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 22/207 (10%)
Query: 72 VYKGMREDGRIIAVKKSKNAVKLLGC-----CLETEVPLLVYEFISNGTLYQH---LHDR 123
VY + + +I K N + LG C + + Y FI L ++ + R
Sbjct: 61 VYNNIYDIDKIALWKNIHN-IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR 119
Query: 124 LQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183
++ + L I ++ L Y+H I H DIK NI++D R + D+G
Sbjct: 120 IKCKNKKLI----KNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGI 172
Query: 184 SKFIAMDQTHVT-TKIQ-----GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
+ + H+ +K Q GT Y + H + +T + D+ S G +++ K P
Sbjct: 173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
Query: 238 IFSAGNTSQENVSLAAYFVHSMRKNRL 264
G+ + F+ + + ++
Sbjct: 233 WKGFGHNGNLIHAAKCDFIKRLHEGKI 259
|
Length = 294 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 55/241 (22%), Positives = 103/241 (42%), Gaps = 44/241 (18%)
Query: 64 LGQGGQGTVYKGMREDGR---------IIAVKKSKNAVKLLGCCLETEVP---------- 104
+G+G G VYK R+DG+ I S +A + + E + P
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 105 -------LLVYEFISNGTLYQ---HLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
L++++ + + H + + L M + ++ + YLH+
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-- 126
Query: 155 SSPIYHRDIKSTNILL----DERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPE 208
+ + HRD+K NIL+ ER R K+AD G ++ + + TF Y PE
Sbjct: 127 -NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 209 YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267
++ K+ D+++ G + ELLT +PIF + QE++ + F H + +R++ +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT-SEPIF---HCRQEDIKTSNPFHHD-QLDRIFSV 240
Query: 268 L 268
+
Sbjct: 241 M 241
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L+Y H I HRD+K N+L++E+ K+ADFG ++ ++ + ++ T Y
Sbjct: 116 LSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRP 171
Query: 207 PE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL 251
P+ S++ + D++ G +L E+ TG +P+F G+T +E + L
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFP-GSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 35/117 (29%), Positives = 46/117 (39%), Gaps = 30/117 (25%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG-------------TSKFIAMDQTH 193
L LH HRD+ NI ++ + K+ADFG SK M +
Sbjct: 132 LNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 194 VTTKIQGTFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
T T Y PE YH + D++S G + ELLTG KP+F N
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFA------VDMWSVGCIFAELLTG-KPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 36/198 (18%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK-------------------------KSKNAVKLLGC 97
+G+G G V+K RE G+I+A+K K N V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
LV+E+ + T+ L++ +N + + +I + A+ + H
Sbjct: 69 FRRKRKLHLVFEYCDH-TV---LNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHK---HN 120
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH-QSSQLT 216
HRD+K NIL+ ++ + K+ DFG ++ + T + T Y PE +Q
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYG 179
Query: 217 DKSDVYSFGVVLVELLTG 234
DV++ G V ELLTG
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 23/52 (44%), Positives = 30/52 (57%), Gaps = 3/52 (5%)
Query: 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185
EM ++ +EVA AL YLH I HRD+K N+L+ K+ DFG SK
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 31/111 (27%), Positives = 61/111 (54%), Gaps = 7/111 (6%)
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
++ LAY H + HRD+K N+L++ER K+ADFG ++ ++ + ++ T
Sbjct: 112 QILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-T 167
Query: 202 FGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL 251
Y P+ SS+ + + D++ G + E+ +G +P+F G+T ++ + L
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLF-PGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 47/217 (21%)
Query: 64 LGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCC 98
LG+G TVYKG + ++A+K K N V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 99 LETEVPLLVYEFISNGTLYQHLHD-----RLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
+ LV+E++ + L Q+L D + N + L +R L Y H
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR---------GLNYCHR- 122
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQS 212
+ HRD+K N+L++ER K+ADFG ++ ++ + ++ T Y P+ S
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV 249
+ + + D++ G + E+ TG +P+F G+T +E +
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG-RPLF-PGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 37/204 (18%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLLGC 97
+G+G G VYK R IA+KK + N V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
+ LV+E++ + L +H+ + +F + ++ +AY HS
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHMD---SSPDFAKNPRLIKTYLYQILRGIAYCHS---HR 122
Query: 158 IYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQL 215
+ HRD+K N+L+D R A K+ADFG ++ + T ++ T Y PE S
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHY 181
Query: 216 TDKSDVYSFGVVLVELLTGKKPIF 239
+ D++S G + E++ +KP+F
Sbjct: 182 STPVDIWSVGCIFAEMVN-QKPLF 204
|
Length = 294 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 15/97 (15%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFG 203
L Y+H+A I HRD+K N+ ++E K+ DFG ++ +++ G T
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRW 180
Query: 204 YLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIF 239
Y PE + T D++S G ++ E+LTG KP+F
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 36/134 (26%), Positives = 69/134 (51%), Gaps = 15/134 (11%)
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFI--AMDQTHVT 195
++ + YLH+ + + HRD+K NIL+ ER R K+AD G ++ +
Sbjct: 116 QILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 196 TKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254
+ TF Y PE ++ K+ D+++ G + ELLT +PIF + QE++ +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIF---HCRQEDIKTSNP 228
Query: 255 FVHSMRKNRLYDIL 268
+ H + +R+++++
Sbjct: 229 YHHD-QLDRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 62/234 (26%)
Query: 63 ILGQGGQGTVYKGM-REDGRIIAVKK-------------------------SKNAVKLLG 96
+GQG G V+K ++ +I+A+KK +N V L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 97 CCLETEVP--------LLVYEFISNGTLYQHLHDR---LQNQEFPLTWEMRLRIATEVAG 145
C P LV+EF HD L N+ T ++ +
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM---DQTHVTTKIQGTF 202
L Y+H + I HRD+K+ NIL+ + K+ADFG ++ ++ + + T T
Sbjct: 131 GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 203 GYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSAGNTSQENVSL 251
Y PE L ++ D++ G ++ E+ T + PI GNT Q ++L
Sbjct: 188 WYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWT-RSPIM-QGNTEQHQLTL 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 31/127 (24%), Positives = 47/127 (37%), Gaps = 43/127 (33%)
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-------------------- 199
HRDIK N+LLD + K++DFG + ++H T +
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 200 -------------------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 240
GT Y+ PE + + D +S GV++ E+L G P S
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 241 AGNTSQE 247
+ QE
Sbjct: 242 --DNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 35/197 (17%)
Query: 64 LGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCC 98
LG+G TVYKG + +G+++A+K K N V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
E LV+E++ L Q++ D+ P ++ L ++ L+Y+H I
Sbjct: 73 HTKETLTLVFEYVHT-DLCQYM-DKHPGGLHPENVKLFL---FQLLRGLSYIHQRY---I 124
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQLTD 217
HRD+K N+L+ + K+ADFG ++ ++ +H + T Y P+ S++ +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 218 KSDVYSFGVVLVELLTG 234
D++ G + VE++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 9e-05
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 10/91 (10%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYL 205
L Y+HSA I HRD+K N+ ++E K+ DFG ++ + T +V T+ Y
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYR 181
Query: 206 DPEYHQS-SQLTDKSDVYSFGVVLVELLTGK 235
PE + D++S G ++ E+LTGK
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 20/96 (20%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L Y+HSA I HRD+K +N+ ++E ++ DFG +A T T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG----LARQADDEMTGYVATRWYRA 183
Query: 207 PE-------YHQSSQLTDKSDVYSFGVVLVELLTGK 235
PE Y+Q+ D++S G ++ ELL GK
Sbjct: 184 PEIMLNWMHYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 59/252 (23%), Positives = 92/252 (36%), Gaps = 91/252 (36%)
Query: 58 FNVNRILGQGGQGTVYKG------MREDGRIIAVKKSKN--AV------KLLGCC----- 98
F + + LG+G G VYK +++G+ + +KK+ AV ++ C
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATEYGAVEIWMNERVRRACPNSCA 192
Query: 99 -----------LETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRL--------- 137
+ E LV+ + TL D +Q++EFP E L
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLA----DLMQSKEFPYNVEPYLLGKVQDLPK 248
Query: 138 ----------RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA-KVADFGTSKF 186
I ++ AL LHS I HRD+K NI+ E + K+ D G
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGA--- 302
Query: 187 IAMDQTHVTTKIQGTFGYLDP------EYHQSSQ---------------------LTDKS 219
A D I F LDP +Y S+Q L D+
Sbjct: 303 -AADLRVGINYIPKEF-LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360
Query: 220 DVYSFGVVLVEL 231
D+YS G++ +++
Sbjct: 361 DIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 35/200 (17%)
Query: 62 RILGQGGQGTVYKGMRED-GRIIAVKK----------SKNAVK---LLGCCLETEVPLLV 107
+ +G G QG V G +AVKK +K A + LL C + L+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 108 YEFISNGTL--YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY--------LHSAASSP 157
F +L +Q ++ ++ + L + + + E L Y LHSA
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--- 143
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTFGYLDPEYHQSSQ 214
I HRD+K +NI++ K+ DFG ++ M +V T+ Y PE
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVILGMG 198
Query: 215 LTDKSDVYSFGVVLVELLTG 234
+ D++S G ++ EL+ G
Sbjct: 199 YKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 36/144 (25%), Positives = 49/144 (34%), Gaps = 46/144 (31%)
Query: 136 RLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG---------TSKF 186
R IA E+ A+ +H HRDIK NIL+D K+ DFG SK+
Sbjct: 104 RFYIA-ELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 187 I--------------------------------AMDQTHVTT-KIQGTFGYLDPEYHQSS 213
+ GT Y+ PE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 214 QLTDKSDVYSFGVVLVELLTGKKP 237
T D +S GV+L E+L G+ P
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 22/114 (19%)
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLD----------------ERYRAKVADF 181
+I + AL Y H+ + H D+K NIL++ + R ++ D
Sbjct: 235 QIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 235
G D+ H T I T Y PE +D++S G ++ EL TGK
Sbjct: 293 GG----CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 20/87 (22%), Positives = 37/87 (42%), Gaps = 6/87 (6%)
Query: 103 VPLLVYEFISNGT---LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
VP ++ S+G L + + ++ E IA ++A LA LH +
Sbjct: 55 VPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKED---IAEQLAELLAKLHQLPLLVLC 111
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKF 186
H D+ NIL+D+ + D+ + +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 39/230 (16%)
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
K+ V L G C+ ++V EF+ G L +H + LT + ++A ++A AL+
Sbjct: 64 KHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH----RKSDVLTTPWKFKVAKQLASALS 119
Query: 149 YLHSAASSPIYHRDIKSTNILL-----DERYRA--KVADFGTSKFIAMDQTHVTTKIQGT 201
YL + H ++ + NILL D K++D G + Q V
Sbjct: 120 YLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----R 171
Query: 202 FGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
++ PE S L+ +D +SFG L E I G ++ +LA
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWE-------ICYNGEIPLKDKTLA-------E 217
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310
K R Y+ V K+ A+L C++ + +RP + ++N
Sbjct: 218 KERFYEGQCMLVTPSCKE-----LADLMTHCMNYDPNQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 11/93 (11%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTF 202
+ +LHSA I HRD+K +NI++ K+ DFG ++ M +V T+
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 190
Query: 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 235
Y PE + D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 33/112 (29%), Positives = 50/112 (44%), Gaps = 26/112 (23%)
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG----TF 202
LAY H + HRD+K N+L+ ER K+ADFG ++ V +K T
Sbjct: 116 LAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR-----AKSVPSKTYSNEVVTL 167
Query: 203 GYLDP-------EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
Y P EY S+ L D++ G + E+ TG +P+F ++
Sbjct: 168 WYRPPDVLLGSTEY--STSL----DMWGVGCIFYEMATG-RPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.004
Identities = 62/260 (23%), Positives = 88/260 (33%), Gaps = 92/260 (35%)
Query: 57 HFNVNRILGQGGQGTVY-KGMREDGRIIAVKK-SKNAV----KLLGCCLETEV------P 104
HF ++LG+G G V+ ++ G++ A+K K + K+ E E+ P
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 105 LLVYEFISNGTLYQH------------------LHDRLQNQEFPLTWEMRLRI------A 140
L TLY L LQ Q L A
Sbjct: 62 FLP-------TLYASFQTETYLCLVMDYCPGGELFRLLQRQP-----GKCLSEEVARFYA 109
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ- 199
EV AL YLH I +RD+K NILL E ++DF SK + +K
Sbjct: 110 AEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD-VEPPPVSKALR 165
Query: 200 ----------------------------GTFGYLDPEY-----HQSSQLTDKSDVYSFGV 226
GT Y+ PE H S+ D ++ G+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-----VDWWTLGI 220
Query: 227 VLVELLTGKKPIFSAGNTSQ 246
+L E+L G P F N +
Sbjct: 221 LLYEMLYGTTP-FKGSNRDE 239
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 29/109 (26%), Positives = 44/109 (40%), Gaps = 11/109 (10%)
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHV--- 194
I +V AL Y+HS HR +K+++ILL + ++ S I +
Sbjct: 106 ILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 195 --TTKIQGTFGYLDPEYHQSSQL--TDKSDVYSFGVVLVELLTGKKPIF 239
+L PE Q + +KSD+YS G+ EL G P
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 33/122 (27%), Positives = 46/122 (37%), Gaps = 36/122 (29%)
Query: 160 HRDIKSTNILLDERYRAKVADFG------------------------------TSKFIA- 188
HRDIK N+LLD + K++DFG SK A
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 189 ---MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245
++ + GT Y+ PE + D +S GV++ E+L G P S T
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS--ETP 241
Query: 246 QE 247
QE
Sbjct: 242 QE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 11/93 (11%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG---TSKFIAMDQTHVTTKIQGTF 202
+ +LHSA I HRD+K +NI++ K+ DFG T+ M +V T+
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 235
Y PE + D++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 33/122 (27%), Positives = 46/122 (37%), Gaps = 36/122 (29%)
Query: 160 HRDIKSTNILLDERYRAKVADFG------------------------------TSKFIA- 188
HRDIK N+LLD + K++DFG SK A
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 189 ---MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245
++ + GT Y+ PE + D +S GV++ E+L G P S T
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS--ETP 241
Query: 246 QE 247
QE
Sbjct: 242 QE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.88 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.64 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.33 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.04 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.71 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.7 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.7 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.56 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.43 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.28 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.23 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.18 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.01 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.0 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.94 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.91 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.82 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.76 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.72 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.66 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.6 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.42 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.36 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.71 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.42 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.95 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.89 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.82 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.05 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 92.91 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.9 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.76 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.5 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 91.98 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 91.9 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.82 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 91.78 | |
| PLN02236 | 344 | choline kinase | 91.75 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 90.55 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=369.74 Aligned_cols=268 Identities=48% Similarity=0.784 Sum_probs=232.4
Q ss_pred cccccChHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc-----------------------ccccchhhhccc
Q 020102 42 RCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-----------------------KSKNAVKLLGCC 98 (331)
Q Consensus 42 ~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-----------------------~~~niv~~~~~~ 98 (331)
....|+.+|+..++++|.....||+|+||.||+|...++..|||| +|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 577899999999999999999999999999999999888999999 389999999999
Q ss_pred ccCC-cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEE
Q 020102 99 LETE-VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAK 177 (331)
Q Consensus 99 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~k 177 (331)
.+.+ ..+||+||+++|+|.+.|... ... +++|..+.+|+.++|+||+|||+...++|+||||||+|||+|+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~--~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGK--KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCC--CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999 599999999999999999863 111 889999999999999999999998877899999999999999999999
Q ss_pred EeeccCcccccC-CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 020102 178 VADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 178 l~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
|+|||+|+.... ....... ..||.+|+|||++..+..+.|+||||||++++|++||+.|..... ......+..|..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAK 294 (361)
T ss_pred ccCccCcccCCccccceeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHH
Confidence 999999975543 2221111 179999999999999999999999999999999999998876543 233334777777
Q ss_pred HHhhcCccccccchHhh-ccCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 257 HSMRKNRLYDILDDQVM-KLGKK-NQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
..+....+.+++|+.+. ..... .....+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 88888899999999877 44443 6788899999999999999999999999999776543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=342.68 Aligned_cols=229 Identities=27% Similarity=0.436 Sum_probs=191.4
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCc-ceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEV-PLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~-~~lv~e~ 110 (331)
+++..+.||+|..|+||++.+ .+++.+|+| .+|+||.+++.|..+.. ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 456678999999999999998 578999999 37899999999999995 9999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|++|||.+.+... +.+++...-.++.+|++||.|||+ .+ |+||||||+||||+..|++||||||.+..+.+
T Consensus 160 MDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred cCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999988763 469999999999999999999996 55 99999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
. ...+++||..|||||.+.+..|+.++||||||++++||.+|+.||........ ....... .+++
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~---~~~~Ll~---------~Iv~ 296 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL---DIFELLC---------AIVD 296 (364)
T ss_pred h---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC---CHHHHHH---------HHhc
Confidence 3 56678899999999999999999999999999999999999999976411111 1111111 1122
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
+..+......++.+|++|+..||+.||.+|||+.|++++
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111222222488899999999999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=325.04 Aligned_cols=236 Identities=24% Similarity=0.405 Sum_probs=193.7
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhc-ccccCC-cceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLG-CCLETE-VPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~-~~~~~~-~~~lv 107 (331)
..|++.++||+|+||.||++.+ .+|..+|.| +|||||++++ .+.+++ .++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4578899999999999999987 689999999 4999999998 444444 48999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS-SPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||.+|+|...++.+ +.+...+++..+|.++.|++.||.++|.+-. .-|+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~-K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHF-KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHH-HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999988766 4455689999999999999999999999431 2399999999999999999999999999998
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
+.... ....+.+|||.||+||.+.+.+|+.++||||+||++|||+.-++||... .+.. ....+..++...
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~-L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLS-LCKKIEQGDYPP 247 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHH-HHHHHHcCCCCC
Confidence 76543 3455678999999999999999999999999999999999999999753 1111 222333333322
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
++ ...++.++..+|..|+..||+.||+...++..++
T Consensus 248 ~p--------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 248 LP--------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred Cc--------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 21 2578899999999999999999998655555544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=337.75 Aligned_cols=231 Identities=25% Similarity=0.373 Sum_probs=191.8
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------------ccccchhhhcccccCC
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------------~~~niv~~~~~~~~~~ 102 (331)
..+.|.+.+.||+|+||.|-+|.. ++|+.|||| .|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788999999999999999987 679999999 3999999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC---CcEEEe
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER---YRAKVA 179 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~---~~~kl~ 179 (331)
..|+||||++||.|.+.+.. ++.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999876 346778888999999999999999999 9999999999999866 779999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhcCCCC---CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL---TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
|||+|+... ......+.+|||.|.|||++.+..+ ..++|+||+||++|-+++|.+||........ ..
T Consensus 322 DFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--------l~ 391 (475)
T KOG0615|consen 322 DFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--------LK 391 (475)
T ss_pred ccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--------HH
Confidence 999999775 4456677899999999999877643 3488999999999999999999975543321 11
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
+....+.... -.......+++.++||.+||..||++|||+.|+++.
T Consensus 392 eQI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 392 EQILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1111221111 012245677889999999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=347.18 Aligned_cols=225 Identities=28% Similarity=0.432 Sum_probs=194.3
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
.+|...+.||+|||++||.+.+ .+|+.||+| +|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999999 889999999 4999999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|+|..++|..+++. .+++++..+..++.||+.||.|||+.+ |+|||||..|++++++.++||+|||+|..+.
T Consensus 98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999988875 358999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.+. ....+.+|||.|.|||++....++..+||||+||++|-|++|++||.... +...+..-...
T Consensus 170 ~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------vkety~~Ik~~--- 233 (592)
T KOG0575|consen 170 YDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------VKETYNKIKLN--- 233 (592)
T ss_pred Ccc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------HHHHHHHHHhc---
Confidence 543 34456799999999999999999999999999999999999999996431 11111110000
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.-..+...+.+..+||..+|+.+|.+|||+++|+..
T Consensus 234 ----~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 234 ----EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011233566788999999999999999999999764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=335.99 Aligned_cols=238 Identities=35% Similarity=0.559 Sum_probs=193.5
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCC-cceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETE-VPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~-~~~lv~e 109 (331)
..+.+.+.||+|+||+||+|.......||+| +|||||+++|+|.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3445566799999999999998655559998 4999999999999988 7999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~ 188 (331)
|+++|+|.+++... ....+++..+..++.||+.|+.|||+.+. |+||||||+|||++.++ ++||+|||+++...
T Consensus 121 y~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred eCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999999763 35689999999999999999999999773 89999999999999998 99999999998654
Q ss_pred CCCceeeeeccccCCccChhhhc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ... .......+
T Consensus 196 ~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~---~~~v~~~~---- 262 (362)
T KOG0192|consen 196 ISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQV---ASAVVVGG---- 262 (362)
T ss_pred ccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHH---HHHHHhcC----
Confidence 322 2223367999999999999 56999999999999999999999999965321 111 11111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
.+...+......+..++.+||+.||+.||++.+++..|+.+....
T Consensus 263 -----~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 263 -----LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred -----CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 122223335667999999999999999999999999999886643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=323.93 Aligned_cols=176 Identities=34% Similarity=0.547 Sum_probs=160.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEe
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
...|.+.+.||+|+||+||+|.. .++..|||| +|||||.+++++..++.+++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35788889999999999999997 568999999 5999999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC------CcEEEeecc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER------YRAKVADFG 182 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~------~~~kl~Dfg 182 (331)
|||.||+|.+++..+ +.+++.++..++.|++.||++||+++ |+||||||.|||++.. ..+||+|||
T Consensus 89 EyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999873 37999999999999999999999998 9999999999999864 458999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 240 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~ 240 (331)
+|+.+.. .....+.+|++.|||||++....|+.|+|+||+|+++|+|++|+.||..
T Consensus 161 fAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 161 FARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9998763 3445568999999999999999999999999999999999999999964
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=319.42 Aligned_cols=219 Identities=29% Similarity=0.450 Sum_probs=185.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.+.|++.+.||+|+||.||.+.. ++++.+|+| +||.||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46789999999999999999987 568899999 499999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
+||+.||.|...|.+ .+.+++..+..++..|+.||.|||+++ |+||||||+|||+|.+|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999986 457999999999999999999999999 999999999999999999999999999843
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.. ....+.+++||+.|||||++.+..|+..+|.||+|+++|||++|.+||....... .. .....+.
T Consensus 176 ~~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~-~~I~~~k---- 241 (357)
T KOG0598|consen 176 LK-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MY-DKILKGK---- 241 (357)
T ss_pred cc-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HH-HHHhcCc----
Confidence 32 2334455899999999999999999999999999999999999999997543211 11 1111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCC
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP 300 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP 300 (331)
....+.-.+.+.++++..+|+.+|+.|.
T Consensus 242 -----~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0111223566899999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=308.88 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=188.0
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
+.|+.+..+|+|+||+||+|.+ .+|+.|||| +|+|+|+++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3577889999999999999997 469999999 48999999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
||+. ++.+.|..+ + ..++...+..++.|++.|+.|+|+++ ++||||||+||||+.+|.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~---p-~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---P-NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecch-HHHHHHHhc---c-CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9984 454556653 2 36888999999999999999999988 99999999999999999999999999998775
Q ss_pred CCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc------chHHHHHHHhhcC
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV------SLAAYFVHSMRKN 262 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~ 262 (331)
.....+..+.|.+|+|||++.| .+|...+||||+||++.||++|.+-|...+.-++... .+..........+
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 3445666789999999998888 6799999999999999999999877754432222110 1111111111222
Q ss_pred cc-ccccchHhh-----ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 RL-YDILDDQVM-----KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 ~~-~~~~~~~~~-----~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
+. ..+.-+... ...-+..+.-+++|+..||+.||.+|+|.+|++..
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11 111111111 11122344568999999999999999999999753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=332.55 Aligned_cols=237 Identities=29% Similarity=0.448 Sum_probs=201.5
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
..+...+.||+|-||.||.|..+....||+| +|+|||+++++|..++.++|||||++.
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 3455678899999999999999877788888 599999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|+|.++|.. ..+..+.....+.++.|||+|++||++++ +|||||.++||||+++..+||+|||+|+....+...
T Consensus 286 GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 286 GSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred CcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999986 34457888999999999999999999998 999999999999999999999999999955544443
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
......-...|.|||.+..+.++.+|||||||++|+||+| |+.|+....+ .++...++...
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------------------~ev~~~le~Gy 421 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------------------EEVLELLERGY 421 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------------------HHHHHHHhccC
Confidence 4444445678999999999999999999999999999999 7888754321 12223344455
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
+.+.+..++..+.+++..||+.+|++|||++.+...|+++....
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 56667888999999999999999999999999999999886543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=328.06 Aligned_cols=230 Identities=28% Similarity=0.385 Sum_probs=194.8
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCc
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~ 103 (331)
.+....|.++++||.|+|++|++|.+ .+++.|||| .||.|++++-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999997 568999999 38999999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
+|+|+||+++|+|.+++.++ +.+++..+..++.+|+.||.|||+.| ||||||||+|||+|++|+++|+|||.
T Consensus 149 LYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccc
Confidence 99999999999999999874 58999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCc------------eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch
Q 020102 184 SKFIAMDQT------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL 251 (331)
Q Consensus 184 a~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~ 251 (331)
|+.+..... .....++||..|.+||++.+...+..+|+|+|||++|+|+.|.+||..... .
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---y---- 293 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---Y---- 293 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---H----
Confidence 987643211 112458999999999999999999999999999999999999999965321 0
Q ss_pred HHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 252 AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+. +.-..++..++.+.+|+.+.|..||.+|+|.+||.+.
T Consensus 294 -liFqkI~~-----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 -LIFQKIQA-----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HHHHHHHH-----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11222211 1112244455789999999999999999999888664
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=324.87 Aligned_cols=239 Identities=26% Similarity=0.378 Sum_probs=191.4
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhcccccCC-ccee
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLETE-VPLL 106 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~~~-~~~l 106 (331)
.-++|.+.+.||.|+||.||+|.. .++..||||+ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346789999999999999999987 5689999992 899999999999988 8999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|||||+ .+|++.++++ +..+++..+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+|+.
T Consensus 88 VfE~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eHHhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 999997 8999988874 568999999999999999999999999 99999999999999888999999999997
Q ss_pred ccCCCceeeeeccccCCccChhh-hcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC---
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN--- 262 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 262 (331)
+.. ....+..+.|.+|+|||+ +..+.|+.+.|+||+|||++|+.+-++-|.+.. ...+... ....+...
T Consensus 160 v~S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-E~Dqi~K----Ic~VLGtP~~~ 232 (538)
T KOG0661|consen 160 VRS--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-EIDQIYK----ICEVLGTPDKD 232 (538)
T ss_pred ccc--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-HHHHHHH----HHHHhCCCccc
Confidence 654 334566789999999995 566789999999999999999999876664322 1111100 11111111
Q ss_pred --------------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 --------------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 --------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.++......+....+ ..+.++.+++..|+++||.+|||++|++++
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111222222222223 378899999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=295.44 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=188.9
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~~~~~~lv~e 109 (331)
.+|...+.||+|.||+||+|.+ .+|+.||||+ |+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999998 6799999993 8899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|++ .+|...+++ ....++...+..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 997 677777765 4568999999999999999999999999 99999999999999999999999999998876
Q ss_pred CCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc-
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI- 267 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 267 (331)
+....... +-|.+|+|||++.|. .|+..+|+||.|||+.||+.| .||+.+.+...+...+-. ........+|++.
T Consensus 154 p~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~-~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 154 PNRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFR-ALGTPTPDQWPEMT 230 (318)
T ss_pred CCcccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHH-HcCCCCcccCcccc
Confidence 55444333 679999999988776 589999999999999999987 566655433222111000 0001111112111
Q ss_pred --cchH--------hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 --LDDQ--------VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 --~~~~--------~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+-. .....-...+.+..+|+..|+..||.+|+|+.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1110 0011233456778999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=310.42 Aligned_cols=234 Identities=29% Similarity=0.419 Sum_probs=186.7
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccccCC--cceeEe
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCLETE--VPLLVY 108 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~~~~--~~~lv~ 108 (331)
..++...+.||+|+||+||++... +|+..||| +|||||+++|.....+ .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345677899999999999999984 48899999 3789999999855544 689999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEeeccCcccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFI 187 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~ 187 (331)
||+++|+|.+++... .+ .+++..+..+++||++||.|||+++ |+|+||||+|||++. ++.+||+|||++...
T Consensus 96 Ey~~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eccCCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 999999999999863 22 6999999999999999999999998 999999999999999 799999999999866
Q ss_pred cC--CCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 188 AM--DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 188 ~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
.. ..........||+.|||||++.++ ....++||||+||++.||+||+.||... ................
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSL 241 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCC
Confidence 53 112223457899999999999853 3345999999999999999999999642 0011111111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
+ ..+...+.+..+|+..|++.+|++|||++++++.--.
T Consensus 242 P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 242 P---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred C---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1 3345567789999999999999999999999887543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=318.39 Aligned_cols=243 Identities=26% Similarity=0.334 Sum_probs=187.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhcccccC--Cccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLET--EVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~~--~~~~l 106 (331)
.+.|+.+++||+|.||.||+|.+ .+|+.||+|+ ||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45688889999999999999998 6799999994 89999999999876 68999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|+|||+. +|.-.+ ....-.+++.++..++.|++.||.|||+.+ |+|||||.+|||||.+|.+||+|||+|++
T Consensus 196 VFeYMdh-DL~GLl----~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLL----SSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEecccc-hhhhhh----cCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence 9999984 444433 345667999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
+........+..+-|.+|+|||++.|. .|+.++|+||.|||+.||++|++.|.......+. ...-..+.......|.
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl--~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL--HKIFKLCGSPTEDYWP 345 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH--HHHHHHhCCCChhccc
Confidence 877666666667789999999988876 6999999999999999999998877543221111 1100011111111111
Q ss_pred --ccc-----ch-----HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 266 --DIL-----DD-----QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 266 --~~~-----~~-----~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
++. .+ ....+.....++...+|+..+|..||.+|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 00 0001112234566889999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=317.67 Aligned_cols=227 Identities=25% Similarity=0.411 Sum_probs=192.7
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
..|.....||+|+.|.||.|.. .+++.|||| +|+|||++++.+...+.+|.||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999987 568889999 4899999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
+||+|.+.+... .+++.++..|++.+++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999888653 5899999999999999999999999 9999999999999999999999999998776543
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
. ...+.+|||.|||||+.....|..++||||||+++.||+.|.+||..... +. ....+..+....+
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lr--AlyLIa~ng~P~l---- 489 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LR--ALYLIATNGTPKL---- 489 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HH--HHHHHhhcCCCCc----
Confidence 3 44567899999999999999999999999999999999999999975211 11 1112222222222
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+..|.+|+.+||+.|+++|||+.|+|+.
T Consensus 490 ---k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 ---KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2244567789999999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=317.02 Aligned_cols=224 Identities=29% Similarity=0.449 Sum_probs=192.9
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|.+.+.||+|+||.||+|.. .+.+.||+| +||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4678889999999999999987 468899999 59999999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+.| +|...+.. ++.++++.+..++.+++.||.|||+.+ |+|||+||.|||++..|.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9985 99998875 467999999999999999999999988 99999999999999999999999999997765
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
+ +...+...|||-|||||+..+.+|+..+|+||+||++|||++|++||.... +...+.....+.
T Consensus 153 ~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~------- 216 (808)
T KOG0597|consen 153 N-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDP------- 216 (808)
T ss_pred C-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCC-------
Confidence 4 455667889999999999999999999999999999999999999997531 111222222111
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...+...+..|..|+...|..||..|.|+.+++..
T Consensus 217 ----v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 ----VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11244677889999999999999999999998653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.86 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=195.7
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcc
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~ 104 (331)
+.......|++...||.|..++||+|.. +.++.|||| .||||++++..|..+..+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 3344567899999999999999999987 678999999 399999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
|+||.||.+||+.+.+...... .+++..+..|++++++||.|||++| .+|||||+.||||+++|.+||+|||.+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceee
Confidence 9999999999999999886532 5999999999999999999999999 999999999999999999999999987
Q ss_pred ccccCCCceee---eeccccCCccChhhhc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 185 KFIAMDQTHVT---TKIQGTFGYLDPEYHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 185 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
..+........ ..++||++|||||++. ...|+.|+||||||++..||.+|+.||..... .......+
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--------mkvLl~tL 245 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--------MKVLLLTL 245 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--------HHHHHHHh
Confidence 65544332221 4568999999999843 34689999999999999999999999953211 11111111
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+..+..............++..+.+++..||+.||++|||++++++.
T Consensus 246 -qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 246 -QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 222222222222333344556689999999999999999999999764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=315.13 Aligned_cols=228 Identities=25% Similarity=0.349 Sum_probs=183.9
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc--------------------------cccchhhhcccccCCccee
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK--------------------------SKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~--------------------------~~niv~~~~~~~~~~~~~l 106 (331)
..+.|+++..||+|+||.||+|.. .+|..+|+|. .+.+|+++-.|.+.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457899999999999999999987 5699999994 5699999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||++||++...|.. ...++++.+..++.+++.|+..+|+.| ++||||||+|+|||..|++||+|||++.-
T Consensus 219 iMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999976 358999999999999999999999999 99999999999999999999999999842
Q ss_pred ccC---------------------CC--c-----ee------------------eeeccccCCccChhhhcCCCCCCcch
Q 020102 187 IAM---------------------DQ--T-----HV------------------TTKIQGTFGYLDPEYHQSSQLTDKSD 220 (331)
Q Consensus 187 ~~~---------------------~~--~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~D 220 (331)
+.. +. . .. ....+|||.|+|||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 210 00 0 00 11257999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC
Q 020102 221 VYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP 300 (331)
Q Consensus 221 iwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP 300 (331)
.||||||+|||+.|.+||.... +.+ .+...+. +...+..+.....+.+..+||++||+ ||+.|.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~t--p~~------T~rkI~n-------wr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSET--PQE------TYRKIVN-------WRETLKFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCC--HHH------HHHHHHH-------HhhhccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999999996431 111 1111111 11122223333445789999999999 999997
Q ss_pred C---HHHH
Q 020102 301 T---MEEV 305 (331)
Q Consensus 301 s---~~ev 305 (331)
. ++||
T Consensus 435 G~~G~~EI 442 (550)
T KOG0605|consen 435 GSKGAEEI 442 (550)
T ss_pred CcccHHHH
Confidence 5 5554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=312.44 Aligned_cols=226 Identities=27% Similarity=0.396 Sum_probs=190.8
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
..|.....||+|+||.||+|.+ .+++.||+| +++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466678999999999999998 578999999 367999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
|.||++.+.+.. +..+.+..+..++++++.|+.|||..+ .+|||||+.||++..+|.+||+|||.+..+...
T Consensus 93 ~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999998865 335588888889999999999999998 999999999999999999999999999877654
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.... .+++|||.|||||++.+..|+.++||||||++.+||.+|.+|+..... .....++..
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------mrvlflIpk 225 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------MRVLFLIPK 225 (467)
T ss_pred hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------------ceEEEeccC
Confidence 4333 678999999999999988999999999999999999999999854311 111122222
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+......++..+.+|+..||+.||+.|||+.++++.
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22222233778889999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=314.87 Aligned_cols=240 Identities=26% Similarity=0.400 Sum_probs=186.4
Q ss_pred hcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhhhcccccC-C
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKLLGCCLET-E 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~~~~~~~~-~ 102 (331)
.++|++.+.||+|+||.||+|.+ .++..||+| .||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999974 235678888 388999999988764 4
Q ss_pred cceeEeecccCCCHHHHHhhhhcC--------------------------------------------------------
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQN-------------------------------------------------------- 126 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 126 (331)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999988652110
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce-eeeeccccCCc
Q 020102 127 -QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGY 204 (331)
Q Consensus 127 -~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y 204 (331)
...++++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0135788899999999999999999988 999999999999999999999999999765332221 11223456789
Q ss_pred cChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHH
Q 020102 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMA 283 (331)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
+|||++.+..++.++|||||||++|||++ |..||....... ........+... ..+...+..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~~---------~~~~~~~~~ 305 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--------EFCQRLKDGTRM---------RAPENATPE 305 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--------HHHHHHhcCCCC---------CCCCCCCHH
Confidence 99999999999999999999999999997 999985432110 111111111111 112334567
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 284 FANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 284 ~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=311.03 Aligned_cols=233 Identities=26% Similarity=0.377 Sum_probs=192.2
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------------c-cccchhhhcccccCC
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------------K-SKNAVKLLGCCLETE 102 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------------~-~~niv~~~~~~~~~~ 102 (331)
...+.|.+.+.||+|+||.|+.|.. .+++.||+| . ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4457899999999999999999976 567888888 2 899999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEeec
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVADF 181 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-~~~kl~Df 181 (331)
..++||||+.||+|.+++.. .+.+.+..+..++.|++.|++|||+.| |+||||||+|||++.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 99999999999999999976 357889999999999999999999999 9999999999999999 99999999
Q ss_pred cCcccccCCCceeeeeccccCCccChhhhcCCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ-LT-DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 182 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
|++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||.... ....... .
T Consensus 166 G~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~k-i 235 (370)
T KOG0583|consen 166 GLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRK-I 235 (370)
T ss_pred ccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHH-H
Confidence 9998764 2233455678999999999999987 76 68999999999999999999996521 1111111 1
Q ss_pred hcCccccccchHhhccCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 260 RKNRLYDILDDQVMKLGKKNQ-IMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
..+.. ..+... +.++.+|+.+||..+|.+|+|+.+|+ .-.-++.
T Consensus 236 ~~~~~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 236 RKGEF----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred hcCCc----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 11111 112222 67899999999999999999999998 5444443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=289.97 Aligned_cols=213 Identities=28% Similarity=0.382 Sum_probs=183.5
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|+..+.||.|+||.|.++.. .+|..+|+| .||.++++++.+.+...+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4678889999999999999987 468889999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||++||.|.+++.+ .+.+++..+..++.||+.|+.|||+.+ |++||+||+|||+|.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999976 357999999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
. .+.+.+|||.|+|||++...++..++|.||||+++|||+.|.+||+.... .......+
T Consensus 196 ~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~--------- 254 (355)
T KOG0616|consen 196 G----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKIL--------- 254 (355)
T ss_pred C----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHH---------
Confidence 3 35567899999999999999999999999999999999999999976532 11111111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCC
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKR 299 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~R 299 (331)
...+ ..+...+.++.+|+..+|+.|-.+|
T Consensus 255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1111 1245566789999999999999999
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=281.09 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=195.6
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-----------------------cccchhhhcccccCC----
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-----------------------SKNAVKLLGCCLETE---- 102 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-----------------------~~niv~~~~~~~~~~---- 102 (331)
+-...++|++.+.||+|||+.||.+.. .++..+|+|+ |||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 344568999999999999999999985 6788899994 789999999886544
Q ss_pred -cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 103 -VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 103 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
..|++++|...|+|.+.+..... .+..+++..++.|+.+|++||.+||+.. ++++||||||.||++++.+.++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence 48999999999999999987643 3447999999999999999999999986 67999999999999999999999999
Q ss_pred cCcccccCCCcee--------eeeccccCCccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc
Q 020102 182 GTSKFIAMDQTHV--------TTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS 250 (331)
Q Consensus 182 g~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~ 250 (331)
|.+....-.-... .....+|..|+|||++.- ...++++|||||||++|+|+.|..||...-.
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------- 246 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------- 246 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence 9987543211111 112357999999998764 4578899999999999999999999953211
Q ss_pred hHHHHHHHhhcCccccc-cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 251 LAAYFVHSMRKNRLYDI-LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 251 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
..+.+.-. .......+....+++.+.+++.+||+.||.+||++.+++..++.+.
T Consensus 247 ---------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ---------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11122211 1223333334458899999999999999999999999999998763
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=310.08 Aligned_cols=243 Identities=19% Similarity=0.263 Sum_probs=184.3
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------ccccchhhhcccccCCcceeEeecccCCCHH
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------KSKNAVKLLGCCLETEVPLLVYEFISNGTLY 117 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (331)
.+|.+.+.||+|+||.||+|.+ .+++.||+| .||||+++++++..+...++|+|++. ++|.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~ 170 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY 170 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence 5799999999999999999998 568899999 49999999999999999999999995 7888
Q ss_pred HHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeee
Q 020102 118 QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197 (331)
Q Consensus 118 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 197 (331)
.++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.............
T Consensus 171 ~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 171 CYLAA-----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 77754 236889999999999999999999998 9999999999999999999999999997543322223334
Q ss_pred ccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc--chHHHHHHHhhcC--ccc--------
Q 020102 198 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV--SLAAYFVHSMRKN--RLY-------- 265 (331)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~--~~~-------- 265 (331)
..||+.|+|||++.+..++.++|||||||++|||++|+.||+.......... ............. ...
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 5799999999999999999999999999999999999998865422111000 0000000000000 000
Q ss_pred ccc---------chHhh--ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 266 DIL---------DDQVM--KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 266 ~~~---------~~~~~--~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
... .+... .......+.++.+|+.+||+.||++|||++|+++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 00000 0001134567899999999999999999999975
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=298.19 Aligned_cols=244 Identities=23% Similarity=0.252 Sum_probs=183.1
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||+||+|.+. +++.+|+| +|||++++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999984 67889998 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|++++.+.. +.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~-~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLEL-LEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHH-HHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999776643 332 1246899999999999999999999988 99999999999999999999999999986643
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc------c-hHHHHHHHhhcC
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV------S-LAAYFVHSMRKN 262 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~------~-~~~~~~~~~~~~ 262 (331)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||........... . ............
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 333233345689999999999998899999999999999999999999865321110000 0 000000000000
Q ss_pred ccccccchH------hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQ------VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~------~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.......+. .........+..+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 000111224567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=309.61 Aligned_cols=228 Identities=23% Similarity=0.337 Sum_probs=196.2
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCc-ceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEV-PLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~-~~lv~ 108 (331)
++|..++.+|+|+||.++...+ .++..+++| +|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788999999999999999876 467789999 49999999999999998 99999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
+||+||++.+.+.... +..++++.+..|+.|++.|+.|||+.. |+|||||+.||+++.++.++|+|||+|+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999998742 457999999999999999999999887 9999999999999999999999999999876
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... ....++.||+.|++||++.+.+|..|+|||||||++|||++-+++|...+... .+....
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--------Li~ki~--------- 219 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--------LILKIN--------- 219 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--------HHHHHh---------
Confidence 544 24456789999999999999999999999999999999999999996543211 111111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.....+.+..++.++..++..||+.+|+.||++.+++.+
T Consensus 220 -~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 -RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111234566788899999999999999999999999887
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=310.20 Aligned_cols=234 Identities=28% Similarity=0.491 Sum_probs=195.2
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------ccccchhhhcccccCCcceeEeecccCCC
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------KSKNAVKLLGCCLETEVPLLVYEFISNGT 115 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~ 115 (331)
+..+.....++.||.|+.|.||+|.. .++.|||| +|+||+.+.|+|.....++||||||..|-
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 33344445568899999999999987 47789999 48999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceee
Q 020102 116 LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 195 (331)
Q Consensus 116 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 195 (331)
|+..|+. +.+++......|..+||.|+.|||.+. |+|||||.=||||+.+..+||+|||.++....- ...
T Consensus 199 L~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 199 LYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred HHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 9999976 457888999999999999999999988 999999999999999999999999998855432 333
Q ss_pred eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhcc
Q 020102 196 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKL 275 (331)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (331)
..+.||..|||||++.+.+.++|+||||||||||||+||..||.+.+... + +..+-...+..+
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---I--------------IwGVGsNsL~Lp 331 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---I--------------IWGVGSNSLHLP 331 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---e--------------EEeccCCccccc
Confidence 45789999999999999999999999999999999999999997543211 0 111111222333
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 276 GKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 276 ~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
.+..++..|.=|+++||+..|..|||+.+|+..|+...
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 45666778889999999999999999999999997653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=299.60 Aligned_cols=222 Identities=25% Similarity=0.357 Sum_probs=182.8
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999984 68899998 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.+|.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999998865 246899999999999999999999998 9999999999999999999999999987653
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ ....
T Consensus 153 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~-~~~~---- 215 (291)
T cd05612 153 DR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKIL-AGKL---- 215 (291)
T ss_pred CC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCCc----
Confidence 32 1234689999999999999999999999999999999999999864321 00111111 1110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~~ 308 (331)
..+...+..+.+++.+||+.||.+||+ ++++++.
T Consensus 216 ------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112233557899999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=295.96 Aligned_cols=233 Identities=21% Similarity=0.352 Sum_probs=185.6
Q ss_pred hcCCccCceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.++|++.+.||+|+||.||+|... .+..||+| +|||++++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999752 36688888 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999888652 246899999999999999999999988 99999999999999999999999998764
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.............++..|+|||.+.+..++.++|||||||++||+++ |..||...... . .......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~-~~~~~~~~~-- 225 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------D-VIKAVEDGF-- 225 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------H-HHHHHHCCC--
Confidence 32221111112335678999999999999999999999999999775 99998643110 0 111111111
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
....+...+..+.+++..||+.+|++|||+++|.+.|..+
T Consensus 226 -------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1112334556789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.26 Aligned_cols=224 Identities=27% Similarity=0.420 Sum_probs=190.5
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
+-|++++-||+|+-|.|-+|.+ .+|+.+||| .|||++.+++++.++..+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578889999999999999987 679999999 4899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||++||.|.+++.. .+++++..+..++.||+.|+.|||..+ |||||+||+|+|+|..+++||+|||+|..-.
T Consensus 92 Eyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999999999976 468999999999999999999999998 9999999999999999999999999997533
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
. ...-.+.+|+|.|.|||++.|.+|. .++||||+|||||.|+||+.||.+.. +.... .....+.+
T Consensus 164 ~--gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--------ir~LL-lKV~~G~f--- 229 (786)
T KOG0588|consen 164 P--GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--------IRVLL-LKVQRGVF--- 229 (786)
T ss_pred C--CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------HHHHH-HHHHcCcc---
Confidence 2 2344556899999999999999985 58999999999999999999996321 11111 11122211
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+.++.+|+.+||..||+.|.|++||+++
T Consensus 230 -------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2345667789999999999999999999999876
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=297.42 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=182.8
Q ss_pred cCCccCceecCCCCeEEEEEEecC-----------------CcEEEEc------------------------ccccchhh
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRED-----------------GRIIAVK------------------------KSKNAVKL 94 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK------------------------~~~niv~~ 94 (331)
++|.+.+.||+|+||.||+|.+.+ +..||+| .||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 3368888 38899999
Q ss_pred hcccccCCcceeEeecccCCCHHHHHhhhhc--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 020102 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQ--------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYH 160 (331)
Q Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H 160 (331)
++++.+.+..++||||+++++|.+++..... .....+++..+..++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999998865321 11234788899999999999999999998 999
Q ss_pred ccCCCCCEEeCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh--CCCC
Q 020102 161 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKP 237 (331)
Q Consensus 161 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~~p 237 (331)
|||||+||+++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999755433221 1222345788999999988899999999999999999987 4556
Q ss_pred CCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 238 IFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
|..... .. ................ ....++..+..+.+++.+||+.+|++|||+++|.+.|+
T Consensus 242 ~~~~~~--~~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD--EQ---VIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH--HH---HHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 643211 10 0111111111110000 00112234567899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=309.02 Aligned_cols=240 Identities=26% Similarity=0.429 Sum_probs=187.1
Q ss_pred HhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhhhcccccCC
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~~~~~~~~~ 102 (331)
..++|++.+.||+|+||.||+|.+ .++..||+| .|+||+++++++....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345789999999999999999874 234579998 3889999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhc---------------------------------------------------------
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQ--------------------------------------------------------- 125 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 125 (331)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998854210
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee-ee
Q 020102 126 --------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TT 196 (331)
Q Consensus 126 --------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 196 (331)
....++++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++.......... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 01235788899999999999999999988 9999999999999999999999999997654332211 11
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhcc
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKL 275 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (331)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ......... ....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--------~~~~~~~~~---------~~~~ 335 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--------KFYKMVKRG---------YQMS 335 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--------HHHHHHHcc---------cCcc
Confidence 2335667999999998899999999999999999997 999986432110 011111111 0011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 276 GKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 276 ~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
.+...+.++.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11223467899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=287.96 Aligned_cols=242 Identities=21% Similarity=0.253 Sum_probs=184.5
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhccccc--CCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLE--TEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~--~~~~~lv 107 (331)
++|+.++.|++|+||.||+|.+ ++++.||+|+ |||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 5678889999999999999998 5799999993 8999999888765 3468999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
||||+ -+|...+... ..++...++..++.|++.|++|||... |+||||||+|+|++..|.+||+|||+|+.+
T Consensus 156 Me~~E-hDLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHH-hhHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99997 5677777653 358999999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
+.+... .+..+-|.+|+|||++.+. .|+...|+||+|||+.||+++++-|...+...+....+ ..........++.
T Consensus 228 gsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If--~llGtPte~iwpg 304 (419)
T KOG0663|consen 228 GSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF--KLLGTPSEAIWPG 304 (419)
T ss_pred cCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH--HHhCCCccccCCC
Confidence 766433 3445679999999988876 58999999999999999999977665432222111100 0001111112222
Q ss_pred ccc--------------hHhhccCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILD--------------DQVMKLGKK-NQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~--------------~~~~~~~~~-~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
+.. ..++....- ..++...+|+..+|..||.+|.|++|.++.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111 111111111 144678899999999999999999998754
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=304.51 Aligned_cols=230 Identities=25% Similarity=0.339 Sum_probs=185.4
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999985 58899999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999998865 246889999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||..... . ............ .
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~------~~~~~i~~~~~~---~ 217 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--N------ETWENLKYWKET---L 217 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--H------HHHHHHHhcccc---c
Confidence 2 22345689999999999999999999999999999999999999864311 0 001111100000 0
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
............+..+.+++.+||+.+|.+|||++++++.
T Consensus 218 ~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000000012346678999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.14 Aligned_cols=228 Identities=23% Similarity=0.319 Sum_probs=182.6
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.|+..+.||+|+||.||+|.+ .+++.||+| .|+|++++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999987 578999999 26789999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++|+|.+.+... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998877542 2336899999999999999999999998 99999999999999999999999999976532
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..........
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-----~~~~~~~~~~------- 220 (285)
T cd05631 155 GE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-----EEVDRRVKED------- 220 (285)
T ss_pred CC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-----HHHHHHhhcc-------
Confidence 22 223346899999999999999999999999999999999999999654221110 0011111000
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSM 307 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~ 307 (331)
....+...+..+.+|+.+||+.||++||| ++++++
T Consensus 221 ---~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 ---QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01122345667899999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=293.36 Aligned_cols=234 Identities=23% Similarity=0.409 Sum_probs=188.9
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.++|++.+.||+|+||.||+|...++..||+| .|+|++++++.+...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35688999999999999999998888889998 37899999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 85 KGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999988652 2346888999999999999999999988 99999999999999999999999999986543322
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... . ..........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~-~~~~~~~~~~------- 222 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------D-VMSALQRGYR------- 222 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------H-HHHHHHcCCC-------
Confidence 22223345678999999998889999999999999999998 89998532110 0 1111111100
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
.+.....+..+.+++.+||+.+|++|||++++.+.|+.+
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 --MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011223456789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=309.91 Aligned_cols=221 Identities=27% Similarity=0.346 Sum_probs=185.4
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~ 104 (331)
...++|.+.++||+|+||.|+++.. .+++.+||| +||.+++++.+|...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3457899999999999999999987 468899999 499999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
+.||||+.||++..+.. ...+++..+..++..|+.||+|||+++ |++||||.+|||+|.+|.+||+|||++
T Consensus 445 ~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 99999999998433222 347999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
+...... ..+.+++|||.|+|||++.+..|+.++|.|||||++|||+.|..||...+.. ..+...+..+
T Consensus 516 Ke~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------e~FdsI~~d~-- 584 (694)
T KOG0694|consen 516 KEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------EVFDSIVNDE-- 584 (694)
T ss_pred cccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcCC--
Confidence 8644333 3566789999999999999999999999999999999999999999643211 1111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
...+...+.+..+++.++|..+|++|..+
T Consensus 585 ---------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ---------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11355567789999999999999999855
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.50 Aligned_cols=240 Identities=25% Similarity=0.322 Sum_probs=182.6
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------cccchhhhcccccCC-----cceeEeecc
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------SKNAVKLLGCCLETE-----VPLLVYEFI 111 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------~~niv~~~~~~~~~~-----~~~lv~e~~ 111 (331)
.|...+++|+|+||.||.|.. .+++.||||+ |||||++.-+|.... ...+||||+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 467779999999999999997 4579999994 999999988886432 356899999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEeeccCcccccCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMD 190 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~ 190 (331)
+ .+|.+.+..+. ..+..++...+..+..||++||+|||+.+ ||||||||.|+|+|.+ |.+||||||.|+.+..+
T Consensus 105 P-~tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 105 P-ETLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred h-HHHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 8 78988887643 33457888899999999999999999988 9999999999999954 99999999999987655
Q ss_pred CceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC-------
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN------- 262 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 262 (331)
... .+...|..|+|||++.|. .|+.+.||||.||++.||+-|++-|.+.+...+. ......+...
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL-----~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL-----VEIIKVLGTPTREDIKS 252 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH-----HHHHHHhCCCCHHHHhh
Confidence 443 345679999999988776 6999999999999999999998776543221111 1111111111
Q ss_pred --------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 --------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+.+.............+.+..+|+.++|+.+|.+|.|+.|++..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111111111233456689999999999999999999999754
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=274.13 Aligned_cols=226 Identities=28% Similarity=0.386 Sum_probs=191.2
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.+.|++.+.||+|-||.||.|.. +++..||+| +||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46789999999999999999986 578889999 499999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
+||..+|+++..|... ....+++.....+..|+|.|+.|+|.++ |+||||||+|+|++.+|.+||+|||-+...
T Consensus 101 lEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999852 3457889999999999999999999988 999999999999999999999999998644
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
. .....+.+||..|.|||+..+..++..+|+|++|++.||++.|..||..... .........
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~k------- 236 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIRK------- 236 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHHH-------
Confidence 3 3344567899999999999999999999999999999999999999965421 011111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
+....+...+..+.++|..||..+|.+|.+..|+++.
T Consensus 237 ----~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 ----VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1112234556678999999999999999999999764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=308.46 Aligned_cols=239 Identities=26% Similarity=0.408 Sum_probs=186.1
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhhhcccccC
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKLLGCCLET 101 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~~~~~~~~ 101 (331)
...++|++.+.||+|+||+||+|.. .++..|||| .||||+++++++.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3345789999999999999999963 245678888 389999999999999
Q ss_pred CcceeEeecccCCCHHHHHhhhhc--------------------------------------------------------
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQ-------------------------------------------------------- 125 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 125 (331)
+..++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999998864210
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 126 --------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 126 --------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
.....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 11235788999999999999999999988 9999999999999999999999999997654332
Q ss_pred cee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 192 THV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 192 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ........+..
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~----- 335 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--------KFYKMIKEGYR----- 335 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--------HHHHHHHhCcc-----
Confidence 211 112334567999999999999999999999999999998 888875321110 11111111110
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
...+...+.++.+|+.+||+.||++|||+.||++.|+.
T Consensus 336 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 ----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 01112234578999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=316.51 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=199.1
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEecCC-cEEEEcc------------------------cccchhhhcccc-c-----
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMREDG-RIIAVKK------------------------SKNAVKLLGCCL-E----- 100 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~------------------------~~niv~~~~~~~-~----- 100 (331)
.....++++.+.|.+|||+.||.|.+..+ ..||+|+ |+|||.+++... .
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456778889999999999999998665 9999994 899999999422 1
Q ss_pred -CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEe
Q 020102 101 -TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179 (331)
Q Consensus 101 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~ 179 (331)
.-.++|.||||.||+|-+++..++.. .|++.++++|+.|+++|+++||.+. ++|+|||||-+||||+.+|..|||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeC
Confidence 12468999999999999999987543 3999999999999999999999986 789999999999999999999999
Q ss_pred eccCcccccCCCc-eeee-------eccccCCccChhhh---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc
Q 020102 180 DFGTSKFIAMDQT-HVTT-------KIQGTFGYLDPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248 (331)
Q Consensus 180 Dfg~a~~~~~~~~-~~~~-------~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~ 248 (331)
|||.|........ .... ...-|+.|+|||++ .+.++++|+|||+|||+||-|+....||...+.
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----- 263 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----- 263 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----
Confidence 9999874322221 1100 12358999999965 577899999999999999999999999965421
Q ss_pred cchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchhh
Q 020102 249 VSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAM 322 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~~ 322 (331)
..++...-..+..+.++..+.+||..||+.||.+||++-||+..+-.+....-+-.+.
T Consensus 264 ----------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 264 ----------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred ----------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 2333444444556789999999999999999999999999999999887755444433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=303.36 Aligned_cols=219 Identities=25% Similarity=0.349 Sum_probs=178.7
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.||+|+||.||+|.+ .+++.||+| .||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 568899999 3889999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 151 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cc
Confidence 99888865 347899999999999999999999998 9999999999999999999999999987432221 22
Q ss_pred eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhc
Q 020102 195 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274 (331)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ........
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~-~~~~~~~~---------- 212 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLF-ELILMEEI---------- 212 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHH-HHHHcCCC----------
Confidence 23456999999999999999999999999999999999999999643110 001 11111110
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 275 LGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 275 ~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
..+...+..+.+++.+||+.||++|| ++.++++.
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11233456789999999999999999 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=296.64 Aligned_cols=238 Identities=23% Similarity=0.334 Sum_probs=179.5
Q ss_pred cCCccCceecCCCCeEEEEEEe--cCCcEEEEc----------------------------ccccchhhhcccc-----c
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR--EDGRIIAVK----------------------------KSKNAVKLLGCCL-----E 100 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK----------------------------~~~niv~~~~~~~-----~ 100 (331)
++|++.+.||+|+||.||+|.+ .++..||+| .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3689999999999999999987 246788888 2889999999875 3
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
....++||||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence 456899999997 6888888652 2346899999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
||++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .. .......
T Consensus 154 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~----~~-~i~~~~~ 226 (290)
T cd07862 154 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----LG-KILDVIG 226 (290)
T ss_pred ccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH----HH-HHHHHhC
Confidence 9999765432 222345689999999999988999999999999999999999999865322110 00 0000000
Q ss_pred ---cCccccc---cchH-------hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 261 ---KNRLYDI---LDDQ-------VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 261 ---~~~~~~~---~~~~-------~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+... .... ......+..+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 0000 000011234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=294.28 Aligned_cols=238 Identities=24% Similarity=0.369 Sum_probs=186.8
Q ss_pred CcccccChHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc--------------------------ccccchhh
Q 020102 41 DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK--------------------------KSKNAVKL 94 (331)
Q Consensus 41 ~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK--------------------------~~~niv~~ 94 (331)
.+.+..+.++++. .-...||+|+++.||+|.. +++.||+| .||||+++
T Consensus 10 ~~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 10 NDIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred CcceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 3444455555522 2235799999999999987 68899999 38899999
Q ss_pred hccccc----CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEE
Q 020102 95 LGCCLE----TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNIL 169 (331)
Q Consensus 95 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nil 169 (331)
++++.+ ....++||||+++|+|.+.+.. ...+++.....++.|++.|+.|||+. + ++||||||+||+
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nil 155 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFL 155 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEE
Confidence 999876 3467899999999999998865 24688999999999999999999984 6 889999999999
Q ss_pred eCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 020102 170 LDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247 (331)
Q Consensus 170 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~ 247 (331)
+++++.+||+|||++....... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 156 l~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---- 227 (283)
T PHA02988 156 VTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---- 227 (283)
T ss_pred ECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----
Confidence 9999999999999987553321 22357899999999876 6789999999999999999999999964311
Q ss_pred ccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 248 NVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
..........+.. ...+...+..+.+++.+||+.||++|||++|+++.|+.++
T Consensus 228 ----~~~~~~i~~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 228 ----KEIYDLIINKNNS---------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ----HHHHHHHHhcCCC---------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0111111111111 1112235667999999999999999999999999998875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.80 Aligned_cols=229 Identities=26% Similarity=0.343 Sum_probs=181.2
Q ss_pred CCccCceecCCCCeEEEEEEe----cCCcEEEEc----------------------------ccccchhhhcccccCCcc
Q 020102 57 HFNVNRILGQGGQGTVYKGMR----EDGRIIAVK----------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK----------------------------~~~niv~~~~~~~~~~~~ 104 (331)
+|++.+.||+|+||+||++.+ .+++.||+| .|+|++++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999876 357889998 267999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999998865 236899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
...............||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+........
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----~~~~~~~~~~~ 227 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-----SEVSRRILKCD 227 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-----HHHHHHHhcCC
Confidence 76543333333345799999999998875 4788999999999999999999999643211110 01111111100
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
...+...+..+.+++.+||+.||++|| +++++++.
T Consensus 228 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 ----------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011223455788999999999999999 66677643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=289.84 Aligned_cols=233 Identities=27% Similarity=0.416 Sum_probs=187.0
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
..|.+.+.||+|+||.||+|.+. .+..+++| .|+|++++++++..++..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45778899999999999999874 58889999 37899999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 86 ~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 86 YGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999988652 2346899999999999999999999988 99999999999999999999999999976544322
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... . .... .....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~------~~~~-~~~~~--------- 221 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--S------QVYE-LLEKG--------- 221 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H------HHHH-HHHCC---------
Confidence 22222334668999999999999999999999999999998 8888753211 0 1111 11111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
.....+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01112233456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=300.90 Aligned_cols=239 Identities=28% Similarity=0.420 Sum_probs=185.4
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||.||++.+. ++..+|+| .|||++++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367899999999999999999984 67888888 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999998865 236889999999999999999999852 299999999999999999999999999875532
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc--C-----
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK--N----- 262 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~----- 262 (331)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ......... .
T Consensus 157 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-----AIFGRPVVDGEEGEPHS 228 (331)
T ss_pred c---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHhcccccccccCCccc
Confidence 2 123346899999999999999999999999999999999999999643211000 000000000 0
Q ss_pred -----------------------cccc----ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 -----------------------RLYD----ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 -----------------------~~~~----~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... +.....+......++.++.+|+.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 000000111122356789999999999999999999999876
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=298.44 Aligned_cols=222 Identities=24% Similarity=0.366 Sum_probs=176.0
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|.+ .+++.||+| .||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 457889988 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|...+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~ 151 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-C
Confidence 999887754 246899999999999999999999998 9999999999999999999999999987532221 1
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........................
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------- 222 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------- 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------
Confidence 22345689999999999999999999999999999999999999964322221111111111111111111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
..+...+..+.+++.+||+.||++|||+
T Consensus 223 -~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1223345678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=306.13 Aligned_cols=229 Identities=27% Similarity=0.341 Sum_probs=185.7
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||+||+|.+. +++.||+| .|+|++++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999984 68999999 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999988762 47899999999999999999999988 9999999999999999999999999997654
Q ss_pred CCC----------------------------ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 020102 189 MDQ----------------------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 240 (331)
Q Consensus 189 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~ 240 (331)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 1122335689999999999999999999999999999999999999965
Q ss_pred CCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 020102 241 AGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-MEEVSME 308 (331)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-~~evl~~ 308 (331)
.... .......... .....+.....+..+.+++..||+ +|.+||+ ++++++.
T Consensus 233 ~~~~--------~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTLQ--------ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCHH--------HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 3210 0111111100 000111111246679999999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=293.69 Aligned_cols=236 Identities=27% Similarity=0.441 Sum_probs=188.0
Q ss_pred cCCccCceecCCCCeEEEEEEecC------CcEEEEc------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRED------GRIIAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
+.|++.+.||+|+||.||+|.... ...|++| .|||++++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998632 2568888 3789999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQE-----------FPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY 174 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~ 174 (331)
++|||+++++|.+++........ ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999876322111 46888999999999999999999988 99999999999999999
Q ss_pred cEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchH
Q 020102 175 RAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 175 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~ 252 (331)
.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999875433221 12223346788999999988899999999999999999998 99998643210
Q ss_pred HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
.....+..... ...+...+..+.+|+.+||+.+|.+|||+.||++.|+.+
T Consensus 234 -~~~~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 -EVIEMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHHHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111111 112345567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=294.67 Aligned_cols=243 Identities=21% Similarity=0.253 Sum_probs=180.2
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||+|+||+||+|.+. ++..||+| +|||++++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46889999999999999999874 68889998 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
++ ++|.+.+... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 97 5888877542 335788999999999999999999998 999999999999999999999999998754332
Q ss_pred CceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc-------chHHHHHHHhhcC
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV-------SLAAYFVHSMRKN 262 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~ 262 (331)
.. ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||........... .....+.......
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 21 1223457899999998865 5688999999999999999999999864321110000 0000000000000
Q ss_pred ccccccchHhh----ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQVM----KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.+.....+... .......+.++.+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000 0011223457899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=298.83 Aligned_cols=223 Identities=26% Similarity=0.368 Sum_probs=182.6
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|.+.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357899999999999999999974 68899999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+.+++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 97 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 97 LEFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EcCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 999999999998875 236889999999999999999999998 999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... . ... .....+..
T Consensus 169 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~------~~~-~~i~~~~~--- 232 (329)
T PTZ00263 169 PDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--F------RIY-EKILAGRL--- 232 (329)
T ss_pred CCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--H------HHH-HHHhcCCc---
Confidence 3321 234689999999999999999999999999999999999999964311 0 011 11111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~~ 308 (331)
..+...+..+.+|+.+||+.||++||+ +++++..
T Consensus 233 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 012223456889999999999999997 5666543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=289.82 Aligned_cols=245 Identities=25% Similarity=0.333 Sum_probs=182.7
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc-----CC
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE-----TE 102 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~-----~~ 102 (331)
....|...+.||+|+||.|+.|.+ .+|+.|||| +|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345666679999999999999997 579999999 48899999998865 44
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..|+|+|+|+ .+|...++. +..++.+.+..++.|++.||.|+|+.+ |+|||+||.|++++.+..+||+|||
T Consensus 100 DvYiV~elMe-tDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHHh-hHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 6899999994 777777764 335999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCC-CceeeeeccccCCccChhhh-cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc------hHHH
Q 020102 183 TSKFIAMD-QTHVTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS------LAAY 254 (331)
Q Consensus 183 ~a~~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~------~~~~ 254 (331)
+|+..... .....+..+.|.+|+|||++ ....|+.+.||||+|||+.||++|+.-|.+.+...+.... ....
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99976432 12333567789999999965 5567999999999999999999998877543322111100 0000
Q ss_pred HHHHhhcCccccccchHhh-------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 255 FVHSMRKNRLYDILDDQVM-------KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....+........+. .++ ...-+......++|+.+||..||.+|+|++|+++.
T Consensus 251 ~l~~i~s~~ar~yi~-slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIK-SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHH-hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111000000000 000 00112445578999999999999999999999765
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=307.45 Aligned_cols=244 Identities=27% Similarity=0.492 Sum_probs=192.3
Q ss_pred hHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCC
Q 020102 48 SKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 48 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~ 102 (331)
.++++...+...+...||+|+||+||+|.+. ..|||| +|-||+-+.|+|...+
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3667777778888999999999999999884 358888 5889999999999888
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
. .||+-+|+|-+|+.+|... +..+...+.+.|++||++|+.|||.++ |+|||||..||++.+++.|||+|||
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred e-eeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 7 9999999999999999753 346889999999999999999999999 9999999999999999999999999
Q ss_pred CcccccC-CCceeeeeccccCCccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 183 TSKFIAM-DQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 183 ~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
++..-.. ..........|...|||||++.- .+|+..+||||||+++|||+||..||... ..++ +.. .
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq--Iif------m 604 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ--IIF------M 604 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh--eEE------E
Confidence 9863221 11122233457889999998864 47999999999999999999999999722 1111 100 0
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
...+-+ . .-......+...++.+|+..||..++++||.+.+|+..|..+..+
T Consensus 605 VGrG~l---~--pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 605 VGRGYL---M--PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred eccccc---C--ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 001100 0 001112345566899999999999999999999999988887764
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=297.46 Aligned_cols=227 Identities=24% Similarity=0.362 Sum_probs=178.5
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||.||+|.+ .+++.||+| .||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999987 468889998 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~ 151 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GD 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CC
Confidence 999887764 247899999999999999999999998 999999999999999999999999998743221 12
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+......................
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--------- 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------
Confidence 22345789999999999999999999999999999999999999964322211111111111111111111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPT------MEEVSM 307 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs------~~evl~ 307 (331)
..+...+..+.+++.+||+.||.+||| ++++++
T Consensus 223 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 -RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112334567899999999999999998 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=289.06 Aligned_cols=230 Identities=27% Similarity=0.412 Sum_probs=184.4
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
++|++.+.||+|+||.||++..+++..+|+| .|||++++++++......++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4578889999999999999988877789998 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 84 ~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 84 GCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999887642 235889999999999999999999988 999999999999999999999999998765433222
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
......++..|+|||.+.+..++.++|+||||+++|||++ |+.||..... ...... ...+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~-i~~~~~~------- 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEM-ISRGFRL------- 220 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH-HHCCCCC-------
Confidence 2222345668999999998889999999999999999999 8888854311 011111 1111110
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
..+...+..+.+++.+||+.+|++|||++++++.|.
T Consensus 221 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 --YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011123457899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=288.73 Aligned_cols=234 Identities=26% Similarity=0.411 Sum_probs=188.0
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.++|++.+.||+|++|.||+|...++..||+| .|+|++++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 45688899999999999999998777889999 37899999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 85 YGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred CCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999988652 2346899999999999999999999988 99999999999999999999999999986653222
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
........+..|+|||.+.+..++.++|+||||+++|||++ |+.||..... ...........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~-------- 221 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---------AEVLQQVDQGY-------- 221 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHHcCC--------
Confidence 11111223457999999999899999999999999999999 8888853210 00111111110
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 -RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0011223456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=313.47 Aligned_cols=230 Identities=25% Similarity=0.328 Sum_probs=186.2
Q ss_pred cCCccCceecCCCCeEEEEEEec-C-CcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-D-GRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
..|.+.+.||+|+||.||+|.+. + +..|++| .||||+++++++..++..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34899999999999999999873 3 5778888 389999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++|+|.+.+..... ...++++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+...
T Consensus 147 ~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999998875432 2347899999999999999999999988 999999999999999999999999999865432
Q ss_pred Cc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 191 QT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 191 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+...
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~-~~~~~---- 289 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVL-YGKYD---- 289 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCCCC----
Confidence 21 123345699999999999999999999999999999999999999854311 01111111 11110
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...+..+.+++..||+.+|++|||+.+++.
T Consensus 290 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112234567899999999999999999999865
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=293.79 Aligned_cols=240 Identities=23% Similarity=0.331 Sum_probs=179.7
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| .|||++++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999985 68899999 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+. ++|.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 996 677777754 2346889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc---Ccc-
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK---NRL- 264 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~- 264 (331)
.. .......+|+.|+|||++.+. .++.++||||+||++|+|++|..||......... +. ........ ..+
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~-~~~~~~~~~~~~~~~ 230 (303)
T cd07869 156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ---LE-RIFLVLGTPNEDTWP 230 (303)
T ss_pred CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH---HH-HHHHHhCCCChhhcc
Confidence 22 122234588999999988654 5788999999999999999999999643211000 00 00000000 000
Q ss_pred -----ccccchHhhc---------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 265 -----YDILDDQVMK---------LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 265 -----~~~~~~~~~~---------~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.......... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 001112356889999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=318.50 Aligned_cols=239 Identities=30% Similarity=0.486 Sum_probs=198.1
Q ss_pred cCCccCceecCCCCeEEEEEEe------cCCcEEEEc------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
.+.+..+.||+|.||.||+|.. .+...|||| .|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 4456678999999999999975 346679999 4999999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcC-----C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 106 LVYEFISNGTLYQHLHDRLQN-----Q----EFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~-----~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
+|+|||..|+|.++|...... . ..+++..+.+.|+.|||.|+.||-++. +|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 999999999999999764211 1 234888999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccccCCCceeee-eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHH
Q 020102 177 KVADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~ 254 (331)
||+|||+++.+...+..... ...-..+|||||.+..+.||.+||||||||+|||+++ |+.||+...+ ..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---------~E 713 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---------QE 713 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---------HH
Confidence 99999999866544433222 1223568999999999999999999999999999998 8999976533 22
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
+...++.+.+ -..+.+.+..+++|+..||+.+|++|||+.||-..|+..-..
T Consensus 714 VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 4555555544 234566777899999999999999999999999999886543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=297.11 Aligned_cols=217 Identities=24% Similarity=0.361 Sum_probs=175.7
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||.||+|.+ .+++.||+| .||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 457889999 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|+|...+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 999888865 236899999999999999999999988 9999999999999999999999999987543222 2
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~-i~~~~---------- 212 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDS-ILNDR---------- 212 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHcCC----------
Confidence 23345689999999999999999999999999999999999999964321 001111 11100
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTME-EVS 306 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~-evl 306 (331)
...+...+..+.+++.+||+.+|++||++. +++
T Consensus 213 ~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 213 PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 011223455788999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=288.27 Aligned_cols=233 Identities=26% Similarity=0.443 Sum_probs=189.3
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
..+|.+.+.||.|+||.||+|.+.++..+++| .|+|++++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34688899999999999999998778899999 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 85 EKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999988752 2346899999999999999999999988 9999999999999999999999999997654322
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ........ ..
T Consensus 159 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~-~~-------- 220 (261)
T cd05148 159 Y-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQIT-AG-------- 220 (261)
T ss_pred c-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHH-hC--------
Confidence 1 1223345678999999998889999999999999999998 8888853210 01111111 11
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
.....+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 -YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 01112334456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=301.18 Aligned_cols=223 Identities=24% Similarity=0.335 Sum_probs=182.4
Q ss_pred hcCCccCceecCCCCeEEEEEEecC--CcEEEEc--------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRED--GRIIAVK--------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK--------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.++|.+.+.||+|+||.||+|.+.. +..||+| .||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4568999999999999999998633 3678998 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++|+|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 109 v~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999998865 246899999999999999999999998 99999999999999999999999999976
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||...... ..... ......
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~-i~~~~~-- 245 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQK-ILEGII-- 245 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHH-HhcCCC--
Confidence 5322 22356899999999999988999999999999999999999999643210 00111 111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
..+...+..+.+++.+||+.+|++|+ |++++++.
T Consensus 246 --------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 --------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01223345688999999999999995 78888654
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=297.13 Aligned_cols=213 Identities=27% Similarity=0.388 Sum_probs=174.2
Q ss_pred ceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|.+. +++.||+| .|||++++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 58889999 278999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~ 151 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-K 151 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-C
Confidence 999888765 236899999999999999999999988 9999999999999999999999999987532222 1
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~-~i~~~~~--------- 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFE-AILNDEV--------- 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHH-HHhcCCC---------
Confidence 223456899999999999999999999999999999999999999643210 1111 1111111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
..+...+..+.+++.+||+.||++||++
T Consensus 214 -~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 -VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122345678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.32 Aligned_cols=238 Identities=25% Similarity=0.387 Sum_probs=189.4
Q ss_pred cChHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------------------c
Q 020102 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------------------K 87 (331)
Q Consensus 46 ~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------------------~ 87 (331)
+...+-.+..++|++...||+|.||.|-+|.+ .+++.|||| .
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 33445556678999999999999999999997 579999999 3
Q ss_pred cccchhhhccccc--CCcceeEeecccCCCHHHHHhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCC
Q 020102 88 SKNAVKLLGCCLE--TEVPLLVYEFISNGTLYQHLHDRLQNQEFP-LTWEMRLRIATEVAGALAYLHSAASSPIYHRDIK 164 (331)
Q Consensus 88 ~~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dik 164 (331)
|||||+++.+..+ .+.+|||+|||..|.+.. . ....+ +++.+++.++++++.||.|||.++ |+|||||
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w-~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIK 237 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW-C-----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIK 237 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCcccc-C-----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccc
Confidence 8899999999876 457899999999887643 1 22345 899999999999999999999999 9999999
Q ss_pred CCCEEeCCCCcEEEeeccCcccccCCC----ceeeeeccccCCccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCC
Q 020102 165 STNILLDERYRAKVADFGTSKFIAMDQ----THVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKK 236 (331)
Q Consensus 165 p~Nill~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~ 236 (331)
|+|+||+++|++||+|||.+....... .......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 999999999999999999987552211 11122357999999999877643 3457899999999999999999
Q ss_pred CCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 237 PIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 237 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
||+.... ... ...++...+..+..++..+.+.+||.++|+.||+.|.+..+|....
T Consensus 318 PF~~~~~--------~~l---------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 318 PFFDDFE--------LEL---------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred CcccchH--------HHH---------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 9975311 001 1123334444444556778899999999999999999999997664
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=313.44 Aligned_cols=238 Identities=27% Similarity=0.345 Sum_probs=187.1
Q ss_pred HHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhcccccCC
Q 020102 49 KELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLETE 102 (331)
Q Consensus 49 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~~~ 102 (331)
.+.....++|.+.+.||+|+||+||+|.+ .+++.||||. |+|+++++..+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34455678999999999999999999987 5789999993 557777666554322
Q ss_pred --------cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 020102 103 --------VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY 174 (331)
Q Consensus 103 --------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~ 174 (331)
..++||||+++|+|.+.+..... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG 180 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence 25799999999999998876432 3357899999999999999999999988 99999999999999999
Q ss_pred cEEEeeccCcccccCCC-ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 020102 175 RAKVADFGTSKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA 253 (331)
Q Consensus 175 ~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~ 253 (331)
.+||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~ 252 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------EE 252 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HH
Confidence 99999999997654322 1223345799999999999999999999999999999999999999854211 11
Q ss_pred HHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...... .+.. ...+...+..+.+++..||+.+|.+|||+.++++.
T Consensus 253 ~~~~~~-~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 VMHKTL-AGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHh-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 1111 11233455679999999999999999999999764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=296.84 Aligned_cols=218 Identities=27% Similarity=0.317 Sum_probs=175.8
Q ss_pred ecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 64 LGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 64 lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
||+|+||.||+|.+. +++.||+| .||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999984 58889999 388999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeee
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 196 (331)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 998865 246899999999999999999999998 9999999999999999999999999987533222 2233
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccC
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......... .. ...
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~-~~----------~~~ 212 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQ-EP----------LRF 212 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHc-CC----------CCC
Confidence 45699999999999999999999999999999999999999964311 111111111 10 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 277 KKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 277 ~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
+...+..+.+++.+||+.||++||++..+.+.|
T Consensus 213 ~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 213 PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 233456789999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=286.97 Aligned_cols=232 Identities=23% Similarity=0.408 Sum_probs=186.2
Q ss_pred cCCccCceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|.+.+.||+|+||.||+|... +...||+| .|||++++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56889999999999999999873 24578888 378999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++... ...+++..+..++.|++.|+.|||+.+ |+|+||+|+||++++++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999988652 236899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 188 AMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 188 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---------~~~~~~~~~~-- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---------DVIKAVEDGY-- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---------HHHHHHHcCC--
Confidence 422211 1222335678999999999899999999999999999998 99998542110 0111111110
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
....+...+..+.+++.+||+.+|++||++++|+++|+++
T Consensus 226 -------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=286.65 Aligned_cols=230 Identities=25% Similarity=0.382 Sum_probs=183.8
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
..|.+.+.||+|+||+||.|...++..+|+| .|||++++++++......+++|||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 3578889999999999999987766678999 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+++... ...+++..++.++.||+.|+.|||+.+ ++|+||+|+||+++.++.+||+|||.+.....+...
T Consensus 84 ~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 84 GCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999988652 236899999999999999999999988 999999999999999999999999998765433222
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ...... ..+...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~-~~~~~~------- 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKV-SQGLRL------- 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHH-hcCCCC-------
Confidence 2222335678999999998889999999999999999998 98998533210 011111 111110
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111223567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=297.42 Aligned_cols=218 Identities=27% Similarity=0.354 Sum_probs=177.2
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.||+|+||.||++.+ .++..||+| .|||++++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999987 468899999 3889999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 151 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cc
Confidence 99887764 246899999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhc
Q 020102 195 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274 (331)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~-~~~~---------- 212 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELIL-MEEI---------- 212 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHh-cCCC----------
Confidence 23356899999999999999999999999999999999999999643211 0011111 1110
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 020102 275 LGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSM 307 (331)
Q Consensus 275 ~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~ 307 (331)
..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11223456789999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=297.48 Aligned_cols=219 Identities=25% Similarity=0.351 Sum_probs=178.1
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.||+|+||.||++.+ .+++.||+| .|||++++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 468899999 3889999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 151 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-AT 151 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cc
Confidence 99887764 246899999999999999999999998 9999999999999999999999999987532221 22
Q ss_pred eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhc
Q 020102 195 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274 (331)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .......
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~-~~~~~~~---------- 212 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFE-LILMEDI---------- 212 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHH-HhccCCc----------
Confidence 23356899999999999999999999999999999999999999643210 0011 1100100
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 275 LGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 275 ~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
..+...+.++.+++.+||+.||++|| ++.|+++.
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11233456789999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=301.74 Aligned_cols=230 Identities=24% Similarity=0.333 Sum_probs=184.7
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||+||+|.+ .+++.||+| .|+|++++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688999999999999999987 468899999 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999988752 246899999999999999999999998 9999999999999999999999999998665
Q ss_pred CCCceeeeeccccCCccChhhhc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQ------SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
...........||+.|+|||++. +..++.++|||||||++|||++|..||...... ..........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~ 225 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------KTYNNIMNFQ 225 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------HHHHHHHcCC
Confidence 44333333456899999999886 456788999999999999999999999643210 1111111111
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... +.....+..+.+|+..||+ +|.+|||+++++..
T Consensus 226 ~~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 RFLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11111 1122345678999999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=296.72 Aligned_cols=221 Identities=27% Similarity=0.361 Sum_probs=178.6
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------------ccccchhhhcccccCCcceeE
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
|++.+.||+|+||.||+|.+ .+++.|||| .|||++++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67789999999999999987 468889999 288999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|...+.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999877643 36899999999999999999999998 999999999999999999999999998743
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ... ........
T Consensus 152 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~-~~i~~~~~--- 218 (324)
T cd05589 152 MGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVF-DSIVNDEV--- 218 (324)
T ss_pred CCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHH-HHHHhCCC---
Confidence 2221 2223456899999999999999999999999999999999999998643110 001 11111110
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~ 307 (331)
..+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 219 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112234567889999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=300.56 Aligned_cols=230 Identities=24% Similarity=0.325 Sum_probs=178.4
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+ .+++.||+| .|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688999999999999999987 468899999 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999998865 246899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCc----------------------------------eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhC
Q 020102 189 MDQT----------------------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG 234 (331)
Q Consensus 189 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 234 (331)
.... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 001234699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHH
Q 020102 235 KKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDL--NGKKRPTMEEVSME 308 (331)
Q Consensus 235 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~--~p~~RPs~~evl~~ 308 (331)
+.||..... . ............ ...+.....+..+.+++.+++.. ++..||+++||++.
T Consensus 233 ~~Pf~~~~~--~------~~~~~i~~~~~~-------~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 233 YPPFCSETP--Q------ETYKKVMNWKET-------LIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCCH--H------HHHHHHHcCcCc-------ccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 999964311 0 111111110000 00011112445678888886642 33346899999775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=303.64 Aligned_cols=231 Identities=24% Similarity=0.338 Sum_probs=184.7
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCccee
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
..++|++.+.||+|+||.||+|.+ .++..||+| .|||++++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356799999999999999999987 468889999 37899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++|+|.+.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999988764 25788889999999999999999988 99999999999999999999999999976
Q ss_pred ccCCCceeeeeccccCCccChhhhcCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~ 263 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHK 263 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCC
Confidence 543332223345799999999988654 378899999999999999999999964321 11111111111
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK--RPTMEEVSME 308 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~--RPs~~evl~~ 308 (331)
.. ...+.....+..+.+++.+||+.+|.+ |||++++++.
T Consensus 264 ~~-------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 NS-------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred Cc-------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 10 011112235678999999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=306.66 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=179.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------ccccchhhhcccccC--------Cccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------KSKNAVKLLGCCLET--------EVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------~~~niv~~~~~~~~~--------~~~~l 106 (331)
..+|.+.+.||+|+||+||+|.+ .+++.|||| .|||++++++++... ...++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 46799999999999999999997 468899999 389999998876432 23678
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEeeccCcc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSK 185 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~ 185 (331)
||||++ +++.+.+.... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+|+
T Consensus 145 vmE~~~-~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 145 VMEFIP-QTVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEecCC-ccHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccch
Confidence 999997 57777665432 23457899999999999999999999998 99999999999999664 69999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch-------HHHHHH
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL-------AAYFVH 257 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~~~ 257 (331)
.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||............. ......
T Consensus 220 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 220 NLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred hccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 654322 22234689999999988764 68999999999999999999999986432111000000 000000
Q ss_pred H---hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 258 S---MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 258 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ...-.+.......+....+...+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 00000011111111112223345679999999999999999999999754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=285.58 Aligned_cols=238 Identities=21% Similarity=0.350 Sum_probs=191.5
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||.||+|.. .+++.||+| .|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999987 468899998 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+.+..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988865322 2346889999999999999999999988 9999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... .. ..........
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------~~-~~~~~~~~~~---- 225 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------FS-LCQKIEQCDY---- 225 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH------HH-HHHHHhcCCC----
Confidence 3221 1223458889999999998889999999999999999999999986432111 01 1111111111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
+.......+..+.+++.+||+.+|++|||+.++++.|+.++
T Consensus 226 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 ----PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11112345567999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.39 Aligned_cols=239 Identities=27% Similarity=0.459 Sum_probs=188.7
Q ss_pred cCCccCceecCCCCeEEEEEEe------cCCcEEEEc-----------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+|.+.+.||+|+||.||++.. .++..+|+| .|+|++++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688899999999999999974 234567888 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhc--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 020102 107 VYEFISNGTLYQHLHDRLQ--------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV 178 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl 178 (331)
||||+++++|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 9999999999998865311 12235899999999999999999999988 999999999999999999999
Q ss_pred eeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHH
Q 020102 179 ADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... . ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~-~~ 232 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------E-VI 232 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------H-HH
Confidence 99999975543221 11222345778999999999899999999999999999998 88887543210 0 11
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
.....+.... .+...+..+.+++.+||+.+|.+|||+.++++.|+.+.+.
T Consensus 233 ~~i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111221111 1122345789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=302.21 Aligned_cols=229 Identities=23% Similarity=0.330 Sum_probs=181.6
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+. +++.|||| .|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999984 68899999 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+.
T Consensus 81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999998865 236899999999999999999999998 9999999999999999999999999987542
Q ss_pred CCCce-------------------------------------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHH
Q 020102 189 MDQTH-------------------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 231 (331)
Q Consensus 189 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 231 (331)
..... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 01124589999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 020102 232 LTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT---MEEVSME 308 (331)
Q Consensus 232 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs---~~evl~~ 308 (331)
++|..||..... . ............ .........+..+.+++.+||. +|.+|++ +.|+++.
T Consensus 233 ~~G~~Pf~~~~~--~------~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 233 LVGYPPFCSDNP--Q------ETYRKIINWKET-------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hcCCCCCCCCCH--H------HHHHHHHcCCCc-------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999964321 0 011111110000 0001111345678899999997 9999998 8887663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=296.44 Aligned_cols=218 Identities=26% Similarity=0.362 Sum_probs=177.0
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEcc---------------------------cccchhhhcccccCCcceeEe
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVKK---------------------------SKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~---------------------------~~niv~~~~~~~~~~~~~lv~ 108 (331)
+|.+.+.||+|+||.||+|.+. +++.||+|. |++++++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999874 578899982 568888999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999888765 236889999999999999999999998 9999999999999999999999999987533
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ....
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~-~~~~---- 218 (323)
T cd05616 153 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIM-EHNV---- 218 (323)
T ss_pred CCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHH-hCCC----
Confidence 222 1223456899999999999999999999999999999999999999643210 1111111 1110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
..+...+..+.+++.+||+.+|++|++.
T Consensus 219 ------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1123345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=285.43 Aligned_cols=229 Identities=28% Similarity=0.417 Sum_probs=183.4
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
.+|++.+.||+|+||.||+|.+.++..+|+| .|+|++++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 3477889999999999999988777788888 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+++... ...+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 84 GCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999988642 236899999999999999999999998 999999999999999999999999998765432222
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... . ... .......
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~------~~~-~~~~~~~--------- 218 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--S------EVV-ESVSAGY--------- 218 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--H------HHH-HHHHcCC---------
Confidence 2222234457999999999999999999999999999999 7888854211 1 001 1111110
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111223566799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=296.66 Aligned_cols=243 Identities=26% Similarity=0.402 Sum_probs=183.3
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||.||++.+. ++..+|+| .|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999884 67888888 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|+++++|.+++.. ...+++..+..++.|++.|+.|||+. + ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999998865 23688999999999999999999974 5 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc------------------
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS------------------ 250 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~------------------ 250 (331)
.. ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||............
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 22 122346899999999999989999999999999999999999998643211000000
Q ss_pred hHHHHHHHhhcCc-----ccccc----chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 251 LAAYFVHSMRKNR-----LYDIL----DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 251 ~~~~~~~~~~~~~-----~~~~~----~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
............. ..... ....+.......+.++.+|+.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000000000 00000 0000000111245678999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=295.49 Aligned_cols=242 Identities=26% Similarity=0.370 Sum_probs=177.0
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC-----Ccce
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET-----EVPL 105 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~-----~~~~ 105 (331)
+|++.+.||+|+||.||+|.+ .++..||+| +||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 578899999999999999997 468999999 388999999987543 2479
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 688887764 236899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCc--eeeeeccccCCccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-------cchHHH
Q 020102 186 FIAMDQT--HVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN-------VSLAAY 254 (331)
Q Consensus 186 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~ 254 (331)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5432221 11233568999999999876 578899999999999999999999986432110000 000000
Q ss_pred HHHHhhcCccccccc---hHhh---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 255 FVHSMRKNRLYDILD---DQVM---KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ............. .... ....+..+..+.+++.+||+.+|++|||++|+++.
T Consensus 232 ~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 I-SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred H-HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0000000000000 0000 00011234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=302.67 Aligned_cols=231 Identities=24% Similarity=0.351 Sum_probs=183.2
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCccee
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
..++|++.+.||+|+||.||++.+. +++.+|+| .|||++++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3568999999999999999999974 57889998 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 121 VMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999998864 25788999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
.............||+.|+|||++.+.. ++.++|+||+||++|+|++|+.||..... ...........
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~ 263 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHK 263 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence 5433333334567999999999987643 77899999999999999999999964321 11111111111
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK--RPTMEEVSME 308 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~--RPs~~evl~~ 308 (331)
.... .+.....+..+.+++..||+.+|.+ |||+.|+++.
T Consensus 264 ~~~~-------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 NSLN-------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cccC-------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1011 1112234567889999999865544 8899998776
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=286.40 Aligned_cols=224 Identities=24% Similarity=0.405 Sum_probs=190.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
..+|++.+.||+|.||.|-+|.. ..|+.|||| .||||+.++.+|.+.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999987 789999999 489999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||..+|.|++++.++ +.+++..+..+++||..|+.|||.++ ++|||||.+|||+|.++++||+|||++..+
T Consensus 132 MEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999873 57999999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.. .....+++|++-|.+||+++|.+|. +.+|.||||++||-|+.|..||...+- ...+ ..+..+..
T Consensus 204 ~~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lv-rQIs~GaY-- 270 (668)
T KOG0611|consen 204 AD--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLV-RQISRGAY-- 270 (668)
T ss_pred cc--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHH-HHhhcccc--
Confidence 53 3345668999999999999999985 689999999999999999999965421 0111 11111211
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .+..+.+..-||+|||..||++|.|+++|...
T Consensus 271 -r--------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 271 -R--------EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -c--------CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1 12233457789999999999999999999765
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=302.28 Aligned_cols=229 Identities=21% Similarity=0.279 Sum_probs=178.6
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.|++.+.||+|+||+||+|.+ .+++.||+| .|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578899999999999999987 568899999 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999998865 236889999999999999999999988 99999999999999999999999999753211
Q ss_pred CCc----------------------------------------------eeeeeccccCCccChhhhcCCCCCCcchHHH
Q 020102 190 DQT----------------------------------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYS 223 (331)
Q Consensus 190 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 223 (331)
... .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 0012346999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhh--ccCCCCCCC
Q 020102 224 FGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCL--DLNGKKRPT 301 (331)
Q Consensus 224 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL--~~~p~~RPs 301 (331)
|||++|||++|..||....... .......... ....+.....+.++.+++.+|+ ..+|..||+
T Consensus 234 lG~il~elltG~~Pf~~~~~~~--------~~~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTE--------TQLKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHH--------HHHHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 9999999999999996432110 0011110000 0011111234567888998854 555666999
Q ss_pred HHHHHHH
Q 020102 302 MEEVSME 308 (331)
Q Consensus 302 ~~evl~~ 308 (331)
+.+++..
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=298.03 Aligned_cols=219 Identities=25% Similarity=0.344 Sum_probs=177.1
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.||+|+||.||++.+ .+++.||+| .||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 468899999 3889999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
+|...+.. ...+++..+..++.||+.||.|||+ .+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~ 151 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-A 151 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-c
Confidence 99887764 2468999999999999999999997 67 9999999999999999999999999987533222 1
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... . ..........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~-~~~~i~~~~~--------- 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------K-LFELILMEEI--------- 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------H-HHHHHhcCCC---------
Confidence 223356999999999999999999999999999999999999999643210 0 0111111110
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
..+...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 214 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 -RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11223455789999999999999996 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.25 Aligned_cols=234 Identities=28% Similarity=0.478 Sum_probs=186.2
Q ss_pred cCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
++|.+.+.||+|+||.||+|... ++..||+| .|+|++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46788899999999999999863 34789998 3789999999999999999
Q ss_pred eEeecccCCCHHHHHhhhh---------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 106 LVYEFISNGTLYQHLHDRL---------QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
+||||+++++|.+++.... ......+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999987531 112345788999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHH
Q 020102 177 KVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~ 254 (331)
+|+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--------~- 232 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--------E- 232 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------H-
Confidence 99999998754322211 1122345778999999999999999999999999999998 99998643211 0
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
.......+... ..+...+..+.+++.+||+.+|++|||+.||++.|+
T Consensus 233 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 VIECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111111111 112234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.78 Aligned_cols=219 Identities=25% Similarity=0.348 Sum_probs=177.1
Q ss_pred ceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||.||+|.+. +++.||+| .||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999874 57889998 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 151 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-V 151 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-c
Confidence 999888765 236889999999999999999999998 9999999999999999999999999987543222 2
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~-~~~~--------- 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESIL-HDDV--------- 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHH-cCCC---------
Confidence 23345689999999999999999999999999999999999999964321 01111111 1110
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRP-------TMEEVSME 308 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RP-------s~~evl~~ 308 (331)
..+...+..+.+++..||+.+|++|| +++++++.
T Consensus 214 -~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 -LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01222346789999999999999999 77777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=295.05 Aligned_cols=218 Identities=26% Similarity=0.356 Sum_probs=175.4
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEcc---------------------------cccchhhhcccccCCcceeEe
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVKK---------------------------SKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~---------------------------~~niv~~~~~~~~~~~~~lv~ 108 (331)
+|++.+.||+|+||.||+|.+. +++.||+|. +++++++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999874 578899992 235778888888889999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999888865 236889999999999999999999998 9999999999999999999999999986432
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ...... ....
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i-~~~~----- 217 (324)
T cd05587 153 FGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSI-MEHN----- 217 (324)
T ss_pred CCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHH-HcCC-----
Confidence 222 1223456899999999999999999999999999999999999999643210 011111 1111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
...+...+..+.+++.+||+.+|.+||+.
T Consensus 218 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -----VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01122345678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=296.54 Aligned_cols=242 Identities=23% Similarity=0.279 Sum_probs=179.7
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCC-----cce
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETE-----VPL 105 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~-----~~~ 105 (331)
+|++.+.||+|+||+||+|.+ .+++.||+| +|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999997 578999999 3789999999998776 789
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+|+||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence 9999997 677776643 346899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc-------chHHH---
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV-------SLAAY--- 254 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~--- 254 (331)
..............+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 6543332223334578999999998875 478899999999999999999999964321110000 00000
Q ss_pred ----HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 255 ----FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 255 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......... ...............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPH-KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCC-CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 0000000001122335678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.28 Aligned_cols=240 Identities=27% Similarity=0.398 Sum_probs=186.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe------cCCcEEEEcc-------------------------cccchhhhccccc-CC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVKK-------------------------SKNAVKLLGCCLE-TE 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~-------------------------~~niv~~~~~~~~-~~ 102 (331)
.++|++.+.||+|+||.||+|.. .+++.||+|. |+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 35789999999999999999964 2357899992 6799999998765 45
Q ss_pred cceeEeecccCCCHHHHHhhhhcC--------------------------------------------------------
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQN-------------------------------------------------------- 126 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 126 (331)
..++++||+++++|.+.+......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999988542110
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee-eeeccccCCcc
Q 020102 127 QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYL 205 (331)
Q Consensus 127 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~ 205 (331)
...++++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0136899999999999999999999988 9999999999999999999999999998654322211 22234567899
Q ss_pred ChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHH
Q 020102 206 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAF 284 (331)
Q Consensus 206 aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
|||++.+..++.++|||||||++|||++ |..||...... ............ ...+...+..+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~---------~~~~~~~~~~~ 305 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTR---------MRAPEYATPEI 305 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCC---------CCCCccCCHHH
Confidence 9999999999999999999999999998 99998542111 011111111111 11122345678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 285 ANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 285 ~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.+++.+||+.+|++|||+.|++++|.++..
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.74 Aligned_cols=217 Identities=25% Similarity=0.384 Sum_probs=175.7
Q ss_pred ceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|.+. +++.||+| .|||++++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999974 57889999 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|+|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-A 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-C
Confidence 999988865 236889999999999999999999988 9999999999999999999999999987432221 1
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... .......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~-~~i~~~~---------- 212 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELF-QSIRMDN---------- 212 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHH-HHHHhCC----------
Confidence 223456899999999999999999999999999999999999999643210 011 1111110
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTME-EVS 306 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~-evl 306 (331)
...+...+..+.+++.+||+.+|++||++. ++.
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 213 PCYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 001223445788999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.68 Aligned_cols=217 Identities=27% Similarity=0.398 Sum_probs=175.4
Q ss_pred ceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||.||+|.+. ++..||+| .|||++++++++.+++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999974 68889998 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|...+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 999888765 246889999999999999999999998 9999999999999999999999999986432211 2
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... .......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~-~~~~~~~---------- 212 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELF-ESIRVDT---------- 212 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHH-HHHHhCC----------
Confidence 233456899999999999999999999999999999999999999643210 011 1111110
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTME-EVS 306 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~-evl 306 (331)
...+...+.++.+++.+||+.||++||++. +++
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 011223455788999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=283.71 Aligned_cols=233 Identities=26% Similarity=0.394 Sum_probs=184.9
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.++|.+.+.||+|+||.||+|.+.+...||+| .|+|++++++.+. ....++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 35689999999999999999988776779998 3789999988774 456799999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+..+.....
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999988652 2335789999999999999999999988 99999999999999999999999999976544332
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......++..|+|||...+..++.++|+|||||++|+|++ |..||..... . . .........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--~------~-~~~~~~~~~-------- 220 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--R------E-VLDQVERGY-------- 220 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--H------H-HHHHHhcCC--------
Confidence 22223346678999999988899999999999999999999 7777753211 0 0 011111110
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
........+..+.+++.+|++.+|++|||+.++++.|+..
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0111234556789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=300.42 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=188.4
Q ss_pred HhcCCccCceecCCCCeEEEEEEec------CCcEEEEc-------------------------ccccchhhhcccccCC
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK-------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK-------------------------~~~niv~~~~~~~~~~ 102 (331)
..++|++.+.||+|+||.||+|.+. .+..|||| .||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568889999999999999999852 23468998 2899999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhc---------------------------------------------------------
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQ--------------------------------------------------------- 125 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 125 (331)
..++||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998865311
Q ss_pred ----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 020102 126 ----------------------------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171 (331)
Q Consensus 126 ----------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~ 171 (331)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 01124788889999999999999999988 99999999999999
Q ss_pred CCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCccccc
Q 020102 172 ERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENV 249 (331)
Q Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~ 249 (331)
.++.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----- 346 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----- 346 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-----
Confidence 9999999999998765332221 1222346788999999999899999999999999999997 88888542110
Q ss_pred chHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 250 SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.........+. ....+...+..+.+++.+||+.+|++|||+.+|.++|+.+..
T Consensus 347 ---~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 ---STFYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00111111110 111123445678999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=278.91 Aligned_cols=229 Identities=27% Similarity=0.394 Sum_probs=187.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEe
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
.++|++.+.||+|.|+.|+++.. .+|+.+|+| +||||+++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45678888999999999999986 578888888 6999999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEeeccCcc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSK 185 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~ 185 (331)
|++.|++|...+..+ ..+++..+...++||++||.|+|.++ |+|||+||+|+++.+ ..-+||+|||+|.
T Consensus 90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999998877664 35788899999999999999999988 999999999999964 3458999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.+. .........|||+|||||++...+|+..+||||.|++||-++.|.+||...+.. ..+....... .
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------rlye~I~~g~--y 229 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYEQIKAGA--Y 229 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------HHHHHHhccc--c
Confidence 776 333444568999999999999999999999999999999999999999753211 1111111110 0
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+....+..+++..+|+++||..||.+|.|+.|.++.
T Consensus 230 -----d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 -----DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -----CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 01122244566789999999999999999999998654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=281.81 Aligned_cols=239 Identities=25% Similarity=0.409 Sum_probs=192.4
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||.||+|... +++.|++| .|+|++++++.+..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999985 78899998 2779999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+.+.... .....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999998886532 23446899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.... ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...... .... ......+....
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~~-- 227 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSL-CKKIEKCDYPP-- 227 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHH-HhhhhcCCCCC--
Confidence 3322 122345888999999999888999999999999999999999998543211 1011 11111111110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
......+..+.+++.+||+.+|++|||+.+|+++|+.+.+
T Consensus 228 ------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 228 ------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred ------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 1112455678999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=281.85 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=184.1
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------ccc-chhhhcccccCC------
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKN-AVKLLGCCLETE------ 102 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~n-iv~~~~~~~~~~------ 102 (331)
..|...++||+|+||+||+|.. .+|+.||+|+ |+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3456667899999999999997 5789999994 667 999999998877
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++|+||++ -+|..++....... ..++...+..++.||+.||+|||+++ |+||||||.||+|+++|.+||+|||
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7899999996 78888887642211 35777899999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
+|+....+... .+..++|.+|+|||++.+. .|+...||||+|||++||++++.-|.... . .+ ........+..
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s-e-~~---ql~~If~~lGt 239 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS-E-ID---QLFRIFRLLGT 239 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc-H-HH---HHHHHHHHcCC
Confidence 99966644433 3445689999999998887 79999999999999999999766554322 2 11 11111111111
Q ss_pred ---Ccccccc---chH--hhcc--------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 020102 262 ---NRLYDIL---DDQ--VMKL--------GKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGI 312 (331)
Q Consensus 262 ---~~~~~~~---~~~--~~~~--------~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l 312 (331)
..++... +-. .+.. ..+....+..+++.+||+.+|..|.|+..++.+ ++.+
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1222111 000 0000 011112478899999999999999999999886 5544
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=282.61 Aligned_cols=238 Identities=22% Similarity=0.357 Sum_probs=191.4
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||.||+|.. .++..+++| .|+|++++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999996 578899998 2789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++.... .....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999886532 23446899999999999999999999988 9999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .... ........
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~---- 225 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLC-KKIEQCDY---- 225 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH------HHHh-hhhhcCCC----
Confidence 3322 1223458899999999998889999999999999999999999986432110 0000 11111000
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
+.......+..+.+++.+||+.+|++|||+.+|++.+.++.
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 ----PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11112345668999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=283.59 Aligned_cols=232 Identities=25% Similarity=0.417 Sum_probs=185.8
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.+.|++.+.||+|+||.||+|...+++.||+| .|+|++++++++. .+..+++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 45788999999999999999998888999999 3789999998864 456899999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+.+.. ..+..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 84 NGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999998764 23346899999999999999999999988 99999999999999999999999999876543222
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+.....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~-~~~~~~~~~~------- 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------E-VIQNLERGYR------- 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------H-HHHHHHcCCC-------
Confidence 22223345678999999998889999999999999999999 99998543210 0 1111111100
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
...+...+..+.+++.+||+.+|++|||++++...|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 --MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01122334579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=290.38 Aligned_cols=221 Identities=24% Similarity=0.341 Sum_probs=174.8
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||.||+|.. .+++.||+| .|||++++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 457889998 278999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 151 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-D 151 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-C
Confidence 999887764 236899999999999999999999998 9999999999999999999999999987432211 2
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .............
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~---------- 219 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TEDYLFQVILEKP---------- 219 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--cHHHHHHHHHhCC----------
Confidence 2234569999999999999999999999999999999999999996432211111 1111111111111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTME 303 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~ 303 (331)
...+...+..+.+++.+||+.||++||++.
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 011223445688999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=289.75 Aligned_cols=218 Identities=25% Similarity=0.358 Sum_probs=177.0
Q ss_pred ceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|.+. ++..||+| .|||++++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 57889998 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|...+.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 151 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-V 151 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-C
Confidence 999887765 236899999999999999999999988 9999999999999999999999999986432221 1
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .... ........
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~-~~i~~~~~--------- 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELF-QSILEDEV--------- 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHH-HHHHcCCC---------
Confidence 22335689999999999999999999999999999999999999964321 0111 11111111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTM-----EEVSM 307 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~-----~evl~ 307 (331)
..+...+..+.+++.+||+.||++|||+ .++++
T Consensus 214 -~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 -RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1122345678999999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=300.61 Aligned_cols=179 Identities=34% Similarity=0.519 Sum_probs=154.6
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcccc----------------------------cchhhhcccccCC
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSK----------------------------NAVKLLGCCLETE 102 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~----------------------------niv~~~~~~~~~~ 102 (331)
+....+|.+.+.||+|+||+|.+|.+ .+++.||||..+ |+|+++++|...+
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 33445899999999999999999998 569999999422 8999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC--CCcEEEee
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE--RYRAKVAD 180 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~--~~~~kl~D 180 (331)
+.|||+|++. -+|+++++. +.-.+++...+..++.||+.||.+||+.+ |||+||||+|||+.+ ...+||+|
T Consensus 262 HlciVfELL~-~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred ceeeeehhhh-hhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEe
Confidence 9999999995 899999986 34457999999999999999999999998 999999999999974 34699999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAG 242 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~ 242 (331)
||.|+.... ... +..-+..|+|||++.|.+|+.+.||||||||++||.+| .|.+.+.
T Consensus 335 FGSSc~~~q---~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ 391 (586)
T KOG0667|consen 335 FGSSCFESQ---RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG-EPLFPGD 391 (586)
T ss_pred cccccccCC---cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcC-ccccCCC
Confidence 999986532 222 45678899999999999999999999999999999999 5555443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=287.81 Aligned_cols=239 Identities=26% Similarity=0.437 Sum_probs=189.3
Q ss_pred cCCccCceecCCCCeEEEEEEec------CCcEEEEc-----------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+|.+.+.||+|+||.||+|... ++..+++| .|+|++++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999742 34567788 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc
Q 020102 107 VYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~ 175 (331)
||||+++++|.+++..... .....+++..+..++.||+.|+.|||+.+ ++|+||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999998865311 11235899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHH
Q 020102 176 AKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAA 253 (331)
Q Consensus 176 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 253 (331)
++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------- 232 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------- 232 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence 99999999875543221 11222346788999999999999999999999999999998 99998643211
Q ss_pred HHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
........+.... .....+..+.+++.+||+.+|++|||+.+|+++|+.+.+.
T Consensus 233 ~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 EVIECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0111112221111 1223456789999999999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=300.03 Aligned_cols=235 Identities=24% Similarity=0.349 Sum_probs=184.8
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCC
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~ 102 (331)
++....++|++.+.||+|+||.||+|.+. +++.+|+| .|||++++++.+.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445688999999999999999999874 68889998 3889999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999988864 25788889999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
++...............||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ...+...
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i 259 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKI 259 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 99865433333334567999999999987543 78899999999999999999999964311 1111111
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK--RPTMEEVSME 308 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~--RPs~~evl~~ 308 (331)
....... ..+.....+..+.+++..||..++.+ ||+++++++.
T Consensus 260 ~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 260 MNHKNSL-------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCCCcc-------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111111 11112345667899999999844433 6788888775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=282.99 Aligned_cols=232 Identities=27% Similarity=0.431 Sum_probs=184.1
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.++|++.+.||+|+||.||+|...++..+|+| .|+|++++++++. ....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 35688899999999999999988888889998 3789999998875 456889999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+.+... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 84 KGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999988652 2346899999999999999999999988 99999999999999999999999999976543322
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .. ....+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~-~~~~~~~~~-------- 220 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------RE-VLEQVERGY-------- 220 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HH-HHHHHHcCC--------
Confidence 22222335667999999988889999999999999999999 8888853211 01 111111110
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
....+...+..+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 -RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223445679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=285.36 Aligned_cols=233 Identities=24% Similarity=0.379 Sum_probs=182.5
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCc----EEEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGR----IIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+|++.+.||+|+||+||+|... +++ .+++| .|||++++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35778899999999999999873 343 36666 38899999998754 55788
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 99999999999988652 346899999999999999999999988 99999999999999999999999999976
Q ss_pred ccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... . ........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~-------~~~~~~~~~~~ 229 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--H-------EVPDLLEKGER 229 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--H-------HHHHHHHCCCc
Confidence 533221 12223456778999999998899999999999999999998 9989854311 0 01111222211
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.. .+...+.++.+++.+||..+|++|||+.|+++.|..+..
T Consensus 230 ~~---------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LA---------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11 111233467889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=287.05 Aligned_cols=238 Identities=26% Similarity=0.385 Sum_probs=186.4
Q ss_pred CCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
+|++.+.||+|+||.||+|... ....+++| .||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999862 23567887 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCC
Q 020102 107 VYEFISNGTLYQHLHDRLQ-------------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTN 167 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~N 167 (331)
++||+.+++|.+++..... ....++++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999998865211 11235889999999999999999999988 9999999999
Q ss_pred EEeCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020102 168 ILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTS 245 (331)
Q Consensus 168 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~ 245 (331)
|++++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||++++||++ |..||.... .
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--P 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC--H
Confidence 99999999999999998754332211 1122345678999999988889999999999999999998 888885321 1
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
. ......... .....+...+.++.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 236 ~-------~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 E-------RLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred H-------HHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 0 011111111 01111233456799999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=291.34 Aligned_cols=235 Identities=24% Similarity=0.420 Sum_probs=184.1
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCc----EEEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGR----IIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+|++.+.||+|+||+||+|.+. ++. .||+| .|||++++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999863 333 37888 388999999998765 5779
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
++||+++|+|.+.+... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 86 v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999988752 235888999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCceee-eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||..... . ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~-------~~~~~~~~~~~ 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--S-------EISSILEKGER 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--H-------HHHHHHhCCCC
Confidence 654332221 12234678999999999999999999999999999997 8888853210 0 01111111110
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
...+...+.++.+++.+||+.+|++|||+.+++..|..+....
T Consensus 230 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0112233457889999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=295.57 Aligned_cols=214 Identities=30% Similarity=0.408 Sum_probs=174.9
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|.+ .+++.||+| .||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999998 468899999 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 999888865 346899999999999999999999998 9999999999999999999999999987532221 2
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~-~~~--------- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILN-KPL--------- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHc-CCC---------
Confidence 23345689999999999999999999999999999999999999964311 011111111 110
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTME 303 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~ 303 (331)
...+..+..+.+++.+||+.+|++||++.
T Consensus 214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 -RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11223456789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.61 Aligned_cols=218 Identities=29% Similarity=0.366 Sum_probs=176.2
Q ss_pred ceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|.+. +++.||+| .|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999974 57789998 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~ 151 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-G 151 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-C
Confidence 999988865 246788899999999999999999998 9999999999999999999999999987532221 2
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........ ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~-~~---------- 212 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILN-KP---------- 212 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHh-CC----------
Confidence 233456999999999999999999999999999999999999999643210 11111111 10
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
....+..+..+.+++.+||+.+|.+||++.+.+.
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 213 LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0112234567899999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.12 Aligned_cols=227 Identities=21% Similarity=0.287 Sum_probs=177.4
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.|++.+.||+|+||+||+|.+ .+++.||+| .|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999987 468889999 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 9999999998865 236889999999999999999999998 99999999999999999999999999753210
Q ss_pred CC----------------------------------------------ceeeeeccccCCccChhhhcCCCCCCcchHHH
Q 020102 190 DQ----------------------------------------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYS 223 (331)
Q Consensus 190 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 223 (331)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00012246899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC--
Q 020102 224 FGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-- 301 (331)
Q Consensus 224 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-- 301 (331)
|||++|||++|+.||...... .......... .....+.....+..+.+++.+|+ .+|++|++
T Consensus 234 lGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~ 297 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPL--------ETQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKN 297 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHH--------HHHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence 999999999999999643210 0011111000 00111112234567888888876 59999997
Q ss_pred -HHHHHH
Q 020102 302 -MEEVSM 307 (331)
Q Consensus 302 -~~evl~ 307 (331)
++++++
T Consensus 298 ~~~ei~~ 304 (382)
T cd05625 298 GADEIKA 304 (382)
T ss_pred CHHHHhc
Confidence 777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=281.07 Aligned_cols=231 Identities=26% Similarity=0.411 Sum_probs=183.8
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
++|.+.+.||+|++|.||+|.+..+..+|+| .|+|++++++++. .+..+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 4688899999999999999998777778998 3789999988875 4568899999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 85 GSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999988652 2345889999999999999999999988 999999999999999999999999999765433222
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
......++..|+|||...+..++.++|+||||+++|+|++ |..||..... . . .........
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~------~-~~~~~~~~~--------- 220 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--R------E-VLEQVERGY--------- 220 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--H------H-HHHHHHcCC---------
Confidence 2222346678999999998899999999999999999999 8888853211 0 0 111111110
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
....+...+..+.+++.+||+.+|++|||+++|++.|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011123445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=283.27 Aligned_cols=225 Identities=23% Similarity=0.304 Sum_probs=178.0
Q ss_pred ecCCCCeEEEEEEe-cCCcEEEEcc--------------------------cccchhhhcccccCCcceeEeecccCCCH
Q 020102 64 LGQGGQGTVYKGMR-EDGRIIAVKK--------------------------SKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 64 lg~G~~g~V~~~~~-~~~~~vavK~--------------------------~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
||+|+||+||++.+ .+++.+|+|. |+|++++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999987 4688999983 77999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeee
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 196 (331)
...+.... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..+..... ...
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 88775422 23457899999999999999999999998 99999999999999999999999999875543222 223
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccC
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .. ......... ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~-~~~~~~~~~----------~~~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KE-LKQRILNDS----------VTY 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HH-HHHhhcccC----------CCC
Confidence 356899999999999999999999999999999999999999643221110 00 000000000 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 277 KKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 277 ~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
+...+..+.+++.+||+.||++|| |++++++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 234566789999999999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=298.02 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=185.0
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
...|.+.+.||+|+||.||+|.+. .++.|||| .|+||+++++++..+...++|||++. ++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 457999999999999999999984 57889999 48999999999999999999999995 788
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce-ee
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VT 195 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~ 195 (331)
.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++........ ..
T Consensus 247 ~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 247 YTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 8877542 236899999999999999999999998 999999999999999999999999999765432211 12
Q ss_pred eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC-----ccccccch
Q 020102 196 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN-----RLYDILDD 270 (331)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 270 (331)
....||+.|+|||++.+..++.++|||||||++|||++|..|++.......... ........+... .+......
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~-~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRP-YDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCC-cHHHHHHHHHhhccccccCCCCcch
Confidence 235699999999999999999999999999999999999887765432211111 111111111111 01100000
Q ss_pred Hhh----------------ccCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVM----------------KLGK---KNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~----------------~~~~---~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+. .... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 0000 0123468899999999999999999999864
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=292.82 Aligned_cols=218 Identities=29% Similarity=0.396 Sum_probs=176.7
Q ss_pred ceecCCCCeEEEEEEe----cCCcEEEEc---------------------------ccccchhhhcccccCCcceeEeec
Q 020102 62 RILGQGGQGTVYKGMR----EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~----~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+.||+|+||.||++.+ .+++.||+| .||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357889998 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999988865 246788899999999999999999998 999999999999999999999999998743222
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+..
T Consensus 154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~-~~~~------ 217 (323)
T cd05584 154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKIL-KGKL------ 217 (323)
T ss_pred C-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHH-cCCC------
Confidence 2 222335689999999999998899999999999999999999999964321 01111111 1110
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSM 307 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~ 307 (331)
..+...+..+.+++.+||+.+|++|| +++++++
T Consensus 218 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 ----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11223455789999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=286.32 Aligned_cols=236 Identities=28% Similarity=0.440 Sum_probs=183.6
Q ss_pred HhcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~ 103 (331)
..++|++.+.||+|+||.||+|... ++..||+| .|+|++++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998752 35678888 37899999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQN-----QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV 178 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl 178 (331)
.++||||+++++|.+++...... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999988653211 1234678889999999999999999988 999999999999999999999
Q ss_pred eeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHH
Q 020102 179 ADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||..... . . ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~------~-~~ 231 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--E------Q-VL 231 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H------H-HH
Confidence 9999987543322211 112235678999999999899999999999999999999 6788753211 0 1 11
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
.......... .+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 232 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 232 RFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111111111 12233457899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=299.73 Aligned_cols=229 Identities=23% Similarity=0.333 Sum_probs=179.3
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||+||++.+ .+++.|||| .||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999987 568899999 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999998865 246889999999999999999999998 9999999999999999999999999986321
Q ss_pred CCCc-------------e---------------------------------eeeeccccCCccChhhhcCCCCCCcchHH
Q 020102 189 MDQT-------------H---------------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVY 222 (331)
Q Consensus 189 ~~~~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 222 (331)
.... . ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 1000 0 00124689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCC---
Q 020102 223 SFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKR--- 299 (331)
Q Consensus 223 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~R--- 299 (331)
||||++|||++|..||...... ............. ..+.....+..+.+++.+||+ +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~-------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSH--------ETYRKIINWRETL-------YFPDDIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCcc-------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 9999999999999998543210 0111111100000 001112345678899999998 67765
Q ss_pred CCHHHHHHH
Q 020102 300 PTMEEVSME 308 (331)
Q Consensus 300 Ps~~evl~~ 308 (331)
+|+.|++..
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 599988765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=300.88 Aligned_cols=229 Identities=21% Similarity=0.296 Sum_probs=179.3
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
+.|++.+.||+|+||+||+|.+ .+++.||+| .|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999999987 468899999 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+|..+.
T Consensus 81 E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999999998865 236888999999999999999999998 9999999999999999999999999975321
Q ss_pred CCC------------------------------------------ceeeeeccccCCccChhhhcCCCCCCcchHHHHHH
Q 020102 189 MDQ------------------------------------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGV 226 (331)
Q Consensus 189 ~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 226 (331)
... ........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 000 00011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC---CHH
Q 020102 227 VLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP---TME 303 (331)
Q Consensus 227 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP---s~~ 303 (331)
++|||++|+.||....... ......... ...........+..+.+++.+|+ .+|.+|+ |+.
T Consensus 233 ilyell~G~~Pf~~~~~~~--------~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAE--------TQLKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred eeeehhhCCCCCCCCCHHH--------HHHHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 9999999999996432110 000000000 00011112234557888898876 5999999 888
Q ss_pred HHHHH
Q 020102 304 EVSME 308 (331)
Q Consensus 304 evl~~ 308 (331)
++++.
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 88765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=280.99 Aligned_cols=224 Identities=27% Similarity=0.409 Sum_probs=177.1
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
+.||+|+||.||+|.+ .+++.+|+| .|||++++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999987 468889999 388999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceee-
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT- 195 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~- 195 (331)
.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 988864 2336889999999999999999999988 99999999999999999999999999875432111111
Q ss_pred eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhc
Q 020102 196 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274 (331)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |..||..... . ......... ...
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~-------~~~~~~~~~---------~~~ 215 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--Q-------QTREAIEQG---------VRL 215 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--H-------HHHHHHHcC---------CCC
Confidence 11122456999999999999999999999999999998 8888753211 0 011111111 011
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 275 LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 275 ~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
..+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 122334567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.11 Aligned_cols=229 Identities=25% Similarity=0.326 Sum_probs=183.2
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
+|++.+.||+|+||+||++.+ .+++.||+| .|+|++++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999987 468899998 27799999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+.+... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999998877542 2346899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
... .....|++.|+|||++.+..++.++||||+||++|||++|..||....... ............
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~------- 220 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKED------- 220 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhhc-------
Confidence 221 223468999999999998899999999999999999999999996432110 000111111100
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
....+...+..+.+|+..||+.||++|| +++++++.
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 ---QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1112334566789999999999999999 78788554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=281.05 Aligned_cols=228 Identities=29% Similarity=0.406 Sum_probs=183.9
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
++|.+.+.||+|++|.||.|.+ .+++.+++| .|||++++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999987 468889988 27899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|+||+++++|.+.+... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999888652 36889999999999999999999998 99999999999999999999999999875
Q ss_pred ccCCCceee--eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
......... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~- 224 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIATQPT- 224 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--------HHHHHHhccCC-
Confidence 533221111 2345788999999999988999999999999999999999998643110 00111111100
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 225 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 --------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111223445678999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=281.16 Aligned_cols=234 Identities=29% Similarity=0.446 Sum_probs=187.7
Q ss_pred HhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
..++|.+.+.||+|+||.||+|...++..+++| .|+|++++++++......++||||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 346789999999999999999998778889998 3889999999999889999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+.+... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 84 SKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred CCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999988652 2346899999999999999999999988 9999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
........++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||..... . .... ......
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~------~~~~-~~~~~~------- 221 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--R------EVLE-QVERGY------- 221 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H------HHHH-HHHcCC-------
Confidence 111222334678999999999889999999999999999998 8988853211 0 0111 111110
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
....+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001122235578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=284.22 Aligned_cols=223 Identities=22% Similarity=0.317 Sum_probs=176.8
Q ss_pred ecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 64 LGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 64 lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
||+|+||+||++.. .+++.+|+| .|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999987 468899988 378999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeee
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 196 (331)
.+.+... ...++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 8877542 2346889999999999999999999988 9999999999999999999999999987654322 223
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccC
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
...|+..|+|||++.+..++.++||||+||++|||++|+.||........ ........ ..... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~---------~~~ 218 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRT-LEDEV---------KFE 218 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHh-hcccc---------ccc
Confidence 34689999999999998999999999999999999999999864321110 00111111 01110 001
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 277 KKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 277 ~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....+.++.+++..||+.||++||++.|+++.
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 12345678999999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=290.75 Aligned_cols=218 Identities=25% Similarity=0.365 Sum_probs=176.3
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------------cccchhhhcccccCCcceeEe
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------------SKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------------~~niv~~~~~~~~~~~~~lv~ 108 (331)
+|++.+.||+|+||+||+|.+ .+++.||+|. |++++++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367789999999999999987 4688999992 457888889999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999888765 246899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ........ ....
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~-~~~~---- 218 (323)
T cd05615 153 VDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIM-EHNV---- 218 (323)
T ss_pred CCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCCC----
Confidence 222 122335689999999999999999999999999999999999999864311 01111111 1110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
..+...+..+.+++.+||+.+|.+|++.
T Consensus 219 ------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1122345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=291.65 Aligned_cols=244 Identities=21% Similarity=0.352 Sum_probs=181.3
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
..+|.+.+.||+|+||.||+|.+. ++..||+| .|+||+++++++...+..++|+|++. ++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 467999999999999999999984 57789999 48999999999999999999999996 688
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeee
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 196 (331)
.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ....
T Consensus 144 ~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~ 214 (357)
T PHA03209 144 YTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFL 214 (357)
T ss_pred HHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--cccc
Confidence 887754 2347899999999999999999999998 999999999999999999999999998743221 1223
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc--chHHHHHHHhhc-----Cccccccc
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV--SLAAYFVHSMRK-----NRLYDILD 269 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~ 269 (331)
...||+.|+|||++.+..++.++|||||||++|||+++..|++.......... ............ ..+.....
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 35689999999999999999999999999999999997766654321110000 000001110000 00000000
Q ss_pred hHh------------------hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 270 DQV------------------MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 270 ~~~------------------~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
... ........+.++.+||.+||+.||++|||+.|+++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000 000011234456779999999999999999999753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=282.09 Aligned_cols=229 Identities=34% Similarity=0.539 Sum_probs=182.0
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
|++.+.||+|+||+||++.+. +++.+|+| +||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999985 56789999 4889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||.+.... ..
T Consensus 81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-EN 151 (260)
T ss_dssp TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-ST
T ss_pred ccccccccccc-----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cc
Confidence 99999998873 247899999999999999999999998 9999999999999999999999999987542 22
Q ss_pred ceeeeeccccCCccChhhhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 192 THVTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
........++..|+|||++. +..++.++|+||+|+++++|++|..||...... .. ........... .. .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~----~~~~~~~~~~~-~~----~ 221 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQ----LEIIEKILKRP-LP----S 221 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HH----HHHHHHHHHTH-HH----H
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccch-hh----hhhhhhccccc-cc----c
Confidence 23334456899999999998 888999999999999999999999998643100 00 00011000000 00 0
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...........+.+++.+||+.||++|||+.++++
T Consensus 222 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 --SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111268999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=287.61 Aligned_cols=245 Identities=25% Similarity=0.375 Sum_probs=190.9
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe--------cCCcEEEEc-------------------------ccccchhhhcccc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR--------EDGRIIAVK-------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK-------------------------~~~niv~~~~~~~ 99 (331)
....+|.+.+.||+|+||.||+|.. .++..+|+| .|||++++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3356788999999999999999963 134578888 3889999999999
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCE
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNI 168 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Ni 168 (331)
.....+++|||+++++|.+++..... .....+++..+..++.||+.||.|||+.+ ++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999876311 11235788899999999999999999988 99999999999
Q ss_pred EeCCCCcEEEeeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 020102 169 LLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQ 246 (331)
Q Consensus 169 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~ 246 (331)
+++.++.++|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999998654322221 122345678999999998889999999999999999998 777774321
Q ss_pred cccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 247 ENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
..... ........ ...+...+..+.+++.+||+.+|.+|||+.++++.|+++...+..
T Consensus 245 ----~~~~~-~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 245 ----VEELF-KLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ----HHHHH-HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 11111 11111111 111234556799999999999999999999999999998775543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=281.29 Aligned_cols=234 Identities=29% Similarity=0.448 Sum_probs=179.1
Q ss_pred CccCceecCCCCeEEEEEEecC-Cc--EEEEc-------------------------ccccchhhhcccccC------Cc
Q 020102 58 FNVNRILGQGGQGTVYKGMRED-GR--IIAVK-------------------------KSKNAVKLLGCCLET------EV 103 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK-------------------------~~~niv~~~~~~~~~------~~ 103 (331)
|.+.+.||+|+||.||+|...+ +. .+|+| .|+|++++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998744 32 57887 388999999876432 24
Q ss_pred ceeEeecccCCCHHHHHhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 104 PLLVYEFISNGTLYQHLHDR-LQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
.++++||+.+++|.+++... .......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998887432 1223345899999999999999999999988 9999999999999999999999999
Q ss_pred CcccccCCCceee-eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 183 TSKFIAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 183 ~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
++........... ....+++.|+|||...+..++.++|||||||++|||++ |..||..... . . ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~------~-~~~~~~ 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--S------E-IYDYLR 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--H------H-HHHHHH
Confidence 9986543322111 12235678999999999999999999999999999999 7888753211 0 0 111111
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
.+... ......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 229 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111 11223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=287.84 Aligned_cols=243 Identities=28% Similarity=0.390 Sum_probs=190.2
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEec------CCcEEEEc-------------------------ccccchhhhccc
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK-------------------------KSKNAVKLLGCC 98 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK-------------------------~~~niv~~~~~~ 98 (331)
++....++|++.+.||+|+||.||++... ....+|+| +|+|++++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34445567889999999999999999863 23578888 388999999999
Q ss_pred ccCCcceeEeecccCCCHHHHHhhhh-----------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCC
Q 020102 99 LETEVPLLVYEFISNGTLYQHLHDRL-----------QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTN 167 (331)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~N 167 (331)
..+...+++|||+++++|..++.... ......+++..+..++.|++.|+.|||+.+ ++|+||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 99999999999999999999886531 023456899999999999999999999988 9999999999
Q ss_pred EEeCCCCcEEEeeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020102 168 ILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTS 245 (331)
Q Consensus 168 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~ 245 (331)
|+++.++.++|+|||++..+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 999999999999999998654322111 122235678999999998899999999999999999997 8888753211
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
.. .......+.. ...+...+..+.+|+.+||+.+|++|||+.++++.|+.+.
T Consensus 241 ------~~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 ------EE-LFKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HH-HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 00 1111111111 1112234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=319.11 Aligned_cols=239 Identities=30% Similarity=0.451 Sum_probs=193.6
Q ss_pred cCCccCceecCCCCeEEEEEEecC--C----cEEEEc------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRED--G----RIIAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~--~----~~vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
.+....+.||+|.||.||.|...+ + ..||+| .|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667899999999999998632 3 348888 4999999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 106 LVYEFISNGTLYQHLHDRLQ--NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
+++|||.+|+|..+|.+... .+...++....+.++.|||+|+.||++++ +|||||..+|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987421 12456899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCceeeee-ccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 184 SKFIAMDQTHVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 184 a~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
|+.+.......... ..-...|||||.+..+.++.|+|||||||++||++| |..||....+.. ........
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~~~~~~g 920 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VLLDVLEG 920 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HHHHHHhC
Confidence 99554433222221 123457999999999999999999999999999999 888986543321 11112222
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
+ +...+..++..+.+++..||+.+|++||++..|++.+..+...
T Consensus 921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 2 2334667788899999999999999999999999988877553
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.35 Aligned_cols=226 Identities=35% Similarity=0.551 Sum_probs=175.2
Q ss_pred cCceecCCCCeEEEEEEec-----CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 60 VNRILGQGGQGTVYKGMRE-----DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+.+.||.|.||.||+|... .+..|+|| +||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999875 36778999 489999999999988889999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++|+|.+++... ....+++..+..++.||+.||.|||+.+ ++|++|+++||++++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999873 2357899999999999999999999988 999999999999999999999999999866322
Q ss_pred Cce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 191 QTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 191 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... ......+...|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---------~~~~~~~~~~~~---- 223 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---------EEIIEKLKQGQR---- 223 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---------HHHHHHHHTTEE----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------cccccccccccc----
Confidence 222 2222446788999999999999999999999999999999 6788754311 011112222211
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
...+...+..+.+++..||+.+|++|||+.++++.|
T Consensus 224 -----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112333456789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=282.56 Aligned_cols=235 Identities=25% Similarity=0.421 Sum_probs=183.7
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCc----EEEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGR----IIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
++|++.+.||+|+||+||+|.. .++. .||+| .|+|++++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 5678889999999999999985 3444 47888 37899999998875 45789
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
++||+++|+|.+.+... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 86 ~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 86 VTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999888642 346899999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
........ .....+++.|+|||...+..++.++|||||||++|||++ |..||..... .. ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~----~~~~~~~~~~ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----RE----IPDLLEKGER 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HH----HHHHHHCCCc
Confidence 64332221 112234678999999999899999999999999999998 8888753211 00 1111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
...+...+..+.+++..||+.||+.|||+.++++.|..+....
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 ---------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0112234557889999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=290.83 Aligned_cols=218 Identities=30% Similarity=0.411 Sum_probs=176.4
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|.+ .+++.+|+| .||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 468899999 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 151 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-D 151 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-C
Confidence 999887764 347899999999999999999999998 9999999999999999999999999987432211 2
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~-~~~--------- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILH-KPL--------- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHc-CCc---------
Confidence 22345689999999999999999999999999999999999999964321 011111111 110
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+..+..+.+++.+||+.+|++||++.+.++
T Consensus 214 -~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 214 -VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 012234567889999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=295.59 Aligned_cols=225 Identities=25% Similarity=0.375 Sum_probs=175.4
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.+|+..+.||+|+||+||+|.+. +++.|||| .|+||+++++++..++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999874 68899999 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+.+++|... ....+..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+...
T Consensus 154 ~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 154 MDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999988542 13467788889999999999999998 999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
. .......||..|+|||.+.. ...+.++|||||||++|||++|+.||....... ........ ....
T Consensus 222 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~-~~~~-- 292 (353)
T PLN00034 222 M-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAI-CMSQ-- 292 (353)
T ss_pred c-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHH-hccC--
Confidence 2 12233568999999998743 234568999999999999999999996321110 00000000 0000
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 293 -------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 -------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223455679999999999999999999999875
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=284.41 Aligned_cols=235 Identities=26% Similarity=0.439 Sum_probs=184.2
Q ss_pred cCCccCceecCCCCeEEEEEEe-----cCCcEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-----EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
..|++.+.||+|+||+||+|.. .++..+++| .|||++++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999974 346788888 37899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 020102 107 VYEFISNGTLYQHLHDRLQ------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY 174 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~ 174 (331)
||||+++++|.+++..... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998854211 01234788899999999999999999998 99999999999999999
Q ss_pred cEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchH
Q 020102 175 RAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 175 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~ 252 (331)
.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|||++ |..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------- 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------- 232 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 999999999976533221 11222345678999999998889999999999999999998 8888854311
Q ss_pred HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
............. ..+...+..+.+++.+||+.+|++||++.+|.++|.+
T Consensus 233 ~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0111111111111 1122345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=284.43 Aligned_cols=244 Identities=29% Similarity=0.388 Sum_probs=182.7
Q ss_pred CccCceecCCCCeEEEEEEe-----cCCcEEEEc------------------------ccccchhhhcccccC--Cccee
Q 020102 58 FNVNRILGQGGQGTVYKGMR-----EDGRIIAVK------------------------KSKNAVKLLGCCLET--EVPLL 106 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK------------------------~~~niv~~~~~~~~~--~~~~l 106 (331)
|.+.+.||+|+||+||++.. .++..||+| .|||++++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988642 457789999 378999999987653 45789
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
+|||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 86 v~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999988864 25899999999999999999999988 99999999999999999999999999876
Q ss_pred ccCCCcee--eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+............... .......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 233 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ---GQMTVVRL 233 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccc---cccchhhh
Confidence 54322111 11223566799999998888999999999999999999999998643221110000000 00000000
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
....+.......+...+..+.+++..||+.+|++|||++++++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111111111123345568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=281.20 Aligned_cols=230 Identities=29% Similarity=0.402 Sum_probs=181.6
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.+|++.+.||+|+||.||+|.+ .+++.||+| +|||++++++.+..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4689999999999999999997 568889998 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+.+.. ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999988764 236899999999999999999999988 9999999999999999999999999987653221
Q ss_pred ceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 192 THVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.......+++.|+|||.+. ...++.++|+|||||++|||++|+.||.......... .+..... .
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---------~~~~~~~---~ 227 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---------LMSKSNF---Q 227 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---------eeecCCC---C
Confidence 1122345888999999874 3457889999999999999999999985432111000 0000000 0
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+.. ......+..+.+++.+||+.+|++|||++++++.
T Consensus 228 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 228 PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0000 0112345679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=288.44 Aligned_cols=242 Identities=27% Similarity=0.369 Sum_probs=188.5
Q ss_pred hcCCccCceecCCCCeEEEEEEec--------CCcEEEEc-------------------------ccccchhhhcccccC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE--------DGRIIAVK-------------------------KSKNAVKLLGCCLET 101 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK-------------------------~~~niv~~~~~~~~~ 101 (331)
.++|.+.+.||+|+||.||++... +...+|+| .|+|++++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357899999999999999999752 23468887 388999999999999
Q ss_pred CcceeEeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL 170 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill 170 (331)
+..++||||+++++|.+++..... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999876321 11235889999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccc
Q 020102 171 DERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQEN 248 (331)
Q Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~ 248 (331)
+.++.++|+|||.+.......... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence 999999999999987553221111 111234568999999999889999999999999999998 778874321
Q ss_pred cchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 249 VSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
... .......... ...+...+..+.+++.+||+.+|++|||+.++++.|+.+.....
T Consensus 248 --~~~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 248 --VEE-LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred --HHH-HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 001 1111111111 11122345678899999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=285.17 Aligned_cols=237 Identities=24% Similarity=0.315 Sum_probs=177.6
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------------ccccchhhhccccc-----CC
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------------KSKNAVKLLGCCLE-----TE 102 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------------~~~niv~~~~~~~~-----~~ 102 (331)
+|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999874 68889999 27899999988764 23
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++++||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence 4789999997 5888877642 2335899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh--
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR-- 260 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 260 (331)
++....... ......+|..|+|||++.+..++.++||||+||++|+|++|+.||........ ... ......
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~----~~~-~~~~~~~~ 226 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----LGK-IFDLIGLP 226 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH----HHH-HHHHhCCC
Confidence 997654322 22234678999999999998999999999999999999999988854321100 000 000000
Q ss_pred -cCcccccc-------c---hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 261 -KNRLYDIL-------D---DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 261 -~~~~~~~~-------~---~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+.... . ........+..+..+.+++.+||+.||++|||+.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0 00000111234567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.30 Aligned_cols=224 Identities=27% Similarity=0.415 Sum_probs=179.3
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCCCHH
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTLY 117 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (331)
+.||+|+||.||+|...++..+|+| .|||++++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888899999 3889999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeee
Q 020102 118 QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197 (331)
Q Consensus 118 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 197 (331)
+++... ...+++..+..++.|++.|+.|+|+.+ ++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 81 SFLRKK----KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 887642 235789999999999999999999988 9999999999999999999999999987543222211122
Q ss_pred ccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccC
Q 020102 198 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276 (331)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
..++..|+|||++.+..++.++||||||+++|++++ |..||...... . ......... ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~-~~~~~~~~~---------~~~~ 215 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------Q-AREQVEKGY---------RMSC 215 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------H-HHHHHHcCC---------CCCC
Confidence 234567999999998899999999999999999998 88898532110 0 011111111 0111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 277 KKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 277 ~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2334568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=291.74 Aligned_cols=214 Identities=29% Similarity=0.384 Sum_probs=173.7
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|.+ .+++.||+| .|||++++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999998 468889998 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E 151 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence 999887764 246888999999999999999999988 9999999999999999999999999987432221 2
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||.+.+..++.++|||||||++|||++|..||..... ........ ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~-~~~---------- 212 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNIL-HKP---------- 212 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHh-cCC----------
Confidence 22345689999999999998999999999999999999999999964311 01111111 111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTME 303 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~ 303 (331)
...+...+..+.+++.+||+.+|.+||++.
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111233456789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.81 Aligned_cols=239 Identities=26% Similarity=0.380 Sum_probs=184.4
Q ss_pred cCCccCceecCCCCeEEEEEEecC-Cc--EEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRED-GR--IIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|++.+.||+|+||.||+|...+ +. .+++| .|||++++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998743 32 35665 378999999999999999999
Q ss_pred eecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 108 YEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
+||+++++|.+++..... .....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999865311 11235889999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHH
Q 020102 177 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
||+|||++...... ........+..|+|||...+..++.++|||||||++|||++ |..||..... ....
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AELY 228 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence 99999998632211 11111223457999999998889999999999999999997 9999854311 0011
Q ss_pred HHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
.... .+ .....+...+..+.+|+.+||+.+|.+|||++++++.|..+....+
T Consensus 229 ~~~~-~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 229 EKLP-QG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHh-cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111 11 0111122345678999999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=278.22 Aligned_cols=223 Identities=27% Similarity=0.404 Sum_probs=176.9
Q ss_pred eecCCCCeEEEEEEe---cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 63 ILGQGGQGTVYKGMR---EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 63 ~lg~G~~g~V~~~~~---~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
.||+|+||.||+|.. .++..+|+| .|+|++++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 357889998 3789999999875 45678999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99988864 236899999999999999999999988 9999999999999999999999999998664433221
Q ss_pred ee--eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 195 TT--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 195 ~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.. ...+++.|+|||.+.+..++.++|+|||||++|||++ |..||...... ........+...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---------~~~~~i~~~~~~------ 217 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---------EVTQMIESGERM------ 217 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHHCCCCC------
Confidence 11 1234578999999988889999999999999999998 89998543110 011111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
..+...+.++.+++.+||+.+|++|||+.+|.+.|+..
T Consensus 218 ---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11233556789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=283.41 Aligned_cols=235 Identities=29% Similarity=0.423 Sum_probs=185.4
Q ss_pred hcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.++|.+.+.||+|+||.||+|... ++..||+| .|+|++++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888999999999999999863 24678988 378999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEe
Q 020102 105 LLVYEFISNGTLYQHLHDRLQN-----QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~ 179 (331)
++||||+++++|.+++...... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999998753221 1234788999999999999999999988 9999999999999999999999
Q ss_pred eccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHH
Q 020102 180 DFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVH 257 (331)
Q Consensus 180 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 257 (331)
|||++..+...... ......++..|+|||.+.+..++.++|||||||++||+++ |..||..... . . ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~------~-~~~ 232 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--E------E-VLK 232 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--H------H-HHH
Confidence 99998755432211 1222346788999999988889999999999999999998 8888753211 0 0 111
Q ss_pred HhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 258 SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
......... .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FVIDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111111 12223567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=287.26 Aligned_cols=232 Identities=23% Similarity=0.336 Sum_probs=179.9
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||++.. .+++.||+| .|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688999999999999999987 468899999 2789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999988642 336889999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~~~~ 225 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKE 225 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCC
Confidence 333222233468999999998863 4578899999999999999999999964311 011111111111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK--RPTMEEVSME 308 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~--RPs~~evl~~ 308 (331)
..... ......+..+.+++.+||+.++++ ||+++++++.
T Consensus 226 ~~~~~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 HFQFP------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cccCC------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11110 011224567889999988764443 7899888766
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=279.98 Aligned_cols=234 Identities=27% Similarity=0.418 Sum_probs=182.3
Q ss_pred CccCceecCCCCeEEEEEEec----CCcEEEEc-------------------------ccccchhhhcccccCCc-----
Q 020102 58 FNVNRILGQGGQGTVYKGMRE----DGRIIAVK-------------------------KSKNAVKLLGCCLETEV----- 103 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK-------------------------~~~niv~~~~~~~~~~~----- 103 (331)
|.+.+.||+|+||.||.|... .+..||+| .|+|++++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999863 24678999 37899999998866554
Q ss_pred -ceeEeecccCCCHHHHHhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 104 -PLLVYEFISNGTLYQHLHDRLQ-NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 104 -~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
.++++||+++++|...+..... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 7999999999999988855321 22346899999999999999999999988 999999999999999999999999
Q ss_pred cCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 020102 182 GTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 182 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~-~~~ 228 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIY-DYL 228 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHH-HHH
Confidence 9997654332211 111234678999999998899999999999999999999 88887532110 111 111
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
..+... ..+...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 229 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111 11234556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.96 Aligned_cols=227 Identities=30% Similarity=0.453 Sum_probs=185.0
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|.+.+.||+|++|.||+|.. .++..|++| .|||++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467788999999999999987 468889998 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+++... ....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999988752 2347899999999999999999999988 999999999999999999999999998865433
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.. ......|++.|+|||+..+..++.++|+|||||++++|++|+.||..... .. .......+...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~-~~~~~~~~~~~----- 219 (256)
T cd08529 155 TN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GA-LILKIIRGVFP----- 219 (256)
T ss_pred cc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHcCCCC-----
Confidence 22 22334688999999999999999999999999999999999999854321 00 11111111111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.....++..+.+++.+||+.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122455679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.93 Aligned_cols=235 Identities=26% Similarity=0.368 Sum_probs=182.7
Q ss_pred hcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~~ 104 (331)
+++|.+.+.||+|+||.||+|... .+..|++| .|+|++++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456889999999999999999874 35678888 378999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---cEEEe
Q 020102 105 LLVYEFISNGTLYQHLHDRLQN--QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY---RAKVA 179 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~---~~kl~ 179 (331)
++||||+++++|.+++...... ....+++..+..++.||+.|+.|||+.+ ++|+||+|+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 9999999999999988763211 1235899999999999999999999998 99999999999998655 58999
Q ss_pred eccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHH
Q 020102 180 DFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVH 257 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 257 (331)
|||++.......... ......+..|+|||++.+..++.++|||||||++|||++ |..||..... . . ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~------~-~~~ 232 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--Q------E-VME 232 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H------H-HHH
Confidence 999998653222111 111223567999999999999999999999999999997 8888853211 1 0 111
Q ss_pred HhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 258 SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
...... ....+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 233 ~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111110 01112334567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=297.78 Aligned_cols=222 Identities=30% Similarity=0.458 Sum_probs=185.1
Q ss_pred eecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecccCCCHHH
Q 020102 63 ILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQ 118 (331)
Q Consensus 63 ~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 118 (331)
+||+|.||+||.|.+. +...+||| +|+|||+++|.+.+++..-|.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5999999999999984 46678999 47899999999999999999999999999999
Q ss_pred HHhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEeeccCcccccCCCceee
Q 020102 119 HLHDRLQNQEFPL--TWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVT 195 (331)
Q Consensus 119 ~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~ 195 (331)
.|... =+|+ .+.++..+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||.++.+.. -+..+
T Consensus 662 LLrsk----WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~T 733 (1226)
T KOG4279|consen 662 LLRSK----WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCT 733 (1226)
T ss_pred HHHhc----cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCccc
Confidence 88763 2356 88899999999999999999988 99999999999997 578999999999987653 34556
Q ss_pred eeccccCCccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 196 TKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
.++.||..|||||++..++ |..++|||||||++.||.||++||...++... .++. -.+. ..-
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFk-----VGmy-----KvH 797 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFK-----VGMY-----KVH 797 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhh-----hcce-----ecC
Confidence 6788999999999998775 78899999999999999999999976543221 1111 0011 112
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+.+.+.++.+..||.+|+.++|..||++.++++.
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 34577888999999999999999999999999653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=284.59 Aligned_cols=177 Identities=27% Similarity=0.427 Sum_probs=143.7
Q ss_pred CceecCCCCeEEEEEEec---CCcEEEEc---------------------ccccchhhhccccc--CCcceeEeecccCC
Q 020102 61 NRILGQGGQGTVYKGMRE---DGRIIAVK---------------------KSKNAVKLLGCCLE--TEVPLLVYEFISNG 114 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~---~~~~vavK---------------------~~~niv~~~~~~~~--~~~~~lv~e~~~~~ 114 (331)
.+.||+|+||+||+|.+. +++.+|+| .||||+++++++.. +...++++||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 468999999999999864 56789999 38899999998854 456789999986 6
Q ss_pred CHHHHHhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe----CCCCcEEEeeccCccc
Q 020102 115 TLYQHLHDRLQ----NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKF 186 (331)
Q Consensus 115 ~L~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~ 186 (331)
+|.+.+..... .....+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 78777653211 11235899999999999999999999998 9999999999999 4567899999999986
Q ss_pred ccCCCce--eeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 020102 187 IAMDQTH--VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSA 241 (331)
Q Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~ 241 (331)
....... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 5433221 22345689999999988774 5889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=284.52 Aligned_cols=234 Identities=21% Similarity=0.345 Sum_probs=183.5
Q ss_pred CCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.|++.+.||+|+||.||+|... .+..||+| .||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677889999999999999863 25778999 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc
Q 020102 107 VYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~ 175 (331)
++||+.+++|.+++..... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 9999999999998853211 11235788899999999999999999988 999999999999999999
Q ss_pred EEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHH
Q 020102 176 AKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAA 253 (331)
Q Consensus 176 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 253 (331)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 99999999875533221 11222345778999999988889999999999999999998 7777753211 01
Q ss_pred HHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
........... ..+...+..+.+++..||+.+|++||++.+|+..|+.
T Consensus 235 -~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 -VIEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111111 1233456678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=279.57 Aligned_cols=230 Identities=26% Similarity=0.303 Sum_probs=189.9
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.+.|++.+.||.|.-|+||++... ++..+|+| .||.++.+|+.+..++..++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 356788899999999999999985 46899999 399999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
||||+||+|...+++ ..+.-+++..+..++..|+-||.|||-.| ||.|||||+||||.++|++-|+||.++...
T Consensus 156 meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999998876 45667999999999999999999999999 999999999999999999999999986432
Q ss_pred cC---------------------------------C-C---------------------ceeeeeccccCCccChhhhcC
Q 020102 188 AM---------------------------------D-Q---------------------THVTTKIQGTFGYLDPEYHQS 212 (331)
Q Consensus 188 ~~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~ 212 (331)
.. . . ......++||-.|+|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 11 0 0 011223679999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhh
Q 020102 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCL 292 (331)
Q Consensus 213 ~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL 292 (331)
...+.++|.|+||+++|||+.|..||...++.. .+..++...+..+..+..+..+.|||+++|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999997654321 122222233333334466778999999999
Q ss_pred ccCCCCCCC----HHHHHH
Q 020102 293 DLNGKKRPT----MEEVSM 307 (331)
Q Consensus 293 ~~~p~~RPs----~~evl~ 307 (331)
.+||.+|.. +.||.+
T Consensus 373 vKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ccChhhhhccccchHHhhc
Confidence 999999987 666643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.63 Aligned_cols=243 Identities=22% Similarity=0.264 Sum_probs=179.3
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC-----
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET----- 101 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~----- 101 (331)
...++|++.+.||+|+||.||+|.+ ..++.||+| .|||++++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999987 468889999 388999999987643
Q ss_pred -CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 102 -EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 102 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
...++||||++ +++.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEee
Confidence 34689999997 466665543 4788999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc----------
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS---------- 250 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~---------- 250 (331)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 163 fg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999754322 2223356899999999999999999999999999999999999998643211000000
Q ss_pred ----hHHHHHHHhhcC-ccccccchHh--------hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 251 ----LAAYFVHSMRKN-RLYDILDDQV--------MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 251 ----~~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
............ .......+.. ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 0000000000 000112234578999999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=279.45 Aligned_cols=232 Identities=23% Similarity=0.410 Sum_probs=184.6
Q ss_pred cCCccCceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.+|++.+.||+|+||.||+|.+. .+..+|+| .|||++++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999863 23468888 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999988652 246899999999999999999999988 999999999999999999999999999866
Q ss_pred cCCCceeeee--ccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 188 AMDQTHVTTK--IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 188 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
.......... ..++..|+|||.+.+..++.++|+|||||++||+++ |..||....... .. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~-~~~~~~~- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VI-KAIEEGY- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HH-HHHhCCC-
Confidence 5433222211 223567999999999889999999999999999886 999986432110 01 1111110
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
........+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=283.02 Aligned_cols=242 Identities=26% Similarity=0.396 Sum_probs=183.2
Q ss_pred cCCccCceecCCCCeEEEEEEe-----cCCcEEEEc-----------------------ccccchhhhccccc--CCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-----EDGRIIAVK-----------------------KSKNAVKLLGCCLE--TEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK-----------------------~~~niv~~~~~~~~--~~~~~ 105 (331)
.+|++.+.||+|+||+||+|.. .++..|++| .|||++++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999973 357889999 38899999987643 45688
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 84 lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 999999999999988642 235899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCceee--eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccc-------ccchHHHHH
Q 020102 186 FIAMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE-------NVSLAAYFV 256 (331)
Q Consensus 186 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~ 256 (331)
.......... ....++..|+|||.+.+..++.++|+|||||++|||++|..|+......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 6643322111 1122345699999999989999999999999999999987775432111000 000000000
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
..... ..........+..+.+++.+||+.+|++|||+.+|++.|+.++
T Consensus 237 ~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 237 ELLKN---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHhc---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 11111 1111122344567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=293.07 Aligned_cols=215 Identities=30% Similarity=0.363 Sum_probs=175.2
Q ss_pred ceecCCCCeEEEEEEe----cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 62 RILGQGGQGTVYKGMR----EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~----~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
+.||+|+||.||++.+ .+++.+|+| .||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357889998 38899999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 9999988864 246899999999999999999999998 9999999999999999999999999987543322
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . ..... ......
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~------~~~~~-i~~~~~-------- 215 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--K------ETMTM-ILKAKL-------- 215 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--H------HHHHH-HHcCCC--------
Confidence 222345689999999999998899999999999999999999999864311 0 00111 111110
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~e 304 (331)
..+...+..+.+++.+||+.||++|||+.+
T Consensus 216 --~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 --GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112234567889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=279.19 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=189.8
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
+|++.+.||+|+||.||+|.+ .++..||+| .|||++++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999987 568889998 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 82 DGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 99988543 14678889999999999999999988 999999999999999999999999998755322
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
......+|..|+|||.+.+..++.++|+|||||++|+|++|+.||............ .. ..........
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~------- 217 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP-LQ-LLQCIVDEDP------- 217 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch-HH-HHHHHhccCC-------
Confidence 222346899999999999989999999999999999999999998643211111100 01 1111111110
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchhhHHHHHhhc
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAMFSKIIKRL 330 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~~~ 330 (331)
........+.++.+++.+||+.+|++||+++++++.---...+.+.-.....|.+++|
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~~~~~~~~~~ 275 (279)
T cd06619 218 -PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRAL 275 (279)
T ss_pred -CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccHHHHHHHHHHHH
Confidence 0011223455789999999999999999999998763322233333333456666665
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=283.77 Aligned_cols=240 Identities=27% Similarity=0.399 Sum_probs=185.8
Q ss_pred HhcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~ 103 (331)
..++|++.+.||+|+||.||+|... .+..||+| .|+|++++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24578998 37899999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQN-----QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV 178 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl 178 (331)
.++||||+++|+|.+++...... .....++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753211 1134567788999999999999999988 999999999999999999999
Q ss_pred eeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHH
Q 020102 179 ADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
+|||+++......... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||..... .. ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~-~~ 231 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQ-VL 231 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HH
Confidence 9999987553322111 112235678999999999899999999999999999998 6778753211 01 11
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.....+.... .+...+..+.+++.+||+.+|++|||+.++++.|+...-
T Consensus 232 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 232 KFVMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 1111111111 112234579999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=293.50 Aligned_cols=243 Identities=23% Similarity=0.336 Sum_probs=183.9
Q ss_pred hcCCccCceecCCCCeEEEEEEec---CCcEEEEc------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE---DGRIIAVK------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
..+|.+.+.||+|+||.||+|... .+..|++| .||||+++++++......+++||++.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 457999999999999999999753 46778888 48999999999999999999999996
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc-
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT- 192 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~- 192 (331)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 170 ~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 170 CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 678887743 347899999999999999999999998 99999999999999999999999999976543322
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc--c----
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY--D---- 266 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---- 266 (331)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||+........ ..+.. ....+...... .
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~l~~-i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS-SQLRS-IIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH-HHHHH-HHHHhccCccccCCccch
Confidence 1223456999999999999999999999999999999999999999754322110 00000 00100000000 0
Q ss_pred --------cc---chH--hhc-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 --------IL---DDQ--VMK-LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 --------~~---~~~--~~~-~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. ... .+. ......+.++.+++.+||+.+|++|||+.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000 000 0011234578899999999999999999999765
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=291.18 Aligned_cols=243 Identities=23% Similarity=0.296 Sum_probs=178.8
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCC----
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETE---- 102 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~---- 102 (331)
...++|++.+.||+|+||.||++.+ .++..||+| .||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3457899999999999999999987 468899999 3789999999886543
Q ss_pred --cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 103 --VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 103 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
..++||||++ +++...+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEec
Confidence 4699999997 456555532 4788899999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-------cchH-
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN-------VSLA- 252 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~-------~~~~- 252 (331)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ....
T Consensus 167 fg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 167 FGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred CCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 9998754322 22233468999999999999999999999999999999999999996432110000 0000
Q ss_pred ------HHHHHHhhc-Ccccccc-chHh-------hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 253 ------AYFVHSMRK-NRLYDIL-DDQV-------MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 253 ------~~~~~~~~~-~~~~~~~-~~~~-------~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......... ....... .... ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 0000000 0000 000111234568999999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=290.54 Aligned_cols=230 Identities=27% Similarity=0.420 Sum_probs=194.3
Q ss_pred HHhcCCccCceecCCCCeEEEEEEecC-CcEEEEc---------------------------ccccchhhhcccccCCcc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRED-GRIIAVK---------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK---------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.....|.+.+.||+|.||.||++..+. |+.+|+| .|||+|.+.+.+.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678999999999999999999854 9999999 289999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC----CCcEEEee
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE----RYRAKVAD 180 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~----~~~~kl~D 180 (331)
++|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.| |+|||+||+|+|+.. ++.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999873 2999999999999999999999998 999999999999963 35799999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
||++..... .......+||+.|+|||++.+.+|+..+||||+|+++|.|++|.+||........ +. ...
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------~~-~i~ 251 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------FL-AIL 251 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------HH-HHH
Confidence 999997765 3445567899999999999999999999999999999999999999975432111 11 111
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+.+ .......+..+..+.+++..||..||..|+|+.++++.
T Consensus 252 ~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 RGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1211 12233455667889999999999999999999999885
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=277.78 Aligned_cols=232 Identities=24% Similarity=0.402 Sum_probs=185.5
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
..+|.+.+.||+|+||.||++...++..+++| .|+|++++++++.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 46788999999999999999988777789998 37799999998877 77899999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 84 KGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999988752 2346788999999999999999999988 99999999999999999999999999876543322
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......++..|+|||.+.+..++.++|+|||||++|++++ |+.||...... ...........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---------~~~~~~~~~~~------- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---------EVIRALERGYR------- 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---------HHHHHHhCCCC-------
Confidence 22222345677999999998889999999999999999999 88888532110 01111111110
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
.......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 222 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 --MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11123345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.87 Aligned_cols=240 Identities=22% Similarity=0.377 Sum_probs=188.5
Q ss_pred HhcCCccCceecCCCCeEEEEEEecC-----CcEEEEc------------------------ccccchhhhccccc-CCc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRED-----GRIIAVK------------------------KSKNAVKLLGCCLE-TEV 103 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK------------------------~~~niv~~~~~~~~-~~~ 103 (331)
..++|.+.+.||+|+||.||+|.+.+ +..|++| .|+|++++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678899999999999999999754 6788888 38899999998766 567
Q ss_pred ceeEeecccCCCHHHHHhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQN---QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
.++++||+++++|.+++...... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999988763211 1146899999999999999999999988 99999999999999999999999
Q ss_pred ccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHH
Q 020102 181 FGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 181 fg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
||+++.+....... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||..... . ... ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~------~~~-~~ 231 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--F------EMA-AY 231 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--H------HHH-HH
Confidence 99997553322211 122345678999999998889999999999999999998 9999854211 0 111 11
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
...+.. .......+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 232 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 232 LKDGYR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHcCCC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111100 00112234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=300.81 Aligned_cols=255 Identities=20% Similarity=0.252 Sum_probs=180.1
Q ss_pred HHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEccc----------------------------ccchhhhcccc
Q 020102 49 KELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKS----------------------------KNAVKLLGCCL 99 (331)
Q Consensus 49 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~----------------------------~niv~~~~~~~ 99 (331)
+++....++|++.+.||+|+||+||+|.+ ..++.||||.. .+++++++++.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455578899999999999999999987 45788999942 24666777766
Q ss_pred cC-CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCC---
Q 020102 100 ET-EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERY--- 174 (331)
Q Consensus 100 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~--- 174 (331)
.. ...++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 53 4688999988 6788887765 2468999999999999999999997 47 99999999999998765
Q ss_pred -------------cEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 020102 175 -------------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSA 241 (331)
Q Consensus 175 -------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~ 241 (331)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999875322 1223457999999999999999999999999999999999999999653
Q ss_pred CCCccccc------chHHHHHH---------Hhhc-CccccccchHhh-------ccCCHHHHHHHHHHHHHhhccCCCC
Q 020102 242 GNTSQENV------SLAAYFVH---------SMRK-NRLYDILDDQVM-------KLGKKNQIMAFANLAERCLDLNGKK 298 (331)
Q Consensus 242 ~~~~~~~~------~~~~~~~~---------~~~~-~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cL~~~p~~ 298 (331)
........ .+...+.. .... ..+....++... ..........+++||.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 22110000 00000000 0000 000000000000 0000112356889999999999999
Q ss_pred CCCHHHHHHH--HHhhhhcc
Q 020102 299 RPTMEEVSME--LNGIRGSS 316 (331)
Q Consensus 299 RPs~~evl~~--L~~l~~~~ 316 (331)
|||++|+++. +......+
T Consensus 429 R~ta~e~L~Hp~~~~~~~~~ 448 (467)
T PTZ00284 429 RLNARQMTTHPYVLKYYPEC 448 (467)
T ss_pred CCCHHHHhcCccccccCCcc
Confidence 9999999873 44443333
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.28 Aligned_cols=237 Identities=26% Similarity=0.391 Sum_probs=187.0
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhhhcccccC
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKLLGCCLET 101 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~~~~~~~~ 101 (331)
...++|.+.+.||+|+||.||+|.. ..+..+|+| .|+|++++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3346789999999999999999974 234578887 388999999999999
Q ss_pred CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
+..+++|||+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999988652 1234899999999999999999999988 999999999999999999999999
Q ss_pred cCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 020102 182 GTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 182 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
|++......... ......++..|+|||.+.+..++.++||||+||++|+|++ |..||...... ..+....
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--------~~~~~~~ 257 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--------SKFYKLI 257 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--------HHHHHHH
Confidence 999865433221 1122345778999999999999999999999999999998 88988543110 0111111
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
..+. ....+...+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 258 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1110 0011222345799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=283.31 Aligned_cols=241 Identities=27% Similarity=0.364 Sum_probs=184.8
Q ss_pred cCCccCceecCCCCeEEEEEEe-----cCCcEEEEc------------------------ccccchhhhcccccC--Ccc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-----EDGRIIAVK------------------------KSKNAVKLLGCCLET--EVP 104 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK------------------------~~~niv~~~~~~~~~--~~~ 104 (331)
..|++.+.||+|+||.||.+.. .++..||+| .|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999999973 357889999 378999999988775 568
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence 8999999999999988642 235899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCCce--eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccc------ccchHHHHH
Q 020102 185 KFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE------NVSLAAYFV 256 (331)
Q Consensus 185 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~ 256 (331)
..+...... ......++..|+|||.+.+..++.++|||||||++|||++++.|.......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 866443321 122345677899999998888999999999999999999987765332111000 000000111
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
.....+. ....+..++..+.+|+.+||+.+|++|||++++++.|+++
T Consensus 237 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111 1111234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.93 Aligned_cols=241 Identities=27% Similarity=0.391 Sum_probs=183.9
Q ss_pred cCCccCceecCCCCeEEEEEEecC-----------------CcEEEEc------------------------ccccchhh
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRED-----------------GRIIAVK------------------------KSKNAVKL 94 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK------------------------~~~niv~~ 94 (331)
.+|++.+.||+|+||.||+|...+ +..||+| .|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 578999999999999999987532 2457888 37899999
Q ss_pred hcccccCCcceeEeecccCCCHHHHHhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCE
Q 020102 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQN------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNI 168 (331)
Q Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Ni 168 (331)
++++..+...++++|++++++|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 99999999999999999999999988764311 1236899999999999999999999988 99999999999
Q ss_pred EeCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCc
Q 020102 169 LLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSAGNTS 245 (331)
Q Consensus 169 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~~p~~~~~~~~ 245 (331)
+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ +..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 9999999999999998754332211 1223346778999999988889999999999999999998 6667643211
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
. ................. ....+...+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 240 ~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 Q---QVIENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 0 00011111100000000 01112234567999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=285.31 Aligned_cols=237 Identities=27% Similarity=0.388 Sum_probs=183.5
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCc--EEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGR--IIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|++.+.||+|+||.||+|.+. ++. .+++| .|+|++++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56888999999999999999863 343 34665 378999999999999999999
Q ss_pred eecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 108 YEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
+||+++++|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999998865321 11235789999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHH
Q 020102 177 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
+|+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...... ...
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY 233 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------HHH
Confidence 99999998632211 11111224567999999988889999999999999999998 99998533111 111
Q ss_pred HHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
.. ..... ....+...+..+.+++.+||+.+|++|||+++++..|..+...
T Consensus 234 ~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 234 EK-LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HH-HhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 11110 0001122345789999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.71 Aligned_cols=230 Identities=28% Similarity=0.448 Sum_probs=183.3
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
..|++.+.||+|+||.||+|.+.++..+++| .|||++++++++......++|+||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4678889999999999999988777889998 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+++.. ....+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 84 GCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999888764 2346889999999999999999999988 999999999999999999999999998755432221
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---------~~~~~~~~~~--------- 218 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---------EVVETINAGF--------- 218 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---------HHHHHHhCCC---------
Confidence 1222235678999999998889999999999999999998 88888542110 0111111110
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
....+...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus 219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 00011223467999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=293.31 Aligned_cols=217 Identities=28% Similarity=0.347 Sum_probs=171.6
Q ss_pred ecCCCCeEEEEEEec-CCcEEEEc-----------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 64 LGQGGQGTVYKGMRE-DGRIIAVK-----------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 64 lg~G~~g~V~~~~~~-~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
||+|+||+||+|.+. +++.||+| .|||++++++.+.+.+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999874 68899998 277899999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~ 151 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-K 151 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-C
Confidence 999888764 346899999999999999999999998 9999999999999999999999999987532221 2
Q ss_pred eeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ..... ....+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~-~i~~~~~-~~----- 216 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYR-NIAFGKV-RF----- 216 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHH-HHHcCCC-CC-----
Confidence 22345699999999988765 478999999999999999999999964321 01111 1111110 00
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPT----MEEVSM 307 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs----~~evl~ 307 (331)
.....+..+.+++.+||+.+|.+||+ +.++++
T Consensus 217 ---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 ---PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11123557889999999999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.21 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=179.7
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|.+.+.||+|+||+||+|.+. +++.||+| +|+|++++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999874 67889999 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
++ ++|.+.+... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 86 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 97 4787776542 335788999999999999999999988 999999999999999999999999998754332
Q ss_pred CceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc-------hHHHHHHHhhcC
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS-------LAAYFVHSMRKN 262 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~ 262 (331)
.. ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||............ ....+.......
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 22 1223457899999998765 45789999999999999999999998643221100000 000000000000
Q ss_pred ccccccchHh----hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQV----MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~----~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.......+.. .....+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 00011234567889999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=281.78 Aligned_cols=228 Identities=26% Similarity=0.339 Sum_probs=180.7
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEcc--------------------------cccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK--------------------------SKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~--------------------------~~niv~~~~~~~~~~~~~lv~e 109 (331)
.|+..+.||+|+||+||++.+ .+++.||+|. |++++.+++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999987 4688999983 6688888888888899999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+.+... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999888542 2236899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
... .....|+..|+|||++.+..++.++||||+||++|+|++|+.||........ .........
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-----~~~~~~~~~--------- 218 (285)
T cd05630 155 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVERLVK--------- 218 (285)
T ss_pred Ccc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-----HHHHHhhhh---------
Confidence 221 1234689999999999999999999999999999999999999964321110 000000000
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSM 307 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~ 307 (331)
..........+..+.+|+..||+.||++||| ++|+++
T Consensus 219 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 219 -EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0001112334567899999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=294.76 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=189.8
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEec------CCcEEEEc-------------------------ccccchhhhccc
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK-------------------------KSKNAVKLLGCC 98 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK-------------------------~~~niv~~~~~~ 98 (331)
++....++|.+.+.||+|+||.||+|.+. .+..||+| .|||++++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 34555567888999999999999999853 34679999 289999999999
Q ss_pred ccCCcceeEeecccCCCHHHHHhhhhc-----------------------------------------------------
Q 020102 99 LETEVPLLVYEFISNGTLYQHLHDRLQ----------------------------------------------------- 125 (331)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 125 (331)
......++|+||+++|+|.+++.....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999998865211
Q ss_pred ----------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCC
Q 020102 126 ----------------------------------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165 (331)
Q Consensus 126 ----------------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp 165 (331)
.....+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 01124677888999999999999999988 99999999
Q ss_pred CCEEeCCCCcEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCC
Q 020102 166 TNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGN 243 (331)
Q Consensus 166 ~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~ 243 (331)
+||++++++.++|+|||++..+..... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999975432221 11122346788999999998889999999999999999998 8888854311
Q ss_pred CcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 244 TSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
.. ........+. ....+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 348 ~~--------~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NE--------QFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hH--------HHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 10 0111111110 01112334567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=289.18 Aligned_cols=242 Identities=21% Similarity=0.272 Sum_probs=178.3
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC------
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET------ 101 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~------ 101 (331)
..++|.+.+.||+|+||.||+|.+ ..++.|||| .|||++++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999987 458889999 378999999887543
Q ss_pred CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
...++||||++ ++|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeC
Confidence 34799999997 567666643 4788899999999999999999988 999999999999999999999999
Q ss_pred cCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc-------hHHH
Q 020102 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS-------LAAY 254 (331)
Q Consensus 182 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~ 254 (331)
|++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||............ ....
T Consensus 171 G~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 171 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CCccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999754322 1223356899999999999999999999999999999999999999643211000000 0000
Q ss_pred -------HHHHhhc-CccccccchHh--------hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 255 -------FVHSMRK-NRLYDILDDQV--------MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 255 -------~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....... ........... ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00000000000 000111234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=276.01 Aligned_cols=229 Identities=28% Similarity=0.439 Sum_probs=185.3
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.+.|++.+.||.|+||.||+|... ++.||+| .|+|++++++++.+....++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 456888999999999999999874 7889999 37899999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 84 KGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99999988752 2236899999999999999999999988 99999999999999999999999999976532211
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
....+..|+|||.+.+..++.++|+||||+++++|++ |..||..... . . .......+..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~------~-~~~~~~~~~~------- 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--K------D-VVPHVEKGYR------- 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--H------H-HHHHHhcCCC-------
Confidence 2234667999999988889999999999999999997 9888853311 0 0 1111111100
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
...+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 --MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111223456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=277.49 Aligned_cols=233 Identities=24% Similarity=0.436 Sum_probs=184.0
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CC---cEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DG---RIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.++|...+.||+|+||.||+|... ++ ..+++| .|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356788899999999999999874 22 368888 37899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++++|.+++.. ....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 9999999999988864 2346899999999999999999999988 99999999999999999999999999876
Q ss_pred ccCCCceeee--eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 187 IAMDQTHVTT--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 187 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
.......... ....+..|+|||.+.+..++.++|||||||++|||++ |+.||..... .. .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~-~~~~i~~~~ 227 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HE-VMKAINDGF 227 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HH-HHHHHhcCC
Confidence 5432221111 1223457999999998889999999999999999997 9999854321 01 111111110
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
..+.....+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 228 ---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ---------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111223445789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=277.30 Aligned_cols=227 Identities=22% Similarity=0.332 Sum_probs=183.9
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
+|++.+.||+|+||.||++.+. ++..+++| .|+|++++++.+.++...++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999874 68888888 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+.+... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999998887642 2346789999999999999999999988 9999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|..||..... ..... ....+...
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~-~~~~~~~~------ 218 (255)
T cd08219 155 A-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLIL-KVCQGSYK------ 218 (255)
T ss_pred c-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHH-HHhcCCCC------
Confidence 2 22235688999999999998899999999999999999999999864210 00111 11111111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+..+.+++.+||+.+|++|||+.+++..
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122345578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=276.52 Aligned_cols=228 Identities=27% Similarity=0.425 Sum_probs=181.0
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc---------------------ccccchhhhcccc-cCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------KSKNAVKLLGCCL-ETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------------~~~niv~~~~~~~-~~~~~~lv~e~~~~ 113 (331)
.+|.+.+.||+|+||.||++... +..+++| .|+|++++++++. .++..++++||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 46888999999999999999764 6778888 3789999998754 45678999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 85 GSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999988652 2335889999999999999999999988 9999999999999999999999999987543221
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||.... ....... ...+.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~-~~~~~--------- 216 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPR-VEKGY--------- 216 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH-HhcCC---------
Confidence 12234568999999999899999999999999999997 888885321 0111111 11110
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
........+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0111233456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=280.98 Aligned_cols=230 Identities=28% Similarity=0.451 Sum_probs=180.0
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccC------Cc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLET------EV 103 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~------~~ 103 (331)
+.+.|++.+.||+|+||.||+|.. .+++.+|+| .|+|++++++.+... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 456788899999999999999987 468888998 378999999988653 35
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.+++|||+++++|.+.+... ....+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 78999999999999988752 2346899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
+....... .......|++.|+|||++. +..++.++|+|||||++|||++|..||...... .... .
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~~--~ 227 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALF--L 227 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHH--H
Confidence 87543222 1223356899999999886 345788999999999999999999998532110 0000 0
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...... ........+..+.+|+.+||+.+|.+|||+.++++
T Consensus 228 ~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IPRNPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HhcCCC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 001100 11112234457899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=309.24 Aligned_cols=240 Identities=23% Similarity=0.376 Sum_probs=186.6
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||.||+|.+. +++.||+| .|||++++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999974 58899999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 109 EFISNGTLYQHLHDRLQN------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
||++|++|.+.+...... .....++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988653211 1234567788999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCc-----------------eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc
Q 020102 183 TSKFIAMDQT-----------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245 (331)
Q Consensus 183 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~ 245 (331)
++........ .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521110 01112468999999999999999999999999999999999999986421100
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhh
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-TMEEVSMELNGIRG 314 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-s~~evl~~L~~l~~ 314 (331)
.. ..... ..+ .........+..+.+++.+||+.||++|| +++++++.|+....
T Consensus 239 ---i~----~~~~i--------~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ---IS----YRDVI--------LSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---hh----hhhhc--------cCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00000 000 00011123455788999999999999996 67778887776543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=281.06 Aligned_cols=235 Identities=26% Similarity=0.425 Sum_probs=182.9
Q ss_pred cCCccCceecCCCCeEEEEEEe------cCCcEEEEc-----------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+|...+.||+|+||.||++.. .++..+++| .|+|++++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4677889999999999999964 235677877 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 107 VYEFISNGTLYQHLHDRLQ----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
+|||+++++|.+++..... .....+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998865311 01135789999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHH
Q 020102 177 KVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~ 254 (331)
+|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~ 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--------A 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------H
Confidence 99999998754332211 1122335678999999999999999999999999999998 888885431110 0
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
. ........ ...+...+..+.+++.+||+.+|.+||++++|++.|++
T Consensus 234 ~-~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 I-ECITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred H-HHHHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1 11111100 01122344578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=285.95 Aligned_cols=232 Identities=22% Similarity=0.323 Sum_probs=180.3
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||.||++... +++.+|+| .|+|++++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999874 57788988 2678999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999998652 236899999999999999999999998 9999999999999999999999999987554
Q ss_pred CCCceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||..... ............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~ 225 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKE 225 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCc
Confidence 33333333456999999999886 34578899999999999999999999964311 111111111111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK--RPTMEEVSME 308 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~--RPs~~evl~~ 308 (331)
.... .......+..+.+++.+||+.+|.+ |++++++++.
T Consensus 226 ~~~~------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQF------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccC------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 0111234567889999999765554 6889998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=294.38 Aligned_cols=229 Identities=24% Similarity=0.333 Sum_probs=178.1
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
+.|++.+.||+|+||+||++.+. +++.||+| .|+|++++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999874 68899999 2679999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.+|.++|+|||++....
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999998865 246899999999999999999999998 9999999999999999999999999986442
Q ss_pred CCCc----------------------------------eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhC
Q 020102 189 MDQT----------------------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG 234 (331)
Q Consensus 189 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 234 (331)
.... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 1100 001134699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 020102 235 KKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT---MEEVSME 308 (331)
Q Consensus 235 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs---~~evl~~ 308 (331)
+.||...... ............. ..+.....+..+.+++.+|+ .+|.+|++ ++++++.
T Consensus 233 ~~Pf~~~~~~--------~~~~~i~~~~~~~-------~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 233 YPPFCSETPQ--------ETYRKVMNWKETL-------VFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCCHH--------HHHHHHHcCCCce-------ecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9999643210 0111111100000 00011124567888998876 59999996 5555443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=280.59 Aligned_cols=236 Identities=18% Similarity=0.290 Sum_probs=171.6
Q ss_pred HhcCCccCceecCCCCeEEEEEEecC----CcEEEEc----------------------------------ccccchhhh
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRED----GRIIAVK----------------------------------KSKNAVKLL 95 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK----------------------------------~~~niv~~~ 95 (331)
..++|.+.+.||+|+||+||+|...+ +..+++| .|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999998743 3455666 245677777
Q ss_pred cccccCC----cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 020102 96 GCCLETE----VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171 (331)
Q Consensus 96 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~ 171 (331)
+++.... ..++++|++. .++.+.+... ...++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~ 160 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVD 160 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence 6554433 2367777764 4565555431 23578888999999999999999988 99999999999999
Q ss_pred CCCcEEEeeccCcccccCCCc------eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc
Q 020102 172 ERYRAKVADFGTSKFIAMDQT------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245 (331)
Q Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~ 245 (331)
.++.++|+|||+|+.+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999976532221 11123469999999999999999999999999999999999999996542211
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
.........+...+..+.. .....+..+.+++..|++.+|++||+++++.+.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKRLHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHHhhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1100000001111111110 0122346789999999999999999999998876
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=286.26 Aligned_cols=239 Identities=23% Similarity=0.290 Sum_probs=176.3
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC------
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET------ 101 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~------ 101 (331)
..++|.+.+.||+|+||+||+|.+ .++..||+| .|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999987 468889999 378999999988643
Q ss_pred CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
...+++++++ +++|.+.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3468899988 6888776643 36899999999999999999999998 999999999999999999999999
Q ss_pred cCcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-------cchHH
Q 020102 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN-------VSLAA 253 (331)
Q Consensus 182 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~-------~~~~~ 253 (331)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .....
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999755332 223468999999999877 568899999999999999999999985432100000 00000
Q ss_pred HHHHHhhcC-------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 254 YFVHSMRKN-------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 254 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
... ..... .+........ ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLK-KISSEHARKYIQSLPHMPQQDL-KKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHH-hcchhhHHHHhhccccccchhH-HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000 0000000000 00001123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=286.36 Aligned_cols=232 Identities=23% Similarity=0.332 Sum_probs=180.2
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||+||++.+. +++.||+| .|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999874 67889999 2679999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999988752 236889999999999999999999988 9999999999999999999999999997665
Q ss_pred CCCceeeeeccccCCccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
...........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||..... ............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~ 225 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHEE 225 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcCCC
Confidence 433333334569999999998876 4678899999999999999999999964311 011111111110
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK--RPTMEEVSME 308 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~--RPs~~evl~~ 308 (331)
.... + ......+..+.+++.+||+.++.+ |++++++++.
T Consensus 226 ~~~~-----p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQF-----P-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccC-----C-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 0 011224567899999999876544 4577777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=284.93 Aligned_cols=240 Identities=26% Similarity=0.386 Sum_probs=186.9
Q ss_pred hcCCccCceecCCCCeEEEEEEec--------CCcEEEEc-------------------------ccccchhhhcccccC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE--------DGRIIAVK-------------------------KSKNAVKLLGCCLET 101 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK-------------------------~~~niv~~~~~~~~~ 101 (331)
..+|.+.+.||+|+||.||+|... ....+|+| .||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999742 24567887 288999999999999
Q ss_pred CcceeEeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL 170 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill 170 (331)
...+++|||+++++|.+++..... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999876321 11245889999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccc
Q 020102 171 DERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQEN 248 (331)
Q Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~ 248 (331)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--~~-- 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--VE-- 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC--HH--
Confidence 999999999999997654321111 111234467999999999899999999999999999999 888874321 00
Q ss_pred cchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 249 VSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
..+ ......... ..+...+.++.+++.+||+.+|++|||+.++++.|+++...
T Consensus 244 ----~~~-~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ----ELF-KLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ----HHH-HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 111 111111110 11223445788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=276.90 Aligned_cols=235 Identities=27% Similarity=0.408 Sum_probs=185.1
Q ss_pred cCCccCceecCCCCeEEEEEEecC----CcEEEEc------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRED----GRIIAVK------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.+|.+.+.||+|+||.||+|...+ ...|++| .|||++++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998633 3468888 38899999998875 457899
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999988652 235899999999999999999999988 999999999999999999999999998765
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
............++..|+|||.+.+..++.++|||||||++||+++ |..||...... .... ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~-~~~~~~~~- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------DVIG-RIENGERL- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHH-HHHcCCcC-
Confidence 4432222222334567999999988889999999999999999986 99998543211 0011 11111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
..+...+..+.+++.+|+..+|.+|||+.++++.|+.++..+
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 112234567999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=280.27 Aligned_cols=241 Identities=26% Similarity=0.364 Sum_probs=181.0
Q ss_pred cCCccCceecCCCCeEEEEEEecC---------------CcEEEEc------------------------ccccchhhhc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRED---------------GRIIAVK------------------------KSKNAVKLLG 96 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK------------------------~~~niv~~~~ 96 (331)
++|++.+.||+|+||.||++.+.+ ...||+| .|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 2347888 3789999999
Q ss_pred ccccCCcceeEeecccCCCHHHHHhhhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEE
Q 020102 97 CCLETEVPLLVYEFISNGTLYQHLHDRLQ-------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNIL 169 (331)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nil 169 (331)
++...+..++||||+++++|.+++..... .....+++..+..++.|++.|++|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998865311 11124688899999999999999999988 999999999999
Q ss_pred eCCCCcEEEeeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCcc
Q 020102 170 LDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSAGNTSQ 246 (331)
Q Consensus 170 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~~p~~~~~~~~~ 246 (331)
+++++.+||+|||++.......... .....++..|+|||.+.+..++.++|+|||||++|+|++ +..||..... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--E 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--H
Confidence 9999999999999987543322111 122345678999999988889999999999999999998 5566643211 1
Q ss_pred cccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 247 ENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
. ............... .....+...+..+.+|+.+||+.+|++|||+.+|++.|+
T Consensus 240 ~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 Q---VIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H---HHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1 000011111100000 000112234467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=277.62 Aligned_cols=224 Identities=28% Similarity=0.423 Sum_probs=181.1
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.|...+.||+|+||.||+|.+ .++..||+| .|||++++++++..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 356667899999999999987 457889999 3889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+.+.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 85 GGGSALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999887753 36889999999999999999999988 9999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
. ......++..|+|||.+.+..++.++|+|||||++|||++|+.|+....... ..........
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---------~~~~~~~~~~------- 218 (277)
T cd06642 156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---------VLFLIPKNSP------- 218 (277)
T ss_pred h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---------HHhhhhcCCC-------
Confidence 1 1222457889999999999899999999999999999999999985321100 0011111110
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......+..+.+++.+||+.+|++|||+.++++.
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 --PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11122345678999999999999999999999884
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=280.49 Aligned_cols=236 Identities=28% Similarity=0.451 Sum_probs=184.6
Q ss_pred hcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.++|++.+.||+|+||.||+|... ++..+|+| .|||++++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356889999999999999999863 46788888 378999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhc-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCC
Q 020102 105 LLVYEFISNGTLYQHLHDRLQ-----------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTN 167 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~N 167 (331)
++++||+++++|.+++..... .....+++..++.++.|++.||.|||+.+ ++|+||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999875311 11235788899999999999999999988 9999999999
Q ss_pred EEeCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020102 168 ILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTS 245 (331)
Q Consensus 168 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~ 245 (331)
|+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999998754322211 1112234667999999998899999999999999999997 7788753211
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
. . .......+... ..+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 239 ~------~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 E------E-VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H------H-HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 1 11111112111 1122345679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=279.65 Aligned_cols=242 Identities=25% Similarity=0.368 Sum_probs=181.9
Q ss_pred cCCccCceecCCCCeEEEEEEec-----------------CCcEEEEc------------------------ccccchhh
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-----------------DGRIIAVK------------------------KSKNAVKL 94 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK------------------------~~~niv~~ 94 (331)
++|++.+.||+|+||.||++... +...+|+| .|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999998532 23457877 37899999
Q ss_pred hcccccCCcceeEeecccCCCHHHHHhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCE
Q 020102 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQN------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNI 168 (331)
Q Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Ni 168 (331)
++++..++..+++|||+++++|.+++...... ....+++..+..++.|++.|++|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999988763211 1124778899999999999999999998 99999999999
Q ss_pred EeCCCCcEEEeeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCc
Q 020102 169 LLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSAGNTS 245 (331)
Q Consensus 169 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~~p~~~~~~~~ 245 (331)
+++.++.++|+|||++..+....... .....+++.|+|||...++.++.++|+|||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 99999999999999987553322111 112234678999999888889999999999999999998 6677753211
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
.... .............. ..+.+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 240 ~~~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVI---ENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHH---HHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1100 00001110000000 001122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=286.81 Aligned_cols=240 Identities=26% Similarity=0.366 Sum_probs=183.4
Q ss_pred hcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhhhccccc-CC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKLLGCCLE-TE 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~~~~~~~-~~ 102 (331)
.++|++.+.||+|+||.||+|.+ .+++.|||| .|+|++++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999974 357789998 26899999998765 45
Q ss_pred cceeEeecccCCCHHHHHhhhhcC--------------------------------------------------------
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQN-------------------------------------------------------- 126 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 126 (331)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999988642100
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce-eeeecc
Q 020102 127 ------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQ 199 (331)
Q Consensus 127 ------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~ 199 (331)
....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124678888999999999999999988 999999999999999999999999998754322211 111233
Q ss_pred ccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCH
Q 020102 200 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKK 278 (331)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (331)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........+... ..+.
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~---------~~~~ 305 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------EFCRRLKEGTRM---------RAPD 305 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--------HHHHHHhccCCC---------CCCC
Confidence 5677999999988899999999999999999997 888885421110 011111111111 0111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 279 NQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 279 ~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
..+..+.+++..||+.+|++|||+.+|++.|+.+..
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 234568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=287.32 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=190.5
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec--------CCcEEEEc-------------------------ccccchhhhccc
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE--------DGRIIAVK-------------------------KSKNAVKLLGCC 98 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK-------------------------~~~niv~~~~~~ 98 (331)
.....+|.+.+.||+|+||.||+|.+. ....||+| .||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 334457899999999999999999742 12367887 388999999999
Q ss_pred ccCCcceeEeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCC
Q 020102 99 LETEVPLLVYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTN 167 (331)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~N 167 (331)
..++..++++||+++++|.+++..... .....+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 999999999999999999999875311 12345788999999999999999999988 9999999999
Q ss_pred EEeCCCCcEEEeeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020102 168 ILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTS 245 (331)
Q Consensus 168 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~ 245 (331)
|+++.++.++|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... .
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~ 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--V 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--H
Confidence 999999999999999987654322111 122234567999999999999999999999999999998 788875321 0
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
.. .......... ...+...+..+.+++.+||+.+|++|||+.|+++.|..+...+..
T Consensus 243 ------~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 243 ------EE-LFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred ------HH-HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 01 1111111111 111223455788999999999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=278.08 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=191.4
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||+|+||.||++.+. ++..||+| .|+|++++++.+..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788999999999999999984 68889998 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
+++++|..++... .....+++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 81 MDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred cCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999998877642 123468999999999999999999997 46 99999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccChhhhcCCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQ------LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
. ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...... ....... ......
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~-~~~~~~ 226 (286)
T cd06622 156 S---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLS-AIVDGD 226 (286)
T ss_pred C---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHH-HHhhcC
Confidence 2 222345788999999886543 478999999999999999999998542110 0000000 000111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchhhHHHHHhhc
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAMFSKIIKRL 330 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~~~ 330 (331)
....+..++.++.+++.+||+.+|++||++++++.. .-+......+.++..++.+++
T Consensus 227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~ 283 (286)
T cd06622 227 ---------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH-PWLVKYKNADVDMAEWVTGAL 283 (286)
T ss_pred ---------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC-hhhhhccCCccchHHHHHHHH
Confidence 111233466788999999999999999999999874 112222233556666776664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=274.91 Aligned_cols=224 Identities=24% Similarity=0.386 Sum_probs=176.0
Q ss_pred eecCCCCeEEEEEEec---CCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCCC
Q 020102 63 ILGQGGQGTVYKGMRE---DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGT 115 (331)
Q Consensus 63 ~lg~G~~g~V~~~~~~---~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~ 115 (331)
.||+|+||.||+|... .+..||+| .|+|++++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 35568888 3889999999875 457899999999999
Q ss_pred HHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceee
Q 020102 116 LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 195 (331)
Q Consensus 116 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 195 (331)
|.+++.. ....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 81 L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 9988764 2346899999999999999999999988 99999999999999999999999999875543322211
Q ss_pred e--eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 196 T--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 196 ~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
. ...+++.|+|||.+.+..++.++|||||||++|++++ |..||...... . .......+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~-~~~~~~~~~--------- 215 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------E-VMSFIEQGK--------- 215 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------H-HHHHHHCCC---------
Confidence 1 1223578999999998889999999999999999996 99998543110 0 111111111
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
+...+...+.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1112334456889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=294.88 Aligned_cols=240 Identities=26% Similarity=0.391 Sum_probs=189.8
Q ss_pred HhcCCccCceecCCCCeEEEEEEecC--C---cEEEEc--------------------------ccccchhhhcccccCC
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRED--G---RIIAVK--------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK--------------------------~~~niv~~~~~~~~~~ 102 (331)
..++-.+.+.||+|+||.||+|.... + ..||+| .|||||+++|++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34455666999999999999998632 2 238999 4999999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
.+++|||+|.||+|.++|.+. ...++..+...++.+.+.||.|||+++ ++||||..+|+|++.++.+||+|||
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 999999999999999999873 226899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
+++.... .........-...|+|||.+..+.|+.++|||||||++||+.+ |..||...... . +....
T Consensus 308 Ls~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~-v~~kI-- 375 (474)
T KOG0194|consen 308 LSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------E-VKAKI-- 375 (474)
T ss_pred cccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------H-HHHHH--
Confidence 9875431 1111101124578999999999999999999999999999998 78888643211 1 11111
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
.....+...+...+..+..++..|+..+|+.||||.++.+.|+.+.+....
T Consensus 376 ------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 376 ------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 011112223334556788899999999999999999999999998776554
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=276.83 Aligned_cols=242 Identities=21% Similarity=0.268 Sum_probs=179.2
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|++.+.||+|+||.||+|.+. +|..+++| .|+|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999984 68889888 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
++ ++|.+.+.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 97 577776654 1346899999999999999999999998 999999999999999999999999998755432
Q ss_pred CceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH--------HHHHhh-
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY--------FVHSMR- 260 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~- 260 (331)
... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..|++............... ......
T Consensus 153 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 153 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 221 2224578899999988765 46889999999999999999999976443211110000000 000000
Q ss_pred --cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 261 --KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 261 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.................+..+..+.+++.+||+.||.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000001112234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=274.15 Aligned_cols=225 Identities=27% Similarity=0.393 Sum_probs=177.3
Q ss_pred ceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||.||+|... .+..+|+| .|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999752 23678888 3789999999876 4567999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+++... ..+++..+..++.|++.|+.|||..+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999988752 26899999999999999999999988 999999999999999999999999999866433322
Q ss_pred eee--eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 194 VTT--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 194 ~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
... ...++..|+|||.+.+..++.++|||||||++|+|++ |..||..... . . .........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~---~-~~~~~~~~~------- 215 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----A---E-VIAMLESGE------- 215 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----H---H-HHHHHHcCC-------
Confidence 211 1223567999999999999999999999999999998 8999854311 0 0 111111111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
....+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 216 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 --RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01122334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=274.31 Aligned_cols=228 Identities=32% Similarity=0.455 Sum_probs=182.9
Q ss_pred ceecCCCCeEEEEEEecC----CcEEEEc------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRED----GRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~----~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||.||+|.... +..+++| .|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998753 7788888 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 114 GTLYQHLHDRLQN----QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 114 ~~L~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
++|.+++...... ....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999988763111 1357899999999999999999999988 99999999999999999999999999986654
Q ss_pred CCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 190 DQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 190 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
... .......+++.|+|||.+.+..++.++||||+||++|+|++ |..||..... .........+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~~~~~---- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---------EEVLEYLRKGY---- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHHcCC----
Confidence 321 11223457889999999998889999999999999999999 5888854311 01111111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
....+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11123334668999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=280.06 Aligned_cols=227 Identities=27% Similarity=0.435 Sum_probs=183.4
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.+|.+.+.||+|+||.||+|.+ .++..|++| .|+|++++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788899999999999999987 468889998 3889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999998754 25788999999999999999999998 9999999999999999999999999987543222
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... .... ...... ..
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~-~~~~~~-~~------ 234 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALY-LIATNG-TP------ 234 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHH-HHhcCC-CC------
Confidence 1 122345889999999999888999999999999999999999998543210 0000 011000 00
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 001123345678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=278.39 Aligned_cols=237 Identities=27% Similarity=0.427 Sum_probs=184.1
Q ss_pred ChHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhccccc--
Q 020102 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLE-- 100 (331)
Q Consensus 47 ~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~-- 100 (331)
+..++....+.|++.+.||+|+||.||+|.+ .+++.+|+| .|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3345555668899999999999999999997 468889998 27899999998853
Q ss_pred ----CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 101 ----TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 101 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
....+++|||+++++|.+.+... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 45679999999999999888652 2345788889999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccccCCCceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch
Q 020102 177 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL 251 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~ 251 (331)
+|+|||++........ ......|++.|+|||.+. +..++.++|+|||||++|||++|..||........
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----- 234 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----- 234 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-----
Confidence 9999999875432211 122346889999999875 34578899999999999999999999854321000
Q ss_pred HHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 252 AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.. .. ... .........++..+.+++.+||+.+|.+|||+.|+++
T Consensus 235 --~~-~~-~~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 --LF-LI-PRN--------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hh-hH-hhC--------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 00 000 0011112235568999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=276.49 Aligned_cols=232 Identities=24% Similarity=0.442 Sum_probs=182.3
Q ss_pred cCCccCceecCCCCeEEEEEEecC-C---cEEEEc------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRED-G---RIIAVK------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
+.|++.+.||+|+||.||+|.... + ..||+| .|||++++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998742 3 368988 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 84 TEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999888642 346899999999999999999999988 999999999999999999999999998765
Q ss_pred cCCCceee--eecc--ccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 188 AMDQTHVT--TKIQ--GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 188 ~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
........ .... .+..|+|||.+.+..++.++|||||||++|||++ |..||...... . ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~-~~~~i~~~ 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------D-VINAIEQD 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------H-HHHHHHcC
Confidence 43221111 1111 2357999999999999999999999999999886 99998643210 0 11111111
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
. ....+...+..+.+++.+||+.+|.+||++++|+..|+.+
T Consensus 228 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 Y---------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0111223456788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=285.30 Aligned_cols=243 Identities=19% Similarity=0.232 Sum_probs=176.7
Q ss_pred cCceecCC--CCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 60 VNRILGQG--GQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 60 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
+.++||+| +|++||++.+ .+++.||+| .||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999987 578999999 3899999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999988652 1235899999999999999999999988 9999999999999999999999998654332111
Q ss_pred ce------eeeeccccCCccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH-------
Q 020102 192 TH------VTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV------- 256 (331)
Q Consensus 192 ~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 256 (331)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 10 0112346778999999876 45889999999999999999999999643211100000000000
Q ss_pred ---HHhh-----cCccccc------------cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 257 ---HSMR-----KNRLYDI------------LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 257 ---~~~~-----~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... ....... .............+..+.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 0000000 00000011223456689999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=274.48 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=192.8
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
..|+..+.||+|+||.||+|.+. ++..||+| .|+|++++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34677789999999999999874 58889998 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+++.. .++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999987753 36888999999999999999999988 999999999999999999999999998765432
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
. .......++..|+|||.+.+..++.++|+|||||++|||++|..||....... .........
T Consensus 155 ~-~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---------~~~~~~~~~------- 217 (277)
T cd06640 155 Q-IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---------VLFLIPKNN------- 217 (277)
T ss_pred c-cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---------HhhhhhcCC-------
Confidence 2 12223457889999999998889999999999999999999999986431100 000111110
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchhhHHHHHhhc
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAMFSKIIKRL 330 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~~~ 330 (331)
........+..+.+++..||+.+|+.||++++++..-= ......+....+.+++|.
T Consensus 218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~--~~~~~~~~~~~~~~~~~~ 273 (277)
T cd06640 218 --PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF--IVKNAKKTSYLTELIDRF 273 (277)
T ss_pred --CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH--hhhcchhhhHHHHHHHHH
Confidence 11223345678999999999999999999999977632 223344455666666653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=277.68 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=178.8
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|.+.+.||+|++|.||+|.+. ++..||+| .|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999874 68899999 278999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+. ++|.+++... ..+..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 6888877642 22346899999999999999999999988 999999999999999999999999998754332
Q ss_pred CceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH-------HHHHHHhh--
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA-------AYFVHSMR-- 260 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~-- 260 (331)
.. ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.............. ..+.....
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 VR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred cc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 21 12223568899999988654 478899999999999999999999864311100000000 00000000
Q ss_pred --cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 261 --KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 261 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
........... ........+.++.+++.+||+.||++|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 00111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=279.75 Aligned_cols=237 Identities=29% Similarity=0.449 Sum_probs=182.2
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||+|+||.||++.+. ++..+|+| .|||++++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999874 57778887 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999988652 468899999999999999999997 46 99999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc------
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR------ 263 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 263 (331)
. ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......... ...........
T Consensus 153 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 153 S---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-----AMFGRPVSEGEAKESHR 224 (308)
T ss_pred c---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-----HhhcCccccccccCCcc
Confidence 2 123346889999999998888999999999999999999999998543211000 00000000000
Q ss_pred --------------ccc----ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 264 --------------LYD----ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 264 --------------~~~----~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
... ......+......++.++.+++.+||+.+|++|||+.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000000000111245679999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=275.16 Aligned_cols=229 Identities=27% Similarity=0.382 Sum_probs=176.1
Q ss_pred ceecCCCCeEEEEEEecC-Cc--EEEEc-------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRED-GR--IIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~-~~--~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||.||+|.+.+ +. .+++| .|||++++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998743 33 35666 388999999999999999999999999
Q ss_pred CCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 114 GTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 114 ~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
++|.+++..... .....+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999998865321 11234789999999999999999999988 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||..... ....... ..
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~-~~ 226 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKL-PQ 226 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHH-hC
Confidence 985322111 1111223567999999988889999999999999999997 9999853211 0111111 11
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
+.. ...+...+..+.+++.+||+.+|.+|||+.+++..|..+.
T Consensus 227 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 100 0111223457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=275.18 Aligned_cols=231 Identities=26% Similarity=0.410 Sum_probs=184.7
Q ss_pred CCccCceecCCCCeEEEEEEecC--CcEEEEc----------------------------------ccccchhhhccccc
Q 020102 57 HFNVNRILGQGGQGTVYKGMRED--GRIIAVK----------------------------------KSKNAVKLLGCCLE 100 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK----------------------------------~~~niv~~~~~~~~ 100 (331)
.|.+.+.||+|+||.||+|.+.. +..+|+| .|||++++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999754 6778877 27899999999999
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEe
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVA 179 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~ 179 (331)
++..+++|||+++++|.+.+.... .....+++..++.++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEe
Confidence 999999999999999998876532 223468999999999999999999996 56 9999999999999999999999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... . .....
T Consensus 157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~-~~~~~ 225 (269)
T cd08528 157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------S-LATKI 225 (269)
T ss_pred cccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------H-HHHHH
Confidence 999997654332 223456889999999999988999999999999999999999998543110 0 01111
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
....... ......+..+.+++.+||+.||++|||+.|+..++.
T Consensus 226 ~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYEP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCCc--------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111100 011134467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=266.49 Aligned_cols=231 Identities=25% Similarity=0.408 Sum_probs=188.6
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------------ccccchhhhcccc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------------~~~niv~~~~~~~ 99 (331)
...+.|.-.++||+|..++|-++.. .++..+|+| -||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456677888999999999998876 567788888 2999999999999
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEe
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~ 179 (331)
.+...++|+|.|+.|.|.++|... -.+++.....|++|++.|+.|||..+ |+||||||+|||++++.+++|+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence 999999999999999999999863 36899999999999999999999988 9999999999999999999999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhcC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA 253 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~ 253 (331)
|||+|+.+..+. .....+|||+|+|||.+.. ..|+..+|+||+|+++|-++.|.+||.-... .
T Consensus 166 DFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----m---- 234 (411)
T KOG0599|consen 166 DFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----M---- 234 (411)
T ss_pred ccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----H----
Confidence 999999775433 3455789999999997753 3478899999999999999999999853210 0
Q ss_pred HHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.....+-.+..+ ...+...+.+....+||.+||+.||+.|.|++|++..
T Consensus 235 lMLR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 235 LMLRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 011111112111 1122345667789999999999999999999999764
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=278.79 Aligned_cols=239 Identities=24% Similarity=0.364 Sum_probs=185.0
Q ss_pred HHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccc-----
Q 020102 49 KELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCL----- 99 (331)
Q Consensus 49 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~----- 99 (331)
+.+....++|++.+.||+|+||.||++.+ .+++.+|+| .|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 45566778999999999999999999987 457888888 3889999999874
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEe
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~ 179 (331)
.++..++||||+++++|.+.+.... .....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 3456899999999999998876532 22346889999999999999999999988 9999999999999999999999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 254 (331)
|||++....... .......|++.|+|||.+.. ..++.++||||+||++|||++|+.||....... .
T Consensus 167 dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-------~- 237 (286)
T cd06638 167 DFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-------A- 237 (286)
T ss_pred cCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-------H-
Confidence 999987654322 12223468999999998753 457889999999999999999999986432100 0
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
... ......... ..+..++..+.+++.+||+.+|++|||+.|+++.
T Consensus 238 ~~~-~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFK-IPRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Hhh-ccccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 000000000 0112234578999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=275.33 Aligned_cols=229 Identities=29% Similarity=0.429 Sum_probs=180.7
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
++|.+.+.||+|+||.||+|.+ .+++.||+| .|||++++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4678889999999999999987 468889998 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+.+.. ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999998764 246899999999999999999999998 9999999999999999999999999987553221
Q ss_pred ceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 192 THVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.......|+..|+|||++. ...++.++|+|||||++|+|++|..||........ .. ........
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~--~~~~~~~~--- 227 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LF--LMTKSNFQ--- 227 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HH--hhhccCCC---
Confidence 1223346899999999874 45688899999999999999999999864321100 00 00001100
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.+.. ......+..+.+++.+||+.+|++|||++++++
T Consensus 228 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 001124457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=272.45 Aligned_cols=226 Identities=24% Similarity=0.365 Sum_probs=181.3
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhccccc-CCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLE-TEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~-~~~~~lv~e 109 (331)
.|++.+.||+|++|.||.+.+. +++.+++| .|+|++++++.+.. +...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999874 57889998 37899999887764 445789999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+++... ....+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999988752 2346899999999999999999999998 99999999999999999999999999976643
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
... ......+++.|+|||++.+..++.++|+||+||++++|++|+.||..... ...... ...+..
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~-~~~~~~----- 219 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYR-IIEGKL----- 219 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH-HHhcCC-----
Confidence 322 22334688999999999999999999999999999999999999853210 011111 111111
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+...+..+.+++.+||+.+|++|||+.++++
T Consensus 220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1123345568999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=272.48 Aligned_cols=229 Identities=29% Similarity=0.421 Sum_probs=173.8
Q ss_pred ceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccc-cCCcceeEeeccc
Q 020102 62 RILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCL-ETEVPLLVYEFIS 112 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~-~~~~~~lv~e~~~ 112 (331)
+.||+|+||.||+|... +...+|+| .|||++++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 24568888 3789999999765 4556899999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++... ....++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999988652 224677788889999999999999988 99999999999999999999999999875432211
Q ss_pred e---eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 193 H---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 193 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
. ......++..|+|||.+.+..++.++|||||||++|||++|..|++..... ......... ...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~-~~~----- 220 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVYLLQ-GRR----- 220 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHhc-CCC-----
Confidence 1 111234567899999998889999999999999999999965544322110 011111111 100
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
...+...+..+.+++..||+.+|++||++.++++.|+.+..
T Consensus 221 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 01112234578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=273.12 Aligned_cols=232 Identities=25% Similarity=0.356 Sum_probs=173.0
Q ss_pred ceecCCCCeEEEEEEec---CCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 62 RILGQGGQGTVYKGMRE---DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~---~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.||+|+||.||+|... ++..+++| .|||++++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999753 34568888 3889999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+|.+++...........++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987643223345677888899999999999999988 9999999999999999999999999987543322111
Q ss_pred -eeeccccCCccChhhhcCC-------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 195 -TTKIQGTFGYLDPEYHQSS-------QLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.....++..|+|||++.+. .++.++|+|||||++|||++ |..||........ ...... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--------~~~~~~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--------LTYTVR-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--------HHHHhh-cccC
Confidence 1223467889999988643 35789999999999999996 9999854321100 000011 1111
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
....+.. ....+..+.+++..|+ .+|++|||+++|+..|+
T Consensus 229 ~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 1123446788999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=292.71 Aligned_cols=221 Identities=32% Similarity=0.467 Sum_probs=184.3
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeec
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
|.-++.||.|+||.||-|.+ .+.+.|||| +|||.+.+-||+..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 45567899999999999998 578899999 499999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
|- ||-.+.+.-. ..++.+..+..|..+.+.||+|||+.+ .+|||||..|||+++.|.|||+|||.|....
T Consensus 108 Cl-GSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 108 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred Hh-ccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 96 7777766542 358999999999999999999999998 9999999999999999999999999986432
Q ss_pred CceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
...+++|||.|||||++. .+.|+.++||||||++..|+...++|+++..... ...-+..+
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---------ALYHIAQN----- 240 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------ALYHIAQN----- 240 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---------HHHHHHhc-----
Confidence 345678999999999764 5689999999999999999999999987643211 11111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+.....+++..|++|+..||+.-|.+|||.++++..
T Consensus 241 ---esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ---ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11222366788899999999999999999999999765
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=278.42 Aligned_cols=239 Identities=27% Similarity=0.384 Sum_probs=186.2
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||+||++... ++..||+| .|||++++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356788899999999999999874 58888888 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|+++++|.+.+.. .+++++..+..++.+++.|+.|||+ .+ ++|+||+|+||++++++.++|+|||++....
T Consensus 84 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 84 FMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred cCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 9999999887764 2368999999999999999999997 46 9999999999999999999999999986442
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc---chHHHHHHHhhcCccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV---SLAAYFVHSMRKNRLY 265 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 265 (331)
... .....|+..|+|||.+.+..++.++|+|||||++|++++|..||........... .......... ....
T Consensus 156 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~- 230 (284)
T cd06620 156 NSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPP- 230 (284)
T ss_pred hhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccC-
Confidence 221 2234689999999999888899999999999999999999999974322111000 0011111111 1110
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
+.......+..+.+|+.+||+.||++|||+.|++++.--++
T Consensus 231 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 231 -------PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -------CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01111224567899999999999999999999998754433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=274.16 Aligned_cols=227 Identities=29% Similarity=0.461 Sum_probs=182.8
Q ss_pred CCccCceecCCCCeEEEEEEecCCcEEEEc-----------------------------ccccchhhhcccccCCcceeE
Q 020102 57 HFNVNRILGQGGQGTVYKGMREDGRIIAVK-----------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
+|.+.+.||+|+||.||+|...+++.+|+| .|+|++++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998888999999 267999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
+||+++++|.+++... .++++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999988652 36789999999999999999999988 999999999999999999999999998754
Q ss_pred cCCC-----ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 188 AMDQ-----THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 188 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
.... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||....... .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~ 224 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYIGAHR 224 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--------HHHHhhhcc
Confidence 3211 112223468899999999999889999999999999999999999996432110 000000000
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.. ....+..++..+.+++.+||+.+|++|||+.+++.
T Consensus 225 ~~--------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GL--------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC--------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 01122345567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=278.73 Aligned_cols=177 Identities=27% Similarity=0.430 Sum_probs=142.9
Q ss_pred CceecCCCCeEEEEEEec---CCcEEEEc---------------------ccccchhhhccccc--CCcceeEeecccCC
Q 020102 61 NRILGQGGQGTVYKGMRE---DGRIIAVK---------------------KSKNAVKLLGCCLE--TEVPLLVYEFISNG 114 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~---~~~~vavK---------------------~~~niv~~~~~~~~--~~~~~lv~e~~~~~ 114 (331)
...||+|+||+||+|... ++..||+| +|||++++++++.. +...++|+||++ +
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 367999999999999864 45788988 38899999998853 567899999987 5
Q ss_pred CHHHHHhhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe----CCCCcEEEeeccCccc
Q 020102 115 TLYQHLHDRL----QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKF 186 (331)
Q Consensus 115 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~ 186 (331)
+|.+.+.... ......+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7777664321 112235889999999999999999999998 9999999999999 5667899999999986
Q ss_pred ccCCCce--eeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 020102 187 IAMDQTH--VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSA 241 (331)
Q Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~ 241 (331)
....... ......+|+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 5433221 12335689999999988764 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=277.28 Aligned_cols=229 Identities=27% Similarity=0.412 Sum_probs=180.5
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEcc-------------------------cccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKK-------------------------SKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~-------------------------~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||.||+|.+. ++..||+|+ |||++++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999984 689999992 7899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|++ ++|.+.+..... ....+++..++.++.||+.|+.|||+. + ++|+||||+||+++.++.+||+|||++..+.
T Consensus 81 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 788887765432 235789999999999999999999986 6 9999999999999999999999999987653
Q ss_pred CCCceeeeeccccCCccChhhhcC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........ ...... ....
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~-~~~~ 225 (283)
T cd06617 156 DSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-------QLKQVV-EEPS 225 (283)
T ss_pred ccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-------HHHHHH-hcCC
Confidence 221 1222457889999998865 4468899999999999999999999854221100 011111 1111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.. .....++..+.+++.+||+.+|.+|||+.++++
T Consensus 226 ~~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQ--------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111235567999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=269.67 Aligned_cols=228 Identities=27% Similarity=0.417 Sum_probs=185.0
Q ss_pred cCCccCceecCCCCeEEEEEEecC-CcEEEEc---------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRED-GRIIAVK---------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK---------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
++|++.+.||+|+||.||+|...+ +..+++| .|+|++++++.+.++...++++||+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 578899999999999999999854 7889988 478999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+.+.. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 83 GSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999998864 2347899999999999999999999988 99999999999999999999999999886543321
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ . ......... .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~-~~~~~~~~~-------~ 218 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------I-FMIPNKPPP-------T 218 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------h-hhhccCCCC-------C
Confidence 22234578899999999999999999999999999999999999864321110 0 000000000 0
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+...+..+.+++.+||+.+|++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1112334567899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=279.67 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=179.8
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|.+.+.||+|+||.||+|.+. +++.||+| .|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999874 67889999 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
++ ++|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 97 6888877642 336889999999999999999999988 999999999999999999999999998754332
Q ss_pred CceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc-------chHHHHHHHhhcC
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV-------SLAAYFVHSMRKN 262 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~ 262 (331)
... .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||........... .....+.......
T Consensus 158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 221 1223568899999987654 578899999999999999999999864321100000 0000000000000
Q ss_pred ccccccchHh----hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQV----MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~----~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.......+.. ........+..+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 00011234557889999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=274.73 Aligned_cols=227 Identities=26% Similarity=0.393 Sum_probs=189.6
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------cccchhhhcccccCCcceeEeecccCCC
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------SKNAVKLLGCCLETEVPLLVYEFISNGT 115 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------~~niv~~~~~~~~~~~~~lv~e~~~~~~ 115 (331)
|.++++||+|+||.||+|++ .+|..+|||+ .|++|++||.+.....+++|||||..|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 66788999999999999987 5699999995 4599999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceee
Q 020102 116 LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 195 (331)
Q Consensus 116 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 195 (331)
+.+.+..+ +.++++..+..+++..++||.|||... -+|||||..|||++.+|.+||+|||.|-.+... ....
T Consensus 115 iSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKR 186 (502)
T KOG0574|consen 115 ISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKR 186 (502)
T ss_pred HHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh-HHhh
Confidence 99987653 468999999999999999999999987 899999999999999999999999999766432 2334
Q ss_pred eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhcc
Q 020102 196 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKL 275 (331)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (331)
.++.|||.|||||++..-.|+.++||||||++..||..|++||... .+..... .+.... .....
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI--HPMRAIF-------MIPT~P-------PPTF~ 250 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI--HPMRAIF-------MIPTKP-------PPTFK 250 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc--cccceeE-------eccCCC-------CCCCC
Confidence 5678999999999999999999999999999999999999999643 1111110 001111 11122
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 276 GKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 276 ~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+...+.++-++++.||-.+|++|-|+.++++.
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 355678899999999999999999999998765
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=269.74 Aligned_cols=225 Identities=27% Similarity=0.413 Sum_probs=178.5
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCCCHH
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTLY 117 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (331)
+.||+|+||.||++.+.+++.|++| .|+|++++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4699999999999998769999999 3789999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceee-e
Q 020102 118 QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT-T 196 (331)
Q Consensus 118 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~ 196 (331)
+++... ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........... .
T Consensus 81 ~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 81 TFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 988642 236789999999999999999999988 99999999999999999999999999875432221111 1
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhcc
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKL 275 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (331)
...++..|+|||.+.+..++.++|+|||||++|+|++ |..||...... . ......... ...
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~-~~~~~~~~~---------~~~ 215 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------Q-TRERIESGY---------RMP 215 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------H-HHHHHhcCC---------CCC
Confidence 1223567999999998899999999999999999999 77777543110 0 111111110 011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 276 GKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 276 ~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
.+...+..+.+++.+||+.+|.+|||++|+++.|++
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 123345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=273.79 Aligned_cols=229 Identities=24% Similarity=0.318 Sum_probs=179.7
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEcc--------------------------cccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK--------------------------SKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~--------------------------~~niv~~~~~~~~~~~~~lv~e 109 (331)
.|+..+.||+|+||+||+|.+ .+++.+|+|. |+|++.+.+.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 366778999999999999987 4688899992 6788888889989999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+.+... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 81 IMNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred eccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 99999998877642 2336899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.. ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||......... ...........
T Consensus 155 ~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-----~~~~~~~~~~~------ 221 (285)
T cd05632 155 GE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-----EEVDRRVLETE------ 221 (285)
T ss_pred CC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHhhhccc------
Confidence 22 122346899999999999989999999999999999999999999643211000 00000000000
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSME 308 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~~ 308 (331)
.......+..+.+|+..||+.+|++||| +.+++..
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 ----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0112234556889999999999999999 5566543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.77 Aligned_cols=226 Identities=27% Similarity=0.419 Sum_probs=184.1
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||.|++|.||+|.+. ++..+++| .|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999974 68889999 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+.+.. .++++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999988864 17899999999999999999999988 999999999999999999999999999866543
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
. .......+++.|+|||.+.+..++.++|||||||++|+|++|..||...... ...............
T Consensus 152 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---------~~~~~~~~~~~~~~~-- 219 (274)
T cd06609 152 M-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---------RVLFLIPKNNPPSLE-- 219 (274)
T ss_pred c-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---------HHHHHhhhcCCCCCc--
Confidence 2 1223346788999999999988999999999999999999999998543210 011111111110000
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...++..+.+++.+||+.+|++|||++++++.
T Consensus 220 ------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 ------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11155679999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=272.04 Aligned_cols=232 Identities=26% Similarity=0.336 Sum_probs=171.5
Q ss_pred ceecCCCCeEEEEEEec---CCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 62 RILGQGGQGTVYKGMRE---DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~---~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.||+|+||.||+|... ....+++| .|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 35899999999999753 24567777 3889999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+|.+++...........++..+..++.||+.|++|||+.+ |+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999987643222234567888999999999999999998 9999999999999999999999999986543222111
Q ss_pred -eeeccccCCccChhhhcC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 195 -TTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.....+++.|+|||+... ..++.++|||||||++|||++ |..||..... . ........ ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~------~~~~~~~~-~~~~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--E------QVLKQVVR-EQDI 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--H------HHHHHHhh-ccCc
Confidence 122345677999998643 356789999999999999999 6777753311 0 00111111 1111
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
....+. .....+..+.+++..|+ .||++|||+++|++.|.
T Consensus 229 ~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 12234556778888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=278.85 Aligned_cols=229 Identities=26% Similarity=0.350 Sum_probs=182.2
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+. +++.+|+| .|+|++++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999985 58899999 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+.+++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999998864 23357899999999999999999999988 9999999999999999999999999986543
Q ss_pred CCCce----------------------------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 020102 189 MDQTH----------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 240 (331)
Q Consensus 189 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~ 240 (331)
..... ......||..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 21110 11123578899999999998899999999999999999999999864
Q ss_pred CCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 020102 241 AGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT----MEEVSM 307 (331)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs----~~evl~ 307 (331)
.... ........ .. .........+..+.+++.+||+.+|++||| ++|++.
T Consensus 235 ~~~~--------~~~~~~~~-~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRD--------ETFSNILK-KE--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchH--------HHHHHHhc-CC--------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3211 00111111 00 011111225678999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.87 Aligned_cols=234 Identities=27% Similarity=0.420 Sum_probs=180.7
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhccccc--CCcc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLE--TEVP 104 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~--~~~~ 104 (331)
...++|.+.+.||+|+||+||+|.+. ++..+|+| .||||++++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999974 56778887 38899999998854 4568
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEEccCCCCCEEeCC--------
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS----SPIYHRDIKSTNILLDE-------- 172 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~----~~i~H~dikp~Nill~~-------- 172 (331)
++||||+++++|.++|..... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 999999999999999876432 23479999999999999999999998541 34999999999999964
Q ss_pred ---------CCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 020102 173 ---------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSA 241 (331)
Q Consensus 173 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~p~~~~ 241 (331)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3458999999997654322 2234568999999998864 45889999999999999999999999643
Q ss_pred CCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 242 GNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
... .. ....+.... .......+..+.+||..||+.+|.+|||+.|++.
T Consensus 247 ~~~-------~q-li~~lk~~p----------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNF-------SQ-LISELKRGP----------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcH-------HH-HHHHHhcCC----------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 211 01 111111110 0011223567999999999999999999999984
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=276.70 Aligned_cols=238 Identities=26% Similarity=0.392 Sum_probs=189.8
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.+|.+.+.||+|+||.||+|.+ .+++.||+| .|+|++++++.+..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788999999999999999997 578999999 3889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999998754 25788999999999999999999988 9999999999999999999999999987553322
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.......... ........
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---------~~~~~~~~------ 233 (297)
T cd06656 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---------LIATNGTP------ 233 (297)
T ss_pred c-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---------eeccCCCC------
Confidence 1 1223458889999999999889999999999999999999999996432111000 00000000
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhhhhccccc
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM--ELNGIRGSSRKK 319 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~--~L~~l~~~~~~~ 319 (331)
....+...+..+.+++.+||+.+|++|||++++++ -++..+...+..
T Consensus 234 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~ 282 (297)
T cd06656 234 -ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLT 282 (297)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccccC
Confidence 00112234456889999999999999999999988 455555555444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=273.81 Aligned_cols=235 Identities=26% Similarity=0.412 Sum_probs=183.9
Q ss_pred cCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
.+|++.+.||+|+||.||+|... +...+++| .|+|++++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999853 34678888 3889999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQ----EFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
+||||+++++|.+++....... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999887532111 125899999999999999999999988 999999999999999999999999
Q ss_pred cCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 182 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... . ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--------~-~~~~~~ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--------E-VLNRLQ 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--------H-HHHHHH
Confidence 9987543322222223346778999999988888999999999999999998 77787532110 0 111111
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
.+.... ......+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 233 ~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111110 112234457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=273.73 Aligned_cols=242 Identities=23% Similarity=0.346 Sum_probs=180.3
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||.||+|.+. +++.+|+| .|+|++++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999985 58899999 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|...... ...+++..+..++.||+.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9998888765442 235899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH-------HHHHHHhhc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA-------AYFVHSMRK 261 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~ 261 (331)
.. .......++..|+|||.+.+. .++.++||||||+++|||++|..||....... ...... .........
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 153 PG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred Cc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhcc
Confidence 32 222334578899999988764 46789999999999999999998885332100 000000 000000000
Q ss_pred C------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 262 N------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 262 ~------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. ...............+..+..+.+++.+||+.+|++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 000000000000112244677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=273.23 Aligned_cols=233 Identities=25% Similarity=0.421 Sum_probs=183.4
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCc----EEEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGR----IIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+|++.+.||+|+||+||+|... ++. .+|+| .|+|++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999863 232 57887 38899999999887 78899
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|+||+++|+|.+.+.. ....+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 86 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999998865 2335899999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCceee-eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
......... ....++..|+|||.+....++.++|+|||||++||+++ |..||..... .. ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~-~~~~~~~~~~ 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VE-IPDLLEKGER 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HH-HHHHHhCCCC
Confidence 543222111 11223567999999988889999999999999999998 9999854311 01 1111111110
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
...+...+..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11122234568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.95 Aligned_cols=250 Identities=19% Similarity=0.247 Sum_probs=174.5
Q ss_pred HHhcCCccCceecCCCCeEEEEEEecC--CcE------------------EEEc----------------------cccc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRED--GRI------------------IAVK----------------------KSKN 90 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~------------------vavK----------------------~~~n 90 (331)
...++|++.+.||+|+||+||+|..+. +.. ++.| .|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999976421 111 0111 4899
Q ss_pred chhhhcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe
Q 020102 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL 170 (331)
Q Consensus 91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill 170 (331)
|+++++++...+..++|++++. ++|.+++...............+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999996 66777665421111223345677889999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc
Q 020102 171 DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS 250 (331)
Q Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~ 250 (331)
+.++.+||+|||++..+............||+.|+|||++.+..++.++|||||||++|||++|..++.......... .
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~-~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK-Q 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH-H
Confidence 999999999999998665433333334579999999999999999999999999999999999876544322111110 0
Q ss_pred hHHHHHHHhh--cCccc-------cccch--------Hhhc-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 251 LAAYFVHSMR--KNRLY-------DILDD--------QVMK-LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 251 ~~~~~~~~~~--~~~~~-------~~~~~--------~~~~-~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
+.... ..+. ...+. ..+.. .... ......+.++.+++.+||+.||++|||+.|++..
T Consensus 380 ~~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 0000 00000 00000 0000 0001123467888999999999999999999763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=313.29 Aligned_cols=244 Identities=28% Similarity=0.463 Sum_probs=192.2
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
...|.....||+|+||.||+|.. .++..||+| +||||++++++|.+.+..++||||+++|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 34577788999999999999987 578899999 4999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+|.+++. .++|..+..++.|++.|++|||....++|+||||||+||+++.++.+++. ||.+......
T Consensus 769 ~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 769 NLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred cHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 9999885 37899999999999999999996544559999999999999999888875 6655432211
Q ss_pred eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhc
Q 020102 195 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274 (331)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||.... ........+..............++....
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCccccC
Confidence 12357899999999999999999999999999999999999984321 11222333333333223333333333322
Q ss_pred --cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 275 --LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 275 --~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
........++.+++.+||+.+|++|||++|++++|+.+...
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 23445667789999999999999999999999999988653
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=271.74 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=193.0
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------------cccchhhhcccccCCcceeEe
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------------SKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------------~~niv~~~~~~~~~~~~~lv~ 108 (331)
.|++.+.||+|+||.||+|.+ .++..+++|. |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999997 5688899981 789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999887753 26899999999999999999999998 9999999999999999999999999988665
Q ss_pred CCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... ......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||....... .. ..........
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~-~~~~~~~~~~- 221 (277)
T cd06917 153 QNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AM-MLIPKSKPPR- 221 (277)
T ss_pred CCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------hh-hccccCCCCC-
Confidence 4332 22334688999999988654 46889999999999999999999985431100 00 0000000000
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchhhHHHHHhhc
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAMFSKIIKRL 330 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~~~ 330 (331)
......+.++.+++.+||+.+|++|||+.+++.. .=++.....+....+++++++
T Consensus 222 -------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~-~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd06917 222 -------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKS-KWIKAHSKTPVSILKELISRY 276 (277)
T ss_pred -------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC-hHhhccccCchhhHHHHHHhh
Confidence 0111245678999999999999999999999874 444455555666777777765
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=270.41 Aligned_cols=230 Identities=28% Similarity=0.433 Sum_probs=183.6
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
++|++.+.||.|+||.||+|.. .++..+++| +|||++++++.+...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788899999999999999987 457788888 4889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999998877652 246899999999999999999999988 9999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 192 THVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
. ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||....... ... .........
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~--~~~~~~~~~-- 223 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALF--LISKSNFPP-- 223 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHH--HHHhccCCC--
Confidence 1 12234578899999998777 78899999999999999999999986432110 000 011110000
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. ........+..+.+++.+||+.+|.+|||+++|+.
T Consensus 224 -~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 -P--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -c--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00113345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=271.89 Aligned_cols=229 Identities=29% Similarity=0.418 Sum_probs=178.6
Q ss_pred ceecCCCCeEEEEEEecC-------CcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 62 RILGQGGQGTVYKGMRED-------GRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~-------~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+.||+|+||.||+|...+ +..+++| .||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998632 2567877 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-----cEEEeeccC
Q 020102 111 ISNGTLYQHLHDRLQN--QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-----RAKVADFGT 183 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-----~~kl~Dfg~ 183 (331)
+++++|.+++...... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998753221 2235788999999999999999999988 99999999999999877 899999999
Q ss_pred cccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 184 SKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 184 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
+.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~-~~~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQ-HVTA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHH-HHhc
Confidence 87553322111 112235678999999999999999999999999999998 99998532110 0111 1111
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
+. ....+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 229 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 111223455678999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=277.52 Aligned_cols=235 Identities=24% Similarity=0.440 Sum_probs=182.7
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCc----EEEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGR----IIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+|+..+.||+|+||.||+|.+. ++. .+|+| .|||++++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45678899999999999999863 343 46777 388999999998754 4678
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
++||+++|+|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 86 v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 99999999999887642 336889999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~ 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGER 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHCCCC
Confidence 5432221 1122345678999999999999999999999999999997 8888853210 001111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
. ..+...+.++.+++..||..+|++||++.++++.|..+....
T Consensus 230 ~---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 L---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 112223457899999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=271.07 Aligned_cols=225 Identities=28% Similarity=0.474 Sum_probs=181.0
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------------ccccchhhhcccccCCc
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------------~~~niv~~~~~~~~~~~ 103 (331)
+|.+.+.||+|++|.||+|.+ .++..+|+| .|||++++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467789999999999999987 457888887 27899999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++++||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999988652 36888999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCc-----eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 184 SKFIAMDQT-----HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 184 a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
+........ .......|+..|+|||.+.+..++.++|+||+||++|+|++|+.||...... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~ 224 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKI 224 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHH
Confidence 876642211 1111245788999999999988999999999999999999999999643110 000000
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. .. .....+...+..+.+++.+||+.+|.+||++.|+++
T Consensus 225 ~-~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 G-EN---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred h-cc---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 00 011112334567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=263.99 Aligned_cols=236 Identities=24% Similarity=0.336 Sum_probs=188.5
Q ss_pred HhcCCccC-ceecCCCCeEEEEEEe-cCCcEEEEc-------------------ccccchhhhccccc----CCcceeEe
Q 020102 54 ATNHFNVN-RILGQGGQGTVYKGMR-EDGRIIAVK-------------------KSKNAVKLLGCCLE----TEVPLLVY 108 (331)
Q Consensus 54 ~~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK-------------------~~~niv~~~~~~~~----~~~~~lv~ 108 (331)
.++.|.+. ++||-|-.|.|-.+.. .+++.+|+| .|||||.+++++.+ ..++.+||
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 35566655 6799999999999987 579999999 38999999999865 45678999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC---CCCcEEEeeccCcc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSK 185 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~ 185 (331)
|.++||.|...+.++ ....+++..+..|++||..|+.|||+.+ |.||||||+|+|.. .+..+||+|||+|+
T Consensus 139 E~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred ecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccc
Confidence 999999999999873 3457999999999999999999999998 99999999999997 45578999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
....+ ....+.+.||.|.|||++....|+..+|+||+||++|-|++|.+||+..... ....+ ....+..+..
T Consensus 213 ~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispg-Mk~rI~~gqy- 284 (400)
T KOG0604|consen 213 ETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPG-MKRRIRTGQY- 284 (400)
T ss_pred ccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChh-HHhHhhccCc-
Confidence 65432 2334457899999999999999999999999999999999999999754221 11111 1112222211
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+ +.+.....++...++|+.+|..+|++|.|++++++.
T Consensus 285 ~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11 222345678889999999999999999999999764
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=269.79 Aligned_cols=227 Identities=29% Similarity=0.410 Sum_probs=184.8
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|+..+.||.|+||.||.+.. .+++.+++| .|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999986 468888888 278999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+.+... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999988753 2346899999999999999999999988 999999999999999999999999998765443
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.. ......+++.|+|||...+..++.++|+||||+++++|++|..||..... ....... ..+...
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~-~~~~~~----- 219 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKI-VQGNYT----- 219 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH-HcCCCC-----
Confidence 32 22335689999999999888889999999999999999999999853210 0111111 111111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......+..+.+++.+||+.+|.+|||+.++++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1123445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=284.66 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=207.9
Q ss_pred HHHHHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------ccccchhhhcccccCCcce
Q 020102 49 KELDKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 49 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------~~~niv~~~~~~~~~~~~~ 105 (331)
++++..........+||-|-||.||.|.++ -...|||| +|||+|+++|+|..+..+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 455555556677789999999999999985 46778998 6999999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
||+|||..|+|.++|.+. ....++....+.++.||..|+.||..++ ++||||...|+|+.++..+|++|||+++
T Consensus 340 IiTEfM~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEecccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999873 2335666777889999999999999988 9999999999999999999999999999
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
++..+.............|.|||-+....++.|+|||+|||+|||+.| |-.||...+ ..++
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------------------lSqV 475 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------------------LSQV 475 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------------------HHHH
Confidence 887666554444456778999999999999999999999999999998 777775421 1223
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRA 321 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~ 321 (331)
..+++...++..+..+++.+.+|++.||+++|.+||++.|+-+.++.+...+.-..+
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdE 532 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDE 532 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHH
Confidence 444555556667788889999999999999999999999999999887665544433
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=275.83 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=187.3
Q ss_pred ccChHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhccccc
Q 020102 45 LFSSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLE 100 (331)
Q Consensus 45 ~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~ 100 (331)
++...++....++|.+.+.||+|+||.||++.. .+++.+|+| .|||++++++++..
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 345566667789999999999999999999987 468888888 37899999998865
Q ss_pred C-----CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc
Q 020102 101 T-----EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175 (331)
Q Consensus 101 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~ 175 (331)
. ...++|+||+++++|.+.+.... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 3 35799999999999999886532 22346899999999999999999999988 999999999999999999
Q ss_pred EEEeeccCcccccCCCceeeeeccccCCccChhhhcCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc
Q 020102 176 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS 250 (331)
Q Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~ 250 (331)
++|+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++|+.||......
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------ 239 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------ 239 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence 99999999876543221 12234578899999987654 3688999999999999999999998643110
Q ss_pred hHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 251 LAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..... ......... ..+......+.+++.+||+.+|++|||+.++++
T Consensus 240 --~~~~~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 --KTLFK-IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HHHHH-HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00111 111111111 112234457899999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=269.97 Aligned_cols=225 Identities=25% Similarity=0.399 Sum_probs=177.7
Q ss_pred ceecCCCCeEEEEEEecC--C--cEEEEc------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRED--G--RIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~--~--~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|++|.||+|.+.+ + ..||+| .|+|++++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998733 2 358888 37899999999988 889999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+.+.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+......
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999887631 146899999999999999999999988 999999999999999999999999999866442221
Q ss_pred --eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 194 --VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ............
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~------ 219 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEGER------ 219 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcCCc------
Confidence 1112346788999999999999999999999999999998 99998532110 011111111100
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 ---LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0112234567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=274.75 Aligned_cols=242 Identities=24% Similarity=0.374 Sum_probs=185.1
Q ss_pred cCCccCceecCCCCeEEEEEEec-----CCcEEEEc------------------------ccccchhhhccccc--CCcc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-----DGRIIAVK------------------------KSKNAVKLLGCCLE--TEVP 104 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK------------------------~~~niv~~~~~~~~--~~~~ 104 (331)
..|.+.+.||+|+||.||+|... ++..+|+| .|+|++++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677899999999999999852 46789998 37899999998877 5678
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 9999999999999988652 225899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCCceee--eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc------cchHHHHH
Q 020102 185 KFIAMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN------VSLAAYFV 256 (331)
Q Consensus 185 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~ 256 (331)
........... ....++..|+|||.+.+..++.++|+|||||+++||++|..|+.......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 86653222111 11234567999999988899999999999999999999999975432111000 00011111
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
..+.... ....+...+..+.+++.+||+.+|++|||+.||+++|+.++
T Consensus 237 ~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 237 ELLKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1111111 11112234467999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=274.55 Aligned_cols=229 Identities=26% Similarity=0.339 Sum_probs=180.6
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
+.|++.+.||.|+||.||+|.+. ++..+++| .|+|++++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999874 57888888 4889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|...+... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 92 PGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999998776542 346899999999999999999999988 9999999999999999999999999986543221
Q ss_pred ceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 192 THVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.......+++.|+|||++. ...++.++|+|||||++|+|++|..||..... ........ ......
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~-~~~~~~ 234 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIA-KSEPPT 234 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHh-cCCCcc
Confidence 1223345788999999874 34567899999999999999999999854211 00111111 111100
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...+...+.++.+++.+||+.+|++||+++++++.
T Consensus 235 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 -------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01123445678999999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=270.05 Aligned_cols=217 Identities=24% Similarity=0.388 Sum_probs=168.1
Q ss_pred ceecCCCCeEEEEEEecC-------------CcEEEEc-----------------------ccccchhhhcccccCCcce
Q 020102 62 RILGQGGQGTVYKGMRED-------------GRIIAVK-----------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~-------------~~~vavK-----------------------~~~niv~~~~~~~~~~~~~ 105 (331)
+.||+|+||.||+|...+ ...+++| .|||++++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997421 2357778 4899999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc-------EEE
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR-------AKV 178 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~-------~kl 178 (331)
+||||+++++|..++.. ....+++..+..++.||+.|+.|||+.+ |+||||||+||+++.++. +++
T Consensus 81 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999877654 2346899999999999999999999988 999999999999986654 899
Q ss_pred eeccCcccccCCCceeeeeccccCCccChhhhc-CCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCcccccchHHHHH
Q 020102 179 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELL-TGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~-~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+..... .. ..
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~-------~~ 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--AE-------KE 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--hH-------HH
Confidence 999998654321 2235788899999886 466889999999999999998 47777643210 00 00
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
... ..... ........+.+|+.+||+.||++||++.+|++.|+
T Consensus 220 ~~~-~~~~~----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFY-EGQCM----------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHH-hcCcc----------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 010 11100 01122456889999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=276.52 Aligned_cols=233 Identities=25% Similarity=0.429 Sum_probs=186.1
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.+|++.+.||.|+||+||+|.+ .+++.|++| .|+|++++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999987 568899999 3889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+.+.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999987754 25899999999999999999999998 9999999999999999999999999987554322
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
. ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... . .. .........
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~-~~-~~~~~~~~~----- 234 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------A-LY-LIATNGTPE----- 234 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------H-HH-HHHhcCCcc-----
Confidence 1 1223458889999999998889999999999999999999999986432100 0 00 011110000
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIRG 314 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~~ 314 (331)
...+...+..+.+++.+||+.+|++|||+.++++. ++..++
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 01122344578899999999999999999999764 444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=266.47 Aligned_cols=229 Identities=24% Similarity=0.313 Sum_probs=182.2
Q ss_pred HHHHhcCCccCcee--cCCCCeEEEEEEe-cCCcEEEEc-------------------ccccchhhhcccccCCcceeEe
Q 020102 51 LDKATNHFNVNRIL--GQGGQGTVYKGMR-EDGRIIAVK-------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 51 ~~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK-------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
.....+.|.+.+.+ |+|+||.||++.. .++..+|+| .|+|++++++.+...+..++||
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 33445667777776 9999999999987 467778888 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEeeccCcccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFI 187 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~ 187 (331)
||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++ .++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 89 DYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999988652 37899999999999999999999998 99999999999999988 9999999998755
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... ...++..|+|||++.+..++.++|+||+|+++|+|++|+.||....... .....+. ... ..
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~-~~~-~~----- 225 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLL-KRQ-QK----- 225 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHH-Hhh-cc-----
Confidence 3221 2357899999999999999999999999999999999999996332111 1111111 000 00
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-MEEVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-~~evl~ 307 (331)
........+..+.+++..||+.+|.+||+ ++|+++
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 -----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00112245668999999999999999996 588864
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=270.20 Aligned_cols=226 Identities=29% Similarity=0.446 Sum_probs=179.4
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc---------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.|.+.+.||+|+||.||++.. +++.+|+| .|||++++++++..+ ..+++|||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 4588899999999999999965 67788988 388999999988665 479999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+|.+++... ....+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 84 ~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 84 NLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999988652 2335889999999999999999999988 999999999999999999999999998753221
Q ss_pred eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 195 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||..... . . .......+. .
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~------~-~~~~~~~~~---------~ 215 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--K------E-VKECVEKGY---------R 215 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--H------H-HHHHHhCCC---------C
Confidence 112234567999999998899999999999999999997 8888854311 0 0 111111111 0
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
.......+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11123345678999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=271.92 Aligned_cols=218 Identities=24% Similarity=0.386 Sum_probs=168.4
Q ss_pred ceecCCCCeEEEEEEecC--------CcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 62 RILGQGGQGTVYKGMRED--------GRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~--------~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+.||+|+||+||+|.+.. ...+++| .|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998632 2236666 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc--------EEEeecc
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR--------AKVADFG 182 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~--------~kl~Dfg 182 (331)
+++|+|.+++... ...+++..+..++.||+.|+.|||+.+ |+||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999988652 236889999999999999999999998 999999999999987665 6999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
++..... .....++..|+|||++.+. .++.++|||||||++|+|++|..|++....... .......
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~ 220 (258)
T cd05078 154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYED 220 (258)
T ss_pred cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHHc
Confidence 8864432 1224578899999998874 578899999999999999999644332211100 0001000
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
....+...+.++.+++.+||+.+|++|||++++++.|+
T Consensus 221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00112223457899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=273.10 Aligned_cols=227 Identities=26% Similarity=0.344 Sum_probs=178.6
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
|++.+.||+|+||.||+|.+. ++..+++| .|+|++++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999985 47777887 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|...+.. ...++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 87 ~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 87 GAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 999887654 2347899999999999999999999988 9999999999999999999999999987543221 1
Q ss_pred eeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 194 VTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
......++..|+|||++. +..++.++|+|||||++|+|++|+.||..... ......... .....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~-~~~~~-- 227 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAK-SEPPT-- 227 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhh-cCCCC--
Confidence 223346899999999874 44577899999999999999999999854311 001111110 10000
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 -----LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122345679999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=272.86 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=179.6
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||.||+|.+. +++.||+| .|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999985 58889998 27899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|++++.+...... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9998877665432 236899999999999999999999988 99999999999999999999999999986544
Q ss_pred CCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH-------HHHHhhc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY-------FVHSMRK 261 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 261 (331)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ..... .......
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhccc
Confidence 321 1223457889999998876 457889999999999999999999986432211000 00000 0000000
Q ss_pred Ccccc---ccchHhh---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 262 NRLYD---ILDDQVM---KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 262 ~~~~~---~~~~~~~---~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..... ....... .......+..+.+|+.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000 0000000 0001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=271.23 Aligned_cols=224 Identities=28% Similarity=0.420 Sum_probs=181.8
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
-|++.+.||+|+||.||+|.+ .++..+|+| .|+|++++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 467788999999999999987 468899999 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++.. ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999888753 36889999999999999999999988 9999999999999999999999999987554322
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ...........
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~------- 218 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---------KVLFLIPKNNP------- 218 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---------HHHHHHhcCCC-------
Confidence 1122345788999999998888899999999999999999999998532110 01111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......+..+.+++.+||+.+|.+||++.++++.
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 --PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11122345678999999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=269.22 Aligned_cols=231 Identities=28% Similarity=0.406 Sum_probs=178.8
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEe
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
..++++.....||+|+||.||+|.+ .++..|++| +|+|++++++++..++..++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3445555667899999999999986 457789998 4889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEeeccCcc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPL--TWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSK 185 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~ 185 (331)
||+++++|.+.+... ..++ ++..+..++.|++.|+.|||+.+ |+|+||||+||+++. ++.++|+|||++.
T Consensus 85 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 85 EQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred ecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999988752 1234 78888999999999999999988 999999999999986 6789999999987
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
....... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||......... .......
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~------~~~~~~~--- 227 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA------MFKVGMF--- 227 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh------Hhhhhhh---
Confidence 5533221 122245789999999886643 788999999999999999999998643211100 0000000
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
......+...+..+.+++.+||+.+|.+|||+.|++.
T Consensus 228 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 -------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0001122334567899999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=267.63 Aligned_cols=224 Identities=27% Similarity=0.379 Sum_probs=181.4
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------------ccccchhhhcccccCCcceeE
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
+|+..+.||+|++|.||+|... ++..|++| .|+|++++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999985 78889998 278999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
+||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999988865 235889999999999999999999988 999999999999999999999999998765
Q ss_pred cCCCceeeeeccccCCccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||..... ..............
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~- 221 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKELP- 221 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhcccCC-
Confidence 4322 223456889999999887776 89999999999999999999999854321 00011111101111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...+..+.+++.+||+.+|.+|||+.+++.
T Consensus 222 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 112234567889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=268.67 Aligned_cols=229 Identities=26% Similarity=0.412 Sum_probs=183.7
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc--CCcceeEe
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE--TEVPLLVY 108 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~--~~~~~lv~ 108 (331)
+|++.+.||.|+||.||++.+ .++..+++| .|+|++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999987 467888888 37899999987754 45678999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH-----SAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-----~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
||+++++|.+.+.... ....++++..++.++.|++.|+.||| +.+ ++|+||+|+||++++++.++|+|||+
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999887642 23457899999999999999999999 655 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
+........ ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||..... . ..........
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~----~~~~~~~~~~ 226 (265)
T cd08217 157 AKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----L----QLASKIKEGK 226 (265)
T ss_pred cccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----H----HHHHHHhcCC
Confidence 986654332 12334689999999999998899999999999999999999999864321 0 1111111111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ...+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 227 ~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 F---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 11233456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=268.10 Aligned_cols=228 Identities=31% Similarity=0.453 Sum_probs=180.5
Q ss_pred CccCceecCCCCeEEEEEEecC-----CcEEEEc------------------------ccccchhhhcccccCCcceeEe
Q 020102 58 FNVNRILGQGGQGTVYKGMRED-----GRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
+++.+.||.|+||.||++.+.+ +..||+| .|+|++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998743 4789999 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+.+.... ...+++..+..++.|++.|+++||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999999887521 112899999999999999999999998 9999999999999999999999999997665
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
...........+++.|+|||.+.+..++.++|+||+|+++++|++ |..||..... ..... ........
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~-~~~~~~~~-- 223 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLE-YLKKGYRL-- 223 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH-HHhcCCCC--
Confidence 432222222336789999999988889999999999999999998 7777643110 11111 11111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
..+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 224 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11222556799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=311.41 Aligned_cols=230 Identities=26% Similarity=0.363 Sum_probs=186.1
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.+-++.-...||.|.||.||.|.. .+|+..|+| +|||+|+++|+=.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345667778899999999999997 568888888 599999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
||||.+|+|.+.+.. +...++.....+..|++.|++|||+.| ||||||||+||+++.+|.+|++|||.|..+
T Consensus 1313 MEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 999999999998764 334666777778999999999999999 999999999999999999999999999887
Q ss_pred cCCCceee---eeccccCCccChhhhcCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 188 AMDQTHVT---TKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 188 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
..+..... ....||+.|||||++.+.. ...+.||||+|||+.||+||++||...++... .+.....
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--------IMy~V~~ 1456 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--------IMYHVAA 1456 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--------HHhHHhc
Confidence 65532222 2367999999999998754 56689999999999999999999975533211 1111112
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
+..+ ..+...+..-.+|+..||+.||++|.++.|+++.
T Consensus 1457 gh~P---------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKP---------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred cCCC---------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2222 2344467788999999999999999998877543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=267.71 Aligned_cols=239 Identities=27% Similarity=0.352 Sum_probs=184.1
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhccccc--CCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLE--TEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~--~~~~~lv~ 108 (331)
++|+..+.||.|++|.||++.+ .+++.+|+| .||||+++++++.+ .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678889999999999999998 457888998 48899999998865 34689999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+.+..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988765432 3446889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.... ....++..|+|||.+.+..++.++|+|||||++|+|++|..||......... ..... ............
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~-~~~~~~~~~~~~ 229 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELL-SYIVNMPNPELK 229 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC---hHHHH-HHHhcCCchhhc
Confidence 2221 2345788999999999999999999999999999999999999754321111 11111 111111111111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. .......+..+.+++.+||+.+|++|||+.|+++.
T Consensus 230 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00 00112346679999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=267.93 Aligned_cols=233 Identities=27% Similarity=0.408 Sum_probs=184.7
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||.|+||+||+|.. .++..+++| .|+|++++++.+..++..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999986 467788888 377999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+.+.... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999887531 2246899999999999999999999988 999999999999999999999999998765543
Q ss_pred Cce---eeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 191 QTH---VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 191 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
... ......|+..|+|||.+... .++.++|+|||||++++|++|+.||....... ......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~-~~- 225 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQND-PP- 225 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhcCC-CC-
Confidence 322 12334688999999988777 78899999999999999999999986432110 011111110 00
Q ss_pred ccchHhhcc-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 267 ILDDQVMKL-GKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 267 ~~~~~~~~~-~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..... .....+..+.+++..||+.+|++|||++++++
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 ----SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ----CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 01245677899999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=267.34 Aligned_cols=229 Identities=24% Similarity=0.420 Sum_probs=182.2
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------------ccccchhhhcccccCCccee
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
+|+..+.||+|+||.||+|.+ .+++.+|+| +|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999987 568889887 37899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEeeccCcc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSK 185 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~ 185 (331)
|+||+++++|.+.+.. ..++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999998865 236889999999999999999999998 99999999999998776 58999999987
Q ss_pred cccCCCce---eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 186 FIAMDQTH---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 186 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
........ ......++..|+|||.+.+..++.++|+||+||++++|++|..||........ ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~- 226 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-----LALIFKIASA- 226 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----HHHHHHHhcc-
Confidence 65432211 11234578899999999888899999999999999999999999854321110 0001000000
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
......+...+.++.+++.+||+.+|.+|||+.++++
T Consensus 227 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 --------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011223445678999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=271.47 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=182.1
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEcc-------------------------cccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKK-------------------------SKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~-------------------------~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||.||+|.+. +++.|++|. |+|++++++++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 588899992 7799999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|++++.+...... ...+++..+..++.||+.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9997666543332 345899999999999999999999988 99999999999999999999999999887654
Q ss_pred CCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc------chHHHHHHHhhcC
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV------SLAAYFVHSMRKN 262 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~ 262 (331)
..........++..|+|||++.+. .++.++|+||||+++|+|++|+.||........... .............
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 433233345678899999999888 789999999999999999999998864321100000 0000000000000
Q ss_pred ------ccccccch-HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 ------RLYDILDD-QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ------~~~~~~~~-~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
........ ......+...+..+.+|+.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 0011112234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=267.98 Aligned_cols=226 Identities=24% Similarity=0.362 Sum_probs=183.3
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|++.+.||+|+||.||.+.. .+++.|++| .|+|++++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478899999999999999987 468889999 278999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+.+++|.+.+... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999888652 2235789999999999999999999988 999999999999999999999999998755432
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.. ......|++.|+|||.+.+..++.++|+|||||++++|++|+.||..... ......... +..
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~-~~~------ 218 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIR-GSY------ 218 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhc-CCC------
Confidence 21 12234578899999999998899999999999999999999999864311 111111111 111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+...+.++.+++.+||+.+|.+||++.+|++
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122344567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=269.87 Aligned_cols=242 Identities=21% Similarity=0.294 Sum_probs=179.0
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEcc--------------------------cccchhhhcccccCCc-----
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK--------------------------SKNAVKLLGCCLETEV----- 103 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~--------------------------~~niv~~~~~~~~~~~----- 103 (331)
++|++.+.||+|+||.||+|.+ .+++.||+|. |+|++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688899999999999999997 4688999992 5899999998877665
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEeecc
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFG 182 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg 182 (331)
.++||||+++ +|.+++..........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 7888876543332457899999999999999999999988 999999999999998 8899999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
++..+...... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||........ ..... .....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~-~~~~~ 230 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ----LLHIF-KLLGT 230 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHH-HHhCC
Confidence 98755332211 122346888999998765 4578999999999999999999999864321110 00000 00000
Q ss_pred C---ccccc-----------cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 262 N---RLYDI-----------LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 262 ~---~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. .+... ..........+..+..+.++|.+||+.+|.+|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000 0000011112235667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=270.80 Aligned_cols=233 Identities=28% Similarity=0.419 Sum_probs=182.0
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccccCC------c
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCLETE------V 103 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~~~~------~ 103 (331)
.+++|++.+.||+|++|.||+|.+. +++.+++| .|+|++++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4678999999999999999999984 57788888 3789999999987644 4
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||+++++|.+.+.... ..+..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 899999999999998876532 12357899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
+....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...... .....
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~- 229 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RALFK- 229 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HHHHH-
Confidence 87543222 22233458899999998754 24678899999999999999999998532110 00111
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
........ ......++..+.+++.+||..||++|||+.++++
T Consensus 230 ~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111100 1112335678999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=271.94 Aligned_cols=233 Identities=27% Similarity=0.354 Sum_probs=177.6
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|...+.||+|+||.||++.+ .+++.+|+|. |+|++++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 355667899999999999987 4588999982 78999999999998899999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
+. +++.+............+++..+..++.|++.||.|||+. + ++||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 5665544322122335789999999999999999999974 6 99999999999999999999999999875543
Q ss_pred CCceeeeeccccCCccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
... .....|+..|+|||.+.+. .++.++|||||||++|+|++|+.||..... ......... .....
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~-~~~~~- 229 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVV-KGDPP- 229 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhc-CCCCC-
Confidence 221 1223578899999998776 688999999999999999999999854320 001111111 01111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..........+..+.+|+.+||+.+|++|||+++|++.
T Consensus 230 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ----ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111223456789999999999999999999999775
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=267.09 Aligned_cols=230 Identities=27% Similarity=0.418 Sum_probs=183.6
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
+|++.+.||+|+||.||++.+. +++.+++| .|||++++++.+..+...++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5778889999999999999885 68889998 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
++++|.+.+... ...+++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 82 DGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred CCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999988752 1478999999999999999999999 77 999999999999999999999999998755332
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
... ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .......... ......
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-~~~~~~---- 223 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIV-NEPPPR---- 223 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---cHHHHHHHHh-cCCCCC----
Confidence 211 15688899999999999999999999999999999999999865422111 1111111111 111100
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......+..+.++|..||..+|++|||+.+++..
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 ----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0111156679999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=273.21 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=180.6
Q ss_pred CCccCceecCCCCeEEEEEEec---CCcEEEEc--------------------------ccccchhhhcccccC--Ccce
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE---DGRIIAVK--------------------------KSKNAVKLLGCCLET--EVPL 105 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK--------------------------~~~niv~~~~~~~~~--~~~~ 105 (331)
+|.+.+.||+|+||.||+|.+. ++..||+| .|||++++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999974 47899998 378999999999888 7899
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC----CCcEEEeec
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE----RYRAKVADF 181 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~----~~~~kl~Df 181 (331)
+||||++ +++.+.+..........+++..++.++.|++.|+.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999997 56777665443333347899999999999999999999998 999999999999999 999999999
Q ss_pred cCcccccCCCc--eeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc-----hHH
Q 020102 182 GTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS-----LAA 253 (331)
Q Consensus 182 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~-----~~~ 253 (331)
|++........ .......+++.|+|||.+.+. .++.++|||||||++++|++|+.||............ ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543322 112234578899999987664 5788999999999999999999998654322210000 000
Q ss_pred HHHHHhhc---------------------CccccccchHhhccCCH--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 254 YFVHSMRK---------------------NRLYDILDDQVMKLGKK--NQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 254 ~~~~~~~~---------------------~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.+ ..+.. ..........+...... ..+..+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00000 00000000000000111 34557899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.30 Aligned_cols=239 Identities=23% Similarity=0.318 Sum_probs=181.0
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|++.+.||+|+||.||+|.+ .++..|++| .|+|++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999997 468889999 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+ +++|.+.+... ..++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999888652 247899999999999999999999988 999999999999999999999999998866543
Q ss_pred CceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC-------
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN------- 262 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 262 (331)
.........++..|+|||.+.+. .++.++||||+||++++|++|..||...... . ............
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-E----QLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-H----HHHHHHHHcCCCChHHHhh
Confidence 32222334688999999987654 4688999999999999999997666432110 0 000000000000
Q ss_pred -----ccccccch----HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 -----RLYDILDD----QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 -----~~~~~~~~----~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........ .......++.+..+.+++.+||+.+|++|||+++++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00001112345789999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=267.21 Aligned_cols=226 Identities=27% Similarity=0.396 Sum_probs=175.8
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------------ccccchhhhccccc--CCcc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------------KSKNAVKLLGCCLE--TEVP 104 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------------~~~niv~~~~~~~~--~~~~ 104 (331)
.+|...+.||+|+||.||+|.+ .++..|++| .|||++++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999987 458888888 37899999998765 3567
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++++||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 899999999999998865 235788999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCC--ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 185 KFIAMDQ--THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 185 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
....... ........++..|+|||.+.+..++.++|+||+||++|||++|+.||...... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~~ 225 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQP 225 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcCC
Confidence 7543211 11112245788999999999988999999999999999999999998543110 0011111000
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. ....+......+.+++ .||..+|++|||++||++
T Consensus 226 ~---------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 T---------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C---------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0 0111223345667777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=271.63 Aligned_cols=229 Identities=27% Similarity=0.340 Sum_probs=182.5
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
++|++.+.||.|+||+||+|.. .++..+|+| .|+|++++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 5688999999999999999987 468889999 4889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 85 DGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred CCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999887652 346899999999999999999999998 9999999999999999999999999886543322
Q ss_pred ceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 192 THVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.......+++.|+|||.+. ...++.++|+|||||++|+|++|+.||...... ...... .......
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~-~~~~~~~ 227 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKI-LKSEPPT 227 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHH-hcCCCCC
Confidence 1223345899999999875 345678999999999999999999998543110 001111 1111100
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...+...+..+.+++..||+.+|.+|||++++++.
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 -------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01123345678999999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=268.70 Aligned_cols=221 Identities=27% Similarity=0.380 Sum_probs=181.1
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||.||++.+. +++.+|+| .|||++++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999874 58889998 2789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999988652 46899999999999999999999988 9999999999999999999999999988654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||..... ........ .+..
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~---- 215 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKIL-EGKV---- 215 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-cCCc----
Confidence 33 2234588999999999888889999999999999999999999864320 00111111 1110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSM 307 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~ 307 (331)
..+...+..+.+++.+||+.+|.+|| +++|+++
T Consensus 216 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11222356788999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=270.95 Aligned_cols=219 Identities=25% Similarity=0.324 Sum_probs=173.6
Q ss_pred eecCCCCeEEEEEEe-cCCcEEEEcc-----------------------------cccchhhhcccccCCcceeEeeccc
Q 020102 63 ILGQGGQGTVYKGMR-EDGRIIAVKK-----------------------------SKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 63 ~lg~G~~g~V~~~~~-~~~~~vavK~-----------------------------~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.||+|+||.||++.+ .+++.+|+|. |+|++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 4588899982 5678888888888889999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999888764 236899999999999999999999998 9999999999999999999999999986543222
Q ss_pred eeeeeccccCCccChhhhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.....|+..|+|||.+. +..++.++|+||+||++|+|++|..||......... ........
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~---------- 213 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRMTLT---------- 213 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH------HHHHHhhc----------
Confidence 12245899999999886 456889999999999999999999999643221110 01000000
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
.....+...+.++.+++.+||+.||++|| |++++++.
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 01112334566889999999999999999 58888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=265.97 Aligned_cols=230 Identities=27% Similarity=0.397 Sum_probs=180.3
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------------------cccchhhhcccccCC
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------------------SKNAVKLLGCCLETE 102 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------------------~~niv~~~~~~~~~~ 102 (331)
+|.+.+.||.|+||.||+|.+ .+++.+|+|. |+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467789999999999999987 4688899882 679999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++|+||+++++|.+.+... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999988652 46889999999999999999999988 9999999999999999999999999
Q ss_pred CcccccCCCce-eeeeccccCCccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 183 TSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 183 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
++......... ......++..|+|||.+.... ++.++|+||||++++++++|..||....... . .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~-~~~~~ 225 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------A-MFKLG 225 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-------H-HHHhh
Confidence 98754322111 122345788999999887755 7889999999999999999999985321100 0 00000
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
........ ........+..+.+++.+||+.+|++|||++++++
T Consensus 226 ~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 226 NKRSAPPI-----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccCCcC-----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000000 11112234568999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=265.56 Aligned_cols=231 Identities=23% Similarity=0.327 Sum_probs=169.2
Q ss_pred ceecCCCCeEEEEEEecC---CcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 62 RILGQGGQGTVYKGMRED---GRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~---~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.||+|+||.||+|...+ ...+++| .|||++++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999997533 2344555 3889999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC-ce
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ-TH 193 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~ 193 (331)
+|.+++..... .....++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99998875321 1234677788899999999999999988 9999999999999999999999999986432111 11
Q ss_pred eeeeccccCCccChhhhcC-------CCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 194 VTTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLTG-KKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
......++..|+|||++.. ..++.++|||||||++|||+++ ..||..... ......... +...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~-~~~~ 227 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIK-DQQV 227 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHh-hccc
Confidence 1223457889999998743 2457799999999999999974 566643211 011111111 1111
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
...++.. ...++..+.+++..|+ .+|++|||+++|++.|.
T Consensus 228 ~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1222111 2234567888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=297.09 Aligned_cols=236 Identities=22% Similarity=0.420 Sum_probs=201.3
Q ss_pred cCCccCceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
+...+.++||.|.||.|++|..+ ....|||| .||||+++-|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45577799999999999999863 35678999 399999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
+|||++|+|+.+|.. .++.+++.+...+++.|+.|+.||-+.+ +|||||..+|||++.+..+|++|||+++.+
T Consensus 709 TEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999976 3467999999999999999999999988 999999999999999999999999999987
Q ss_pred cCCCceeeeeccc--cCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 188 AMDQTHVTTKIQG--TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 188 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
.++.....++.-| ..+|.|||.+....++.++||||||+++||.++ |.+||.+.. +.++
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS------------------NQdV 843 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS------------------NQDV 843 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc------------------hHHH
Confidence 6655333332222 467999999999999999999999999999887 999996543 2333
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
...++...+-+.+-+++..+.+|+.+||++|-.+||++.||+..|+.+-.+.
T Consensus 844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 4445555566667788999999999999999999999999999998876543
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=266.08 Aligned_cols=226 Identities=27% Similarity=0.384 Sum_probs=177.7
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------------ccccchhhhcccccC--Ccc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------------KSKNAVKLLGCCLET--EVP 104 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------------~~~niv~~~~~~~~~--~~~ 104 (331)
.+|.+.+.||+|+||.||.|.+ .++..|++| .|+|++++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999987 458889998 277999999987663 457
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999888652 35788889999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCc--eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 185 KFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 185 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
........ .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... ........ .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~-~ 224 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIAT-Q 224 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--------HHHHHHhc-C
Confidence 75432111 1122345888999999998888999999999999999999999998532100 00111100 0
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. .....+...+..+.+++.+|+. +|++|||++++++
T Consensus 225 ~--------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 P--------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C--------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 0111234456678899999994 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=269.27 Aligned_cols=225 Identities=24% Similarity=0.388 Sum_probs=178.9
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
|.....||+|+||.||++.+ .++..|||| .|+|++++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33346799999999999987 468889998 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+++.. ..+++..+..++.||+.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 104 ~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 104 GALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 999887743 25789999999999999999999988 99999999999999999999999999875433221
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... . ... ..... .... ..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~------~~~-~~~~~-~~~~----~~- 238 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--L------QAM-RRIRD-NLPP----RV- 238 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H------HHH-HHHHh-cCCC----cc-
Confidence 22234588999999999988899999999999999999999999864311 0 000 01100 0000 00
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......+..+.+++..||+.+|.+|||++++++.
T Consensus 239 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 -KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0112345578899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=276.12 Aligned_cols=230 Identities=25% Similarity=0.329 Sum_probs=179.0
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEecCCcEEEEcc--------------------------cccchhhhcccccCCcce
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK--------------------------SKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~--------------------------~~niv~~~~~~~~~~~~~ 105 (331)
...+..|++.+.||+||.+.||++...+.+.+|+|+ +.+|++++++-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 344568999999999999999999988888888884 558999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||= ..+|..+|.... ...+.-.+..+..||+.|+.++|+.| |||.||||.|+|+-. |.+||+|||+|.
T Consensus 437 mvmE~G-d~DL~kiL~k~~----~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKK----SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred EEeecc-cccHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhc
Confidence 999975 488888887632 22332377889999999999999999 999999999998864 589999999999
Q ss_pred cccCCCceee-eeccccCCccChhhhcCCC-----------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 020102 186 FIAMDQTHVT-TKIQGTFGYLDPEYHQSSQ-----------LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA 253 (331)
Q Consensus 186 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~ 253 (331)
.+..+.+... ...+||+.||+||.+.... .+.++||||+|||||+|+.|+.||....
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----------- 576 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----------- 576 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----------
Confidence 8876665443 4568999999999775432 5678999999999999999999995321
Q ss_pred HHHHHhhcCccccccchHh--hcc-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 254 YFVHSMRKNRLYDILDDQV--MKL-GKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+ ..+..+.++.. ..+ .+... ++++++..||+.||.+|||..++++.
T Consensus 577 ---n~~--aKl~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 ---NQI--AKLHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHH--HHHHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 111 11222222211 111 11111 28999999999999999999999764
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=269.29 Aligned_cols=216 Identities=23% Similarity=0.368 Sum_probs=166.4
Q ss_pred eecCCCCeEEEEEEec-------------------------CCcEEEEc-----------------------ccccchhh
Q 020102 63 ILGQGGQGTVYKGMRE-------------------------DGRIIAVK-----------------------KSKNAVKL 94 (331)
Q Consensus 63 ~lg~G~~g~V~~~~~~-------------------------~~~~vavK-----------------------~~~niv~~ 94 (331)
.||+|+||.||+|... ....|++| .|||++++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999998631 12347777 38999999
Q ss_pred hcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 020102 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY 174 (331)
Q Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~ 174 (331)
++++.++...++||||+++++|...+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 9999999999999999999999887754 2346889999999999999999999988 99999999999997543
Q ss_pred -------cEEEeeccCcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCc
Q 020102 175 -------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELL-TGKKPIFSAGNTS 245 (331)
Q Consensus 175 -------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~-~g~~p~~~~~~~~ 245 (331)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999987643211 12346788999998865 56889999999999999995 6888885432111
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
. ........ ..+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 230 ~---------~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K---------ERFYEKKH-----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---------HHHHHhcc-----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 00010000 001112346889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=264.32 Aligned_cols=225 Identities=27% Similarity=0.417 Sum_probs=181.1
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|++.+.||+|+||.||++.. .++..+++| .|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999987 467888888 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~ 189 (331)
+++++|.+++... ....+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999988753 2346899999999999999999999988 9999999999999855 4579999999986643
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
... .....++..|+|||.+.+..++.++||||||+++++|++|+.||...... ........ ....
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~-~~~~---- 219 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIMS-GTFA---- 219 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHHh-cCCC----
Confidence 322 22345788999999999888999999999999999999999998542110 11111111 1111
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...+..+.+++.+||+.+|++|||+.|++.
T Consensus 220 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 -----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.11 Aligned_cols=229 Identities=29% Similarity=0.443 Sum_probs=186.8
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||+|++|.||+|.+. +++.|++| +|+|++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999985 58899998 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
+++++|.+.+... .++++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999988752 478999999999999999999999 88 99999999999999999999999999886543
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........... .....
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~-~~~~~---- 221 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAIC-DGPPP---- 221 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHh-cCCCC----
Confidence 3322 2234578899999999998999999999999999999999999865432 01111111111 11111
Q ss_pred hHhhccCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 270 DQVMKLGKKN-QIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 270 ~~~~~~~~~~-~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+.. .+..+.+++..||+.+|++|||+.++++.
T Consensus 222 -----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 -----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11222 56789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=261.94 Aligned_cols=216 Identities=25% Similarity=0.420 Sum_probs=169.4
Q ss_pred ceecCCCCeEEEEEEecCCc-----------EEEEc----------------------ccccchhhhcccccCCcceeEe
Q 020102 62 RILGQGGQGTVYKGMREDGR-----------IIAVK----------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~-----------~vavK----------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
+.||+|+||.||+|.+.+.. .+++| .|||++++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 36899999999999875432 46777 38899999999988 7789999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-------cEEEeec
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-------RAKVADF 181 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-------~~kl~Df 181 (331)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+||
T Consensus 80 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 80 EYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999988752 226889999999999999999999988 99999999999999887 7999999
Q ss_pred cCcccccCCCceeeeeccccCCccChhhhcCC--CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHH
Q 020102 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 182 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
|++..... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||....... ....
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---------~~~~ 218 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---------KERF 218 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---------HHHH
Confidence 99875432 1223467789999998877 78999999999999999999 466664432110 0001
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
...... .+......+.+++.+||+.+|.+|||+.++++.|+
T Consensus 219 ~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 100000 00111157899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=265.03 Aligned_cols=228 Identities=31% Similarity=0.446 Sum_probs=180.9
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|.+.+.||+|+||.||+|.+ .+++.|++| .|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999987 468889988 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+.+.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999998864 235788999999999999999999988 999999999999999999999999998866443
Q ss_pred Cceeee---eccccCCccChhhhcCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 191 QTHVTT---KIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 191 ~~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
...... ...++..|+|||.+.+.. ++.++||||||++++++++|+.||........ .... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-------~~~~-~~~~~~ 224 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-------IMFH-VGAGHK 224 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-------HHHH-HhcCCC
Confidence 322211 345788999999988776 88899999999999999999999864321100 0000 000110
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
... +.....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 225 ~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPI-------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC-------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 011123567889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=273.05 Aligned_cols=233 Identities=24% Similarity=0.308 Sum_probs=183.0
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||.||++.+. +++.|++| .|||++++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999874 57889998 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999998865 236899999999999999999999988 9999999999999999999999999886321
Q ss_pred CCCc--------------eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 020102 189 MDQT--------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 189 ~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 254 (331)
.... .......++..|+|||.+.+..++.++|+|||||++|||++|..||..... . ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~------~~ 224 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--E------EL 224 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H------HH
Confidence 1000 011123578899999999888899999999999999999999999863211 0 11
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
..... ...... + ......+..+.+++.+||+.+|++|||+.++.+.|+.-
T Consensus 225 ~~~~~-~~~~~~---~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 225 FGQVI-SDDIEW---P----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHH-hcccCC---C----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11111 111000 0 00113456789999999999999999987777777663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=268.41 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=177.7
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||+|++|.||+|.+. +++.||+| .|+|++++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999975 68889998 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
++ ++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 98 5888877642 236889999999999999999999988 999999999999999999999999998754322
Q ss_pred CceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc--------chHHHHHHHhhc
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV--------SLAAYFVHSMRK 261 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~ 261 (331)
... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........... ............
T Consensus 157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 211 122346788999998875 4578899999999999999999999854321100000 000000000000
Q ss_pred Ccccc----cc-chHhhcc-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 262 NRLYD----IL-DDQVMKL-GKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 262 ~~~~~----~~-~~~~~~~-~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..... .. ....... ........+.+++.+||+.+|++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00 0000000 00111257889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.27 Aligned_cols=224 Identities=28% Similarity=0.364 Sum_probs=183.0
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
+|++.+.||.|+||.||+|.+. ++..||+| .|||++++++.+.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999985 58889998 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+.+++|.+.+... .++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999888652 47899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..........
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~-------- 216 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQET-------- 216 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhcc--------
Confidence 32 2233458889999999998889999999999999999999999987543210 1111111110
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM--EEVS 306 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~--~evl 306 (331)
.....+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111223345789999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=269.15 Aligned_cols=228 Identities=26% Similarity=0.410 Sum_probs=183.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.++|.+.+.||+|+||.||++.+ .++..|++| .|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36889999999999999999986 467889998 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 98 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999988864 25788999999999999999999998 999999999999999999999999988755432
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.. ......+++.|+|||.+.+..++.++|+|||||++|++++|+.||.......... ...... .
T Consensus 169 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--------~~~~~~-~------ 232 (293)
T cd06647 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATNG-T------ 232 (293)
T ss_pred cc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--------ehhcCC-C------
Confidence 22 2223458889999999988889999999999999999999999996432111000 000000 0
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.........+..+.+++.+||+.+|++||++.+++.+
T Consensus 233 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 -PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122345578899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.84 Aligned_cols=224 Identities=27% Similarity=0.402 Sum_probs=179.1
Q ss_pred ccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 59 NVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
.....||+|+||.||+|.+ .++..||+| .|||++++++++..++..++++||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3445799999999999987 468889999 3889999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+|...+.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 104 ~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 173 (297)
T cd06659 104 ALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 173 (297)
T ss_pred CHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence 99886643 35889999999999999999999988 99999999999999999999999999875433221 1
Q ss_pred eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhc
Q 020102 195 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274 (331)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
.....++..|+|||++.+..++.++|+|||||++|||++|+.||....... ....+....... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~~~-------~ 237 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---------AMKRLRDSPPPK-------L 237 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHhccCCCC-------c
Confidence 223468899999999999899999999999999999999999986432100 001111110000 0
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 275 LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 275 ~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......+..+.+++.+||+.+|++|||++++++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0112334568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=283.61 Aligned_cols=224 Identities=24% Similarity=0.442 Sum_probs=177.0
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEE---Ec------------------------ccccchhhhcccccCCc--ceeE
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIA---VK------------------------KSKNAVKLLGCCLETEV--PLLV 107 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~va---vK------------------------~~~niv~~~~~~~~~~~--~~lv 107 (331)
.+...+||+|+|-+||+|.+. +|-.|| +| +||||+++++.|.+... ..+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 455678999999999999983 454443 22 59999999999988665 7889
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~ 186 (331)
+|++..|+|..++.+. +..+...+..|++||++||.|||++. ++|+|||||-+||+|+ ..|.|||+|+|+|..
T Consensus 122 TEL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHH
Confidence 9999999999999874 35778899999999999999999987 7899999999999998 468999999999987
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... ....+.|||.|||||+.. ..|++.+||||||++++||+|+..||.. +.....+..-+..-.+...+..
T Consensus 196 ~r~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 196 LRKS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred hhcc---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHHHHHHHcCCCHHHhhc
Confidence 6432 233478999999999988 7899999999999999999999999853 2211111111211112222222
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
+-+ +.+.+||.+||.. .++|||+.|+++.
T Consensus 268 V~d------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 VKD------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cCC------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 222 2578899999999 9999999999764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=273.71 Aligned_cols=226 Identities=24% Similarity=0.344 Sum_probs=189.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEe
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
..-|.+.+-||+|-|+.|-+|.+ -+|..|||| +|||||++|.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45577888999999999999976 579999999 5999999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEeeccCcccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFI 187 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~ 187 (331)
|+=++|+|++++.+. +..+.++.+.+++.||+.|+.|||+.. +|||||||+||.+- .-|-+||.|||++..+
T Consensus 97 ELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999999999999863 447999999999999999999999998 99999999998876 5688999999999765
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
... ...++.+|+..|.|||++.|..|+ +++||||||||||-|++|+.||.......- +..
T Consensus 170 ~PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-----------------LTm 230 (864)
T KOG4717|consen 170 QPG--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-----------------LTM 230 (864)
T ss_pred CCc--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----------------hhh
Confidence 433 334567899999999999999987 478999999999999999999965322110 000
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
++| ..-..+...+.++++||..||..||.+|.|.++|+..
T Consensus 231 ImD--CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 231 IMD--CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhc--ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 111 1223466778899999999999999999999999654
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=267.61 Aligned_cols=238 Identities=22% Similarity=0.296 Sum_probs=177.9
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|+..+.||.|++|.||+|.+. ++..|+|| .|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999874 68889998 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+. ++|.+++.. .....+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 678777754 22346899999999999999999999988 999999999999999999999999998755432
Q ss_pred CceeeeeccccCCccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh---------
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR--------- 260 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 260 (331)
... .....+++.|+|||.+.+.. ++.++|||||||++|+|+||+.||....... .........-.
T Consensus 154 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 154 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred ccc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhhh
Confidence 211 12234688899999877654 5889999999999999999999986432110 00000000000
Q ss_pred ------cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 261 ------KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 261 ------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
............ ....+..+..+.+++.+||+.||++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 229 TSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 0011223456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=266.68 Aligned_cols=234 Identities=28% Similarity=0.440 Sum_probs=178.7
Q ss_pred CccCceecCCCCeEEEEEEec----CCcEEEEc-------------------------ccccchhhhcccccCC------
Q 020102 58 FNVNRILGQGGQGTVYKGMRE----DGRIIAVK-------------------------KSKNAVKLLGCCLETE------ 102 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK-------------------------~~~niv~~~~~~~~~~------ 102 (331)
|.+.+.||+|+||.||+|... ++..||+| .|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999852 46789998 3789999999876532
Q ss_pred cceeEeecccCCCHHHHHhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 103 VPLLVYEFISNGTLYQHLHDRL-QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
..++++||+.+++|.+++.... ......+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988775421 122235788999999999999999999988 999999999999999999999999
Q ss_pred cCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 020102 182 GTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 182 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
|++......... ......+++.|++||.+.+..++.++|||||||++|+|++ |+.||..... . .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~---~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----S---EIYNYLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----H---HHHHHHH
Confidence 998865432211 1122335678999999998889999999999999999999 7788753211 0 1111111
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
..... ..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 230 ~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 01123456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=269.09 Aligned_cols=242 Identities=26% Similarity=0.273 Sum_probs=178.9
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------------ccccchhhhcccccCCcceeE
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
+|.+.+.||+|+||.||+|.+. +++.|++| +|+|++++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999974 68899998 278999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 89999888652 136899999999999999999999998 999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH-----HHhhc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV-----HSMRK 261 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~ 261 (331)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ............ .....
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhc
Confidence 43321 1222346788999998855 4578899999999999999999666643211 100000000000 00000
Q ss_pred CccccccchHh-----hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 NRLYDILDDQV-----MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........... ........+..+.+++.+||+.+|++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 001112345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=256.23 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=184.5
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec---C--CcEEEEc-------------------------ccccchhhhccccc-C
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE---D--GRIIAVK-------------------------KSKNAVKLLGCCLE-T 101 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK-------------------------~~~niv~~~~~~~~-~ 101 (331)
..-..|+..+.||+|.||.||+|... + ...+||| +|||++.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34467899999999999999999752 2 3368888 48899999999988 7
Q ss_pred CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC----CcEE
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER----YRAK 177 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~----~~~k 177 (331)
...++++||.+ -+|+..+.-........++...+.+|+.||+.|+.|||++. |+||||||.||++..+ |.+|
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 88999999997 67877776544444467999999999999999999999999 9999999999999877 8999
Q ss_pred EeeccCcccccCCCcee--eeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc----cc
Q 020102 178 VADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN----VS 250 (331)
Q Consensus 178 l~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~----~~ 250 (331)
|+|||+++.+..+-... ...++-|.+|+|||++.|. .|+.+.||||.|||+.||+|..+-|.......... ..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999886654332 3446779999999988876 58999999999999999999876664322111111 01
Q ss_pred hHHHHHHHhh---cCccccccc---------hHh-hccCC----------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 251 LAAYFVHSMR---KNRLYDILD---------DQV-MKLGK----------KNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 251 ~~~~~~~~~~---~~~~~~~~~---------~~~-~~~~~----------~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...-..+.+. ...++.+.. +.. ....+ ..-+....+|+..+|+.||.+|.|++|.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 1111111111 111211110 000 00000 001223678999999999999999999977
Q ss_pred H
Q 020102 308 E 308 (331)
Q Consensus 308 ~ 308 (331)
.
T Consensus 337 h 337 (438)
T KOG0666|consen 337 H 337 (438)
T ss_pred c
Confidence 5
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=273.89 Aligned_cols=242 Identities=21% Similarity=0.303 Sum_probs=179.2
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC------
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET------ 101 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~------ 101 (331)
..++|++.+.||+|+||.||+|.+ .+++.||+| .|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999997 468899999 367999999887643
Q ss_pred CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
...++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 34699999996 578777653 3788899999999999999999998 999999999999999999999999
Q ss_pred cCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-------cchHHH
Q 020102 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN-------VSLAAY 254 (331)
Q Consensus 182 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~ 254 (331)
|++....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... .....+
T Consensus 163 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 163 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred ccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9997654322 2223457889999999999999999999999999999999999986432110000 000000
Q ss_pred -------HHHHhhcCc------cccccch----HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 255 -------FVHSMRKNR------LYDILDD----QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 255 -------~~~~~~~~~------~~~~~~~----~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......... +...... ..........+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0000000 00000122345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=277.34 Aligned_cols=230 Identities=28% Similarity=0.440 Sum_probs=197.2
Q ss_pred ccCceecCCCCeEEEEEEec---C--CcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 59 NVNRILGQGGQGTVYKGMRE---D--GRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~---~--~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
...++||.|-||.||.|... . .-.|||| .||||++++|+|.+. ..+||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 44578999999999999852 2 3457888 399999999999765 5899999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
+++-|.|..+|+.. ...++..+...++.||+.||+|||+.. +|||||..+|||+.+...+||+|||+++.+..
T Consensus 471 L~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 471 LAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred cccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999863 347888889999999999999999998 99999999999999999999999999998877
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
+.........-...|||||.++-..++.++|||-|||++||++. |..||+... ..++...+
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------------NsDVI~~i 605 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------------NSDVIGHI 605 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc------------------ccceEEEe
Confidence 66554444445678999999999999999999999999999977 999997543 23445555
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
+...+.+.+++++..+..|+.+||+.+|.+||++.++...|.++..
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 6666777888999999999999999999999999999999988766
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=269.08 Aligned_cols=243 Identities=22% Similarity=0.285 Sum_probs=179.3
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccC--CcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLET--EVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~--~~~~lv 107 (331)
++|++.+.||.|+||.||+|.+. +++.+++| .|||++++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999985 57888888 378999999998877 889999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
+||++ ++|.+.+... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99997 5888877652 236899999999999999999999998 999999999999999999999999998865
Q ss_pred cCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch-------HHHHHHH-
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL-------AAYFVHS- 258 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~~~~- 258 (331)
..... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||............. .......
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 54321 12234578899999988765 46889999999999999999999986432110000000 0000000
Q ss_pred -h---hcCccccccchHhhccCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 259 -M---RKNRLYDILDDQVMKLGKKN-QIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 259 -~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
+ .................+.. .+..+.+++.+||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00000000011111111111 3667889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=261.13 Aligned_cols=226 Identities=26% Similarity=0.359 Sum_probs=185.0
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|++.+.||+|+||.||++.+ .++..+++| .|+|++++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999986 467888988 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+++.... .....+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999887642 23357899999999999999999999988 999999999999999999999999999766443
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||..... . ............
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~----~~~~~~~~~~~~----- 219 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----Q----DLRYKVQRGKYP----- 219 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHhcCCCC-----
Confidence 22224578899999999998899999999999999999999999854321 0 011111111111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
......+.++.+++.+||+.+|++|||+.++++
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 ----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 122345677999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=267.42 Aligned_cols=241 Identities=21% Similarity=0.289 Sum_probs=176.9
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
+..|.+.+.||+|+||.||+|.+ .++..|++| .|+|++++++++..+...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46789999999999999999987 468889998 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+. +++.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 84 YMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred ccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 996 7777766431 235788889999999999999999988 99999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc--------chHHHHHHHhh
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV--------SLAAYFVHSMR 260 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~ 260 (331)
... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||........... +....+....
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (291)
T cd07870 156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS- 233 (291)
T ss_pred CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh-
Confidence 221 11223478899999988764 578899999999999999999999864322100000 0000000000
Q ss_pred cCccccccchHhhc---------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 261 KNRLYDILDDQVMK---------LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 261 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
............ ......+..+.+++.+||+.||++|||+.|++.
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 --KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred --hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 000112457889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=264.16 Aligned_cols=221 Identities=26% Similarity=0.310 Sum_probs=176.2
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||.||+|.+ .+++.||+| .|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999987 458899999 267999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+++.. ..++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999998865 236889999999999999999999988 99999999999999999999999999875432
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... . ..+ ......... ..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~------~~~-~~~~~~~~~------~~ 213 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--D------AVF-DNILSRRIN------WP 213 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--H------HHH-HHHHhcccC------CC
Confidence 2234578899999999888889999999999999999999999853211 0 011 111111100 00
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
.......+..+.+++.+||+.+|++|||+.++.+.|.
T Consensus 214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0111234567899999999999999998876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=279.68 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=188.9
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCC------cce
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETE------VPL 105 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~------~~~ 105 (331)
.+...+.||+|+||.||+|.. .+|+.|||| +|+|||++++.=.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 345567899999999999995 689999999 4899999998865544 468
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC--CCCc--EEEeec
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD--ERYR--AKVADF 181 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~--~~~~--~kl~Df 181 (331)
+|||||.||||...+.+- .+...+++...+.++.++..||.|||+++ |+||||||.||++- .+|+ .||+||
T Consensus 94 lvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecc
Confidence 999999999999999873 44457999999999999999999999988 99999999999994 3343 699999
Q ss_pred cCcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 182 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
|.|+.+..+. ...+++||+.|++||+... ..|+..+|.|||||++|+++||..||...+....-.. ..+....-.
T Consensus 169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~--~~~~~~tkk 244 (732)
T KOG4250|consen 169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE--IMWHIITKK 244 (732)
T ss_pred cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch--hhhhhhccC
Confidence 9999765443 6677899999999999984 8899999999999999999999999976544321100 001111111
Q ss_pred cCccccccchH----------hh--ccCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhhhhc
Q 020102 261 KNRLYDILDDQ----------VM--KLGKKNQIMAFANLAERCLDLNGKKRP--TMEEVSMELNGIRGS 315 (331)
Q Consensus 261 ~~~~~~~~~~~----------~~--~~~~~~~~~~~~~li~~cL~~~p~~RP--s~~evl~~L~~l~~~ 315 (331)
...+.-..... ++ -...+.....+-..+..+|..+|++|- ...+....+.+|...
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11111111111 11 111233445567789999999999998 777887777776543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=265.69 Aligned_cols=218 Identities=23% Similarity=0.315 Sum_probs=173.3
Q ss_pred eecCCCCeEEEEEEe-cCCcEEEEcc-----------------------------cccchhhhcccccCCcceeEeeccc
Q 020102 63 ILGQGGQGTVYKGMR-EDGRIIAVKK-----------------------------SKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 63 ~lg~G~~g~V~~~~~-~~~~~vavK~-----------------------------~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.||+|+||.||+|.+ .+++.||+|. ||+++.+.+.+.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999987 4588999992 5788888888888899999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
|++|.+.+.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 9999887754 246899999999999999999999988 9999999999999999999999999987543221
Q ss_pred eeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.....|+..|+|||.+.+. .++.++||||+||++|+|++|+.||.......... ........
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~~--------- 214 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE------IDRMTLTM--------- 214 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH------HHHHhhcc---------
Confidence 1234689999999998754 68899999999999999999999996542211100 00000000
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSM 307 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~ 307 (331)
....+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 215 -~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 -AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0111222356799999999999999999 8989875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=262.78 Aligned_cols=238 Identities=23% Similarity=0.296 Sum_probs=176.1
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC--CcceeEee
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET--EVPLLVYE 109 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~--~~~~lv~e 109 (331)
|.+.+.||+|+||.||+|.+ .++..||+| .|+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999987 468888998 278999999999887 88999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|++ +++.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 5887777642 246899999999999999999999988 999999999999999 9999999999976543
Q ss_pred CCceeeeeccccCCccChhhhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-------cchHHHHHHHhhc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN-------VSLAAYFVHSMRK 261 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~ 261 (331)
... .....++..|+|||.+. +..++.++||||+||++|||++|..||.......... .....+ ......
T Consensus 152 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 228 (282)
T cd07831 152 KPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRK 228 (282)
T ss_pred CCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcc
Confidence 222 12245788999999764 4557889999999999999999999985432110000 000000 000000
Q ss_pred CccccccchHh----hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 262 NRLYDILDDQV----MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 262 ~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
........+.. ........+..+.+++.+||+.+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000 00112245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=261.80 Aligned_cols=226 Identities=24% Similarity=0.386 Sum_probs=181.6
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|.+.+.||+|+||.||+|... ++..+|+| +|+|++++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999974 57888888 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc-EEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR-AKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~-~kl~Dfg~a~~~~~ 189 (331)
+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++. ++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999988652 2335799999999999999999999988 999999999999998864 69999999876543
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
... ......|++.|+|||...+..++.++|+||||+++++|++|..||.... ......... ....
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~----- 219 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKIC-QGYF----- 219 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHh-cccC-----
Confidence 222 2223458899999999988889999999999999999999999985321 011111111 1111
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
....+..+..+.+++.+||+.+|++|||+.++++
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 ----APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112334567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=274.26 Aligned_cols=241 Identities=25% Similarity=0.352 Sum_probs=191.2
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.+...+.++||+|-||.|.++.-..+..||+| +||||+.++++|..++.+++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 35567889999999999999998888999999 599999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++|+|.+++.... .. .+.-..-..|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++.+..+
T Consensus 617 mEnGDLnqFl~ahe--ap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 617 MENGDLNQFLSAHE--LP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HhcCcHHHHHHhcc--Cc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999998731 11 1334455679999999999999998 999999999999999999999999999976655
Q ss_pred Cceee-eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 191 QTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 191 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
..... ...+-..+|||||.+.-++++.++|+|+||+++||+++ ...||....+ + ..........+.+.....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e---~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--E---QVVENAGEFFRDQGRQVV 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--H---HHHHhhhhhcCCCCccee
Confidence 54333 23455789999999999999999999999999999865 6788754311 1 111112222222222211
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
+ ..+.-++..+.+++..||..+.++|||++++...|+..
T Consensus 766 l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 L------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred c------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 22445667889999999999999999999999988764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=278.16 Aligned_cols=228 Identities=26% Similarity=0.388 Sum_probs=181.5
Q ss_pred CCccCceecCCCCeEEEEEEecCCcEE-EEc-----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 57 HFNVNRILGQGGQGTVYKGMREDGRII-AVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~~~~~v-avK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.+.++..||-|+||.||+|..++...+ |-| .||+||++++.|..++.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 456788999999999999987543332 333 49999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
||.+...+.. .+.++.+.++.-++.|++.||.|||+++ |+|||||..|||++-+|.++|+|||.+.... ...
T Consensus 113 GGAVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STR 184 (1187)
T ss_pred CchHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-hHH
Confidence 9999877665 2458999999999999999999999998 9999999999999999999999999875321 122
Q ss_pred eeeeeccccCCccChhhh-----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 193 HVTTKIQGTFGYLDPEYH-----QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
....++.|||.|||||+. ...+|+.++||||||++|.||..+.+|-... ....... .+.....+.+
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--------npMRVll-KiaKSePPTL 255 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLL-KIAKSEPPTL 255 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--------chHHHHH-HHhhcCCCcc
Confidence 234567899999999964 4568999999999999999999998885321 1111111 1111222111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+..++..|.+|+..||..||..||++.++++.
T Consensus 256 -------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 -------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2356788899999999999999999999999765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=292.90 Aligned_cols=234 Identities=27% Similarity=0.374 Sum_probs=193.0
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc--------------------------cccchhhhcccccCC
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK--------------------------SKNAVKLLGCCLETE 102 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~--------------------------~~niv~~~~~~~~~~ 102 (331)
++......|.++++||+|+||.|..+.. .+++.||.|. .+-|++++-.|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 4455568899999999999999999987 5688899993 347899999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
++|+||||++||+|...+.++ + .++++.+..++..|+-||.-+|+.| +|||||||+|||+|..|++||+|||
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~----~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF----D-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc----C-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999988864 2 6999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVH 257 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 257 (331)
.+..+..++.-.....+|||.|.+||++.. +.|+..+|.||+||++|||+.|..||+.. .+...+..
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------slveTY~K 292 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------SLVETYGK 292 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------HHHHHHHH
Confidence 998888777777777899999999998753 56889999999999999999999999753 12233333
Q ss_pred HhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 020102 258 SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT---MEEVSM 307 (331)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs---~~evl~ 307 (331)
.+.......++ .....++...+||+..+. +|+.|.. ++++-.
T Consensus 293 Im~hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 293 IMNHKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred HhchhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 33332222222 234477889999999885 6777876 777644
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.32 Aligned_cols=230 Identities=26% Similarity=0.405 Sum_probs=178.4
Q ss_pred HhcCCccCceecCCCCeEEEEEEecC-CcEEEEcc-------------------------cccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRED-GRIIAVKK-------------------------SKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~-------------------------~~niv~~~~~~~~~~~~~lv 107 (331)
..++|.+.+.||+|+||.||+|.+.+ +..||||. |+|++++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34668889999999999999999854 88899982 78999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|||+. +++.+.+... ..++++..+..++.|++.|++|||+ .+ ++|+||+|+||++++++.++|+|||++..
T Consensus 93 ~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 93 MELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 99985 5676655431 2378999999999999999999997 46 99999999999999999999999999876
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
+..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||....... .........
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~- 234 (296)
T cd06618 165 LVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-------EVLTKILQE- 234 (296)
T ss_pred ccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-------HHHHHHhcC-
Confidence 543221 12234788999999887654 7889999999999999999999985421110 011111111
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... .....++..+.+++.+||+.+|.+|||++++++.
T Consensus 235 ~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 235 EPPSL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11000 0111345678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.83 Aligned_cols=243 Identities=23% Similarity=0.300 Sum_probs=180.4
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
+|++.+.||.|++|.||+|.+. ++..||+| .|+|++++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999984 68889998 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
+ ++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 D-KDLKKYMDTH--GVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred C-ccHHHHHHhc--CCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 8 5888877652 22346899999999999999999999988 9999999999999999999999999987543322
Q ss_pred ceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc-------hHHHHHHHhhc--
Q 020102 192 THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS-------LAAYFVHSMRK-- 261 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~-- 261 (331)
. ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||............ ....+......
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 11223578899999987664 5688999999999999999999998643221100000 00000000000
Q ss_pred --CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 262 --NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 262 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
........ .......+..+..+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCCh-HHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0011112234567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=272.43 Aligned_cols=245 Identities=22% Similarity=0.280 Sum_probs=182.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC-----Cc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET-----EV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~-----~~ 103 (331)
.++|.+.+.||+|+||+||+|.+ .++..||+| .|+|++++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999999987 468899998 378999999988654 34
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++|+||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999996 688777754 246899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh--
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR-- 260 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 260 (331)
+....... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... . ..........
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~----~~~~~~~~~~~~ 228 (337)
T cd07858 155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-H----QLKLITELLGSP 228 (337)
T ss_pred ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-H----HHHHHHHHhCCC
Confidence 97654322 22233457889999998765 46889999999999999999999998543110 0 0000000000
Q ss_pred ---------cCcc-------ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhc
Q 020102 261 ---------KNRL-------YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIRGS 315 (331)
Q Consensus 261 ---------~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~~~ 315 (331)
.... ........ ....+..+..+.+++.+||+.+|++|||++++++. +..+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0000 00000000 01122356778999999999999999999999887 6655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=263.58 Aligned_cols=235 Identities=26% Similarity=0.320 Sum_probs=183.8
Q ss_pred CCccCceecCCCCeEEEEEEe----cCCcEEEEc----------------------------ccccchhhhcccccCCcc
Q 020102 57 HFNVNRILGQGGQGTVYKGMR----EDGRIIAVK----------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK----------------------------~~~niv~~~~~~~~~~~~ 104 (331)
+|.+.+.||+|++|.||++.+ .++..||+| .|+|++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999975 356778888 267999999999989999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999888764 236889999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
...............|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||........ ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~- 227 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRILKS- 227 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHHcc-
Confidence 765433322223345889999999987765 78899999999999999999999854321110 00111111100
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
....+...+..+.+++.+||+.+|++|||+.++.+.|+...-
T Consensus 228 ----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 228 ----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred ----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 011122344578899999999999999999988888876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=269.08 Aligned_cols=226 Identities=26% Similarity=0.324 Sum_probs=183.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc--------------------------cccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK--------------------------SKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~--------------------------~~niv~~~~~~~~~~~~~lv 107 (331)
-+.|..-++||+||||.||-+.. .+|+.+|.|+ .+.||.+--.+...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 36788889999999999999976 5789999883 45788887788889999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
+..|+||+|.-+|.. ..+..+++..+..++.+|+.||.+||+.+ ||.||+||+|||+|+.|++.|+|+|+|..+
T Consensus 264 LtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999887765 23357999999999999999999999998 999999999999999999999999999877
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
..... ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||.....-. .... +....
T Consensus 338 ~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----k~eE-vdrr~-------- 402 (591)
T KOG0986|consen 338 PEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----KREE-VDRRT-------- 402 (591)
T ss_pred CCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----hHHH-HHHHH--------
Confidence 65443 333479999999999999999999999999999999999999996432111 0000 10000
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTME 303 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~ 303 (331)
.. .....+..+++++.++++..|+.||++|....
T Consensus 403 ~~--~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 403 LE--DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hc--chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 00 11223567788999999999999999997543
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=267.64 Aligned_cols=223 Identities=30% Similarity=0.452 Sum_probs=177.5
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
..|.+.+.||+|+||+||+|... +++.||+| .|||++++++++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999874 68889988 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+. |++.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 6776666431 236899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.. ....+++.|+|||++. ...++.++||||||+++|||++|..||....... .. ........
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~-~~~~~~~~- 231 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------AL-YHIAQNDS- 231 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HH-HHHhcCCC-
Confidence 22 2245788999999874 4568889999999999999999999986431100 00 00111111
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......++..+.+++.+||+.+|++|||+.+++..
T Consensus 232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111123356679999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=253.44 Aligned_cols=229 Identities=27% Similarity=0.396 Sum_probs=177.5
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~~~~~~lv~e 109 (331)
+..+.+..||.|+.|+||++.. .+|...|||. .|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3445667899999999999987 4688999993 4799999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
.|. ..+...+.. -..++++..+-++...++.||.||-++. +|+|||+||+|||+|+.|++||||||++-.+..
T Consensus 172 lMs-~C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHH-HHHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 984 334444433 2357999999999999999999998853 499999999999999999999999999976654
Q ss_pred CCceeeeeccccCCccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
... .+...|.+.|||||.+... .|+.++||||||++++||.||+.||..-..... . ....+. +..
T Consensus 245 SkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe---~----ltkvln-~eP-- 312 (391)
T KOG0983|consen 245 SKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE---V----LTKVLN-EEP-- 312 (391)
T ss_pred ccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH---H----HHHHHh-cCC--
Confidence 332 2334689999999977543 588899999999999999999999965322211 1 111111 111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
+.++. ...++.+|++|+..||+.|+.+||...++++.
T Consensus 313 ---P~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 ---PLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---CCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11111 12278899999999999999999999999764
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=271.92 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=180.4
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccC-----Ccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLET-----EVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~-----~~~ 104 (331)
+++|.+.+.||+|+||.||+|.+ .++..||+| +|+|++++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999987 468899999 378999999876543 347
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++++||+. +++.+.+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 99999997 577666643 36899999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCce--eeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 185 KFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 185 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
......... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ........+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~~~~ 228 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGVLGT 228 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCC
Confidence 755332211 1123467899999998654 568899999999999999999999985432100 00000000000
Q ss_pred C---ccccccchH-------hh-------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhc
Q 020102 262 N---RLYDILDDQ-------VM-------KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIRGS 315 (331)
Q Consensus 262 ~---~~~~~~~~~-------~~-------~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~~~ 315 (331)
. .+..+.... .. ....+..+..+.+++.+||+.+|++|||+.|+++. +....+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0 000000000 00 00012235678999999999999999999999887 6555543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=265.00 Aligned_cols=224 Identities=25% Similarity=0.378 Sum_probs=179.2
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
|...+.||+|++|.||++.+ .+++.+++| .|+|++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 34457899999999999987 468889998 378999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+.+.. ..+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 101 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 101 GALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 999988764 35889999999999999999999998 99999999999999999999999998875443222
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... .... ...........
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~-~~~~~~~~~~~------ 235 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAM-KRIRDNLPPKL------ 235 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHH-HHHHhcCCCCC------
Confidence 22234588999999999988899999999999999999999999864211 0001 11111110000
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
......+..+.+++.+||+.+|++|||+.++++
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 011224567999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=268.39 Aligned_cols=240 Identities=25% Similarity=0.322 Sum_probs=177.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC--Cccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET--EVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~--~~~~l 106 (331)
.++|++.+.||+|+||.||+|.+ .+++.||+| +|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46789999999999999999997 468899999 377999999988754 46899
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+. ++|.+.+... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 86 v~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence 999997 5787777642 246899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC---
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN--- 262 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 262 (331)
....... .....+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||........ . ..........
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~----~-~~~~~~~~~~~~~ 231 (309)
T cd07845 158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ----L-DLIIQLLGTPNES 231 (309)
T ss_pred cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHHHhcCCCChh
Confidence 5433211 122345788999998865 4578999999999999999999999864321100 0 0000000000
Q ss_pred c-----------cccccchHhh--ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 R-----------LYDILDDQVM--KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 ~-----------~~~~~~~~~~--~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .......... .......+..+.+++.+||+.||++|||++|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000000000 00011235678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=259.44 Aligned_cols=228 Identities=29% Similarity=0.415 Sum_probs=185.7
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|.+.+.||+|+||.||++.+. ++..+++| +|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999984 68889998 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+.+..... ....+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999998876421 2357899999999999999999999998 999999999999999999999999999765443
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
. .......|++.|+|||...+..++.++|+||+|+++++|++|+.||..... ........ .....
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~----- 221 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKIL-KGQYP----- 221 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHh-cCCCC-----
Confidence 2 223334688999999999988899999999999999999999999854321 11111111 11111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 222 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 ----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 112244567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=263.74 Aligned_cols=237 Identities=23% Similarity=0.291 Sum_probs=177.9
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
|++.+.||.|++|+||+|.+ .++..|++| .|+|++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999987 468899998 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
+ ++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 6888887652 1236899999999999999999999988 9999999999999999999999999987553322
Q ss_pred ceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC--------
Q 020102 192 THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN-------- 262 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 262 (331)
.. .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ............
T Consensus 154 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 154 RT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ----LFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHHhhhhh
Confidence 11 1223468899999987664 568899999999999999999999864321100 000000000000
Q ss_pred -------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 -------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
......... ........+..+.+++.+||+.+|++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 229 SLPDYKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hchhhhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 01112234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=260.23 Aligned_cols=219 Identities=27% Similarity=0.309 Sum_probs=175.7
Q ss_pred ecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 64 LGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 64 lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
||.|++|.||+|.+. ++..+++| .|||++++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999984 48889998 378999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeee
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 196 (331)
.+.+... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 9988652 35889999999999999999999988 9999999999999999999999999998664332 222
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccC
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ............ ....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~ 215 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILKGNG---------KLEF 215 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhccCC---------CCCC
Confidence 3467899999999988889999999999999999999999996543200 111111111000 0111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 020102 277 KKNQIMAFANLAERCLDLNGKKRPT-----MEEVSM 307 (331)
Q Consensus 277 ~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~ 307 (331)
+...+..+.+++.+||+.+|++||| ++|+++
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2223567999999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=262.13 Aligned_cols=225 Identities=28% Similarity=0.402 Sum_probs=183.3
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------c-cccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------K-SKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~-~~niv~~~~~~~~~~~~~lv 107 (331)
++|.+.+.||+|+||.||+|... ++..|++| . |+|++++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999874 68889888 2 88999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+.+++|.+.+... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999988752 37999999999999999999999988 999999999999999999999999998765
Q ss_pred cCCCc-------------------eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc
Q 020102 188 AMDQT-------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248 (331)
Q Consensus 188 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~ 248 (331)
..... .......++..|+|||...+..++.++|+||||++++++++|..||..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~ 228 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----Y 228 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----H
Confidence 43221 112234578899999999888899999999999999999999999864421 0
Q ss_pred cchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 020102 249 VSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM----EEVSM 307 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~----~evl~ 307 (331)
..+.... .. ....+...+..+.+++.+||+.+|++|||+ +++++
T Consensus 229 ----~~~~~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 ----LTFQKIL-KL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----HHHHHHH-hc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0011111 00 011123335678999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=264.45 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=174.8
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCc-----
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEV----- 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~----- 103 (331)
.++|++.+.||+|+||.||+|.+. +++.||+| +|||++++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999974 68899998 37899999998866543
Q ss_pred ---ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 104 ---PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 104 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
.++||||+. ++|.+.+.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence 499999997 577777654 2346899999999999999999999988 99999999999999999999999
Q ss_pred ccCcccccCCCce---eeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 020102 181 FGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 181 fg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
||++......... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... ..........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~ 240 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLC 240 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHh
Confidence 9999765432221 11223567889999988665 4688999999999999999999888543211 0000000000
Q ss_pred HHhhcC--------------ccccccchHhhc-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 257 HSMRKN--------------RLYDILDDQVMK-LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 257 ~~~~~~--------------~~~~~~~~~~~~-~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...... ............ ......+..+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000 000000000000 000012346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.28 Aligned_cols=221 Identities=24% Similarity=0.306 Sum_probs=174.4
Q ss_pred ecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 64 LGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 64 lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
||+|+||+||+|.+ .+++.|++| +|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999986 468889988 378999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeee
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 196 (331)
.+.+... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ...
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 9888753 2236899999999999999999999998 9999999999999999999999999987654321 222
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccC
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
...++..|+|||.+.+..++.++|+||+||++|+|++|+.||.......... .... .... .....
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~----~~~~------~~~~~ 217 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-----ELKR----RTLE------MAVEY 217 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-----HHHh----cccc------ccccC
Confidence 3457889999999988889999999999999999999999986432211100 0000 0000 01112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 020102 277 KKNQIMAFANLAERCLDLNGKKRP-----TMEEVSM 307 (331)
Q Consensus 277 ~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~ 307 (331)
+...+..+.+++.+||+.+|++|| ++.+++.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 233466789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=265.64 Aligned_cols=221 Identities=31% Similarity=0.444 Sum_probs=174.7
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeec
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
|...+.||+|+||+||+|.+ .++..|++| .|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56667899999999999987 468889988 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+. +++.+.+.. ...++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 96 677776654 2346899999999999999999999988 99999999999999999999999998864321
Q ss_pred CceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||....... ..... .......
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--------~~~~~-~~~~~~~- 239 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHI-AQNDSPT- 239 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHH-HhcCCCC-
Confidence 22346888999999874 4568889999999999999999999986532111 00011 1111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......+..+.+++.+||+.+|.+||++.+++..
T Consensus 240 -------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122334568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=265.55 Aligned_cols=226 Identities=31% Similarity=0.453 Sum_probs=178.3
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.|...+.||+|+||.||+|.+ .++..+|+| .|+|++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 367788999999999999987 468889988 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+. |++.+.+... ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 997 5777766532 346899999999999999999999988 99999999999999999999999998864432
Q ss_pred CCceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.....+++.|+|||.+. ...++.++|+|||||++|+|++|+.||...... ....... ....
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~-~~~~-- 241 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIA-QNES-- 241 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHH-hccC--
Confidence 12345788999999873 456888999999999999999999998643110 0001111 1111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
........+..+.+++.+||+.+|.+|||+.++++.+-.+
T Consensus 242 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 ------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 1111223455789999999999999999999999865433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=268.77 Aligned_cols=241 Identities=20% Similarity=0.266 Sum_probs=174.3
Q ss_pred ceecCC--CCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQG--GQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G--~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
..||+| +||+||++.+ .+++.||+| .||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999997 478999999 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
+++.+.+.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99998887632 235889999999999999999999988 999999999999999999999999865432211111
Q ss_pred e------eeeccccCCccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc-------------hH
Q 020102 194 V------TTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS-------------LA 252 (331)
Q Consensus 194 ~------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~-------------~~ 252 (331)
. .....++..|+|||++.+. .++.++|||||||++|+|++|..||............ ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 0112346679999998764 4788999999999999999999998643211100000 00
Q ss_pred HHHHH---------------HhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 253 AYFVH---------------SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 253 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... ......................++..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 000000000001111122234567789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=253.24 Aligned_cols=225 Identities=31% Similarity=0.467 Sum_probs=181.7
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEEEcc-----------------------cccchhhhcccccCCcceeEeecccC
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVKK-----------------------SKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~-----------------------~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
|.+.+.||+|++|.||++.+. ++..+++|. |+|++++++++..+...++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 677889999999999999985 688899883 67999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
++|.+.+... ...+++..+..++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 82 GSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9998887652 247899999999999999999999988 99999999999999999999999999876654332
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .. ............
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~-~~~~~~~~~~~~----- 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--------AL-FKIATNGPPGLR----- 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--------HH-HHHHhcCCCCcC-----
Confidence 233468899999999998889999999999999999999999986432100 00 001111111111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
....++..+.+++.+||+.+|++|||+.++++
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11113567999999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=260.56 Aligned_cols=236 Identities=25% Similarity=0.324 Sum_probs=179.7
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
|.+.+.||+|++|.||+|... +++.+++| .|+|++++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999874 68889998 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
+ +++.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 D-TDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred C-CCHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 7 4887777652 247899999999999999999999988 9999999999999999999999999987665433
Q ss_pred ceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc---Cccccc
Q 020102 192 THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK---NRLYDI 267 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 267 (331)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ . ......... ..+...
T Consensus 153 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 153 R-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--L---FKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred c-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--H---HHHHHHcCCCchHhcccc
Confidence 1 12223578889999988776 788999999999999999999999854321110 0 000000000 000000
Q ss_pred cc-------------hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 268 LD-------------DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 268 ~~-------------~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.. ........+..+..+.+++..||+.+|.+||++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 00001112345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=268.63 Aligned_cols=244 Identities=21% Similarity=0.318 Sum_probs=178.5
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc----CCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE----TEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~----~~~~ 104 (331)
.++|++.+.||+|+||.||+|.+ .++..||+| .|||++++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46889999999999999999987 468899999 37899999988763 3467
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++|+||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999996 688777653 245899999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCCce---eeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-------cchHH
Q 020102 185 KFIAMDQTH---VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN-------VSLAA 253 (331)
Q Consensus 185 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~-------~~~~~ 253 (331)
......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 755432211 1123468899999998766 457899999999999999999999995432110000 00000
Q ss_pred HHHHHhhcCccccccchH------hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 254 YFVHSMRKNRLYDILDDQ------VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.........+....... ......+..+..+.+++.+||+.+|++|||+++++..
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 235 -VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred -hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000000000 0000112346789999999999999999999998774
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.74 Aligned_cols=218 Identities=26% Similarity=0.354 Sum_probs=180.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
-++|..+++||+|.||.|.++.. .+++.+|+| +||.+..+--.|...+.++.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 36789999999999999999986 579999999 477888887788899999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||..||.|.-.|.. ...+++.....+-..|+.||.|||+.+ ||.||+|.+|+++|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999888875 347899999999999999999999988 999999999999999999999999999743
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
-. ......+++|||.|+|||++....|..++|.|.+||++|||++|+.||.+.+.... +.-.+ ..+
T Consensus 319 I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL--------FeLIl-~ed---- 384 (516)
T KOG0690|consen 319 IK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL--------FELIL-MED---- 384 (516)
T ss_pred cc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH--------HHHHH-hhh----
Confidence 22 22345568999999999999999999999999999999999999999976532111 11110 000
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCC
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP 300 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP 300 (331)
...+...+.+...|+..+|..||.+|.
T Consensus 385 ------~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 ------LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ------ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 012344556788899999999999995
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=258.35 Aligned_cols=241 Identities=26% Similarity=0.366 Sum_probs=178.2
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEEEcc-------------------------cccchhhhcccccCCcceeEeecc
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVKK-------------------------SKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~-------------------------~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
|.+.+.||+|++|+||+|... +++.|+||+ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999985 578899982 889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
+++|.+.+... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 78998887652 1246899999999999999999999988 9999999999999999999999999987554322
Q ss_pred ceeeeeccccCCccChhhhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc-------chHHHHHHHhh-cC
Q 020102 192 THVTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV-------SLAAYFVHSMR-KN 262 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~-~~ 262 (331)
......++..|+|||.+. +..++.++|+||||+++++|++|+.||........... .....+..... ..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 122345788999999775 44578999999999999999999998854321110000 00000000000 00
Q ss_pred ccccccchHh---hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQV---MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~---~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.......... ........+..+.+++.+||+.+|++|||++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 00011122567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=275.09 Aligned_cols=220 Identities=23% Similarity=0.298 Sum_probs=179.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+..|.+...+|.|+|+.|-.+.+ .+++..++| .|||++++.+.+.++...++|||.+.|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 56788889999999999988876 456667777 489999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe-CCCCcEEEeeccCcccccCCCc
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL-DERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill-~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+-+.+.+... +.....+..|+.+|+.|+.|||++| |+||||||+|||+ ++.|+++|+|||.++.....
T Consensus 401 ~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 401 GELLRRIRSK------PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred cHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9887766541 2223677789999999999999999 9999999999999 68999999999999865433
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
..+.+-|..|.|||+.....+++++|+||||++||+|++|+.||...... ......+..+.
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~~~--------- 530 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQMPK--------- 530 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcCCc---------
Confidence 33335688999999999999999999999999999999999999765322 00111111111
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.....+..+.+|+.+||+.||.+||++.++..
T Consensus 531 ---~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 ---FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 12456678999999999999999999999854
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=261.93 Aligned_cols=241 Identities=24% Similarity=0.342 Sum_probs=177.8
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCC----
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETE---- 102 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~---- 102 (331)
...++|++.+.||+|+||+||+|.+. +++.||+| +|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567899999999999999999984 58889988 3789999999887654
Q ss_pred ------cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 103 ------VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 103 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
..++|+||+++ ++...+.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcE
Confidence 78999999985 67666654 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 020102 177 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
||+|||++...............++..|+|||.+.+. .++.++|||||||++++|++|+.||...... ... ..+
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~----~~~-~~~ 230 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL----AQL-ELI 230 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHH-HHH
Confidence 9999999876544332222223467889999987654 5688999999999999999999998543210 000 001
Q ss_pred HHHhhcC---ccccccc--------------hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 256 VHSMRKN---RLYDILD--------------DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 256 ~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
....... .+..+.. .... ......+..+.+++..||+.+|.+|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100000 0000000 0000 001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=259.99 Aligned_cols=237 Identities=24% Similarity=0.324 Sum_probs=177.2
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccC--CcceeEee
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLET--EVPLLVYE 109 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~--~~~~lv~e 109 (331)
|++.+.||.|+||.||+|... ++..+|+| .|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999875 57888888 378999999999887 88999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|++ ++|.+.+... ...+++..+..++.||+.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 997 4787776542 247899999999999999999999988 99999999999999999999999999986654
Q ss_pred CCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh---cCccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR---KNRLY 265 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 265 (331)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .... ...... ...+.
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~----~~~~-~~~~~~~~~~~~~~ 227 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE----QLEK-IFELCGSPTDENWP 227 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHH-HHHHhCCCchhhcc
Confidence 33222233456888999997765 457889999999999999999999986432110 0000 000000 00000
Q ss_pred c--------------ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 266 D--------------ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 266 ~--------------~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. .............++..+.+++.+||+.+|.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000111111113667899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=261.40 Aligned_cols=229 Identities=27% Similarity=0.373 Sum_probs=177.9
Q ss_pred CCccCceecCCCCeEEEEEEe----cCCcEEEEc----------------------------ccccchhhhcccccCCcc
Q 020102 57 HFNVNRILGQGGQGTVYKGMR----EDGRIIAVK----------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK----------------------------~~~niv~~~~~~~~~~~~ 104 (331)
+|++.+.||+|+||.||.+.+ .++..||+| .|+||+.+++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 368889999 267999999999888889
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++|+||+++++|.+++.. ..++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999998865 236889999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
...............|+..|+|||.+.+. .++.++||||||+++|+|++|..||....... .............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~ 228 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSE 228 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc----cHHHHHHHhhccC
Confidence 76543322222335688999999988753 46789999999999999999999985321111 1111111111100
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
...+...+..+.+++.+||+.+|++|| ++++++..
T Consensus 229 -----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011223455788999999999999997 66666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=262.41 Aligned_cols=231 Identities=25% Similarity=0.428 Sum_probs=184.7
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------ccccchhhhcccccCCcceeEeec
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
..+.|+....||+|++|.||+|.+. ++..+++| .|+|++++++.+...+..++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3566888899999999999999985 68889998 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+.+.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 97 MDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred cCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999887631 37899999999999999999999988 999999999999999999999999988654432
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ..... .........
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~-~~~~~~~~~--- 236 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFL-ITTKGIPPL--- 236 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HHhcCCCCC---
Confidence 21 222345788999999999888999999999999999999999998532110 00000 111111110
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......+..+.+++.+||+.+|..|||+.++++.
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 ----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0112245678999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=258.06 Aligned_cols=222 Identities=27% Similarity=0.362 Sum_probs=176.4
Q ss_pred ecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 64 LGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 64 lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
||+|+||.||++.+. +++.+++| .|+|++++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999985 48899999 278999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc----
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---- 192 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~---- 192 (331)
.+.+... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9988752 26899999999999999999999988 99999999999999999999999999875433211
Q ss_pred ---eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 193 ---HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 193 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.......++..|+|||...+...+.++|+||||+++|++++|..||..... ........ .+...
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~---- 219 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNIL-NGKIE---- 219 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-cCCcC----
Confidence 122334578899999999888899999999999999999999999854321 11111111 11110
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
.......+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 ----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0001112567899999999999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=258.02 Aligned_cols=226 Identities=27% Similarity=0.387 Sum_probs=178.4
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------------ccccchhhhcccccC--Ccc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------------KSKNAVKLLGCCLET--EVP 104 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------------~~~niv~~~~~~~~~--~~~ 104 (331)
.+|++.+.||+|+||.||+|.+ .++..+++| +|+|++++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999987 458889988 377999999988654 457
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++++||+++++|.+.+.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999988864 235788999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCc--eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 185 KFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 185 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
........ .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~ 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIATQP 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHHcCC
Confidence 75532111 1112345889999999999888999999999999999999999998542110 0011111000
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.....+...+..+.+++.+||+ +|..|||+.+++.
T Consensus 226 ---------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ---------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1112244556779999999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=260.80 Aligned_cols=238 Identities=23% Similarity=0.320 Sum_probs=176.8
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|++|+||+|.+. +++.|++| .|+|++++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999874 68889999 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~ 188 (331)
|++ ++|.+.+... ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 5787776542 2334688889999999999999999988 999999999999985 5579999999997553
Q ss_pred CCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... ......+++.|+|||.+.+. .++.++||||+||++|+|++|..||........ ... ...... ......
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~----~~~-~~~~~~-~~~~~~ 227 (294)
T PLN00009 155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE----LFK-IFRILG-TPNEET 227 (294)
T ss_pred CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH-HHHHhC-CCChhh
Confidence 3221 12223578899999988664 578899999999999999999999864321100 000 000000 000000
Q ss_pred c-------c---------hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 268 L-------D---------DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 268 ~-------~---------~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
+ + ........+..+..+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 00000012234567899999999999999999999976
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=257.27 Aligned_cols=237 Identities=25% Similarity=0.327 Sum_probs=178.0
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEEEc----------------------------ccccchhhhcccccCCc-----
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------------KSKNAVKLLGCCLETEV----- 103 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------------~~~niv~~~~~~~~~~~----- 103 (331)
|++.+.||+|+||.||+|.+. ++..+|+| .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999985 48889998 27899999999988776
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.+++|||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCc
Confidence 899999997 5788877642 2235899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC-
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN- 262 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 262 (331)
+........ .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...... + .............
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~ 227 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--D--QLDKIFDVIGLPSE 227 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--H--HHHHHHHHcCCCCh
Confidence 876543322 12234788999999999999999999999999999999998887542211 0 0000000000000
Q ss_pred -cccc-------ccc---hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 -RLYD-------ILD---DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 -~~~~-------~~~---~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.+.. ... ........+..+..+.+++.+||+.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 000 00001112244567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=263.74 Aligned_cols=242 Identities=19% Similarity=0.228 Sum_probs=173.9
Q ss_pred cCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 60 VNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.+.+|.|+++.|+++.. +++.||+| +|+|++++++++.+++..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455556655555544 68899999 3889999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc--
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-- 192 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-- 192 (331)
+|.+.+.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 85 SCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999887532 235889999999999999999999988 99999999999999999999999998865432111
Q ss_pred ----eeeeeccccCCccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh------
Q 020102 193 ----HVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR------ 260 (331)
Q Consensus 193 ----~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 260 (331)
.......++..|+|||++.+. .++.++|+|||||+++||++|..||....................+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 111224567889999998763 57889999999999999999999996432111000000000000000
Q ss_pred -cCccc--------cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 261 -KNRLY--------DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 261 -~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... ...............+.++.+++.+||+.+|++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 0000111122334556789999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=252.29 Aligned_cols=227 Identities=29% Similarity=0.432 Sum_probs=183.7
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccC--CcceeEe
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLET--EVPLLVY 108 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~--~~~~lv~ 108 (331)
+|...+.||+|++|.||+|.+. ++..|++| .|+|++++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999985 68889998 378999999999888 8899999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+++... ..+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999988752 27899999999999999999999988 9999999999999999999999999988665
Q ss_pred CCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 189 MDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 189 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
..... ......++..|+|||.+.+...+.++||||||+++++|++|..||...... ............
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~---- 221 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-------MAALYKIGSSGE---- 221 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHhccccCC----
Confidence 43321 123346889999999999888999999999999999999999998654310 001111110001
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
....+...+..+.+++.+||+.+|++||++.+++.
T Consensus 222 -----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 -----PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -----CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122333568999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=266.00 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=176.4
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCC------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETE------ 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~------ 102 (331)
.++|.+.+.||+|+||.||+|.+ .++..||+| .|+|++++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999997 468899998 2789999999886543
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++|+||+. .++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence 3589999986 45654432 25889999999999999999999988 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch------HHHH
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL------AAYF 255 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~------~~~~ 255 (331)
++...... .....++..|+|||.+.+ ..++.++|+|||||++|||++|+.||............. ...+
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 163 LARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 98754321 122457889999998876 468889999999999999999999996432100000000 0000
Q ss_pred HHHhhcCccccc-------cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 020102 256 VHSMRKNRLYDI-------LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIRG 314 (331)
Q Consensus 256 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~~ 314 (331)
............ ...... ...+..+..+.+++.+||+.||++|||+++++.. ++.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000000 000000 0011234568899999999999999999999865 665544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=267.05 Aligned_cols=249 Identities=27% Similarity=0.340 Sum_probs=180.5
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccC--Ccc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLET--EVP 104 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~--~~~ 104 (331)
..++|.+.+.||+|+||.||+|.+. ++..+|+| .|+|++++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567889999999999999999975 57888888 578999999988653 367
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||++ ++|...+.. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999997 588777754 26788999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCCc----eeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc------hHH
Q 020102 185 KFIAMDQT----HVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS------LAA 253 (331)
Q Consensus 185 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~------~~~ 253 (331)
........ .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||............ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 76543322 12233568899999997755 45788999999999999999999998543211100000 000
Q ss_pred HHHHHhhc---Cccccccc-h--HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 020102 254 YFVHSMRK---NRLYDILD-D--QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGI 312 (331)
Q Consensus 254 ~~~~~~~~---~~~~~~~~-~--~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l 312 (331)
.....+.. ........ . .......+..+..+.+++.+||+.+|++|||+.++++. ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00000000 00000000 0 00001112246678999999999999999999999876 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=255.76 Aligned_cols=227 Identities=21% Similarity=0.296 Sum_probs=177.8
Q ss_pred CCccCceecCCCCeEEEEEEecC-CcEE---EEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 57 HFNVNRILGQGGQGTVYKGMRED-GRII---AVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~~-~~~v---avK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
+|.+.+.||+|+||+||++.+.. +..+ ++| .|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998632 2222 222 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
+||+++++|.+.+.... .....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++. +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999998886542 23357899999999999999999999988 999999999999985 56999999998765
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ......... .+..
T Consensus 156 ~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~-~~~~--- 222 (260)
T cd08222 156 MGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIV-EGPT--- 222 (260)
T ss_pred CCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHH-cCCC---
Confidence 4322 22233457889999999988888999999999999999999999985321 001111111 1111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+..++..+.+++.+||+.+|++||++.++++
T Consensus 223 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 ------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1123355668999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=266.88 Aligned_cols=244 Identities=26% Similarity=0.350 Sum_probs=183.7
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCC-----cce
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETE-----VPL 105 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~-----~~~ 105 (331)
+|.+.+.||.|++|.||+|... ++..|++| .|+|++++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999974 58899998 3789999999988775 789
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
++|||++ ++|.+.+.. ..++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 577776654 237899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCc--eeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh---
Q 020102 186 FIAMDQT--HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM--- 259 (331)
Q Consensus 186 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 259 (331)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ ........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~~~~ 226 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-----LNLIVEVLGTP 226 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHHHhcCCC
Confidence 6644321 122334578899999999887 789999999999999999999999865421100 00000000
Q ss_pred --------hcCccccccch------HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 020102 260 --------RKNRLYDILDD------QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIRG 314 (331)
Q Consensus 260 --------~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~~ 314 (331)
........+.. .......+..+..+.+++.+||+.+|++|||+++++.. ++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000 00000112245678999999999999999999999875 555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.18 Aligned_cols=239 Identities=24% Similarity=0.293 Sum_probs=174.6
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCC------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETE------ 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~------ 102 (331)
.++|.+.+.||+|+||.||+|.+. +++.+++| +|+|++++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999974 68889998 3789999998875433
Q ss_pred --cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 103 --VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 103 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
..++|+||+. +++...+.. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence 4699999997 466665543 2346999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCCce----------eeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc
Q 020102 181 FGTSKFIAMDQTH----------VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV 249 (331)
Q Consensus 181 fg~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~ 249 (331)
||++......... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~- 237 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH- 237 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 9998755432211 11223568889999987654 57889999999999999999999985432111000
Q ss_pred chHHHHHHHhhc---------Ccccccc--------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 250 SLAAYFVHSMRK---------NRLYDIL--------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 250 ~~~~~~~~~~~~---------~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. ....... ..+.... ..... .........+.+++.+||+.+|++|||+.+++.
T Consensus 238 ---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 ---L-IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ---H-HHHHhCCCChhhchhhhhcccccccccCCCCCccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 0000000 0000000 00000 011123367889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=254.45 Aligned_cols=224 Identities=28% Similarity=0.464 Sum_probs=182.2
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+|.+.+.||+|++|.||++.+. +++.|++| .|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999874 57889998 378999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+.+... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999888652 47899999999999999999999988 999999999999999999999999999866543
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
... .....++..|+|||...+..++.++|+||+|+++++|++|..||...... .... .......
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~--~~~~~~~------ 216 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALF--RIVQDDH------ 216 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHH--HHhccCC------
Confidence 321 22345788999999998888899999999999999999999998643210 0001 0111111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 217 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 ---PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112234567899999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=234.73 Aligned_cols=240 Identities=22% Similarity=0.308 Sum_probs=181.1
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
|.-.++||+|.||+||+|.. .+++.||+| +|+|||+++++...++...+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 44457899999999999986 568999999 5889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
. +.+++++...++.++.+.+..++.|+++|+.++|+++ +.|||+||.|++|+.+|++|++|||+++.+.-+.
T Consensus 84 d-----qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 84 D-----QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred h-----HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 6 3455555566788999999999999999999999988 9999999999999999999999999999776554
Q ss_pred ceeeeeccccCCccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc--
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL-- 268 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 268 (331)
... ...+-|.+|.+|.++.|.. |+...|+||.||++.|+.....|.+.+.....+.. ..-.......+++++..-
T Consensus 156 rcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk-rif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 RCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred Eee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH-HHHHHhCCCccccCCccccC
Confidence 332 2334699999999988875 78899999999999999987777765533222111 111111111222222111
Q ss_pred -chHh-h--------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 269 -DDQV-M--------KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 269 -~~~~-~--------~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
+-.. + ....+.....-++++...|.-+|..|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1000 0 0111223334678999999999999999998865
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=274.73 Aligned_cols=231 Identities=23% Similarity=0.394 Sum_probs=189.3
Q ss_pred ccCceecCCCCeEEEEEEec--C--CcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 59 NVNRILGQGGQGTVYKGMRE--D--GRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~--~--~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
...++||+|.||.|++|.+. + .-.|||| +|+|++++||+..+ ....+|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 45578999999999999873 3 3467999 49999999999998 778999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
++.|||.+.|.+. ....+.......++.|||.|+.||.+++ +|||||...|+++...-.+||+|||+.+.+..+
T Consensus 192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999872 3346778888899999999999999998 999999999999999889999999999977655
Q ss_pred Cceeeee--ccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 191 QTHVTTK--IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 191 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
....... ..-...|+|||.+....|+.++|||+|||++|||++ |..||..-.. .++...
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------------~qIL~~ 327 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------------IQILKN 327 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------------HHHHHh
Confidence 4333211 123457999999999999999999999999999998 7888864311 122333
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
+|...+-.-+..+++++++++..||..+|.+|||+..|.+.+-..++
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 44555555678899999999999999999999999999766544433
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=262.26 Aligned_cols=223 Identities=30% Similarity=0.439 Sum_probs=175.7
Q ss_pred CCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.|...+.||+|+||+||+|.+. ++..+++| .|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999974 57788888 37799999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+. +++.+.+.. ...++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 997 677776653 1346889999999999999999999988 99999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
. ....+++.|+|||.+. ...++.++|||||||++|+|++|..||....... ..........
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~-- 231 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------ALYHIAQNES-- 231 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---------HHHHHhhcCC--
Confidence 1 2245788999999874 3467889999999999999999999985431100 0001111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
+......++..+.+++.+||+.+|++||+++++++.-
T Consensus 232 ------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 ------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1111234556789999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=260.63 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=186.3
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCC----cceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETE----VPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~----~~~lv~e 109 (331)
...++.+++|+|.||.||+|... ++.|||| +|+||+++++.-.... .++||++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34566789999999999999874 5899999 4789999998876555 7899999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA------SSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
|.+.|||.++|... .++|.....++..+++||+|||+-- +++|+|||||+.||||.++++..|+|||+
T Consensus 289 fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999873 7999999999999999999999732 56899999999999999999999999999
Q ss_pred cccccCCCc-eeeeeccccCCccChhhhcCCC-CC-----CcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch-----
Q 020102 184 SKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQ-LT-----DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL----- 251 (331)
Q Consensus 184 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~----- 251 (331)
|..+..... ...-..+||.+|||||++.+.- +. .+.||||+|.|+|||++...-++. +..+....++
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEVG 441 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHhc
Confidence 987653221 1222357999999999988753 22 367999999999999986554432 2222222111
Q ss_pred -----HHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 252 -----AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 252 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
..+..........+.+.+.=. .-....-+++.+..||..||+.|.|+.=+.+++..+.-..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111111222222222211111 1134556899999999999999999999988888775544
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=258.38 Aligned_cols=221 Identities=25% Similarity=0.396 Sum_probs=176.1
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEcc-----------------------cccchhhhcccccCCcceeEeecccCCCHH
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVKK-----------------------SKNAVKLLGCCLETEVPLLVYEFISNGTLY 117 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK~-----------------------~~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (331)
..||+|+||.||++.. .++..||+|+ |+|++++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999987 5788999983 789999999999999999999999999998
Q ss_pred HHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeee
Q 020102 118 QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197 (331)
Q Consensus 118 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 197 (331)
+.+.. ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 106 ~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 106 DIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 86643 25789999999999999999999988 99999999999999999999999999875543221 2233
Q ss_pred ccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCC
Q 020102 198 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGK 277 (331)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (331)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... . . ........ ... .. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~---~----~~~~~~~~-~~~----~~--~~~ 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--L---K----AMKMIRDN-LPP----KL--KNL 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---H----HHHHHHhh-CCc----cc--CCc
Confidence 4588999999999888889999999999999999999999864211 0 0 00011100 000 00 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 278 KNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 278 ~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...+..+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 2234568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=252.57 Aligned_cols=202 Identities=24% Similarity=0.241 Sum_probs=165.5
Q ss_pred CCCeEEEEEEe-cCCcEEEEcc------------------cccchhhhcccccCCcceeEeecccCCCHHHHHhhhhcCC
Q 020102 67 GGQGTVYKGMR-EDGRIIAVKK------------------SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQ 127 (331)
Q Consensus 67 G~~g~V~~~~~-~~~~~vavK~------------------~~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 127 (331)
|.+|.||++.+ .+++.+|+|+ |||++++++++.+.+..+++|||+++++|.+.+...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---- 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---- 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh----
Confidence 89999999998 5688899993 689999999999999999999999999999988652
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccCh
Q 020102 128 EFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207 (331)
Q Consensus 128 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP 207 (331)
..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+...... .....++..|+||
T Consensus 80 -~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aP 151 (237)
T cd05576 80 -LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAP 151 (237)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCC
Confidence 35899999999999999999999988 999999999999999999999999987654322 1223457789999
Q ss_pred hhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHH
Q 020102 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANL 287 (331)
Q Consensus 208 E~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (331)
|...+..++.++|+||+||++|||++|..|+........ .. .....+...+..+.++
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~~---------~~~~~~~~~~~~~~~l 208 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------TH---------TTLNIPEWVSEEARSL 208 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------cc---------cccCCcccCCHHHHHH
Confidence 999888889999999999999999999988643211000 00 0001123345678999
Q ss_pred HHHhhccCCCCCCCHH
Q 020102 288 AERCLDLNGKKRPTME 303 (331)
Q Consensus 288 i~~cL~~~p~~RPs~~ 303 (331)
+.+||+.||++|||+.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=268.77 Aligned_cols=227 Identities=26% Similarity=0.346 Sum_probs=190.7
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcc
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.......|.+...||+|.|+.|.+|.. .++..|||| .|||||+++.+......+
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 345567899999999999999999987 569999999 499999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
|+||||+.+|.+++++... +...+..+..++.|+..|++|||+++ |+|||||++|||++.+.++||+|||++
T Consensus 131 ylV~eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred EEEEEeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccc
Confidence 9999999999999999862 35666888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
..+.. .....+.+|++.|.|||++.+..+ .+.+|+||+|+++|-|+.|..||....-
T Consensus 203 ~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------------- 260 (596)
T KOG0586|consen 203 TFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------------- 260 (596)
T ss_pred eeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------------
Confidence 87763 334456789999999999999876 4689999999999999999999964311
Q ss_pred cccccchHhhc--cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 264 LYDILDDQVMK--LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 264 ~~~~~~~~~~~--~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+-.+.+.+ -.+...+.++.++++++|-.+|.+|++++++++.
T Consensus 261 -k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 261 -KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111111 1233345578899999999999999999999764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=280.34 Aligned_cols=242 Identities=20% Similarity=0.266 Sum_probs=163.5
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-C----CcEEEEcccc-------------------cchhhhcc------cccCCc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-D----GRIIAVKKSK-------------------NAVKLLGC------CLETEV 103 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~-------------------niv~~~~~------~~~~~~ 103 (331)
..++|.+.+.||+|+||.||+|.+. + +..||+|+.. ++..+... ...+..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 4578999999999999999999974 4 6899999632 11111111 134567
Q ss_pred ceeEeecccCCCHHHHHhhhhc---------C------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCE
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQ---------N------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNI 168 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~---------~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Ni 168 (331)
.++|+||+++++|.+.+..... . .........+..++.||+.||.|||+.+ |+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHE
Confidence 8999999999999988864210 0 0011123456789999999999999988 99999999999
Q ss_pred EeCC-CCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCC----------------------CCCCcchHHHHH
Q 020102 169 LLDE-RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS----------------------QLTDKSDVYSFG 225 (331)
Q Consensus 169 ll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslG 225 (331)
|++. ++.+||+|||+|+.+............+|+.|+|||.+... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 68999999999986654444444556789999999965322 234567999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC--cc---ccccchH----hh--ccCCHHHHHHHHHHHHHhhcc
Q 020102 226 VVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN--RL---YDILDDQ----VM--KLGKKNQIMAFANLAERCLDL 294 (331)
Q Consensus 226 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~----~~--~~~~~~~~~~~~~li~~cL~~ 294 (331)
|++|||+++..|+... ... +...+... .. .....+. .. ............+|+.+||+.
T Consensus 367 viL~el~~~~~~~~~~------~~~----~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 367 LIFLQMAFPNLRSDSN------LIQ----FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHhCcCCCchH------HHH----HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999876553211 000 00000000 00 0000000 00 000111123456899999999
Q ss_pred CCCCCCCHHHHHHH
Q 020102 295 NGKKRPTMEEVSME 308 (331)
Q Consensus 295 ~p~~RPs~~evl~~ 308 (331)
||++|||+.|+++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.31 Aligned_cols=248 Identities=24% Similarity=0.304 Sum_probs=179.5
Q ss_pred ChHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc
Q 020102 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE 100 (331)
Q Consensus 47 ~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~ 100 (331)
...++....++|.+.+.||+|+||.||+|.+ .++..||+| +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456677789999999999999999999986 568899999 37899999988754
Q ss_pred C------CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 020102 101 T------EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY 174 (331)
Q Consensus 101 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~ 174 (331)
. ...+++++++ +++|.+.+.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 3 3467788876 6888776643 25899999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch--
Q 020102 175 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL-- 251 (331)
Q Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~-- 251 (331)
.++|+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 158 ~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 158 ELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred CEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999875432 1223457889999998766 467889999999999999999999985432110000000
Q ss_pred ----HHHHHHHhhcCccccccc--hHhhc----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 252 ----AAYFVHSMRKNRLYDILD--DQVMK----LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 252 ----~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......+.......... +..+. ......+..+.+++.+||+.+|.+|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000000000 00000 0001234568899999999999999999999765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=264.74 Aligned_cols=242 Identities=24% Similarity=0.308 Sum_probs=178.1
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEcc-------------------------cccchhhhcccccCCc---
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKK-------------------------SKNAVKLLGCCLETEV--- 103 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~-------------------------~~niv~~~~~~~~~~~--- 103 (331)
...++|.+.+.||+|++|.||+|.+. ++..||+|. |+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999984 578899983 7799999988876654
Q ss_pred ---ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 104 ---PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 104 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
.++|+||+ +++|.+.+.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 5788887754 36899999999999999999999988 99999999999999999999999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc------hHH
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS------LAA 253 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~------~~~ 253 (331)
||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............ ...
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 9998765332 223457889999998765 36788999999999999999999998643211000000 000
Q ss_pred HHHHHhhcCccccccchHhh------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 254 YFVHSMRKNRLYDILDDQVM------KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.....+........+..... .......+..+.+++.+||+.+|++|||+.+|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000000000 00011236679999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=262.81 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=172.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccC---------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLET--------- 101 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~--------- 101 (331)
..+|.+.+.||.|+||.||+|.+ .++..||+| +|||++++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999998 468889998 378999999876654
Q ss_pred -----CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCc
Q 020102 102 -----EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYR 175 (331)
Q Consensus 102 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~ 175 (331)
...++|+||++ ++|.+.+.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCce
Confidence 34789999997 588776643 36889999999999999999999988 99999999999998 4567
Q ss_pred EEEeeccCcccccCCCce--eeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH
Q 020102 176 AKVADFGTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 176 ~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~ 252 (331)
++|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 899999998754321111 1122357889999997654 5678899999999999999999999964321110000000
Q ss_pred --------------HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 253 --------------AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 253 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
............ . ..... .......+..+.+++.+||+.+|++|||+++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGG-E-PRRPL-RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhccc-c-cCCCH-HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000000000 0 00000 00111244678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=250.93 Aligned_cols=240 Identities=27% Similarity=0.324 Sum_probs=178.3
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
|+..+.||+|++|.||+|... +++.+++| .|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999984 58899998 3789999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
+ ++|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 8 5898888752 146899999999999999999999998 9999999999999999999999999987654332
Q ss_pred ceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc-------chHHHHHHHh----
Q 020102 192 THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV-------SLAAYFVHSM---- 259 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~---- 259 (331)
. ......++..|+|||.+.+. .++.++|+|||||+++||++|..||........... .....+....
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 2 12223457789999988776 788999999999999999999888854321100000 0000000000
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
............. ....+..+..+.+++..||+.+|++||++++++.
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 0111123567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=260.26 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=172.3
Q ss_pred CCccCceecCCCCeEEEEEEec-C--CcEEEEc--------------------------ccccchhhhccccc----CCc
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-D--GRIIAVK--------------------------KSKNAVKLLGCCLE----TEV 103 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK--------------------------~~~niv~~~~~~~~----~~~ 103 (331)
+|.+.+.||+|+||.||++.+. + +..||+| .|||++++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999974 3 6788998 27899998886533 245
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++++||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 678888886 688877753 346899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCce---eeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-------cchH
Q 020102 184 SKFIAMDQTH---VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN-------VSLA 252 (331)
Q Consensus 184 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~-------~~~~ 252 (331)
+......... ......||..|+|||.+.+ ..++.++|+||+||++|+|++|..||.......... ....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9765432211 1223468999999998765 468899999999999999999999986432100000 0000
Q ss_pred HHHHHHhhcCcccccc------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 253 AYFVHSMRKNRLYDIL------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....... ........ .........+..+..+.+++.+||+.+|++|||+.+++..
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIG-SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhh-hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00000000 0000000111234578999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=252.55 Aligned_cols=233 Identities=25% Similarity=0.314 Sum_probs=181.1
Q ss_pred ccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhcccccCCcceeEeeccc
Q 020102 59 NVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
+-+..||.|+||+|++..+ ++|+..|||+ .||||+++|.+..+..+|+.||+|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3457899999999999986 6799999995 4699999999999999999999996
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
.|+..+.+.....+...++++..-.|....+.||.||-+.- .|+|||+||+|||++..|.+||||||.+-.+...
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 78877665555555667999999999999999999998743 4999999999999999999999999998755432
Q ss_pred eeeeeccccCCccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 193 HVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
...+.-.|...|||||.+... .|+.++||||||+++||+.||..|+....+..+ ..... -.++.+.+..+
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe-------ql~~V-v~gdpp~l~~~ 293 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE-------QLCQV-VIGDPPILLFD 293 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH-------HHHHH-HcCCCCeecCc
Confidence 222334588999999977543 488999999999999999999999865422110 01111 11222222211
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....+++..+..++.-||-.|...||...++.+.
T Consensus 294 ----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 ----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1123577789999999999999999999998664
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=258.34 Aligned_cols=241 Identities=24% Similarity=0.299 Sum_probs=177.3
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCC---
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETE--- 102 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~--- 102 (331)
-...++|.+.+.||+|+||.||+|.+ .++..||+| .|+||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999986 468899999 3789999999887654
Q ss_pred ---cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEe
Q 020102 103 ---VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179 (331)
Q Consensus 103 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~ 179 (331)
..++||||+ +++|.+.+.. ..+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 348999998 6788776643 36899999999999999999999988 9999999999999999999999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc------chH
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV------SLA 252 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~------~~~ 252 (331)
|||++...... .....+++.|+|||.+.+ ..++.++|+|||||++|++++|..||........... ...
T Consensus 161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 161 DFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99998754322 123457889999998876 4578899999999999999999999864321100000 000
Q ss_pred HHHHHHhhcCcc-------ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 253 AYFVHSMRKNRL-------YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 253 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...+..... ....... ........+..+.+++.+||+.||++|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKD-FRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcch-HHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 0000000 00111234556889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=250.96 Aligned_cols=275 Identities=23% Similarity=0.348 Sum_probs=198.5
Q ss_pred cCchhhHHhhhhcCCCccCcccccChHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------
Q 020102 23 NGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------- 86 (331)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------- 86 (331)
+++..++.++.....| ++.+-.+.---.....+..+.+.||+|.||.||+|.+ -|+.||||
T Consensus 180 ~~~stl~Dll~~~~tS--GSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEI 256 (513)
T KOG2052|consen 180 AGDSTLKDLLDDLETS--GSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEI 256 (513)
T ss_pred cCCccHHHHHHhhccC--CCCCCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHH
Confidence 4555666666433211 1112222223344567788899999999999999987 48899999
Q ss_pred ------ccccchhhhcccccCC----cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh----
Q 020102 87 ------KSKNAVKLLGCCLETE----VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS---- 152 (331)
Q Consensus 87 ------~~~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---- 152 (331)
+|+||+.+++.-..++ .++||++|.+.|||+++|.. ..++-+...+++..+|.||++||-
T Consensus 257 YqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~G 330 (513)
T KOG2052|consen 257 YQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVG 330 (513)
T ss_pred HHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhc
Confidence 6999999998865443 47999999999999999986 278899999999999999999995
Q ss_pred -cCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce---eeeeccccCCccChhhhcCCC----C--CCcchHH
Q 020102 153 -AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSSQ----L--TDKSDVY 222 (331)
Q Consensus 153 -~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~~Diw 222 (331)
+|++.|+|||||+.||||..+|...|+|+|+|......... ..+..+||-+|||||++...- + -..+|||
T Consensus 331 TqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIY 410 (513)
T KOG2052|consen 331 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIY 410 (513)
T ss_pred CCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHH
Confidence 67889999999999999999999999999999765443221 123457999999999886542 2 2368999
Q ss_pred HHHHHHHHHHhC----------CCCCCCCCCCcccccchHHHHH-HHhhcCccccccchHhhccCCHHHHHHHHHHHHHh
Q 020102 223 SFGVVLVELLTG----------KKPIFSAGNTSQENVSLAAYFV-HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERC 291 (331)
Q Consensus 223 slG~il~el~~g----------~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 291 (331)
|||.|+||+... +.||.+.-..+.........+. ..++ . ...+.....+....+.++++.|
T Consensus 411 afgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~R-P-------~ipnrW~s~~~l~~m~klMkeC 482 (513)
T KOG2052|consen 411 AFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLR-P-------NIPNRWKSDPALRVMAKLMKEC 482 (513)
T ss_pred HHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccC-C-------CCCcccccCHHHHHHHHHHHHh
Confidence 999999999753 4566543211111111111000 0000 0 0011223445667789999999
Q ss_pred hccCCCCCCCHHHHHHHHHhhhh
Q 020102 292 LDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 292 L~~~p~~RPs~~evl~~L~~l~~ 314 (331)
|..+|..|-|+--+-+.|..+..
T Consensus 483 W~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 483 WYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred hcCCchhhhHHHHHHHHHHHHhc
Confidence 99999999999999999988864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=261.39 Aligned_cols=242 Identities=23% Similarity=0.295 Sum_probs=177.5
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhccccc-CCcc
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLE-TEVP 104 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~-~~~~ 104 (331)
...+++|.+.+.||+|+||.||+|.+. +++.||+| +|||++++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999874 78889998 37899999998865 5678
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++++||+ +++|.+.+.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 86 ~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 9999998 4688776653 35788889999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-------cchHHHHH
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN-------VSLAAYFV 256 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~ 256 (331)
...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.......... ........
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 754221 122457888999998765 568899999999999999999999985432100000 00000000
Q ss_pred HHhhcCccccccchH-hhc-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 257 HSMRKNRLYDILDDQ-VMK-----LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... .......... ... ...+..+..+.+++.+||+.+|++|||+++++..
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICS-ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccc-hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000 000 0011235679999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=259.20 Aligned_cols=239 Identities=23% Similarity=0.280 Sum_probs=176.3
Q ss_pred cCCc-cCceecCCCCeEEEEEEec-CCcEEEEcc-------------------------------------cccchhhhc
Q 020102 56 NHFN-VNRILGQGGQGTVYKGMRE-DGRIIAVKK-------------------------------------SKNAVKLLG 96 (331)
Q Consensus 56 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~-------------------------------------~~niv~~~~ 96 (331)
++|. +.+.||.|+||+||+|.+. +++.||+|. |+|++++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 4577999999999999974 688888882 679999999
Q ss_pred ccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 97 CCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
++...+..++||||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 9999999999999997 688887754 236889999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccccCCC-------------ceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 020102 177 KVADFGTSKFIAMDQ-------------THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAG 242 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~ 242 (331)
+|+|||++....... ........+++.|+|||.+.+. .++.++|+|||||++|+|++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987554111 1111123467889999988764 46889999999999999999999986442
Q ss_pred CCcccccchHHHHHHHhhcCc---ccccc-----------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 243 NTSQENVSLAAYFVHSMRKNR---LYDIL-----------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
... ............. +.... .+..........+..+.+++..||+.+|++|||++|++..
T Consensus 239 ~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 239 EID-----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHH-----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 110 0011111110000 00000 0000001112335678999999999999999999999763
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=278.68 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=193.4
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEec--------CCcEEEEc-------------------------ccccchhhhc
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMRE--------DGRIIAVK-------------------------KSKNAVKLLG 96 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK-------------------------~~~niv~~~~ 96 (331)
.++....+..+.+.||+|.||.|++|... ....|||| +|+|++++++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34444555567779999999999999741 15678999 4999999999
Q ss_pred ccccCCcceeEeecccCCCHHHHHhhhh---------cCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCC
Q 020102 97 CCLETEVPLLVYEFISNGTLYQHLHDRL---------QNQE--FPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165 (331)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp 165 (331)
+|...+..++|+||+..|+|..++.... .... ..++......++.||+.|+.||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998753 1111 13888999999999999999999988 99999999
Q ss_pred CCEEeCCCCcEEEeeccCcccccCCCceeeeeccc--cCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 020102 166 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG--TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAG 242 (331)
Q Consensus 166 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~ 242 (331)
+|||++.+..+||+|||+|+..............+ ...|||||.+....|+.++||||||+++|||++ |..||...
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~- 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI- 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-
Confidence 99999999999999999998655544443332233 234999999999999999999999999999998 78888531
Q ss_pred CCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 243 NTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
.....+...+..+ .+...+..++.++.+++..||+.+|++||++.++.+.+....
T Consensus 526 -------~~~~~l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 526 -------PPTEELLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -------CcHHHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1011112223332 223345566778999999999999999999999999998853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=271.04 Aligned_cols=228 Identities=26% Similarity=0.453 Sum_probs=189.1
Q ss_pred ccCceecCCCCeEEEEEEe-cCC----cEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 59 NVNRILGQGGQGTVYKGMR-EDG----RIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~-~~~----~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
+-.++||+|+||+||+|.+ .++ -+||+| .|||+++++++|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457899999999999986 333 456777 3899999999998776 889999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++|+|.+++.. ...++.....+.|..||++|+.|||++. ++||||..+||||..-..+||.|||+++.+..
T Consensus 778 ~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999976 3457888999999999999999999988 99999999999999999999999999997765
Q ss_pred CCceeee-eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 190 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 190 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
+...... ...-.+.|||-|.+....|+.++|||||||++||++| |..|++... ..++.++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~------------------~~eI~dl 912 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP------------------AEEIPDL 912 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC------------------HHHhhHH
Confidence 4433322 2233567999999999999999999999999999998 888986532 1223334
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
++...+-..++-.+.++..++.+||..|+..||+++++...+.+.
T Consensus 913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 444444556777888999999999999999999999999888764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=261.74 Aligned_cols=236 Identities=28% Similarity=0.403 Sum_probs=186.4
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc------------------------------cccchhhhcccc-c
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK------------------------------SKNAVKLLGCCL-E 100 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~------------------------------~~niv~~~~~~~-~ 100 (331)
...++|-++.+||+|||+.||+|++ .+.+.||+|. ||.||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3456788899999999999999998 6789999993 679999999986 4
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC---CCCcEE
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD---ERYRAK 177 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~---~~~~~k 177 (331)
.+.++-|+|||+|.+|.-+|+. ...+++..+..|+.||+.||.||.+.. ++|+|.||||.|||+- .-|.+|
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred cccceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeE
Confidence 5678899999999999888875 347899999999999999999999986 7899999999999995 457899
Q ss_pred EeeccCcccccCCCc------eeeeeccccCCccChhhhcCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 020102 178 VADFGTSKFIAMDQT------HVTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247 (331)
Q Consensus 178 l~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~ 247 (331)
|.|||+++.+..+.. ..+....||++|++||.+.-+ .++.++||||+|||+|.++.|+.||..... .
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--Q- 690 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--Q- 690 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--H-
Confidence 999999998765432 223446799999999976543 478899999999999999999999964311 1
Q ss_pred ccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 248 NVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+..+.+... ..+..+..+-.+.+..+||++||++.-++|....++..
T Consensus 691 --------QdILqeNTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 --------QDILQENTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --------HHHHhhhchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111112222111 12223334455667889999999999999999888764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=252.04 Aligned_cols=221 Identities=28% Similarity=0.381 Sum_probs=181.9
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCcc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.....|.++.+||+|+||.|.+|..+ +.+.+||| +-|.+++++.+|..-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 33457888999999999999999874 56778888 346889999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
|.||||+.||+|-..++.. +.+-+..+..++..|+-||-+||++| |+.||||.+||+++.+|++||+|||++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccc
Confidence 9999999999998888764 46777888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
+.--.+ ...+.+++|||.|+|||++...+|+.++|.||+|++||||+.|+.||...+.. ..+...+..+
T Consensus 498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--------elF~aI~ehn-- 566 (683)
T KOG0696|consen 498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQAIMEHN-- 566 (683)
T ss_pred cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHcc--
Confidence 742222 22345689999999999999999999999999999999999999999643211 1122221111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT 301 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs 301 (331)
...+...+.+..+++...|...|.+|..
T Consensus 567 ---------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 ---------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ---------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1235667778899999999999999953
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=253.25 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=185.6
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEcccc----------------------------cchhhhcccccCC
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKKSK----------------------------NAVKLLGCCLETE 102 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----------------------------niv~~~~~~~~~~ 102 (331)
+..+++|.+...+|+|.||.|-.+.+. .+..||||..+ -++.+.++|.-.+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 344789999999999999999999874 47899999433 3556667777888
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC----------
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---------- 172 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---------- 172 (331)
+.+||+|.+ |-|+++++.. +.-.+++...+..++.|++.++++||+.. ++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccC
Confidence 899999998 4799999976 34568999999999999999999999988 999999999999932
Q ss_pred ----------CCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 020102 173 ----------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAG 242 (331)
Q Consensus 173 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~ 242 (331)
+..++++|||.|....... ...+.|..|+|||++.+-.++..+||||+||||.|+.||..-|....
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 2358999999998654332 44678999999999999999999999999999999999999988765
Q ss_pred CCcccc------cchHHHH-HHH-----hhcCccc-----------cccch----HhhccCCHHHHHHHHHHHHHhhccC
Q 020102 243 NTSQEN------VSLAAYF-VHS-----MRKNRLY-----------DILDD----QVMKLGKKNQIMAFANLAERCLDLN 295 (331)
Q Consensus 243 ~~~~~~------~~~~~~~-~~~-----~~~~~~~-----------~~~~~----~~~~~~~~~~~~~~~~li~~cL~~~ 295 (331)
+..... .++.... ... ...+.+. ...+. ..-....+.+..++.+|+..||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 433210 0110000 000 0011000 00000 0011234456677999999999999
Q ss_pred CCCCCCHHHHHHH
Q 020102 296 GKKRPTMEEVSME 308 (331)
Q Consensus 296 p~~RPs~~evl~~ 308 (331)
|.+|+|+.|++..
T Consensus 394 P~~RiTl~EAL~H 406 (415)
T KOG0671|consen 394 PARRITLREALSH 406 (415)
T ss_pred ccccccHHHHhcC
Confidence 9999999999753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=246.56 Aligned_cols=213 Identities=30% Similarity=0.376 Sum_probs=172.7
Q ss_pred ecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 64 LGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 64 lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
||+|+||.||++.+. +++.+++| .|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999974 58889988 378999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeee
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 196 (331)
.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 151 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTN 151 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-Cccc
Confidence 9988752 36899999999999999999999988 9999999999999999999999999987654322 1223
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccC
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
...++..|+|||...+...+.++|+||||+++|++++|..||..... ......... .. ...
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~----------~~~ 212 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-DP----------LRF 212 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-CC----------CCC
Confidence 34578899999999888889999999999999999999999854321 011111111 10 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 020102 277 KKNQIMAFANLAERCLDLNGKKRPTMEE 304 (331)
Q Consensus 277 ~~~~~~~~~~li~~cL~~~p~~RPs~~e 304 (331)
+...+..+.+++.+||..+|++|||+.+
T Consensus 213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 213 PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2223567899999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=279.55 Aligned_cols=180 Identities=28% Similarity=0.377 Sum_probs=132.2
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
+||-||||+...+.+.+.... ..-..+..|.++++|+.||+|+|+.| ++||||||.||++++++.+||+|||+
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGL 743 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGL 743 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeeccccc
Confidence 478899999776666665421 11146889999999999999999999 99999999999999999999999999
Q ss_pred ccccc------C-----------CCceeeeeccccCCccChhhhcCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 020102 184 SKFIA------M-----------DQTHVTTKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFSAGN 243 (331)
Q Consensus 184 a~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~p~~~~~~ 243 (331)
|+... . ......+..+||.-|+|||++.+.. |+.|+|+||||+|++||+ .||...
T Consensus 744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~Ts-- 818 (1351)
T KOG1035|consen 744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTS-- 818 (1351)
T ss_pred chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCch--
Confidence 98621 0 0111234567999999999988765 999999999999999998 466432
Q ss_pred CcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 244 TSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.+. ......++.+.++.- .....+....=..+|.+||+.||.+|||+.|++.
T Consensus 819 --MER----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 819 --MER----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --HHH----HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 111 122333333433322 0112223334467999999999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=239.33 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=177.2
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC--------
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET-------- 101 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~-------- 101 (331)
+.|+-..++|+|.||.||+|.. ++++.||+| +|+|+++++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4455667899999999999986 568888988 489999999998643
Q ss_pred CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
..+++||.+|+ -+|.-.|.. ....++..++..++.++..||.|+|+.. |+|||+||+|+||+.+|.+||+||
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 23799999997 456665654 3356899999999999999999999987 999999999999999999999999
Q ss_pred cCcccccCCCcee---eeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 020102 182 GTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVH 257 (331)
Q Consensus 182 g~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 257 (331)
|+++.+....... .+..+-|.+|++||.+.|. .++.+.|||+.||++.||+|+.+-+. +. +......+......
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq-gn-teqqql~~Is~LcG 246 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ-GN-TEQQQLHLISQLCG 246 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc-CC-hHHHHHHHHHHHhc
Confidence 9997655433222 2234459999999987776 68999999999999999999865543 32 22333222222222
Q ss_pred HhhcCccccccchHhhccC------------CHHH------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 258 SMRKNRLYDILDDQVMKLG------------KKNQ------IMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~------------~~~~------~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......|+....-.+-... -.+. ..+..+|+..+|..||.+|+++.+++..
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 2222222222111110000 0011 2257899999999999999999999765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=270.24 Aligned_cols=122 Identities=34% Similarity=0.483 Sum_probs=111.8
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||+||+|.+. +++.|||| +|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999985 68899999 3789999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
||+.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999988652 35788999999999999999999988 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=255.59 Aligned_cols=219 Identities=25% Similarity=0.280 Sum_probs=180.0
Q ss_pred cCCccCceecCCCCeEEEEEEecCCc-EEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGR-IIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
.+++.+.-||-||||.|=+...+... .+|+| ..|.||++|..|.++...|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566778999999999888764333 36776 2468999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|-|-||.++..+.+ .+.++..++..++..+++|+.|||+++ |+.|||||+|++++.+|-+||.|||+|+.+.
T Consensus 500 EaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999987 357888999999999999999999999 9999999999999999999999999999886
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.+. .+.+++|||.|.|||++.+...+.++|.||||+++|||++|.+||...+...-.+..+...
T Consensus 572 ~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-------------- 635 (732)
T KOG0614|consen 572 SGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-------------- 635 (732)
T ss_pred cCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh--------------
Confidence 543 4566899999999999999999999999999999999999999997653322211111110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCC
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT 301 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs 301 (331)
.....+........+|++.+...+|.+|..
T Consensus 636 ---d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 636 ---DKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---hhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 111224445567889999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=236.61 Aligned_cols=233 Identities=23% Similarity=0.353 Sum_probs=177.0
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
+.||+|+|+.|-.+.. .++..+||| -|+||+.++++|.++...|||||-+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 5799999999988875 788999999 288999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---cEEEeeccCcccccCCC--
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY---RAKVADFGTSKFIAMDQ-- 191 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~-- 191 (331)
...+.++ .-+++..+..+.++|+.||.+||.+| |.|||+||+|||..... -+|||||.+..-+....
T Consensus 164 LshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 164 LSHIQKR-----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999874 36899999999999999999999999 99999999999997544 37999998765332211
Q ss_pred ----ceeeeeccccCCccChhhhc---C--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcc--cccchHHHHHHHhh
Q 020102 192 ----THVTTKIQGTFGYLDPEYHQ---S--SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSMR 260 (331)
Q Consensus 192 ----~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~ 260 (331)
+....+.+|+..|||||+.. + ..|+.++|.||||+|+|-|++|.+||.......= ............+-
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 11122356888999999643 2 3478899999999999999999999976543210 01111111111111
Q ss_pred c---CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 261 K---NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 261 ~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. ..-.++ +.......+....+++..+|..++..|-++.++++
T Consensus 316 esIQEGkYeF-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 ESIQEGKYEF-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHhccCCcC-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0 011111 11123355677889999999999999999999876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=262.89 Aligned_cols=231 Identities=26% Similarity=0.411 Sum_probs=188.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhccccc-----CCcce
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLE-----TEVPL 105 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~-----~~~~~ 105 (331)
++.|++...||.|.+|.||++.. ++++..|+| -|||++.+++++.- ++.+|
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 46688999999999999999986 567778888 38999999999853 56789
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
||||||.+||..+.++..+ +..+.|..+.-|+..++.|+.+||... ++|||||-.|||++.+|.+||+|||++.
T Consensus 98 LVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 9999999999999998754 567999999999999999999999987 9999999999999999999999999987
Q ss_pred cccCCCceeeeeccccCCccChhhhcCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
.+.. ......+..|||.|||||++... .|+.++|+||||++..||..|.+|+...- +. .......
T Consensus 172 Qlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH--Pm-------raLF~Ip 241 (953)
T KOG0587|consen 172 QLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH--PM-------RALFLIP 241 (953)
T ss_pred eeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc--hh-------hhhccCC
Confidence 6543 23334557899999999988654 47789999999999999999999986431 10 0111111
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
++ +......+...+..|.++|..||..|-+.||++.++++.
T Consensus 242 RN-------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 RN-------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CC-------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11 112222366788999999999999999999999998764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=235.43 Aligned_cols=227 Identities=23% Similarity=0.353 Sum_probs=182.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+.|.+++.||+|+|+.|..+.. ++.+.+|+| .+|.+|-+..+|..+..++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 36789999999999999999986 568889988 37789999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|.||++||+|--..+. ...++++.+..+...|..||.|||+.| |+.||||.+|||+|..|++||.|+|+++.
T Consensus 329 vieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 9999999998655554 236899999999999999999999999 99999999999999999999999999984
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
--. ....+.+++|||.|.|||++.+..|...+|.|++|++++||+.|+.||.-.+....+... .++....+...++
T Consensus 401 ~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt-edylfqvilekqi-- 476 (593)
T KOG0695|consen 401 GLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT-EDYLFQVILEKQI-- 476 (593)
T ss_pred CCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch-hHHHHHHHhhhcc--
Confidence 332 234456689999999999999999999999999999999999999999754432222111 1121111111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT 301 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs 301 (331)
..+...+-....++...|+.||.+|..
T Consensus 477 --------riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 --------RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 123344455677999999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=254.57 Aligned_cols=246 Identities=21% Similarity=0.241 Sum_probs=165.8
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-----------------cCCcEEEEcccc---------------------------
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-----------------EDGRIIAVKKSK--------------------------- 89 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~--------------------------- 89 (331)
..++|.+.++||+|+||+||+|.. .+++.||||+..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 235679999632
Q ss_pred ---------------cchhhhccccc--------CCcceeEeecccCCCHHHHHhhhhc-------------------CC
Q 020102 90 ---------------NAVKLLGCCLE--------TEVPLLVYEFISNGTLYQHLHDRLQ-------------------NQ 127 (331)
Q Consensus 90 ---------------niv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~ 127 (331)
++++++++|.. ....++||||+++++|.+++..... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 12344555432 3457999999999999998864210 01
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccCh
Q 020102 128 EFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207 (331)
Q Consensus 128 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP 207 (331)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123567889999999999999999988 99999999999999999999999999975443222222223357899999
Q ss_pred hhhcCCC----------------------CCCcchHHHHHHHHHHHHhCCC-CCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 208 EYHQSSQ----------------------LTDKSDVYSFGVVLVELLTGKK-PIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 208 E~~~~~~----------------------~~~~~DiwslG~il~el~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
|.+.... ...+.|+||+||++|+|++|.. |+......... ..........+..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~~~~~~~~r~--- 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQYDNDLNRWRM--- 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-HhhccchHHHHHh---
Confidence 9765322 1234799999999999999875 55321100000 0000000000000
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNG---KKRPTMEEVSME 308 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p---~~RPs~~evl~~ 308 (331)
...........+..+....+|+.+||..+| .+|+|++|++++
T Consensus 456 --~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 --YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000000111223345678999999999866 689999999753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-33 Score=263.01 Aligned_cols=225 Identities=28% Similarity=0.409 Sum_probs=171.7
Q ss_pred CccCceecCCCCeE-EEEEEecCCcEEEEc---------------------ccccchhhhcccccCCcceeEeecccCCC
Q 020102 58 FNVNRILGQGGQGT-VYKGMREDGRIIAVK---------------------KSKNAVKLLGCCLETEVPLLVYEFISNGT 115 (331)
Q Consensus 58 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK---------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~ 115 (331)
|.-.+++|.|+-|+ ||+|.. +++.|||| .|||||++++.-.+....||+.|.|. .+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 33446789999865 699977 68899999 39999999999999999999999996 89
Q ss_pred HHHHHhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---C--CcEEEeeccCcccccC
Q 020102 116 LYQHLHDRLQNQEFP-LTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---R--YRAKVADFGTSKFIAM 189 (331)
Q Consensus 116 L~~~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~--~~~kl~Dfg~a~~~~~ 189 (331)
|.+++... ..... ..-...+.++.|++.||++||+.+ |+||||||.||||+. + ..++|+|||+++.+..
T Consensus 589 L~dlie~~--~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 589 LQDLIESS--GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred HHHHHhcc--ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 99988762 11111 111445778899999999999998 999999999999975 3 4689999999998876
Q ss_pred CCceee--eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 190 DQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG-KKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 190 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
+..... ....||.+|+|||.+....-+.++||||+||++|+.++| .+||........ ..+....-..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------NIl~~~~~L~ 733 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------NILTGNYTLV 733 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----------hhhcCcccee
Confidence 654433 346799999999999999888899999999999999995 899965421110 0111110000
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.+ ....+. ...+||.+|++++|..||++.+|+.
T Consensus 734 ~L------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HL------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ee------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 011111 6789999999999999999999954
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=250.80 Aligned_cols=221 Identities=25% Similarity=0.339 Sum_probs=178.6
Q ss_pred CceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 61 NRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
.+.||+|-||+||-|+. ++|+.|||| .||.||++-.-|+..+..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 37899999999999987 689999999 3889999999999999999999999754
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEeeccCcccccCCC
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~ 191 (331)
-|.-.|.. ..+.+++.....++.||+.||.|||-++ |+|+||||+|||+.+ -.++||||||+|+.+..
T Consensus 649 MLEMILSs----EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-- 719 (888)
T KOG4236|consen 649 MLEMILSS----EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-- 719 (888)
T ss_pred HHHHHHHh----hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch--
Confidence 44444433 3457888888899999999999999999 999999999999974 35699999999998864
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
......++|||.|+|||++....|...-|+||.|+|+|--+.|-.||.....-.. ++ . .. .++.
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-QI---Q-------NA---aFMy-- 783 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-QI---Q-------NA---AFMY-- 783 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-Hh---h-------cc---cccc--
Confidence 3455668899999999999999999999999999999999999999964321110 00 0 00 0111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
+.....+.+...++||..+|+..-.+|.|.++-+.
T Consensus 784 -Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 784 -PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 11224456678999999999999999999887644
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=227.29 Aligned_cols=215 Identities=32% Similarity=0.407 Sum_probs=171.3
Q ss_pred CCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCCCHHHHHhh
Q 020102 68 GQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHD 122 (331)
Q Consensus 68 ~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 122 (331)
+||.||+|... +++.+++| .|+|++++++++......++++||+++++|.+.+..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999985 48889999 367999999999999999999999999999998865
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccC
Q 020102 123 RLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 202 (331)
Q Consensus 123 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~ 202 (331)
. ..+++..+..++.+++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++.
T Consensus 81 ~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 81 R-----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred c-----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 2 23889999999999999999999988 9999999999999999999999999998664432 223345788
Q ss_pred CccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHH
Q 020102 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM 282 (331)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (331)
.|+|||.+.+..++.++|+||||++++++++|..||....... .............. ......+.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--------~~~~~~~~~~~~~~-------~~~~~~~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--------ELFKKIGKPKPPFP-------PPEWKISP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--------HHHHHHhccCCCCc-------cccccCCH
Confidence 9999999988888999999999999999999999985421110 01111111111000 00000446
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 283 AFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 283 ~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.+.+++.+||..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 7999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=245.50 Aligned_cols=179 Identities=25% Similarity=0.377 Sum_probs=152.3
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEcc--------------------------cccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKK--------------------------SKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~--------------------------~~niv~~~~~~~~~~~~~lv 107 (331)
..-|..++-||-|+||.|.++... +...+|.|. .+-||++|-.|.+++++|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 456778889999999999999863 456677772 34789999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|+|++||++-.+|.+ .+-+.++.+..++..+..|+.+.|..| ++||||||+|||||.+|++||.|||++.=+
T Consensus 708 MdYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EeccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 999999999998876 347899999999999999999999999 999999999999999999999999998522
Q ss_pred ---------cCCCce--------------------------------eeeeccccCCccChhhhcCCCCCCcchHHHHHH
Q 020102 188 ---------AMDQTH--------------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGV 226 (331)
Q Consensus 188 ---------~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 226 (331)
..+... ..-..+||+.|+|||++....++..+|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 110000 001246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 020102 227 VLVELLTGKKPIFSA 241 (331)
Q Consensus 227 il~el~~g~~p~~~~ 241 (331)
|||||+.|+.||...
T Consensus 860 il~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLAD 874 (1034)
T ss_pred HHHHHhhCCCCccCC
Confidence 999999999999654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=217.30 Aligned_cols=185 Identities=28% Similarity=0.398 Sum_probs=152.8
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhcccccCCccee
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~~~~~~l 106 (331)
...+...-...||+|++|.|-+..+ .+|...|+|+ .|.+|.++|........++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3344455668899999999988876 6799999995 4688999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
.||.+. -||..+....++ .+..+++..+-+|+..++.||.|||++- .++|||+||+||||+.+|++|+||||.+-.
T Consensus 123 cME~M~-tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 123 CMELMD-TSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred eHHHhh-hhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 999996 788766655543 4568999999999999999999999965 399999999999999999999999999876
Q ss_pred ccCCCceeeeeccccCCccChhhhcCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~~g~~p~~~~~~ 243 (331)
+.+.-. .+...|.-.|+|||.+..+ .|+.++||||||+++.||.+++.||.....
T Consensus 199 L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 199 LVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred ehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 643221 1213578889999977543 689999999999999999999999976543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=214.97 Aligned_cols=241 Identities=22% Similarity=0.345 Sum_probs=177.4
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------ccccchhhhcccccC--CcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------KSKNAVKLLGCCLET--EVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------~~~niv~~~~~~~~~--~~~~lv~e~ 110 (331)
.++|++.+.+|+|.|+.||.|.. .+++.++|| .+|||+++++...+. ..+.+++||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 46799999999999999999986 567788887 278999999999874 457899999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~ 189 (331)
+++.+...... .++.-.+..++.+++.||.|||+.| |.|||+||.|++||. .-.++|+|+|+|.++..
T Consensus 117 v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 117 VNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99877655443 3677788889999999999999999 999999999999995 45699999999998765
Q ss_pred CCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH-----HHHHHHhhcC-
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA-----AYFVHSMRKN- 262 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~- 262 (331)
..... ..+.+..|--||++... .|+..-|+|||||++..|+..+.||+-+.+...+.+.+. .....-+..-
T Consensus 186 ~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Cceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 44332 23567788899987655 478899999999999999999999986543322221111 1111111110
Q ss_pred -----ccccccchH--------hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 -----RLYDILDDQ--------VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 -----~~~~~~~~~--------~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....++... ......--.+.+.++|+...|..|-.+|||+.|.+..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111111110 0111111234678999999999999999999998754
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=238.60 Aligned_cols=184 Identities=25% Similarity=0.284 Sum_probs=156.9
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEcccc----------------------------cchhhhccccc
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKKSK----------------------------NAVKLLGCCLE 100 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----------------------------niv~~~~~~~~ 100 (331)
--+..-.+|.+....|+|-|++|.+|.+. -|..||||..+ |+++++..|..
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 33455678999999999999999999984 47799999432 78899999999
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEe
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVA 179 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-~~~kl~ 179 (331)
.+++|||+|.+. .+|.+.|+.+. .+..+....+..++.|++-||..|-.++ |+|.||||+|||+++. ..+|||
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeec
Confidence 999999999995 89999999864 3446778899999999999999999999 9999999999999964 567999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAG 242 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~ 242 (331)
|||.|.....+.- +.+.-+..|.|||++.|.+|+...|+||.||+|||+.||+..|....
T Consensus 580 DfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 580 DFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 9999987654432 22334667999999999999999999999999999999999886543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=223.47 Aligned_cols=238 Identities=23% Similarity=0.302 Sum_probs=167.9
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEccccc-------------------------chhhhcccccCC-----ccee
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSKN-------------------------AVKLLGCCLETE-----VPLL 106 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~n-------------------------iv~~~~~~~~~~-----~~~l 106 (331)
.+-.+.||-|+||.||...+ ++|+.||+|+.|| ++..++.....+ ..|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 35568899999999999998 6899999997654 333333332221 2466
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
++|++. .+|...+.. ...++.+.+.-++.||++||.|||+.+ |.||||||.|+|++++..+||||||+++.
T Consensus 135 ~TELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 777775 455554432 457899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
...+.....+..+-|-.|+|||++.|. .|+.+.||||.||++.|++..+.-|...+... ........+......
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq-----QL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE-----QLQMIIDLLGTPSQE 280 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH-----HHHHHHHHhCCCcHH
Confidence 655544444555668899999998886 58999999999999999998877775432111 111111111111110
Q ss_pred c-----------ccchHhh---------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 266 D-----------ILDDQVM---------KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 266 ~-----------~~~~~~~---------~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
. ++....+ ...+.........+...++..||..|.+.++.+..+
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0 0000000 001112233467889999999999999999887654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=228.22 Aligned_cols=243 Identities=24% Similarity=0.351 Sum_probs=188.1
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccc
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~ 99 (331)
++..-..+++....+-+|.||.||.|++. +.+.|.+| .|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 44444567888889999999999999753 24445555 3899999999986
Q ss_pred c-CCcceeEeecccCCCHHHHHhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc
Q 020102 100 E-TEVPLLVYEFISNGTLYQHLHDRL---QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175 (331)
Q Consensus 100 ~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~ 175 (331)
+ ...++.++.+..-|+|..+|..-. ......++-.+...++.|++.|+.|||+.+ |+|.||..+|++||+.-+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 5 556888999999999999987221 122234666778889999999999999998 999999999999999999
Q ss_pred EEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHH
Q 020102 176 AKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAA 253 (331)
Q Consensus 176 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 253 (331)
+||+|=.+++.+-..+.. ..........||+||.+....|+.++|+||||+++|||+| |+.|+...+..
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--------- 505 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--------- 505 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---------
Confidence 999998888744222211 1122234568999999999999999999999999999998 89998654211
Q ss_pred HHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
++...+.+.-+-..+.+++.++..++.-||...|++||+++|++.-|.++-
T Consensus 506 ---------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 506 ---------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ---------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 111122223333446677889999999999999999999999999888764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=215.65 Aligned_cols=240 Identities=23% Similarity=0.306 Sum_probs=176.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------cccchhhhcccccCC------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------SKNAVKLLGCCLETE------ 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------~~niv~~~~~~~~~~------ 102 (331)
..+|.-.+.+|.|.. .|..|.+ -.++.||+|+ |+|+++++.++....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888889999998 7777766 3588899983 789999999987654
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..|+|||++. .+|...+.. .++-.++..++.|++.|+.|||+.+ |+||||||+||++..++.+||.|||
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccch
Confidence 4699999996 788777663 4677889999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc------cch-HHHH
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN------VSL-AAYF 255 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~------~~~-~~~~ 255 (331)
+|..-. .....+..+.|..|+|||++.+..+.+.+||||+||++.||++|..-|.+.+.-++-. ... ..+.
T Consensus 164 ~ar~e~--~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 164 LARTED--TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hhcccC--cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 998543 2345566778999999999999999999999999999999999988775322111100 000 0000
Q ss_pred HHHhhc----------C---ccccccchHh---hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 256 VHSMRK----------N---RLYDILDDQV---MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 256 ~~~~~~----------~---~~~~~~~~~~---~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...... . .......+.. ..+.++.....+++++.+||..+|++|.|+++++..
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000 0 0000000000 001122334457899999999999999999999764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=234.52 Aligned_cols=230 Identities=29% Similarity=0.421 Sum_probs=184.5
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.++|+..+.+|.|+||.||++.+ .+++..|+| +|+||+.+++.+......+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35788999999999999999987 567888877 599999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
|.||+|.+...- .+++++.++....+..++|++|||+.+ -+|||||-.||++++.|.+|++|||.+..+..-
T Consensus 94 cgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred cCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 999999886543 468999999999999999999999999 899999999999999999999999998765432
Q ss_pred CceeeeeccccCCccChhhh---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 191 QTHVTTKIQGTFGYLDPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
-.....+.||+.|||||+. ..+.|...+|||++|+...|+-.-+.|.+.. .+ ....+ .+......
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl--hp-----mr~l~--LmTkS~~q-- 233 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL--HP-----MRALF--LMTKSGFQ-- 233 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc--ch-----HHHHH--HhhccCCC--
Confidence 2223457899999999965 4567899999999999999998888886532 11 11111 22211110
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..........++.|-+|++.||..+|++|||++.++.
T Consensus 234 ---pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 ---PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0011123456778999999999999999999998865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=228.70 Aligned_cols=175 Identities=22% Similarity=0.364 Sum_probs=151.7
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------------------ccccchhhhcccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------------------~~~niv~~~~~~~ 99 (331)
...|...+.||.|+||.|+.|.++ +...|+|| .|+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346889999999999999999985 46678888 2889999999999
Q ss_pred cCCcceeEeeccc-CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 020102 100 ETEVPLLVYEFIS-NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV 178 (331)
Q Consensus 100 ~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl 178 (331)
+++.+||+||-.. |.+|.+++.. ...+++..+..|++||+-|+++||+++ |+|||||-+||.++.+|-+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence 9999999999764 4567777754 346899999999999999999999999 999999999999999999999
Q ss_pred eeccCcccccCCCceeeeeccccCCccChhhhcCCCCCC-cchHHHHHHHHHHHHhCCCCCCC
Q 020102 179 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFS 240 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~p~~~ 240 (331)
+|||.|.....+ ....++||..|.|||++.|.+|-. .-|||++|++||-++....||++
T Consensus 712 idfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999998765432 345578999999999999998854 56999999999999988888853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=219.02 Aligned_cols=109 Identities=28% Similarity=0.400 Sum_probs=94.2
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEccc------------------------------ccchhhhccccc----
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKS------------------------------KNAVKLLGCCLE---- 100 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~------------------------------~niv~~~~~~~~---- 100 (331)
.+|.+.++||=|-|+|||+|.+ ...+.||+|.. ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 6899999999999999999988 46788999932 279999999865
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL 170 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill 170 (331)
+.+.++|+|++ |.+|..++... .-..++...+..|++||+.||.|||+.. +|+|.||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 55789999999 68898888763 2346888999999999999999999965 39999999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=250.92 Aligned_cols=192 Identities=19% Similarity=0.194 Sum_probs=136.7
Q ss_pred ccchhhhccc-------ccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 020102 89 KNAVKLLGCC-------LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHR 161 (331)
Q Consensus 89 ~niv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 161 (331)
+||+++++.| .+...++.++|++ +++|.+++.. ....+++..+..++.||+.||.|||+++ |+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 6889999988 3334677888887 5799998864 2346899999999999999999999998 9999
Q ss_pred cCCCCCEEeCCCC-------------------cEEEeeccCcccccCCC---------------ceeeeeccccCCccCh
Q 020102 162 DIKSTNILLDERY-------------------RAKVADFGTSKFIAMDQ---------------THVTTKIQGTFGYLDP 207 (331)
Q Consensus 162 dikp~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~---------------~~~~~~~~gt~~y~aP 207 (331)
||||+||||+..| .+|++|||+++...... ........||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 45555666554321100 0001113578899999
Q ss_pred hhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHH
Q 020102 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANL 287 (331)
Q Consensus 208 E~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (331)
|++.+..++.++|||||||++|||++|..|+..... ....+... ...+. .........++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----------~~~~~~~~----~~~~~-----~~~~~~~~~~~ 244 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----------TMSSLRHR----VLPPQ-----ILLNWPKEASF 244 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----------HHHHHHHh----hcChh-----hhhcCHHHHHH
Confidence 999999999999999999999999998877532100 00000000 00000 01112345688
Q ss_pred HHHhhccCCCCCCCHHHHHHH
Q 020102 288 AERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 288 i~~cL~~~p~~RPs~~evl~~ 308 (331)
+.+||+.+|.+|||+.|+++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 999999999999999999763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=202.06 Aligned_cols=187 Identities=38% Similarity=0.593 Sum_probs=161.0
Q ss_pred ecCCCCeEEEEEEecC-CcEEEEcc------------------------cccchhhhcccccCCcceeEeecccCCCHHH
Q 020102 64 LGQGGQGTVYKGMRED-GRIIAVKK------------------------SKNAVKLLGCCLETEVPLLVYEFISNGTLYQ 118 (331)
Q Consensus 64 lg~G~~g~V~~~~~~~-~~~vavK~------------------------~~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 118 (331)
||+|++|.||++...+ ++.+++|. +++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999854 88889883 5688888888888889999999999999999
Q ss_pred HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEeeccCcccccCCCceeeee
Q 020102 119 HLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMDQTHVTTK 197 (331)
Q Consensus 119 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 197 (331)
++... ...+++..+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 81 LLKEN----EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 88752 136889999999999999999999998 999999999999999 89999999999875543321 1223
Q ss_pred ccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccC
Q 020102 198 IQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276 (331)
Q Consensus 198 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
..+...|++||..... .++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578899999998887 788999999999999998
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 277 KKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 277 ~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=218.59 Aligned_cols=244 Identities=26% Similarity=0.405 Sum_probs=177.6
Q ss_pred HhcCCccCceecCCCCeEEEEEEec----CCcEEEEcc----------------------cccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE----DGRIIAVKK----------------------SKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~----------------------~~niv~~~~~~~~~~~~~lv 107 (331)
..+.|....+||.|+|++||++.+. ..+.||+|. +.||+++.+++..++...+|
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 3467889999999999999999863 578899995 33999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~ 186 (331)
+||++.....++... ++...+..++..++.||.++|.+| |+||||||.|+|.+ ..+.-.|.|||+|..
T Consensus 114 lp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred ecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence 999999888877653 668889999999999999999999 99999999999998 456789999999962
Q ss_pred ccC----------------C-----------------C----------ceeeeeccccCCccChhhhcCCC-CCCcchHH
Q 020102 187 IAM----------------D-----------------Q----------THVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVY 222 (331)
Q Consensus 187 ~~~----------------~-----------------~----------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diw 222 (331)
... + . ........||++|+|||++...+ -+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 100 0 0 00011245999999999877654 67899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCcccccchHHH-----HHHHh-hcCc--------cccccc----------hHh------
Q 020102 223 SFGVVLVELLTGKKPIFSAGNTSQENVSLAAY-----FVHSM-RKNR--------LYDILD----------DQV------ 272 (331)
Q Consensus 223 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~-~~~~--------~~~~~~----------~~~------ 272 (331)
|.|+|++.+++++.||+...........+... ....- ..+. +..+.+ +..
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999998643332221111000 00000 0011 000000 000
Q ss_pred ---hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 273 ---MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 273 ---~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......-.+..+.+|+.+||..||.+|.|+++.++.
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 001111234468999999999999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=199.46 Aligned_cols=169 Identities=24% Similarity=0.254 Sum_probs=126.0
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|+|.+.+... +.++++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence 6788888652 346999999999999999999999865 999999999999999 99987553321
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... .......... . .
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~---~~~~-~~~~~~~~~~----~---~ 128 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA---ILEI-LLNGMPADDP----R---D 128 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH---HHHH-HHHHhccCCc----c---c
Confidence 2588999999999999999999999999999999999999854321110 0000 1111100000 0 0
Q ss_pred ccCCHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 274 KLGKKNQIM--AFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 274 ~~~~~~~~~--~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
......... .+.+++.+||+.+|++|||+.|+++.+..+..
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 011222333 68999999999999999999999999877644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=204.35 Aligned_cols=231 Identities=19% Similarity=0.295 Sum_probs=169.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-----------------------cccchhhhcc-cccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-----------------------SKNAVKLLGC-CLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-----------------------~~niv~~~~~-~~~~~~~~lv~e 109 (331)
.+.|.+.+.||+|.||.+.++.+ .+...+++|- |.||+.-+++ |...+..+.++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 57899999999999999999987 4677888883 6688887766 445566778999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC--CCCcEEEeeccCcccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFI 187 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~--~~~~~kl~Dfg~a~~~ 187 (331)
|++.|+|.+.+.. ..+.+.....++.|+++|+.|+|+++ +||||||.+||||- +..++||||||.....
T Consensus 103 ~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred cCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999887754 36788888999999999999999998 99999999999994 4457999999998643
Q ss_pred cCCCceeeeeccccCCccChhhhcC---C--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQS---S--QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
+. .......+..|.+||.... + ...+.+|+|.||+++|.++||+.||......+.. ...+.... ..
T Consensus 174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~--~r 244 (378)
T KOG1345|consen 174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWL--KR 244 (378)
T ss_pred Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHh--cc
Confidence 32 1122335678999995432 2 2467889999999999999999999743322222 11111111 11
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
......+ .-...++.+..+.++-|..+|++|--..++.++-
T Consensus 245 k~~~~P~------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 245 KNPALPK------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCccCch------hhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1111111 1234566788899999999999996666665554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=197.50 Aligned_cols=176 Identities=36% Similarity=0.546 Sum_probs=150.3
Q ss_pred CccCceecCCCCeEEEEEEecC-CcEEEEc------------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 58 FNVNRILGQGGQGTVYKGMRED-GRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
|.+.+.||+|++|+||++...+ +..+++| .|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999854 7889988 26788999999988899999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+.+... ...+++..+..++.+++.++.+||+.+ ++|+|++|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999988752 112789999999999999999999988 99999999999999999999999999886654321
Q ss_pred eeeeeccccCCccChhhh-cCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 020102 193 HVTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 240 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~p~~~ 240 (331)
.......++..|++||.+ ....++.++|+||||+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122334578889999988 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-24 Score=194.10 Aligned_cols=240 Identities=23% Similarity=0.269 Sum_probs=178.6
Q ss_pred CCccCceecCCCCeEEEEEEecCC--cEEEEccc---------------------------ccchhhhccc-ccCCccee
Q 020102 57 HFNVNRILGQGGQGTVYKGMREDG--RIIAVKKS---------------------------KNAVKLLGCC-LETEVPLL 106 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~---------------------------~niv~~~~~~-~~~~~~~l 106 (331)
+|.+.+.||+|+||.||.+.+.+. ..+|+|.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999998553 47888821 2556666666 36667899
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-----CcEEEeec
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-----YRAKVADF 181 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-----~~~kl~Df 181 (331)
||+.+ |.+|.+..... ....++..++..++.|++.+|.++|+.| ++||||||+|+++... -.+.|.||
T Consensus 99 VM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99988 69998866543 2468999999999999999999999999 9999999999999854 35899999
Q ss_pred cCcc--cccCCCc-------eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH
Q 020102 182 GTSK--FIAMDQT-------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 182 g~a~--~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~ 252 (331)
|+++ .+..... .......||..|+++..+.+...+.+.|+||++.++.++..|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~ 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence 9998 3322211 112235699999999999999999999999999999999999999954332211 1
Q ss_pred HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
..+........... .....+..+.++...+-..+..++|....+...|+.....++
T Consensus 247 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred HHHHHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 11111111110000 112223456667777777999999999999999988776653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=183.96 Aligned_cols=256 Identities=16% Similarity=0.217 Sum_probs=191.7
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEccc----------------------ccchhhhcccccCCcceeEe
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKS----------------------KNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~----------------------~niv~~~~~~~~~~~~~lv~ 108 (331)
...+-.|++.++||+|+||..+.|.. -+++.||||-- ++|..++-+...+.+-.||+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34567899999999999999999986 68999999942 37777777777788889999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-----CcEEEeeccC
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-----YRAKVADFGT 183 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-----~~~kl~Dfg~ 183 (331)
|++ |.||.+.+. .++..++..++..++.|++.-+.|+|++. +|.|||||+|+||... ..+.++|||+
T Consensus 104 dLL-GPSLEDLFD----~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 104 DLL-GPSLEDLFD----LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhh-CcCHHHHHH----HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 998 689988664 35678999999999999999999999988 9999999999999743 3479999999
Q ss_pred cccccCCCcee------eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 020102 184 SKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVH 257 (331)
Q Consensus 184 a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 257 (331)
|+.+..+.+.. .....||.+||+-..+.|..-+.+.|+-|+|-++.+.+.|..||.......- ..-...
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-----K~kYeK 250 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-----KEKYEK 250 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-----HHHHHH
Confidence 99887655432 2346799999999999999999999999999999999999999975422110 000111
Q ss_pred HhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchh-hHHHH
Q 020102 258 SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRA-MFSKI 326 (331)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~-~~~~~ 326 (331)
. ++......-. ..-..++.++..-+.-.-..+-.+-|..+-+-..+..+.+-.+-+.+ .+||+
T Consensus 251 I---Ge~Kr~T~i~---~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~ 314 (449)
T KOG1165|consen 251 I---GETKRSTPIE---VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM 314 (449)
T ss_pred h---ccccccCCHH---HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 0 1110000000 01112445666667777777888889998887777776665544444 55554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=178.39 Aligned_cols=242 Identities=20% Similarity=0.294 Sum_probs=179.3
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------ccc----------------cchhhhcccccCCcceeEee
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------KSK----------------NAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------~~~----------------niv~~~~~~~~~~~~~lv~e 109 (331)
...+.|.+++.||.|+||.+|.|.. .+|+.|||| +|| .+..+..+..+...-.+||+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3457899999999999999999987 789999999 354 56667777778888899999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEeeccCccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKF 186 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~ 186 (331)
++ |.||.+.+.- +...++..+++.++-|++.-+.|+|..+ ++||||||+|+|..- ...+.|+|||+|+.
T Consensus 92 LL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 98 6888886653 4557999999999999999999999999 999999999999973 34689999999987
Q ss_pred ccCCCcee------eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 187 IAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 187 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
+....+.. .....||..|.+-..+.+-.-+.+.|+-|+|.++.++-.|..||.........+. . +.+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK-----y-EkI~ 237 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK-----Y-EKIS 237 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH-----H-HHHH
Confidence 65433221 2335699999998888888889999999999999999999999975432211110 0 0011
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
+..+...++. + =..++.++.-.+.-|-...-++-|...-+-+...-+.
T Consensus 238 EkK~s~~ie~-L----C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 238 EKKMSTPIEV-L----CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HhhcCCCHHH-H----hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1111111110 0 1123456777788888888888887766655554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=206.04 Aligned_cols=231 Identities=23% Similarity=0.291 Sum_probs=170.2
Q ss_pred ccCceecCCCCeEEEEEEec-CCc-----EEEEc------------------------ccccchhhhcccccCCcceeEe
Q 020102 59 NVNRILGQGGQGTVYKGMRE-DGR-----IIAVK------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~-~~~-----~vavK------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
.....+|.|++|.|+.+... ... .++++ .|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977776541 111 12211 4778777777777666666669
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|||++ +|...+... ..+....+-.+++|++.|+.|+|+.| +.|||+||+|+++..+|.+||+|||.+....
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 99998 998888752 36888899999999999999999999 9999999999999999999999999987665
Q ss_pred CCCc---eeeeeccccCCccChhhhcCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 189 MDQT---HVTTKIQGTFGYLDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 189 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
.+.. ......+|+..|+|||++.+..|.. ..||||.|+++..|++|+.||.......... ........
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~ 543 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQ 543 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccc
Confidence 4433 3345578999999999999999876 5799999999999999999996543222110 00000000
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... -........+...+.++.+||+++|.+|.|+++|++.
T Consensus 544 ~~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 RNIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000 1111233455678899999999999999999999753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=201.21 Aligned_cols=227 Identities=23% Similarity=0.271 Sum_probs=167.4
Q ss_pred CCccCceecCCCCeEEEEEEecCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMREDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++...+.||.+.|=.|.+|.+++|. |+|| ++||.+.+..+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777899999999999999998887 6777 377888888887778888999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc--c
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI--A 188 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~--~ 188 (331)
+. -+|++.+..+ ..+...+.+.|+.|++.|+..+|..| |+|+|||.+||||++-.-+.|+||..-+.. .
T Consensus 103 vk-hnLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hh-hhhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence 96 7898888763 24667788889999999999999999 999999999999999999999999876533 2
Q ss_pred CCCc----eeeeeccccCCccChhhhcCC----------C-CCCcchHHHHHHHHHHHHhC-CCCCCCCCCCcccccchH
Q 020102 189 MDQT----HVTTKIQGTFGYLDPEYHQSS----------Q-LTDKSDVYSFGVVLVELLTG-KKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 189 ~~~~----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~el~~g-~~p~~~~~~~~~~~~~~~ 252 (331)
.+.. ....+.....+|.|||.+... . .+++.||||+||+++|+++- ++||. ..+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-LSQ--------- 243 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-LSQ--------- 243 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-HHH---------
Confidence 2221 222333455689999966431 2 56789999999999999985 55552 110
Q ss_pred HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 020102 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~ 311 (331)
.-.++.+. ....+..+. ..+ ...++.++..|++.||+.|.|+++.++.-.+
T Consensus 244 ---L~aYr~~~-~~~~e~~Le-~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 244 ---LLAYRSGN-ADDPEQLLE-KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ---HHhHhccC-ccCHHHHHH-hCc---CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 01111111 111111111 111 1258899999999999999999999877443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=175.51 Aligned_cols=212 Identities=22% Similarity=0.275 Sum_probs=134.7
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEcccc------------------------------------cchhhhccc-
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSK------------------------------------NAVKLLGCC- 98 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~------------------------------------niv~~~~~~- 98 (331)
.+...+.||.|+++.||.+.+ .+++.+|+|... .++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 445678899999999999999 469999999311 000001111
Q ss_pred --------ccC---C-----cceeEeecccCCCHHHHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 020102 99 --------LET---E-----VPLLVYEFISNGTLYQHLHDRLQNQ--EFPLTWEMRLRIATEVAGALAYLHSAASSPIYH 160 (331)
Q Consensus 99 --------~~~---~-----~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H 160 (331)
... . +.+++|+-+. ++|.+.+....... ...+....+..+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 001 1 2356777774 78877654321111 123444556777899999999999999 999
Q ss_pred ccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcC--------CCCCCcchHHHHHHHHHHHH
Q 020102 161 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--------SQLTDKSDVYSFGVVLVELL 232 (331)
Q Consensus 161 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~ 232 (331)
+||+|+|++++.+|.++|+||+....... .... ...+..|.|||.... ..++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE---EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc---eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987654321 1111 335678999996643 24788999999999999999
Q ss_pred hCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCC
Q 020102 233 TGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKR 299 (331)
Q Consensus 233 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~R 299 (331)
||..||........ .+..-..+. +.++.+.+||..+|+.+|++|
T Consensus 245 C~~lPf~~~~~~~~----------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEAD----------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGST----------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccc----------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999964311110 000122344 677789999999999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-21 Score=170.52 Aligned_cols=238 Identities=29% Similarity=0.393 Sum_probs=173.5
Q ss_pred CccCceecCCCCeEEEEEEecCCcEEEEcc--------------------------cc-cchhhhcccccCCcceeEeec
Q 020102 58 FNVNRILGQGGQGTVYKGMREDGRIIAVKK--------------------------SK-NAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~--------------------------~~-niv~~~~~~~~~~~~~lv~e~ 110 (331)
|.+.+.||.|+||.||.+.+. ..+++|. ++ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999886 5666662 34 688888888777778999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~ 189 (331)
+.++++.+.+...... ..++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999998655542111 36888999999999999999999999 99999999999999988 799999999975543
Q ss_pred CCce-----eeeeccccCCccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 190 DQTH-----VTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 190 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
.... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ............
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~ 229 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILE 229 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHh
Confidence 3321 2345679999999999988 57888999999999999999999996543221 000011111111
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... .................+.+++..|+..+|..|.+..+....
T Consensus 230 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1100 000000000001223467899999999999999998887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=179.74 Aligned_cols=145 Identities=22% Similarity=0.199 Sum_probs=109.6
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEec--CCcEEEEcc----------------------------cccchh-hhccc
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMRE--DGRIIAVKK----------------------------SKNAVK-LLGCC 98 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~----------------------------~~niv~-~~~~~ 98 (331)
......+.|.+.+.||+|+||+||+|.+. +++.+|||+ |+|++. +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34455678999999999999999999864 577789984 334443 322
Q ss_pred ccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC-CCCCEEeCCCCcEE
Q 020102 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDI-KSTNILLDERYRAK 177 (331)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~di-kp~Nill~~~~~~k 177 (331)
....++||||++|++|.. +. +.. ...++.|++.||.|||+.+ |+|||| ||+||+++.++.++
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~~--------~~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-AR--------PHG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-hC--------ccc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 245799999999998862 21 111 1357889999999999998 999999 99999999999999
Q ss_pred EeeccCcccccCCCcee-------eeeccccCCccChhhhcCC
Q 020102 178 VADFGTSKFIAMDQTHV-------TTKIQGTFGYLDPEYHQSS 213 (331)
Q Consensus 178 l~Dfg~a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 213 (331)
|+|||+|+.+....... .+...+++.|+|||.+...
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999998665432111 1345678889999977543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=170.37 Aligned_cols=197 Identities=22% Similarity=0.270 Sum_probs=141.0
Q ss_pred ccccchhhhccccc---------------------------CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHH
Q 020102 87 KSKNAVKLLGCCLE---------------------------TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139 (331)
Q Consensus 87 ~~~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i 139 (331)
+|||||.++++|.+ ...+|+||...+ .+|..++... ..+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC------CCchHHHHHH
Confidence 48999999888743 223588888775 7888888752 4566677778
Q ss_pred HHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC--CCC--cEEEeeccCcccccC-----CCceeeeeccccCCccChhhh
Q 020102 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLD--ERY--RAKVADFGTSKFIAM-----DQTHVTTKIQGTFGYLDPEYH 210 (331)
Q Consensus 140 ~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~--~~~--~~kl~Dfg~a~~~~~-----~~~~~~~~~~gt~~y~aPE~~ 210 (331)
+.|+++|+.|||++| |.|||+|++|||+. +++ .+.++|||++--... +-.+.....-|....||||+.
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999999 99999999999993 444 468999998753222 111111223477789999987
Q ss_pred cCCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHH
Q 020102 211 QSSQ------LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAF 284 (331)
Q Consensus 211 ~~~~------~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
..-+ -..++|.|+.|.+.||++....||+..+....+. ..+.+.+++. .+...+..+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~--------r~Yqe~qLPa---------lp~~vpp~~ 486 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT--------RTYQESQLPA---------LPSRVPPVA 486 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech--------hhhhhhhCCC---------CcccCChHH
Confidence 6432 2358999999999999999999998643222111 1122222222 233445578
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 285 ANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 285 ~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
++++...|+.||++|+|+.-....|+
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 99999999999999999887777664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-22 Score=165.10 Aligned_cols=228 Identities=21% Similarity=0.339 Sum_probs=173.1
Q ss_pred CccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 58 FNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
..+..+|.+.-.|..|+|.+..+..| .| .||||+.+++.|....++.++..|++
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34556788999999999987544433 23 48999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
.|||+..|.+. .+...+-.++.+++.+|++|++|||+.. +-|.---+.+..++||++.+++|+- +-+++ +
T Consensus 271 ~gslynvlhe~---t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf-----s 340 (448)
T KOG0195|consen 271 FGSLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----S 340 (448)
T ss_pred chHHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----e
Confidence 99999999863 3334677888999999999999999976 3345557899999999998877642 11111 1
Q ss_pred eeeeeccccCCccChhhhcCCCCC---CcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLT---DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.......-.|.|++||.++..+-+ .++|+|||++++||+.|...||.......- . .++.-
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--------g---------mkial 403 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--------G---------MKIAL 403 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--------h---------hhhhh
Confidence 111122346889999999877643 478999999999999999999975422110 0 01122
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
+.++...++..+..+..|+.-|+..||.+||.+..|+-.|+..+
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34455567778888999999999999999999999999988753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=185.56 Aligned_cols=237 Identities=19% Similarity=0.279 Sum_probs=178.9
Q ss_pred hHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEccc-----------------------ccchhhhcccccCCcc
Q 020102 48 SKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKS-----------------------KNAVKLLGCCLETEVP 104 (331)
Q Consensus 48 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-----------------------~niv~~~~~~~~~~~~ 104 (331)
..+....+..|.|.+.||+|+||.||+|...+++.||||.. +-+..+..+..-.+..
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34566667889999999999999999999988999999942 3566666777777888
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-------CCCcEE
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-------ERYRAK 177 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-------~~~~~k 177 (331)
++|+||.+.|+|.+.+.. .+.+++..+..++.|++.-+.+||..+ |||+||||+|++|. +...++
T Consensus 770 ~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred eeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 999999999999998873 557999999999999999999999999 99999999999994 234589
Q ss_pred EeeccCcccccCCC-ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 020102 178 VADFGTSKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 178 l~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
|+|||.+..+..-. .......++|-.+-.+|+..|.+++...|.|.++.+++-|+.|+.-=...+.....
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~--------- 912 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMV--------- 912 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceec---------
Confidence 99999987554322 23445567899999999999999999999999999999999987532111110000
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
....+.....+. .-+|+..+|+.+-..=|...++...++......
T Consensus 913 ------------~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 913 ------------KTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred ------------cccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 000111111122 234666666655555578888888887776543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=174.22 Aligned_cols=230 Identities=23% Similarity=0.417 Sum_probs=170.1
Q ss_pred ccccchhhhcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 020102 87 KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKST 166 (331)
Q Consensus 87 ~~~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~ 166 (331)
.|.|+.++++.+.+++..+.|.+||..|+|.+.+.. ....+++.....+.++|+.||.|+|... -..|+.+++.
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 488999999999999999999999999999999876 3457899999999999999999999854 1399999999
Q ss_pred CEEeCCCCcEEEeeccCcccccC-CCceeeeeccccCCccChhhhcCCC-------CCCcchHHHHHHHHHHHHhCCCCC
Q 020102 167 NILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQ-------LTDKSDVYSFGVVLVELLTGKKPI 238 (331)
Q Consensus 167 Nill~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~g~~p~ 238 (331)
|++++....+||+|||+...... ..........-..-|.|||.+.+.. .+.+.|+||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999875532 0111111122345699999887642 466799999999999999999999
Q ss_pred CCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 239 FSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
......... ...... +..+. .....+.+.. ..+..+.+..++..||..+|++||++++|-..+..+.+....
T Consensus 159 ~~~~~~~~~-~eii~~----~~~~~-~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~ 230 (484)
T KOG1023|consen 159 DLRNLVEDP-DEIILR----VKKGG-SNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSS 230 (484)
T ss_pred ccccccCCh-HHHHHH----HHhcC-CCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccc
Confidence 764333322 111111 11100 0001111110 013334689999999999999999999999999998776555
Q ss_pred chhhHHHHHhhc
Q 020102 319 KRAMFSKIIKRL 330 (331)
Q Consensus 319 ~~~~~~~~~~~~ 330 (331)
+....|.++++|
T Consensus 231 ~~nl~D~m~~~l 242 (484)
T KOG1023|consen 231 KGNLMDSLFRML 242 (484)
T ss_pred cchhHHHHHHHH
Confidence 567788877765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-20 Score=153.54 Aligned_cols=118 Identities=20% Similarity=0.258 Sum_probs=90.8
Q ss_pred CceecCCCCeEEEEEEecCCcEEEEccccc-----------------------------------------chhhhcccc
Q 020102 61 NRILGQGGQGTVYKGMREDGRIIAVKKSKN-----------------------------------------AVKLLGCCL 99 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~n-----------------------------------------iv~~~~~~~ 99 (331)
.+.||+|+||.||+|.+.+|+.||+|..+. +.++.....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999988899999996421 111111110
Q ss_pred ------cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEccCCCCCEEeCC
Q 020102 100 ------ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL-HSAASSPIYHRDIKSTNILLDE 172 (331)
Q Consensus 100 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~i~H~dikp~Nill~~ 172 (331)
.....++||||++++++...... ..+++...+..++.|++.+|.++ |+.+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 01223799999998766543222 24688999999999999999999 6888 99999999999998
Q ss_pred CCcEEEeeccCcccc
Q 020102 173 RYRAKVADFGTSKFI 187 (331)
Q Consensus 173 ~~~~kl~Dfg~a~~~ 187 (331)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=150.59 Aligned_cols=119 Identities=24% Similarity=0.293 Sum_probs=90.6
Q ss_pred CceecCCCCeEEEEEEecCCcEEEEccccc-----------------------------------------chhhhcccc
Q 020102 61 NRILGQGGQGTVYKGMREDGRIIAVKKSKN-----------------------------------------AVKLLGCCL 99 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~n-----------------------------------------iv~~~~~~~ 99 (331)
.+.||+|++|+||+|.+.+|+.||||..+. +.++.....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 578999999999999988899999995321 001100000
Q ss_pred c------CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCC
Q 020102 100 E------TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDE 172 (331)
Q Consensus 100 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~ 172 (331)
. ....++||||++|+++...... ...++...+..++.|++.++.++|+ .| |+||||||+||+++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 0 0123799999998755433222 1357788899999999999999999 88 99999999999999
Q ss_pred CCcEEEeeccCccccc
Q 020102 173 RYRAKVADFGTSKFIA 188 (331)
Q Consensus 173 ~~~~kl~Dfg~a~~~~ 188 (331)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.3e-20 Score=153.98 Aligned_cols=150 Identities=13% Similarity=0.148 Sum_probs=112.2
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEecCCcEEEEcc--------------------------------cccchhhhcccc
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK--------------------------------SKNAVKLLGCCL 99 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~--------------------------------~~niv~~~~~~~ 99 (331)
+...++|++.+++|.|+||.||+... ++..+|+|. |+++..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34578999999999999999999655 677899993 456666666544
Q ss_pred c--------CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 020102 100 E--------TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171 (331)
Q Consensus 100 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~ 171 (331)
. ....+++|||++|.+|.+.. .++. ....+++.++..+|+.| ++|+|++|+||+++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~ 169 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVS 169 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEe
Confidence 2 23578999999999987652 1222 24568999999999999 99999999999999
Q ss_pred CCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHH
Q 020102 172 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 232 (331)
Q Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 232 (331)
++| ++|+|||........... ..+.....+..++|+||||+++....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987643211100 11333344667899999999887644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-20 Score=173.12 Aligned_cols=208 Identities=27% Similarity=0.305 Sum_probs=161.6
Q ss_pred ecCCCCeEEEEEEe----cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 64 LGQGGQGTVYKGMR----EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 64 lg~G~~g~V~~~~~----~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+|+|.||.|+++.. ..+..+|.| .+|.++++.-.+..+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999987642 224444444 267888888888889999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|.+...+.. ...+.+.....+...++-++.++|+.+ ++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 82 g~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 82 GDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred chhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 988877765 235677777788888999999999999 999999999999999999999999999865433222
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
+||..|||||++. ......|.||||++.+||+||-.||.. ......+ ...
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il-----------~~~ 203 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRIL-----------KAE 203 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHh-----------hhc
Confidence 7999999999999 456789999999999999999999864 0011111 111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHHHHH
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTM--EEVSMEL 309 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~--~evl~~L 309 (331)
...+...+..+.+++..++..+|..|--. .-+.+.+
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 23466677788999999999999999754 3444443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=141.35 Aligned_cols=163 Identities=17% Similarity=0.145 Sum_probs=118.4
Q ss_pred ccCceecCCCCeEEEEEEecCCcEEEEcc----------------------------cccchhhhcccccCCcceeEeec
Q 020102 59 NVNRILGQGGQGTVYKGMREDGRIIAVKK----------------------------SKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~----------------------------~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.+...|++|+||+||.+.. .+..++.+. ++++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998866 566666442 2456666664 346999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC-CCCCEEeCCCCcEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDI-KSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~di-kp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
+.|.+|...+.. . ...++.|++.++.++|+.| |+|||| ||+||+++.+|.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~-----------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR-----------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh-----------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999888643211 1 1347789999999999999 999999 79999999999999999999985443
Q ss_pred CCce----e--------eeeccccCCccChhhhcCC-CCC-CcchHHHHHHHHHHHHhCCCCCCCC
Q 020102 190 DQTH----V--------TTKIQGTFGYLDPEYHQSS-QLT-DKSDVYSFGVVLVELLTGKKPIFSA 241 (331)
Q Consensus 190 ~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~el~~g~~p~~~~ 241 (331)
.... . ......++.|++|+-..-. ..+ .+.+.++-|+-+|.++|++.|....
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 2210 0 0012357888888844332 233 4567889999999999999987644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-19 Score=172.07 Aligned_cols=210 Identities=26% Similarity=0.349 Sum_probs=142.8
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEcccccchhhhcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCH
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTW 133 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 133 (331)
...|..++.+..|+||.||...++ ..+.+|+|..++-+-+.+...--++.+.| |+-...++. -++++.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~a~npfvv------gDc~tllk~-----~g~lPv 150 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTFAGNPFVV------GDCATLLKN-----IGPLPV 150 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccccCCccee------chhhhhccc-----CCCCcc
Confidence 467889999999999999999875 46678886443221111111112233333 222232322 123443
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc--------------eeeeecc
Q 020102 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT--------------HVTTKIQ 199 (331)
Q Consensus 134 ~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~ 199 (331)
+ ++.++.|||+.+ |+|||+||+|.+|..-|++|+.|||+.+....... .....++
T Consensus 151 d--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvc 219 (1205)
T KOG0606|consen 151 D--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVC 219 (1205)
T ss_pred h--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhcccc
Confidence 2 378999999999 99999999999999999999999999864322111 1123468
Q ss_pred ccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHH
Q 020102 200 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKN 279 (331)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (331)
||+.|.|||++....|...+|.|++|+|+||.+.|..||+... .++ .+...+... ..+. +....
T Consensus 220 gTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt--pee------lfg~visd~--i~wp------E~dea 283 (1205)
T KOG0606|consen 220 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEE------LFGQVISDD--IEWP------EEDEA 283 (1205)
T ss_pred CCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC--HHH------HHhhhhhhh--cccc------ccCcC
Confidence 9999999999999999999999999999999999999997542 221 111111111 0011 11223
Q ss_pred HHHHHHHHHHHhhccCCCCCCCH
Q 020102 280 QIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 280 ~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
...+..+++.++|+.+|.+|--.
T Consensus 284 ~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 284 LPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred CCHHHHHHHHHHHHhChHhhccc
Confidence 34578899999999999999633
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=164.58 Aligned_cols=173 Identities=24% Similarity=0.349 Sum_probs=128.5
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
++++.|++|.-.+|.+++..+. .....++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 5789999999999999997642 23356778889999999999999 66 9999999999999999999999999
Q ss_pred CcccccCCC-----ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCcccccchHHHHH
Q 020102 183 TSKFIAMDQ-----THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG-KKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 183 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
+........ ....+...||..||+||.+.+..|+.++||||||++++|++.- ..++. + .-..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r--------~~t~ 469 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----R--------IATL 469 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----H--------HHhh
Confidence 987665443 2233456799999999999999999999999999999999961 12221 0 0011
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~e 304 (331)
..++.+.++... ..++ +.-..|+.++|.+.|.+||++.+
T Consensus 470 ~d~r~g~ip~~~--------~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 470 TDIRDGIIPPEF--------LQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhcCCCChHH--------hhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 122223332100 0011 12347999999999999994433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.4e-16 Score=132.60 Aligned_cols=111 Identities=23% Similarity=0.374 Sum_probs=89.9
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEcc-------------------------------cccchhhhcccccCCcceeEeec
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVKK-------------------------------SKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK~-------------------------------~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
+.||+|++|.||+|.. .+..+++|. ++++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 566788883 11333333444456678899999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
++|++|.+.+... .+ ....++.+++.++.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999998887541 12 77889999999999999998 99999999999999 78899999998763
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=6e-17 Score=139.15 Aligned_cols=124 Identities=19% Similarity=0.222 Sum_probs=94.1
Q ss_pred hcCCccCceecCCCCeEEEEEE--ecCCcEEEEcccccc---------------------------------------hh
Q 020102 55 TNHFNVNRILGQGGQGTVYKGM--REDGRIIAVKKSKNA---------------------------------------VK 93 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~ni---------------------------------------v~ 93 (331)
+.-|.+.+.||+|+||.||+|. ..+|+.||+|..+.- .+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4458889999999999999998 468999999954310 00
Q ss_pred hh-------cccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 020102 94 LL-------GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKST 166 (331)
Q Consensus 94 ~~-------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~ 166 (331)
+. ..+ .....++||||++|+++...... ........+..++.|++.++.+||+.+. ++|+||||+
T Consensus 107 L~~~~i~~p~~~-~~~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~ 178 (237)
T smart00090 107 LYEAGVPVPKPI-AWRRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY 178 (237)
T ss_pred HHhcCCCCCeee-EecCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence 00 011 12245899999998887654321 2345666678899999999999998653 999999999
Q ss_pred CEEeCCCCcEEEeeccCcccc
Q 020102 167 NILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 167 Nill~~~~~~kl~Dfg~a~~~ 187 (331)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998744
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=133.21 Aligned_cols=124 Identities=21% Similarity=0.229 Sum_probs=93.9
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEccccc-------------------------------------ch
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSKN-------------------------------------AV 92 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~n-------------------------------------iv 92 (331)
++......|.+.+.||+|+||.||++...+++.||||.++. +.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444455888899999999999999988899999995220 00
Q ss_pred hhhcc------cccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 020102 93 KLLGC------CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKST 166 (331)
Q Consensus 93 ~~~~~------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~ 166 (331)
.+.+. .......++||||++|++|...... .....++.+++.++.++|+.+ ++|+||+|+
T Consensus 89 ~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceeecCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 11111 0112346899999999888653220 234568889999999999988 999999999
Q ss_pred CEEeCCCCcEEEeeccCcccc
Q 020102 167 NILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 167 Nill~~~~~~kl~Dfg~a~~~ 187 (331)
||++++++.++|+|||++...
T Consensus 155 Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cEEEcCCCcEEEEECCccccC
Confidence 999999999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=132.40 Aligned_cols=112 Identities=21% Similarity=0.237 Sum_probs=85.0
Q ss_pred cCceecCCCCeEEEEEEecCCcEEEEc----------------------------ccccchhhhcccccCC---c-ceeE
Q 020102 60 VNRILGQGGQGTVYKGMREDGRIIAVK----------------------------KSKNAVKLLGCCLETE---V-PLLV 107 (331)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------------~~~niv~~~~~~~~~~---~-~~lv 107 (331)
-...||+|+||.||. .-.++.. +|| .||||+++++++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 357899999999996 2233433 567 2689999999998864 3 3378
Q ss_pred eec--ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEccCCCCCEEeCC----CCcEEEee
Q 020102 108 YEF--ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL-AYLHSAASSPIYHRDIKSTNILLDE----RYRAKVAD 180 (331)
Q Consensus 108 ~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~~~i~H~dikp~Nill~~----~~~~kl~D 180 (331)
+|| +.+++|.+++.+ ..+++. ..++.+++.++ .|||+++ |+||||||+||+++. ++.++|+|
T Consensus 84 ~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred ecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 999 557999999964 135544 35577888777 8999998 999999999999973 34799999
Q ss_pred -ccCc
Q 020102 181 -FGTS 184 (331)
Q Consensus 181 -fg~a 184 (331)
||..
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 5543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.8e-18 Score=161.46 Aligned_cols=232 Identities=24% Similarity=0.323 Sum_probs=172.9
Q ss_pred hcCCccCceecCCCCeEEEEEEec--CCcEEEEc--------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE--DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
...|.+.+.||+|+|+.|-..... ....+|.| +|+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 456788888999999998777542 23333444 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEccCCCCCEEeCCCC-cEEEeeccC
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEF-PLTWEMRLRIATEVAGALAYLH-SAASSPIYHRDIKSTNILLDERY-RAKVADFGT 183 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH-~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~ 183 (331)
+++|..|+++.+.+.. ... ..+...+-.++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+
T Consensus 99 ~~~~s~g~~~f~~i~~----~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH----PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred ccCccccccccccccc----CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchh
Confidence 9999999998877631 122 4566777889999999999999 777 99999999999999999 999999999
Q ss_pred cccccC-CC-ceeeeeccc-cCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 184 SKFIAM-DQ-THVTTKIQG-TFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 184 a~~~~~-~~-~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
|..+.. .. .......+| ++.|+|||...+. ......|+||.|+++.-+++|..||............... ..
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~---~~- 247 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS---NK- 247 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc---cc-
Confidence 987665 22 333344568 9999999988884 4566889999999999999999999765333221111000 00
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.. ..............+++..++..+|+.|.+.+++..
T Consensus 248 --~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 --GR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cc--------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00 001112233345778999999999999999988743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=127.38 Aligned_cols=107 Identities=21% Similarity=0.377 Sum_probs=83.4
Q ss_pred eecCCCCeEEEEEEecCCcEEEEcccc-------------------------------cchhhhcccccCCcceeEeecc
Q 020102 63 ILGQGGQGTVYKGMREDGRIIAVKKSK-------------------------------NAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 63 ~lg~G~~g~V~~~~~~~~~~vavK~~~-------------------------------niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.||+|+||.||+|.. ++..+++|... ++....-++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 56778888521 1111112223455568999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
+|++|.+.+... . . .++.+++.++.++|+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~----~-~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----N-D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----H-H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998876541 0 1 68899999999999998 99999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-15 Score=144.86 Aligned_cols=114 Identities=21% Similarity=0.330 Sum_probs=88.6
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc------------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK------------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK------------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
..|...+.||+|+||+||+|.......++.+ ++++++....++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 4456678999999999999876443322211 1234444444555566788
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||++|++|.+.+. ....++.+++.++.+||+.+ ++||||||+||++ +++.++|+|||+++
T Consensus 413 lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 9999999999988774 23568899999999999998 9999999999999 67789999999986
Q ss_pred c
Q 020102 186 F 186 (331)
Q Consensus 186 ~ 186 (331)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 4
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-15 Score=124.68 Aligned_cols=116 Identities=25% Similarity=0.328 Sum_probs=85.1
Q ss_pred CceecCCCCeEEEEEEecCCcEEEEcccccch------------------------h---------------hhcc----
Q 020102 61 NRILGQGGQGTVYKGMREDGRIIAVKKSKNAV------------------------K---------------LLGC---- 97 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~niv------------------------~---------------~~~~---- 97 (331)
.+.||+|+||+||+|.+.+++.||||..+.-. . +...
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999533100 0 0000
Q ss_pred --cccCCcceeEeecccCCCHHH-HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCC
Q 020102 98 --CLETEVPLLVYEFISNGTLYQ-HLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDER 173 (331)
Q Consensus 98 --~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~ 173 (331)
.......++||||++++.+.. .+... ... ..+..++.+++.++.++|. .+ ++|+||+|+||+++ +
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 001124579999999855422 12211 011 5677899999999999999 87 99999999999999 8
Q ss_pred CcEEEeeccCcccc
Q 020102 174 YRAKVADFGTSKFI 187 (331)
Q Consensus 174 ~~~kl~Dfg~a~~~ 187 (331)
+.++|+|||.+...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 89999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-14 Score=122.17 Aligned_cols=197 Identities=20% Similarity=0.296 Sum_probs=136.0
Q ss_pred cccchhhhcccccCC-----cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcc
Q 020102 88 SKNAVKLLGCCLETE-----VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162 (331)
Q Consensus 88 ~~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 162 (331)
|.|+|+++.++.+.. ...+++||+..|++..+|++..... ..+....-.+|+-||+.||.|||+.. ++|+|++
T Consensus 126 HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~~-Ppiihgn 203 (458)
T KOG1266|consen 126 HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSCD-PPIIHGN 203 (458)
T ss_pred HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhccC-CccccCC
Confidence 669999999987644 4678999999999999998864443 46777788899999999999999986 7899999
Q ss_pred CCCCCEEeCCCCcEEEeeccCcccccC----CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 020102 163 IKSTNILLDERYRAKVADFGTSKFIAM----DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 238 (331)
Q Consensus 163 ikp~Nill~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~ 238 (331)
+.-+.|++..+|-+|++- +....... -.........+-++|.+||.=.-...+..+|||+||+...+|..+..-.
T Consensus 204 lTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~ 282 (458)
T KOG1266|consen 204 LTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQS 282 (458)
T ss_pred cchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheecc
Confidence 999999999999888752 11111100 0011111234678899999766666778999999999999998876542
Q ss_pred CCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 239 FSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......-....... ..+...-++. =+.++..|++..|..||+|.+++-.
T Consensus 283 tnseS~~~~ee~ia---------~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 283 TNSESKVEVEENIA---------NVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred CCCcceeehhhhhh---------hheeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 22111111000000 0011111111 1358899999999999999998654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=127.74 Aligned_cols=226 Identities=22% Similarity=0.241 Sum_probs=165.1
Q ss_pred hcCCccCceecC--CCCeEEEEEEe---cCCcEEEEcc--------------------------cccchhhhcccccCCc
Q 020102 55 TNHFNVNRILGQ--GGQGTVYKGMR---EDGRIIAVKK--------------------------SKNAVKLLGCCLETEV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~--------------------------~~niv~~~~~~~~~~~ 103 (331)
...|.+...+|. |.+|.||.+.. .++..+|+|+ |+|.++.+..+.+.+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345677889999 99999999875 4678888884 5588888888999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEE
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG----ALAYLHSAASSPIYHRDIKSTNILLDER-YRAKV 178 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~~~i~H~dikp~Nill~~~-~~~kl 178 (331)
.++-+|++. .+|..+... ....++....+..+.+... |+.++|+.+ ++|.|+||+||+...+ ...++
T Consensus 193 lfiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred ceeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence 999999996 666666654 3445777888888888888 999999988 9999999999999999 88999
Q ss_pred eeccCcccccCCCceee----eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 020102 179 ADFGTSKFIAMDQTHVT----TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 254 (331)
+|||+...+..+.-... ....|...|++||..++ .++...|+||+|.++.+..++..+.-.+...
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---------- 333 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS---------- 333 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC----------
Confidence 99999987765442111 12257778999998776 4577899999999999999886654322100
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.|..+....++.+.-..-+..+...+..|++.+|..|++.+.+..
T Consensus 334 --------~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 --------SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --------CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000000000000111111224555899999999999999877643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.3e-13 Score=106.65 Aligned_cols=113 Identities=25% Similarity=0.244 Sum_probs=90.3
Q ss_pred cCceecCCCCeEEEEEEecCCcEEEEccc-----------------------ccchhhhcccccCCcceeEeecccCCCH
Q 020102 60 VNRILGQGGQGTVYKGMREDGRIIAVKKS-----------------------KNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-----------------------~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
+.+.||+|.++.||++...+ ..+++|.. .++++++.+....+..++++||++++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 35789999999999998754 67888842 2555666666666678999999987765
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
... +......++.+++.+++++|.....+++|+|++|+||++++.+.+++.|||.+.
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 432 446667788999999999998643459999999999999998999999999876
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.5e-13 Score=114.86 Aligned_cols=111 Identities=23% Similarity=0.363 Sum_probs=80.7
Q ss_pred ceec-CCCCeEEEEEEecCCcEEEEcccc------------------------------------c--chhhhcccccCC
Q 020102 62 RILG-QGGQGTVYKGMREDGRIIAVKKSK------------------------------------N--AVKLLGCCLETE 102 (331)
Q Consensus 62 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~------------------------------------n--iv~~~~~~~~~~ 102 (331)
..|| .||.|+||.+... +..++||... + ++..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 8888888888664 6677776321 1 233333322211
Q ss_pred ----cceeEeecccC-CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEE
Q 020102 103 ----VPLLVYEFISN-GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAK 177 (331)
Q Consensus 103 ----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~k 177 (331)
..++|||+++| .+|.+.+.. .+++.. .+.+++.++.+||+.| |+|+||||.|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 12599999997 688777653 244543 3568999999999999 99999999999999988999
Q ss_pred EeeccCccc
Q 020102 178 VADFGTSKF 186 (331)
Q Consensus 178 l~Dfg~a~~ 186 (331)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=7e-13 Score=123.84 Aligned_cols=117 Identities=21% Similarity=0.215 Sum_probs=84.9
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEcc-cccc-------------------------------------------------
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVKK-SKNA------------------------------------------------- 91 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK~-~~ni------------------------------------------------- 91 (331)
+.||+|++|+||+|...+|+.||||. +|++
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999994 2321
Q ss_pred -----hhhhccccc-------------CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 020102 92 -----VKLLGCCLE-------------TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG-ALAYLHS 152 (331)
Q Consensus 92 -----v~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~-~l~~lH~ 152 (331)
.++...+.+ ....++||||++|++|.+...... . ..+ ...++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~-~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---A-GLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---c-CCC---HHHHHHHHHHHHHHHHHh
Confidence 111111111 223579999999999987654310 1 122 2345555555 4678898
Q ss_pred cCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 153 ~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
.| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=3e-12 Score=121.29 Aligned_cols=121 Identities=20% Similarity=0.194 Sum_probs=83.7
Q ss_pred hcCCccCceecCCCCeEEEEEEecC-CcEEEEcc-cc-------------------------------------------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRED-GRIIAVKK-SK------------------------------------------- 89 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~-~~------------------------------------------- 89 (331)
...|.. +.||+|++|+||+|..++ |+.||||. +|
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999876 99999994 22
Q ss_pred -----------cchhhhcccccCCc-------------ceeEeecccCCCHHHHHhhhhcCCC---CCCCHHHHHHHHHH
Q 020102 90 -----------NAVKLLGCCLETEV-------------PLLVYEFISNGTLYQHLHDRLQNQE---FPLTWEMRLRIATE 142 (331)
Q Consensus 90 -----------niv~~~~~~~~~~~-------------~~lv~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~i~~~ 142 (331)
|+.++...+.+.+. .++||||++|+++.+.-.- ...+ ..+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHHHHHHHHHHHHHHH
Confidence 34444444433332 3599999999999763211 1111 12333334444444
Q ss_pred HHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC----cEEEeeccCccccc
Q 020102 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERY----RAKVADFGTSKFIA 188 (331)
Q Consensus 143 i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~a~~~~ 188 (331)
++ ..| ++|+|++|.||+++.+| .+++.|||++..+.
T Consensus 276 if-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 43 455 99999999999999887 99999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-11 Score=101.05 Aligned_cols=118 Identities=20% Similarity=0.193 Sum_probs=82.5
Q ss_pred CceecCCCCeEEEEEEecC-------CcEEEEcccc--------------------------cchhh-------------
Q 020102 61 NRILGQGGQGTVYKGMRED-------GRIIAVKKSK--------------------------NAVKL------------- 94 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~--------------------------niv~~------------- 94 (331)
...||.|--+.||.|...+ +..+|||.|+ |-.++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998653 4789999432 11111
Q ss_pred --hcccc------cCCcceeEeecccCCCHHH-HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEccCC
Q 020102 95 --LGCCL------ETEVPLLVYEFISNGTLYQ-HLHDRLQNQEFPLTWEMRLRIATEVAGALAYL-HSAASSPIYHRDIK 164 (331)
Q Consensus 95 --~~~~~------~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~i~H~dik 164 (331)
..... .-...++||||+.+..+.. .+.+ ..++......+..+++.++..+ |+.+ ++|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 11100 1123579999997654422 2222 2345556677889999999988 8888 9999999
Q ss_pred CCCEEeCCCCcEEEeeccCccccc
Q 020102 165 STNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 165 p~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
+.||++++ +.++|+|||.+....
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCC
Confidence 99999974 679999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.6e-11 Score=110.10 Aligned_cols=158 Identities=21% Similarity=0.244 Sum_probs=116.5
Q ss_pred ceecCCCCeEEEEEEecCCcEE-----EEc-----ccccchhhhcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCC
Q 020102 62 RILGQGGQGTVYKGMREDGRII-----AVK-----KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPL 131 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~v-----avK-----~~~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 131 (331)
.....|++-.||.....++..+ |+| +||||+++++.+......|+|+|-+ ..|...+.+ +
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~--------l 101 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE--------L 101 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH--------h
Confidence 3455678888888876666222 233 7999999999999999999999998 466677765 2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhc
Q 020102 132 TWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211 (331)
Q Consensus 132 ~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 211 (331)
+...+...+.||+.||.+||..+ +++|++|.-+.|+++..|..||++|.++........ ......--..|..|+.+.
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcC
Confidence 35666778899999999998644 299999999999999999999999988754322111 111111223456666544
Q ss_pred CCCCCCcchHHHHHHHHHHHHhC
Q 020102 212 SSQLTDKSDVYSFGVVLVELLTG 234 (331)
Q Consensus 212 ~~~~~~~~DiwslG~il~el~~g 234 (331)
... ...|.|.|||+++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 432 356999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.7e-12 Score=118.14 Aligned_cols=238 Identities=21% Similarity=0.258 Sum_probs=168.7
Q ss_pred cccChHH-HHHHhcCCccCceecCCCCeEEEEEEe--cCCcEEEEcc--------------------------cccchhh
Q 020102 44 KLFSSKE-LDKATNHFNVNRILGQGGQGTVYKGMR--EDGRIIAVKK--------------------------SKNAVKL 94 (331)
Q Consensus 44 ~~~~~~e-~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~--------------------------~~niv~~ 94 (331)
.+|..++ ......+|..+..||.|.|+.|+.... .++..|++|. |.+++..
T Consensus 252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 4444444 333456788889999999999998764 4577888882 5688888
Q ss_pred hcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-
Q 020102 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER- 173 (331)
Q Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~- 173 (331)
+..|......++--|||.++++...... ...+.+..++.+..|++.++.++|+.. ++|+|++|+||++..+
T Consensus 332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 332 NSSWSQLRQGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCccccccccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccch
Confidence 8888888888899999999988665532 224677888999999999999999988 9999999999999986
Q ss_pred CcEEEeeccCcccccCCCceeeeeccccCCc-cChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH
Q 020102 174 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGY-LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~ 252 (331)
+..+++|||++..+.. ........+..| .+|.......+..+.|++|||..+.+.+++..--... .
T Consensus 404 ~~~~~~~~~~~t~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~--------- 470 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-V--------- 470 (524)
T ss_pred hhhhccccccccccce---ecccccccccccccchhhccccccccccccccccccccccccCcccCccc-c---------
Confidence 7779999999864211 111111223334 3566667778889999999999999999875432111 0
Q ss_pred HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.+..+.....+ ..+.....+..+...++..++..||.+.++.....-.++
T Consensus 471 ----------~~~~i~~~~~p--~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 471 ----------QSLTIRSGDTP--NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred ----------cceeeeccccc--CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 01111111000 011122567788999999999999999888766554443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.13 E-value=2e-10 Score=93.60 Aligned_cols=107 Identities=25% Similarity=0.254 Sum_probs=77.7
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEccccc-----------------------chhhhcccccCCcceeEeecccCCCHHH
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVKKSKN-----------------------AVKLLGCCLETEVPLLVYEFISNGTLYQ 118 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK~~~n-----------------------iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 118 (331)
+.|+.|.++.||++... +..+++|..+. +++++.+ .....++||||++|.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 56899999999998764 67789996321 1222222 2234689999999887643
Q ss_pred HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 119 HLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA--SSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 119 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
. . .....++.+++.+++.||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 81 ~--~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 E--D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred c--c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 2 0 111235678999999999976 22359999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-09 Score=97.26 Aligned_cols=203 Identities=17% Similarity=0.210 Sum_probs=130.5
Q ss_pred ceeEeecccCC-CHHHHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 104 PLLVYEFISNG-TLYQHLHDRLQNQ-EFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 104 ~~lv~e~~~~~-~L~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
..++|..+.+. .+..++......+ .....|......++.++.+.+-||..| .+-+|++++|+|+++++.+.|.|=
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 56677777653 2233332221222 234689999999999999999999999 999999999999999999999885
Q ss_pred cCcccccCCCceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCcccccchHHHH
Q 020102 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTG-KKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 182 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~ 255 (331)
..-.... ........+|...|.+||.-. +..-+..+|.|.||+++++++.| ++||...-..........
T Consensus 162 Dsfqi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--- 236 (637)
T COG4248 162 DSFQINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--- 236 (637)
T ss_pred cceeecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---
Confidence 4332211 122333456899999999543 44567789999999999999886 899864321111111110
Q ss_pred HHHhhcCccccccchH------hhccCCHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHhhhhc
Q 020102 256 VHSMRKNRLYDILDDQ------VMKLGKKNQIMAFANLAERCLDL--NGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cL~~--~p~~RPs~~evl~~L~~l~~~ 315 (331)
..+..+.+....+.. .......-.+.++..+..+|+.. ++.-|||++.++..|..+.++
T Consensus 237 -~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 237 -TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred -hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 001111111111110 00111112345677788888875 367899999999999888764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.5e-10 Score=111.90 Aligned_cols=227 Identities=22% Similarity=0.259 Sum_probs=154.8
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEcc--------------------------cccchhhhcccccCCcce
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKK--------------------------SKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~--------------------------~~niv~~~~~~~~~~~~~ 105 (331)
...+.+.+.+-+-+|+++.++.+.-. .+...+.|. +|-++...--+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34566777788889999999887542 232223331 122222222233456789
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
++++|+.+++|...+... ...+.+........+..++.+||... +.|+|++|.|.++..+|..+++|||...
T Consensus 881 L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 999999999998887652 24565666667777889999999976 8999999999999999999999998432
Q ss_pred cccCC---------------------C---------ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCC
Q 020102 186 FIAMD---------------------Q---------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 235 (331)
Q Consensus 186 ~~~~~---------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 235 (331)
....- . ........+|+.|.+||...+......+|.|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 21100 0 00112256899999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 020102 236 KPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTME 303 (331)
Q Consensus 236 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~ 303 (331)
.||........ +. .+....... ...+...+....+++...+..+|.+|-.+.
T Consensus 1033 pp~na~tpq~~--------f~-ni~~~~~~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQI--------FE-NILNRDIPW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhh--------hh-ccccCCCCC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99865321110 11 111111110 112334455678899999999999997665
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.1e-09 Score=83.95 Aligned_cols=119 Identities=23% Similarity=0.321 Sum_probs=85.1
Q ss_pred cCceecCCCCeEEEEEEecCCcEEEEc-------ccc------------cchhh------------hcccccCCcceeEe
Q 020102 60 VNRILGQGGQGTVYKGMREDGRIIAVK-------KSK------------NAVKL------------LGCCLETEVPLLVY 108 (331)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~vavK-------~~~------------niv~~------------~~~~~~~~~~~lv~ 108 (331)
...++-+|+-+.|+++.. .|+...|| +|| +-.++ .=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457889999999999976 57888888 355 11111 11234555667899
Q ss_pred ecccC-CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc---EEEeeccCc
Q 020102 109 EFISN-GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR---AKVADFGTS 184 (331)
Q Consensus 109 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a 184 (331)
||++| .++.+++..... . +........++..|-+.+.-||..+ ++|+||..+||++..++. +.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~--~-~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--D-ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHcc--C-cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 99986 366777765321 1 2222333678889999999999988 999999999999976553 589999997
Q ss_pred c
Q 020102 185 K 185 (331)
Q Consensus 185 ~ 185 (331)
.
T Consensus 164 ~ 164 (229)
T KOG3087|consen 164 S 164 (229)
T ss_pred h
Confidence 5
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.2e-09 Score=84.68 Aligned_cols=107 Identities=26% Similarity=0.369 Sum_probs=78.6
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEc-------ccc----------------cchhh--------hcccccCCcceeEeec
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVK-------KSK----------------NAVKL--------LGCCLETEVPLLVYEF 110 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK-------~~~----------------niv~~--------~~~~~~~~~~~lv~e~ 110 (331)
..+++|+-+.++.+... |..+++| +|| .+.+. .=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999998553 4446777 233 11111 1122345566799999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++++.+ +.++|||++.
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccc
Confidence 9998888888752 1346667777778999998 99999999999999875 9999999986
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-08 Score=91.57 Aligned_cols=195 Identities=21% Similarity=0.294 Sum_probs=140.4
Q ss_pred CeEEEEEEe-cCCcEEEEcc-----------------------cccchhhhcccc----cCCcceeEeecccC-CCHHHH
Q 020102 69 QGTVYKGMR-EDGRIIAVKK-----------------------SKNAVKLLGCCL----ETEVPLLVYEFISN-GTLYQH 119 (331)
Q Consensus 69 ~g~V~~~~~-~~~~~vavK~-----------------------~~niv~~~~~~~----~~~~~~lv~e~~~~-~~L~~~ 119 (331)
-.+.|++.. .+|..|++|+ |.|+|.+.+++. .+..+++|++|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 367788876 5788888884 669999988886 35568899999986 556654
Q ss_pred Hhhhh----------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 120 LHDRL----------QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 120 l~~~~----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
..... ...+...++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++++.+++|+..|.-..+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43211 122345788999999999999999999999 98899999999999999999998887654433
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
+.. +.+.+ -.+-|.=.||.+++.|.||...-...+...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~------------------------ 483 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQ------------------------ 483 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchH------------------------
Confidence 220 11111 126799999999999999965422111000
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
..-.......++.++++++.-....++++ -+.++++.+.
T Consensus 484 ~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 484 SSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 00012234567788999999999999987 6888887765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-09 Score=90.07 Aligned_cols=73 Identities=30% Similarity=0.426 Sum_probs=48.5
Q ss_pred ceeEeeccc--CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 104 PLLVYEFIS--NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY-LHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 104 ~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
..+||||++ |..+.. +... .++......++.+++..+.. +|..| ++|+|+.+.||+++++ .+.|+|
T Consensus 81 ~~ivME~I~~~G~~~~~-l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPR-LKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp TEEEEE--EETTEEGGC-HHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred CEEEEEecCCCccchhh-HHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 479999998 655544 3331 11133445577777775555 57888 9999999999999988 899999
Q ss_pred ccCcccc
Q 020102 181 FGTSKFI 187 (331)
Q Consensus 181 fg~a~~~ 187 (331)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.9e-09 Score=89.21 Aligned_cols=118 Identities=24% Similarity=0.262 Sum_probs=85.2
Q ss_pred CCccCceecCCCCeEEEEEEecCCcEEEEcccc-------------------------------------cchhhhcc--
Q 020102 57 HFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------------------------NAVKLLGC-- 97 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-------------------------------------niv~~~~~-- 97 (331)
-..+...||-|--|.||.|.+.+|..+|||-|+ -+..++..
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456778999999999999999999999999654 11112211
Q ss_pred c----ccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC
Q 020102 98 C----LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER 173 (331)
Q Consensus 98 ~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~ 173 (331)
- .+.+...+|||+++|..|... +++......++..|+.-+.-+-..| ++|+|+++-||+++++
T Consensus 172 ~VP~P~~~nRHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIAWNRHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCccccccceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 0 123446799999998655331 1123344455666666666666777 9999999999999999
Q ss_pred CcEEEeeccCcccc
Q 020102 174 YRAKVADFGTSKFI 187 (331)
Q Consensus 174 ~~~kl~Dfg~a~~~ 187 (331)
|.+.++||-.+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999877643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.2e-10 Score=105.65 Aligned_cols=156 Identities=24% Similarity=0.272 Sum_probs=106.5
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeee--------eccccCCcc
Q 020102 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--------KIQGTFGYL 205 (331)
Q Consensus 134 ~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~--------~~~gt~~y~ 205 (331)
+....=+.+++.|+.|+|...+ +||++|.|++|.++.+|.+||+.|+.+.....+...... ...-...|.
T Consensus 99 e~~f~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ 176 (700)
T KOG2137|consen 99 EDGFANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFL 176 (700)
T ss_pred cHhhhhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccc
Confidence 4444455667799999998653 999999999999999999999999988654432221111 123456799
Q ss_pred ChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-CCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHH
Q 020102 206 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAG-NTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAF 284 (331)
Q Consensus 206 aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
|||++.+...+.++|+||+||++|-+..|..+..... ...... + .....+.. ..-...+.+.++
T Consensus 177 apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~------~--~~~~~~~~-------~~~~s~~~p~el 241 (700)
T KOG2137|consen 177 APEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS------F--SRNLLNAG-------AFGYSNNLPSEL 241 (700)
T ss_pred cchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh------h--hhcccccc-------cccccccCcHHH
Confidence 9999999888999999999999999985555543322 111110 0 00000110 111124455678
Q ss_pred HHHHHHhhccCCCCCCCHHHHH
Q 020102 285 ANLAERCLDLNGKKRPTMEEVS 306 (331)
Q Consensus 285 ~~li~~cL~~~p~~RPs~~evl 306 (331)
.+=+.+++..++..||++.++.
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhh
Confidence 8889999999999999877763
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-08 Score=86.26 Aligned_cols=118 Identities=25% Similarity=0.338 Sum_probs=86.1
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEcccc--------------------------cchhhhcccccC---CcceeEeeccc
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVKKSK--------------------------NAVKLLGCCLET---EVPLLVYEFIS 112 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK~~~--------------------------niv~~~~~~~~~---~~~~lv~e~~~ 112 (331)
+.|+.|..+.||++...+|..+++|..+ ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999987666788899422 234455555443 25689999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA-------------------------------------- 154 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------------------------------------- 154 (331)
|.++.+.+.. ..++......++.++++++..||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 8877553321 24666677777777888887777531
Q ss_pred ---------------CCCeEEccCCCCCEEeCC--CCcEEEeeccCcc
Q 020102 155 ---------------SSPIYHRDIKSTNILLDE--RYRAKVADFGTSK 185 (331)
Q Consensus 155 ---------------~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~ 185 (331)
...++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 134799999999999998 6668999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.8e-08 Score=83.33 Aligned_cols=77 Identities=21% Similarity=0.249 Sum_probs=63.4
Q ss_pred cceeEeecccCC-CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-------CC
Q 020102 103 VPLLVYEFISNG-TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-------RY 174 (331)
Q Consensus 103 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-------~~ 174 (331)
..++|||++++. +|.+++.... ..+.+......++.+++..+.-||..| |+|+|+++.|||++. ++
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 467999999976 7888775421 234566777889999999999999999 999999999999975 46
Q ss_pred cEEEeeccCcc
Q 020102 175 RAKVADFGTSK 185 (331)
Q Consensus 175 ~~kl~Dfg~a~ 185 (331)
.+.|+||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 78999999875
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.3e-07 Score=75.75 Aligned_cols=132 Identities=23% Similarity=0.294 Sum_probs=90.6
Q ss_pred hHHHHHHhcCCccC---ceecCCCCeEEEEEEecCCcEEEEccc------------------------------------
Q 020102 48 SKELDKATNHFNVN---RILGQGGQGTVYKGMREDGRIIAVKKS------------------------------------ 88 (331)
Q Consensus 48 ~~e~~~~~~~~~~~---~~lg~G~~g~V~~~~~~~~~~vavK~~------------------------------------ 88 (331)
.+.+....++..+. ..|++|--+.||+|...++..+|+|..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 34455555555444 456678888999999888999999932
Q ss_pred ---ccchhhhcccccCC------cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCe
Q 020102 89 ---KNAVKLLGCCLETE------VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPI 158 (331)
Q Consensus 89 ---~niv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i 158 (331)
.|+-+++.....-+ .-.|||||+..... .......-++.......+..++++.+.-|-. .+ +
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~-----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---L 188 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGL-----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---L 188 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCC-----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---c
Confidence 15555555543322 23689999965411 1111122234444677788888888887776 66 9
Q ss_pred EEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 159 YHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 159 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+||+.-|||+. ++.+.|+|||-|....
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999999 7799999999887544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.3e-07 Score=86.50 Aligned_cols=140 Identities=17% Similarity=0.162 Sum_probs=91.9
Q ss_pred cCcccccChHHHHHHhc------------CCccCceecCCCCeEEEEEEecCCcEEEEcc-cc-----------------
Q 020102 40 IDRCKLFSSKELDKATN------------HFNVNRILGQGGQGTVYKGMREDGRIIAVKK-SK----------------- 89 (331)
Q Consensus 40 ~~~~~~~~~~e~~~~~~------------~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~----------------- 89 (331)
.+.++.|+.+|+..... .|. .+.||.-+.|+||+|..++|+.||||. ||
T Consensus 134 qD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~ 212 (538)
T KOG1235|consen 134 QDQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLA 212 (538)
T ss_pred hccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHH
Confidence 36777788877765532 232 267999999999999999999999994 33
Q ss_pred ----------------------------------cchhhhccccc----------------CCcceeEeecccCCCHHHH
Q 020102 90 ----------------------------------NAVKLLGCCLE----------------TEVPLLVYEFISNGTLYQH 119 (331)
Q Consensus 90 ----------------------------------niv~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~ 119 (331)
|.-++...+.+ .....|+|||++|..+.+.
T Consensus 213 ~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl 292 (538)
T KOG1235|consen 213 KVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDL 292 (538)
T ss_pred HHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCH
Confidence 22222222222 2245799999999888664
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC----CCcEEEeeccCcccccC
Q 020102 120 LHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE----RYRAKVADFGTSKFIAM 189 (331)
Q Consensus 120 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~----~~~~kl~Dfg~a~~~~~ 189 (331)
-.- . ...++...+..-+.+...-+-+. .| ++|.|=+|.||+++. ++.+.+.|||+...+..
T Consensus 293 ~~i--~--~~gi~~~~i~~~l~~~~~~qIf~--~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 293 DAI--D--KRGISPHDILNKLVEAYLEQIFK--TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHH--H--HcCCCHHHHHHHHHHHHHHHHHh--cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 221 1 12456554444333332222222 23 999999999999983 67899999999876543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.8e-07 Score=85.64 Aligned_cols=117 Identities=21% Similarity=0.217 Sum_probs=78.8
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEcc-cc---------------------------------------------------
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVKK-SK--------------------------------------------------- 89 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK~-~~--------------------------------------------------- 89 (331)
..|+.++-|+||+|...+|+.||||. +|
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999993 22
Q ss_pred ---cchhhhccccc-------------CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHH-HHHHHh
Q 020102 90 ---NAVKLLGCCLE-------------TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA-LAYLHS 152 (331)
Q Consensus 90 ---niv~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~-l~~lH~ 152 (331)
|..++-..+.+ .....|+|||++|..+.+...-. . ...+...+ +..++.+ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~--~g~d~k~i---a~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--S--AGIDRKEL---AELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--h--cCCCHHHH---HHHHHHHHHHHHHh
Confidence 11112122221 23457999999998887764321 1 23443332 2222222 112222
Q ss_pred cCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 153 ~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
.| +.|.|.+|.||+++.+|.+.+.|||+...+.
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 34 9999999999999999999999999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.9e-07 Score=75.26 Aligned_cols=75 Identities=29% Similarity=0.413 Sum_probs=62.7
Q ss_pred ceeEeecccCC-CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---cEEEe
Q 020102 104 PLLVYEFISNG-TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY---RAKVA 179 (331)
Q Consensus 104 ~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~---~~kl~ 179 (331)
.++|+|++++. +|.+.+.... ..+......++.+++..++-||+.| |+|+|++|.|||++.++ .+.++
T Consensus 92 s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lI 163 (206)
T PF06293_consen 92 SYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLI 163 (206)
T ss_pred EEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEE
Confidence 47899999874 6877776521 2556677889999999999999999 99999999999999887 78999
Q ss_pred eccCccc
Q 020102 180 DFGTSKF 186 (331)
Q Consensus 180 Dfg~a~~ 186 (331)
||+-+..
T Consensus 164 Dld~~~~ 170 (206)
T PF06293_consen 164 DLDRMRF 170 (206)
T ss_pred cchhcee
Confidence 9997753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=9.2e-06 Score=67.68 Aligned_cols=114 Identities=21% Similarity=0.163 Sum_probs=81.2
Q ss_pred ecCCCCeEEEEEEecCCcEEEEccc----------c---------------------cchhhhcccc-c----CCcceeE
Q 020102 64 LGQGGQGTVYKGMREDGRIIAVKKS----------K---------------------NAVKLLGCCL-E----TEVPLLV 107 (331)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~vavK~~----------~---------------------niv~~~~~~~-~----~~~~~lv 107 (331)
-|+||-+.|++-.. +|..+.+|+. | .+++.. ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36689999998755 3447888852 2 122222 111 1 1125789
Q ss_pred eecccC-CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc--EEEeeccCc
Q 020102 108 YEFISN-GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR--AKVADFGTS 184 (331)
Q Consensus 108 ~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a 184 (331)
+|-++| -+|.+++.+. .-.+.+......+..+++.++.-||+.| +.|+|+.+.||+++.+|. +.++||.-+
T Consensus 104 Te~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 997654 5676666541 2224567777889999999999999999 999999999999986677 899999866
Q ss_pred c
Q 020102 185 K 185 (331)
Q Consensus 185 ~ 185 (331)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 5
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=8.3e-06 Score=68.24 Aligned_cols=115 Identities=19% Similarity=0.255 Sum_probs=77.5
Q ss_pred HHhcCCccCceecCCCCeEEEEEEecCCcEEEEcccc------------------------cchhh-----------hcc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK------------------------NAVKL-----------LGC 97 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~------------------------niv~~-----------~~~ 97 (331)
...++|.+.+++-.....-|.+-. -++..+.+|..+ ++.++ +.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe-i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE-IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE-ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 345677877788777777776653 367888888432 11111 111
Q ss_pred cc-----cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC
Q 020102 98 CL-----ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE 172 (331)
Q Consensus 98 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~ 172 (331)
.. -....+++|||++|..|.+... +++ .++..++.++.-+|+.| ++|+|.+|.|+++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 11 1223468999999987754321 222 24566778899999999 999999999999996
Q ss_pred CCcEEEeeccCcc
Q 020102 173 RYRAKVADFGTSK 185 (331)
Q Consensus 173 ~~~~kl~Dfg~a~ 185 (331)
++ +++.||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 65 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.6e-05 Score=65.08 Aligned_cols=29 Identities=21% Similarity=0.249 Sum_probs=25.8
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.|.||++++++ +.++||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3579999999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00012 Score=60.61 Aligned_cols=93 Identities=26% Similarity=0.373 Sum_probs=71.4
Q ss_pred ccchhhhcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCE
Q 020102 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNI 168 (331)
Q Consensus 89 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Ni 168 (331)
+++++++|+|. .++|+||.+.+++...-.. ...-...+|..+..|+.++++.+.+++......+.-.|++|+|+
T Consensus 20 ~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nf 93 (188)
T PF12260_consen 20 EPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNF 93 (188)
T ss_pred CCCCCeeeECC----CEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHe
Confidence 37788888884 4678899987766432000 00112468999999999999999999985545588999999999
Q ss_pred EeCCCCcEEEeeccCcccc
Q 020102 169 LLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 169 ll~~~~~~kl~Dfg~a~~~ 187 (331)
-++++|++|+.|...+...
T Consensus 94 gv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 94 GVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeCCCcEEEEechhcchh
Confidence 9999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.0002 Score=61.03 Aligned_cols=123 Identities=23% Similarity=0.246 Sum_probs=66.2
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEcccc-----------------------cchhhhccccc---CCcceeEeecccCCC
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCLE---TEVPLLVYEFISNGT 115 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK~~~-----------------------niv~~~~~~~~---~~~~~lv~e~~~~~~ 115 (331)
+.|+.|..+.||+....+ ..+++|..+ .+.+++..... ....+++|++++|..
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 578999999999998876 588889543 13344443222 224688999999887
Q ss_pred HHH----------------HHhhhhcC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh---
Q 020102 116 LYQ----------------HLHDRLQN--QEFPLTWEMR---------LRI------------ATEVAG-ALAYLHS--- 152 (331)
Q Consensus 116 L~~----------------~l~~~~~~--~~~~~~~~~~---------~~i------------~~~i~~-~l~~lH~--- 152 (331)
+.. .+...... ...+...... ... ...+.. .+..+++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 766 11111111 1111111110 000 011222 2333332
Q ss_pred -cCCCCeEEccCCCCCEEeC-CCCcEEEeeccCcc
Q 020102 153 -AASSPIYHRDIKSTNILLD-ERYRAKVADFGTSK 185 (331)
Q Consensus 153 -~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~ 185 (331)
.....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234499999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00032 Score=60.59 Aligned_cols=30 Identities=23% Similarity=0.234 Sum_probs=26.3
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 348999999999999998778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=3.8e-06 Score=79.39 Aligned_cols=170 Identities=21% Similarity=0.168 Sum_probs=114.9
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc------------------cccc-chhhhcccccCCcceeEeecccCC-
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK------------------KSKN-AVKLLGCCLETEVPLLVYEFISNG- 114 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK------------------~~~n-iv~~~~~~~~~~~~~lv~e~~~~~- 114 (331)
+..+....-+++|+++.+++......+....+ .+|| .+..++-+..+...+++++++.++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34445556678999999999865322222222 3667 666666677777888999999776
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
+....... ....+..-....+.+.-.++++++|+.. -+|+| ||+.++ +..+..||+.+..+.... .
T Consensus 321 s~~~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~ 386 (829)
T KOG0576|consen 321 SSALEMTV----SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K 386 (829)
T ss_pred cccccCCh----hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--c
Confidence 21111100 0111222233345555677888999854 47888 777666 578999999987654432 3
Q ss_pred eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 020102 195 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 238 (331)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~ 238 (331)
.....+|+.++|||+.....+..+.|+||+|.-..++.-|-+|-
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 44567999999999999999999999999998877777776664
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00011 Score=64.79 Aligned_cols=119 Identities=19% Similarity=0.271 Sum_probs=81.5
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEcccc-------cchh------------------------------hhc--
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------NAVK------------------------------LLG-- 96 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-------niv~------------------------------~~~-- 96 (331)
.-+.+++.||-|--+.||.+-+.+|.+.++|-|+ |+-+ +++
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3467789999999999999999999999999654 1111 111
Q ss_pred c----cccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC
Q 020102 97 C----CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE 172 (331)
Q Consensus 97 ~----~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~ 172 (331)
+ -.+.+..++|||++.|-.|...-. ..+ ...+...+..-+.-|...| ++|+|+.-=||++++
T Consensus 172 fpVPkpiD~~RH~Vvmelv~g~Pl~~v~~--------v~d---~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 172 FPVPKPIDHNRHCVVMELVDGYPLRQVRH--------VED---PPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCCcccccceeeHHHhhcccceeeeee--------cCC---hHHHHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence 0 012344578888888766643211 111 1223444445555666667 999999999999999
Q ss_pred CCcEEEeeccCccccc
Q 020102 173 RYRAKVADFGTSKFIA 188 (331)
Q Consensus 173 ~~~~kl~Dfg~a~~~~ 188 (331)
++.++++||.-.....
T Consensus 238 d~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVSTS 253 (465)
T ss_pred CCCEEEeechHhhccC
Confidence 9999999998665443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00049 Score=69.74 Aligned_cols=185 Identities=18% Similarity=0.176 Sum_probs=123.3
Q ss_pred ccccchhhhcccccCCcce----eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcc
Q 020102 87 KSKNAVKLLGCCLETEVPL----LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162 (331)
Q Consensus 87 ~~~niv~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 162 (331)
.|+|++.++.+........ +..+++...++...+.. -...+..+...+..+...|+.|+|+.. ..|.-
T Consensus 240 ~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-----v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~ 311 (1351)
T KOG1035|consen 240 AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-----VGSIPLETLRILHQKLLEGLAYLHSLS---LEHVV 311 (1351)
T ss_pred ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-----ccccCHHHHHHHHHHHhhhHHHHHHhc---cceeE
Confidence 3678888777766544332 34577777777776654 246888999999999999999999976 66655
Q ss_pred CCCC---CEEeCCCCcEEEe--eccCcccccCCCceeeeeccccCCccChhhhcCCCCCC--cchHHHHHHHHHHHHhCC
Q 020102 163 IKST---NILLDERYRAKVA--DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD--KSDVYSFGVVLVELLTGK 235 (331)
Q Consensus 163 ikp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG~il~el~~g~ 235 (331)
+..+ +.-.+..+.+.++ ||+....+......... ..+..+.+||......+.. ..|+|.+|.....+..|.
T Consensus 312 L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 312 LSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred EecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence 5555 4455566667766 88888765544332222 2345577888766655443 479999999999999876
Q ss_pred CCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 236 KPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 236 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
.+-...... ...+ + ........+....|+..++++|+++.+++...
T Consensus 390 ~i~~~~~~~-----------~~~l---------~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 390 DISEKSAVP-----------VSLL---------D--------VLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred cccccccch-----------hhhh---------c--------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 553211100 0000 0 00000466789999999999999999997764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0017 Score=66.14 Aligned_cols=30 Identities=23% Similarity=0.401 Sum_probs=24.1
Q ss_pred CeEEccCCCCCEEeCC-CCc-EEEeeccCccc
Q 020102 157 PIYHRDIKSTNILLDE-RYR-AKVADFGTSKF 186 (331)
Q Consensus 157 ~i~H~dikp~Nill~~-~~~-~kl~Dfg~a~~ 186 (331)
.+||+|+++.||+++. ++. .-|.||.++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 3999999999999985 334 57899988753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0022 Score=53.25 Aligned_cols=39 Identities=33% Similarity=0.448 Sum_probs=32.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 138 ~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
.-+.+|.+-+..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 34567778888999999 999999999987 4589999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0022 Score=57.66 Aligned_cols=120 Identities=19% Similarity=0.282 Sum_probs=87.4
Q ss_pred ccCceecCCCCeEEEEEEecCCcEEEEccc-----------------------------------------ccchhhhcc
Q 020102 59 NVNRILGQGGQGTVYKGMREDGRIIAVKKS-----------------------------------------KNAVKLLGC 97 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-----------------------------------------~niv~~~~~ 97 (331)
.+..+|..|--+.||.|...+|..+|||.. +|+.++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456889999999999999999999999931 255555555
Q ss_pred cccCCc------ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 020102 98 CLETEV------PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171 (331)
Q Consensus 98 ~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~ 171 (331)
....+. ..|||+++....- -.. .....+++...+..+-.|++.-+.-|.+.+. +||.||+--|+|+.
T Consensus 227 GIP~PePIlLk~hVLVM~FlGrdgw---~aP--kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILLKNHVLVMEFLGRDGW---AAP--KLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceeeecceEeeeeccCCCC---cCc--ccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE
Confidence 443332 3689999963321 111 2234567777888888888888887766543 99999999999997
Q ss_pred CCCcEEEeeccCccc
Q 020102 172 ERYRAKVADFGTSKF 186 (331)
Q Consensus 172 ~~~~~kl~Dfg~a~~ 186 (331)
+. .+.|+|.+-+.-
T Consensus 300 dG-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DG-KLYIIDVSQSVE 313 (520)
T ss_pred CC-EEEEEEcccccc
Confidence 54 799999887653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0014 Score=52.85 Aligned_cols=111 Identities=19% Similarity=0.182 Sum_probs=69.1
Q ss_pred ccCceecCCCCeEEEEEEecCCcEEEEcccc------c------chhhhcccc------cCCcceeEeecccCCCHHHHH
Q 020102 59 NVNRILGQGGQGTVYKGMREDGRIIAVKKSK------N------AVKLLGCCL------ETEVPLLVYEFISNGTLYQHL 120 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~------n------iv~~~~~~~------~~~~~~lv~e~~~~~~L~~~l 120 (331)
+..+.|++|++|.||+|... +..+|+|..+ | +..+..-.. .-+..++.|||+.|.+|.+.-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~ 103 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLE 103 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhh
Confidence 45578999999999999875 4477888422 1 111111111 112234569999988886644
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCC-CCEEeCCCCcEEEeeccCcc
Q 020102 121 HDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS-TNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp-~Nill~~~~~~kl~Dfg~a~ 185 (331)
.. .+...+ ..++++..-|...| |-|..|+- ...++-+++.+.|+||..|+
T Consensus 104 ~~--------~~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 104 IG--------GDRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hc--------ccHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 32 122232 34555655667777 99998874 44444444589999999886
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0034 Score=55.95 Aligned_cols=55 Identities=7% Similarity=0.092 Sum_probs=38.4
Q ss_pred CceecCCCCeEEEEEEecCCcEEEEcccc------------------------cchhhhccccc---CCcceeEeecccC
Q 020102 61 NRILGQGGQGTVYKGMREDGRIIAVKKSK------------------------NAVKLLGCCLE---TEVPLLVYEFISN 113 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~------------------------niv~~~~~~~~---~~~~~lv~e~~~~ 113 (331)
.+.||.|..+.||+....+++ +.+|..+ .++++++++.. .+..++|||+++|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 467999999999998765565 3334211 45566766643 3568999999998
Q ss_pred CCH
Q 020102 114 GTL 116 (331)
Q Consensus 114 ~~L 116 (331)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0044 Score=53.18 Aligned_cols=30 Identities=27% Similarity=0.470 Sum_probs=25.4
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.|.||++++++..-|.||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 348999999999999877656799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.00 E-value=8.6e-05 Score=76.90 Aligned_cols=134 Identities=13% Similarity=0.039 Sum_probs=100.2
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA--SSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
..+.+++|+.+|.+.+.+.+.... ..++...-+.....+...+..-+|+.. .+..+|+++|+.|.+|..+..+++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee-~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEE-SPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhcccc-CCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 457889999999999888664222 224444444444444455566655532 45679999999999999999999999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 238 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~ 238 (331)
+|+.+. ..+.........+++.|++|+..+.-.++.++|+|+.|+.+|+...|..+|
T Consensus 1384 ~gLdKI-knp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1384 GGLDKI-KNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccc-cCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 999983 333344444566888899999999888999999999999999988887765
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.01 Score=53.47 Aligned_cols=30 Identities=20% Similarity=0.264 Sum_probs=25.7
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..+||+|+.|.||+++++...-|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 359999999999999976556899999875
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0062 Score=52.13 Aligned_cols=29 Identities=28% Similarity=0.446 Sum_probs=25.9
Q ss_pred CeEEccCCCCCEEeCC-CCcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDE-RYRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~-~~~~kl~Dfg~a~ 185 (331)
.++|+|+.+.||++++ ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 4899999999999998 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.016 Score=51.46 Aligned_cols=30 Identities=27% Similarity=0.313 Sum_probs=26.4
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.|.||++++++.+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 349999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.02 Score=47.72 Aligned_cols=83 Identities=25% Similarity=0.260 Sum_probs=54.5
Q ss_pred cchhhhcccccCCcceeEeecccC--CC----HHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC
Q 020102 90 NAVKLLGCCLETEVPLLVYEFISN--GT----LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDI 163 (331)
Q Consensus 90 niv~~~~~~~~~~~~~lv~e~~~~--~~----L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~di 163 (331)
++.+++|+...+.-..+|+|.+.+ |+ |.+++.. ..++. ... ..+-.-..||-+.+ |+.+|+
T Consensus 78 ~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl 144 (199)
T PF10707_consen 78 HIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE------GGLTE-ELR---QALDEFKRYLLDHH---IVIRDL 144 (199)
T ss_pred ccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc------CCccH-HHH---HHHHHHHHHHHHcC---CeecCC
Confidence 677788888888888899988754 33 4444432 24554 333 33334445777666 999999
Q ss_pred CCCCEEeCCC--C--cEEEee-ccCcc
Q 020102 164 KSTNILLDER--Y--RAKVAD-FGTSK 185 (331)
Q Consensus 164 kp~Nill~~~--~--~~kl~D-fg~a~ 185 (331)
+|.||++... + .+.|+| ||...
T Consensus 145 ~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred CcccEEEEecCCCceEEEEEeCCCCcc
Confidence 9999999632 2 467777 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.02 Score=52.98 Aligned_cols=29 Identities=24% Similarity=0.369 Sum_probs=24.9
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.|.||++..+ .++++||-++.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 348999999999999877 58999998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.032 Score=49.97 Aligned_cols=30 Identities=27% Similarity=0.314 Sum_probs=26.6
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..+||+|+++.||++++++...|.||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 459999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.097 Score=46.88 Aligned_cols=30 Identities=20% Similarity=0.387 Sum_probs=27.4
Q ss_pred CeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 157 PIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
.++|+|+.+.|++++..+.+-+.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 689999999999999988899999999863
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.12 Score=47.80 Aligned_cols=28 Identities=14% Similarity=0.303 Sum_probs=23.4
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
...+|+|+.|.||++++++ .++.|.-++
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~ 257 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFA 257 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhh
Confidence 4589999999999999875 788886655
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.13 Score=46.92 Aligned_cols=28 Identities=29% Similarity=0.357 Sum_probs=24.0
Q ss_pred CeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
.++|+|+.+.||++++++ ++++|+..+.
T Consensus 193 ~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred eeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 489999999999998764 7799988764
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.038 Score=48.90 Aligned_cols=53 Identities=21% Similarity=0.254 Sum_probs=32.2
Q ss_pred CceecCCCCeEEEEEEecCCcEEEEcccc-----------------------cchhhhcccccCCcceeEeecccCC
Q 020102 61 NRILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~-----------------------niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
.+.++-|....+|+.. .+++.+.||..+ .+++++++....+..++|+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3668888889999876 677788888532 4667777777677779999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.16 Score=46.11 Aligned_cols=105 Identities=16% Similarity=0.148 Sum_probs=68.8
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..|++|++- |+++. .+ ....+.++..++.+.+.-++-+.... +.-|||+.-.||+|+ +|++.|+||-
T Consensus 300 y~yl~~kdh-gt~is-~i--------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 300 YLYLHFKDH-GTPIS-II--------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred EEEEEEecC-Cceee-ee--------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 456677764 34432 12 13567888999998888888887754 489999999999999 9999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHH
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVV 227 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 227 (331)
+++.-..+...... ..-.|-.+.|.. +..-+||-+--.
T Consensus 367 lsRl~~~q~~isy~------rldhp~lF~G~d-d~QFeIYrlMr~ 404 (488)
T COG5072 367 LSRLSYSQGIISYN------RLDHPDLFNGVD-DYQFEIYRLMRR 404 (488)
T ss_pred eeecccCCceeecc------ccCchhhhcCcc-ceeeeHHHHHHH
Confidence 99843322211111 123455555433 556677764433
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.1 Score=46.47 Aligned_cols=30 Identities=27% Similarity=0.366 Sum_probs=26.5
Q ss_pred CCeEEccCCCCCEEeCCC----CcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDER----YRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~ 185 (331)
..+||+|+.|.||+++++ +.+.++||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 458999999999999975 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.047 Score=44.87 Aligned_cols=28 Identities=14% Similarity=0.255 Sum_probs=25.0
Q ss_pred CeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..+|+|+.|.|++++++| ++++||+.|.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 369999999999998887 8899999875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.89 E-value=0.14 Score=45.76 Aligned_cols=29 Identities=31% Similarity=0.418 Sum_probs=25.1
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999998 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.21 Score=44.62 Aligned_cols=41 Identities=22% Similarity=0.182 Sum_probs=29.7
Q ss_pred HHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCC
Q 020102 133 WEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDER 173 (331)
Q Consensus 133 ~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~ 173 (331)
.+-+..++.||+.-.-.+.+ .+....+|.||||+||||-+.
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 35567788888876645533 335569999999999999544
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.13 E-value=0.28 Score=45.26 Aligned_cols=59 Identities=15% Similarity=0.151 Sum_probs=39.8
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~ 171 (331)
.++=+|..|.++..++.. ...++.....++.-.+.|+--+--.. +++|.|+.|.||++.
T Consensus 321 vl~E~~~~Gl~v~~~v~~------~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKW------KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhc------ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 456677788887777754 23455566666666666665443322 399999999999995
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.065 Score=45.09 Aligned_cols=28 Identities=29% Similarity=0.498 Sum_probs=20.3
Q ss_pred eEEccCCCCCEEe-CCCCcEEEeeccCcc
Q 020102 158 IYHRDIKSTNILL-DERYRAKVADFGTSK 185 (331)
Q Consensus 158 i~H~dikp~Nill-~~~~~~kl~Dfg~a~ 185 (331)
++|+|+.|.||++ +.++.++|+||..|.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 8999999999999 788999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=92.91 E-value=0.078 Score=46.06 Aligned_cols=28 Identities=18% Similarity=0.318 Sum_probs=25.0
Q ss_pred CeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
.++|+|+.|.||++++++ +.|+||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 489999999999999887 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.90 E-value=0.2 Score=43.95 Aligned_cols=29 Identities=21% Similarity=0.302 Sum_probs=26.7
Q ss_pred CeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
.+||+|+.|.|++.++.+.++|+||..|.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCC
Confidence 38999999999999999999999998774
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.76 E-value=0.3 Score=44.10 Aligned_cols=28 Identities=29% Similarity=0.545 Sum_probs=25.4
Q ss_pred eEEccCCCCCEEeCCCCc-EEEeeccCcc
Q 020102 158 IYHRDIKSTNILLDERYR-AKVADFGTSK 185 (331)
Q Consensus 158 i~H~dikp~Nill~~~~~-~kl~Dfg~a~ 185 (331)
+||+|+.|.||+++.+.. .-+.||+.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998875 8899999875
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.50 E-value=0.26 Score=44.30 Aligned_cols=40 Identities=23% Similarity=0.188 Sum_probs=27.0
Q ss_pred HHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeCC
Q 020102 133 WEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLDE 172 (331)
Q Consensus 133 ~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~~ 172 (331)
.+-+..++.|||.-.--+.+. +....+|.||||+|||+-+
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 314 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFD 314 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEec
Confidence 345666777876544324332 3456999999999999943
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.25 E-value=0.25 Score=44.20 Aligned_cols=30 Identities=17% Similarity=0.314 Sum_probs=27.2
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..+||+|+.++|+++++++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 359999999999999999999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=91.98 E-value=0.14 Score=45.17 Aligned_cols=29 Identities=31% Similarity=0.538 Sum_probs=24.8
Q ss_pred CeEEccCCCCCEEeCCCCc-EEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDERYR-AKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~-~kl~Dfg~a~ 185 (331)
.++|+|++|.||++++++. .-|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997565 4699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=91.90 E-value=0.16 Score=42.84 Aligned_cols=74 Identities=22% Similarity=0.171 Sum_probs=48.4
Q ss_pred HHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHH
Q 020102 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYS 223 (331)
Q Consensus 144 ~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 223 (331)
+.+|.-.|+.. .+.+|+|-.|+||+-|..|.+||.|-+... ........ .. ....+.++.+-+
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~~V~~vN------~~--------Y~~lT~~aE~~~ 213 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--ENQVNMVN------IE--------YESLTQEAEVKV 213 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--hheeeEEe------ee--------ccccChHHHHHH
Confidence 45677788643 459999999999999999999999987542 11111111 11 123355666767
Q ss_pred HHHHHHHHHhC
Q 020102 224 FGVVLVELLTG 234 (331)
Q Consensus 224 lG~il~el~~g 234 (331)
|-..++++...
T Consensus 214 fv~s~l~~v~~ 224 (308)
T PF07387_consen 214 FVKSCLKLVEK 224 (308)
T ss_pred HHHHHHHHHHH
Confidence 66666666653
|
The function of this family is unknown. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.82 E-value=0.17 Score=42.16 Aligned_cols=29 Identities=24% Similarity=0.347 Sum_probs=24.6
Q ss_pred CeEEccCCCCCEEeCCCC-----cEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDERY-----RAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~-----~~kl~Dfg~a~ 185 (331)
.++|+|+.+.|+++..++ .+.+.||..+.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 489999999999998543 58999999875
|
subfamily of choline kinases |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=91.78 E-value=0.062 Score=40.82 Aligned_cols=34 Identities=21% Similarity=0.221 Sum_probs=29.2
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEcc-cccchhhh
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVKK-SKNAVKLL 95 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK~-~~niv~~~ 95 (331)
..||.|+.|+||+|...+|+.||||. +|++...+
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i 51 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQI 51 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchHHHHHH
Confidence 67999999999999998999999995 77666543
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.75 E-value=0.26 Score=44.93 Aligned_cols=29 Identities=24% Similarity=0.463 Sum_probs=25.5
Q ss_pred CeEEccCCCCCEEeCC-CCcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDE-RYRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~-~~~~kl~Dfg~a~ 185 (331)
.++|+|+++.||++++ ++.+.++||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 4899999999999986 4679999998875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=90.55 E-value=2 Score=36.68 Aligned_cols=28 Identities=21% Similarity=0.390 Sum_probs=23.7
Q ss_pred cchhhhcccccCCcceeEeecccCCCHH
Q 020102 90 NAVKLLGCCLETEVPLLVYEFISNGTLY 117 (331)
Q Consensus 90 niv~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (331)
++.+++.+..+..+.++|+||++-+.+.
T Consensus 72 ~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 72 TVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cccceEEecCCCCeeEEEEeeccCCCCC
Confidence 6778888888899999999999986664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 331 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-43 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-43 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-08 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-08 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-08 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-08 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-08 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-08 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-08 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-08 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-08 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-08 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-110
Identities = 106/304 (34%), Positives = 158/304 (51%), Gaps = 30/304 (9%)
Query: 33 NSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKS---- 88
S V +L++ATN+F+ ++G G G VYKG+ DG +A+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 89 -------------------KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEF 129
+ V L+G C E +L+Y+++ NG L +HL+
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM- 134
Query: 130 PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIA 188
++WE RL I A L YLH+ I HRD+KS NILLDE + K+ DFG SK
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248
+DQTH++T ++GT GY+DPEY +LT+KSDVYSFGVVL E+L + I + +E
Sbjct: 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ--SLPREM 249
Query: 249 VSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308
V+LA + V S +L I+D + + + F + A +CL L+ + RP+M +V +
Sbjct: 250 VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
Query: 309 LNGI 312
L
Sbjct: 310 LEYA 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-102
Identities = 102/310 (32%), Positives = 166/310 (53%), Gaps = 25/310 (8%)
Query: 44 KLFSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK---------------- 87
K FS +EL A+++F+ ILG+GG G VYKG DG ++AVK+
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 88 --------SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
+N ++L G C+ LLVY +++NG++ L +R ++Q PL W R RI
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PLDWPKRQRI 136
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
A A LAYLH I HRD+K+ NILLDE + A V DFG +K + THVTT ++
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 200 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259
GT G++ PEY + + ++K+DV+ +GV+L+EL+TG++ A + ++V L + +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKK 319
++ +L ++D + K ++ +A C + +RP M EV L G + R +
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316
Query: 320 RAMFSKIIKR 329
++ ++
Sbjct: 317 EWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 280 bits (720), Expect = 4e-94
Identities = 96/308 (31%), Positives = 143/308 (46%), Gaps = 45/308 (14%)
Query: 42 RCKLFSSKELDKATNHFN------VNRILGQGGQGTVYKGMREDGRIIAVKKSK------ 89
R FS EL TN+F+ +G+GG G VYKG + +AVKK
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDIT 69
Query: 90 ---------------------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQE 128
N V+LLG + + LVY ++ NG+L L +
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGT 127
Query: 129 FPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FI 187
PL+W MR +IA A + +LH HRDIKS NILLDE + AK++DFG ++
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
QT +T++I GT Y+ PE ++T KSD+YSFGVVL+E++TG + + +E
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV----DEHRE 239
Query: 248 NVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307
L + + + D+ M + A ++A +CL KRP +++V
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 308 ELNGIRGS 315
L + S
Sbjct: 300 LLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-67
Identities = 62/310 (20%), Positives = 105/310 (33%), Gaps = 50/310 (16%)
Query: 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK------------------ 87
++ L + + + +G G V+K +AVK
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 88 ----SKNAVKLLGCCLETEVP----LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
+N ++ +G L+ F G+L L ++W I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHI 126
Query: 140 ATEVAGALAYLHSAASS-------PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192
A +A LAYLH I HRDIKS N+LL A +ADFG + ++
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 193 HVTTKIQ-GTFGYLDPEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
T Q GT Y+ PE + + D+Y+ G+VL EL + +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 247 ---ENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM-AFANLAERCLDLNGKKRPTM 302
E + M++ ++ + +K+ M E C D + + R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 303 EEVSMELNGI 312
V + +
Sbjct: 307 GCVGERITQM 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-59
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 51/292 (17%)
Query: 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK------------------- 87
S +D V ++G+G G V K + +A+K+
Sbjct: 1 SLHMIDY--KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSR 57
Query: 88 --SKNAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144
N VKL G CL P+ LV E+ G+LY LH T + + +
Sbjct: 58 VNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCS 112
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYR-AKVADFGTSKFIAMDQTHVTTKIQGTFG 203
+AYLHS + HRD+K N+LL K+ DFGT+ D T +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAA 168
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263
++ PE + S ++K DV+S+G++L E++T +KP F + A + R
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP-FDEIGGPAFRIMWAVH-----NGTR 222
Query: 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
++ KN +L RC + +RP+MEE+ + +
Sbjct: 223 P-PLI---------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-57
Identities = 80/286 (27%), Positives = 122/286 (42%), Gaps = 47/286 (16%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------------N 90
N+ +G G GTV++ G +AVK N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
V +G + +V E++S G+LY+ LH L RL +A +VA + YL
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 210
H+ + PI HR++KS N+L+D++Y KV DFG S+ A + GT ++ PE
Sbjct: 154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVL 211
Query: 211 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270
+ +KSDVYSFGV+L EL T ++P + N +Q V + RL +I
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQP-WGNLNPAQ-----VVAAV-GFKCKRL-EI--- 260
Query: 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
+N A + E C KRP+ + L + S+
Sbjct: 261 ------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-56
Identities = 75/295 (25%), Positives = 121/295 (41%), Gaps = 64/295 (21%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK--------------------------- 87
N + +G+GG G V+KG +D ++A+K
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 88 ---SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144
N VKL G P +V EF+ G LY L ++ P+ W ++LR+ ++A
Sbjct: 79 NLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLL----DKAHPIKWSVKLRLMLDIA 132
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDER-----YRAKVADFGTSKFIAMDQTHVTTKIQ 199
+ Y+ + + PI HRD++S NI L AKVADFG S+ H + +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLL 187
Query: 200 GTFGYLDPE--YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVH 257
G F ++ PE + T+K+D YSF ++L +LTG+ P F + + +
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGK-----IKFINM 241
Query: 258 SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
+ I +D N+ E C + KKRP + EL+ +
Sbjct: 242 IREEGLRPTIPED---------CPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 8e-56
Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 62/292 (21%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------------- 89
+ I+G GG G VY+ G +AVK ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 90 -NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
N + L G CL+ LV EF G L + L + + ++ + A ++A +
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMN 119
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYR--------AKVADFGTSKFIAMDQTHVTTKIQG 200
YLH A PI HRD+KS+NIL+ ++ K+ DFG ++ +T + G
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAA-G 176
Query: 201 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
+ ++ PE ++S + SDV+S+GV+L ELLTG+ P F + AY V +M
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP-FRGIDGLA-----VAYGV-AMN 229
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
K L I FA L E C + + RP+ + +L I
Sbjct: 230 KLAL-PIP---------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-52
Identities = 53/288 (18%), Positives = 101/288 (35%), Gaps = 58/288 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------------N 90
N L + G ++KG R G I VK K N
Sbjct: 10 KQLNFLTKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 91 AVKLLGCCLETEVPLL--VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
+ +LG C P + ++ G+LY LH+ F + ++ A ++A +A
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMA 125
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
+LH+ I + S ++++DE A+++ ++ PE
Sbjct: 126 FLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPE 178
Query: 209 ---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265
+D++SF V+L EL+T + P F+ + + V ++ R
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVP-FADLSNME-----IGMKV-ALEGLRP- 230
Query: 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
I + L + C++ + KRP + + L ++
Sbjct: 231 TI---------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-51
Identities = 60/335 (17%), Positives = 114/335 (34%), Gaps = 61/335 (18%)
Query: 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK------------------ 87
++ E ++ + ++G+G G VYKG D R +AVK
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKG-SLDERPVAVKVFSFANRQNFINEKNIYRV 61
Query: 88 ----SKNAVKLLGCCLETEVP-----LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLR 138
N + + LLV E+ NG+L ++L W R
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCR 115
Query: 139 IATEVAGALAYLHSAASS------PIYHRDIKSTNILLDERYRAKVADFGTSKFIA---- 188
+A V LAYLH+ I HRD+ S N+L+ ++DFG S +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 189 ---MDQTHVTTKIQGTFGYLDPEY-------HQSSQLTDKSDVYSFGVVLVELLTGKKPI 238
++ + GT Y+ PE + D+Y+ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 239 FSAGNTSQENVSLAAYF-----VHSMRKNRLYDILDDQVMKLGKKNQIM--AFANLAERC 291
F + + ++ M+ + + + K+N + + E C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 292 LDLNGKKRPTMEEVSMELNGIRGSSRKKRAMFSKI 326
D + + R T + + + + +++
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 51/297 (17%), Positives = 96/297 (32%), Gaps = 67/297 (22%)
Query: 60 VNRILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVK 93
+ ++G+G G VY G + +A++ N V
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
+G C+ ++ TLY + D + L +IA E+ + YLH+
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHA- 148
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA----MDQTHVTTKIQGTFGYLDPEY 209
I H+D+KS N+ D + + DFG + G +L PE
Sbjct: 149 --KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 210 HQSSQL---------TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260
+ + SDV++ G + EL + P F + +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-FKTQPAEA-----IIWQMG--- 256
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317
++ + K +++ C ++RPT ++ L + +R
Sbjct: 257 TGMKPNLSQIGMGK--------EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-49
Identities = 70/282 (24%), Positives = 114/282 (40%), Gaps = 56/282 (19%)
Query: 62 RILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLL 95
+ +G G GTVYKG D +AVK N + +
Sbjct: 30 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 96 GCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
G T L +V ++ +LY HLH E + + IA + A + YLH+
Sbjct: 87 GYS--TAPQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 155 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLDPE---YH 210
I HRD+KS NI L E K+ DFG + + +H ++ G+ ++ PE
Sbjct: 139 -KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 211 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270
S+ + +SDVY+FG+VL EL+TG+ P + +++ + R + D+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIEMV-----GRGSLSPDLSKV 250
Query: 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
+ N L CL +RP+ + E+ +
Sbjct: 251 R------SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-49
Identities = 63/289 (21%), Positives = 107/289 (37%), Gaps = 60/289 (20%)
Query: 62 RILGQGGQGTVYKGM-REDGRIIAVKKSK-----------------------NAVKLLGC 97
+LG+G G K RE G ++ +K+ N +K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
+ + + E+I GTL + + W R+ A ++A +AYLHS
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-------------GTFGY 204
I HRD+ S N L+ E VADFG ++ + ++T G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264
+ PE +K DV+SFG+VL E++ + L + +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFGLN--VRGFLDRYCP 245
Query: 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
+ +F + RC DL+ +KRP+ ++ L +R
Sbjct: 246 PNCPP-------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-46
Identities = 60/301 (19%), Positives = 102/301 (33%), Gaps = 50/301 (16%)
Query: 62 RILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCL 99
+ +G+G G V+ G + G +AVK + +N + + +
Sbjct: 43 KQIGKGRYGEVWMG-KWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 100 ETEVP----LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
+ L+ ++ NG+LY +L L + L++A L +LH+
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 156 S-----PIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTFGYLDP 207
S I HRD+KS NIL+ + +AD G + + GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 208 E------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSM 259
E Q +D+YSFG++L E+ ++ + M
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 260 RKNRLYDILDDQVMKLGKKNQIM-AFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318
R+ L ++ + L C N R T V L + S
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335
Query: 319 K 319
K
Sbjct: 336 K 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 59/304 (19%), Positives = 100/304 (32%), Gaps = 70/304 (23%)
Query: 62 RILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCL 99
+G+G G V++G G +AVK + +N + + +
Sbjct: 14 ECVGKGRYGEVWRG-SWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 100 ETEVP----LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
+ L+ + G+LY +L L LRI +A LA+LH
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 156 S-----PIYHRDIKSTNILLDERYRAKVADFGTSKFIA----MDQTHVTTKIQGTFGYLD 206
I HRD+KS NIL+ + + +AD G + + ++ GT Y+
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMA 185
Query: 207 PE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPI---------FSAGNTSQENVSL 251
PE + D+++FG+VL E+ F + +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 252 AAYFVHSMRKNRLY---DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308
V + + R D + + A L + C N R T +
Sbjct: 246 MRKVV-CVDQQRPNIPNRWFSDPTLT--------SLAKLMKECWYQNPSARLTALRIKKT 296
Query: 309 LNGI 312
L I
Sbjct: 297 LTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 60/302 (19%), Positives = 107/302 (35%), Gaps = 54/302 (17%)
Query: 63 ILGQGGQGTVYKGMREDGRIIAVKK----------------------SKNAVKLLGCCLE 100
+G+G G V++G + G +AVK +N + + +
Sbjct: 49 SIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 101 TEVP----LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASS 156
LV ++ +G+L+ +L+ +T E +++A A LA+LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 157 -----PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI---QGTFGYLDPE 208
I HRD+KS NIL+ + +AD G + + GT Y+ PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 209 --------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHS 258
H S ++D+Y+ G+V E+ + ++ + V
Sbjct: 222 VLDDSINMKHFES--FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 259 MRKNRLYDILDDQVMKLGKKNQIM-AFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317
MRK L + + + + A + C NG R T + L+ +
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339
Query: 318 KK 319
K
Sbjct: 340 IK 341
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 60 VNRILGQGGQGTVYKGMRED---GRIIAVK------------------KSKNAVKL---- 94
+ LG GG TVY ED +A+K + N+ +L
Sbjct: 15 IVDKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 95 ------LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
+ E + LV E+I TL +++ PL+ + + ++ +
Sbjct: 73 IVSMIDVDE--EDDCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIK 125
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGYLD 206
+ H I HRDIK NIL+D K+ DFG +K A+ +T +T + GT Y
Sbjct: 126 HAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFS 180
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
PE + + +D+YS G+VL E+L G+ P
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 54/277 (19%), Positives = 99/277 (35%), Gaps = 47/277 (16%)
Query: 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK--------------------------S 88
+F + + +G+G VY+ DG +A+KK
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
N +K +E +V E G L + + + + + + ++ AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTVWKYFVQLCSALE 150
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
++HS + HRDIK N+ + K+ D G +F + T + + GT Y+ PE
Sbjct: 151 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 206
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
+ KSD++S G +L E+ + P F + ++ I
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP-FYGDKMNLYSL--------------CKKIE 251
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
L + L C++ + +KRP + V
Sbjct: 252 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 57/271 (21%), Positives = 88/271 (32%), Gaps = 48/271 (17%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNAVKLLGCCLET--EVPLL------- 106
F LG G G V+K +EDGR+ AVK+S + + EV
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 107 -----VYEFISNGTLY-------QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
+ G LY L + L + ALA+LHS
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-- 175
Query: 155 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 214
+ H D+K NI L R R K+ DFG + +G Y+ PE Q
Sbjct: 176 -QGLVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRYMAPELLQ-GS 231
Query: 215 LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274
+DV+S G+ ++E+ + +R+ L +
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEG------------WQQLRQGYLPPEFTAGLSS 279
Query: 275 LGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
++ L+ + K R T E +
Sbjct: 280 --------ELRSVLVMMLEPDPKLRATAEAL 302
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 53/226 (23%)
Query: 60 VNRILGQGGQGTVYKGMRED---GRIIAVK------------------KSKNAVKL---- 94
+ R++G+GG G VY+ ED RI+A+K +++ A +L
Sbjct: 38 LRRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 95 ------LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
G + I+ L L + PL + I ++ AL
Sbjct: 96 VVPIHDFGE--IDGQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALD 148
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGYLD 206
H+A HRD+K NIL+ A + DFG + A +T GT Y+
Sbjct: 149 AAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMA 203
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252
PE S T ++D+Y+ VL E LTG P + + +S+
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPP-YQG-----DQLSVM 243
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 66/285 (23%), Positives = 108/285 (37%), Gaps = 60/285 (21%)
Query: 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSK 89
+ V +G G G K R DG+I+ K K
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 90 NAVKLLGCCLETEVPLL--VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
N V+ ++ L V E+ G L + + ++ L E LR+ T++ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLAL 124
Query: 148 AYLHS--AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
H + HRD+K N+ LD + K+ DFG ++ + D + T + GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265
PE +KSD++S G +L EL P F+A + +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKE------------------- 223
Query: 266 DILDDQVMKLGKKNQIM-----AFANLAERCLDLNGKKRPTMEEV 305
L ++ + GK +I + R L+L RP++EE+
Sbjct: 224 --LAGKIRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 62/286 (21%), Positives = 101/286 (35%), Gaps = 67/286 (23%)
Query: 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSK-------------------NAVKLL 95
F ++G GG G V+K DG+ +K+ K N V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYN 70
Query: 96 GCCLETEVPL----------------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
GC + + EF GTL Q + R L + L +
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLALEL 127
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
++ + Y+HS + +RD+K +NI L + + K+ DFG ++ T+ +
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKRTRSK 182
Query: 200 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259
GT Y+ PE S + D+Y+ G++L ELL F F +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----------FFTDL 231
Query: 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
R + DI D + L ++ L + RP E+
Sbjct: 232 RDGIISDIFDKK------------EKTLLQKLLSKKPEDRPNTSEI 265
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 41/210 (19%), Positives = 72/210 (34%), Gaps = 50/210 (23%)
Query: 60 VNRILGQGGQGTVYKG--MREDGRIIAVKKSKNA------------------------VK 93
V + GG G +Y +GR + +K ++ V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 94 LL-----GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
+ V +V E++ +L + L + E+ AL+
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALS 196
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
YLHS + + D+K NI+L E + K+ D G ++ + GT G+ PE
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY---LYGTPGFQAPE 247
Query: 209 YHQ-SSQLTDKSDVYSFGVVLVELLTGKKP 237
+ T +D+Y+ G L L
Sbjct: 248 --IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 79/277 (28%), Positives = 112/277 (40%), Gaps = 56/277 (20%)
Query: 60 VNRILGQGGQGTVYKGMRED---GRIIAVK------------------KSKNAVKL---- 94
+ ILG GG V+ D R +AVK +++NA L
Sbjct: 16 LGEILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 95 ------LGC--CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
G +P +V E++ TL +H P+T + + + + A
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQA 128
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGY 204
L + H I HRD+K NI++ KV DFG ++ IA VT + GT Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVH------S 258
L PE + + +SDVYS G VL E+LTG+ P F+ + VS+A V S
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-FTGDSP----VSVAYQHVREDPIPPS 240
Query: 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLN 295
R L LD V+K KN + AE DL
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-32
Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 56/280 (20%)
Query: 58 FNVNRILGQGGQGTVYKGMREDGRIIAVKK-SKNAVKLLGCCLETEVPLL---------- 106
F +LG G +GT+ D R +AVK+ + EV LL
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF----ADREVQLLRESDEHPNVI 81
Query: 107 ----VYEFISNGTLY-------QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
+ Y L + ++ ++F + + + LA+LHS
Sbjct: 82 RYFCTEK--DRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN- 138
Query: 156 SPIYHRDIKSTNILLDE-----RYRAKVADFGTSKFIAMDQ--THVTTKIQGTFGYLDPE 208
I HRD+K NIL+ + +A ++DFG K +A+ + + + GT G++ PE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 209 Y---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265
T D++S G V +++ F Q N+ +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---------LLGACSL 247
Query: 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
D L +K++ + L E+ + ++ +KRP+ + V
Sbjct: 248 DCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 59/287 (20%), Positives = 105/287 (36%), Gaps = 57/287 (19%)
Query: 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------ 86
+ ++K + + +G+G G EDGR +K
Sbjct: 18 LYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE 73
Query: 87 -------KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMR-LR 138
K N V+ E +V ++ G L++ ++ + + F E + L
Sbjct: 74 VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQ---EDQILD 129
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 198
++ AL ++H I HRDIKS NI L + ++ DFG ++ + I
Sbjct: 130 WFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI 186
Query: 199 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258
GT YL PE ++ +KSD+++ G VL EL T K F AG+ +
Sbjct: 187 -GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA-FEAGSMKN---------LVL 235
Query: 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + +L + N + RP++ +
Sbjct: 236 KIISGSFPPVSLHYSY--------DLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 59/309 (19%), Positives = 107/309 (34%), Gaps = 59/309 (19%)
Query: 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK----------------- 87
F + H+ + LG+GG V DG A+K+
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 88 ------SKNAVKLLGCCLETEVP----LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRL 137
N ++L+ CL L+ F GTL+ + F LT + L
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQIL 137
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197
+ + L +H+ HRD+K TNILL + + + D G+ +
Sbjct: 138 WLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 198 IQ--------GTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
+ T Y PE + +++DV+S G VL ++ G+ P +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-YDMVFQKG 253
Query: 247 ENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVS 306
++V+LA +N+L + A L + ++ +RP + +
Sbjct: 254 DSVALA-------VQNQLSIPQSPRHSS--------ALWQLLNSMMTVDPHQRPHIPLLL 298
Query: 307 MELNGIRGS 315
+L ++
Sbjct: 299 SQLEALQPP 307
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 57/277 (20%), Positives = 108/277 (38%), Gaps = 61/277 (22%)
Query: 61 NRILGQGGQGTVYKGM-REDGRIIAVK-------------------------KSKNAVKL 94
+ +G+G TVYKG+ E +A + N V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 95 LGCCLETEVP----LLVYEFISNGTLYQHLHDRLQNQEF-PLTWEMRLRIATEVAGALAY 149
T +LV E +++GTL +L + F + ++ ++ L +
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL------KRFKVMKIKVLRSWCRQILKGLQF 144
Query: 150 LHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
LH+ + PI HRD+K NI + K+ D G + + + GT ++ PE
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA-VIGTPEFMAPE 200
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYF-VHSMRKNRLYDI 267
++ + + DVY+FG+ ++E+ T + P S+ + Y V S K +D
Sbjct: 201 MYEE-KYDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDK 253
Query: 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ +K + E C+ N +R ++++
Sbjct: 254 VAIPEVK-----------EIIEGCIRQNKDERYSIKD 279
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 64/299 (21%), Positives = 108/299 (36%), Gaps = 69/299 (23%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKK-SKNAVKLLGCCLETEVPLL-------- 106
N +ILG G GTV GR +AVK+ + + E+ LL
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI----ALMEIKLLTESDDHPN 70
Query: 107 ---VYEFIS------------NGTLYQHLHDRLQNQEFPLTWEMR--LRIATEVAGALAY 149
Y + N L + + + E + + + ++A +A+
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 150 LHSAASSPIYHRDIKSTNILLD-------------ERYRAKVADFGTSKFIAMDQTHVTT 196
LHS I HRD+K NIL+ E R ++DFG K + Q+ T
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 197 KIQ---GTFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
+ GT G+ PE +LT D++S G V +L+ K F + +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 247 ENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
N+ + + + + D ++ +L + +D + KRPT +V
Sbjct: 248 SNIIRGIF-----SLDEMKCLHDRSLIAEAT--------DLISQMIDHDPLKRPTAMKV 293
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 56/298 (18%), Positives = 97/298 (32%), Gaps = 73/298 (24%)
Query: 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSK------------------------N 90
F + LG+GG G V++ D A+K+ +
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 91 AVKLLGCCLE---------TEVPLLVY---EFISNGTLYQHLHDRLQNQEFPLTWEMRLR 138
V+ LE + + +Y + L ++ R +E + L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLH 122
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 198
I ++A A+ +LHS + HRD+K +NI KV DFG + D+ T
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 199 Q-----------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
GT Y+ PE + + K D++S G++L ELL
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------------- 225
Query: 248 NVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
F M + R + + + + + L + +RP +
Sbjct: 226 ------PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 57/289 (19%), Positives = 101/289 (34%), Gaps = 65/289 (22%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------------KS 88
+++ + +G GG V++ + E +I A+K S
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
++L + + +V E N L L + + R + A+
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVH 141
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGYLDP 207
+H I H D+K N L+ + K+ DFG + + D T V Q GT Y+ P
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 208 E-----------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256
E S+++ KSDV+S G +L + GK P F
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQQIINQIS--------- 247
Query: 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+L+ I+D ++ + CL + K+R ++ E+
Sbjct: 248 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 53/242 (21%), Positives = 86/242 (35%), Gaps = 48/242 (19%)
Query: 22 QNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-REDG 80
N G+LL + L D + + + +G+G G V++ ++ G
Sbjct: 36 DNEGVLLTEKLKPVDYEYREEVHWMTHQPR------------VGRGSFGEVHRMKDKQTG 83
Query: 81 RIIAVK------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHD 122
AVK S V L G E + E + G+L
Sbjct: 84 FQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL----GQ 139
Query: 123 RLQNQ-EFPLTWEMRLRIAT-EVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVA 179
++ P E R + L YLH+ I H D+K+ N+LL RA +
Sbjct: 140 LIKQMGCLP---EDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALC 193
Query: 180 DFGTSKFIAMDQTHVTTK----IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 235
DFG + + D + I GT ++ PE K D++S +++ +L G
Sbjct: 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
Query: 236 KP 237
P
Sbjct: 254 HP 255
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 63/304 (20%), Positives = 113/304 (37%), Gaps = 72/304 (23%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK------------------- 89
L+ + +G+G G V+ G R D ++AVK +
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 90 -----NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144
N V+L+G C + + +V E + G L+ + L + L++ + A
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF----LTFLRTEGARLRVKTLLQMVGDAA 223
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
+ YL S HRD+ + N L+ E+ K++DFG S+ A D + +
Sbjct: 224 AGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPV 279
Query: 205 --LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHS--- 258
PE + + +SDV+SFG++L E + G P ++Q+ FV
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY--PNLSNQQ----TREFVEKGGR 333
Query: 259 MRK-----NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
+ + ++ + M+ +C +RP+ + EL IR
Sbjct: 334 LPCPELCPDAVFRL-----ME---------------QCWAYEPGQRPSFSTIYQELQSIR 373
Query: 314 GSSR 317
R
Sbjct: 374 KRHR 377
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 57/289 (19%), Positives = 101/289 (34%), Gaps = 65/289 (22%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------------KS 88
+++ + +G GG V++ + E +I A+K S
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
++L + + +V E N L L + + R + A+
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVH 122
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGYLDP 207
+H I H D+K N L+ + K+ DFG + + D T V Q GT Y+ P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 208 E-----------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256
E S+++ KSDV+S G +L + GK P F
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQQIINQIS--------- 228
Query: 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+L+ I+D ++ + CL + K+R ++ E+
Sbjct: 229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK------------------- 89
E+++ + LG G G VY+G+ ++ +AVK K
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 273
Query: 90 ---NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
N V+LLG C ++ EF++ G L +L + ++ + L +AT+++ A
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSA 330
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+ YL HR++ + N L+ E + KVADFG S+ + D + +
Sbjct: 331 MEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 387
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE ++ + KSDV++FGV+L E+ T G P
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 62/305 (20%), Positives = 106/305 (34%), Gaps = 82/305 (26%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK-------------------NA 91
+ F +LGQG G V K D R A+K ++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 92 VKLLGCCLETEVPL-------------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLR 138
V+ LE + + E+ NGTLY D + ++ + R
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY----DLIHSENLNQQRDEYWR 120
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI----------- 187
+ ++ AL+Y+HS I HRD+K NI +DE K+ DFG +K +
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 188 ---AMDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
++T+ I GT Y+ E + +K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------- 227
Query: 244 TSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGK---KNQIMAFANLAERCLDLNGKKRP 300
F M + + L ++ N++ + +D + KRP
Sbjct: 228 -----------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276
Query: 301 TMEEV 305
+
Sbjct: 277 GARTL 281
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 57/289 (19%), Positives = 103/289 (35%), Gaps = 65/289 (22%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------------KS 88
+++ + +G GG V++ + E +I A+K S
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
++L + + +V E N L L + WE + + A+
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP----WERK-SYWKNMLEAVH 169
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGYLDP 207
+H I H D+K N L+ + K+ DFG + + D T V Q G Y+ P
Sbjct: 170 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 208 E-----------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256
E S+++ KSDV+S G +L + GK P F +S +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQ---QIINQISKLHAII 281
Query: 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ DI + + ++ + CL + K+R ++ E+
Sbjct: 282 DPNHEIEFPDIPEKDLQ------------DVLKCCLKRDPKQRISIPEL 318
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 66/271 (24%), Positives = 104/271 (38%), Gaps = 51/271 (18%)
Query: 62 RILGQGGQGTVYKGM-REDGRIIAVK-----------------------KSKNAVKLLGC 97
+LG+G G VY G + IA+K K KN V+ LG
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT-EVAGALAYLHSAASS 156
E + E + G+L L R + E + T ++ L YLH +
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALL--RSKWGPLKDN-EQTIGFYTKQILEGLKYLHD---N 141
Query: 157 PIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE--YHQSS 213
I HRDIK N+L++ K++DFGTSK +A T GT Y+ PE
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPR 200
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
+D++S G ++E+ TGK P + G AA F + +++ + + +
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMF--KVGMFKVHPEIPESMS 252
Query: 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
K +C + + KR +
Sbjct: 253 AEAK--------AFILKCFEPDPDKRACAND 275
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 57/296 (19%)
Query: 62 RILGQGGQGTVYKGM-----REDGRIIAVKKSK-----------------------NAVK 93
+ LG+G G+V G ++AVKK + N VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 94 LLGCCLET-EVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
G C L L+ E++ G+L D LQ + + L+ +++ + YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSL----RDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEY 209
+ HRD+ + NIL++ R K+ DFG +K + D+ K G + PE
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269
S+ + SDV+SFGVVL EL T + S + ++
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----------GQMIV 238
Query: 270 DQVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317
+++L K N + + C + N +RP+ ++++ ++ IR +
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 58/300 (19%), Positives = 107/300 (35%), Gaps = 81/300 (27%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK------------------------ 89
T F+ +G G G+V+K + R DG I A+K+SK
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 90 --NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQE-FPLTWEMRLR-IATEVAG 145
+ V+ E + L+ E+ + G+L + + + F E L+ + +V
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK---EAELKDLLLQVGR 126
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDE-------------------RYRAKVADFGTSKF 186
L Y+HS + H DIK +NI + + K+ D G
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 187 IAMDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245
I+ Q G +L E ++ K+D+++ + +V +P+ G+
Sbjct: 184 ISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-EPLPRNGDQ- 236
Query: 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
H +R+ RL I L + F L + + + ++RP+ +
Sbjct: 237 ----------WHEIRQGRLPRIPQ----VLSQ-----EFTELLKVMIHPDPERRPSAMAL 277
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-27
Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 57/296 (19%)
Query: 62 RILGQGGQGTVYKGM-----REDGRIIAVKKSK-----------------------NAVK 93
+ LG+G G+V G ++AVKK + N VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 94 LLGCCLET-EVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
G C L L+ E++ G+L D LQ + + L+ +++ + YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSL----RDYLQKHKERIDHIKLLQYTSQICKGMEYL- 161
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEY 209
+ HRD+ + NIL++ R K+ DFG +K + D+ + K G + PE
Sbjct: 162 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269
S+ + SDV+SFGVVL EL T + S + ++
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----------GQMIV 269
Query: 270 DQVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317
+++L K N + + C + N +RP+ ++++ ++ IR
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 46/264 (17%), Positives = 84/264 (31%), Gaps = 50/264 (18%)
Query: 27 LLQQM---LNSYDGSVIDRCKLFSSK---ELDKATNHFNVNRILGQGGQGTVYKGMR--- 77
LL + ++SY + +CKL + K E + V+ +LG+G VY+ +
Sbjct: 30 LLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89
Query: 78 ---EDGRIIAVKKSK-----------------------NAVKLLGCCLETEVPLLVYEFI 111
++ + +K K +K L +LV E
Sbjct: 90 NDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELY 149
Query: 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171
S GTL ++ E + + + A + + +H I H DIK N +L
Sbjct: 150 SYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILG 206
Query: 172 ERYRA-----------KVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
+ + D G S + + + T T G+ E + +
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266
Query: 220 DVYSFGVVLVELLTGKKPIFSAGN 243
D + + +L G
Sbjct: 267 DYFGVAATVYCMLFGTYMKVKNEG 290
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 30/314 (9%), Positives = 63/314 (20%), Gaps = 77/314 (24%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKG---------------------------MREDGRI 82
L + + L G + V+ + E
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 83 IAVKKSKNAVKLLGCCLETEVP--------------------------LLVYEFISNGTL 116
A ++ + LL+ S L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDL 174
Query: 117 YQ--HLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY 174
D + + ++ A L S + H N+ +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDG 231
Query: 175 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY--HQSSQLTDKSDVYSFGVVLVELL 232
R + D Y E+ ++ T + + G+ + +
Sbjct: 232 RLMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 233 TGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFA-NLAERC 291
P F + + + + F L R
Sbjct: 288 CLFLP-FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP----------LPDFVKTLIGRF 336
Query: 292 LDLNGKKRPTMEEV 305
L+ + ++R E
Sbjct: 337 LNFDRRRRLLPLEA 350
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 27/210 (12%), Positives = 57/210 (27%), Gaps = 32/210 (15%)
Query: 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYH 160
+ L + T + L + L RL++ +V LA LH + H
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHK-SLVHHARLQLTLQVIRLLASLHHYG---LVH 234
Query: 161 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-----YHQSSQL 215
++ +I+LD+R + F + H + +
Sbjct: 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLM 294
Query: 216 TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKL 275
T D ++ G+ + + P + + + ++ +I
Sbjct: 295 TFAFDTWTLGLAIYWIWCADLP-NTD-----DAALGGSEWIFR----SCKNIPQ------ 338
Query: 276 GKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
L E L + R +
Sbjct: 339 -------PVRALLEGFLRYPKEDRLLPLQA 361
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 43/209 (20%)
Query: 62 RILGQGGQGTVYKGM----REDGRI-IAVKKSK------------------------NAV 92
++LG G GTVYKG+ E +I +A+K+ + +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
+LLG CL + V L+ + + G L D ++ + + + L ++A + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT---FGYLDPEY 209
+ HRD+ + N+L+ K+ DFG +K + ++ +G ++ E
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALES 190
Query: 210 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
T +SDV+S+GV + EL+T G KP
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 60/301 (19%)
Query: 62 RILGQGGQGTVYKGM-----REDGRIIAVKKSK-----------------------NAVK 93
LG+G G+V G ++AVK+ + VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 94 LLGCCLET-EVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
G L LV E++ +G L D LQ L L ++++ + YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCL----RDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEY 209
S HRD+ + NIL++ K+ADFG +K + +D+ + + G + PE
Sbjct: 145 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 210 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
+ + +SDV+SFGVVL EL T K + + M
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR------------MMGCERDVPA 249
Query: 269 DDQVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKR 320
++++L ++ Q + L + C + + RP+ + +L+ + SR
Sbjct: 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309
Query: 321 A 321
Sbjct: 310 T 310
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------- 89
E+ + + LGQG G V+ G +A+K K
Sbjct: 263 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 320
Query: 90 --NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
V+L +E P+ +V E++S G+L L L + +A ++A
Sbjct: 321 HEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASG 375
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+AY+ HRD+++ NIL+ E KVADFG ++ I ++ + +
Sbjct: 376 MAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + T KSDV+SFG++L EL T G+ P
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 40/220 (18%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYKG---MREDGRI-IAVKKSK--------------- 89
+E++ + ++ +I+G G G V G + + +A+K K
Sbjct: 44 REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 90 ---------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIA 140
N ++L G + ++V E++ NG+L L+ + T + +
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL----DTFLRTHDGQFTIMQLVGML 157
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
V + YL + HRD+ + N+L+D KV+DFG S+ + D T G
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 201 TFGYL--DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + SDV+SFGVV+ E+L G++P
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------- 89
E+ + + LGQG G V+ G +A+K K
Sbjct: 180 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 237
Query: 90 --NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
V+L +E P+ +V E++S G+L L L + +A ++A
Sbjct: 238 HEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASG 292
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+AY+ HRD+++ NIL+ E KVADFG ++ I ++ + +
Sbjct: 293 MAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + T KSDV+SFG++L EL T G+ P
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 42/323 (13%), Positives = 80/323 (24%), Gaps = 99/323 (30%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIA--------------VKKSKNAVKL 94
EL + +LGQ + +E G +K+ K V
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 95 LGCCLETEVP---------------------------------------LLVYEFI--SN 113
L + +Y + +
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER 173
T + L + L RL++ +V LA LH + H ++ +I+LD+R
Sbjct: 187 QTFGEVLLSHSSTHK-SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 242
Query: 174 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-----------TDKSDVY 222
+ F + G+ PE T D +
Sbjct: 243 GGVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297
Query: 223 SFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM 282
+ G+V+ + P + + + ++ KN + V L +
Sbjct: 298 ALGLVIYWIWCADLP-ITK-----DAALGGSEWIFRSCKN-----IPQPVRAL-----LE 341
Query: 283 AFANLAERCLDLNGKKRPTMEEV 305
L + R +
Sbjct: 342 -------GFLRYPKEDRLLPLQA 357
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------- 89
L+ + + +G+G G V G G +AVK K
Sbjct: 189 ALNM--KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH 245
Query: 90 -NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
N V+LLG +E + L +V E+++ G+L +L R L + L+ + +V A+
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAM 302
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYL 205
YL + HRD+ + N+L+ E AKV+DFG +K T T K ++ T
Sbjct: 303 EYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWT---- 353
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + + + KSDV+SFG++L E+ + G+ P
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 60/317 (18%), Positives = 107/317 (33%), Gaps = 72/317 (22%)
Query: 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK----------------- 87
F + ++ V R+L +GG VY+ GR A+K+
Sbjct: 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 88 -------SKNAVKLLGCCLETEVP-------LLVYEFISNGTLYQHLHDRLQNQEFPLTW 133
N V+ + L+ + G L + L
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS--- 134
Query: 134 EMR-LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192
L+I + A+ ++H PI HRD+K N+LL + K+ DFG++ I+
Sbjct: 135 CDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
Query: 193 HVTTKIQ-----------GTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPI 238
+ + + T Y PE + + + +K D+++ G +L L + P
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP- 252
Query: 239 FSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK 298
F ++ L N Y I F +L L +N ++
Sbjct: 253 F------EDGAKLRI-------VNGKYSIPPHDTQYT-------VFHSLIRAMLQVNPEE 292
Query: 299 RPTMEEVSMELNGIRGS 315
R ++ EV +L I +
Sbjct: 293 RLSIAEVVHQLQEIAAA 309
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 58/303 (19%), Positives = 107/303 (35%), Gaps = 64/303 (21%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK---------------------N 90
+ + ++ ILGQG V++G ++ G + A+K N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 91 AVKLLGC--CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
VKL T +L+ EF G+LY L + + + L L + +V G +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMN 126
Query: 149 YLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
+L I HR+IK NI+ D + K+ DFG ++ ++ + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYGTEEY 181
Query: 205 LDPEYHQSSQLTD--------KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL----- 251
L P+ ++ + L D++S GV TG P F + N +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-FRPFEGPRRNKEVMYKII 240
Query: 252 ---------AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302
+ + D+ + G + + + L+ + +K
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL---TPVLANILEADQEKCWGF 297
Query: 303 EEV 305
++
Sbjct: 298 DQF 300
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 74/284 (26%), Positives = 108/284 (38%), Gaps = 75/284 (26%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK-----------------------N 90
F + R LG+G G VY ++ I+A+K K++ N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 91 AVKLLGCCLETEVPL-LVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGAL 147
++L G + L+ E+ GT+Y+ L + Q TE+A AL
Sbjct: 71 ILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR-------TATYITELANAL 122
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
+Y HS + HRDIK N+LL K+ADFG S A GT YL P
Sbjct: 123 SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLPP 176
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAY----FVHSMRK 261
E + +K D++S GV+ E L GK P F A + + +S + FV +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRVEFTFPDFVTEGAR 235
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+L R L N +RP + EV
Sbjct: 236 ------------------------DLISRLLKHNPSQRPMLREV 255
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK------------------- 89
E+++ + LG G G VY+G+ ++ +AVK K
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 90 ---NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
N V+LLG C ++ EF++ G L +L + ++ + L +AT+++ A
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSA 123
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK----IQGTF 202
+ YL HRD+ + N L+ E + KVADFG S+ + D I+ T
Sbjct: 124 MEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT- 179
Query: 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE ++ + KSDV++FGV+L E+ T G P
Sbjct: 180 ---APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 59/307 (19%), Positives = 107/307 (34%), Gaps = 58/307 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK---------------------N 90
+ + ++ ILGQG V++G ++ G + A+K N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 91 AVKLLGC--CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
VKL T +L+ EF G+LY L + + + L L + +V G +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMN 126
Query: 149 YLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
+L I HR+IK NI+ D + K+ DFG ++ ++ + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYGTEEY 181
Query: 205 LDPEYHQSSQLTD--------KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL----- 251
L P+ ++ + L D++S GV TG P F + N +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-FRPFEGPRRNKEVMYKII 240
Query: 252 -AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFA-----NLAERCLDLNGKKRPTMEEV 305
+ + D + + + L+ + +K ++
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 306 SMELNGI 312
E + I
Sbjct: 301 FAETSDI 307
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 57/307 (18%), Positives = 113/307 (36%), Gaps = 56/307 (18%)
Query: 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK---KSK-------------- 89
KE DK N + + R L QG + +D + A+K KS
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 90 -----------------------NAVKLLGCCLETEVPL-LVYEFISNGTLYQHL--HDR 123
+ G + + ++YE++ N ++ +
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 124 LQNQEFPLTWEMRLR-IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182
L ++ I V + +Y+H+ + I HRD+K +NIL+D+ R K++DFG
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG 197
Query: 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD--KSDVYSFGVVLVELLTGKKPIFS 240
S+++ + ++ GT+ ++ PE+ + + K D++S G+ L + P
Sbjct: 198 ESEYMVDKKIK-GSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 241 AGNTSQ--ENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK 298
+ + N+ R + LY + + + + + L N +
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED-IDFLKLFLRKNPAE 313
Query: 299 RPTMEEV 305
R T E+
Sbjct: 314 RITSEDA 320
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 44/211 (20%)
Query: 62 RILGQGGQGTVYKG--MREDGRII--AVK------------------------KSKNAVK 93
++G+G G VY G + DG+ I AVK N +
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 94 LLGCCLETEVPLL-VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
LLG CL +E L V ++ +G L + ++N+ T + + +VA + +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDL----RNFIRNETHNPTVKDLIGFGLQVAKGMKFL-- 208
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL-----DP 207
AS HRD+ + N +LDE++ KVADFG ++ + + T L
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMAL 265
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
E Q+ + T KSDV+SFGV+L EL+T G P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYKGM----REDGRI-IAVKKSK-------------- 89
+ + ++LG G GTV+KG+ E +I + +K +
Sbjct: 8 RIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65
Query: 90 ----------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
+ V+LLG C LV +++ G+L D ++ L ++ L
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNW 120
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
++A + YL + HR++ + N+LL + +VADFG + + D +
Sbjct: 121 GVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--S 175
Query: 200 GT---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
++ E + T +SDV+S+GV + EL+T G +P
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 34/212 (16%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------- 89
E+ + + + LG G G V+ +AVK K
Sbjct: 184 EIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ 241
Query: 90 --NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
VKL T+ P+ ++ EF++ G+L L + + + ++A
Sbjct: 242 HDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEG 296
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+A++ HRD+++ NIL+ K+ADFG ++ I ++ + +
Sbjct: 297 MAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 353
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE T KSDV+SFG++L+E++T G+ P
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 68/339 (20%), Positives = 115/339 (33%), Gaps = 76/339 (22%)
Query: 21 KQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGM---- 76
+ G L D +V + + R LG+G G V
Sbjct: 9 HHHHGALEVLFQGPGDPTVFHK-------------RYLKKIRDLGEGHFGKVSLYCYDPT 55
Query: 77 -REDGRIIAVK------------------------KSKNAVKLLGCCLETEVP--LLVYE 109
G ++AVK ++ +K GCC + LV E
Sbjct: 56 NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115
Query: 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNIL 169
++ G+L D L + L A ++ +AYLH+ HRD+ + N+L
Sbjct: 116 YVPLGSL----RDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVL 166
Query: 170 LDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYHQSSQLTDKSDVYSFGVV 227
LD K+ DFG +K + + + G + PE + + SDV+SFGV
Sbjct: 167 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226
Query: 228 LVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM---- 282
L ELLT + T + A + ++ +L ++ + +
Sbjct: 227 LYELLTHCDSS--QSPPTKFLELIGIAQ----------GQMTVLRLTELLERGERLPRPD 274
Query: 283 ----AFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317
+L + C + RPT E + L + +
Sbjct: 275 KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 65/293 (22%), Positives = 107/293 (36%), Gaps = 61/293 (20%)
Query: 62 RILGQGGQGTVYKGM-----REDGRIIAVKKSK------------------------NAV 92
R LG+G G V G +AVK K N V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 93 KLLGCCLETEVP--LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
K G C E L+ EF+ +G+L + L + + + +L+ A ++ + YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSL----KEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPE 208
S HRD+ + N+L++ ++ K+ DFG +K I D+ + T K + PE
Sbjct: 143 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267
S+ SDV+SFGV L ELLT + + + M RL +
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD----SSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 268 LDDQVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTMEEVSMELNGI 312
L K+ + + L +C + R + + + +
Sbjct: 256 L--------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 44/211 (20%)
Query: 62 RILGQGGQGTVYKGM--REDGRII--AVKKSK------------------------NAVK 93
++G+G G VY G DG+ I AVK N +
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 94 LLGCCLETEVPLL-VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
LLG CL +E L V ++ +G L + ++N+ T + + +VA + YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDL----RNFIRNETHNPTVKDLIGFGLQVAKGMKYL-- 144
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL-----DP 207
AS HRD+ + N +LDE++ KVADFG ++ + + T L
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMAL 201
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
E Q+ + T KSDV+SFGV+L EL+T G P
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 48/219 (21%)
Query: 60 VNRILGQGGQGTVYKG----MREDGRIIAVKKSK-------------------------N 90
+ +ILG+G G+V +G +AVK K N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 91 AVKLLGCCLETE-----VPLLVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRIATEVA 144
++LLG C+E P+++ F+ G L+ +L + RL+ + + L+ ++A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
+ YL ++ HRD+ + N +L + VADFG SK I + QG
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAK 210
Query: 205 L-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
+ E T KSDV++FGV + E+ T G P
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 49/220 (22%)
Query: 60 VNRILGQGGQGTVYKGM--REDGRII--AVK-------------------------KSKN 90
+ R+LG+G G+V + +EDG + AVK +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 91 AVKLLGCCLETE------VPLLVYEFISNGTLYQHL-HDRLQNQEFPLTWEMRLRIATEV 143
KL+G L + +P+++ F+ +G L+ L R+ F L + +R ++
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
A + YL +S HRD+ + N +L E VADFG S+ I + QG
Sbjct: 147 ACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCAS 199
Query: 204 YL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
L E + T SDV++FGV + E++T G+ P
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 40/220 (18%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYKGM----REDGRIIAVKKSK--------------- 89
KELD + ++++++G G G V G + +A+K K
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 90 ---------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIA 140
N ++L G +++ ++V E++ NG+L L+ + T + +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL----DSFLRKHDAQFTVIQLVGML 153
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
+A + YL + HRD+ + NIL++ KV+DFG + + D T G
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 201 TFGYL--DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + T SDV+S+G+VL E+++ G++P
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 41/221 (18%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYKGM-----REDGRIIAVKKSK-------------- 89
E+ + +++G G G VYKGM + +A+K K
Sbjct: 39 TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 90 ----------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
N ++L G + + +++ E++ NG L L+ ++ + + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL----DKFLREKDGEFSVLQLVGM 152
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
+A + YL A+ HRD+ + NIL++ KV+DFG S+ + D T
Sbjct: 153 LRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 200 GTFGY--LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
G PE + T SDV+SFG+V+ E++T G++P
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 40/215 (18%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------- 89
EL + + + LG G G V G + +AVK K
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61
Query: 90 --NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
VK G C + +V E+ISNG L +L ++ L L + +V +
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGM 117
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFG 203
A+L S HRD+ + N L+D KV+DFG ++++ DQ + V TK ++ +
Sbjct: 118 AFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS-- 172
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + + KSDV++FG+++ E+ + GK P
Sbjct: 173 --APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 62 RILGQGGQGTVYKG--MREDGRI---IAVKKSK------------------------NAV 92
++LG G GTVYKG + E ++ +A+K+ + +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
+LLG CL L+ + + G L D ++ + + + L ++A + YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT---FGYLDPEY 209
+ HRD+ + N+L+ K+ DFG +K + ++ +G ++ E
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALES 190
Query: 210 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
T +SDV+S+GV + EL+T G KP
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------- 89
E+D + LG G G V G +A+K K
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 77
Query: 90 --NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
V+L G C + ++ E+++NG L + L+ + L + +V A+
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCL----LNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFG 203
YL S HRD+ + N L++++ KV+DFG S+++ D+ + V +K ++ +
Sbjct: 134 EYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS-- 188
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE S+ + KSD+++FGV++ E+ + GK P
Sbjct: 189 --PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 38/214 (17%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------- 89
E+ + + LG G G V+ G +AVK K
Sbjct: 9 EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 90 --NAVKLLGCCLETEVPLL-VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
V+L T+ P+ + E++ NG+L L LT L +A ++A
Sbjct: 67 HQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEG 121
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY-- 204
+A++ HRD+++ NIL+ + K+ADFG ++ I ++ T + F
Sbjct: 122 MAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKW 176
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE T KSDV+SFG++L E++T G+ P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 44/211 (20%)
Query: 62 RILGQGGQGTVYKGM----REDGRIIAVK------------------------KSKNAVK 93
R++G+G G VY G ++ A+K N +
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 94 LLGCCLETE-VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
L+G L E +P ++ ++ +G L +++ + T + + +VA + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDL----LQFIRSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL-----DP 207
A HRD+ + N +LDE + KVADFG ++ I + Q L
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKWTAL 197
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
E Q+ + T KSDV+SFGV+L ELLT G P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-24
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------- 89
+D + + +G G G V+ G + +A+K +
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS 61
Query: 90 --NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
V+L G CLE LV EF+ +G L D L+ Q E L + +V +
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCL----SDYLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFG 203
AYL + + HRD+ + N L+ E KV+DFG ++F+ DQ + TK ++
Sbjct: 118 AYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-- 172
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE S+ + KSDV+SFGV++ E+ + GK P
Sbjct: 173 --SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 6e-24
Identities = 42/208 (20%), Positives = 77/208 (37%), Gaps = 36/208 (17%)
Query: 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNI 168
+ L ++ R ++ + L I ++A A+ +LHS + HRD+K +NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDRE--HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNI 195
Query: 169 LLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-----------GTFGYLDPEYHQSSQLTD 217
KV DFG + D+ T GT Y+ PE + +
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 218 KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGK 277
K D++S G++L ELL T E V + + +R + + + +
Sbjct: 256 KVDIFSLGLILFELLYSFS-------TQMERVRI----ITDVRNLKFPLLFTQKYPQE-- 302
Query: 278 KNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + L + +RP ++
Sbjct: 303 -------HMMVQDMLSPSPTERPEATDI 323
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-24
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 45/221 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVK---KSK---------------------- 89
+ F++ R LG+G G VY +++ I+A+K KS+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 90 -NAVKLLGCCLETEVPL-LVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAG 145
N +++ + L+ EF G LY+ L H R Q E+A
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-------SATFMEELAD 125
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
AL Y H + HRDIK N+L+ + K+ADFG S + GT YL
Sbjct: 126 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYL 179
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
PE + +K D++ GV+ E L G P F + + ++
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP-FDSPSHTE 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-24
Identities = 70/330 (21%), Positives = 109/330 (33%), Gaps = 113/330 (34%)
Query: 56 NHFNVNRILGQGGQGTVYKGM------REDGRIIAVKKSK-------------------- 89
+ + + LG+G G V + R +AVK K
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 90 -----NAVKLLGCCLETEVPLLV-YEFISNGTLYQHL-----------HDRLQNQEFPLT 132
N V LLG C + PL+V EF G L +L + LT
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 133 WEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192
E + + +VA + +L AS HRD+ + NILL E+ K+ DFG ++ I
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI----- 198
Query: 193 HVTTKIQGTFGYLDPEYHQSSQ-----------------LTDKSDVYSFGVVLVELLT-G 234
Y DP+Y + T +SDV+SFGV+L E+ + G
Sbjct: 199 -----------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 235 KKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM--------AFAN 286
P Y ++ + + + K+ M
Sbjct: 248 ASP----------------YP--GVKIDE-------EFCRRLKEGTRMRAPDYTTPEMYQ 282
Query: 287 LAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
C +RPT E+ L + ++
Sbjct: 283 TMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-24
Identities = 53/209 (25%), Positives = 81/209 (38%), Gaps = 41/209 (19%)
Query: 62 RILGQGGQGTVYKG--MREDGRII--AVKKSK--------------------------NA 91
LG G G V +G G+ + AVK K N
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
++L G L + +V E G+L DRL+ + R A +VA + YL
Sbjct: 84 IRLYGVVLTPPM-KMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYL- 137
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LDPEY 209
S HRD+ + N+LL R K+ DFG + + + H + + PE
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 210 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
++ + SD + FGV L E+ T G++P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 38/204 (18%)
Query: 64 LGQGGQGTVYKGM--REDGRI-IAVKKSK------------------------NAVKLLG 96
LG G G+V +G+ +I +A+K K V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 97 CCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASS 156
C + +LV E G L H L + + + +V+ + YL
Sbjct: 404 VCQAEAL-MLVMEMAGGGPL----HKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 157 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LDPEYHQSSQ 214
HR++ + N+LL R+ AK++DFG SK + D ++ T + G + PE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 215 LTDKSDVYSFGVVLVELLT-GKKP 237
+ +SDV+S+GV + E L+ G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-24
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 38/208 (18%)
Query: 60 VNRILGQGGQGTVYKGM--REDGRI-IAVKKSK------------------------NAV 92
+ LG G G+V +G+ +I +A+K K V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
+L+G C + +LV E G L H L + + + +V+ + YL
Sbjct: 74 RLIGVCQAEAL-MLVMEMAGGGPL----HKFLVGKREEIPVSNVAELLHQVSMGMKYL-- 126
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYH 210
HRD+ + N+LL R+ AK++DFG SK + D ++ T + G + + PE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 211 QSSQLTDKSDVYSFGVVLVELLT-GKKP 237
+ + +SDV+S+GV + E L+ G+KP
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 48/218 (22%)
Query: 61 NRILGQGGQGTVYKGM------REDGRIIAVK------------------------KSKN 90
+R LGQG G VY+G+ E +A+K +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDR-----LQNQEFPLTWEMRLRIATEVAG 145
V+LLG + + L++ E ++ G L +L P + +++A E+A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
+AYL ++ HRD+ + N ++ E + K+ DFG ++ I + +G G L
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLL 202
Query: 206 -----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + T SDV+SFGVVL E+ T ++P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 40/213 (18%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------- 89
L+ + + +G+G G V G G +AVK K
Sbjct: 17 ALNM--KELKLLQTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRH 73
Query: 90 -NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
N V+LLG +E + L +V E+++ G+L +L R ++ L + L+ + +V A+
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAM 130
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYL 205
YL + HRD+ + N+L+ E AKV+DFG +K + T T K ++ T
Sbjct: 131 EYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWT---- 181
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE + + + KSDV+SFG++L E+ + G+ P
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 40/209 (19%)
Query: 60 VNRILGQGGQGTVYKGM-REDGRII--AVKKSK-------------------------NA 91
++ LG G GTV KG + + AVK K
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
V+++G C E +LV E G L ++L + + + + +V+ + YL
Sbjct: 81 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYL- 133
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEY 209
S HRD+ + N+LL ++ AK++DFG SK + D+ + + G + + PE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 210 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
+ + KSDV+SFGV++ E + G+KP
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 39/217 (17%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGM--REDGRII--AVKKSK---------------- 89
E+ + + R +G+G G V++G+ + + A+K K
Sbjct: 11 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 90 --------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
+ VKL+G E ++ E + G L LQ +++ L + A
Sbjct: 69 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL----RSFLQVRKYSLDLASLILYAY 123
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
+++ ALAYL S HRDI + N+L+ K+ DFG S+++ + +K +
Sbjct: 124 QLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
++ PE + T SDV+ FGV + E+L G KP
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 67/270 (24%), Positives = 110/270 (40%), Gaps = 48/270 (17%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVK---------------------KSKNAVKLL 95
F+V LG+G G+VYK + +E G+I+A+K S + VK
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 96 GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
G + +V E+ G++ D ++ + LT + I L YLH
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGLEYLHF--- 143
Query: 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 215
HRDIK+ NILL+ AK+ADFG + + T I GT ++ PE Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 202
Query: 216 TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKL 275
+D++S G+ +E+ GK P +H MR ++ I +
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYAD---------------IHPMRA--IFMIPTNPPPTF 245
Query: 276 -GKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ F + ++CL + ++R T +
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-23
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 39/211 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK---------------------- 89
F V +LG+G VY+ G +A+K K
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 90 -NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLT-WEMRLRIATEVAGA 146
+ ++L E + LV E NG + ++L +R++ P + E R ++
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEAR-HFMHQIITG 124
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+ YLHS I HRD+ +N+LL K+ADFG + + M T + GT Y+
Sbjct: 125 MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYIS 180
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
PE S +SDV+S G + LL G+ P
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 52/272 (19%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVK-----------------------KSKNAVK 93
+ +GQG GTVY M G+ +A++ K+ N V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
L L + +V E+++ G+L + + + + E AL +LHS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS- 134
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
+ + HRDIKS NILL K+ DFG I +Q+ +T + GT ++ PE
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
K D++S G++ +E++ G+ P + + +R LY I +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLN---------------ENPLRA--LYLIATNGTP 234
Query: 274 KLGKKNQI-MAFANLAERCLDLNGKKRPTMEE 304
+L ++ F + RCL+++ +KR + +E
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-23
Identities = 60/308 (19%), Positives = 107/308 (34%), Gaps = 60/308 (19%)
Query: 47 SSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK------------------- 86
K + + F LG G G V+K + G ++A K
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 83
Query: 87 -----KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
S V G + E + G+L D++ + + ++ +++
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-----DQVLKKAGRIPEQILGKVSI 138
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
V L YL I HRD+K +NIL++ R K+ DFG S + + + + GT
Sbjct: 139 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GT 193
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
Y+ PE Q + + +SD++S G+ LVE+ G+ PI E + +
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253
Query: 262 NRLYDILDDQVMKLGKKNQIM-------------------------AFANLAERCLDLNG 296
+ K G ++ F + +CL N
Sbjct: 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313
Query: 297 KKRPTMEE 304
+R +++
Sbjct: 314 AERADLKQ 321
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 53 KATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSKNAVKLLGCCLETEV----- 103
+ + + LG GG G V + + ++ G +A+K + + CLE ++
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 104 ----------------------PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
PLL E+ G L ++L+ L + +
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLS 128
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHVTTKI 198
+++ AL YLH + I HRD+K NI+L +R K+ D G +K +DQ + T+
Sbjct: 129 DISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEF 183
Query: 199 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
GT YL PE + + T D +SFG + E +TG +P Q
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-23
Identities = 54/217 (24%), Positives = 80/217 (36%), Gaps = 48/217 (22%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVKKSK------------------------NA 91
R LG G G VY+G +AVK N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGALAY 149
V+ +G L++ ++ E ++ G L L +Q L L +A ++A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 150 LHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL- 205
L + HRDI + N LL AK+ DFG ++ I + +G L
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR----KGGCAMLP 208
Query: 206 ----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE T K+D +SFGV+L E+ + G P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-23
Identities = 53/238 (22%), Positives = 89/238 (37%), Gaps = 81/238 (34%)
Query: 62 RILGQGGQGTVYKGM--------REDGRIIAVKKSK------------------------ 89
+ LG+G G V ++ +AVK K
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 90 -NAVKLLGCCLETEVPLLVYEFISNGTLYQHL-----------HDRLQNQEFPLTWEMRL 137
N + LLG C + ++ E+ S G L ++L +D + E +T++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197
++A + YL AS HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI---------- 207
Query: 198 IQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKKP 237
Y +++ L D +SDV+SFGV++ E+ T G P
Sbjct: 208 ------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 9e-23
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYKG---MREDGRI-IAVK------------------ 86
E+ + + R +G+G G V++G E+ + +A+K
Sbjct: 385 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 87 ------KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIA 140
+ VKL+G E V ++ E + G L LQ ++F L + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGEL----RSFLQVRKFSLDLASLILYA 497
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
+++ ALAYL S HRDI + N+L+ K+ DFG S+++ + +K +
Sbjct: 498 YQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 201 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
++ PE + T SDV+ FGV + E+L G KP
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 70/331 (21%), Positives = 111/331 (33%), Gaps = 120/331 (36%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVKKSK------------------------NA 91
+ LG+G G V K R +AVK K +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHL-------------------HDRLQNQEFPLT 132
+KL G C + LL+ E+ G+L L E LT
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 133 WEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192
+ A +++ + YL A + HRD+ + NIL+ E + K++DFG S+ +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV----- 200
Query: 193 HVTTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-G 234
Y + Y + SQ L D +SDV+SFGV+L E++T G
Sbjct: 201 -----------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 235 KKPIFSAGNTSQENVSLAAYFV---HSMRK-----NRLYDILDDQVMKLGKKNQIMAFAN 286
P G + + + H M + +Y + M
Sbjct: 250 GNP--YPGIPPERLFN----LLKTGHRMERPDNCSEEMYRL-----ML------------ 286
Query: 287 LAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317
+C KRP ++S +L + R
Sbjct: 287 ---QCWKQEPDKRPVFADISKDLEKMMVKRR 314
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 63/308 (20%), Positives = 113/308 (36%), Gaps = 86/308 (27%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVK-----------------------KSKNAV 92
LG+G G V+ +D ++AVK + ++ V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHL----------HDRLQNQEFPLTWEMRLRIATE 142
+ G C E L+V+E++ +G L + L PL L +A++
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 202
VA + YL A HRD+ + N L+ + K+ DFG S+ I + ++ G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGR- 219
Query: 203 GYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFV 256
L PE + T +SDV+SFGVVL E+ T GK+P +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP----------------W-- 261
Query: 257 HSMRKNRLYDILDDQVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTMEEVSME 308
Y + + + + + + + + C ++R ++++V
Sbjct: 262 --------YQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
Query: 309 LNGIRGSS 316
L + +
Sbjct: 314 LQALAQAP 321
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 37/205 (18%)
Query: 62 RILGQGGQGTVYKGM--REDGRII--AVKKSK------------------------NAVK 93
RILG+G G VY+G+ G I AVK K + VK
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
L+G E E ++ E G L L+ + L + + ++ A+AYL
Sbjct: 78 LIGIIEE-EPTWIIMELYPYGEL----GHYLERNKNSLKVLTLVLYSLQICKAMAYL--- 129
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
S HRDI NIL+ K+ DFG S++I + + + + ++ PE
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 214 QLTDKSDVYSFGVVLVELLT-GKKP 237
+ T SDV+ F V + E+L+ GK+P
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 65/293 (22%), Positives = 104/293 (35%), Gaps = 58/293 (19%)
Query: 47 SSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK------------------- 86
+ D +G+G G+V K + + G+I+AVK
Sbjct: 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLD 72
Query: 87 ------KSKNAVKLLGCCL-ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRL-R 138
V+ G E + + E + + + + + + E L +
Sbjct: 73 VVMRSSDCPYIVQFYGALFREGDC-WICMELM-STSFDKFYKYVYSVLDDVIP-EEILGK 129
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 198
I AL +L I HRDIK +NILLD K+ DFG S + + T+
Sbjct: 130 ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ--LVDSIAKTRD 185
Query: 199 QGTFGYLDPEYHQSSQLTD----KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254
G Y+ PE S +SDV+S G+ L EL TG+ P
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK-------------- 231
Query: 255 FVHSMRKNRLYDILDDQVMKLGKKNQI---MAFANLAERCLDLNGKKRPTMEE 304
+S+ +L ++ +L + +F N CL + KRP +E
Sbjct: 232 -WNSVFD-QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 65/321 (20%), Positives = 112/321 (34%), Gaps = 115/321 (35%)
Query: 62 RILGQGGQGTVYKGM--------REDGRIIAVKKSK------------------------ 89
+ LG+G G V ++ +AVK K
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 90 -NAVKLLGCCLETEVPLLVYEFISNGTLYQHL-----------HDRLQNQEFPLTWEMRL 137
N + LLG C + ++ E+ S G L ++L +D + E +T++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197
++A + YL AS HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI---------- 253
Query: 198 IQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKKPIF 239
Y +++ L D +SDV+SFGV++ E+ T G P
Sbjct: 254 ------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-- 305
Query: 240 SAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM--------AFANLAERC 291
Y I +++ KL K+ M + C
Sbjct: 306 --------------Y----------PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDC 341
Query: 292 LDLNGKKRPTMEEVSMELNGI 312
+RPT +++ +L+ I
Sbjct: 342 WHAVPSQRPTFKQLVEDLDRI 362
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 69/276 (25%), Positives = 107/276 (38%), Gaps = 59/276 (21%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK------------------------KSKNA 91
F +G+G G V+KG+ +++A+K S
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT---EVAGALA 148
K G L+ ++ E++ G+ D L+ T IAT E+ L
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQ-----IATILREILKGLD 133
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
YLHS HRDIK+ N+LL E K+ADFG + + Q T + GT ++ PE
Sbjct: 134 YLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 189
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
+ S K+D++S G+ +EL G+ P +H M+ L+ I
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSE---------------LHPMKV--LFLIP 232
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ L + N E CL+ RPT +E
Sbjct: 233 KNNPPTL-EGNYSKPLKEFVEACLNKEPSFRPTAKE 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 55/281 (19%), Positives = 93/281 (33%), Gaps = 65/281 (23%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK----------------------- 89
+ R LG+GG ++ + + A K KS
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 90 NAVKLLGCCLETEVPL-LVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGA 146
+ V G E + +V E +L + L E R ++
Sbjct: 76 HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE------AR-YYLRQIVLG 127
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
YLH + HRD+K N+ L+E K+ DFG + + D + GT Y+
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIA 183
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSMRKNRL 264
PE + + DV+S G ++ LL GK P F + + Y
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEY---------- 232
Query: 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + +L ++ L + RPT+ E+
Sbjct: 233 --SIPKHINPVAA--------SLIQKMLQTDPTARPTINEL 263
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 52/266 (19%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVK-----------------------KSKNAVKLLGCCL 99
+G+G G V + GR +AVK + N V++ L
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159
E ++ EF+ G L + + L E + V ALAYLH+ +
Sbjct: 113 VGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA---QGVI 163
Query: 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 219
HRDIKS +ILL R K++DFG I+ D + + GT ++ PE S +
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEV 222
Query: 220 DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKN 279
D++S G++++E++ G+ P FS ++ + + D KL +
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFS---------------DSPVQA--MKRLRDSPPPKLKNSH 265
Query: 280 QI-MAFANLAERCLDLNGKKRPTMEE 304
++ + ER L + ++R T +E
Sbjct: 266 KVSPVLRDFLERMLVRDPQERATAQE 291
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 56/279 (20%), Positives = 94/279 (33%), Gaps = 61/279 (21%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK----------------------- 89
+ R LG+GG ++ + + A K KS
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 90 NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
+ V G E + +V E +L + R E E R ++
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEAR-YYLRQIVLGCQ 155
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
YLH + HRD+K N+ L+E K+ DFG + + D + GT Y+ PE
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 211
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSMRKNRLYD 266
+ + DV+S G ++ LL GK P F + + Y
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEY------------ 258
Query: 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + +L ++ L + RPT+ E+
Sbjct: 259 SIPKHINPVAA--------SLIQKMLQTDPTARPTINEL 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 66/275 (24%), Positives = 107/275 (38%), Gaps = 60/275 (21%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKK-------------------------SKNAVKLLGC 97
LG+G G V K G+I+AVK+ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 98 CL-ETEVPLLVYEF--ISNGTLYQHLHDRLQNQEFPLTWEMRL-RIATEVAGALAYLHSA 153
E +V + E S Y+ + D+ Q P E L +IA + AL +LHS
Sbjct: 75 LFREGDV-WICMELMDTSLDKFYKQVIDK--GQTIP---EDILGKIAVSIVKALEHLHSK 128
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE----Y 209
S + HRD+K +N+L++ + K+ DFG S + + G Y+ PE
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPERINPE 184
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269
+ KSD++S G+ ++EL + P S + ++ L +++
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDS--------------WGTPFQQ--LKQVVE 228
Query: 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ +L F + +CL N K+RPT E
Sbjct: 229 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 69/280 (24%), Positives = 105/280 (37%), Gaps = 60/280 (21%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK--------------------------K 87
F+ R +G G G VY + ++A+K +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 88 SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
N ++ GC L LV E+ D L+ + PL + L
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSAS-----DLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
AYLHS + HRD+K+ NILL E K+ DFG++ +A + V GT ++ P
Sbjct: 168 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAP 219
Query: 208 E---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264
E Q K DV+S G+ +EL K P+F+ +++M L
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN---------------MNAMSA--L 262
Query: 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
Y I ++ L + F N + CL + RPT E
Sbjct: 263 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 62/309 (20%), Positives = 120/309 (38%), Gaps = 87/309 (28%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVKKSKNA-----------------------V 92
R LG+G G V+ +D ++AVK K+ V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDR-----------LQNQEFPLTWEMRLRIAT 141
K G C + + ++V+E++ +G L + L + + L L IA+
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
++A + YL AS HRD+ + N L+ K+ DFG S+ + + ++ G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH 194
Query: 202 FGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYF 255
L PE + T +SDV+SFGV+L E+ T GK+P +
Sbjct: 195 -TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----------------W- 236
Query: 256 VHSMRKNRLYDILDDQVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTMEEVSM 307
+ + + +V++ + +++ ++ C ++R ++E+
Sbjct: 237 ---------FQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
Query: 308 ELNGIRGSS 316
L+ + ++
Sbjct: 288 ILHALGKAT 296
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 54/217 (24%), Positives = 81/217 (37%), Gaps = 48/217 (22%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVKKSK------------------------NA 91
R LG G G VY+G +AVK N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDR--LQNQEFPLTWEMRLRIATEVAGALAY 149
V+ +G L++ ++ E ++ G L L + +Q L L +A ++A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 150 LHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL- 205
L + HRDI + N LL AK+ DFG ++ I + +G L
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGCAMLP 249
Query: 206 ----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
PE T K+D +SFGV+L E+ + G P
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 56/239 (23%), Positives = 88/239 (36%), Gaps = 81/239 (33%)
Query: 61 NRILGQGGQGTVYKGM--------REDGRIIAVKKSK----------------------- 89
+ LG+G G V +AVK K
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 90 --NAVKLLGCCLETEVPLLVYEFISNGTLYQHL-----------HDRLQNQEFPLTWEMR 136
N + LLG C + ++ E+ S G L ++L ++ N E L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 137 LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196
+ A +VA + YL AS HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--------- 241
Query: 197 KIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKKP 237
+ Y +++ L D +SDV+SFGV+L E+ T G P
Sbjct: 242 -------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-22
Identities = 63/242 (26%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 36 DGSVIDRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKG-MREDGRIIAVK------- 86
D +R + E T N F R+LG+GG G V +R G++ A K
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 222
Query: 87 KSKNAVKL------------------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQ 127
K + + L ET+ L LV ++ G L H++ +
Sbjct: 223 KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQA 281
Query: 128 EFPLTWEMRLRI-ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186
FP E R A E+ L LH I +RD+K NILLD+ +++D G +
Sbjct: 282 GFP---EARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335
Query: 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
+ QT GT GY+ PE ++ + T D ++ G +L E++ G+ P F
Sbjct: 336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKI 392
Query: 247 EN 248
+
Sbjct: 393 KR 394
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-22
Identities = 66/325 (20%), Positives = 105/325 (32%), Gaps = 110/325 (33%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVKKSK-------------------------N 90
+ LG G G V + + +AVK K N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEF---------PLTWEMRLRIAT 141
V LLG C L++ E+ G L L + + E + L ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
+VA +A+L AS HRD+ + N+LL + AK+ DFG ++ I
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-------------- 214
Query: 202 FGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKKPIFSAGN 243
D Y + D +SDV+S+G++L E+ + G P G
Sbjct: 215 --MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPGI 270
Query: 244 TSQENVSLAAYFV---HSMRK-----NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLN 295
V + M + +Y I M+ C L
Sbjct: 271 LVNSKF---YKLVKDGYQMAQPAFAPKNIYSI-----MQ---------------ACWALE 307
Query: 296 GKKRPTMEEVSMELNGIRGSSRKKR 320
RPT +++ L R++R
Sbjct: 308 PTHRPTFQQICSFLQEQAQEDRRER 332
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 61/280 (21%), Positives = 102/280 (36%), Gaps = 55/280 (19%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK-----------------------KSKN 90
+ + LG G G VYK +E G + A K
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
VKLLG ++ EF G + + + LT + ++ AL +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-- 208
HS I HRD+K+ N+L+ ++ADFG S + I GT ++ PE
Sbjct: 134 HS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVV 189
Query: 209 ---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265
+ + K+D++S G+ L+E+ + P ++ MR L
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE---------------LNPMRV--LL 232
Query: 266 DILDDQVMKLGKKNQI-MAFANLAERCLDLNGKKRPTMEE 304
I L ++ + F + + LD N + RP+ +
Sbjct: 233 KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 68/291 (23%), Positives = 107/291 (36%), Gaps = 63/291 (21%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVK------------------------KSKN 90
+ + + ++G G V +A+K N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 91 AVKLLGCCLETEVPLLVYEFISNG---TLYQHLHDRLQNQEFPLTWEMRLRIAT---EVA 144
V + + LV + +S G + +H+ + +++ L E IAT EV
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-E--STIATILREVL 131
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF-G 203
L YLH HRD+K+ NILL E ++ADFG S F+A K++ TF G
Sbjct: 132 EGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 204 ---YLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259
++ PE Q K+D++SFG+ +EL TG P M
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK---------------YPPM 233
Query: 260 R------KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ +N + K K +F + CL + +KRPT E
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 70/313 (22%), Positives = 109/313 (34%), Gaps = 90/313 (28%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVKKSK-------------------------N 90
+ LG G G V + + +AVK K N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDR-------------LQNQEFPLTWEMRL 137
V LLG C L++ E+ G L L + +++ E L E L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197
+ +VA +A+L AS HRD+ + NILL K+ DFG ++ I D +V
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--- 202
Query: 198 IQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSL 251
L PE + T +SDV+S+G+ L EL + G P
Sbjct: 203 -VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-------------- 247
Query: 252 AAYFVHSMRKNRLYDILDDQVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTME 303
Y M + + K+ K+ M ++ + C D + KRPT +
Sbjct: 248 --YP--GMPVDS-------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 304 EVSMELNGIRGSS 316
++ + S
Sbjct: 297 QIVQLIEKQISES 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 57/221 (25%), Positives = 83/221 (37%), Gaps = 55/221 (24%)
Query: 62 RILGQGGQGTVYKGM---REDGRIIAVKKSK-------------------------NAVK 93
++G+G G V K A+K+ K N +
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFP-----------LTWEMRLRIATE 142
LLG C L E+ +G L L + P L+ + L A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 202
VA + YL + HRD+ + NIL+ E Y AK+ADFG S+ + T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--EVYVKKTM----- 200
Query: 203 GYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
G L E S T SDV+S+GV+L E+++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 71/288 (24%), Positives = 107/288 (37%), Gaps = 65/288 (22%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK-----------------------KSKN 90
F + ++G G G VYKG + G++ A+K +N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 91 AVKLLGCCLETEVPL------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT--- 141
G ++ P LV EF G++ L + W IA
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEW-----IAYICR 136
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
E+ L++LH + HRDIK N+LL E K+ DFG S + T I GT
Sbjct: 137 EILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GT 192
Query: 202 FGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256
++ PE + D KSD++S G+ +E+ G P+ +
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD---------------M 237
Query: 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
H MR L+ I + +L K F + E CL N +RP E+
Sbjct: 238 HPMRA--LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 65/300 (21%), Positives = 100/300 (33%), Gaps = 77/300 (25%)
Query: 47 SSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK------------------- 86
+ N +G G G V+K R+ G +IAVK
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 87 ------KSKNAVKLLGCCLETEVPLLVYEFISNGTLY---------QHLHDRLQNQEFPL 131
V+ G FI+N ++ + P
Sbjct: 76 VVLKSHDCPYIVQCFGT------------FITNTDVFIAMELMGTCAEKLKKRMQGPIP- 122
Query: 132 TWEMRL-RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190
E L ++ + AL YL + HRD+K +NILLDER + K+ DFG S +
Sbjct: 123 --ERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR--LV 176
Query: 191 QTHVTTKIQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSAGNTS 245
+ G Y+ PE T ++DV+S G+ LVEL TG+ P +
Sbjct: 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-- 234
Query: 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQI-MAFANLAERCLDLNGKKRPTMEE 304
L +L ++ L F + + CL + +KRP +
Sbjct: 235 ------------DFEV--LTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-21
Identities = 47/223 (21%), Positives = 90/223 (40%), Gaps = 54/223 (24%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVK------------------------KSKNA 91
LG+ G VYKG E + +A+K + N
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDR-----------LQNQEFPLTWEMRLRIA 140
V LLG + + +++ + S+G L++ L R + + L + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
++A + YL +S + H+D+ + N+L+ ++ K++D G + + K+ G
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYKLLG 188
Query: 201 TFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
L PE + + SD++S+GVVL E+ + G +P
Sbjct: 189 N-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 56/238 (23%), Positives = 95/238 (39%), Gaps = 38/238 (15%)
Query: 41 DRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKG-MREDGRIIAVK-------KSKNA 91
R + E + F R+LG+GG G V+ M+ G++ A K K +
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 92 VKL------------------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQE-FPL 131
+ L ET+ L LV ++ G + H+++ ++ F
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ- 287
Query: 132 TWEMRLRI-ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190
E R ++ L +LH I +RD+K N+LLD+ +++D G + +
Sbjct: 288 --EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248
QT GT G++ PE + D ++ GV L E++ + P F A EN
Sbjct: 343 QTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP-FRARGEKVEN 398
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 45/225 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVK-------KSKNAVKL------------- 94
N F+V+RI+G+GG G VY + G++ A+K K K L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 95 --------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVA 144
+ T L + + ++ G L+ HL Q+ F E +R A E+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFS---EADMRFYAAEII 302
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
L ++H+ + +RD+K NILLDE +++D G + + + H + GT GY
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGY 356
Query: 205 LDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQEN 248
+ PE Q D S D +S G +L +LL G P F T ++
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH 400
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 57/243 (23%), Positives = 88/243 (36%), Gaps = 42/243 (17%)
Query: 34 SYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKG-MREDGRIIAVK---KSK 89
+ G + +F + + + + + LG G G V + A+K K+
Sbjct: 15 YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 90 ----------------------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQ 127
N +KL + LV E G L+ D + ++
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF----DEIIHR 130
Query: 128 EFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTS 184
I +V + YLH I HRD+K N+LL ++ K+ DFG S
Sbjct: 131 MK-FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244
+ + GT Y+ PE + +K DV+S GV+L LL G P G T
Sbjct: 187 AVF--ENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFG--GQT 241
Query: 245 SQE 247
QE
Sbjct: 242 DQE 244
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 59/227 (25%), Positives = 92/227 (40%), Gaps = 50/227 (22%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVK-------KSKNAVKLLGCCLETE----- 102
+HF + R +G+G G V + ++ A+K +N V+ + E
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR----NVFKELQIMQ 70
Query: 103 -------VPL-----------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEV 143
V L +V + + G L HL QN F E +++ E+
Sbjct: 71 GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFK---EETVKLFICEL 124
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
AL YL + I HRD+K NILLDE + DF + + + T + GT
Sbjct: 125 VMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKP 179
Query: 204 YLDPEYHQSSQLT--DKS-DVYSFGVVLVELLTGKKPIFSAGNTSQE 247
Y+ PE S + + D +S GV ELL G++P +TS +
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 39/218 (17%)
Query: 58 FNVNRILGQGGQGTVYKG-MREDGRIIAVK--KSKNAVKL-------------------- 94
F +ILG+G TV R A+K + ++ +K
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 95 ---LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAY 149
L + + L + NG L +++ + F E R E+ AL Y
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFD---ETCTRFYTAEIVSALEY 145
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLDPE 208
LH I HRD+K NILL+E ++ DFGT+K ++ + GT Y+ PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
SD+++ G ++ +L+ G P F AGN
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYL 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 54/226 (23%), Positives = 84/226 (37%), Gaps = 44/226 (19%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKL-------------------- 94
+ F + +++G+G V M++ G++ A+K L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 95 -----LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGAL 147
L + E L LV E+ G L L + R E+ A+
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIP-AEMARFYLAEIVMAI 175
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
+H HRDIK NILLD ++ADFG+ + D T + GT YL P
Sbjct: 176 DSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 208 EYHQSSQLTDKSDVY-------SFGVVLVELLTGKKPIFSAGNTSQ 246
E Q+ + Y + GV E+ G+ P F A +T++
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP-FYADSTAE 277
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 60/294 (20%)
Query: 44 KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-MREDGRIIAVK---KSK---------- 89
+F ++ + R+LG+G G V + G+ AVK K +
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 90 -------------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMR 136
N +KL + LV E + G L+ D + +++ +
Sbjct: 74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF----DEIISRKR-FSEVDA 128
Query: 137 LRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTH 193
RI +V + Y+H I HRD+K N+LL + ++ DFG S + +
Sbjct: 129 ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASK 183
Query: 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSL 251
GT Y+ PE + +K DV+S GV+L LL+G P F+ N + V
Sbjct: 184 KMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKVEK 241
Query: 252 AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
Y + + + + K +L + L R + +
Sbjct: 242 GKY---TFELPQWKKVSES-----AK--------DLIRKMLTYVPSMRISARDA 279
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 62/231 (26%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVK------------------------KSKNA 91
R +G+G G V++ E ++AVK + N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDR-------------------LQNQEFPLT 132
VKLLG C + L++E+++ G L + L PL+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 133 WEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192
+L IA +VA +AYL + HRD+ + N L+ E K+ADFG S+ I
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 193 HVTTKIQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
+ + PE ++ T +SDV+++GVVL E+ + G +P
Sbjct: 230 YK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 47/236 (19%), Positives = 81/236 (34%), Gaps = 69/236 (29%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRI--------IAVKKSKNA---------- 91
++ N LGQG ++KG+R + + +K A
Sbjct: 4 KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 92 -------------VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLR 138
V G C+ + +LV EF+ G+L L+ + + +L
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSL----DTYLKKNKNCINILWKLE 117
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR--------AKVADFGTSKFIAMD 190
+A ++A A+ +L + + H ++ + NILL K++D G S +
Sbjct: 118 VAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 191 QTHVTTKIQGTFGYLD-------PE-YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
L PE L +D +SFG L E+ + G KP
Sbjct: 175 D------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 51/243 (20%), Positives = 79/243 (32%), Gaps = 86/243 (35%)
Query: 62 RILGQGGQGTVYKGM------REDGRIIAVKKSK-------------------------N 90
++LG G G V +AVK K N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDR------------------LQNQEFPLT 132
V LLG C + L++E+ G L +L + + LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 133 WEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192
+E L A +VA + +L HRD+ + N+L+ K+ DFG ++ I
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI----- 222
Query: 193 HVTTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-G 234
D Y L + KSDV+S+G++L E+ + G
Sbjct: 223 -----------MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271
Query: 235 KKP 237
P
Sbjct: 272 VNP 274
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 69/292 (23%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------------- 89
+ + +++ LG G G V R+ + +A++ K K
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 90 -------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATE 142
+K+ + E +V E + G L+ D++ + L +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF----DKVVGNKR-LKEATCKLYFYQ 247
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
+ A+ YLH I HRD+K N+LL +E K+ DFG SK + +T + +
Sbjct: 248 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC 302
Query: 200 GTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256
GT YL PE ++ D +S GV+L L+G P FS T +
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRTQVS--------L 353
Query: 257 HSMRKNRLYDILD---DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ Y+ + +V + +L ++ L ++ K R T EE
Sbjct: 354 KDQITSGKYNFIPEVWAEVSEKAL--------DLVKKLLVVDPKARFTTEEA 397
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 40/229 (17%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------------N 90
+H++++ LG G G V++ R G A K
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 91 AVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
V L E + + ++YEF+S G L+ +++ ++ ++ + + +V L +
Sbjct: 216 LVNLHDAF-EDDNEMVMIYEFMSGGELF----EKVADEHNKMSEDEAVEYMRQVCKGLCH 270
Query: 150 LHSAASSPIYHRDIKSTNILLDER--YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
+H H D+K NI+ + K+ DFG + + D GT + P
Sbjct: 271 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAP 325
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAY 254
E + + +D++S GV+ LL+G P F N + NV +
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDW 373
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 7e-20
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 56 NHFNVNRILGQGGQGTVY----KGMREDGRIIAVK-------KSKNAVKLLG-------- 96
+ F + ++LGQG G V+ + ++ A+K K ++ V+
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 97 ---------CCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAG 145
+TE L L+ +F+ G L+ L + F E ++ E+A
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFT---EEDVKFYLAELAL 137
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
AL +LHS I +RD+K NILLDE K+ DFG SK ++D GT Y+
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 193
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
PE T +D +SFGV++ E+LTG P F + +
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKE 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-20
Identities = 64/255 (25%), Positives = 103/255 (40%), Gaps = 39/255 (15%)
Query: 21 KQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKGMRED 79
KQ + + + D S + ++ +K + T N F ++LG+G G V +
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA 171
Query: 80 -GRIIAVKKSKNAVKL-------------------------LGCCLETEVPL-LVYEFIS 112
GR A+K K V + L +T L V E+ +
Sbjct: 172 TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231
Query: 113 NGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171
G L+ HL + + F E R R E+ AL YLHS + + +RD+K N++LD
Sbjct: 232 GGELFFHLS---RERVFS---EDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD 283
Query: 172 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 231
+ K+ DFG K + GT YL PE + + D + GVV+ E+
Sbjct: 284 KDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342
Query: 232 LTGKKPIFSAGNTSQ 246
+ G+ P F + +
Sbjct: 343 MCGRLP-FYNQDHEK 356
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 43/223 (19%)
Query: 56 NHFNVNRILGQGGQGTVY----KGMREDGRIIAVKKSKNAVKL----------------- 94
F + R+LG+GG G V+ G+I A+K K A+ +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 95 ---------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEV 143
L +T L L+ E++S G L+ L + F E E+
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFM---EDTACFYLAEI 130
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
+ AL +LH I +RD+K NI+L+ + K+ DFG K ++ VT GT
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIE 186
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
Y+ PE S D +S G ++ ++LTG P F+ N +
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKK 228
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 55/223 (24%), Positives = 85/223 (38%), Gaps = 43/223 (19%)
Query: 56 NHFNVNRILGQGGQGTVYK-GMREDGRIIAVK--KSKNAVKL------------------ 94
+ V +++G+G G V + ++ A+K +K
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 95 -----LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGAL 147
L + + L +V E++ G L + N + P E R EV AL
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVP---EKWARFYTAEVVLAL 181
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
+HS HRD+K N+LLD+ K+ADFGT + + GT Y+ P
Sbjct: 182 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 208 EYHQSSQLT---DKS-DVYSFGVVLVELLTGKKPIFSAGNTSQ 246
E +S + D +S GV L E+L G P F A +
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP-FYADSLVG 280
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 49/259 (18%), Positives = 100/259 (38%), Gaps = 44/259 (16%)
Query: 29 QQMLNSYDGSVIDRCKLFSSKEL----DKATNHFNVNRILGQGGQGTVYKGM-REDGRII 83
+N YD D K + + + +++++ LG G G V++ + + GR+
Sbjct: 20 GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 79
Query: 84 AVK---KSK--------------------NAVKLLGCCLETEVPL-LVYEFISNGTLYQH 119
K + L E + + L+ EF+S G L+
Sbjct: 80 VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGELF-- 136
Query: 120 LHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL--DERYRAK 177
DR+ +++ ++ + + L ++H + I H DIK NI+ + K
Sbjct: 137 --DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVK 191
Query: 178 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
+ DFG + + + + T + PE + +D+++ GV+ LL+G P
Sbjct: 192 IIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
Query: 238 IFSAGNTSQ--ENVSLAAY 254
F+ + + +NV +
Sbjct: 250 -FAGEDDLETLQNVKRCDW 267
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 42/224 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKL-------------------- 94
F + +++G+G G V ++ ++ A+K L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 95 -----LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGAL 147
L + + L LV ++ G L L E L E R E+ A+
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL----SKFEDRLP-EEMARFYLAEMVIAI 188
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
+H HRDIK NIL+D ++ADFG+ + D T ++ GT Y+ P
Sbjct: 189 DSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 208 EYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSAGNTSQ 246
E Q+ + D +S GV + E+L G+ P F A + +
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVE 288
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 59/243 (24%), Positives = 87/243 (35%), Gaps = 54/243 (22%)
Query: 45 LFSSKELDKATNHFNVNRILGQGGQGTVYKG-MREDGRIIAVK---KSK----------- 89
++ K+ K + R LG G G V + A+K KS+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 90 ----------------------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQ 127
N +KL + + LV EF G L+ +++ N+
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF----EQIINR 140
Query: 128 EFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTS 184
I ++ + YLH I HRDIK NILL + K+ DFG S
Sbjct: 141 HK-FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 185 KFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
F + + GT Y+ PE + +K DV+S GV++ LL G P F N
Sbjct: 197 SFF--SKDYKLRDRLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPP-FGGQN 251
Query: 244 TSQ 246
Sbjct: 252 DQD 254
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 60/227 (26%), Positives = 86/227 (37%), Gaps = 53/227 (23%)
Query: 55 TNHFNVNRILGQGGQGTVYKG-MREDGRIIAVK---KSK--------------------- 89
+N+ +LG+G G V K R + AVK K+
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 90 -NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
N +KL E +V E + G L+ D + ++ + RI +V +
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELF----DEIIKRKR-FSEHDAARIIKQVFSGI 134
Query: 148 AYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
Y+H I HRD+K NILL ++ K+ DFG S Q GT Y
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYY 189
Query: 205 LDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
+ PE Y +K DV+S GV+L LL+G P F N
Sbjct: 190 IAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP-FYGKNEYD 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-19
Identities = 30/275 (10%), Positives = 63/275 (22%), Gaps = 85/275 (30%)
Query: 64 LGQGGQGTVYKGMRED---GRIIAVK--------------------------KSKNAVKL 94
G ++ D R +A+ ++
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
L L+V E+I G+L + +R +A A H A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-------AIRAMQSLAAAADAAHRA- 148
Query: 155 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 214
+ + + + +A +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA------ 179
Query: 215 LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274
+ D+ G L LL + P LA Q ++
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP-LPEAGVRS---GLAP----------AERDTAGQPIE 224
Query: 275 LGKKNQIM--AFANLAERCLDLNGKKRPTMEEVSM 307
++ + + +A R + +G R +++
Sbjct: 225 PADIDRDIPFQISAVAARSVQGDGGIRSASTLLNL 259
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 65/237 (27%), Positives = 98/237 (41%), Gaps = 46/237 (19%)
Query: 46 FSSKELDKAT-NHFNVNRILGQGGQGTVY----KGMREDGRIIAVKKSKNAVKL------ 94
+ +K +F + ++LG G G V+ + G++ A+K K A +
Sbjct: 43 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 102
Query: 95 ---------------------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLT 132
L +TE L L+ ++I+ G L+ HL Q + F
Sbjct: 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFT-- 157
Query: 133 WEMRLRI-ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191
E ++I E+ AL +LH I +RDIK NILLD + DFG SK D+
Sbjct: 158 -EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213
Query: 192 THVTTKIQGTFGYLDPE-YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQ 246
T GT Y+ P+ DK+ D +S GV++ ELLTG P F+
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKN 269
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 72/296 (24%), Positives = 112/296 (37%), Gaps = 76/296 (25%)
Query: 47 SSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK------------- 89
S + ++ + + +G+G V GR +A+K K++
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV 65
Query: 90 ---------NAVKLLGCCLETEVPL-LVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRL 137
N VKL +ETE L L+ E+ S G ++ +L H R++ +E
Sbjct: 66 RIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE-------AR 117
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 197
++ A+ Y H I HRD+K+ N+LLD K+ADFG S +
Sbjct: 118 SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF- 173
Query: 198 IQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENV 249
G Y PE Y + DV+S GV+L L++G P F N + E V
Sbjct: 174 -CGAPPYAAPELFQGKKYDGP-----EVDVWSLGVILYTLVSGSLP-FDGQNLKELRERV 226
Query: 250 SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
Y + + NL +R L LN KR T+E++
Sbjct: 227 LRGKYRIPFY--------MSTDC------------ENLLKRFLVLNPIKRGTLEQI 262
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 48/316 (15%), Positives = 86/316 (27%), Gaps = 75/316 (23%)
Query: 55 TNHFNVNRILGQGGQ--GTVYKGM-REDGRIIAVK------------------------- 86
+ + ++G+G + TV + G + V+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 87 KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT---EV 143
N V + +V F++ G+ + L IA V
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELA-----IAYILQGV 137
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ---- 199
AL Y+H HR +K+++IL+ + ++ ++ +
Sbjct: 138 LKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 200 --GTFGYLDPEYHQSSQL--TDKSDVYSFGVVLVELLTGKKPIF---------------- 239
+L PE Q + KSD+YS G+ EL G P
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 240 -----------SAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLA 288
S + S+ + D + F +
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314
Query: 289 ERCLDLNGKKRPTMEE 304
E+CL N RP+
Sbjct: 315 EQCLQRNPDARPSAST 330
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 65/348 (18%), Positives = 106/348 (30%), Gaps = 93/348 (26%)
Query: 31 MLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK--- 86
M + + S F L + +++ +GQG G V + + I A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 87 KSK-------------------------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLH 121
K+K N +L + + LV E G L L+
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 122 DRLQNQEFPLTWEMRL-----------------------------------RIATEVAGA 146
+ + ++ I ++ A
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 147 LAYLHSAASSPIYHRDIKSTNILL--DERYRAKVADFGTSKFIA---MDQTHVTTKIQGT 201
L YLH+ I HRDIK N L ++ + K+ DFG SK + + T GT
Sbjct: 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 202 FGYLDPE--YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVH 257
++ PE + K D +S GV+L LL G P F N + V
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP-FPGVNDADTISQVLNKKL--- 293
Query: 258 SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + L + +L L+ N +R
Sbjct: 294 -----CFENPNYNVLSPLAR--------DLLSNLLNRNVDERFDAMRA 328
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK-------------------NA 91
+ + LG+G G V++ + + K N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 92 VKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
+ L E+ L +++EFIS ++ +R+ F L + +V AL +L
Sbjct: 64 LHLHESF-ESMEELVMIFEFISGLDIF----ERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 151 HSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
HS I H DI+ NI+ R + K+ +FG ++ + + Y PE
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPE 173
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAY 254
HQ ++ +D++S G ++ LL+G P F A Q EN+ A Y
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEY 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 59/282 (20%), Positives = 102/282 (36%), Gaps = 57/282 (20%)
Query: 55 TNHFNVNRILGQGGQGTVYKG-MREDGRIIAVK---KSK--------------------- 89
+ F R LG G G V+ R G +K K +
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 90 NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
N +K+ E + +V E G L + + + L+ + ++ ALA
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEGYVAELMKQMMNALA 138
Query: 149 YLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
Y HS + H+D+K NIL K+ DFG ++ +T GT Y+
Sbjct: 139 YFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAGTALYM 193
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSMRKNR 263
PE + +T K D++S GVV+ LLTG P F+ + + + + +
Sbjct: 194 APEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP-FTGTSLEEVQQKATYKEPNYAVECRP- 250
Query: 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ +L ++ L + ++RP+ +V
Sbjct: 251 --------LTPQAV--------DLLKQMLTKDPERRPSAAQV 276
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVK-------KSKNAVK-------------- 93
N F+ ++LG+G G V + GR A+K +K+ V
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 94 ----LLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGAL 147
L +T L V E+ + G L+ HL + + F E R R E+ AL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFT---EERARFYGAEIVSAL 118
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
YLHS + +RDIK N++LD+ K+ DFG K + GT YL P
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 174
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
E + + D + GVV+ E++ G+ P F + +
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHER 212
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-18
Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 40/220 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKL-------------------- 94
+ F+ +++G+G G V + + AVK + L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 95 ------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGA 146
L +T L V ++I+ G L+ HL + + F E R R A E+A A
Sbjct: 98 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFL---EPRARFYAAEIASA 151
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L YLHS I +RD+K NILLD + + DFG K ++ T+ GT YL
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLA 207
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
PE D + G VL E+L G P F + NT++
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP-FYSRNTAE 246
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 68/220 (30%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKL-------------------- 94
++F R+LG+G G V ++E G + AVK K V L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 95 ------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGA 146
L CC +T L V EF++ G L H+ +++ F E R R A E+ A
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFD---EARARFYAAEIISA 136
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L +LH I +RD+K N+LLD K+ADFG K + T GT Y+
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIA 192
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
PE Q D ++ GV+L E+L G P F A N
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDD 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 59/220 (26%), Positives = 85/220 (38%), Gaps = 40/220 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKL-------------------- 94
FN +LG+G G V + + AVK K V +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 95 ------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGA 146
L C +T L V E+++ G L H+ Q F E A E+A
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK---EPHAVFYAAEIAIG 454
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L +L S I +RD+K N++LD K+ADFG K + T GT Y+
Sbjct: 455 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIA 510
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
PE D ++FGV+L E+L G+ P F + +
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDE 549
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 69/302 (22%), Positives = 105/302 (34%), Gaps = 87/302 (28%)
Query: 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---KSK------------- 89
KE + + + V +LG GG G+VY G+R D +A+K K +
Sbjct: 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 90 ---------------NAVKLLGCCLETEVPL-LVYEFISN-GTLYQHL--HDRLQNQEFP 130
++LL E L+ E L+ + LQ +
Sbjct: 94 PMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEEL-- 150
Query: 131 LTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAM 189
R +V A+ + H+ + HRDIK NIL+D R K+ DFG+ +
Sbjct: 151 ----AR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL--L 200
Query: 190 DQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
T T GT Y PE YH + V+S G++L +++ G P F
Sbjct: 201 KDTVYTD-FDGTRVYSPPEWIRYHRYHGR-----SAAVWSLGILLYDMVCGDIP-FE--- 250
Query: 244 TSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTME 303
E + F + + +L CL L RPT E
Sbjct: 251 -HDEEIIRGQVFFRQR--------VSSECQ------------HLIRWCLALRPSDRPTFE 289
Query: 304 EV 305
E+
Sbjct: 290 EI 291
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 39/211 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKL-------------------- 94
F++ R++G+G V +++ RI A+K K +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 95 ------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGA 146
L C +TE L V E+++ G L H+ + ++ P E R + E++ A
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP---EEHARFYSAEISLA 122
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L YLH I +RD+K N+LLD K+ D+G K + T+ GT Y+
Sbjct: 123 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIA 178
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
PE + D ++ GV++ E++ G+ P
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 55/231 (23%), Positives = 89/231 (38%), Gaps = 50/231 (21%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------------- 89
+ + +++ LG G G V R+ + +A+K K K
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 90 -------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATE 142
+K+ + E +V E + G L+ D++ + L +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF----DKVVGNKR-LKEATCKLYFYQ 122
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
+ A+ YLH I HRD+K N+LL +E K+ DFG SK + +T + +
Sbjct: 123 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC 177
Query: 200 GTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
GT YL PE ++ D +S GV+L L+G P FS T
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRTQVS 227
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 59/226 (26%), Positives = 87/226 (38%), Gaps = 51/226 (22%)
Query: 55 TNHFNVNRILGQGGQGTVYKG-MREDGRIIAVK---KSK--------------------- 89
+N+ +LG+G G V K R + AVK K+
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 90 -NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
N +KL ++ +V E + G L+ D + ++ + RI +V +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELF----DEIIKRKR-FSEHDAARIIKQVFSGIT 135
Query: 149 YLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
Y+H I HRD+K NILL ++ K+ DFG S Q GT Y+
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYI 190
Query: 206 DPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
PE Y +K DV+S GV+L LL+G P F N
Sbjct: 191 APEVLRGTY------DEKCDVWSAGVILYILLSGTPP-FYGKNEYD 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 44/232 (18%)
Query: 55 TNHFNVNR--ILGQGGQGTVYKGM-REDGRIIAVK---KSK------------------- 89
+ + V++ ILG G G V+K G +A K
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 90 -NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
N ++L E++ + LV E++ G L+ DR+ ++ + LT + ++ +
Sbjct: 146 ANLIQLYDA-FESKNDIVLVMEYVDGGELF----DRIIDESYNLTELDTILFMKQICEGI 200
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
++H I H D+K NIL R K+ DFG ++ GT +L
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFL 255
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE---NVSLAAY 254
PE ++ +D++S GV+ LL+G P F G+ E N+ +
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP-F-LGDNDAETLNNILACRW 305
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 59/220 (26%), Positives = 85/220 (38%), Gaps = 40/220 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVKKSKNAVKL-------------------- 94
FN +LG+G G V + + AVK K V +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 95 ------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGA 146
L C +T L V E+++ G L H+ Q F E A E+A
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK---EPHAVFYAAEIAIG 133
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L +L S I +RD+K N++LD K+ADFG K + T GT Y+
Sbjct: 134 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIA 189
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
PE D ++FGV+L E+L G+ P F + +
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDE 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 39/211 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVK-------KSKNAVK-------------- 93
F++ R++G+G V +++ RI A++ +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 94 -----LLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGA 146
L C +TE L V E+++ G L H+ + ++ P E R + E++ A
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP---EEHARFYSAEISLA 165
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L YLH I +RD+K N+LLD K+ D+G K + T+ GT Y+
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIA 221
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
PE + D ++ GV++ E++ G+ P
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 57/286 (19%), Positives = 93/286 (32%), Gaps = 69/286 (24%)
Query: 55 TNHFNVNRILGQGGQGTVYKG-MREDGRIIAVK---KSK--------------------N 90
++ + +G+G G V + A K K N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 91 AVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
++L E + LV E + G L+ +R+ ++ RI +V A+AY
Sbjct: 68 IIRLYETF-EDNTDIYLVMELCTGGELF----ERVVHKRV-FRESDAARIMKDVLSAVAY 121
Query: 150 LHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
H + HRD+K N L K+ DFG + + GT Y+
Sbjct: 122 CHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPYYVS 176
Query: 207 PE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSM 259
P+ Y + D +S GV++ LL G P FSA S+ + +
Sbjct: 177 PQVLEGLY------GPECDEWSAGVMMYVLLCGYPP-FSAPTDSEVMLKIREGTFTFPEK 229
Query: 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
V + +L R L + K+R T +
Sbjct: 230 DW--------LNVSPQAE--------SLIRRLLTKSPKQRITSLQA 259
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 40/220 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKG-MREDGRIIAVK-------KSKNAVK-------------- 93
F ++++LG+G G V+ ++ + A+K + V+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 94 -----LLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGA 146
+ C +T+ L V E+++ G L H+ +F R A E+
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD---LSRATFYAAEIILG 130
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
L +LHS I +RD+K NILLD+ K+ADFG K M T GT Y+
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIA 186
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
PE + D +SFGV+L E+L G+ P F + +
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEE 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 56/223 (25%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------NAVKL 94
+ +++G G G VY+ + G ++A+KK N V+L
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 95 LGCCLET-----EVPL-LVYEFISNGTLYQHL-HDRLQNQEFPL------TWEMRLRIAT 141
+ EV L LV +++ T+Y+ H Q P+ +++ R
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL-FR--- 167
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQ--TH-VTTK 197
+LAY+HS I HRDIK N+LLD K+ DFG++K + + + ++
Sbjct: 168 ----SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 198 IQGTFGYLDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
Y PE ++ T DV+S G VL ELL G +PIF
Sbjct: 221 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIF 257
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 55/230 (23%)
Query: 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK----------------- 89
K ++ + +++G G G V++ + +A+KK
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK 90
Query: 90 --NAVKLLGCCLET-----EVPL-LVYEFISNGTLYQHL-HDRLQNQEFPL------TWE 134
N V L EV L LV E++ T+Y+ H Q P+ ++
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 135 MRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQ-- 191
+ LR +LAY+HS I HRDIK N+LLD K+ DFG++K + +
Sbjct: 150 L-LR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 192 TH-VTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
+ ++ Y PE ++ T D++S G V+ EL+ G +P+F
Sbjct: 199 VSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLF 242
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 57/217 (26%), Positives = 83/217 (38%), Gaps = 41/217 (18%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------------N 90
F +LG G V+ R G++ A+K KS N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 91 AVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
V L E+ LV + +S G L+ DR+ + T + + +V A+ Y
Sbjct: 68 IVTLEDIY-ESTTHYYLVMQLVSGGELF----DRILERGV-YTEKDASLVIQQVLSAVKY 121
Query: 150 LHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
LH I HRD+K N+L +E + + DFG SK Q + + GT GY+
Sbjct: 122 LHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVA 175
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
PE + D +S GV+ LL G P F
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPP-FYEET 211
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 53/230 (23%), Positives = 84/230 (36%), Gaps = 53/230 (23%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------------- 89
++ ILG+G V + + + + AVK +
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 90 ---------NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
N ++L ET LV++ + G L+ D L + L+ + +I
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELF----DYLTEKVT-LSEKETRKI 129
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
+ + LH I HRD+K NILLD+ K+ DFG S + D ++
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVC 184
Query: 200 GTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
GT YL PE + D++S GV++ LL G P F
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRK 233
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 68/310 (21%), Positives = 105/310 (33%), Gaps = 101/310 (32%)
Query: 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---KSK------------- 89
K+ + + + +LG+GG GTV+ G R D +A+K +++
Sbjct: 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 90 -----------------NAVKLLGCCLETEVPL-LVYEFISNGT-LYQHL--HDRLQNQE 128
++LL ET+ LV E L+ ++ L
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 129 FPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFI 187
R +V A+ + HS + HRDIK NIL+D R AK+ DFG+
Sbjct: 141 ------SR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL- 189
Query: 188 AMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP---- 237
+ T GT Y PE YH + V+S G++L +++ G P
Sbjct: 190 -LHDEPYTD-FDGTRVYSPPEWISRHQYHAL-----PATVWSLGILLYDMVCGDIPFERD 242
Query: 238 --IFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLN 295
I A +VS L RCL
Sbjct: 243 QEILEAELHFPAHVSPDC-------------------------------CALIRRCLAPK 271
Query: 296 GKKRPTMEEV 305
RP++EE+
Sbjct: 272 PSSRPSLEEI 281
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 43/235 (18%)
Query: 41 DRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKG-MREDGRIIAVK--KSKNAVKL-- 94
D K + + + A + F+ + LG G G V +E G A+K + VKL
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84
Query: 95 ---------------------LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLT 132
L + L +V E+++ G ++ HL F
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFS-- 139
Query: 133 WEMRLRI-ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191
E R A ++ YLHS + +RD+K N+L+D++ +V DFG +K +
Sbjct: 140 -EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV---- 191
Query: 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
T + GT L PE S D ++ GV++ E+ G P F A Q
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP-FFADQPIQ 245
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 63/284 (22%), Positives = 103/284 (36%), Gaps = 67/284 (23%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK---------------------NA 91
+++ + LG+G G V + R +AVK + N
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 92 VKLLGCCLETEVPL-LVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGALA 148
VK G L E+ S G L+ + + + R ++ +
Sbjct: 68 VKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-------AQRFFHQLMAGVV 119
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDP 207
YLH I HRDIK N+LLDER K++DFG + ++ + K+ GT Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 208 E------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
E +H DV+S G+VL +L G+ P ++ QE Y K
Sbjct: 177 ELLKRREFHAE-----PVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YS---DWK 222
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + + L + L N R T+ ++
Sbjct: 223 EKKTYLNPWKKIDSAPL-------ALLHKILVENPSARITIPDI 259
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 59/237 (24%), Positives = 94/237 (39%), Gaps = 49/237 (20%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSKNAVKLLGCC---LETEVPL-- 105
+ +++ LG G V K + G A K K ++ G +E EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 106 ---------------------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144
L+ E +S G L+ D L +E L+ E ++
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELF----DFLAQKES-LSEEEATSFIKQIL 125
Query: 145 GALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
+ YLH + I H D+K NI+L K+ DFG + I + I G
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFG 180
Query: 201 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE---NVSLAAY 254
T ++ PE L ++D++S GV+ LL+G P F G+T QE N++ +Y
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-F-LGDTKQETLANITSVSY 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 56/273 (20%), Positives = 107/273 (39%), Gaps = 48/273 (17%)
Query: 61 NRILGQGGQGTVYKGM-REDGRIIAVK---KSK------------------NAVKLLGCC 98
++ LG+G K + ++ + AVK K N VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
+ LV E ++ G L+ +R++ ++ + I ++ A++++H +
Sbjct: 76 HDQLHTFLVMELLNGGELF----ERIKKKKH-FSETEASYIMRKLVSAVSHMHDVG---V 127
Query: 159 YHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 215
HRD+K N+L ++ K+ DFG ++ D + T T Y PE +
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGY 186
Query: 216 TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD---DQV 272
+ D++S GV+L +L+G+ P F + + S S ++K + V
Sbjct: 187 DESCDLWSLGVILYTMLSGQVP-FQSHDRSLTCTSAVEIM-KKIKKGD-FSFEGEAWKNV 243
Query: 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ K +L + L ++ KR M +
Sbjct: 244 SQEAK--------DLIQGLLTVDPNKRLKMSGL 268
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-16
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 41/213 (19%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------------- 89
+++++V LG+G V + + + G A K K
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 90 -NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
N V+L + E LV++ ++ G L+ + + +EF + ++ ++
Sbjct: 65 PNIVRLHDSI-QEESFHYLVFDLVTGGELF----EDIVAREF-YSEADASHCIQQILESI 118
Query: 148 AYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
AY HS I HR++K N+LL + K+ADFG + + + + GT GY
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGY 173
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
L PE + + D+++ GV+L LL G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 38/225 (16%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------- 89
D ++ F V LG+G VY+ + + A+K K+
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL 105
Query: 90 ---NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
N +KL ET + LV E ++ G L+ DR+ + + + ++
Sbjct: 106 SHPNIIKLKEIF-ETPTEISLVLELVTGGELF----DRIVEKGY-YSERDAADAVKQILE 159
Query: 146 ALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 202
A+AYLH I HRD+K N+L K+ADFG SK + + + + GT
Sbjct: 160 AVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTP 214
Query: 203 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
GY PE + + D++S G++ LL G +P F Q
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP-FYDERGDQF 258
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 60/237 (25%), Positives = 95/237 (40%), Gaps = 49/237 (20%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSKNAVKLLGCC---LETEVPL-- 105
+ +++ LG G V K + G A K K ++ G C +E EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 106 ---------------------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144
L+ E +S G L+ D L +E L+ E ++
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELF----DFLAQKES-LSEEEATSFIKQIL 125
Query: 145 GALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
+ YLH+ I H D+K NI+L K+ DFG + I + I G
Sbjct: 126 DGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFG 180
Query: 201 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE---NVSLAAY 254
T ++ PE L ++D++S GV+ LL+G P F G+T QE N++ +Y
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-F-LGDTKQETLANITAVSY 235
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 42/237 (17%)
Query: 37 GSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--- 89
G + R F K +++++V LG+G V + + + G A K K
Sbjct: 10 GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA 69
Query: 90 -------------------NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEF 129
N V+L + E LV++ ++ G L+ + + +EF
Sbjct: 70 RDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELF----EDIVAREF 124
Query: 130 PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKF 186
+ ++ ++AY HS I HR++K N+LL + K+ADFG +
Sbjct: 125 -YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
+ + + GT GYL PE + + D+++ GV+L LL G P F +
Sbjct: 181 V--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP-FWDED 234
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 63/284 (22%), Positives = 103/284 (36%), Gaps = 67/284 (23%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK---------------------NA 91
+++ + LG+G G V + R +AVK + N
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 92 VKLLGCCLETEVPL-LVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGALA 148
VK G L E+ S G L+ + + + R ++ +
Sbjct: 68 VKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-------AQRFFHQLMAGVV 119
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDP 207
YLH I HRDIK N+LLDER K++DFG + ++ + K+ GT Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 208 E------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
E +H DV+S G+VL +L G+ P ++ QE Y K
Sbjct: 177 ELLKRREFHAE-----PVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YS---DWK 222
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + + L + L N R T+ ++
Sbjct: 223 EKKTYLNPWKKIDSAPL-------ALLHKILVENPSARITIPDI 259
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-16
Identities = 63/237 (26%), Positives = 96/237 (40%), Gaps = 49/237 (20%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSKNAVKLLGCC---LETEVPL-- 105
+H+ + LG G V K + G+ A K K + + G +E EV +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 106 ---------------------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144
L+ E +S G L+ D L +E LT + + ++
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELF----DFLAEKES-LTEDEATQFLKQIL 118
Query: 145 GALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
+ YLHS I H D+K NI+L R K+ DFG + I + + I G
Sbjct: 119 DGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFG 173
Query: 201 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE---NVSLAAY 254
T ++ PE L ++D++S GV+ LL+G P F G T QE N+S Y
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-F-LGETKQETLTNISAVNY 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 57/253 (22%), Positives = 103/253 (40%), Gaps = 71/253 (28%)
Query: 36 DGSVIDRCKLFSSKELD-KATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK------ 87
GS++ ++ E K + F V R+ GQG GTV G + G +A+KK
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 88 ----------------SKNAVKLL------GCCLETEVPL-LVYEFISNGTLYQHL-HDR 123
N V+L G ++ L +V E++ + TL++ +
Sbjct: 62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY 120
Query: 124 LQNQEFPL------TWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRA 176
+ P +++ +R ++ LH S + HRDIK N+L++E
Sbjct: 121 RRQVAPPPILIKVFLFQL-IR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTL 171
Query: 177 KVADFGTSKFIAMDQTH---VTTK-------IQGTFGYLDPEYHQSSQLTDKSDVYSFGV 226
K+ DFG++K ++ + + + ++ I G Y T D++S G
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHY-----------TTAVDIWSVGC 220
Query: 227 VLVELLTGKKPIF 239
+ E++ G +PIF
Sbjct: 221 IFAEMMLG-EPIF 232
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 34/218 (15%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK-----------------NAVK 93
T+ + V +G G + + + AVK KSK N +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
L + + +V E + G L D++ Q+F + + + + YLH+
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELL----DKILRQKF-FSEREASAVLFTITKTVEYLHAQ 135
Query: 154 ASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
+ HRD+K +NIL ++ DFG +K + + + T T ++ PE
Sbjct: 136 G---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEV 191
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
+ D++S GV+L +LTG P + + + E
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 64/237 (27%), Positives = 95/237 (40%), Gaps = 49/237 (20%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSKNAVKLLGCC---LETEVPL-- 105
++++ LG G V K + G A K K + G +E EV +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 106 ---------------------LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144
L+ E ++ G L+ D L +E LT E ++
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELF----DFLAEKES-LTEEEATEFLKQIL 124
Query: 145 GALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
+ YLHS I H D+K NI+L + R K+ DFG + I D + I G
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFG 179
Query: 201 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE---NVSLAAY 254
T ++ PE L ++D++S GV+ LL+G P F G+T QE NVS Y
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-F-LGDTKQETLANVSAVNY 234
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 39/216 (18%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------------- 89
+ + + ++G+G V + + RE G+ AVK +K
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 90 ----NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144
+ V+LL ++ L +V+EF+ L + R + F + + ++
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKR-ADAGFVYSEAVASHYMRQIL 140
Query: 145 GALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
AL Y H I HRD+K +LL + K+ FG + + ++ GT
Sbjct: 141 EALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
++ PE + DV+ GV+L LL+G P
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 51/229 (22%), Positives = 91/229 (39%), Gaps = 52/229 (22%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------------- 89
++ ++G+G V + + R G AVK +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 90 --------NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIA 140
+ + L+ E+ + LV++ + G L+ D L + L+ + I
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELF----DYLTEKVA-LSEKETRSIM 206
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
+ A+++LH+ I HRD+K NILLD+ + +++DFG S ++ ++ G
Sbjct: 207 RSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELCG 261
Query: 201 TFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243
T GYL PE + D+++ GV+L LL G P F
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP-FWHRR 309
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 57/307 (18%), Positives = 105/307 (34%), Gaps = 72/307 (23%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA-------------VKLLGCC-- 98
+ + +G G QG V R +A+KK + L+ C
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 99 ------LETEVPL----------LVYEFISNGTLYQHLHDRLQNQEF-PLTWEMRLRIAT 141
L P +V E + L Q + L ++ L ++M L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM-LC--- 138
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
+ +LHSA I HRD+K +NI++ K+ DFG ++ + + T T
Sbjct: 139 ----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 189
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT--------------SQE 247
Y PE + D++S G ++ E++ G +F + E
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPCPE 248
Query: 248 NV----SLAAYFVHSMRK------NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGK 297
+ +V + K +L+ + K + +L + L ++
Sbjct: 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308
Query: 298 KRPTMEE 304
KR +++E
Sbjct: 309 KRISVDE 315
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-15
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 54/217 (24%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK----------------------- 89
H+ + LG G G V G + G +AVK + K
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 90 NAVKLLGCCLETEVPL-LVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGA 146
+ +KL + T +V E++S G L+ ++ H R++ E R+ ++ A
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-------ARRLFQQILSA 123
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+ Y H + HRD+K N+LLD AK+ADFG S ++ + T+ G+ Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAA 178
Query: 207 PE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
PE Y + D++S GV+L LL G P
Sbjct: 179 PEVISGRLYAGP-----EVDIWSCGVILYALLCGTLP 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 53/246 (21%), Positives = 93/246 (37%), Gaps = 46/246 (18%)
Query: 44 KLFSSKELDKATNHFNVN-RILGQGGQGTVYKGM-REDGRIIAVK---KSK--------- 89
+ + ++ N + + + LG+G V + + + G+ A K K +
Sbjct: 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI 75
Query: 90 --------------NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWE 134
+ L E + L+ E+ + G ++ L ++
Sbjct: 76 LHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEM---VSEN 131
Query: 135 MRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQ 191
+R+ ++ + YLH I H D+K NILL K+ DFG S+ I
Sbjct: 132 DVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GH 186
Query: 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE---N 248
+I GT YL PE +T +D+++ G++ LLT P F G +QE N
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-F-VGEDNQETYLN 244
Query: 249 VSLAAY 254
+S
Sbjct: 245 ISQVNV 250
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 59/285 (20%), Positives = 102/285 (35%), Gaps = 63/285 (22%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK--------------------- 89
T + + LG+G V + + G+ A K
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 90 -NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
N V+L E L+++ ++ G L+ + + +E+ + ++ A+
Sbjct: 70 PNIVRLHDSI-SEEGHHYLIFDLVTGGELF----EDIVAREY-YSEADASHCIQQILEAV 123
Query: 148 AYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 204
+ H + HR++K N+LL + K+ADFG + + +Q GT GY
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGY 179
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSMRKN 262
L PE + D+++ GV+L LL G P F + + + + AY S
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPP-FWDEDQHRLYQQIKAGAYDFPS---- 234
Query: 263 RLYDILD--DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
D V K +L + L +N KR T E
Sbjct: 235 ------PEWDTVTPEAK--------DLINKMLTINPSKRITAAEA 265
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 63/277 (22%), Positives = 106/277 (38%), Gaps = 41/277 (14%)
Query: 39 VIDRCKLFSSKELDKATNHFNVNRILGQGGQ--GTVYKGMREDGRIIAVKKSK--NAVKL 94
V+ + KL + G Q G + + +E I +KK N VKL
Sbjct: 45 VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE---IAILKKLDHPNVVKL 101
Query: 95 ---LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
L E + +V+E ++ G + + + PL+ + ++ + YLH
Sbjct: 102 VEVLDDPNEDHL-YMVFELVNQGPVM----EVPTLK--PLSEDQARFYFQDLIKGIEYLH 154
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
I HRDIK +N+L+ E K+ADFG S + + GT ++ PE
Sbjct: 155 YQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSNTVGTPAFMAPESLS 210
Query: 212 SSQLT---DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
++ DV++ GV L + G+ P F +HS K++ +
Sbjct: 211 ETRKIFSGKALDVWAMGVTLYCFVFGQCP-FMDERIMC---------LHSKIKSQALEFP 260
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
D + K +L R LD N + R + E+
Sbjct: 261 DQPDIAEDLK-------DLITRMLDKNPESRIVVPEI 290
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 62/286 (21%), Positives = 105/286 (36%), Gaps = 67/286 (23%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK----------------------- 89
+ + +LG+G G V + + E AVK K K
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 90 -NAVKLLG-CCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
N ++L+ E + + +V E+ G Q + D + + FP + ++
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFP-VCQAH-GYFCQLIDG 121
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS---KFIAMDQTHVTTKIQGTFG 203
L YLHS I H+DIK N+LL K++ G + A D T T+ QG+
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPA 176
Query: 204 YLDPEYHQSSQLTD--KSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSM 259
+ PE K D++S GV L + TG P F N + EN+ +Y
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGDNIYKLFENIGKGSY----- 230
Query: 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + ++L + L+ KR ++ ++
Sbjct: 231 ---AIPGDCGPPL------------SDLLKGMLEYEPAKRFSIRQI 261
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 52/223 (23%), Positives = 83/223 (37%), Gaps = 60/223 (26%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK----------------------- 89
++ LG G G V+ + +E + + VK K K
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 90 -----NAVKLLGCCLETEVPL-LVYEFISNGT-LYQHL--HDRLQNQEFPLTWEMRLRIA 140
N +K+L E + LV E +G L+ + H RL I
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL------AS-YIF 136
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 200
++ A+ YL I HRDIK NI++ E + K+ DFG++ ++ + T G
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CG 191
Query: 201 TFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
T Y PE Y + +++S GV L L+ + P
Sbjct: 192 TIEYCAPEVLMGNPYRGP-----ELEMWSLGVTLYTLVFEENP 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 42/217 (19%)
Query: 58 FNVNRILGQGGQGTVYKG-MREDGRIIAVK--KSKNAVKL-------------------- 94
F + R LG G G V+ R +GR A+K K + V+L
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 95 ---LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI-ATEVAGALAY 149
+ + + ++ ++I G L+ L ++Q FP + A EV AL Y
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFP---NPVAKFYAAEVCLALEY 121
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
LHS I +RD+K NILLD+ K+ DFG +K++ VT + GT Y+ PE
Sbjct: 122 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEV 174
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ 246
+ D +SFG+++ E+L G P F NT +
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMK 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 13/114 (11%)
Query: 130 PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189
LT E + + +VA + +L AS HRD+ + NILL E+ K+ DFG ++ I
Sbjct: 189 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 190 DQTHVTTKIQGTFGYLD-----PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 237
D +V + L PE T +SDV+SFGV+L E+ + G P
Sbjct: 246 DPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 47/215 (21%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK---------------------NAV 92
+ + + R LG+G V++ + + + VK K N +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 94
Query: 93 KLLGCCL--ETEVPLLVYEFISNGTLYQHLHDRLQNQEFP-LTWEMRLRIATEVAGALAY 149
L + P LV+E ++N Q L + + +E+ L+ AL Y
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEI-LK-------ALDY 145
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQT---HVTTKIQGTFGYL 205
HS I HRD+K N+++D +R ++ D+G ++F Q V ++ +
Sbjct: 146 CHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FK 197
Query: 206 DPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 239
PE Q+ D S D++S G +L ++ K+P F
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 54/300 (18%), Positives = 101/300 (33%), Gaps = 58/300 (19%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA-------------VKLLGCC-- 98
+ + +G G QG V R +A+KK + L+ C
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 99 ------LETEVPLLVYEFISNGTLYQHLHD----RLQNQEFPLTWEMRLRIATEVAGALA 148
L P E + L L D ++ L E + ++ +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIK 178
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
+LHSA I HRD+K +NI++ K+ DFG ++ + + T T Y PE
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE 233
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT--------------SQENV----S 250
+ D++S G ++ E++ K +F + E +
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 251 LAAYFVHSMRK------NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+V + K +L+ K + +L + L ++ KR ++++
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 57/318 (17%), Positives = 109/318 (34%), Gaps = 83/318 (26%)
Query: 60 VNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA----------VKLLGCCLETE------ 102
+ R LG G TV+ + +A+K + +KLL + +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 103 ------VPLLVYEFISNGTLYQH-----------LHDRLQNQEF-PLTWEMRLRIATEVA 144
+ LL + F G H L ++ E + +I+ ++
Sbjct: 83 MGANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 145 GALAYLHSAASSPIYHRDIKSTNILLDERYRA------KVADFGTSKFIAMDQTHVTTKI 198
L Y+H I H DIK N+L++ K+AD G + + H T I
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNSI 196
Query: 199 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF---SAGNTSQENVSLA--- 252
Q Y PE + +D++S ++ EL+TG +F + ++++ +A
Sbjct: 197 QTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQII 254
Query: 253 ------------------AYF--------VHSMRKNRLYDILDDQVMKLGKKNQIMAFAN 286
+F + ++ L D+L ++ K++ ++
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK--FSKDEAKEISD 312
Query: 287 LAERCLDLNGKKRPTMEE 304
L L+ +KR
Sbjct: 313 FLSPMLQLDPRKRADAGG 330
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 64/293 (21%), Positives = 108/293 (36%), Gaps = 69/293 (23%)
Query: 63 ILGQGGQGTVYKGM-REDGRIIAVK---KSK---------------------NAVKLLGC 97
+LG+G V + + AVK K N ++L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
E + LV+E + G++ H+H R E E + +VA AL +LH+
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNE----LEAS-VVVQDVASALDFLHNKG--- 131
Query: 158 IYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQ------GTFGYLDPE 208
I HRD+K NIL ++ K+ DF I ++ G+ Y+ PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 209 ----YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263
+ + + + DK D++S GV+L LL+G P F S +N
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP-FVGRCGSDCGWDRGEACPAC--QNM 248
Query: 264 LYD-ILD----------DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
L++ I + + K +L + L + K+R + +V
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAK--------DLISKLLVRDAKQRLSAAQV 293
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 77/287 (26%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK----------------------- 89
H+ + LG G G V G G +AVK + K
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 90 NAVKLLGCCLETEVPL-LVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGA 146
+ +KL + T + +V E++S G L+ ++ + RL +E R+ ++
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE-------SRRLFQQILSG 128
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+ Y H + HRD+K N+LLD AK+ADFG S ++ + T+ G+ Y
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAA 183
Query: 207 PE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHS 258
PE Y + D++S GV+L LL G P F + + + +
Sbjct: 184 PEVISGRLYAGP-----EVDIWSSGVILYALLCGTLP-FDDDHVPTLFKKICDGIF---- 233
Query: 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
L+ V +L + L ++ KR T++++
Sbjct: 234 ----YTPQYLNPSV------------ISLLKHMLQVDPMKRATIKDI 264
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 43/206 (20%), Positives = 84/206 (40%), Gaps = 37/206 (17%)
Query: 53 KATNHFNVNRIL------GQGGQGTVYKGMREDGRIIAVKKSKNAVKLLGCCLETEVPL- 105
K +H N+ +++ G + N K + L
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 106 LVYEFISNGTLYQHL-HDRLQNQEFPL------TWEMRLRIATEVAGALAYLHSAASSPI 158
++ E++ + TL++ L + P+ +++ R A+ ++HS I
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQL-FR-------AVGFIHSLG---I 162
Query: 159 YHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLDPE-YHQSS 213
HRDIK N+L++ + K+ DFG++K + + + ++ Y PE ++
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGAT 217
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIF 239
+ T D++S G V EL+ G KP+F
Sbjct: 218 EYTPSIDLWSIGCVFGELILG-KPLF 242
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 37/208 (17%)
Query: 63 ILGQGGQGTVYKGM-REDGRIIAVK---KSK----------------NAVKLLGCCLETE 102
+LG G G V + R G+ A+K S + V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH 95
Query: 103 VP----LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
L++ E + G L+ + +R +Q F T I ++ A+ +LHS I
Sbjct: 96 HGKRCLLIIMECMEGGELFSRIQER-GDQAF--TEREAAEIMRDIGTAIQFLHSHN---I 149
Query: 159 YHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 215
HRD+K N+L ++ K+ DFG +K Q + T T Y+ PE +
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYYVAPEVLGPEKY 206
Query: 216 TDKSDVYSFGVVLVELLTGKKPIFSAGN 243
D++S GV++ LL G P F +
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPP-FYSNT 233
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 56/302 (18%), Positives = 102/302 (33%), Gaps = 61/302 (20%)
Query: 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSKNAVKLLGC---------CLET--EV 103
+ + V R + G G V G+ +G +A+K+ N V C E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 104 PLL-------------VYEFISNGT-----LYQH-----LHDRLQNQEFPLTWEMRLRIA 140
LL ++ L L + +Q ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---HVTTK 197
+ L LH A + HRD+ NILL + + DF ++ D +VT +
Sbjct: 141 YHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 198 IQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNT-SQENVSLA--- 252
Y PE + K D++S G V+ E+ K +F +Q N +
Sbjct: 198 W-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQLNKIVEVVG 251
Query: 253 ---AYFVHSMRKNRLYDILDDQVMKLGKKN--QIMAFAN-----LAERCLDLNGKKRPTM 302
V D L + + + + ++ A+ L + L+ N ++R +
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311
Query: 303 EE 304
E+
Sbjct: 312 EQ 313
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 68/341 (19%), Positives = 108/341 (31%), Gaps = 116/341 (34%)
Query: 52 DKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK------------------------ 86
D + V +++G+G G V K + + +A+K
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK 152
Query: 87 ----KSKNAVKLLGC-------CLETEVPLL---VYEFISNGTLYQHLHDRLQNQEFPLT 132
+ N + +L C+ E LL +YE I +N+ +
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIK------------KNKFQGFS 198
Query: 133 WEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMD 190
+ + A + L LH I H D+K NILL ++ R+ KV DFG+S + +
Sbjct: 199 LPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---E 252
Query: 191 QTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244
V T IQ F Y PE Y D++S G +L ELLTG P+ +
Sbjct: 253 HQRVYTYIQSRF-YRAPEVILGARYGMPI------DMWSLGCILAELLTG-YPLLPGEDE 304
Query: 245 SQ-----------------ENVSLAAYFVHSM------------------------RKNR 263
+ A FV S R
Sbjct: 305 GDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKL 364
Query: 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ K F + ++CL+ + R T +
Sbjct: 365 RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 64/309 (20%), Positives = 113/309 (36%), Gaps = 88/309 (28%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA-------------VKLLG---- 96
+ +G G G+V + + G +A+KK + LL
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 97 ----CCLETEVPL----------LVYEFISNGTLYQHLHDRLQNQEF-PLTWEMRLRIAT 141
L+ P LV F+ L + + + ++ L ++M L+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLVYQM-LK--- 137
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQG 200
L Y+HSA + HRD+K N+ ++E K+ DFG ++ + T V T+
Sbjct: 138 ----GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-- 188
Query: 201 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNT--------------S 245
Y PE S +++ D++S G ++ E+LTG K +F +
Sbjct: 189 ---YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPG 244
Query: 246 QENVSL-----AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFAN-----LAERCLDLN 295
E V A ++ S+ + D Q+ A+ L E+ L+L+
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDF-----------TQLFPRASPQAADLLEKMLELD 293
Query: 296 GKKRPTMEE 304
KR T +
Sbjct: 294 VDKRLTAAQ 302
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 69/346 (19%), Positives = 113/346 (32%), Gaps = 119/346 (34%)
Query: 52 DKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA------------------- 91
+K + + ++ ++G+G G V K R + +A+K KN
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK 109
Query: 92 ---------VKLLGC-------CLETEVPLL---VYEFISNGTLYQHLHDRLQNQEFPLT 132
V L CL E +L +Y+ + ++
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLR------------NTNFRGVS 155
Query: 133 WEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMD 190
+ + A ++ AL +L + S I H D+K NILL R+ K+ DFG+S
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDFGSSCQ---L 211
Query: 191 QTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244
+ IQ F Y PE Y + D++S G +LVE+ TG +P+FS N
Sbjct: 212 GQRIYQYIQSRF-YRSPEVLLGMPYDLAI------DMWSLGCILVEMHTG-EPLFSGANE 263
Query: 245 SQ-----------------ENVSLAAYFVHS--------------------MRKNRLYDI 267
+ A F +L++I
Sbjct: 264 VDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNI 323
Query: 268 LDDQVMKLGKKNQIMA---------FANLAERCLDLNGKKRPTMEE 304
L + G + + F +L R LD + K R
Sbjct: 324 LGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 57/303 (18%), Positives = 110/303 (36%), Gaps = 75/303 (24%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA-------------VKLLG---- 96
+ + +G G G V + G +A+KK ++LL
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 97 ----CCLETEVPLLVYEFISNGTLYQH-----LHDRLQNQEFPLTWEMRLRIATEVAGAL 147
L+ P + ++ L L ++++ L + + ++ L
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGL 141
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLD 206
Y+H+A I HRD+K N+ ++E K+ DFG ++ + T +V T+ Y
Sbjct: 142 RYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRA 193
Query: 207 PEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNT--------------SQENVSL 251
PE + ++ D++S G ++ E++TG K +F + E V
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 252 -----AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFAN-----LAERCLDLNGKKRPT 301
A ++ + + D I+ A+ L E+ L L+ ++R T
Sbjct: 253 LQSDEAKNYMKGLPELEKKDF-----------ASILTNASPLAVNLLEKMLVLDAEQRVT 301
Query: 302 MEE 304
E
Sbjct: 302 AGE 304
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 63/289 (21%), Positives = 96/289 (33%), Gaps = 77/289 (26%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK-------------------NAVK 93
++ + +G G G + ++AVK + N V+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVR 80
Query: 94 LLGCCLETEVPL-LVYEFISNGTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
+ T L ++ E+ S G LY+ + R E ++ ++Y
Sbjct: 81 FKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSEDE-------ARFFFQQLLSGVSYC 132
Query: 151 HSAASSPIYHRDIKSTNILLDERY--RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
HS I HRD+K N LLD R K+ DFG SK + +T GT Y+ PE
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 187
Query: 209 ------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262
Y +DV+S GV L +L G P F RK
Sbjct: 188 VLLRQEYDGK-----IADVWSCGVTLYVMLVGAYP-FEDPEEP-----------RDYRKT 230
Query: 263 RL------YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
Y I DD + +L R + R ++ E+
Sbjct: 231 IQRILSVKYSIPDDIRISPECC-------HLISRIFVADPATRISIPEI 272
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 72/338 (21%), Positives = 114/338 (33%), Gaps = 108/338 (31%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA-------------VKLLGCCLE 100
+ + + LG+G G V+K + R G ++AVKK +A + +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 101 TE--VPLL----------VYEFISNGTLYQH-----LHDRLQNQEFPLTWEMR------- 136
E V LL VY L LH ++ L +
Sbjct: 68 HENIVNLLNVLRADNDRDVY-------LVFDYMETDLHAVIRAN--ILEPVHKQYVVYQL 118
Query: 137 LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196
++ + YLHS + HRD+K +NILL+ KVADFG S+ +
Sbjct: 119 IK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 197 KIQGTFGYLDPEYHQSSQLTD---------------------KSDVYSFGVVLVELLTGK 235
+ LTD D++S G +L E+L G
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG- 227
Query: 236 KPIFSAGNT--------------SQENVS-----LAAYFVHSMRKNRLYDILDDQVMKLG 276
KPIF +T S E+V A + S+++ + + +
Sbjct: 228 KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287
Query: 277 KKNQI-----MAFAN-----LAERCLDLNGKKRPTMEE 304
KN + A N L ++ L N KR + +
Sbjct: 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 51/222 (22%)
Query: 62 RILGQGGQGTVYKGM-REDGRIIAVK---KSK----------------NAVKLLGCCLET 101
++LG G G V + + A+K + V+++ E
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVY-EN 126
Query: 102 EVP-----LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASS 156
L+V E + G L+ + DR +Q F T I + A+ YLHS
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDR-GDQAF--TEREASEIMKSIGEAIQYLHSIN-- 181
Query: 157 PIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE----- 208
I HRD+K N+L K+ DFG +K + T T Y+ PE
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 238
Query: 209 -YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQEN 248
Y DKS D++S GV++ LL G P +S +
Sbjct: 239 KY-------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 3e-12
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 44/207 (21%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLLGC 97
+G+G GTV+K RE I+A+K+ + N V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
+ LV+EF Q L + L E+ ++ L + HS
Sbjct: 70 LHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RN 121
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY-----HQS 212
+ HRD+K N+L++ K+A+FG ++ + + ++ T Y P+ S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIF 239
+ + D++S G + EL +P+F
Sbjct: 181 TSI----DMWSAGCIFAELANAGRPLF 203
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 44/206 (21%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKKSK-------------------------NAVKLLGCC 98
+G+G G VYK GRI+A+K+ + N V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
LV+EF + + L L + L ++ +A+ H I
Sbjct: 89 HSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRI 140
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY-----HQSS 213
HRD+K N+L++ K+ADFG ++ + T ++ T Y P+ S+
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYST 199
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIF 239
+ D++S G + E++TG KP+F
Sbjct: 200 SV----DIWSIGCIFAEMITG-KPLF 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 46/185 (24%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGY 204
L Y+HSA I HRD+K +N+ ++E K+ DFG ++ A + T +V T+ Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195
Query: 205 LDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNT--------------SQENV 249
PE + +++ D++S G ++ ELLTG + +F + E +
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 250 SL-----AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFAN-----LAERCLDLNGKKR 299
A ++ S+ + + + AN L E+ L L+ KR
Sbjct: 255 KKISSESARNYIQSLTQMPKMNF-----------ANVFIGANPLAVDLLEKMLVLDSDKR 303
Query: 300 PTMEE 304
T +
Sbjct: 304 ITAAQ 308
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 51/215 (23%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSKNAVKLLGCCLETEVPLL------ 106
+ + LG+G G V + + +A+K + + +E E+ L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 107 ----VYEFISN------------GTLYQHL--HDRLQNQEFPLTWEMRLRIATEVAGALA 148
+Y+ I+ G L+ ++ R+ E R ++ A+
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDE-------GRRFFQQIICAIE 122
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
Y H I HRD+K N+LLD+ K+ADFG S + T+ G+ Y PE
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177
Query: 209 ------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
Y + DV+S G+VL +L G+ P
Sbjct: 178 VINGKLYAGP-----EVDVWSCGIVLYVMLVGRLP 207
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 2e-11
Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 44/206 (21%)
Query: 64 LGQGGQGTVYKGMREDGRIIAVKKSK-------------------------NAVKLLGCC 98
+G+G G VYK G A+KK + N VKL
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
+ +LV+E L Q L L E L ++ +AY H +
Sbjct: 70 HTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-----YHQSS 213
HRD+K N+L++ K+ADFG ++ + T +I T Y P+ S+
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIF 239
+ D++S G + E++ G P+F
Sbjct: 181 TI----DIWSVGCIFAEMVNG-TPLF 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLLGC 97
+G+G G V K ++ GRI+A+KK N V LL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
C + + LV+EF+ + T+ L L +++ + ++ + + HS
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD 217
I HRDIK NIL+ + K+ DFG ++ +A ++ T Y PE
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYG 203
Query: 218 KS-DVYSFGVVLVELLTGKKPIF 239
K+ DV++ G ++ E+ G +P+F
Sbjct: 204 KAVDVWAIGCLVTEMFMG-EPLF 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 50/217 (23%)
Query: 64 LGQGGQGTVYKGMRED---GRIIAVKKSK---------------------NAVKLLGCCL 99
+G+G G VYK R+D + A+K+ + N + L L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 100 E-TEVPL-LVYEFISN---GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA 154
+ + L++++ + + H + + L M + ++ + YLH+
Sbjct: 89 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 155 SSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAM---DQTHVTTKIQGTFGYLDP 207
+ HRD+K NIL+ ER R K+AD G ++ + + TF Y P
Sbjct: 149 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAP 204
Query: 208 E-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
E H + + D+++ G + ELLT +PIF
Sbjct: 205 ELLLGARHYTKAI----DIWAIGCIFAELLT-SEPIF 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 63/291 (21%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK------------------------NAVKLLGCC 98
LG G TVYKG+ + G +A+K+ K N V+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 99 LETEVPLLVYEFISNGTLYQHLHDR-LQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
LV+EF+ N L +++ R + N L + ++ LA+ H +
Sbjct: 73 HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NK 128
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY-----HQS 212
I HRD+K N+L+++R + K+ DFG ++ + ++++ T Y P+ S
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYS 187
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE------------------NVS-LAA 253
+ + D++S G +L E++TG KP+F G +E +V+ L
Sbjct: 188 TSI----DIWSCGCILAEMITG-KPLF-PGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241
Query: 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
Y + + R L + K+ + L LN R + ++
Sbjct: 242 Y--NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 44/206 (21%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK------------------------NAVKLLGCC 98
LG+G TVYKG + ++A+K+ + N V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPI 158
+ LV+E+ L + L L + + ++ LAY H +
Sbjct: 70 HTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---V 121
Query: 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY-----HQSS 213
HRD+K N+L++ER K+ADFG ++ ++ ++ T Y P+ S+
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYST 180
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIF 239
Q+ D++ G + E+ TG +P+F
Sbjct: 181 QI----DMWGVGCIFYEMATG-RPLF 201
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 42/186 (22%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT--TKIQGTFG 203
L Y+HSA + HRD+K +N+LL+ K+ DFG ++ D H T+ T
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 204 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNT--------------SQEN 248
Y PE +S+ KS D++S G +L E+L+ +PIF + SQE+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 249 VSL-----AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFAN-----LAERCLDLNGKK 298
++ A ++ S+ N++ A+ L ++ L N K
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPW-----------NRLFPNADSKALDLLDKMLTFNPHK 304
Query: 299 RPTMEE 304
R +E+
Sbjct: 305 RIEVEQ 310
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 47/203 (23%), Positives = 79/203 (38%), Gaps = 37/203 (18%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLLGC 97
+G+G G V+K R+ G+I+A+KK N V LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 98 CLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSP 157
LV+E+ + T+ L + + + I + A+ + H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 158 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD 217
HRD+K NIL+ + K+ DFG ++ + + ++ T Y PE
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYG 181
Query: 218 KS-DVYSFGVVLVELLTGKKPIF 239
DV++ G V ELL+G P++
Sbjct: 182 PPVDVWAIGCVFAELLSG-VPLW 203
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 55/229 (24%), Positives = 86/229 (37%), Gaps = 55/229 (24%)
Query: 60 VNRILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVK 93
+ +I GQG G V+K R+ G+ +A+KK N V
Sbjct: 22 LAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 94 LLGCCLETEVPL--------LVYEFISNGTLYQHLHDR---LQNQEFPLTWEMRLRIATE 142
L+ C P LV++F HD L N T R+
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG-- 200
+ L Y+H + I HRD+K+ N+L+ K+ADFG ++ ++ + +
Sbjct: 133 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 201 -TFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247
T Y PE D++ G ++ E+ T + PI GNT Q
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIM-QGNTEQH 236
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 51/211 (24%), Positives = 76/211 (36%), Gaps = 34/211 (16%)
Query: 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSKNAVKLLGCCLETEVPLL-------- 106
N F + R +G G G +Y G + +A+K K L E +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTG 64
Query: 107 ---VYEFISNGT--------LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
V F G L L D L+ + L +A ++ + ++HS +
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 156 SPIYHRDIKSTNILLDERYRAK---VADFGTSKFIAMDQTHV------TTKIQGTFGYLD 206
HRDIK N L+ RA + DFG +K TH + GT Y
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
H + + + D+ S G VL+ L G P
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 39/191 (20%), Positives = 72/191 (37%), Gaps = 52/191 (27%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH-------VTTK 197
L Y+HSA + HRD+K N+ ++ E K+ DFG ++ + +H + TK
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 198 IQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNT------------ 244
Y P S K+ D+++ G + E+LTG K +F+ +
Sbjct: 189 -----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHELEQMQLILESIP 242
Query: 245 --SQENV----SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFAN-----LAERCLD 293
+E+ S+ ++ + + Q++ + E+ L
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPL-----------TQLLPGISREAVDFLEQILT 291
Query: 294 LNGKKRPTMEE 304
+ R T EE
Sbjct: 292 FSPMDRLTAEE 302
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 41/214 (19%), Positives = 78/214 (36%), Gaps = 55/214 (25%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NAVKLLGC 97
LG+G G VYK + +A+K+ + N ++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 98 CLETEVPLLVYEFISNGTLYQHLHD--RLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
L++E+ +D + ++ ++ + ++ + + HS
Sbjct: 102 IHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR- 152
Query: 156 SPIYHRDIKSTNILLDERYRA-----KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY- 209
HRD+K N+LL + K+ DFG ++ + T +I T Y PE
Sbjct: 153 --CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEIL 209
Query: 210 ----HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
H S+ + D++S + E+L P+F
Sbjct: 210 LGSRHYSTSV----DIWSIACIWAEMLMK-TPLF 238
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 41/226 (18%), Positives = 75/226 (33%), Gaps = 62/226 (27%)
Query: 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSKNAVKLLGCCLETEVPLLVYEFISNG 114
H+ V R +G+G G +++G + + +A+K ++ P L E+
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR---------RSDAPQLRDEY---- 56
Query: 115 TLYQHLHD--------------------------------RLQNQEFPLTWEMRLRIATE 142
Y+ L L ++F + + A +
Sbjct: 57 RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSV--KTVAMAAKQ 114
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAK-----VADFGTSKFIAMDQTHV--- 194
+ + +H + + +RDIK N L+ V DFG KF T
Sbjct: 115 MLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171
Query: 195 ---TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
+ GT Y+ H + + + D+ + G V + L G P
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 45/211 (21%), Positives = 73/211 (34%), Gaps = 34/211 (16%)
Query: 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSKNAVKLLGCCLETEVPLL-------- 106
N + + R +G G G +Y G G +A+K K L E +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVG 66
Query: 107 ---VYEFISNGT--------LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
+ + G L L D + + L +A ++ + Y+HS
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 156 SPIYHRDIKSTNILLDERYRAK---VADFGTSKFIAMDQTHV------TTKIQGTFGYLD 206
HRD+K N L+ + + DFG +K +TH + GT Y
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
H + + + D+ S G VL+ G P
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 62/223 (27%)
Query: 60 VNRILGQGGQGTVYKG--MREDGRIIAVKKSK---------------------------- 89
V I G+G G V+K ++ GR +A+K+ +
Sbjct: 16 VAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 90 NAVKLLGCCLETEVPL-----LVYEFISNGTLYQHLHDRLQNQEFP------LTWEMRLR 138
N V+L C + LV+E + L +L D++ P + +++ LR
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQL-LR 131
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTT 196
L +LHS + HRD+K NIL+ + K+ADFG ++ M T V
Sbjct: 132 -------GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
T Y PE S D++S G + E+ +KP+F
Sbjct: 182 ----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF 219
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 54/219 (24%), Positives = 79/219 (36%), Gaps = 52/219 (23%)
Query: 60 VNRILGQGGQGTVYKGM-REDGRIIAVKKSK----------------------------- 89
V I G G GTVYK G +A+K +
Sbjct: 14 VAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 90 --NAVKLLGCCLETEVPL-----LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATE 142
N V+L+ C + LV+E + L +L L E + +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA---PPPGLPAETIKDLMRQ 128
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTTKIQG 200
L +LH+ + I HRD+K NIL+ K+ADFG ++ M T V
Sbjct: 129 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV---- 181
Query: 201 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 239
T Y PE S D++S G + E+ +KP+F
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF 219
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 41/194 (21%), Positives = 70/194 (36%), Gaps = 50/194 (25%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG-- 203
A+ LH + + HRD+K +N+L++ KV DFG ++ I + G
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 204 -------YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNT----------- 244
Y PE +S ++ DV+S G +L EL +PIF +
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRHQLLLIFGII 239
Query: 245 ----SQENVSL-----AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFAN-----LAER 290
S ++ A ++ S+ + ++ N L +R
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPL-----------EKMFPRVNPKGIDLLQR 288
Query: 291 CLDLNGKKRPTMEE 304
L + KR T +E
Sbjct: 289 MLVFDPAKRITAKE 302
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 70/353 (19%), Positives = 101/353 (28%), Gaps = 131/353 (37%)
Query: 52 DKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK------------------------ 86
N F V R +G G G V ++ + AVK
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN 90
Query: 87 ---KSKNAVKLLGC-------CLETEVPLL---VYEFISNGTLYQHLHDRLQNQEFPLTW 133
+ N VK G CL E L +YE I+ +N
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIIT------------RNNYNGFHI 136
Query: 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE--------------------- 172
E E+ AL YL + + H D+K NILLD+
Sbjct: 137 EDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 173 ----RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVY 222
K+ DFG + F + + I Y PE + SS D++
Sbjct: 194 YRTKSTGIKLIDFGCATF---KSDYHGSIINTRQ-YRAPEVILNLGWDVSS------DMW 243
Query: 223 SFGVVLVELLTGKKPIFSAGNTSQENVSLA----------AYFVHSMRKNRLYDILDDQV 272
SFG VL EL TG +F T + LA ++ K ++
Sbjct: 244 SFGCVLAELYTG-SLLFR---THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDE 299
Query: 273 MKLGKKNQI---------------------MAFANLAERCLDLNGKKRPTMEE 304
+KL F + L ++ RP+ E
Sbjct: 300 LKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 42/222 (18%), Positives = 76/222 (34%), Gaps = 67/222 (30%)
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ-THVTTKIQGTFGY 204
++H + I HRD+K N LL++ KV DFG ++ I ++ T++ ++
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 205 LDPEYHQSSQLTD--------------------KS-DVYSFGVVLVELLTG--------- 234
+ QLT KS D++S G + ELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 235 -KKPIFSAGNTSQENVSLAAYFVHSMRK-----NRLYDIL----DDQVMKLGKKN----- 279
+ P+F G++ + N +++I+ +D + + K
Sbjct: 258 NRFPLF-PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316
Query: 280 ------------QIMAFAN-----LAERCLDLNGKKRPTMEE 304
Q + L E L N KR T+++
Sbjct: 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQ 358
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 60/342 (17%), Positives = 97/342 (28%), Gaps = 121/342 (35%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM--REDGRIIAVK-------------------------- 86
+ + LG+G G V + + +A+K
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKD 77
Query: 87 --KSKNAVKLLGC-------CLETEVPLL---VYEFISNGTLYQHLHDRLQNQEFPLTWE 134
V + C+ E LL +EF+ +N P
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLK------------ENNFQPYPLP 123
Query: 135 MRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA------------------ 176
+A ++ AL +LH + H D+K NIL
Sbjct: 124 HVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 177 -KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLV 229
+VADFG++ F D H TT + Y PE + Q DV+S G +L
Sbjct: 181 IRVADFGSATF---DHEHHTTIVATRH-YRPPEVILELGWAQPC------DVWSIGCILF 230
Query: 230 ELLTGKKPIFSAGNTSQ-----------------ENVSLAAYFVHSMRKNRLYDILDDQV 272
E G +F + YF + D +
Sbjct: 231 EYYRG-FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG-GLVWDENSSDGRY 288
Query: 273 MKLGKKN----------QIMAFANLAERCLDLNGKKRPTMEE 304
+K K + + +L R L+ + +R T+ E
Sbjct: 289 VKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-09
Identities = 65/345 (18%), Positives = 111/345 (32%), Gaps = 121/345 (35%)
Query: 52 DKATNHFNVNRILGQGGQGTVYKG--MREDGRIIAVK----------------------- 86
D + + + LG+G G V + + GR +AVK
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 87 -----KSKNAVKLLGC-------CLETEVPLL---VYEFISNGTLYQHLHDRLQNQEFPL 131
+ V++L C+ E LL Y+FI +N P
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIK------------ENGFLPF 115
Query: 132 TWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA--------------- 176
+ ++A ++ ++ +LHS + H D+K NIL +
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 177 ----KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGV 226
KV DFG++ + D H +T + Y PE + Q DV+S G
Sbjct: 173 NPDIKVVDFGSATY---DDEHHSTLVSTRH-YRAPEVILALGWSQPC------DVWSIGC 222
Query: 227 VLVELLTGKKPIFSAGNTSQE------------------NVSLAAYFVH---------SM 259
+L+E G +F + S+E YF H S
Sbjct: 223 ILIEYYLG-FTVF-PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280
Query: 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ + L + + +L ++ L+ + KR T+ E
Sbjct: 281 GRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 56/359 (15%), Positives = 99/359 (27%), Gaps = 126/359 (35%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA-------------VKLLG---- 96
+ + + ++G G G V + + + R++A+KK + +L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 97 ----CCLETEVPL---------LVYEFISNGT-LYQHLHDRLQNQEFPLTWEMR------ 136
L+ +P +V E + + LT
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFR---TPV--YLTELHIKTLLYN 164
Query: 137 -LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG------TSKFIAM 189
L + Y+HSA I HRD+K N L+++ KV DFG +
Sbjct: 165 LLV-------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTD--------------------KS-DVYSFGVVL 228
+ + QLT ++ DV+S G +
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 229 VELLT----------GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD----ILD----- 269
ELL + P+F + + A D I +
Sbjct: 275 AELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTP 334
Query: 270 --------------DQVMKLGKK-----NQIMAFAN-----LAERCLDLNGKKRPTMEE 304
+ K+ + ++ L +R L N KR T+ E
Sbjct: 335 SEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINE 393
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 56/222 (25%), Positives = 82/222 (36%), Gaps = 63/222 (28%)
Query: 64 LGQGGQGTVYKGM-REDGRIIAVKKSK----------------------------NAVKL 94
LG+G TVYK + +I+A+KK K N + L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWE-------MRLRIATEVAGAL 147
L LV++F + L +++ LT M L+ L
Sbjct: 78 LDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTLQ-------GL 125
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
YLH I HRD+K N+LLDE K+ADFG +K T ++ T Y P
Sbjct: 126 EYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAP 181
Query: 208 EY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244
E + D+++ G +L ELL P G++
Sbjct: 182 ELLFGARMYGVGV----DMWAVGCILAELLLR-VPFL-PGDS 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 43/240 (17%), Positives = 76/240 (31%), Gaps = 64/240 (26%)
Query: 52 DKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSKNAVKLLGCCLETEVPLLVYE-- 109
D A + V +GQGG G +Y + VK+ ++ L E
Sbjct: 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDA-PCVVKVE----PSDNGPLFTELK 85
Query: 110 ---------------------------------FISNGTLYQHL-HDRL----------Q 125
NG Y+ + DR
Sbjct: 86 FYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN 145
Query: 126 NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV--ADFGT 183
+ F + L+++ + L Y+H H DIK++N+LL+ + +V D+G
Sbjct: 146 AKRFSR--KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGL 200
Query: 184 SKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
+ + H GT + + H + + D+ G +++ LTG P
Sbjct: 201 AYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 40/240 (16%), Positives = 73/240 (30%), Gaps = 64/240 (26%)
Query: 52 DKATNHFNVNRILGQGGQGTVYKGMREDGRII--AVKKSKNAVKL--LGCCLETEVPLL- 106
DK+ + + + QG +Y+ +K K ++KL L E
Sbjct: 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 107 ------------------------VYEFISNGTLY------------QHLHDRLQNQEFP 130
F + Y Q D
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS 157
Query: 131 LTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV--ADFGTSKFIA 188
L++A + AL +LH H ++ + NI +D +++V A +G +
Sbjct: 158 E--RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 189 MDQTHV------TTKIQGTFGYLDPEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKP 237
HV + +G E+ H+ + +SD+ S G +++ L G P
Sbjct: 213 PSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 43/216 (19%), Positives = 74/216 (34%), Gaps = 42/216 (19%)
Query: 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSKNAVKLLGCCLETEVPLL-------- 106
+F V + +G G G + G +A+K + L E
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDG 66
Query: 107 ---VYEFISNGTLY-----------QHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
VY F G + L D L ++ F L + L IA ++ + Y+HS
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFD-LCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 153 AASSPIYHRDIKSTNILLDERYRAK-----VADFGTSKFIAMDQTHV------TTKIQGT 201
+ +RD+K N L+ + DF +K +T + GT
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
Y+ H + + + D+ + G + + L G P
Sbjct: 181 ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 47/228 (20%), Positives = 76/228 (33%), Gaps = 51/228 (22%)
Query: 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSK----------NAVKLL----GCCLE 100
N + + + +G GG G +Y A K + +K
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 101 TE-----------VPLLVY--EFISNGTLYQHL-HDRL---------QNQEFPLTWEMRL 137
+ +PL G Y+ + +RL QN F L
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK--STVL 154
Query: 138 RIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV--ADFGTSKFIAMDQTHV- 194
++ + L Y+H H DIK+ N+LL + +V AD+G S + H
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 195 -----TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237
GT + + H+ L+ +SDV G ++ L GK P
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 4e-07
Identities = 53/369 (14%), Positives = 102/369 (27%), Gaps = 114/369 (30%)
Query: 11 MDIKLKEGFFKQNGGLL---LQQMLNSYD-GSVIDRCK-LFSSKELDKATNHFNVNRILG 65
MD + E ++ +L ++++D V D K + S +E+D I+
Sbjct: 7 MDFETGEHQYQ-YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDH---------IIM 56
Query: 66 QGGQGTVYKGMREDGRIIAV--KKSKNAVK-LLGCCLETEVPLLVYEFIS---------- 112
G R+ K + V+ + L Y+F+
Sbjct: 57 SK---DAVSGTL---RLFWTLLSKQEEMVQKFVEEVLRIN-----YKFLMSPIKTEQRQP 105
Query: 113 --NGTLYQHLHDRLQN--QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDI----- 163
+Y DRL N Q F RL+ ++ AL L +++
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP-------AKNVLIDGV 158
Query: 164 ----KST---NILLDERYRAKVADFGTS--KFIAMDQTHVTTKIQGTFGY-LDPEYHQSS 213
K+ ++ L + + K DF + ++ Y +DP +
Sbjct: 159 LGSGKTWVALDVCLSYKVQCK-MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT--- 214
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
+D S L +N L +L +
Sbjct: 215 SRSDHSSNIKL------------------RIHSIQAELRRLLKSKPYENCL-LVLLN--- 252
Query: 274 KLGKKNQIMAFANLAERC--------------LDLNGKKRPTMEEVSMELNGIRGSSRKK 319
+ AF C L +++ SM L + +
Sbjct: 253 -VQNAKAWNAFNL---SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL-----TPDEV 303
Query: 320 RAMFSKIIK 328
+++ K +
Sbjct: 304 KSLLLKYLD 312
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 72/368 (19%), Positives = 118/368 (32%), Gaps = 125/368 (33%)
Query: 52 DKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA----------VKLLGCCLE 100
D ++V R LG G TV+ + + +A+K K+A ++LL
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN 92
Query: 101 TE--------VPLLVYEFI---SNGT--------LYQHLHD---RLQNQEFPLTWEMRLR 138
++ V L+ +F NGT L HL + Q PL +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPL--PCVKK 150
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILL---------------------------- 170
I +V L YLH+ I H DIK NILL
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 171 ---------------------DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
E+ + K+AD G + + H T IQ T Y E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ-TRQYRSLEV 264
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS---LA-------------- 252
S +D++S + EL TG +F + + +A
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATG-DYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 253 -------AYF--------VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGK 297
+F + ++ L+++L ++ + ++ F + L+L +
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEK-YEWSQEE-AAGFTDFLLPMLELIPE 381
Query: 298 KRPTMEEV 305
KR T E
Sbjct: 382 KRATAAEC 389
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 9e-07
Identities = 47/222 (21%), Positives = 78/222 (35%), Gaps = 60/222 (27%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVK---KSK----------------NAVKLL 95
++ +++LG G G V + + A+K + V+++
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIV 77
Query: 96 GCCLETEVP-----LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMR-LRIATEVAGALAY 149
E L+V E + G L+ R+Q++ E I + A+ Y
Sbjct: 78 DVY-ENLYAGRKCLLIVMECLDGGELF----SRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 150 LHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
LHS I HRD+K N+L K+ DFG +K T + Y D
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETTGE-----KY-D 176
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248
D++S GV++ LL G P +S +
Sbjct: 177 KS----------CDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 7e-06
Identities = 17/93 (18%), Positives = 33/93 (35%), Gaps = 8/93 (8%)
Query: 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165
+V EF G + + +L + I ++ +LA ++ HRD+
Sbjct: 139 IVLEFEFGGIDLEQMRTKL------SSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190
Query: 166 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 198
N+LL + K+ K + + I
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.08 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.05 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.79 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.7 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.04 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 89.7 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.67 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.21 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 87.88 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 87.54 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 86.35 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.96 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.82 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.29 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=390.85 Aligned_cols=238 Identities=26% Similarity=0.430 Sum_probs=193.9
Q ss_pred cCCccCceecCCCCeEEEEEEec------CCcEEEEc-----------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~l 106 (331)
++|.+.+.||+|+||+||+|... ++..|||| +|||||+++++|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999999999999853 47889999 49999999999999999999
Q ss_pred EeecccCCCHHHHHhhhh--------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 020102 107 VYEFISNGTLYQHLHDRL--------QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV 178 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl 178 (331)
|||||++|+|.++|.... ......+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997531 123457999999999999999999999988 999999999999999999999
Q ss_pred eeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHH
Q 020102 179 ADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
+|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .. ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~-~~ 240 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NE-VI 240 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HH-HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH-HH
Confidence 9999998654433222 223568999999999999999999999999999999998 8999964321 11 11
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.....+... ..+...+.++.+|+.+||+.||++|||++||++.|+.+..
T Consensus 241 ~~i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 241 ECITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222222211 1234456789999999999999999999999999998765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=388.90 Aligned_cols=235 Identities=22% Similarity=0.225 Sum_probs=192.2
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------ccccchhhhcccccCCcceeEeecccCCC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------KSKNAVKLLGCCLETEVPLLVYEFISNGT 115 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~ 115 (331)
.+.|.+.+.||+|+||+||+|.+ .+|+.|||| +|||||++++++.+++..+||||||+||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 35678888999999999999998 569999999 49999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEeeccCcccccCCCce-
Q 020102 116 LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMDQTH- 193 (331)
Q Consensus 116 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~- 193 (331)
|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+| .+||+|||+|+.+......
T Consensus 137 L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 137 LGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp HHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999763 47999999999999999999999998 99999999999999988 6999999999876533211
Q ss_pred ---eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 194 ---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
....++||+.|||||++.+..++.++|||||||++|||+||+.||........ ...... ...
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--------~~~i~~-~~~------ 273 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--------CLKIAS-EPP------ 273 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--------HHHHHH-SCC------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--------HHHHHc-CCC------
Confidence 12335799999999999999999999999999999999999999964322111 011111 110
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
.....++..+..+.+|+.+||+.||++|||+.|+++.|....
T Consensus 274 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 274 -PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp -GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 011224456678999999999999999999999999886654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=383.14 Aligned_cols=237 Identities=27% Similarity=0.424 Sum_probs=185.7
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.+++.+.+.||+|+||+||+|...+ .|||| +|||||++++++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4677889999999999999998743 58888 49999999998865 56899999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
||++|+|.+++.. ...++++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999865 2357999999999999999999999988 99999999999999999999999999986543
Q ss_pred CC-ceeeeeccccCCccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 190 DQ-THVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 190 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.. ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||...... .........+...
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--------~~~~~~~~~~~~~ 256 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--------DQIIFMVGRGYAS 256 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------HHHHHHHHTTCCC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcCCCC
Confidence 22 223345679999999999864 45899999999999999999999999643211 1111111111110
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
+ .....+...+..+.+|+.+||+.||++|||+.||++.|+.++.
T Consensus 257 ----p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 257 ----P-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp ----C-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ----C-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0 0011234456789999999999999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=390.50 Aligned_cols=239 Identities=26% Similarity=0.431 Sum_probs=188.6
Q ss_pred cCCccCceecCCCCeEEEEEEec------CCcEEEEc-----------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+|.+.+.||+|+||+||+|... ++..|||| +|||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777889999999999999853 47889999 49999999999999999999
Q ss_pred EeecccCCCHHHHHhhhhc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 107 VYEFISNGTLYQHLHDRLQ----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
|||||++|+|.+++..... ....++++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999875321 12357999999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHH
Q 020102 177 KVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~ 254 (331)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~- 268 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TE- 268 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------HH-
Confidence 9999999986643322 22334679999999999999999999999999999999999 8999964321 01
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....+..+.. ...+...+.++.+|+.+||+.||++|||++||++.|+.+...
T Consensus 269 ~~~~i~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 269 AIDCITQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111112211 122344566899999999999999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=393.95 Aligned_cols=228 Identities=23% Similarity=0.354 Sum_probs=185.6
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||+||+|.+ .+++.|||| +|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999997 569999999 48999999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
||+||+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999752 3446899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
. .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ......... .+...
T Consensus 178 ~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~-~~~~~---- 243 (350)
T 4b9d_A 178 T-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKII-SGSFP---- 243 (350)
T ss_dssp H-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHH-HTCCC----
T ss_pred C-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHH-cCCCC----
Confidence 2 122344679999999999999999999999999999999999999996431 111111111 12111
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+.++.+||.+||+.||++|||++|+++.
T Consensus 244 -----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 -----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1233456789999999999999999999999763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-55 Score=387.41 Aligned_cols=236 Identities=22% Similarity=0.355 Sum_probs=193.4
Q ss_pred cCCccCceecCCCCeEEEEEEe------cCCcEEEEc------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
..+++.+.||+|+||+||+|.. .+++.|||| +|||||+++++|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 3467788999999999999985 357889999 4999999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 020102 106 LVYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY 174 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~ 174 (331)
+|||||++|+|.++|..... .....+++..+..++.||+.||.|||+++ |+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 11246899999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchH
Q 020102 175 RAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 175 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~ 252 (331)
.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--------- 253 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------- 253 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---------
Confidence 999999999986643322 22334679999999999999999999999999999999998 8999864321
Q ss_pred HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
..+......+.. .+.+..++..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 254 ~~~~~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 QDVVEMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122222221 122445667899999999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=383.83 Aligned_cols=227 Identities=24% Similarity=0.359 Sum_probs=190.4
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
..|++.+.||+|+||+||+|.+ .+|+.|||| +|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4699999999999999999998 469999999 4899999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
+||+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 99999998864 36999999999999999999999998 9999999999999999999999999998765433
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .... ..........
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~-~~i~~~~~~~----- 289 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAM-KMIRDNLPPR----- 289 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH-HHHHHSSCCC-----
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHH-HHHHcCCCCC-----
Confidence 234457899999999999999999999999999999999999999964311 0111 1111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......+.++.+|+.+||+.||++|||++|+++.
T Consensus 290 --~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11123456789999999999999999999999763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=382.76 Aligned_cols=224 Identities=26% Similarity=0.383 Sum_probs=190.4
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+ .+++.|||| .|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999997 579999999 4899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|||+||+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999763 47999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCC-ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 189 MDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 189 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
... .....+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ......... ...
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~-~~~--- 251 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIK-LEY--- 251 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-TCC---
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc-CCC---
Confidence 332 3344567899999999999999999999999999999999999999964311 111111111 111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVS 306 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl 306 (331)
..+...+.++.+|+.+||+.||++|||++|++
T Consensus 252 -------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11233456789999999999999999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=387.11 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=199.9
Q ss_pred ChHHHHHHhcCCccCceecCCCCeEEEEEEec------CCcEEEEcc-------------------------cccchhhh
Q 020102 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVKK-------------------------SKNAVKLL 95 (331)
Q Consensus 47 ~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~-------------------------~~niv~~~ 95 (331)
...+++...++|++.+.||+|+||+||+|... .++.||||. |||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 44556666789999999999999999999863 246799982 48999999
Q ss_pred ccccc-CCcceeEeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC
Q 020102 96 GCCLE-TEVPLLVYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDI 163 (331)
Q Consensus 96 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~di 163 (331)
++|.+ ++..++|||||++|+|.++|..... .....+++..+..++.||+.||.|||+++ |+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 99876 4568999999999999999976321 11345899999999999999999999998 999999
Q ss_pred CCCCEEeCCCCcEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 020102 164 KSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSA 241 (331)
Q Consensus 164 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~ 241 (331)
||+|||+++++.+||+|||+|+.+..... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654433 23345679999999999999999999999999999999998 89999643
Q ss_pred CCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 242 GNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.... .+...+..+.. ...+...+.++.+++.+||+.||++|||+.||+++|+.+..
T Consensus 292 ~~~~--------~~~~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 292 KIDE--------EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCSH--------HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHH--------HHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 2111 12222222211 12233455689999999999999999999999999988754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=374.68 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=190.0
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCC----cceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETE----VPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~----~~~lv~e 109 (331)
.+|.+.+.||+|+||+||+|.+ +|+.|||| +|||||++++++.+++ ..+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4578889999999999999987 58899999 4999999999998754 4799999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA-----SSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
|+++|+|.+++.. .++++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+|
T Consensus 82 y~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 82 YHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999975 36899999999999999999999861 234999999999999999999999999999
Q ss_pred ccccCCCcee---eeeccccCCccChhhhcCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc------c
Q 020102 185 KFIAMDQTHV---TTKIQGTFGYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN------V 249 (331)
Q Consensus 185 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~------~ 249 (331)
+......... .....||+.|+|||++.+. .++.++|||||||++|||+||..|+.......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 8765433222 2235799999999998765 36779999999999999999988775332111110 0
Q ss_pred chHHHHHHHhhcCccccccchHhh-ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 250 SLAAYFVHSMRKNRLYDILDDQVM-KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
............... .+..+ .....+.+..+.+|+.+||+.||++|||+.||++.|+.+...+.
T Consensus 236 ~~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred chHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 011111111111111 11111 11233566789999999999999999999999999999876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=374.72 Aligned_cols=224 Identities=23% Similarity=0.372 Sum_probs=180.0
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc----CCcceeE
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE----TEVPLLV 107 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~----~~~~~lv 107 (331)
|++.+.||+|+||+||+|.+ .++..||+| +|||||++++++.+ ++.+++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36677899999999999998 468899999 49999999999865 4568999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~ 186 (331)
||||+||+|.+++... ..+++..+..++.||+.||.|||+++ .+|+||||||+|||++ .+|.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999999763 47899999999999999999999976 4599999999999998 479999999999975
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
... ....+.+||+.|||||++.+ .++.++|||||||++|||+||+.||...... .. .......+...
T Consensus 182 ~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~-~~~~i~~~~~~- 248 (290)
T 3fpq_A 182 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQ-IYRRVTSGVKP- 248 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HH-HHHHHTTTCCC-
T ss_pred CCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HH-HHHHHHcCCCC-
Confidence 432 23345689999999999875 6999999999999999999999999643211 01 11111111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+...++++.+|+.+||+.||++|||++|+++
T Consensus 249 -------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112223456899999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=385.19 Aligned_cols=227 Identities=24% Similarity=0.359 Sum_probs=190.4
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
..|++.+.||+|+||+||+|.+ .+|+.|||| +|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4699999999999999999998 569999999 4899999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
+||+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999998864 36899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .... ..+..+....
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~-~~i~~~~~~~----- 366 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAM-KMIRDNLPPR----- 366 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH-HHHHHSCCCC-----
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHH-HHHHcCCCCC-----
Confidence 234457899999999999999999999999999999999999999964311 0111 1111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......+..+.+||.+||+.||++|||++|+++.
T Consensus 367 --~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp --CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01123456689999999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=369.42 Aligned_cols=222 Identities=24% Similarity=0.372 Sum_probs=174.6
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+ .+++.||+| +|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999997 569999999 4899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+ +|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 6899998875 247999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.. ....+.+||+.|+|||++.+..+ +.++||||+||++|+|+||+.||.... ........ ..+..
T Consensus 164 ~~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i-~~~~~--- 229 (275)
T 3hyh_A 164 DG--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNI-SNGVY--- 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH-HHTCC---
T ss_pred CC--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHH-HcCCC---
Confidence 32 22345679999999999998886 579999999999999999999995421 11111111 11111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 230 -------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112334567899999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=372.24 Aligned_cols=219 Identities=29% Similarity=0.352 Sum_probs=182.4
Q ss_pred cCCccCceecCCCCeEEEEEEe----cCCcEEEEc-------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR----EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
++|++.+.||+|+||+||+|.+ .+++.||+| .|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999986 247889999 48999999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|||||+||+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999763 47999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
..... ....+.+||+.|+|||++.+..++.++||||+||++|||+||+.||..... ........ ....
T Consensus 176 ~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~-~~~~-- 243 (304)
T 3ubd_A 176 SIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMIL-KAKL-- 243 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCCC--
T ss_pred ccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHH-cCCC--
Confidence 54322 233456799999999999999999999999999999999999999964311 11111111 1111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
..+...+.++.+|+.+||+.||++|||+
T Consensus 244 --------~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 --------GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123456679999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=363.82 Aligned_cols=227 Identities=24% Similarity=0.343 Sum_probs=170.7
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCC--------
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETE-------- 102 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~-------- 102 (331)
++|++.+.||+|+||+||+|.+ .+++.|||| +|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588999999999999999997 579999999 4999999999987644
Q ss_pred ----cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 020102 103 ----VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV 178 (331)
Q Consensus 103 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl 178 (331)
..++|||||++|+|.+++... ......++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 368999999999999999763 22224567778999999999999999998 999999999999999999999
Q ss_pred eeccCcccccCCCce-----------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 020102 179 ADFGTSKFIAMDQTH-----------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~ 247 (331)
+|||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||... ..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~~ 232 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----ME 232 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----HH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----cH
Confidence 999999876543211 1234579999999999999999999999999999999996 76421 00
Q ss_pred ccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 248 NVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. .. ..........+. .....++.+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~---~~-~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 R---VR-TLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H---HH-HHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---HH-HHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00 111111111110 11233456788999999999999999999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=365.66 Aligned_cols=178 Identities=24% Similarity=0.416 Sum_probs=154.2
Q ss_pred HhcCCccCceecCCCCeEEEEEEec----CCcEEEEc----------------------ccccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
..++|++.+.||+|+||+||+|.++ +++.||+| .||||+++++++.+++..++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 4578999999999999999999863 47889999 289999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~ 186 (331)
|||+++|+|.+.+. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 99 mE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 99 MPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999998873 4899999999999999999999999 9999999999999876 7999999999975
Q ss_pred ccCCCc---------------------------eeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 020102 187 IAMDQT---------------------------HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPI 238 (331)
Q Consensus 187 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~ 238 (331)
...... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 432211 112335799999999998876 4899999999999999999999999
Q ss_pred CCCC
Q 020102 239 FSAG 242 (331)
Q Consensus 239 ~~~~ 242 (331)
+...
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 7553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=354.71 Aligned_cols=276 Identities=37% Similarity=0.623 Sum_probs=230.7
Q ss_pred CcccccChHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc------------------------ccccchhhhc
Q 020102 41 DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK------------------------KSKNAVKLLG 96 (331)
Q Consensus 41 ~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK------------------------~~~niv~~~~ 96 (331)
.....|+..++....++|.+.+.||+|+||+||+|...+++.||+| .||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 4567789999999999999999999999999999988889999999 3889999999
Q ss_pred ccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 97 CCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
++...+..++||||+++++|.+.+.... ....++++..+..++.|++.||.|||+....+|+||||||+||+++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 9999999999999999999999987642 233469999999999999999999999821229999999999999999999
Q ss_pred EEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 020102 177 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
||+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||...............+..
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999999876655555555567999999999999989999999999999999999999999532222222333344444
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
............+...........+..+.+++.+||+.||++|||+.||+++|++..-..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~ 314 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER 314 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhh
Confidence 4444455556666666666778889999999999999999999999999999987654443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=359.25 Aligned_cols=239 Identities=21% Similarity=0.299 Sum_probs=182.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc------CC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE------TE 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~------~~ 102 (331)
.++|++.+.||+|+||+||+|.+ .+|+.|||| +|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999998 579999999 48999999998754 46
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
.+|+|||||+ |+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecc
Confidence 7899999996 778888864 357999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCC---ceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 183 TSKFIAMDQ---THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 183 ~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
+|+.+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ........
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-----~l~~I~~~ 278 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-----QLQLIMMV 278 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-----HHHHHHHH
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-----HHHHHHHh
Confidence 998654322 2233457899999999998876 46899999999999999999999996432110 00001111
Q ss_pred hhcCccccccch--------Hh---h-------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 259 MRKNRLYDILDD--------QV---M-------KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 259 ~~~~~~~~~~~~--------~~---~-------~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...... ..... .. + ....+..+.++.+|+.+||+.||++|||++|+++.
T Consensus 279 ~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 279 LGTPSP-AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HCCCCG-GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCCCh-HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00000 00 0 00012235678999999999999999999999764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=372.74 Aligned_cols=225 Identities=24% Similarity=0.332 Sum_probs=187.3
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
++|++.+.||+|+||.||+|.+ .+|+.||+| .|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999998 569999999 3799999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||++||+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999763 47999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
.+... ...+.+||+.|+|||++.+ ..|+.++|+||+||++|||++|+.||........ ......... ..
T Consensus 341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~~-~~- 410 (689)
T 3v5w_A 341 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLT-MA- 410 (689)
T ss_dssp ECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHHH-CC-
T ss_pred ecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhcC-CC-
Confidence 66433 2344689999999999964 5799999999999999999999999964322111 111111111 11
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSM 307 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~ 307 (331)
...+...+.++.+||.+||+.||++|++ ++||++
T Consensus 411 ---------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1123345678999999999999999998 577654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=342.13 Aligned_cols=264 Identities=39% Similarity=0.647 Sum_probs=218.3
Q ss_pred cChHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc-----------------------ccccchhhhcccccCC
Q 020102 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-----------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 46 ~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-----------------------~~~niv~~~~~~~~~~ 102 (331)
++..++...+++|.+.+.||+|+||+||+|.+.+++.||+| .||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44456666789999999999999999999998889999999 3899999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||+++++|.+++... ......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSS-CCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhcc-CCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999887643 122346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCC-ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........+.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESHNN 262 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS--SSCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc--HHHHHHHHHhhhcccc
Confidence 997644322 2223345689999999999999999999999999999999999999975432 2222333333334444
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
+.+...+++..........+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 555566666666667788899999999999999999999999999999988654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=366.16 Aligned_cols=230 Identities=20% Similarity=0.322 Sum_probs=189.9
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.++|++.+.||+|+||+||+|.+ .+|+.||+| +|||||++++++.+++..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999998 569999999 489999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC--CcEEEeeccCccccc
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER--YRAKVADFGTSKFIA 188 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~--~~~kl~Dfg~a~~~~ 188 (331)
|+||+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 236 ~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 236 MSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred cCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999998864 2347999999999999999999999998 9999999999999854 899999999998765
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. ......+||+.|+|||++.+..|+.++||||+||++|||++|..||..... ...... ....... .
T Consensus 309 ~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~-i~~~~~~-~- 375 (573)
T 3uto_A 309 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRN-VKSCDWN-M- 375 (573)
T ss_dssp TT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH-HHTTCCC-C-
T ss_pred CC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHH-HHhCCCC-C-
Confidence 43 233456799999999999999999999999999999999999999964321 011111 1111110 0
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........+..+.+||.+||+.||++|||+.|++++
T Consensus 376 ----~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 ----DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111123345678999999999999999999999763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.82 Aligned_cols=238 Identities=26% Similarity=0.413 Sum_probs=194.4
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
++|.+.+.||+|+||+||+|.+ .+++.||+| +||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5688999999999999999998 468999999 4899999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999998752 347899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cee-------------eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 192 THV-------------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 192 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
... .....||+.|+|||.+.+..++.++|||||||++|+|++|..|+...............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~----- 237 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR----- 237 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH-----
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh-----
Confidence 211 11356999999999999999999999999999999999999998654322211111111
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
.......+...+..+.+++.+||+.||++|||+.++++.|+.++...
T Consensus 238 -----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 238 -----------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -----------HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111122334456889999999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=320.29 Aligned_cols=262 Identities=35% Similarity=0.560 Sum_probs=207.8
Q ss_pred cccccChHHHHHHhcCCccC------ceecCCCCeEEEEEEecCCcEEEEc---------------------------cc
Q 020102 42 RCKLFSSKELDKATNHFNVN------RILGQGGQGTVYKGMREDGRIIAVK---------------------------KS 88 (331)
Q Consensus 42 ~~~~~~~~e~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK---------------------------~~ 88 (331)
+...|+..++..++++|... +.||+|+||+||+|.. ++..||+| +|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678899999999988777 8999999999999987 57889998 38
Q ss_pred ccchhhhcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCE
Q 020102 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNI 168 (331)
Q Consensus 89 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Ni 168 (331)
|||+++++++.+.+..++||||+++++|.+++.... ...++++..+..++.|++.||.|||+.+ ++|+||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 899999999999999999999999999999887532 2347999999999999999999999998 99999999999
Q ss_pred EeCCCCcEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 020102 169 LLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247 (331)
Q Consensus 169 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~ 247 (331)
+++.++.++|+|||++........ .......||+.|+|||.+.+ .++.++|||||||++|+|++|..||........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~- 242 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL- 242 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-
Confidence 999999999999999976543322 22234568999999998876 578999999999999999999999965432211
Q ss_pred ccchHHHHHHHhh-cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 248 NVSLAAYFVHSMR-KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 248 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
.......... ...+...++.. ........+..+.+++.+||+.+|++|||+.++++.|+.+.++
T Consensus 243 ---~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 243 ---LLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp ---TTHHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred ---HHHHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 1111111111 11111222211 1224567788899999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=327.41 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=193.1
Q ss_pred HhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCc----ceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEV----PLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~----~~lv 107 (331)
..++|++.+.||+|+||+||+|.+. ++.|||| +||||+++++++..... .++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 3468999999999999999999875 7899999 38999999999987554 6999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEEccCCCCCEEeCCCCcEE
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA----------ASSPIYHRDIKSTNILLDERYRAK 177 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----------~~~~i~H~dikp~Nill~~~~~~k 177 (331)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+|
T Consensus 101 ~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 999999999999875 2589999999999999999999998 7 99999999999999999999
Q ss_pred EeeccCcccccCCCce-eeeeccccCCccChhhhcCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc--
Q 020102 178 VADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV-- 249 (331)
Q Consensus 178 l~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~-- 249 (331)
|+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999766543322 22335689999999998873 456688999999999999999999975432211100
Q ss_pred -----chHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 250 -----SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 250 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
..................... .......+..+.+|+.+||+.||++|||+.|+++.|+.++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001111111111111111111 111234567799999999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=335.11 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=194.9
Q ss_pred hcCCccCceecCCCCeEEEEEEec--------CCcEEEEc-------------------------ccccchhhhcccccC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE--------DGRIIAVK-------------------------KSKNAVKLLGCCLET 101 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK-------------------------~~~niv~~~~~~~~~ 101 (331)
.++|.+.+.||+|+||+||+|.+. ++..||+| +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999852 35679999 389999999999999
Q ss_pred CcceeEeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL 170 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill 170 (331)
+..++||||+++|+|.+++..... .....+++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976321 12245899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccc
Q 020102 171 DERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQEN 248 (331)
Q Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~ 248 (331)
+.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--~-- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--E-- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--G--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--H--
Confidence 9999999999999986543322 12223457889999999999999999999999999999999 9999864311 1
Q ss_pred cchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 249 VSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
. .......+.. ...+...+..+.+++.+||+.+|++|||+.|+++.|+.+.....
T Consensus 313 -~----~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 -E----LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp -G----HHHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -H----HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0 1111111111 11233455679999999999999999999999999999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=325.75 Aligned_cols=245 Identities=25% Similarity=0.404 Sum_probs=194.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||+||+|.+ .++..||+| .||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999997 468899999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++... .++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999998763 36899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
............||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ......... ....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~-~~~~-- 230 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQ-DSVP-- 230 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHS-SCCC--
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhh-ccCC--
Confidence 54433334456799999999999999999999999999999999999999964321 001111111 1111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhccccchh
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-TMEEVSMELNGIRGSSRKKRA 321 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-s~~evl~~L~~l~~~~~~~~~ 321 (331)
..........+..+.+++.+||+.||++|| +++++.+.|+.+....+..+.
T Consensus 231 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 231 ---NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp ---CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred ---CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 111122334556799999999999999999 999999999998776655443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=321.25 Aligned_cols=237 Identities=25% Similarity=0.369 Sum_probs=195.5
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.++|++.+.||+|+||+||+|...++..||+| .||||+++++++.+....++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 46789999999999999999998888889999 48899999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 87 NGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999998763 235899999999999999999999998 99999999999999999999999999986655443
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ......
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~-~~~~~~------- 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLK-VSQGHR------- 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHH-HHTTCC-------
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHH-HHcCCC-------
Confidence 33344456778999999999899999999999999999999 99998543210 11111 111110
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
...+...+..+.+++.+||+.+|++|||+.|+++.|+.++...
T Consensus 224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 224 --LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1112223457899999999999999999999999999997643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=324.17 Aligned_cols=228 Identities=26% Similarity=0.424 Sum_probs=189.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| .||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999997 578999999 489999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999998875 25899999999999999999999998 999999999999999999999999998765543
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......... ...
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~-~~~---- 235 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNG-TPE---- 235 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHC-SCC----
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-CCC----
Confidence 32 233457999999999999999999999999999999999999999643110 0011111111 100
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 236 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 ---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ---CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11123455678999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=322.12 Aligned_cols=236 Identities=28% Similarity=0.415 Sum_probs=195.0
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.++|++.+.||+|+||+||+|.+.++..||+| .||||+++++++.+++..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 35789999999999999999999888899999 48899999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 89 ~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 89 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 9999998865 2346899999999999999999999998 99999999999999999999999999986543332
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||..... .... .......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~-~~~~~~~-------- 224 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVV-EDISTGF-------- 224 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH-HHHHTTC--------
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHH-HHHhcCc--------
Confidence 23333456788999999999999999999999999999999 8999854211 0111 1111110
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....+...+..+.+++..||+.+|++|||+.|+++.|+.+..+
T Consensus 225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1111233456799999999999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=322.69 Aligned_cols=241 Identities=24% Similarity=0.365 Sum_probs=188.8
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhccccc----CCcceeEe
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLE----TEVPLLVY 108 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~----~~~~~lv~ 108 (331)
.++|++.+.||+|+||+||+|.. +++.|||| .||||+++++++.. ....++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 46799999999999999999987 68899999 48999999998654 34589999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH--------SAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
||+++|+|.+++.. ..+++..+..++.|++.||.||| +.+ |+||||||+||+++.++.+||+|
T Consensus 86 e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 86 HYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp CCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred hhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 99999999998853 36899999999999999999999 777 99999999999999999999999
Q ss_pred ccCcccccCCCcee---eeeccccCCccChhhhcCC------CCCCcchHHHHHHHHHHHHhC----------CCCCCCC
Q 020102 181 FGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTG----------KKPIFSA 241 (331)
Q Consensus 181 fg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~p~~~~ 241 (331)
||++.......... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997665443322 2234699999999999877 455799999999999999999 7777543
Q ss_pred CCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 242 GNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
...... .................. ........+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 237 ~~~~~~---~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPS---FEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCC---HHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc---hhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 222111 111111111111111111 1112345678899999999999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=327.44 Aligned_cols=239 Identities=25% Similarity=0.411 Sum_probs=192.4
Q ss_pred hcCCccCceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.++|.+.+.||+|+||+||+|.+. .+..|||| .||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999973 34569999 48899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 128 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999998864 2347999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCce--eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 187 IAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... . .........
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~-~~~~~~~~~ 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------D-VISSVEEGY 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------H-HHHHHHTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------H-HHHHHHcCC
Confidence 6543222 2222346778999999999999999999999999999999 99998543210 1 111111110
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
....+...+..+.+++..||+.||++|||+.+|++.|+.+..+...
T Consensus 272 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 272 ---------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ---------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 1112334556799999999999999999999999999998776543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=331.18 Aligned_cols=229 Identities=24% Similarity=0.366 Sum_probs=185.3
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999974 58889998 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++|+|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999988763 36999999999999999999999998 99999999999999999999999999975
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..........................
T Consensus 203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 3322 2234456799999999999999999999999999999999999999964432221111111111111111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
..+...+..+.+|+.+||+.||++||++
T Consensus 280 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 --------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1233455678999999999999999996
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=322.80 Aligned_cols=249 Identities=31% Similarity=0.425 Sum_probs=187.9
Q ss_pred HHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCCc
Q 020102 49 KELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 49 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~~ 103 (331)
.++....++|++.+.||+|+||+||+|.+ ++..||+| +||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34444567899999999999999999977 67889999 48899999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ .+|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHST--THHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999988752 11124899999999999999999999975 4599999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ............
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~~ 256 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFKCK 256 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHHSCC
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCC
Confidence 97543322 223345699999999999999999999999999999999999999964311 011111100111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccc
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKK 319 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~ 319 (331)
. ...+...+..+.+++.+||+.+|++|||+.++++.|+.+......+
T Consensus 257 ~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 257 R---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred C---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 1 1123344567999999999999999999999999999987765443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=322.17 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=194.5
Q ss_pred HHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccC----C
Q 020102 49 KELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLET----E 102 (331)
Q Consensus 49 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~----~ 102 (331)
.......++|++.+.||+|+||.||+|.+. ++.|||| .||||+++++++... .
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334455678999999999999999999875 8899999 489999999998876 6
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEEccCCCCCEEeCCCC
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA--------ASSPIYHRDIKSTNILLDERY 174 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~~~~i~H~dikp~Nill~~~~ 174 (331)
..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+||+++.++
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred ceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 78999999999999999965 2689999999999999999999988 6 99999999999999999
Q ss_pred cEEEeeccCcccccCCCcee---eeeccccCCccChhhhcCCCCCCc------chHHHHHHHHHHHHhC----------C
Q 020102 175 RAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSSQLTDK------SDVYSFGVVLVELLTG----------K 235 (331)
Q Consensus 175 ~~kl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~el~~g----------~ 235 (331)
.+||+|||++.......... .....||+.|+|||++.+...+.. +|||||||++|||++| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997654333221 123569999999999988776665 9999999999999999 5
Q ss_pred CCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 236 KPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 236 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
.||......... .................. ........+..+.+++.+||+.||++|||+.|+++.|+.+..+
T Consensus 260 ~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 260 LPYHDLVPSDPS----YEDMREIVCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CTTTTTSCSSCC----HHHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccHhhhcCCCCc----hhhhHHHHhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 555432111111 111111111111111110 1112346778899999999999999999999999999999876
Q ss_pred cc
Q 020102 316 SR 317 (331)
Q Consensus 316 ~~ 317 (331)
..
T Consensus 333 ~~ 334 (337)
T 3mdy_A 333 QD 334 (337)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=334.55 Aligned_cols=239 Identities=26% Similarity=0.383 Sum_probs=194.0
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
....++|.+.+.||+|+||.||+|.+. +++.|||| .||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 334567889999999999999999985 78999999 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 190 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 99999999999998753 235899999999999999999999998 99999999999999999999999999975
Q ss_pred ccCCCceee-eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
......... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .........+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------~~~~~~~~~~~- 332 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTREFVEKGG- 332 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------HHHHHHHHTTC-
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCC-
Confidence 432211111 11235778999999999999999999999999999998 9999854321 01111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....+...+..+.+++.+||+.||++|||++++++.|+.+++.
T Consensus 333 --------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 --------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1112333456789999999999999999999999999998763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=330.58 Aligned_cols=248 Identities=18% Similarity=0.238 Sum_probs=192.7
Q ss_pred HhcCCccCceecCCCCeEEEEEEecC------CcEEEEcc----------------------------------cccchh
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRED------GRIIAVKK----------------------------------SKNAVK 93 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~----------------------------------~~niv~ 93 (331)
..++|++.+.||+|+||+||+|.+.. ++.||||. ||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 47899993 899999
Q ss_pred hhcccccC----CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEE
Q 020102 94 LLGCCLET----EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNIL 169 (331)
Q Consensus 94 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nil 169 (331)
+++++... ...++||||+ +++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence 99998775 4589999999 8999998875 2347999999999999999999999998 999999999999
Q ss_pred eC--CCCcEEEeeccCcccccCCCce------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 020102 170 LD--ERYRAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSA 241 (331)
Q Consensus 170 l~--~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~ 241 (331)
++ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 8899999999999765432211 112345999999999999999999999999999999999999999643
Q ss_pred CCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 242 GNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
..... ......... ...+..+.+... .....+..+.+++..||+.+|++|||+.+|++.|+.+.....
T Consensus 265 ~~~~~----~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 265 LKDPK----YVRDSKIRY-RENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp TTCHH----HHHHHHHHH-HHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCHH----HHHHHHHHh-hhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 21111 000011000 111111111111 112345679999999999999999999999999988766443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=315.65 Aligned_cols=245 Identities=18% Similarity=0.226 Sum_probs=196.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| .|+|++++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 46799999999999999999997 678999999 3779999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc-----EEEeeccCccc
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR-----AKVADFGTSKF 186 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~-----~kl~Dfg~a~~ 186 (331)
+++|.+++... ..++++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 89 -~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 89 -GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred -CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 89999998752 346999999999999999999999998 999999999999987766 99999999986
Q ss_pred ccCCCce------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 187 IAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 187 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~ 238 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEKKQ 238 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH--HHHHHHhhcc
Confidence 6543321 2234569999999999999999999999999999999999999997543211110 0000000000
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
.... .......+..+.+++..||+.+|++|||+++|++.|+.+......
T Consensus 239 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 239 STPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 0000 001123456799999999999999999999999999998765443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=344.15 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=203.4
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------ccccchhhhcccccCCcceeEeec
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
...+|.+.+.||+|+||.||+|.+. ++..|||| +||||+++++++...+..++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4567888899999999999999985 48899999 489999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 298 ~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 298 MTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred cCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999752 2346899999999999999999999998 999999999999999999999999999876543
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||...... . ....+..+
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----~----~~~~~~~~------- 435 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----Q----VYELLEKD------- 435 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----G----HHHHHHTT-------
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----H----HHHHHHcC-------
Confidence 3222233446788999999999999999999999999999999 88888643211 1 11111111
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchhhHHHHHh
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAMFSKIIK 328 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~ 328 (331)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+........+....+-+
T Consensus 436 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~~~~~~~l~~ 492 (495)
T 1opk_A 436 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK 492 (495)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSCHHHHHHHHHHC
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccccchHHHHHhcc
Confidence 111223345568999999999999999999999999999997766655555554433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=325.12 Aligned_cols=226 Identities=26% Similarity=0.351 Sum_probs=188.5
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
..++|++.+.||+|+||.||+|.+ .+++.|||| .||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999998 679999999 389999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp ECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999998763 36899999999999999999999998 999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... ......||+.|+|||++.+..++ .++||||+||++|+|++|+.||..... ....... ..+..
T Consensus 165 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i-~~~~~-- 231 (328)
T 3fe3_A 165 TVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERV-LRGKY-- 231 (328)
T ss_dssp SSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HHCCC--
T ss_pred CCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HhCCC--
Confidence 4332 23446799999999999988875 789999999999999999999964311 1111111 11111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+..+.+|+.+||+.||.+|||++|+++.
T Consensus 232 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 --------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122345678999999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=319.87 Aligned_cols=237 Identities=22% Similarity=0.370 Sum_probs=192.0
Q ss_pred HhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
..++|++.+.||+|+||+||+|...++..||+| .||||+++++++.+.+..++||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 356789999999999999999999888899999 4889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 102 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 102 ANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp TTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred CCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999988652 236899999999999999999999998 9999999999999999999999999998654332
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...... . .........
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~-~~~~~~~~~------- 238 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------E-TAEHIAQGL------- 238 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------H-HHHHHHTTC-------
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------H-HHHHHhccc-------
Confidence 222233456788999999999999999999999999999998 99998643210 1 111111110
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....+...+..+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus 239 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 --RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111223345789999999999999999999999999988653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=320.70 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=202.9
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------ccccchhhhcccccCCcceeEee
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
...++|.+.+.||+|+||+||+|.+. ++..||+| +||||+++++++.+.+..++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34578899999999999999999985 48889999 48899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 90 FMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp CCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred cCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999998752 3356899999999999999999999999 99999999999999999999999999987665
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
..........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... .. .......
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----~~----~~~~~~~------ 228 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QV----YELLEKD------ 228 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GH----HHHHHTT------
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HH----HHHHhcc------
Confidence 54444444567889999999999999999999999999999999 88888543211 01 1111111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchhhH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAMF 323 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~ 323 (331)
.....+...+..+.+++..||+.||++|||+.++++.|+.+........+..
T Consensus 229 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~~~~ 280 (288)
T 3kfa_A 229 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 280 (288)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccchhh
Confidence 1111233445679999999999999999999999999999887655444443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.58 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=190.3
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhccc-----ccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCC-----LETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~-----~~~~~~~lv 107 (331)
.++|++.+.||+|+||+||+|.. +++.|||| .||||+++++.+ ......++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 46899999999999999999976 68899999 388999998743 234467899
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEEccCCCCCEEeCCCCcEEE
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA---------ASSPIYHRDIKSTNILLDERYRAKV 178 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---------~~~~i~H~dikp~Nill~~~~~~kl 178 (331)
|||+++|+|.+++... ..++..+..++.||+.||.|||+. + |+||||||+||+++.++.+||
T Consensus 91 ~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp ECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 9999999999998652 458899999999999999999998 7 999999999999999999999
Q ss_pred eeccCcccccCCCc-------eeeeeccccCCccChhhhcC-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 020102 179 ADFGTSKFIAMDQT-------HVTTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~p~~~~~~~ 244 (331)
+|||++..+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||+.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999986543221 11223569999999999987 35667899999999999999998888765433
Q ss_pred cccccchH---------HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 245 SQENVSLA---------AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 245 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
........ .................. ........+..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 32211111 011111111110000000 0112334677899999999999999999999999999988754
Q ss_pred ccc
Q 020102 316 SRK 318 (331)
Q Consensus 316 ~~~ 318 (331)
-.+
T Consensus 320 ~~~ 322 (336)
T 3g2f_A 320 WER 322 (336)
T ss_dssp CCC
T ss_pred HHh
Confidence 433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=321.52 Aligned_cols=228 Identities=24% Similarity=0.371 Sum_probs=183.8
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|++.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56899999999999999999984 68899999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999988752 36899999999999999999999998 999999999999999999999999999753
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+......................
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 236 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 236 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence 3222 223446799999999999999999999999999999999999999965332221111111111111111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
..+...+..+.+++.+||+.||++||++
T Consensus 237 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 -------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1123455679999999999999999996
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.32 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=198.4
Q ss_pred cChHHHHHHhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc------------------------ccccchhhh
Q 020102 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK------------------------KSKNAVKLL 95 (331)
Q Consensus 46 ~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK------------------------~~~niv~~~ 95 (331)
+...++....++|.+.+.||+|+||.||+|.+ .++..||+| .||||++++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 33344445567899999999999999999986 245789999 389999999
Q ss_pred cccccCCcceeEeecccCCCHHHHHhhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 020102 96 GCCLETEVPLLVYEFISNGTLYQHLHDRLQN-------------------QEFPLTWEMRLRIATEVAGALAYLHSAASS 156 (331)
Q Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 156 (331)
+++.+.+..++||||+++++|.+++...... ....+++..++.++.||+.||.|||+.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 170 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-- 170 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999764221 1234899999999999999999999998
Q ss_pred CeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-C
Q 020102 157 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-G 234 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g 234 (331)
|+||||||+||+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++|||||||++|+|++ |
T Consensus 171 -ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 171 -LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp -EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred -CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998664433222 223457788999999999999999999999999999999 9
Q ss_pred CCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 235 KKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 235 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
..||...... . .......... ...+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 250 ~~p~~~~~~~-----~----~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 250 GNPYPGIPPE-----R----LFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CCSSTTCCGG-----G----HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHH-----H----HHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9998543211 0 1111111111 11233455679999999999999999999999999999866
Q ss_pred c
Q 020102 315 S 315 (331)
Q Consensus 315 ~ 315 (331)
.
T Consensus 312 ~ 312 (314)
T 2ivs_A 312 K 312 (314)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=315.86 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=193.7
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCC--cceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETE--VPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~--~~~lv 107 (331)
.++|.+.+.||+|+||+||+|.+. +++.|||| +||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367899999999999999999985 58999999 3889999999987655 67999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe----CCCCcEEEeeccC
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGT 183 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~ 183 (331)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999997642 2234899999999999999999999998 9999999999999 7888899999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhc--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQ--------SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
+....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........... ..
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~----~~ 236 (319)
T 4euu_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE----VM 236 (319)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH----HH
T ss_pred ceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH----HH
Confidence 98664433 223356899999999886 56789999999999999999999999965432221111 11
Q ss_pred HHHhhcCc---ccccc-----------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 256 VHSMRKNR---LYDIL-----------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 256 ~~~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
........ +.... .-..........+..+.+++.+||+.||++|||++|+++..++.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111110 00000 00111234567788899999999999999999999999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=329.01 Aligned_cols=237 Identities=22% Similarity=0.403 Sum_probs=182.4
Q ss_pred hcCCccCceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
..+|.+.+.||+|+||+||+|... ++..|||| .||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457999999999999999999864 57789999 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 124 v~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999998865 2346899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCceee--eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 187 IAMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 187 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
......... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .........+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---------~~~~~~i~~~- 266 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAVDEG- 266 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---------HHHHHHHHTT-
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcC-
Confidence 654322211 12345778999999999999999999999999999998 9999864321 0111111111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
.....+...+..+.+++.+||+.+|++|||+.+|++.|+.+..+.
T Consensus 267 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 --------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp --------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred --------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111123345567999999999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=330.57 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=198.6
Q ss_pred cChHHHHHHhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhh
Q 020102 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKL 94 (331)
Q Consensus 46 ~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~ 94 (331)
+....+....++|++.+.||+|+||.||+|.+ .+++.|||| .||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44566667788999999999999999999973 346889999 37899999
Q ss_pred hcccccCC-cceeEeecccCCCHHHHHhhhhcC-----------------------------------------------
Q 020102 95 LGCCLETE-VPLLVYEFISNGTLYQHLHDRLQN----------------------------------------------- 126 (331)
Q Consensus 95 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------------------- 126 (331)
++++.+.+ ..++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99988755 489999999999999999764210
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 127 --------------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 127 --------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 0122899999999999999999999998 99999999999999999999999999986544332
Q ss_pred -eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 193 -HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 193 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||....... ...........
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~------ 314 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------EFCRRLKEGTR------ 314 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--------HHHHHHHHTCC------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--------HHHHHHHcCCC------
Confidence 23334568999999999999999999999999999999998 999986432211 11111111111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
...+...+..+.+++..||+.||++|||+.|++++|+.+...
T Consensus 315 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 315 ---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 111233456789999999999999999999999999988653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=328.93 Aligned_cols=247 Identities=27% Similarity=0.363 Sum_probs=198.4
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec--------CCcEEEEc-------------------------ccccchhhhccc
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE--------DGRIIAVK-------------------------KSKNAVKLLGCC 98 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK-------------------------~~~niv~~~~~~ 98 (331)
....++|.+.+.||+|+||+||+|.+. .+..||+| +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344578999999999999999999862 24579998 489999999999
Q ss_pred ccCCcceeEeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCC
Q 020102 99 LETEVPLLVYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTN 167 (331)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~N 167 (331)
..++..++||||+++++|.+++..... .....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999986421 11246999999999999999999999998 9999999999
Q ss_pred EEeCCCCcEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020102 168 ILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTS 245 (331)
Q Consensus 168 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~ 245 (331)
|+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999986543222 22233457889999999999999999999999999999999 9999854311
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccc
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKK 319 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~ 319 (331)
......+..+.. ...+...+..+.+++.+||+.+|++|||+.||++.|+.+.+.....
T Consensus 300 -------~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 300 -------EELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp -------HHHHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred -------HHHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 111112221111 1112334567999999999999999999999999999987765443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=317.87 Aligned_cols=237 Identities=25% Similarity=0.400 Sum_probs=180.6
Q ss_pred HhcCCccCceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccccCCcce
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
..++|++.+.||+|+||+||+|.+. .+..||+| .||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3468899999999999999999873 24578998 3889999999984 56789
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999988752 346899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
..............+|+.|+|||++.+..++.++|||||||++|||++ |..||....... . . ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~---~-~~i~~~~~ 235 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----V---I-GRIENGER 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H---H-HHHHTTCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----H---H-HHHHcCCC
Confidence 765433333334457789999999999999999999999999999997 888986432110 0 1 11111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
...+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 236 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1123345567999999999999999999999999999986643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=335.68 Aligned_cols=237 Identities=23% Similarity=0.320 Sum_probs=191.2
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCc
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~ 103 (331)
+....++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3344678999999999999999999985 57889999 38899999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999998752 347999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
|+..............||+.|+|||++. ...++.++|||||||++|||++|+.||..... .......
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------~~~~~~i 293 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKI 293 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--------hHHHHhh
Confidence 9866554444445567999999999987 56789999999999999999999999964311 0111111
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK--RPTMEEVSME 308 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~--RPs~~evl~~ 308 (331)
+........ .......+..+.+|+.+||+.+|++ ||+++|+++.
T Consensus 294 ~~~~~~~~~------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHKERFQF------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHHHHCCC------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhccccccC------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 110000000 0011234567999999999998888 9999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=321.64 Aligned_cols=226 Identities=27% Similarity=0.351 Sum_probs=187.7
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357899999999999999999984 68999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999988752 36899999999999999999999998 999999999999999999999999999754
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ......... ...
T Consensus 156 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~-~~~--- 222 (337)
T 1o6l_A 156 ISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILM-EEI--- 222 (337)
T ss_dssp CCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC---
T ss_pred ccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CCC---
Confidence 3222 223446799999999999999999999999999999999999999964311 111111111 111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
..+...+..+.+|+.+||+.||++|| +++|+++.
T Consensus 223 -------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 -------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11233456789999999999999999 88888654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=314.95 Aligned_cols=239 Identities=26% Similarity=0.399 Sum_probs=194.1
Q ss_pred cccChHHHHHHhcC----------CccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccc
Q 020102 44 KLFSSKELDKATNH----------FNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSK 89 (331)
Q Consensus 44 ~~~~~~e~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~ 89 (331)
..|+.+++..+++. |...+.||+|+||+||+|.+. +++.|||| +||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777888777654 677789999999999999985 79999999 388
Q ss_pred cchhhhcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEE
Q 020102 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNIL 169 (331)
Q Consensus 90 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nil 169 (331)
||+++++++...+..++||||+++++|.+.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 999999999999999999999999999998754 36899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc
Q 020102 170 LDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV 249 (331)
Q Consensus 170 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~ 249 (331)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------ 246 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------ 246 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 99999999999999986544322 22345799999999999999999999999999999999999999964311
Q ss_pred chHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 250 SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. .............. .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 247 --~~-~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 --VQ-AMKRLRDSPPPKLK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HH-HHHHHHHSSCCCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HH-HHHHHhcCCCCCcC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 11111111111110 122345678999999999999999999999774
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=315.56 Aligned_cols=240 Identities=21% Similarity=0.287 Sum_probs=186.4
Q ss_pred HhcCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCCcceeEe
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
..++|++.+.||+|+||+||+|.+.+++.||+| .||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 357899999999999999999999889999999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||++ ++|.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 99 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9998 578777764 2346899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC---cc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN---RL 264 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 264 (331)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .......... .+
T Consensus 171 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 171 IPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL-----PKIFSILGTPNPREW 244 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH-----HHHHHHHCCCCTTTS
T ss_pred CCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHHHHCCCChHHh
Confidence 3322 2233468999999999876 56899999999999999999999999654322110 1111111100 00
Q ss_pred ccc-------------cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 265 YDI-------------LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 265 ~~~-------------~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
... ..........+..+.++.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 0000001112234567899999999999999999999976
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=332.43 Aligned_cols=233 Identities=24% Similarity=0.348 Sum_probs=190.4
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcc
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~ 104 (331)
....++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+....
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 344578999999999999999999984 58899999 389999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||++||+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++
T Consensus 145 ~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 999999999999998865 25899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
+..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .........
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~ 287 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMN 287 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHT
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHHHHHh
Confidence 876554433444678999999999988765 78899999999999999999999964311 111111111
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK--RPTMEEVSME 308 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~--RPs~~evl~~ 308 (331)
... ....+.....+..+.+||.+||+.+|.+ ||+++||++.
T Consensus 288 ~~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 100 0011111234567999999999999988 9999999765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=320.59 Aligned_cols=222 Identities=26% Similarity=0.297 Sum_probs=181.1
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||+||+|.+. +++.|||| .|||++++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999985 79999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+ +++|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 136 ~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 67998888763 346999999999999999999999998 999999999999999999999999998765
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ....+.....
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------------~~~~~~~~~~--- 269 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------------GWQQLRQGYL--- 269 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------------HHHHHTTTCC---
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------------HHHHHhccCC---
Confidence 4322 2334568999999999886 78999999999999999999977764320 0111111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
... .....+..+.+++.+||+.||++|||++|+++
T Consensus 270 -~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 -PPE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -Ccc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 11234567999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=316.81 Aligned_cols=242 Identities=16% Similarity=0.204 Sum_probs=192.9
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++...+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 46799999999999999999997 578999999 4889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc-----EEEeeccCccc
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR-----AKVADFGTSKF 186 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~-----~kl~Dfg~a~~ 186 (331)
+++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 88 -GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred -CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 89999988752 347999999999999999999999998 999999999999998887 99999999986
Q ss_pred ccCCCce------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 187 IAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 187 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-----~~~~~~i~~ 234 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-----KERYQKIGD 234 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-----HHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-----HHHHHHHHh
Confidence 5443321 12346799999999999999999999999999999999999999975422111 011111000
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
.... ..... .....+ .+.+++..||+.+|.+||++++|.+.|+.+....
T Consensus 235 -~~~~-~~~~~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 235 -TKRA-TPIEV----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -HHHH-SCHHH----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -hhcc-CCHHH----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000 00000 011123 7999999999999999999999999998876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=315.51 Aligned_cols=245 Identities=24% Similarity=0.398 Sum_probs=188.5
Q ss_pred hcCCccCceecCCCCeEEEEEEe-----cCCcEEEEc-----------------------ccccchhhhccccc--CCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-----EDGRIIAVK-----------------------KSKNAVKLLGCCLE--TEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK-----------------------~~~niv~~~~~~~~--~~~~ 104 (331)
.++|++.+.||+|+||+||+|.. .+++.||+| +||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999973 468899999 38899999998854 4568
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred EEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 9999999999999998763 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCce--eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-------cccccchHHHH
Q 020102 185 KFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT-------SQENVSLAAYF 255 (331)
Q Consensus 185 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~ 255 (331)
......... ......++..|+|||.+.+..++.++|||||||++|+|++|..|+...... ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 866443221 122345777899999999999999999999999999999999987532100 00000000001
Q ss_pred HHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....... .....+...+..+.+++..||+.||++|||+.|+++.|+.++++
T Consensus 242 ~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 11122345567899999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=313.41 Aligned_cols=235 Identities=27% Similarity=0.409 Sum_probs=193.7
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.++|++.+.||+|+||.||+|.+.++..||+| .|||++++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35788999999999999999999888899999 48999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 87 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999988752 346899999999999999999999998 99999999999999999999999999976543222
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......+++.|+|||++.+..++.++||||||+++|+|++ |+.||..... .. .......+.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~-~~~~i~~~~-------- 222 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SE-VVEDISTGF-------- 222 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH-HHHHHHTTC--------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HH-HHHHHhcCC--------
Confidence 22223456788999999998899999999999999999999 8989854311 01 111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
....+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 223 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011122345678999999999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=323.23 Aligned_cols=227 Identities=26% Similarity=0.353 Sum_probs=182.8
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~ 104 (331)
...++|++.+.||+|+||+||+|.+ .+++.||+| .||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3457899999999999999999997 468999999 389999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccce
Confidence 9999999999999988763 36899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
+..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ...
T Consensus 172 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~-~~~ 241 (353)
T 3txo_A 172 KEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILN-DEV 241 (353)
T ss_dssp BCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC
T ss_pred eecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHc-CCC
Confidence 753322 2233446799999999999998999999999999999999999999964311 111111111 111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM------EEVSM 307 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~------~evl~ 307 (331)
..+...+..+.+++.+||+.||++||++ +|+++
T Consensus 242 ----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1122345678999999999999999998 66654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=338.99 Aligned_cols=244 Identities=23% Similarity=0.383 Sum_probs=197.0
Q ss_pred hHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcce
Q 020102 48 SKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 48 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~ 105 (331)
..++....++|.+.+.||+|+||+||+|...++..|||| +||||+++++++. .+..+
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 344555667899999999999999999999888899999 4899999999986 66789
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 259 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 9999999999999997531 125788999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
..............+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .. ....+..+
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~-~~~~i~~~-- 401 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PE-VIRALERG-- 401 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH-HHHHHHHT--
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcC--
Confidence 654322122223346788999999999999999999999999999999 9999854211 01 11111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
.....+...+..+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 402 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 -------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 111123345668999999999999999999999999999986643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=321.01 Aligned_cols=242 Identities=17% Similarity=0.213 Sum_probs=196.7
Q ss_pred HHHHHHhcCCccCceecCCCCeEEEEEE------ecCCcEEEEcc-----------------------cccchhhhcccc
Q 020102 49 KELDKATNHFNVNRILGQGGQGTVYKGM------REDGRIIAVKK-----------------------SKNAVKLLGCCL 99 (331)
Q Consensus 49 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~-----------------------~~niv~~~~~~~ 99 (331)
.++....++|.+.+.||+|+||+||+|. ..+++.||+|. |+|++++++++.
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3444556789999999999999999994 35688999992 789999999999
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-------
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE------- 172 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~------- 172 (331)
..+..++||||+++|+|.+++..........+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 9999999999999999999998754445567999999999999999999999998 999999999999998
Q ss_pred ----CCcEEEeeccCcccccC-CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 020102 173 ----RYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247 (331)
Q Consensus 173 ----~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~ 247 (331)
++.+||+|||+|+.+.. ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 89999999999975532 2233445567999999999999999999999999999999999999998543211100
Q ss_pred ccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHhhhhcc
Q 020102 248 NVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKR-PTMEEVSMELNGIRGSS 316 (331)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~R-Ps~~evl~~L~~l~~~~ 316 (331)
.... ... ....+.+.+++..||+.+|.+| |+++++.+.|+.+....
T Consensus 295 ----------------~~~~----~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 295 ----------------PEGL----FRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ----------------ECSC----CTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----------------echh----ccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0000 000 0124467789999999999999 58888888888876643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=321.71 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=195.0
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhhhcccc
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~~~~~~ 99 (331)
+....++|.+.+.||+|+||+||+|.+ .++..||+| .||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344567899999999999999999986 245679999 3899999999999
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhcC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQN------------------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHR 161 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 161 (331)
..+..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999763210 0124799999999999999999999998 9999
Q ss_pred cCCCCCEEeCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 020102 162 DIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIF 239 (331)
Q Consensus 162 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~ 239 (331)
||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999866543322 2333557889999999999999999999999999999998 999986
Q ss_pred CCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 240 SAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
...... .......... ....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 277 ~~~~~~--------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDA--------NFYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSH--------HHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHH--------HHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 432111 1111111111 1112233456799999999999999999999999999998663
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=316.31 Aligned_cols=230 Identities=23% Similarity=0.365 Sum_probs=188.4
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.++|.+.+.||+|+||+||+|.+. +++.+|+| .||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 468999999999999999999984 68889998 4899999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC--CCcEEEeeccCcccccC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE--RYRAKVADFGTSKFIAM 189 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~ 189 (331)
++++|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++.....
T Consensus 84 ~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 84 SGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999998864 2346999999999999999999999998 999999999999997 78999999999986653
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........ ..... ..
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~-~~~~~--~~ 223 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIM-NAEYT--FD 223 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-HTCCC--CC
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHH-cCCCC--CC
Confidence 32 23445689999999999998899999999999999999999999964311 01111111 11110 00
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 224 ~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 EE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 012345678999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=327.78 Aligned_cols=240 Identities=25% Similarity=0.332 Sum_probs=192.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe------cCCcEEEEc------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.++|.+.+.||+|+||+||+|.. .+++.|||| .||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46789999999999999999984 357789999 388999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---cEEEe
Q 020102 105 LLVYEFISNGTLYQHLHDRLQ--NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY---RAKVA 179 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~---~~kl~ 179 (331)
++||||+++|+|.+++..... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 12245899999999999999999999998 99999999999999555 49999
Q ss_pred eccCcccccCCC-ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHH
Q 020102 180 DFGTSKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVH 257 (331)
Q Consensus 180 Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 257 (331)
|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .. ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~-~~~ 297 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QE-VLE 297 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH-HHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHH
Confidence 999997543222 122233567899999999999999999999999999999998 9999854311 01 111
Q ss_pred HhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 258 SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....+.. ...+...+..+.+|+.+||+.+|++|||+.+|++.|+.+...
T Consensus 298 ~i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 298 FVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111111 112234456789999999999999999999999999988664
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=321.71 Aligned_cols=230 Identities=27% Similarity=0.439 Sum_probs=187.1
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999985 78999999 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+..
T Consensus 86 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 9999999887754 346899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCc-eeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 190 DQT-HVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 190 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..........
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~--- 227 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTY--- 227 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-------HHHHHTTCTT---
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhccccc---
Confidence 322 22234579999999999988775 77899999999999999999999654322110 1111111100
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......+..+.+|+.+||+.||++|||++|+++.
T Consensus 228 ------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 ------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01122345678899999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=318.64 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=197.2
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhhhcccc
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~~~~~~ 99 (331)
+....++|.+.+.||+|+||+||+|.+ .+++.||+| .||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 334457899999999999999999984 357789999 3899999999999
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQ-------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKST 166 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~ 166 (331)
..+..++||||+++++|.+++..... .....+++..++.++.|++.||.|||+.+ ++|+||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999876321 11235899999999999999999999998 999999999
Q ss_pred CEEeCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCC
Q 020102 167 NILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNT 244 (331)
Q Consensus 167 Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~ 244 (331)
||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999866544322 2233457889999999999999999999999999999999 99998643211
Q ss_pred cccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 245 SQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
. ......... .....+...+..+.+++.+||+.||++|||+.|+++.|+.+..+.
T Consensus 255 ~--------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 S--------KFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp H--------HHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred h--------HHHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1 011111111 011122344567999999999999999999999999999887644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=312.47 Aligned_cols=231 Identities=32% Similarity=0.497 Sum_probs=180.9
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc---------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||+||+|.+. +..||+| +||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367899999999999999999874 7889998 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC--------CCcEEEe
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE--------RYRAKVA 179 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~--------~~~~kl~ 179 (331)
|||+++++|.+.+.. ..+++..+..++.|++.||.|||+.+..+++||||||+||+++. ++.++|+
T Consensus 85 ~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999887753 37899999999999999999999987445889999999999986 7789999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... . .....
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~-~~~~~ 226 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------A-VAYGV 226 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------H-HHHHH
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------H-HHHhh
Confidence 999997654322 22346899999999999999999999999999999999999999643210 0 11111
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
..... ....+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 227 ~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKL--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCCC--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11111 1112334456799999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=320.50 Aligned_cols=233 Identities=24% Similarity=0.415 Sum_probs=185.2
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcE----EEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRI----IAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
++|++.+.||+|+||+||+|.+. ++.. ||+| .||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57889999999999999999873 3443 7777 4899999999886 566889
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+.+|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999988652 346888999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
....... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||....... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------~~~~~~~~~~ 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---------VPDLLEKGER 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---------HHHHHHTTCB
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---------HHHHHHcCCC
Confidence 6543322 2334567889999999999999999999999999999999 999986432111 1111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
...+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11122233468899999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=323.43 Aligned_cols=227 Identities=24% Similarity=0.358 Sum_probs=186.9
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCc
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~ 103 (331)
....++|.+.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445678999999999999999999984 68899999 38899999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChh
Confidence 99999999999999998763 36899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
++...... .......||+.|+|||++.+..++.++|+|||||++|||++|..||..... ........ ...
T Consensus 165 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~-~~~ 234 (345)
T 1xjd_A 165 CKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIR-MDN 234 (345)
T ss_dssp CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCC
T ss_pred hhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHH-hCC
Confidence 97543222 223456799999999999999999999999999999999999999964311 01111111 111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTME-EVS 306 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~-evl 306 (331)
. ..+...+..+.+|+.+||+.||++||++. +++
T Consensus 235 ~----------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 P----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C----------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 11223456789999999999999999997 664
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=322.47 Aligned_cols=228 Identities=24% Similarity=0.344 Sum_probs=186.8
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.+.|.+.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999984 68999998 388999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC----cEEEee
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY----RAKVAD 180 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~----~~kl~D 180 (331)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 91 ~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999998864 347999999999999999999999998 99999999999998776 799999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...... ..
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~-i~ 231 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLAN-IT 231 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH-HH
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HH
Confidence 99998664432 23345699999999999999999999999999999999999999964311 011111 11
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.... . ..+.. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~-~-~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 AVSY-D-FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTCC-C-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCC-C-CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1110 0 01111 1233557899999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=326.67 Aligned_cols=231 Identities=22% Similarity=0.323 Sum_probs=187.2
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
..++|++.+.||+|+||+||+|.+ .+++.+|+| .||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456799999999999999999987 568899998 489999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC---CCCcEEEeeccCc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTS 184 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a 184 (331)
|||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+||+|||++
T Consensus 89 ~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 89 FDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp ECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 999999999998876 246999999999999999999999998 99999999999998 4678999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
........ ......||+.|+|||++.+..++.++||||+||++|+|++|..||..... .... .....+..
T Consensus 161 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~-~~i~~~~~ 230 (444)
T 3soa_A 161 IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLY-QQIKAGAY 230 (444)
T ss_dssp BCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHH-HHHHHTCC
T ss_pred EEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHH-HHHHhCCC
Confidence 86654332 22345799999999999999999999999999999999999999964311 0111 11111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .. .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~-~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 D-FP-----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp C-CC-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-CC-----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 00 01112345679999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=320.11 Aligned_cols=224 Identities=23% Similarity=0.342 Sum_probs=185.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|.+.+.||+|+||+||+|.+ .+++.||+| +||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999997 678999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+ +|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 68998888763 36899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... .
T Consensus 159 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------~ 218 (336)
T 3h4j_B 159 TDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------K 218 (336)
T ss_dssp TTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------------C
T ss_pred cCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------------H
Confidence 4332 2234579999999999988876 68999999999999999999999643211110 0
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+... ....+...+..+.+|+.+||+.||.+|||++|+++.
T Consensus 219 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 219 KVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00000 011223345678999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=319.28 Aligned_cols=233 Identities=24% Similarity=0.361 Sum_probs=187.9
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------------ccccchhhhcccccCCcce
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
.+.|++.+.||+|+||+||+|.+ .+++.|||| +||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999987 468999999 3889999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc---EEEeecc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR---AKVADFG 182 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg 182 (331)
+||||+++++|.+.+..... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999888866432 2346899999999999999999999998 999999999999986654 9999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........ .+
T Consensus 179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~-~~ 247 (351)
T 3c0i_A 179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGII-KG 247 (351)
T ss_dssp TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHH-HT
T ss_pred ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHH-cC
Confidence 998665432 22334579999999999999999999999999999999999999996421 01111111 11
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
... ..+.. ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 248 ~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 248 KYK--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 110 00000 11235678999999999999999999999763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=322.02 Aligned_cols=242 Identities=27% Similarity=0.414 Sum_probs=194.5
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCC
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~ 102 (331)
...++|++.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999874 34789999 4889999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQN-------------------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDI 163 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~di 163 (331)
..++||||+++++|.+++...... ....+++..++.++.||+.||.|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999999763111 1257899999999999999999999998 999999
Q ss_pred CCCCEEeCCCCcEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 020102 164 KSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSA 241 (331)
Q Consensus 164 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~ 241 (331)
||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999976543221 12233467899999999999999999999999999999999 99998643
Q ss_pred CCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 242 GNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
.. .........+... ..+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 281 ~~---------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 281 AH---------EEVIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CH---------HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred Ch---------HHHHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 11 0111122222211 12234456799999999999999999999999999998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=308.38 Aligned_cols=247 Identities=20% Similarity=0.314 Sum_probs=188.9
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------cccchhhhccc-ccCCcceeEeec
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------SKNAVKLLGCC-LETEVPLLVYEF 110 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------~~niv~~~~~~-~~~~~~~lv~e~ 110 (331)
..++|++.+.||+|+||+||+|.+ .+++.||+|. |++++..+..+ ...+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 457899999999999999999997 6789999993 44555444444 567778999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe---CCCCcEEEeeccCcccc
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFI 187 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~ 187 (331)
+ +++|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 87 L-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp C-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred c-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9 89999988742 346999999999999999999999998 9999999999999 78899999999999866
Q ss_pred cCCCce------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 188 AMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 188 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~- 236 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMS- 236 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-HHHHHHHHHH-
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh-hhhhhccccc-
Confidence 543321 22345689999999999999999999999999999999999999975432221111 1100000000
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccc
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKK 319 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~ 319 (331)
... + ......+..+.+++..||+.+|++|||++++++.|+.+....+..
T Consensus 237 ~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 237 TPI-----E----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp SCH-----H----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred chh-----h----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 000 0 001223567999999999999999999999999999987755443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=315.41 Aligned_cols=256 Identities=22% Similarity=0.342 Sum_probs=198.6
Q ss_pred cChHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCC-
Q 020102 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETE- 102 (331)
Q Consensus 46 ~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~- 102 (331)
.+...-....++|.+.+.||+|+||+||+|.+ +++.|||| .||||+++++++....
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 34444456678999999999999999999988 58899999 3899999999998776
Q ss_pred ---cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEccCCCCCEEeC
Q 020102 103 ---VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH--------SAASSPIYHRDIKSTNILLD 171 (331)
Q Consensus 103 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~i~H~dikp~Nill~ 171 (331)
..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+||+++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred ccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 78999999999999999975 26899999999999999999999 777 99999999999999
Q ss_pred CCCcEEEeeccCcccccCCCce---eeeeccccCCccChhhhcCCC------CCCcchHHHHHHHHHHHHhC--------
Q 020102 172 ERYRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSSQ------LTDKSDVYSFGVVLVELLTG-------- 234 (331)
Q Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~el~~g-------- 234 (331)
.++.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999866544332 123356899999999988763 33689999999999999999
Q ss_pred --CCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 235 --KKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 235 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
..||......... . ...............+.. .......+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 262 ~~~~p~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPS---V-EEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCTTTTTSCSSCC---H-HHHHHHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCccccCcCccc---H-HHHHHHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6777543221111 1 111111111111111110 112345677899999999999999999999999999999
Q ss_pred hhcccc
Q 020102 313 RGSSRK 318 (331)
Q Consensus 313 ~~~~~~ 318 (331)
..+.+.
T Consensus 335 ~~~~~~ 340 (342)
T 1b6c_B 335 SQQEGI 340 (342)
T ss_dssp HHTTC-
T ss_pred HHHhcC
Confidence 876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.90 Aligned_cols=239 Identities=23% Similarity=0.306 Sum_probs=190.4
Q ss_pred hHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhccccc
Q 020102 48 SKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLE 100 (331)
Q Consensus 48 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~ 100 (331)
.++.....++|++.+.||+|+||.||+|.+ .+++.||+| .||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344455568899999999999999999998 479999999 37899999999999
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
.+..++||||+++|+|.+++... +..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999763 236899999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhc-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-------SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA 253 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~ 253 (331)
||+++..............||+.|+|||++. +..++.++|+|||||++|||++|+.||..... ..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~ 277 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AE 277 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HH
Confidence 9999876554443444567999999999887 35689999999999999999999999964321 01
Q ss_pred HHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 020102 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKR---PTMEEVSME 308 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~R---Ps~~evl~~ 308 (331)
.............. .......+..+.+||.+||+ +|++| |+++|+++.
T Consensus 278 ~~~~i~~~~~~~~~------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 278 TYGKIVHYKEHLSL------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHHTHHHHCCC------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHHhcccCcCC------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111110000000 00112355689999999999 99998 588888654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=317.16 Aligned_cols=244 Identities=25% Similarity=0.398 Sum_probs=180.5
Q ss_pred HhcCCccCceecCCCCeEEEEEEecC-C---cEEEEc-------------------------ccccchhhhcccccCCcc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRED-G---RIIAVK-------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK-------------------------~~~niv~~~~~~~~~~~~ 104 (331)
..++|++.+.||+|+||+||+|.+.. + ..||+| .||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999998743 2 278999 388999999999877655
Q ss_pred ------eeEeecccCCCHHHHHhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEE
Q 020102 105 ------LLVYEFISNGTLYQHLHDRLQ-NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAK 177 (331)
Q Consensus 105 ------~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~k 177 (331)
++||||+.+++|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999876432 22236899999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHH
Q 020102 178 VADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 178 l~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... . .
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~---~ 249 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----I---Y 249 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H---H
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----H---H
Confidence 999999986543322 12223456788999999999999999999999999999999 888886432111 0 1
Q ss_pred HHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
.... ... ....+...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 250 ~~~~-~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 250 NYLI-GGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp HHHH-TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred HHHh-cCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 1111 111 1112334456799999999999999999999999999988765443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=310.22 Aligned_cols=221 Identities=27% Similarity=0.407 Sum_probs=186.0
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57899999999999999999984 68999999 3899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||++....
T Consensus 86 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999875 246899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. .....||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ......... ...
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~-~~~---- 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILN-AEL---- 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-CCC----
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCC----
Confidence 22 2345799999999999999999999999999999999999999964311 111111111 111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSM 307 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~ 307 (331)
..+...+..+.+++.+||+.||++|| +++++++
T Consensus 221 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11233456789999999999999999 8888864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=309.14 Aligned_cols=238 Identities=22% Similarity=0.299 Sum_probs=181.1
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||+|+||+||+|.+.+++.||+| +||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999999889999999 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
++ ++|.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LD-QDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CS-EEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 98 488887764 2347899999999999999999999998 999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC---cccc
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN---RLYD 266 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 266 (331)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..... ........ .+..
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~-~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA----DQLMR-IFRILGTPNSKNWPN 227 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH-HHHHHCCCCTTTSTT
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHHHHCCCChhhchh
Confidence 22 22334689999999998764 5899999999999999999999998643211 00000 11111000 0000
Q ss_pred c-----cchHh-------hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 267 I-----LDDQV-------MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 267 ~-----~~~~~-------~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. .++.. ........+..+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000 00111234567899999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=313.65 Aligned_cols=239 Identities=22% Similarity=0.310 Sum_probs=184.1
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||+||+|.+ .+++.||+| +||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5789999999999999999998 468999999 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++ ++.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9984 66666554 2347999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCceeeeeccccCCccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC---ccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN---RLY 265 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 265 (331)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||+........ . .......... .+.
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~---~-~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---L-KRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH---H-HHHHHHHCCCCTTTCT
T ss_pred ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH---H-HHHHHHhCCCChhhhh
Confidence 322 223356899999999988766 799999999999999999999997654321110 1 1111111000 000
Q ss_pred ccc------------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 266 DIL------------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 266 ~~~------------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
... .........+..+..+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000001112345667899999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=320.13 Aligned_cols=233 Identities=24% Similarity=0.427 Sum_probs=185.1
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCc----EEEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGR----IIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
++|++.+.||+|+||+||+|.+. +++ .||+| .||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56899999999999999999863 343 35777 3889999999998754 788
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 94 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999988762 346999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------~~~~~~~~~- 236 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE- 236 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---------HHHHHHcCC-
Confidence 6543322 2223456889999999999999999999999999999999 999986432110 111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
....+...+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111233445679999999999999999999999999988754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=329.35 Aligned_cols=233 Identities=27% Similarity=0.418 Sum_probs=190.2
Q ss_pred HhcCCccCceecCCCCeEEEEEEecCCcEEEEc---------------------ccccchhhhcccccCC-cceeEeecc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------KSKNAVKLLGCCLETE-VPLLVYEFI 111 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------------~~~niv~~~~~~~~~~-~~~lv~e~~ 111 (331)
..++|++.+.||+|+||.||+|... ++.|||| +||||+++++++...+ ..++||||+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 3467889999999999999999875 7799999 4899999999987655 789999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp TTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 999999999763 2234799999999999999999999998 999999999999999999999999999754321
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... .......+.
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---------~~~~i~~~~------- 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGY------- 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---------HHHHHHTTC-------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcCC-------
Confidence 122357889999999999999999999999999999998 999986432211 111111111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....+...+..+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 404 --~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 --KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1122344566899999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=322.65 Aligned_cols=248 Identities=20% Similarity=0.250 Sum_probs=186.3
Q ss_pred hcCCccCceecCC--CCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQG--GQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.++|++.+.||+| +||+||+|.+. +++.|||| +||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999985 69999999 48999999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999998762 2346899999999999999999999998 99999999999999999999999998865
Q ss_pred ccCCCc------eeeeeccccCCccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 187 IAMDQT------HVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 187 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 432211 11122468999999999987 5789999999999999999999999965432221111110000000
Q ss_pred hhcCc------------------ccccc---------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 259 MRKNR------------------LYDIL---------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 259 ~~~~~------------------~~~~~---------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... ..... ............+..+.+|+.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 00000 0000011233456679999999999999999999999865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=311.28 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=184.8
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------------cccchhhhccccc
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------------SKNAVKLLGCCLE 100 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------------~~niv~~~~~~~~ 100 (331)
...++|++.+.||+|+||+||+|.+ .+++.||+|. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999997 5789999992 8999999999977
Q ss_pred CC-----cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc
Q 020102 101 TE-----VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175 (331)
Q Consensus 101 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~ 175 (331)
.. ..++||||+. ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCC
Confidence 55 4799999997 6999988752 2335899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 020102 176 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . .....
T Consensus 159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~-~~~~i 231 (308)
T 3g33_A 159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----D-QLGKI 231 (308)
T ss_dssp EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH----H-HHHHH
T ss_pred EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----H-HHHHH
Confidence 9999999998654322 234467899999999999999999999999999999999999998643211 0 01111
Q ss_pred HHHhhc---Cccccccc---h-------HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 256 VHSMRK---NRLYDILD---D-------QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 256 ~~~~~~---~~~~~~~~---~-------~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...... ..+..... . .......+..+..+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111100 00000000 0 00001122345678999999999999999999999753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=314.66 Aligned_cols=239 Identities=24% Similarity=0.408 Sum_probs=193.7
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEee
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
....++|++.+.||+|+||+||+|...++..||+| .|||++++++++.+ +..++|||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 34457899999999999999999998888899999 48899999998864 56899999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999886521 126899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
..........+++.|+|||.+.+..++.++|||||||++|+|++ |..||..... .. .......+.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~-~~~~~~~~~----- 227 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PE-VIQNLERGY----- 227 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH-HHHHHHTTC-----
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HH-HHHHHhccc-----
Confidence 43333333457789999999998899999999999999999999 8889854211 01 111111110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....+...+..+.+++..||+.+|++|||+.++++.|+.+...
T Consensus 228 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 228 ----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1112234456799999999999999999999999999988654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=320.97 Aligned_cols=231 Identities=24% Similarity=0.372 Sum_probs=187.9
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCccee
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
...++|.+.+.||+|+||.||+|.+ .+++.||+| .||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4457899999999999999999997 468999999 48999999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC---CcEEEeeccC
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER---YRAKVADFGT 183 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~ 183 (331)
||||+.+++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999988865 246899999999999999999999998 9999999999999865 4599999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..... ....+.
T Consensus 178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~-~i~~~~ 246 (362)
T 2bdw_A 178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYA-QIKAGA 246 (362)
T ss_dssp CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHTC
T ss_pred ceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHH-HHHhCC
Confidence 98664322 22345799999999999999999999999999999999999999964311 01111 111111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. .. .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~-~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 YD-YP-----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC-CC-----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC-CC-----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 00 01112345678999999999999999999999765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=334.44 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=191.1
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeE
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.+....++|.+.+.||+|+||.||+|.+.++..|||| +||||+++++++.+ +..++|
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 3444567788999999999999999999888889999 48999999999876 678999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 257 ~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp ECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred ehhhcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999999997531 235899999999999999999999998 999999999999999999999999999866
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
............+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... .. .......+.
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~-~~~~i~~~~--- 398 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------RE-VLDQVERGY--- 398 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH-HHHHHHTTC---
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcCC---
Confidence 5433222333457788999999999999999999999999999999 8999854311 01 111111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
....+...+..+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 399 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 399 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 11223445668999999999999999999999999999987644
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=323.97 Aligned_cols=235 Identities=23% Similarity=0.336 Sum_probs=179.4
Q ss_pred hcCCccC-ceecCCCCeEEEEEEec-CCcEEEEc-------------------ccccchhhhccccc----CCcceeEee
Q 020102 55 TNHFNVN-RILGQGGQGTVYKGMRE-DGRIIAVK-------------------KSKNAVKLLGCCLE----TEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK-------------------~~~niv~~~~~~~~----~~~~~lv~e 109 (331)
.+.|.+. +.||+|+||+||+|.+. +++.|||| .||||+++++++.. ....++|||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 3456665 68999999999999984 68999999 38999999998865 667899999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEeeccCccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKF 186 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~ 186 (331)
|+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 140 ~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 140 CLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp CCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 99999999998752 2346999999999999999999999998 999999999999997 78999999999986
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ... ....+...
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~----~i~~~~~~- 285 (400)
T 1nxk_A 214 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKT----RIRMGQYE- 285 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHH----HHHHTCCC-
T ss_pred cCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHH----HHHcCccc-
Confidence 54322 23345789999999999999999999999999999999999999975432211110 000 11111110
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 286 ~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 F-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C-----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 001112345679999999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=316.26 Aligned_cols=229 Identities=26% Similarity=0.367 Sum_probs=186.3
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.+.|.+.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356899999999999999999984 68899998 388999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC----cEEEee
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY----RAKVAD 180 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~----~~kl~D 180 (331)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999998864 347999999999999999999999998 99999999999999887 799999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... . ...... .
T Consensus 162 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~------~~~~~~-~ 230 (326)
T 2y0a_A 162 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--Q------ETLANV-S 230 (326)
T ss_dssp CTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--H------HHHHHH-H
T ss_pred CCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--H------HHHHHH-H
Confidence 99998664332 22345699999999999999999999999999999999999999964311 0 011111 1
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... . .... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~-~-~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 231 AVNY-E-FEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HTCC-C-CCHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hcCC-C-cCcc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1100 0 0011 012234578899999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=320.24 Aligned_cols=188 Identities=30% Similarity=0.347 Sum_probs=164.4
Q ss_pred ccccChHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------------cccchhh
Q 020102 43 CKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------------SKNAVKL 94 (331)
Q Consensus 43 ~~~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------------~~niv~~ 94 (331)
...|+..+.....++|.+.+.||+|+||+||+|.+ .+++.||||. ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 33455556666678999999999999999999998 5688999991 8899999
Q ss_pred hcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC--
Q 020102 95 LGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-- 172 (331)
Q Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-- 172 (331)
++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 99999999999999999 89999988763 2336899999999999999999999998 999999999999975
Q ss_pred -----------------------CCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHH
Q 020102 173 -----------------------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLV 229 (331)
Q Consensus 173 -----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 229 (331)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 788999999999754332 23356899999999999999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 020102 230 ELLTGKKPIFSA 241 (331)
Q Consensus 230 el~~g~~p~~~~ 241 (331)
+|++|+.||...
T Consensus 251 ell~g~~pf~~~ 262 (360)
T 3llt_A 251 ELYTGSLLFRTH 262 (360)
T ss_dssp HHHHSSCSCCCS
T ss_pred HHHHCCCCCCCC
Confidence 999999999643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=310.30 Aligned_cols=237 Identities=28% Similarity=0.398 Sum_probs=187.6
Q ss_pred HhcCCccCceecCCCCeEEEEEEecC----CcEEEEc------------------------ccccchhhhcccccCCcce
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRED----GRIIAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
..++|.+.+.||+|+||+||+|.+.. +..||+| +|||++++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678999999999999999998632 3468998 48899999999865 4578
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 999999999999998763 246899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
..............+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||....... .. ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-----~~----~~~~~~~~ 232 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VI----GVLEKGDR 232 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----HH----HHHHHTCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----HH----HHHhcCCC
Confidence 665433333334457889999999999999999999999999999998 999986432111 11 11111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
...+...+..+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus 233 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 233 ---------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 1112234567999999999999999999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.11 Aligned_cols=227 Identities=26% Similarity=0.377 Sum_probs=185.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||.||+|.+ .+++.||+| .||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36789999999999999999997 468899999 389999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+.||+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||++...
T Consensus 94 ~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp ECCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 999999999998875 346999999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... ......
T Consensus 166 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~~-~~~~~~- 236 (384)
T 4fr4_A 166 PRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----KEIVH-TFETTV- 236 (384)
T ss_dssp CTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----HHHHH-HHHHCC-
T ss_pred cCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----HHHHH-HHhhcc-
Confidence 432 23345679999999999874 4589999999999999999999999964322211 11111 111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-MEEVSM 307 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-~~evl~ 307 (331)
...+...+..+.+|+.+||+.||++||+ ++++++
T Consensus 237 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ---------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1123345568999999999999999998 666643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=317.32 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=201.6
Q ss_pred cccccChHHHHHHhcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccc
Q 020102 42 RCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNA 91 (331)
Q Consensus 42 ~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~ni 91 (331)
....+..+++....++|.+.+.||+|+||+||+|.+. ++..||+| .||||
T Consensus 11 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 11 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB
T ss_pred cccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 3445666777778889999999999999999999864 36789999 38899
Q ss_pred hhhhcccccCCcceeEeecccCCCHHHHHhhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 020102 92 VKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQ-----NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKST 166 (331)
Q Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~ 166 (331)
+++++++.+.+..++||||+++++|.+++..... ....++++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~ 167 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAAR 167 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGG
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccc
Confidence 9999999999999999999999999999876321 11246799999999999999999999998 999999999
Q ss_pred CEEeCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCC
Q 020102 167 NILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNT 244 (331)
Q Consensus 167 Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~ 244 (331)
||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 246 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN- 246 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-
Confidence 999999999999999999865433221 1223456889999999999999999999999999999999 7888854311
Q ss_pred cccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 245 SQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.. ........... ..+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 247 -------~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 -------EQ-VLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -------HH-HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------HH-HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 01 11111111111 1123445679999999999999999999999999988754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.25 Aligned_cols=244 Identities=24% Similarity=0.331 Sum_probs=173.9
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| +||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46789999999999999999987 468999999 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQN-QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|++ ++|.+++...... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6999988764322 2245899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC---cc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN---RL 264 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 264 (331)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... . ............ .+
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~---~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--E---QLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H---HHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--H---HHHHHHHHhCCCChhHh
Confidence 3322 22334689999999998764 6899999999999999999999999643211 0 001111110000 00
Q ss_pred c-----------------cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 265 Y-----------------DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 265 ~-----------------~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ..+............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000011111222345679999999999999999999999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.71 Aligned_cols=243 Identities=19% Similarity=0.237 Sum_probs=184.0
Q ss_pred hcCCccCceecCCCCeEEEEEEec----CCcEEEEc----------------------------------ccccchhhhc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK----------------------------------KSKNAVKLLG 96 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK----------------------------------~~~niv~~~~ 96 (331)
.++|.+.+.||+|+||+||+|.+. ++..+|+| .||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999984 57788988 3789999999
Q ss_pred cccc----CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC
Q 020102 97 CCLE----TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE 172 (331)
Q Consensus 97 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~ 172 (331)
++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEcc
Confidence 9887 67899999999 89999988752 27899999999999999999999998 999999999999987
Q ss_pred CC--cEEEeeccCcccccCCCce------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 020102 173 RY--RAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244 (331)
Q Consensus 173 ~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~ 244 (331)
++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 77 9999999999765432211 113356999999999999999999999999999999999999999532111
Q ss_pred cccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 245 SQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.... ........ ..+.... .........+..+.+++..||+.||++|||+++|++.|+.+..
T Consensus 267 ~~~~----~~~~~~~~-~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVAV----QTAKTNLL-DELPQSV---LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHH----HHHHHHHH-HTTTHHH---HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHHH----HHHHHhhc-ccccHHH---HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1100 00000000 0010000 0000111455689999999999999999999999999987643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=321.00 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=197.0
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEecC------CcEEEEc-------------------------ccccchhhhccc
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMRED------GRIIAVK-------------------------KSKNAVKLLGCC 98 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK-------------------------~~~niv~~~~~~ 98 (331)
.+....++|.+.+.||+|+||+||+|.+.. ...||+| .||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 445556889999999999999999998732 3479998 389999999999
Q ss_pred ccCCcceeEeecccCCCHHHHHhhhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEE
Q 020102 99 LETEVPLLVYEFISNGTLYQHLHDRLQN---------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNIL 169 (331)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nil 169 (331)
.+.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 9999999999999999999998764210 1346899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCccc
Q 020102 170 LDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQE 247 (331)
Q Consensus 170 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~ 247 (331)
++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 999999999999999865443322 2233457889999999999999999999999999999998 888986432111
Q ss_pred ccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 248 NVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
.......... ....+...+..+.+++..||+.||.+|||+.|+++.|+.+....+
T Consensus 275 ------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 275 ------KFYKLVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp ------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------HHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 1111111111 111122334578999999999999999999999999998876443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=319.36 Aligned_cols=231 Identities=22% Similarity=0.316 Sum_probs=177.7
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| +||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 468999999999999999999985 78999999 4899999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc--EEEeeccCcccccC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR--AKVADFGTSKFIAM 189 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~~~~~ 189 (331)
++++|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++.....
T Consensus 99 ~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 99 SGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999988752 36899999999999999999999998 999999999999987765 99999999874332
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ............ .
T Consensus 171 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~-~---- 239 (361)
T 3uc3_A 171 H--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSVK-Y---- 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTTC-C----
T ss_pred c--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcCC-C----
Confidence 2 22234569999999999988887665 8999999999999999999965322111 111111111110 0
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001111245678999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=309.90 Aligned_cols=237 Identities=27% Similarity=0.427 Sum_probs=191.1
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------ccccchhhhccccc-------------
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------KSKNAVKLLGCCLE------------- 100 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------~~~niv~~~~~~~~------------- 100 (331)
...+|++.+.||+|+||.||+|.+. +++.||+| .|||++++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 4567899999999999999999985 78999999 48999999998754
Q ss_pred ---CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEE
Q 020102 101 ---TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAK 177 (331)
Q Consensus 101 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~k 177 (331)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence 445799999999999999997632 346899999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 020102 178 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVH 257 (331)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 257 (331)
|+|||++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|..|+... .....
T Consensus 163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----------~~~~~ 229 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----------SKFFT 229 (284)
T ss_dssp ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----------HHHHH
T ss_pred ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----------HHHHH
Confidence 99999998664432 223346899999999999999999999999999999999999886421 00111
Q ss_pred HhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccchh
Q 020102 258 SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRA 321 (331)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~~ 321 (331)
....... +...+..+.+++.+||+.||++|||+.|+++.|..++.+....++
T Consensus 230 ~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~ 281 (284)
T 2a19_B 230 DLRDGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281 (284)
T ss_dssp HHHTTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred Hhhcccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence 1111111 223345688999999999999999999999999999876665443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=321.06 Aligned_cols=225 Identities=29% Similarity=0.366 Sum_probs=185.5
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.++|++.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999984 58889999 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999988762 36899999999999999999999998 99999999999999999999999999975
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... ........||+.|+|||++.+..++.++|+|||||++|||++|..||..... ......... ...
T Consensus 189 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~-~~~-- 256 (373)
T 2r5t_A 189 NIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILN-KPL-- 256 (373)
T ss_dssp GBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHH-SCC--
T ss_pred cccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-ccc--
Confidence 4322 2233456799999999999999999999999999999999999999964311 111111111 111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...+..+.+|+.+||+.||++||++.+.++
T Consensus 257 --------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 257 --------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp --------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 112334567899999999999999999864433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=315.36 Aligned_cols=230 Identities=23% Similarity=0.346 Sum_probs=164.4
Q ss_pred ceecCCCCeEEEEEEe-cCCcEEEEc---------------------ccccchhhhcccccCCcceeEeecccCCCHHHH
Q 020102 62 RILGQGGQGTVYKGMR-EDGRIIAVK---------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQH 119 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~-~~~~~vavK---------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 119 (331)
+.||+|+||+||+|.+ .+++.|||| .||||+++++++.++...++||||+++++|.+.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 96 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFER 96 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHH
Confidence 7899999999999998 468999999 289999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---cEEEeeccCcccccCCCceeee
Q 020102 120 LHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY---RAKVADFGTSKFIAMDQTHVTT 196 (331)
Q Consensus 120 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~ 196 (331)
+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||++....... ....
T Consensus 97 l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 167 (325)
T 3kn6_A 97 IKK-----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK 167 (325)
T ss_dssp HHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence 876 247999999999999999999999998 99999999999998665 79999999997654332 2233
Q ss_pred eccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccC
Q 020102 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLG 276 (331)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ... .........+... ... ..
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~-~~~~~~i~~~~~~-~~~-----~~ 239 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSA-VEIMKKIKKGDFS-FEG-----EA 239 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCH-HHHHHHHTTTCCC-CCS-----HH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccH-HHHHHHHHcCCCC-CCc-----cc
Confidence 456899999999999999999999999999999999999999654221111 111 1111122222111 000 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 277 KKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 277 ~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....+..+.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12345679999999999999999999999744
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=314.54 Aligned_cols=221 Identities=23% Similarity=0.318 Sum_probs=185.9
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67899999999999999999984 68999999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||++....
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999998763 36899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ........ .+..
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~-~~~~---- 255 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIV-SGKV---- 255 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCCC----
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHH-cCCC----
Confidence 32 2345799999999999999999999999999999999999999964311 11111111 1111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSM 307 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~ 307 (331)
..+...+..+.+++.+||+.||++||+ ++||++
T Consensus 256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112334567999999999999999998 777754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=317.29 Aligned_cols=242 Identities=25% Similarity=0.349 Sum_probs=190.8
Q ss_pred cCCccCceecCCCCeEEEEEEe-----cCCcEEEEc------------------------ccccchhhhcccccC--Ccc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-----EDGRIIAVK------------------------KSKNAVKLLGCCLET--EVP 104 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK------------------------~~~niv~~~~~~~~~--~~~ 104 (331)
.+|++.+.||+|+||.||+|.. .+++.||+| .|||++++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588999999999999999982 468999999 388999999999876 668
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 9999999999999998653 246899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCce--eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC------cccccchHHHHH
Q 020102 185 KFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT------SQENVSLAAYFV 256 (331)
Q Consensus 185 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~ 256 (331)
......... ......+|..|+|||.+.+..++.++|||||||++|+|++|..|+...... ............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 876544322 223356788899999999999999999999999999999999986432100 000000001111
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
...... .....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 254 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 111223455678999999999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=315.26 Aligned_cols=228 Identities=23% Similarity=0.347 Sum_probs=179.2
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCC-------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETE------- 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~------- 102 (331)
.++|++.+.||+|+||+||+|.+. +++.|||| +||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999985 79999999 4899999999886543
Q ss_pred --------------------------------------------------cceeEeecccCCCHHHHHhhhhcCCCCCCC
Q 020102 103 --------------------------------------------------VPLLVYEFISNGTLYQHLHDRLQNQEFPLT 132 (331)
Q Consensus 103 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 132 (331)
..++||||+++++|.+++... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--CSLEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--CSGGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--cCccchh
Confidence 278999999999999999763 2233467
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc-----------eeeeecccc
Q 020102 133 WEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-----------HVTTKIQGT 201 (331)
Q Consensus 133 ~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~gt 201 (331)
+..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7789999999999999999998 99999999999999999999999999986654321 112234699
Q ss_pred CCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHH
Q 020102 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQI 281 (331)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (331)
+.|+|||++.+..++.++|||||||++|||++|..|+... ............. ......+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----------~~~~~~~~~~~~~---------~~~~~~~ 299 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----------VRIITDVRNLKFP---------LLFTQKY 299 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----------HHHHHHHHTTCCC---------HHHHHHC
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----------HHHHHHhhccCCC---------cccccCC
Confidence 9999999999999999999999999999999987664210 0011111111111 1123345
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 282 MAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 282 ~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+.+++.+||+.||++|||+.|+++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 67889999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=316.36 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=193.9
Q ss_pred HhcCCccCceecCCCCeEEEEEEe--------cCCcEEEEc-------------------------ccccchhhhccccc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR--------EDGRIIAVK-------------------------KSKNAVKLLGCCLE 100 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK-------------------------~~~niv~~~~~~~~ 100 (331)
..++|.+.+.||+|+||+||+|.+ .++..||+| .||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 457899999999999999999986 246789999 48999999999999
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEE
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQN-----------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNIL 169 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nil 169 (331)
.+..++||||+++++|.+++...... ....+++..++.++.||+.||.|||+.+ |+|+||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 99999999999999999999763210 1235899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCccc
Q 020102 170 LDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQE 247 (331)
Q Consensus 170 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~ 247 (331)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 999999999999999866543322 1223457888999999999899999999999999999999 9999854311
Q ss_pred ccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 248 NVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
.. .......... ...+...+..+.+++.+||+.+|++|||+.|+++.|+.+.....
T Consensus 266 ----~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 266 ----EE-LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp ----HH-HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ----HH-HHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 01 1111111111 11223445679999999999999999999999999999876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=313.28 Aligned_cols=241 Identities=23% Similarity=0.313 Sum_probs=183.6
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcce
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
...++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999974 68899999 3789999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+++++|.+++... .++++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 111 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS 182 (309)
T ss_dssp EEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred EEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCc
Confidence 999999999999988763 36899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
..............||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... ..
T Consensus 183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~-~~ 252 (309)
T 2h34_A 183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQA-IP 252 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSC-CC
T ss_pred cccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccC-CC
Confidence 6554333333445689999999999999999999999999999999999999854210 0111111111 00
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhccc
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-TMEEVSMELNGIRGSSR 317 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-s~~evl~~L~~l~~~~~ 317 (331)
. ........+..+.+++.+||+.||++|| |++++++.|+.+.+...
T Consensus 253 ~------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 253 R------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp C------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred C------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0 1112334455789999999999999999 99999999998866443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=305.14 Aligned_cols=246 Identities=20% Similarity=0.296 Sum_probs=190.2
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------cccchhhhcc-cccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------SKNAVKLLGC-CLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------~~niv~~~~~-~~~~~~~~lv~e~~ 111 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+|. |++++..+.. ....+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 57899999999999999999997 6799999993 4444444444 45667789999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC---CCCcEEEeeccCccccc
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIA 188 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~ 188 (331)
+++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||++....
T Consensus 88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 88 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 89999988642 346999999999999999999999998 99999999999994 78899999999998665
Q ss_pred CCCce------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 189 MDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 189 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
..... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........... .......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~-~ 237 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMS-T 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-HHHHHHHHHH-S
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh-hhhhcccccC-C
Confidence 43321 12345799999999999999999999999999999999999999975432211111 1110100000 0
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccc
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKK 319 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~ 319 (331)
.. + ......+..+.+++.+||+.||++|||++++++.|+.+.......
T Consensus 238 ~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 238 PI-----E----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp CH-----H----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ch-----H----HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 00 0 011234567999999999999999999999999999987655543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=316.82 Aligned_cols=235 Identities=23% Similarity=0.428 Sum_probs=182.3
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcE----EEEc------------------------ccccchhhhcccccCCcce
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRI----IAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
.++|++.+.||+|+||+||+|.+. +++. |++| .||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999863 3443 5666 3889999999998765 78
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+|+||+.+++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 899999999999988762 346899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 186 FIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 186 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||....... .........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---------~~~~~~~~~ 236 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCC
Confidence 66433221 2223456788999999999999999999999999999999 999986432111 111111111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....+...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 237 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 ---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1112333556799999999999999999999999999988653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=307.85 Aligned_cols=232 Identities=32% Similarity=0.554 Sum_probs=185.5
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------------ccccchhhhcccccCCc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------------~~~niv~~~~~~~~~~~ 103 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| .||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46899999999999999999998 578999999 3789999999987654
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc-----EEE
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR-----AKV 178 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~-----~kl 178 (331)
++||||+++++|.+.+.. ....+++..+..++.|++.||.|||+.+ .+|+|+||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence 799999999999888865 2347999999999999999999999975 45999999999999988776 999
Q ss_pred eeccCcccccCCCceeeeeccccCCccChhhh--cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 020102 179 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH--QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||........ . ..
T Consensus 171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~-~~ 239 (287)
T 4f0f_A 171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------K-FI 239 (287)
T ss_dssp CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH------H-HH
T ss_pred CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH------H-HH
Confidence 99999974332 23345689999999998 455678899999999999999999999964322111 0 01
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
........ ....+...+..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 240 ~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 NMIREEGL--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHSCC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHhccCC--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111111 1112334456799999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=307.35 Aligned_cols=232 Identities=22% Similarity=0.341 Sum_probs=187.7
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccC--CcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLET--EVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~--~~~~lv 107 (331)
.++|.+.+.||+|+||+||+|.+. +..||+| .||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357899999999999999999885 8889999 389999999999887 788999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999975 22336899999999999999999999865 45999999999999999999999999887643
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCC---cchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTD---KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
.. ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||..... .............
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~ 229 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVALEGLR 229 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHHHHSCCC
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHHHhcCCC
Confidence 22 1235899999999998776554 79999999999999999999964311 1111111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
...+...+..+.+++..||+.||++|||++|+++.|+.+..
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 ---------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11223445679999999999999999999999999998854
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.39 Aligned_cols=226 Identities=26% Similarity=0.360 Sum_probs=185.9
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc---------------------------ccccchhhhcccccCCcce
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK---------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
..++|++.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999985 47889999 3789999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||+++
T Consensus 98 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999998763 36899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
...... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ......... ...
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~-~~~- 238 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIME-HNV- 238 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC-
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-CCC-
Confidence 543222 223446799999999999999999999999999999999999999964311 111111111 111
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM-----EEVSM 307 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~-----~evl~ 307 (331)
..+...+..+.+|+.+||+.||++||++ +++++
T Consensus 239 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1123455679999999999999999964 56644
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=316.91 Aligned_cols=234 Identities=19% Similarity=0.278 Sum_probs=187.6
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
..++|++.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+++..++||||++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 3567999999999999999999984 68899999 38999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC----CcEEEeeccCccccc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIA 188 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~~~~ 188 (331)
+|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++.+. +.+||+|||++....
T Consensus 100 gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 100 GGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp SCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999998865 246899999999999999999999998 9999999999998533 359999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .......+....
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~-~~~~i~~~~~~~-- 242 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-----EE-ILARIGSGKFSL-- 242 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-----HH-HHHHHHHCCCCC--
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-----HH-HHHHHccCCccc--
Confidence 4322 23345789999999999888889999999999999999999999964321111 11 111111121110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 243 ----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011123455679999999999999999999999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=328.54 Aligned_cols=226 Identities=25% Similarity=0.340 Sum_probs=186.4
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||.||+|.+ .+++.|||| .||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999997 568999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++..
T Consensus 227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999988762 368999999999999999999998 88 99999999999999999999999999975
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ...
T Consensus 299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~-~~~-- 366 (446)
T 4ejn_A 299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILM-EEI-- 366 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC--
T ss_pred ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHh-CCC--
Confidence 43322 223446799999999999999999999999999999999999999964321 011111111 111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
..+...+..+.+|+.+||+.||++|| |++|+++.
T Consensus 367 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 --------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11233456789999999999999999 99998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=315.49 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=197.6
Q ss_pred ChHHHHHHhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhhh
Q 020102 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKLL 95 (331)
Q Consensus 47 ~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~~ 95 (331)
...++....++|.+.+.||+|+||+||+|.+ .+++.||+| .||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445555678999999999999999999974 356889999 278999999
Q ss_pred cccccCC-cceeEeecccCCCHHHHHhhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC
Q 020102 96 GCCLETE-VPLLVYEFISNGTLYQHLHDRLQN-----------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDI 163 (331)
Q Consensus 96 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~di 163 (331)
+++...+ ..++||||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987654 589999999999999998763210 0123889999999999999999999998 999999
Q ss_pred CCCCEEeCCCCcEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 020102 164 KSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSA 241 (331)
Q Consensus 164 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~ 241 (331)
||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986544332 22334567899999999999999999999999999999998 99998643
Q ss_pred CCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 242 GNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
.... ........+.. ...+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 255 ~~~~--------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDE--------EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSH--------HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhH--------HHHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 2111 11111111111 1112234557899999999999999999999999999887644
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=314.79 Aligned_cols=233 Identities=25% Similarity=0.377 Sum_probs=180.9
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc---------------------ccccchhhhcccccCCcceeEee
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK---------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK---------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
....++|++.+.||+|+||+||+|.+. +++.|||| .||||+++++++.+.+..++|||
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 345678999999999999999999985 58889999 38999999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEeeccCccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKF 186 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~ 186 (331)
|+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++..
T Consensus 129 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 129 LVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred eCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999998864 346899999999999999999999998 999999999999975 88999999999986
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....... .....
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~-~~~~~- 269 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRIL-NCEYY- 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHH-TTCCC-
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHH-hCCCc-
Confidence 5432 22234568999999999999999999999999999999999999996432111 0111111 11110
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 270 ~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 F-----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp C-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001123345678999999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=318.50 Aligned_cols=229 Identities=23% Similarity=0.315 Sum_probs=178.3
Q ss_pred HhcCCccCceecCCCCeEEEEEEecCCcEEEEcc-------------------------c--ccchhhhcccccCCccee
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK-------------------------S--KNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~-------------------------~--~niv~~~~~~~~~~~~~l 106 (331)
..++|++.+.||+|+||+||+|.+.+++.||||. | +||+++++++..++..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3567999999999999999999998899999992 3 899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++..
T Consensus 87 v~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEC-CCSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEe-CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 999 557899999876 247899999999999999999999998 99999999999997 57899999999986
Q ss_pred ccCCCce-eeeeccccCCccChhhhcC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 020102 187 IAMDQTH-VTTKIQGTFGYLDPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 187 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 254 (331)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~ 229 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISK 229 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHH
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------HHH
Confidence 6443322 2334579999999999865 67888999999999999999999999542110 011
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........ .....+...+..+.+|+..||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~---------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 LHAIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhcCC---------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111111 1111122223568899999999999999999999765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=321.07 Aligned_cols=241 Identities=25% Similarity=0.358 Sum_probs=175.0
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCC--c
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETE--V 103 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~--~ 103 (331)
...++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999997 568999999 2899999999987544 6
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||++ ++|...+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999997 688888865 26899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCC--------------------CceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 020102 184 SKFIAMD--------------------QTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAG 242 (331)
Q Consensus 184 a~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~ 242 (331)
|+.+... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9765321 1112234579999999999876 678999999999999999999999996432
Q ss_pred CCcccccchHHHHHHHhhcCc-----------------------------ccccc---chH-hhccCCHHHHHHHHHHHH
Q 020102 243 NTSQENVSLAAYFVHSMRKNR-----------------------------LYDIL---DDQ-VMKLGKKNQIMAFANLAE 289 (331)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~---~~~-~~~~~~~~~~~~~~~li~ 289 (331)
.... ............ ..... ... .........+..+.+|+.
T Consensus 236 ~~~~-----~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 236 TMNQ-----LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp HHHH-----HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred HHHH-----HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 1110 000000000000 00000 000 000011134567899999
Q ss_pred HhhccCCCCCCCHHHHHHH
Q 020102 290 RCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 290 ~cL~~~p~~RPs~~evl~~ 308 (331)
+||+.||++|||++|+++.
T Consensus 311 ~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HhhccCcccCCCHHHHhCC
Confidence 9999999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=311.45 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=187.0
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCccee
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
..++|++.+.||+|+||.||+|.+ .+++.||+| .||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999997 578999999 37899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 9999999999998876432 2347899999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ............
T Consensus 186 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~ 257 (310)
T 2wqm_A 186 FSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYS-LCKKIEQCDYPP 257 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHH-HHHHHHTTCSCC
T ss_pred ecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHH-HHHHhhcccCCC
Confidence 543222 223356899999999999999999999999999999999999998643211 011 111111111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccch
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKR 320 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~~ 320 (331)
. .....+..+.+++.+||+.||++|||+.++++.|+.+.+....+.
T Consensus 258 ~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 258 L--------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp C--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred C--------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 1 122345679999999999999999999999999999988665544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=309.14 Aligned_cols=238 Identities=24% Similarity=0.364 Sum_probs=191.8
Q ss_pred cCCccCc-eecCCCCeEEEEEEec---CCcEEEEc------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNR-ILGQGGQGTVYKGMRE---DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|.+.+ .||+|+||+||+|.+. ++..||+| .||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999853 57889999 488999999999 55678999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999998864 2346999999999999999999999998 999999999999999999999999999866
Q ss_pred cCCCceee--eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 188 AMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 188 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
........ ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...... . .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~-~~~~i~~~~~ 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------E-VMAFIEQGKR 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------H-HHHHHHTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------H-HHHHHhcCCc
Confidence 54332221 22346889999999998899999999999999999998 99998643211 0 1111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKK 319 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~ 319 (331)
...+...+..+.+++..||+.+|++|||+.++++.|+.+..+...+
T Consensus 232 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 232 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 1123345568999999999999999999999999999987765544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.36 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=189.3
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccc----cCCcce
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCL----ETEVPL 105 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~----~~~~~~ 105 (331)
..++|++.+.||+|+||.||+|.+ .+++.||+| .||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999998 678999999 3889999999987 345789
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 99999999999998876432 3457999999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCce--------eeeeccccCCccChhhhcCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 020102 186 FIAMDQTH--------VTTKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 186 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 254 (331)
........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~-- 257 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVA-- 257 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHH--
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhh--
Confidence 54321100 011235799999999987654 6889999999999999999999984210000 0000
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
..... ..........+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 258 --~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 258 --LAVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp --HHHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred --HHhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00000 0111112344567999999999999999999999999999987643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.43 Aligned_cols=238 Identities=29% Similarity=0.430 Sum_probs=185.3
Q ss_pred hcCCccCceecCCCCeEEEEEEecC----CcEEEEc------------------------ccccchhhhccc-ccCCcce
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRED----GRIIAVK------------------------KSKNAVKLLGCC-LETEVPL 105 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK------------------------~~~niv~~~~~~-~~~~~~~ 105 (331)
..+|++.+.||+|+||+||+|.+.+ ...+|+| .||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568889999999999999998632 3357888 388999999985 4566789
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 104 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccc
Confidence 99999999999998864 2346899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCc---eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 186 FIAMDQT---HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 186 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
....... .......+|+.|+|||.+.+..++.++|||||||++|+|++|..|++....... . ..... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~---~~~~~-~~ 248 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----I---TVYLL-QG 248 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----H---HHHHH-TT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----H---HHHHh-cC
Confidence 6543221 122334578899999999999999999999999999999995555443221111 0 01111 11
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
.. ...+...+..+.+++.+||+.+|++|||+.|+++.|+.+...-
T Consensus 249 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 249 RR---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 10 1112233457999999999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.12 Aligned_cols=238 Identities=29% Similarity=0.478 Sum_probs=178.0
Q ss_pred HhcCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCCcceeEe
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
..++|++.+.||+|+||+||+|.+.. .+|+| .|||++++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 35789999999999999999998643 48888 488999999965 456689999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+.+.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 99 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 99 QWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp ECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999988854 2347899999999999999999999998 9999999999999999999999999997554
Q ss_pred CCC-ceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 189 MDQ-THVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 189 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
... ........||+.|+|||++. +..++.++|||||||++|+|++|+.||....... ...........
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~ 243 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--------QIIEMVGRGSL 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--------HHHHHHHHTSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--------HHHHHhccccc
Confidence 321 22233456899999999986 6678889999999999999999999996532211 11122222211
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.... ......++..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 244 ~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 SPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred Ccch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1100 11123445679999999999999999999999999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=316.19 Aligned_cols=231 Identities=28% Similarity=0.377 Sum_probs=187.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe----cCCcEEEEc----------------------------ccccchhhhcccccCC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR----EDGRIIAVK----------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK----------------------------~~~niv~~~~~~~~~~ 102 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 368999999 2789999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999998763 36899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~ 280 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILK 280 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHH
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhc
Confidence 9986544333334456799999999999863 478899999999999999999999964322111 1111111111
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
. ....+...+..+.+|+.+||+.||++|| |++|+++.
T Consensus 281 ~-----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 281 S-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp C-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred c-----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1 0112334456789999999999999999 88888765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.81 Aligned_cols=236 Identities=26% Similarity=0.372 Sum_probs=187.1
Q ss_pred CCccCceecCCCCeEEEEEEec-C---CcEEEEc------------------------ccccchhhhcccccCCcc-eeE
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE-D---GRIIAVK------------------------KSKNAVKLLGCCLETEVP-LLV 107 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK------------------------~~~niv~~~~~~~~~~~~-~lv 107 (331)
.|.+.+.||+|+||+||+|.+. + +..+|+| .||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999863 2 3368988 389999999999876655 999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+.+++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 102 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp ECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 999999999998865 2347899999999999999999999998 999999999999999999999999999755
Q ss_pred cCCC---ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 188 AMDQ---THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 188 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
.... ........+|+.|+|||.+.+..++.++|||||||++|+|++|..|++....... .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--------~~~~~~~~~- 245 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--------LTHFLAQGR- 245 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--------HHHHHHTTC-
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--------HHHHhhcCC-
Confidence 4322 1122335678899999999999999999999999999999997777654322111 111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
....+...+..+.+++.+||+.||++|||+.++++.|+.+...-
T Consensus 246 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 --------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 11112334567999999999999999999999999999886643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=308.62 Aligned_cols=237 Identities=24% Similarity=0.361 Sum_probs=179.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEe
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| .|||++++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46789999999999999999998 578999999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
||++ ++|.+.+..... ....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++...
T Consensus 86 e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 588887765433 345799999999999999999999997 8 999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccChhhh----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYH----QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
.... ......||+.|+|||.+ .+..++.++|||||||++|+|++|+.||....... ..........
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~- 230 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-------QQLKQVVEEP- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-------HHHHHHHHSC-
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-------HHHHHHhccC-
Confidence 4332 22234689999999996 55678899999999999999999999996432111 1111111111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhhhh
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM--ELNGIRG 314 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~--~L~~l~~ 314 (331)
.. .......+..+.+++.+||+.||++|||+.|+++ -++....
T Consensus 231 ~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 231 SP--------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp CC--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred CC--------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 11 1112234567999999999999999999999987 3444433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=316.57 Aligned_cols=245 Identities=27% Similarity=0.362 Sum_probs=189.3
Q ss_pred CccCceecCCCCeEEEEEEe-----cCCcEEEEc------------------------ccccchhhhcccccC--Cccee
Q 020102 58 FNVNRILGQGGQGTVYKGMR-----EDGRIIAVK------------------------KSKNAVKLLGCCLET--EVPLL 106 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK------------------------~~~niv~~~~~~~~~--~~~~l 106 (331)
|++.+.||+|+||+||++.. .+++.|||| .||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999998864 368899999 488999999999874 56899
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 113 v~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 9999999999998865 25899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCce--eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc--cchHHHHHHHhhcC
Q 020102 187 IAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN--VSLAAYFVHSMRKN 262 (331)
Q Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~ 262 (331)
....... ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||.......... ...... ...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~ 258 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-----TVL 258 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH-----HHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch-----hHH
Confidence 6543322 1233457888999999999999999999999999999999999985421100000 000000 000
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
.+...+........+...+..+.+|+.+||+.||++|||+.|+++.|+.+...-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 001111111122233455678999999999999999999999999999886543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=319.44 Aligned_cols=230 Identities=19% Similarity=0.314 Sum_probs=187.5
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.+.|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999984 68899999 489999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC--CCcEEEeeccCccccc
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE--RYRAKVADFGTSKFIA 188 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~ 188 (331)
+.+++|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 130 ~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 130 LSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999988764 2346899999999999999999999998 999999999999974 5779999999998665
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..... ........
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~-~i~~~~~~--- 268 (387)
T 1kob_A 203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQ-NVKRCDWE--- 268 (387)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH-HHHHCCCC---
T ss_pred CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHH-HHHhCCCC---
Confidence 432 22334699999999999999999999999999999999999999964311 01111 11111110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 269 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 ---FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011122345679999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=309.88 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=180.5
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|.+.+.||+|+||+||+|.+. +++.||+| +||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999984 78999999 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 97 6888888752 346899999999999999999999998 999999999999999999999999999755432
Q ss_pred CceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc---Ccccc
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK---NRLYD 266 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 266 (331)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .. ........... ..+..
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~---~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 154 TK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EE---QLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH---HHHHHHHHHCCCCTTTSTT
T ss_pred cc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHHHHHhCCCChHhchh
Confidence 22 2233468999999998876 5689999999999999999999999964321 10 11111111110 01111
Q ss_pred ccchHh-------------hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQV-------------MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~-------------~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...... ........+..+.+|+.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 100000 001122345678999999999999999999999763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=309.58 Aligned_cols=234 Identities=29% Similarity=0.465 Sum_probs=180.9
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc---------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
++|++.+.||+|+||+||+|... ++.||+| +||||+++++++.+ ..++||||++++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 56889999999999999999874 7889999 48999999999874 489999999999
Q ss_pred CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc-EEEeeccCcccccCCCce
Q 020102 115 TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR-AKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 115 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~ 193 (331)
+|.+++... .....+++..++.++.|++.||.|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 85 SLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp BHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999998752 22234788999999999999999999932233999999999999998886 799999999754322
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ...........
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~-~~~~~~~~~~~-------- 223 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------R-IMWAVHNGTRP-------- 223 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH------H-HHHHHHTTCCC--------
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH------H-HHHHHhcCCCC--------
Confidence 2234589999999999999999999999999999999999999964322110 0 11111111111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
......+..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 224 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1122345578999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=304.44 Aligned_cols=224 Identities=30% Similarity=0.431 Sum_probs=183.5
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||+||+|.+. ++..||+| .||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999874 57789999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999988763 36899999999999999999999988 999999999999999999999999988644
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ..... ......
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~-~~~~~~---- 223 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYK-RISRVE---- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH-HHHHTC----
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHH-HHHhCC----
Confidence 322 22335689999999999999999999999999999999999999854211 01111 111110
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 224 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11123345678899999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=315.85 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=184.8
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------ccccchhhhccccc----------
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------KSKNAVKLLGCCLE---------- 100 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------~~~niv~~~~~~~~---------- 100 (331)
+....++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 345567899999999999999999987 579999999 48999999999843
Q ss_pred ----------------------------CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 020102 101 ----------------------------TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152 (331)
Q Consensus 101 ----------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 152 (331)
....++||||++ ++|.+.+...... ...+++..+..++.||+.||.|||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 334789999998 6888888765433 4579999999999999999999999
Q ss_pred cCCCCeEEccCCCCCEEeC-CCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHH
Q 020102 153 AASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVE 230 (331)
Q Consensus 153 ~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~e 230 (331)
.+ |+||||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++||||+||++||
T Consensus 160 ~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 160 LG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp TT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred Cc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 98 99999999999997 68899999999998654332 22335689999999988775 48999999999999999
Q ss_pred HHhCCCCCCCCCCCcccccchHHHHHHHhhc---------------CccccccchHhhccCCHHHHHHHHHHHHHhhccC
Q 020102 231 LLTGKKPIFSAGNTSQENVSLAAYFVHSMRK---------------NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLN 295 (331)
Q Consensus 231 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~ 295 (331)
|++|+.||........ .......... ...............+...+..+.+|+.+||+.|
T Consensus 235 ll~g~~pf~~~~~~~~-----~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQ-----LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHSSCSSCCSSHHHH-----HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHhCCCCCCCCChHHH-----HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999964321110 0001010000 0011111111122223345667999999999999
Q ss_pred CCCCCCHHHHHHH
Q 020102 296 GKKRPTMEEVSME 308 (331)
Q Consensus 296 p~~RPs~~evl~~ 308 (331)
|++|||+.|+++.
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=312.08 Aligned_cols=238 Identities=24% Similarity=0.410 Sum_probs=185.6
Q ss_pred hcCCccCceecCCCCeEEEEEEecC-----CcEEEEc------------------------ccccchhhhcccccCCcce
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRED-----GRIIAVK------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
..+|.+.+.||+|+||+||+|.... +..||+| .||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3577888999999999999998642 3458999 3889999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 123 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999988752 347899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCcee--eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 186 FIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 186 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
......... .....+|+.|+|||.+.+..++.++|||||||++|||++ |..||..... .. .......+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~-~~~~~~~~ 266 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HE-VMKAINDG 266 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH-HHHHHHTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HH-HHHHHHCC
Confidence 664332211 122346788999999999999999999999999999999 9999854311 01 11111111
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
. ....+...+..+.+++.+||+.+|++|||+.++++.|+.+.....
T Consensus 267 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 267 F---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp C---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred C---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 1 011123445679999999999999999999999999998765433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.00 Aligned_cols=249 Identities=15% Similarity=0.224 Sum_probs=189.3
Q ss_pred hcCCccCceecCCCCeEEEEEEec---------CCcEEEEc------------------ccccchhh-------------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE---------DGRIIAVK------------------KSKNAVKL------------- 94 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~vavK------------------~~~niv~~------------- 94 (331)
.++|.+.+.||+|+||+||+|.+. +++.||+| +|||++++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 468999999999999999999985 37899999 37788874
Q ss_pred --hccccc-CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 020102 95 --LGCCLE-TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171 (331)
Q Consensus 95 --~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~ 171 (331)
++++.. +...++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVD 193 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEc
Confidence 444444 67789999999 99999999762 1347999999999999999999999998 99999999999999
Q ss_pred CCC--cEEEeeccCcccccCCCce------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 020102 172 ERY--RAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243 (331)
Q Consensus 172 ~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~ 243 (331)
.++ .+||+|||++..+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 8999999999765432211 11234799999999999999999999999999999999999999965421
Q ss_pred CcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 244 TSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
... ......... . .......... ......+..+.+++.+||+.||++|||++++++.|+.+....+.
T Consensus 274 ~~~---~~~~~~~~~-~-~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 274 NTE---DIMKQKQKF-V-DKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp CHH---HHHHHHHHH-H-HSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CHH---HHHHHHHhc-c-CChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 111 011111111 1 1111111100 00112346799999999999999999999999999998765543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.81 Aligned_cols=236 Identities=26% Similarity=0.401 Sum_probs=179.9
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcc---
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVP--- 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~--- 104 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999997 678999999 388999999998876554
Q ss_pred -eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 105 -LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 105 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
++||||+++++|.+++... .++++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 9999999999999998752 36899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCc--eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 184 SKFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 184 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
+........ .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ..........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~ 234 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVRE 234 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcC
Confidence 986544322 122335689999999999999999999999999999999999999954311 0111111111
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHH-HHHHHHhhh
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE-VSMELNGIR 313 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~e-vl~~L~~l~ 313 (331)
.... . .......+..+.+++.+||+.||++||++.+ +...+..+.
T Consensus 235 ~~~~----~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 235 DPIP----P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCCC----H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCC----c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1110 0 0112234567899999999999999996555 445565543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=311.61 Aligned_cols=220 Identities=23% Similarity=0.353 Sum_probs=185.1
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------------ccccchhhhcccccC
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------------KSKNAVKLLGCCLET 101 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------------~~~niv~~~~~~~~~ 101 (331)
..++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999987 568899998 388999999999999
Q ss_pred CcceeEeecccCC-CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 102 EVPLLVYEFISNG-TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 102 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999766 99888865 346999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 174 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------------- 238 (335)
T 3dls_A 174 FGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE------------- 238 (335)
T ss_dssp CTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------
T ss_pred cccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------
Confidence 99998665433 2234569999999999988876 7899999999999999999999954211000
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. . ...+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 239 --~----~------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 --A----A------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --T----C------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --h----c------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 01122245578999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=320.22 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=194.8
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCC--cceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETE--VPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~--~~~lv 107 (331)
.++|.+.+.||+|+||+||+|.+. +++.|||| .||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467899999999999999999984 58999999 3889999999988755 67999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe----CCCCcEEEeeccC
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGT 183 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~ 183 (331)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp ECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999987632 2234899999999999999999999998 9999999999999 7788899999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcC--------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQS--------SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ...
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~----~~~ 236 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK----EVM 236 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH----HHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH----HHH
Confidence 98654332 2234569999999998865 457789999999999999999999996543222111 111
Q ss_pred HHHhhcCc---ccccc-----------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 256 VHSMRKNR---LYDIL-----------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 256 ~~~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
........ +.... .-..........+..+.+++.+||+.||++|||+.|+++.+..+...
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111110 00000 00111223467788899999999999999999999999999887653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=311.68 Aligned_cols=225 Identities=27% Similarity=0.380 Sum_probs=181.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe----cCCcEEEEc---------------------------ccccchhhhcccccCCc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR----EDGRIIAVK---------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK---------------------------~~~niv~~~~~~~~~~~ 103 (331)
.++|++.+.||+|+||.||+|.+ .+++.||+| +||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999987 478899999 38899999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999988762 36899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......... ..
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~-~~ 237 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILK-CK 237 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH-TC
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh-CC
Confidence 87543222 223345799999999999999999999999999999999999999964311 011111111 11
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSM 307 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~ 307 (331)
. ..+...+..+.+++.+||+.||++|| +++|+++
T Consensus 238 ~----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 L----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 11233456789999999999999999 6677755
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=321.02 Aligned_cols=228 Identities=23% Similarity=0.323 Sum_probs=178.7
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEcc---------------------------cccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK---------------------------SKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~---------------------------~~niv~~~~~~~~~~~~~lv 107 (331)
...|.+.+.||+|+||+||+|.+.+++.||||. ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 356999999999999999999988899999992 48999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++..+
T Consensus 135 ~E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EE-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred Ee-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99 5678999988762 36889999999999999999999998 99999999999996 578999999999866
Q ss_pred cCCCce-eeeeccccCCccChhhhcC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 020102 188 AMDQTH-VTTKIQGTFGYLDPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 188 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~ 277 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKL 277 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHH
Confidence 433222 2334579999999999875 36888999999999999999999999643211 0111
Q ss_pred HHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........ ....+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 278 ~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 HAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCccc---------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111 111112224578999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=319.55 Aligned_cols=221 Identities=19% Similarity=0.193 Sum_probs=173.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------------ccccchhhhc-------c
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------------KSKNAVKLLG-------C 97 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------------~~~niv~~~~-------~ 97 (331)
.++|.+.+.||+|+||+||+|.+ .+++.|||| .||||+++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36788899999999999999997 569999999 3789999984 4
Q ss_pred cccCC-----------------cceeEeecccCCCHHHHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 020102 98 CLETE-----------------VPLLVYEFISNGTLYQHLHDRLQNQ--EFPLTWEMRLRIATEVAGALAYLHSAASSPI 158 (331)
Q Consensus 98 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i 158 (331)
+.+.+ ..++||||+ +|+|.+++....... ...+++..++.++.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 43332 378999999 589999997642211 123456888899999999999999998 9
Q ss_pred EEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCC-----------CCCCcchHHHHHHH
Q 020102 159 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-----------QLTDKSDVYSFGVV 227 (331)
Q Consensus 159 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~i 227 (331)
+||||||+|||++.++.+||+|||++.... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999998532 23334567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 228 LVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 228 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
+|||++|+.||......... ..+.. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~-----------------~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS-----------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCS-----------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccch-----------------hhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999643211110 00000 01233457899999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=310.18 Aligned_cols=234 Identities=25% Similarity=0.395 Sum_probs=184.2
Q ss_pred hcCCccCceecCCCCeEEEEEEecC-C-------cEEEEc-----------------------ccccchhhhcccccCCc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRED-G-------RIIAVK-----------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK-----------------------~~~niv~~~~~~~~~~~ 103 (331)
.++|.+.+.||+|+||+||+|.+.. + ..||+| .||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578899999999999999998743 3 468988 48899999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc--------
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR-------- 175 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~-------- 175 (331)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999762 234899999999999999999999998 999999999999998877
Q ss_pred EEEeeccCcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 020102 176 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 254 (331)
+||+|||++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..|+....... ..
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------~~ 227 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-------RK 227 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-------HH
Confidence 99999999865432 123458999999999887 678999999999999999999766654332111 00
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccc
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKK 319 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~ 319 (331)
.......... +...+..+.+++.+||+.||++|||+.++++.|+.+......+
T Consensus 228 ~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 228 LQFYEDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HHHHHTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred HHHhhccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 1111111111 1122346889999999999999999999999999987655443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.85 Aligned_cols=239 Identities=26% Similarity=0.369 Sum_probs=192.0
Q ss_pred HhcCCccCc-eecCCCCeEEEEEEe---cCCcEEEEc-------------------------ccccchhhhcccccCCcc
Q 020102 54 ATNHFNVNR-ILGQGGQGTVYKGMR---EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 54 ~~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~ 104 (331)
..++|.+.+ .||+|+||+||+|.+ .+++.|||| .||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788887 999999999999964 347889999 388999999999 66778
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 999999999999999876 236899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCceee--eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 185 KFIAMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 185 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
........... ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~~~ 235 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLEK 235 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHHT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHHc
Confidence 86654433222 22346788999999999889999999999999999999 9999864321 011111111
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccc
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKK 319 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~ 319 (331)
+.. ...+...+..+.+++.+||+.||++|||+.++++.|+.+..+...+
T Consensus 236 ~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 236 GER---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 111 1123345567999999999999999999999999999987765443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=317.56 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=191.1
Q ss_pred cCCccCceecCCCCeEEEEEEe-----cCCcEEEEc-----------------------ccccchhhhcccc--cCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-----EDGRIIAVK-----------------------KSKNAVKLLGCCL--ETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK-----------------------~~~niv~~~~~~~--~~~~~~ 105 (331)
++|++.+.||+|+||.||+|.. .+++.||+| .||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5789999999999999999983 468899999 3889999999886 456689
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 103 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999998763 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCcee--eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcc------cccchHHHHHH
Q 020102 186 FIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ------ENVSLAAYFVH 257 (331)
Q Consensus 186 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~ 257 (331)
......... .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||........ ...........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 665433222 2234578889999999999999999999999999999999999854211000 00000011111
Q ss_pred HhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 258 SMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
... .......+...+..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 256 ~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 256 LLE---------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred Hhh---------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 111 111122244556789999999999999999999999999998876544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=310.15 Aligned_cols=226 Identities=24% Similarity=0.371 Sum_probs=178.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc----------------------------------------------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------------------------------- 87 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------------------------------- 87 (331)
.++|.+.+.||+|+||+||+|.+ .+++.||||.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999987 4688899882
Q ss_pred ---cccchhhhccccc--CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcc
Q 020102 88 ---SKNAVKLLGCCLE--TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRD 162 (331)
Q Consensus 88 ---~~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 162 (331)
||||+++++++.+ ....++||||+++++|.+.+. ..++++..+..++.||+.||.|||+.+ |+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 6899999999886 567899999999999876432 247999999999999999999999998 99999
Q ss_pred CCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCC---CCCcchHHHHHHHHHHHHhCCCCCC
Q 020102 163 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIF 239 (331)
Q Consensus 163 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~p~~ 239 (331)
|||+||+++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999986654322 233457999999999988765 3778999999999999999999996
Q ss_pred CCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 240 SAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.... .... ......... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~--------~~~~-~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERI--------MCLH-SKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSH--------HHHH-HHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccH--------HHHH-HHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 4310 0111 111111110 0112234567999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=315.99 Aligned_cols=235 Identities=28% Similarity=0.431 Sum_probs=176.3
Q ss_pred CCccCceecCCCCeEEEEEEec--C--CcEEEEc------------------------ccccchhhhccccc-CCcceeE
Q 020102 57 HFNVNRILGQGGQGTVYKGMRE--D--GRIIAVK------------------------KSKNAVKLLGCCLE-TEVPLLV 107 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~~--~--~~~vavK------------------------~~~niv~~~~~~~~-~~~~~lv 107 (331)
.|.+.+.||+|+||+||+|... + ...||+| +||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999863 2 2457888 38999999998654 5678999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 170 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999998864 2346889999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCce---eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 188 AMDQTH---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 188 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||....... .. .....+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~----~~~~~~~ 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----IT----VYLLQGR 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HH----HHHHTTC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HH----HHHHcCC
Confidence 432211 1223457788999999999999999999999999999999 556664332111 11 1111111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
. ...+...+..+.+++.+||+.+|++|||+.|+++.|+.+...-
T Consensus 314 ~---------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 314 R---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred C---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 1112334567999999999999999999999999999887643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=310.31 Aligned_cols=240 Identities=24% Similarity=0.365 Sum_probs=180.6
Q ss_pred hcCCccC-ceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEe
Q 020102 55 TNHFNVN-RILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 55 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
.+.|++. +.||+|+||+||+|.+ .+++.|||| .||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4568874 7899999999999997 478999999 3899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc---EEEeeccCcc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR---AKVADFGTSK 185 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a~ 185 (331)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999998763 36899999999999999999999998 999999999999998776 9999999987
Q ss_pred cccCCCc------eeeeeccccCCccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc---cc-
Q 020102 186 FIAMDQT------HVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN---VS- 250 (331)
Q Consensus 186 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~---~~- 250 (331)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 5532211 11123458999999999875 457889999999999999999999997543221100 00
Q ss_pred --hHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 251 --LAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 251 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.............. ..... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~i~~~~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PACQNMLFESIQEGKY-EFPDK-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHHCCC-CCCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHHhccCc-ccCch-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00011111111111 00000 011245678999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=315.39 Aligned_cols=242 Identities=24% Similarity=0.298 Sum_probs=186.6
Q ss_pred HHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------------ccccchhhhcccc
Q 020102 49 KELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 49 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------------~~~niv~~~~~~~ 99 (331)
.++....++|++.+.||+|+||+||+|.+ .++..||+| +||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 34566778899999999999999999998 568889999 3889999999999
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhcCC-----------------------------------CCCCCHHHHHHHHHHHH
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQ-----------------------------------EFPLTWEMRLRIATEVA 144 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------------------------------~~~~~~~~~~~i~~~i~ 144 (331)
+.+..++||||+++++|.+.+....... ...+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 9999999999999999999885321110 12246778889999999
Q ss_pred HHHHHHHhcCCCCeEEccCCCCCEEeCCCC--cEEEeeccCcccccCCCc---eeeeeccccCCccChhhhcC--CCCCC
Q 020102 145 GALAYLHSAASSPIYHRDIKSTNILLDERY--RAKVADFGTSKFIAMDQT---HVTTKIQGTFGYLDPEYHQS--SQLTD 217 (331)
Q Consensus 145 ~~l~~lH~~~~~~i~H~dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~ 217 (331)
.||.|||+.+ |+||||||+||+++.++ .+||+|||++..+..... .......||+.|+|||++.+ ..++.
T Consensus 179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999998 99999999999998776 899999999986543221 12334569999999999875 67889
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCC
Q 020102 218 KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGK 297 (331)
Q Consensus 218 ~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~ 297 (331)
++|||||||++|||++|+.||...... ............. ........+..+.+|+.+||+.||.
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999999643210 1111111111100 0011123456799999999999999
Q ss_pred CCCCHHHHHHH
Q 020102 298 KRPTMEEVSME 308 (331)
Q Consensus 298 ~RPs~~evl~~ 308 (331)
+|||+.|+++.
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=306.06 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=180.2
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999984 58999999 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999888877654 246899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc------hHHHHHHHhhcC
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS------LAAYFVHSMRKN 262 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~ 262 (331)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ ............
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 155 PSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 322 2234568999999998876 56899999999999999999999999643211100000 000000000000
Q ss_pred cccc---ccch---HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 RLYD---ILDD---QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 ~~~~---~~~~---~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... ..+. .......+..+..+.+|+.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0000 00000112355678999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=308.86 Aligned_cols=233 Identities=26% Similarity=0.395 Sum_probs=183.5
Q ss_pred HhcCCccCceecCCCCeEEEEEEecCCcEEEEc---------------------ccccchhhhccccc-CCcceeEeecc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------KSKNAVKLLGCCLE-TEVPLLVYEFI 111 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------------~~~niv~~~~~~~~-~~~~~lv~e~~ 111 (331)
..++|++.+.||+|+||+||+|.+ .++.||+| +|||++++++++.+ .+..++||||+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 356899999999999999999987 48899999 48899999998655 45789999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp TTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999987631 123789999999999999999999998 999999999999999999999999998754322
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... . .. .....+.
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~---~~-~~~~~~~------- 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----D---VV-PRVEKGY------- 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----G---HH-HHHTTTC-------
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----H---HH-HHHhcCC-------
Confidence 122357889999999999999999999999999999998 99998543110 0 01 1111111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
....+...+..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 232 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1112334556799999999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=300.75 Aligned_cols=229 Identities=24% Similarity=0.378 Sum_probs=186.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEe
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| .||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999997 468899999 4889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc---EEEeeccCcc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR---AKVADFGTSK 185 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a~ 185 (331)
||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||++.
T Consensus 85 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999888763 36899999999999999999999998 999999999999986655 9999999997
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... . .......+...
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~-~~~~~~~~~~~ 225 (284)
T 3kk8_A 157 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------R-LYAQIKAGAYD 225 (284)
T ss_dssp ECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------H-HHHHHHHTCCC
T ss_pred EcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--------H-HHHHHHhcccc
Confidence 654332 223456899999999999999999999999999999999999999543110 0 11111111110
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. +.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 226 -~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 -Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -C-----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 001112345678999999999999999999999774
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=308.33 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=183.5
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec----CCcEEEEc-------------------------ccccchhhhcccccCC-
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK-------------------------KSKNAVKLLGCCLETE- 102 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK-------------------------~~~niv~~~~~~~~~~- 102 (331)
...++|.+.+.||+|+||+||+|... ++..||+| +||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578899999999999999999763 35579999 3889999999987755
Q ss_pred ----cceeEeecccCCCHHHHHhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEE
Q 020102 103 ----VPLLVYEFISNGTLYQHLHDRL-QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAK 177 (331)
Q Consensus 103 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~k 177 (331)
..++||||+++++|.+++.... ......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 3599999999999999885432 123457999999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHH
Q 020102 178 VADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 178 l~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... . .
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~---~ 259 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-----M---Y 259 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----H---H
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----H---H
Confidence 999999986543322 12223457889999999999999999999999999999999 888885432110 0 1
Q ss_pred HHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.... .+.. ...+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 260 ~~~~-~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 260 DYLL-HGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHH-TTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH-cCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 1111 11223445679999999999999999999999999998865
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=315.48 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=176.8
Q ss_pred hHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccc---
Q 020102 48 SKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCL--- 99 (331)
Q Consensus 48 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~--- 99 (331)
...+.....+|++.+.||+|+||.||+|.+ .+++.||+| .||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 334444567899999999999999999997 478999999 2899999999883
Q ss_pred -----cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 020102 100 -----ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY 174 (331)
Q Consensus 100 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~ 174 (331)
.....++||||+. |+|.+++.... ...++++..++.++.||+.||.|||+.+ .+|+||||||+||+++.++
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTS
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCC
Confidence 3445799999996 79988887632 2347999999999999999999999875 4599999999999999999
Q ss_pred cEEEeeccCcccccCCCcee-----------eeeccccCCccChhhh---cCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 020102 175 RAKVADFGTSKFIAMDQTHV-----------TTKIQGTFGYLDPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 240 (331)
Q Consensus 175 ~~kl~Dfg~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~p~~~ 240 (331)
.+||+|||++.......... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998664332211 1134589999999988 566788999999999999999999999854
Q ss_pred CCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 241 AGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
..... . .............+..+.+|+.+||+.||++|||+.|+++.|+.+.....
T Consensus 256 ~~~~~------------~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 256 GAKLR------------I---------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hhHHH------------h---------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 31110 0 00000011111223357899999999999999999999999998876443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.13 Aligned_cols=241 Identities=22% Similarity=0.285 Sum_probs=176.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCC------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETE------ 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~------ 102 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 468999999 3889999999986654
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||+++ ++.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence 46999999975 56665542 4899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc------------
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS------------ 250 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~------------ 250 (331)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 210 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp CC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99865432 2234467999999999999999999999999999999999999999643211000000
Q ss_pred --hHHHHHHHhhcC-ccc-----cccchHhh---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 251 --LAAYFVHSMRKN-RLY-----DILDDQVM---KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 251 --~~~~~~~~~~~~-~~~-----~~~~~~~~---~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
............ ... ........ .......+..+.+|+.+||+.||++|||++|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 000 00000000 00011236789999999999999999999999775
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=323.76 Aligned_cols=225 Identities=25% Similarity=0.393 Sum_probs=187.1
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|.+.+.||+|+||.||+|.+. +++.|||| .||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367899999999999999999984 79999999 389999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 95 ~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 95 MEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 999999999998864 347999999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ........ .+..
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~-~~~~-- 233 (476)
T 2y94_A 167 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKIC-DGIF-- 233 (476)
T ss_dssp CTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHH-TTCC--
T ss_pred cccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHh-cCCc--
Confidence 4322 2334579999999999998776 6799999999999999999999964321 11111111 1111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 234 --------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 --------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1122344578999999999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=311.06 Aligned_cols=238 Identities=27% Similarity=0.395 Sum_probs=189.5
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEE--EEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRII--AVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~v--avK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|++.+.||+|+||.||+|.+. ++..+ ++| .||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67899999999999999999874 45544 777 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhh-----------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 108 YEFISNGTLYQHLHDRL-----------QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
|||+++++|.+++.... ......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999987531 022347899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHH
Q 020102 177 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
||+|||++...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||..... .. .
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~-~ 250 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE-L 250 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH-H
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HH-H
Confidence 99999998743221 11222356889999999999889999999999999999998 9999854311 01 1
Q ss_pred HHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
......+. ....+...+..+.+++.+||+.+|++|||++|+++.|+.+....
T Consensus 251 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 251 YEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111110 11122344567999999999999999999999999999886643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=327.36 Aligned_cols=231 Identities=24% Similarity=0.326 Sum_probs=189.1
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||.||+|.+ .+++.||+| .||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999998 479999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||++||+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++...
T Consensus 263 mEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999988752 2335899999999999999999999998 999999999999999999999999999866
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... .........
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~-i~~~i~~~~---- 405 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REE-VERLVKEVP---- 405 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHH-HHHHHHHCC----
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHH-HHHHhhccc----
Confidence 4332 22345799999999999999999999999999999999999999965422111 111 111111110
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
...+...+..+.+|+.+||+.||++|| +++|+++.
T Consensus 406 ------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 ------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111234556899999999999999999 67888653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=301.83 Aligned_cols=226 Identities=25% Similarity=0.358 Sum_probs=166.1
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|.+.+.||+|+||+||+|.+ .+++.||+| +|||++++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35789999999999999999997 578999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++.. ...++++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999998875 2347899999999999999999999998 999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
..... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......... ... ....
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~-~~~~---- 228 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--------NKV-VLAD---- 228 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------C-CSSC----
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--------HHH-hhcc----
Confidence 43222 222356899999999999989999999999999999999999999643211100 000 0000
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+...+..+.+++.+||+.||++|||++++++
T Consensus 229 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 ------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0112234567899999999999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=336.10 Aligned_cols=243 Identities=26% Similarity=0.380 Sum_probs=195.9
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeE
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.+....++|++.+.||+|+||.||+|.+.++..|||| +|+||+++++++.+ +..++|
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 3444567788999999999999999999888889999 48999999999876 678999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+.+|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 340 ~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp ECCCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eehhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999997531 235899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
............++..|+|||++.+..++.++|||||||++|||++ |+.||..... .. ....+..+.
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~-~~~~i~~~~--- 481 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------RE-VLDQVERGY--- 481 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HH-HHHHHHTTC---
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcCC---
Confidence 4322112223446788999999999999999999999999999999 8999854311 01 111111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
....+..++..+.+|+.+||+.||++|||+++|++.|+.+.....
T Consensus 482 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 482 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 111233456679999999999999999999999999999866443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=312.72 Aligned_cols=242 Identities=23% Similarity=0.267 Sum_probs=184.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc------------------------------cccchhhhcccc----
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK------------------------------SKNAVKLLGCCL---- 99 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~------------------------------~~niv~~~~~~~---- 99 (331)
.++|++.+.||+|+||+||+|.+ .+++.||||. |+|++++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 47899999999999999999987 5688999992 667999999987
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeCCCC----
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLDERY---- 174 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~~~~---- 174 (331)
.....++||||+ ++++.+.+... ....+++..+..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 566899999999 57777766642 234699999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------cEEEeeccCcccccCCCceeeeeccccCCccChhh
Q 020102 175 ---------------------------------------------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209 (331)
Q Consensus 175 ---------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~ 209 (331)
.+||+|||++...... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999865432 233468999999999
Q ss_pred hcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-cchHHHHHHHhhc--------Ccc-----------ccccc
Q 020102 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN-VSLAAYFVHSMRK--------NRL-----------YDILD 269 (331)
Q Consensus 210 ~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~--------~~~-----------~~~~~ 269 (331)
+.+..++.++|||||||++|||++|+.||.......... ............. ... .....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997543222110 0001111111000 000 00000
Q ss_pred -------h--HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 270 -------D--QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 270 -------~--~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. ......+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 0011234667788999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=304.23 Aligned_cols=224 Identities=22% Similarity=0.320 Sum_probs=181.9
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999985 79999999 489999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC--------------
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-------------- 173 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-------------- 173 (331)
|||+++++|.+++...... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999764221 246899999999999999999999998 9999999999999844
Q ss_pred -----CcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 020102 174 -----YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247 (331)
Q Consensus 174 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~ 247 (331)
..++|+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|+|++|..|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 479999999998654322 23489999999998876 56689999999999999999987654220
Q ss_pred ccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 248 NVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......+... ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 -------~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -------QWHEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------HHHHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------HHHHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 01111112111 1123345679999999999999999999999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=319.22 Aligned_cols=246 Identities=20% Similarity=0.314 Sum_probs=192.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc----------------------cccchhhhcccccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK----------------------SKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~----------------------~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.++|++.+.||+|+||.||+|.+ .+++.||||. ++++..+..++...+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 47899999999999999999997 5789999993 245566666667788889999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe---CCCCcEEEeeccCccccc
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIA 188 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~ 188 (331)
+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 86 -g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 86 -GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 89999988742 347999999999999999999999998 9999999999999 588999999999998765
Q ss_pred CCCce------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 189 MDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 189 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-----~~~~i~-~~ 231 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-----KYEKIS-EK 231 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH-----HHHHHH-HH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH-----HHHHHh-hc
Confidence 43321 1224679999999999999999999999999999999999999997543221111 011000 00
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccccc
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKK 319 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~~ 319 (331)
.....+. .+ ...++..+.+|+..||+.+|++||++.+|++.|+.+.......
T Consensus 232 ~~~~~~~-~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 232 KVATSIE-AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HHHSCHH-HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cccccHH-HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 0000000 00 1223467999999999999999999999999999987655433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=324.07 Aligned_cols=227 Identities=22% Similarity=0.310 Sum_probs=185.7
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999984 69999999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||++||+|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.+||+|||++..+.
T Consensus 265 E~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999887532 12346999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.... ......||+.|+|||++.+..++.++|+|||||++|||++|+.||........ .......... ..
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~-~~----- 409 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLE-QA----- 409 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHH-CC-----
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhh-cc-----
Confidence 3322 23345799999999999999999999999999999999999999965422111 1111111111 11
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
...+...+..+.+|+.+||+.||++||++
T Consensus 410 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 -----VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 01123455688999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.06 Aligned_cols=223 Identities=30% Similarity=0.449 Sum_probs=182.5
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
..|.+.+.||+|+||+||+|.+ .+++.|||| +||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999997 578999999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+. |+|.+.+... ..++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9997 6888877542 347899999999999999999999998 9999999999999999999999999997653
Q ss_pred CCCceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.. ....||+.|+|||++. +..++.++|||||||++|||++|+.||...... ....... .....
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------~~~~~~~-~~~~~ 271 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIA-QNESP 271 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHH-HSCCC
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHH-hcCCC
Confidence 22 2356899999999884 567899999999999999999999998643210 1111111 11111
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ......+..+.+|+.+||+.||++|||++++++.
T Consensus 272 ~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 A--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 1122345678999999999999999999999765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=304.63 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=180.9
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
....++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34467899999999999999999987 468899999 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 107 VYEFISNGTLYQHLHDRLQN---QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
||||+++++|.+++...... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999988753221 2346899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCc----eeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 020102 184 SKFIAMDQT----HVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258 (331)
Q Consensus 184 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 258 (331)
+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~ 239 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--------VLMLT 239 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--------HHHHH
Confidence 875543221 11233568999999998876 568899999999999999999999996532111 01111
Q ss_pred hhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. ...................+..+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQ-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HT-SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hc-cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11 11111111111111223445678999999999999999999999763
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=302.28 Aligned_cols=229 Identities=24% Similarity=0.339 Sum_probs=186.6
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.++|++.+.||+|+||.||+|.+. +++.||+| .||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999984 68899998 378999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC----cEEEee
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY----RAKVAD 180 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~----~~kl~D 180 (331)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++ .++|+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 999999999999998865 346899999999999999999999998 99999999999999887 799999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... . ..... ..
T Consensus 163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~------~~~~~-i~ 231 (321)
T 2a2a_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--Q------ETLAN-IT 231 (321)
T ss_dssp CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--H------HHHHH-HH
T ss_pred CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--H------HHHHH-HH
Confidence 99998654432 22335689999999999999999999999999999999999999964311 0 11111 11
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... ...... ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 232 SVSY--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TTCC--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hccc--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 001111 12234578999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=308.67 Aligned_cols=241 Identities=18% Similarity=0.243 Sum_probs=179.0
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcce
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
....++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 44567899999999999999999987 478899999 3889999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-----CCCcEEEee
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-----ERYRAKVAD 180 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-----~~~~~kl~D 180 (331)
+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+||+|
T Consensus 110 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999998 599888875 236899999999999999999999998 99999999999994 555699999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..... .....
T Consensus 181 fg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~-~~~~~ 254 (329)
T 3gbz_A 181 FGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI----DQLFK-IFEVL 254 (329)
T ss_dssp TTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH-HHHHH
T ss_pred CCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH----HHHHH-HHHHh
Confidence 999986543322 22334689999999998875 4899999999999999999999998643211 00000 10100
Q ss_pred hcC----------------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 260 RKN----------------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 260 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
... ..................+..+.+|+.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 000000111111112224567899999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=306.44 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=190.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-----cCCcEEEEc-----------------------ccccchhhhcccccCC--cc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-----EDGRIIAVK-----------------------KSKNAVKLLGCCLETE--VP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK-----------------------~~~niv~~~~~~~~~~--~~ 104 (331)
.++|++.+.||+|+||.||+|.. .+++.||+| +||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46789999999999999999983 468899999 3889999999887644 78
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 9999999999999998762 246899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCcee--eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-------cccccchHHHH
Q 020102 185 KFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT-------SQENVSLAAYF 255 (331)
Q Consensus 185 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~ 255 (331)
.......... .....++..|+|||.+.+..++.++|||||||++|+|++|..|+...... ...........
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8765433221 12234677899999999988999999999999999999999987532000 00000000001
Q ss_pred HHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
....... .....+...+..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 273 ~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 273 IELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhcC---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 0111233456789999999999999999999999999999865
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=303.32 Aligned_cols=230 Identities=25% Similarity=0.347 Sum_probs=179.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|.+.+.||+|+||+||+|.+ .++..+|+| .||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35789999999999999999997 468899999 48899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe---CCCCcEEEeeccCccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKF 186 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~ 186 (331)
|+++++|.+.+..... ....+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++..
T Consensus 101 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 101 TCEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred eCCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999998865422 2347999999999999999999999998 9999999999999 4567899999999976
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
..... ......||+.|+|||.+. ..++.++|||||||++|+|++|+.||..... ...............
T Consensus 177 ~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~~~ 245 (285)
T 3is5_A 177 FKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQKATYKEPNYA 245 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC
T ss_pred cCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhhhccCCcccc
Confidence 54322 223456899999999886 4688999999999999999999999964311 011111111110000
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 246 -~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 -V-------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -C---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -c-------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01113457889999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=331.44 Aligned_cols=221 Identities=27% Similarity=0.359 Sum_probs=184.8
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcce
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
..++|++.+.||+|+||.||+|.+ .+++.|||| .||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999997 468889999 3789999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999998763 36899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ...
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~-~~~- 559 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIME-HNV- 559 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHS-SCC-
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-CCC-
Confidence 543222 234456799999999999999999999999999999999999999964311 111111111 111
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
..+...+.++.+||.+||+.||++||++
T Consensus 560 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ---------CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1233456689999999999999999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=315.94 Aligned_cols=177 Identities=25% Similarity=0.360 Sum_probs=155.4
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEcc----------------------------cccchhhhcccccCCcc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKK----------------------------SKNAVKLLGCCLETEVP 104 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~----------------------------~~niv~~~~~~~~~~~~ 104 (331)
...+|++.+.||+|+||+||+|.+. +++.||||. |+|++++++++...+..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3467999999999999999999874 589999992 56999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc--EEEeecc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR--AKVADFG 182 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~--~kl~Dfg 182 (331)
++||||+. ++|.+.+... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999996 7999888762 2345899999999999999999999998 999999999999999887 9999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSA 241 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~ 241 (331)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99754322 22356899999999999999999999999999999999999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.58 Aligned_cols=171 Identities=25% Similarity=0.402 Sum_probs=135.8
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhccccc-----CCc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLE-----TEV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~-----~~~ 103 (331)
.++|++.+.||+|+||+||+|.+. +++.|||| .||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999874 68999999 38899999999854 356
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccc-cchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccccc
Confidence 899999985 788888764 346999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCc--------------------------eeeeeccccCCccChhhh-cCCCCCCcchHHHHHHHHHHHHhC
Q 020102 184 SKFIAMDQT--------------------------HVTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTG 234 (331)
Q Consensus 184 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g 234 (331)
++....... ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 986543211 122345789999999976 566799999999999999999994
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=301.60 Aligned_cols=230 Identities=27% Similarity=0.439 Sum_probs=185.9
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||.||+|.+. +++.||+| .|||++++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999984 68999999 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999887753 346899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCc-eeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 190 DQT-HVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 190 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
... .......||+.|+|||.+.+..+ +.++|||||||++|+|++|..||......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~--- 227 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTY--- 227 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-------HHHHHTTCTT---
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHhhhcccc---
Confidence 221 12234568999999999988765 67899999999999999999999654322110 1111111000
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......+..+.+++.+||+.||++|||++|+++.
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 ------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01122345678899999999999999999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.16 Aligned_cols=229 Identities=22% Similarity=0.295 Sum_probs=184.6
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccccCCcceeEee
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
..++|.+.+.||+|+||+||+|.+. ++..+|+| .||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567999999999999999999984 57788988 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe---CCCCcEEEeeccCccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKF 186 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~ 186 (331)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++..
T Consensus 87 ~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 87 LCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp CCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999988762 36899999999999999999999998 9999999999999 7889999999999976
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
..... ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||..... .. .......+...
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~-~~~~~~~~~~~- 225 (277)
T 3f3z_A 159 FKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SE-VMLKIREGTFT- 225 (277)
T ss_dssp CCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHCCCC-
T ss_pred ccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HH-HHHHHHhCCCC-
Confidence 54332 22335689999999998765 89999999999999999999999964311 01 11111111110
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 226 ~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 226 FPEK-----DWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCch-----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011235678999999999999999999999763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=305.23 Aligned_cols=241 Identities=21% Similarity=0.314 Sum_probs=183.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------ccccchhhhccccc--CCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------KSKNAVKLLGCCLE--TEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------~~~niv~~~~~~~~--~~~~~lv~e~ 110 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| .||||+++++++.+ ....++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 36799999999999999999987 578999999 28999999999987 6678999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~ 189 (331)
+.+++|.+.+. .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||++.....
T Consensus 115 ~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 115 VNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999988774 3788999999999999999999998 99999999999999776 899999999986543
Q ss_pred CCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHH-----HHHHHhhcCc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA-----YFVHSMRKNR 263 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 263 (331)
... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||............... ..........
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 322 233468999999999877 67899999999999999999999999654322111000000 0000000000
Q ss_pred c--------------ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 264 L--------------YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 264 ~--------------~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ................+..+.+|+.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 00000001111122356789999999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.23 Aligned_cols=227 Identities=28% Similarity=0.415 Sum_probs=187.5
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
...|.+.+.||+|+||+||+|.+ .+++.||+| .|||++++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35689999999999999999987 468899999 37899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 101 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 101 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999998753 36899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .. ..........
T Consensus 172 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~-~~~~~~~~~~----- 236 (303)
T 3a7i_A 172 TQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MK-VLFLIPKNNP----- 236 (303)
T ss_dssp TB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HH-HHHHHHHSCC-----
T ss_pred cc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HH-HHHHhhcCCC-----
Confidence 32 222345689999999999999999999999999999999999999854311 00 1111111111
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L 309 (331)
.......+..+.+++..||+.||++|||+.|+++..
T Consensus 237 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 237 ----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ----CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ----CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 111223456789999999999999999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=312.77 Aligned_cols=243 Identities=26% Similarity=0.397 Sum_probs=185.1
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||+||+|.+. ++..||+| .||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357899999999999999999984 68899999 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|+++++|.+++... ..+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.++|+|||++....
T Consensus 112 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999998763 3689999999999999999999995 7 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch-----------------
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL----------------- 251 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~----------------- 251 (331)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 22 2233568999999999999999999999999999999999999996432110000000
Q ss_pred ----HHHHHHHhhcCccccccchH----hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 252 ----AAYFVHSMRKNRLYDILDDQ----VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 252 ----~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.................+.. .........+..+.+|+.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000000000000000 0011122345679999999999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=315.59 Aligned_cols=232 Identities=23% Similarity=0.320 Sum_probs=176.2
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------------ccccchhhhcccc
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------------~~~niv~~~~~~~ 99 (331)
....++|.+.+.||+|+||+||+|.+ .+++.||+| .||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34568999999999999999999987 468899998 3889999999975
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---cE
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY---RA 176 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~---~~ 176 (331)
. +..++||||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCE
T ss_pred c-CceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceE
Confidence 4 457999999999999887654 347999999999999999999999998 99999999999997544 59
Q ss_pred EEeeccCcccccCCCceeeeeccccCCccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 020102 177 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA 253 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~ 253 (331)
||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .
T Consensus 282 kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~-- 353 (419)
T 3i6u_A 282 KITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----L-- 353 (419)
T ss_dssp EECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----H--
T ss_pred EEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----H--
Confidence 99999999865432 23344679999999998853 5678899999999999999999999964322111 1
Q ss_pred HHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
......+.... . +. .....+..+.+|+.+||+.||++|||++|+++.
T Consensus 354 --~~~i~~~~~~~-~-~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 354 --KDQITSGKYNF-I-PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HHHHHTTCCCC-C-HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHhcCCCCC-C-ch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111111110 0 00 012245678999999999999999999999763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=309.67 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=181.4
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeEe
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999984 58999999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99998888776543 236999999999999999999999998 9999999999999999999999999997654
Q ss_pred CCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch------HHHHHHHhhc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL------AAYFVHSMRK 261 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~ 261 (331)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............. ..........
T Consensus 176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 3322 22335689999999998875 68999999999999999999999986432110000000 0000000000
Q ss_pred C------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 N------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ...............+..+..+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0011111000111122456789999999999999999999999764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=332.48 Aligned_cols=230 Identities=24% Similarity=0.356 Sum_probs=182.4
Q ss_pred eecCCCCeEEEEEEec---CCcEEEEc------------------------ccccchhhhcccccCCcceeEeecccCCC
Q 020102 63 ILGQGGQGTVYKGMRE---DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEFISNGT 115 (331)
Q Consensus 63 ~lg~G~~g~V~~~~~~---~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~ 115 (331)
.||+|+||.||+|... ++..|||| +||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999863 46679999 38899999999976 56899999999999
Q ss_pred HHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceee
Q 020102 116 LYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 195 (331)
Q Consensus 116 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 195 (331)
|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 9998864 2346999999999999999999999998 99999999999999999999999999986643322211
Q ss_pred --eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 196 --TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 196 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... . ....+..+.
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~-~~~~i~~~~--------- 556 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------E-VMAFIEQGK--------- 556 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------H-HHHHHHTTC---------
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------H-HHHHHHcCC---------
Confidence 22345689999999999999999999999999999998 99999643211 0 111121221
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
....+..++..+.+|+..||+.+|++|||+.+|++.|+.+..+...
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 1122334567899999999999999999999999999987654433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.05 Aligned_cols=223 Identities=26% Similarity=0.379 Sum_probs=185.6
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|.+.+.||+|+||+||+|.+. ++..||+| .|||++++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999984 57889999 3889999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999988763 36899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ........ ....
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~-~~~~---- 229 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIV-NVDL---- 229 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-TTCC----
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHh-cccc----
Confidence 321 2335689999999999999999999999999999999999999864311 00111111 1110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+..+.+++.+||+.||++|||++++++.
T Consensus 230 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 ------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1123345678999999999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=308.84 Aligned_cols=235 Identities=23% Similarity=0.321 Sum_probs=185.0
Q ss_pred HHHHhcCCccC-ceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCC
Q 020102 51 LDKATNHFNVN-RILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 51 ~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~ 102 (331)
.+...++|.+. +.||+|+||+||+|.+. +++.||+| .||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34556678877 88999999999999984 68999999 2589999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEe
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVA 179 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~ 179 (331)
..++||||+.+++|.+.+.. .....+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999887754 22357999999999999999999999998 999999999999997 7899999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .......
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~ 246 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--------ETYLNIS 246 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--------HHHHHHH
Confidence 999998654322 223456999999999999999999999999999999999999999643210 0011111
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... .........+..+.+++.+||+.||++|||++|+++.
T Consensus 247 -~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 -QVNVD------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -HTCCC------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -hcccc------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11000 0111122345678999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=318.41 Aligned_cols=229 Identities=25% Similarity=0.356 Sum_probs=185.2
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
..++|++.+.||+|+||+||+|.+. +++.|||| .||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999984 78999999 389999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC---CCCcEEEeeccCc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTS 184 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a 184 (331)
|||+.+++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999988763 36899999999999999999999998 99999999999995 4567999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||..... .. .......+..
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~-~~~~i~~~~~ 239 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YD-ILKRVETGKY 239 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHTCC
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHhCCC
Confidence 8654332 2334569999999999886 589999999999999999999999964311 01 1111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. ..+.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 240 ~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 AF------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CS------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CC------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 001123345678999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.39 Aligned_cols=176 Identities=25% Similarity=0.370 Sum_probs=148.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC-----Cc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET-----EV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~-----~~ 103 (331)
.++|.+.+.||+|+||+||+|.+ .+++.|||| +||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999997 468899999 388999999999776 56
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||++ ++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence 899999997 699888864 346999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCce---------------------eeeeccccCCccChhhh-cCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 020102 184 SKFIAMDQTH---------------------VTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIF 239 (331)
Q Consensus 184 a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~p~~ 239 (331)
++........ ......||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 9866433211 22456799999999986 56679999999999999999998655543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=306.48 Aligned_cols=243 Identities=24% Similarity=0.259 Sum_probs=181.5
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------------ccccchhhhcccccCC
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------------~~~niv~~~~~~~~~~ 102 (331)
....++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344678999999999999999999984 68999999 3789999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred ceEEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 99999999985 88777754 2346888999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... .......+ .....
T Consensus 158 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~~~~~i~-~~~~~ 231 (346)
T 1ua2_A 158 LAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIF-ETLGT 231 (346)
T ss_dssp GGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HHHCC
T ss_pred cceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHH-HHcCC
Confidence 9986643322 23345689999999998764 478999999999999999999988754311 11111111 11100
Q ss_pred C---ccccccc------hH-h----hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 N---RLYDILD------DQ-V----MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~---~~~~~~~------~~-~----~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .+..... .. . ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0000000 00 0 000113345689999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=307.97 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=188.8
Q ss_pred HhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc------------------------ccccchhhhcccccCCc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK------------------------~~~niv~~~~~~~~~~~ 103 (331)
..++|.+.+.||+|+||+||+|.. .++..||+| .||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 357899999999999999999983 357789999 48899999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEE
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQN--QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKV 178 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl 178 (331)
.++||||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. +..++|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999764211 1245899999999999999999999998 999999999999994 446999
Q ss_pred eeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHH
Q 020102 179 ADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||..... ....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------~~~~ 255 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---------QEVL 255 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------HHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---------HHHH
Confidence 99999875543222 12233467889999999999999999999999999999998 8888854311 0111
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
........ ...+...+..+.+++.+||+.||++|||+.++++.|..+....
T Consensus 256 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 256 EFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 11111111 1112334567899999999999999999999999999886543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=316.60 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=183.6
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------ccccchhhhcccccCCc------ceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------KSKNAVKLLGCCLETEV------PLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------~~~niv~~~~~~~~~~~------~~lv~e 109 (331)
..+|.+.+.||+|+||+||+|.+..+..+|+| +||||+++++++..... .++|||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 45799999999999999999998777778888 38999999999865433 789999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~ 188 (331)
|+++ ++...+..... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+||+|||+++...
T Consensus 119 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 119 YVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp CCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9985 45444443322 2347999999999999999999999998 99999999999999 79999999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh-------
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR------- 260 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 260 (331)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ + ........
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----l-~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ----L-VEIIKVLGTPSREQI 266 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----H-HHHHHHHCCCCHHHH
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHHHHhCCCCHHHH
Confidence 3322 2345689999999988765 589999999999999999999999964321110 0 00101000
Q ss_pred --------cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 020102 261 --------KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIR 313 (331)
Q Consensus 261 --------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~ 313 (331)
....................+..+.+|+.+||+.||++|||+.|+++. +++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000111111111111223355689999999999999999999999875 44443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=310.38 Aligned_cols=223 Identities=22% Similarity=0.291 Sum_probs=176.3
Q ss_pred CceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecccCCCH
Q 020102 61 NRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
.+.||+|+||.||+|.+ .+++.||+| .||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999987 568999999 489999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe--CCCCcEEEeeccCcccccCCCcee
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL--DERYRAKVADFGTSKFIAMDQTHV 194 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (331)
.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++....... .
T Consensus 174 ~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 174 FDRIIDE----SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp HHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 9888652 236899999999999999999999998 9999999999999 577899999999998664332 2
Q ss_pred eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhc
Q 020102 195 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMK 274 (331)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... ........ ..+. .. .
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~-~~~~-~~-----~ 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNNILA-CRWD-LE-----D 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHH-TCCC-SC-----S
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-ccCC-CC-----h
Confidence 23346999999999999999999999999999999999999999643210 11111111 1110 00 0
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 275 LGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 275 ~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
......+..+.+|+.+||+.||++|||+.|+++
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111234567999999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=307.37 Aligned_cols=234 Identities=24% Similarity=0.305 Sum_probs=176.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCC------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETE------ 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~------ 102 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| +||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999998 579999999 3889999999987764
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||+ +++|.+.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 7899888865 36899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ..........
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----l~~i~~~~g~ 244 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-----LKEIMKVTGT 244 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHHHCC
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcCC
Confidence 99865432 233568999999998877 6789999999999999999999999964321100 0000000000
Q ss_pred C------------------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 N------------------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .+....... ........+..+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCC-HHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 000000000 001122345679999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=302.83 Aligned_cols=236 Identities=25% Similarity=0.384 Sum_probs=185.7
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccc--cCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCL--ETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~--~~~~~~l 106 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| +||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999984 68999999 4889999999874 4667899
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA--SSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ..+++|+||||+||+++.++.+||+|||++
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999999876432 2346899999999999999999999976 234999999999999999999999999998
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
....... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||..... .........+..
T Consensus 164 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~i~~~~~ 233 (279)
T 2w5a_A 164 RILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------KELAGKIREGKF 233 (279)
T ss_dssp HHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHTCC
T ss_pred eeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---------HHHHHHHhhccc
Confidence 7654322 122235689999999999999999999999999999999999999864311 011111222221
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
. ..+...+..+.+++.+||+.||++|||++|+++.+.
T Consensus 234 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 234 R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred c---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1 122345567999999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=300.79 Aligned_cols=226 Identities=24% Similarity=0.355 Sum_probs=187.0
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|.+.+.||+|+||+||+|.+. +++.+|+| .||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999985 57889988 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999987652 36899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... .....
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~--- 232 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRI-KKNEY--- 232 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH-HTTCC---
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-hhccC---
Confidence 43322 22335689999999999999999999999999999999999999864311 0111111 11111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+..+.+++.+||+.||++|||++|+++.
T Consensus 233 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1122344578899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=306.00 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=174.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCC------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETE------ 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~------ 102 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999987 468899999 3889999999987655
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||++ ++|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence 6799999997 578777753 5889999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc-------c-----
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV-------S----- 250 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~-------~----- 250 (331)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... .
T Consensus 173 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 173 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99765432 223345789999999999999999999999999999999999999964321100000 0
Q ss_pred --hHHHHHHHhhcC-cccc-----ccchHhh---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 251 --LAAYFVHSMRKN-RLYD-----ILDDQVM---KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 251 --~~~~~~~~~~~~-~~~~-----~~~~~~~---~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
............ .... ....... .......+..+.+|+.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 0000 0000000 00112346789999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.82 Aligned_cols=231 Identities=23% Similarity=0.428 Sum_probs=186.6
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------------ccccchhhhccc
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------------KSKNAVKLLGCC 98 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------------~~~niv~~~~~~ 98 (331)
....++|.+.+.||+|+||+||+|.+. +|+.|||| .||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 444578999999999999999999984 79999999 388999999999
Q ss_pred ccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 020102 99 LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKV 178 (331)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl 178 (331)
......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+|.++|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999988752 36899999999999999999999998 999999999999999999999
Q ss_pred eeccCcccccCCCceeeeeccccCCccChhhhcC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH
Q 020102 179 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~ 252 (331)
+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~ 311 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------I 311 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------H
Confidence 9999998665332 2334579999999998864 3578899999999999999999999964211 0
Q ss_pred HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. .......+... ...+. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 312 ~-~~~~i~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 L-MLRMIMEGQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H-HHHHHHHTCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-HHHHHHhCCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 11111111110 00000 1123456899999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=302.64 Aligned_cols=237 Identities=24% Similarity=0.386 Sum_probs=182.4
Q ss_pred hcCCccCceecCCCCeEEEEEEec--CCc--EEEEc--------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE--DGR--IIAVK--------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK--------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.++|++.+.||+|+||+||+|.+. ++. .||+| .|||++++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357899999999999999999852 233 68988 3889999999998765 8
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++|+||+++++|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence 8999999999999988763 236899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCcee--eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 185 KFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 185 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ..........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~ 240 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKE 240 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTS
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHcc
Confidence 8665433221 223457788999999999889999999999999999999 9999864311 0111111111
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
... ...+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 241 ~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 241 GER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp CCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCC---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 110 1122345567999999999999999999999999999887643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=317.25 Aligned_cols=229 Identities=24% Similarity=0.352 Sum_probs=182.0
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
..++|++.+.||+|+||+||+|.+. ++..||+| .||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3557999999999999999999984 68899999 389999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC---CcEEEeeccCc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER---YRAKVADFGTS 184 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~a 184 (331)
|||+.+|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.. +.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999988763 36899999999999999999999998 9999999999999764 45999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||..... .. .......+..
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~-~~~~i~~~~~ 254 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QE-ILRKVEKGKY 254 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHTCC
T ss_pred eECCCCc--cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHhCCC
Confidence 8665432 2334569999999998874 689999999999999999999999964311 01 1111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ... ......+..+.+|+.+||+.+|++|||+.|+++.
T Consensus 255 ~-~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 255 T-FDS-----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp C-CCS-----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C-CCc-----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0 000 0112345678999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=306.27 Aligned_cols=226 Identities=24% Similarity=0.355 Sum_probs=187.1
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|.+.+.||+|+||.||++.+. +++.||+| .|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999984 57889988 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999988652 36899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....... .....
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~-~~~~~--- 258 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRI-KKNEY--- 258 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH-HHTCC---
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHH-hcCCC---
Confidence 43322 22345689999999999999999999999999999999999999854311 0111111 11111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 259 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122334578899999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.49 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=166.7
Q ss_pred cCCcc-CceecCCCCeEEEEEEec---CCcEEEEc---------------------ccccchhhhcccc--cCCcceeEe
Q 020102 56 NHFNV-NRILGQGGQGTVYKGMRE---DGRIIAVK---------------------KSKNAVKLLGCCL--ETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK---------------------~~~niv~~~~~~~--~~~~~~lv~ 108 (331)
+.|++ .++||+|+||+||+|... +++.||+| +||||+++++++. .+...++||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 44666 458999999999999964 57889999 4899999999994 477899999
Q ss_pred ecccCCCHHHHHhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe----CCCCcEEEee
Q 020102 109 EFISNGTLYQHLHDRLQ----NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL----DERYRAKVAD 180 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill----~~~~~~kl~D 180 (331)
||+. ++|.+.+..... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9997 688877754321 12235899999999999999999999998 9999999999999 6788999999
Q ss_pred ccCcccccCCCc--eeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc----chHH
Q 020102 181 FGTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV----SLAA 253 (331)
Q Consensus 181 fg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~----~~~~ 253 (331)
||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........... ....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999986643221 223346789999999998874 589999999999999999999999964432111100 0000
Q ss_pred HHHHHhhcC---cccccc---ch------------------HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 254 YFVHSMRKN---RLYDIL---DD------------------QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 254 ~~~~~~~~~---~~~~~~---~~------------------~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.....+... .+..+. .. ..........+..+.+|+.+||+.||++|||++|+++.
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 011111000 000000 00 00000000114568899999999999999999999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=304.34 Aligned_cols=244 Identities=22% Similarity=0.396 Sum_probs=184.6
Q ss_pred hHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCC
Q 020102 48 SKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 48 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~ 102 (331)
..+.....++|++.+.||+|+||+||+|.+.. .+|+| +||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34455557889999999999999999998754 37777 3889999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++ ++.++|+|||
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCS
T ss_pred ceEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecC
Confidence 99999999999999998864 2346899999999999999999999998 99999999999998 6799999999
Q ss_pred CcccccCCC----ceeeeeccccCCccChhhhcC---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc
Q 020102 183 TSKFIAMDQ----THVTTKIQGTFGYLDPEYHQS---------SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV 249 (331)
Q Consensus 183 ~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~ 249 (331)
++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------ 248 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------ 248 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 987543211 111223458999999998875 3578899999999999999999999864311
Q ss_pred chHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcccc
Q 020102 250 SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318 (331)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~~ 318 (331)
.. .......+..... .....+..+.+++..||+.||++|||+.++++.|+.+....++
T Consensus 249 --~~-~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 249 --EA-IIWQMGTGMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp --HH-HHHHHHTTCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred --HH-HHHHhccCCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 00 1111111111111 1112344688999999999999999999999999998876544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=306.90 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=180.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc--------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE-------- 100 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~-------- 100 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| +||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999998 578999999 38899999999876
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
.+..++||||++ ++|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccC-CCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEcc
Confidence 346899999998 5777777542 346999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCC---ceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 020102 181 FGTSKFIAMDQ---THVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 181 fg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
||++..+.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .. ......
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~---~~~~i~ 242 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QH---QLALIS 242 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH---HHHHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HH---HHHHHH
Confidence 99998654322 122234568999999998876 4579999999999999999999999864321 10 001111
Q ss_pred HHhhc---CccccccchHh--------------h-ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 257 HSMRK---NRLYDILDDQV--------------M-KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 257 ~~~~~---~~~~~~~~~~~--------------~-~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... ..+........ . .......+..+.+|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11000 00000000000 0 00000114568899999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.92 Aligned_cols=231 Identities=13% Similarity=0.046 Sum_probs=167.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc----------------------------cccchhhhccc-------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK----------------------------SKNAVKLLGCC------- 98 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~----------------------------~~niv~~~~~~------- 98 (331)
...|.+.+.||+|+||+||+|.+ .+++.||+|. |||+++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45589999999999999999997 4789999991 78877755322
Q ss_pred ccC-----------------CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCC
Q 020102 99 LET-----------------EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMR------LRIATEVAGALAYLHSAAS 155 (331)
Q Consensus 99 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~lH~~~~ 155 (331)
... ...++||||++ ++|.+++..... .+.+..+ ..++.||+.||+|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKG- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence 221 33799999998 899999986421 3444555 677899999999999998
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcC--CCCCCcchHHHHHHHHHHHHh
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLT 233 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~ 233 (331)
|+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 215 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 --LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp --EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred --CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999985532 2223457799999999987 679999999999999999999
Q ss_pred CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 234 GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 234 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
|+.||........... .....................+..+.+|+.+||+.||++|||+.|+++
T Consensus 289 g~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSW----------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCC----------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccch----------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999975422111100 000000000011111112345668999999999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=318.32 Aligned_cols=230 Identities=29% Similarity=0.397 Sum_probs=184.4
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------------------ccccchhhh
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------------------KSKNAVKLL 95 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------------------~~~niv~~~ 95 (331)
...++|.+.+.||+|+||+||+|.+. ++..||+| .||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45688999999999999999999984 57889988 288999999
Q ss_pred cccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-
Q 020102 96 GCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY- 174 (331)
Q Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~- 174 (331)
+++.+....++||||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 9999999999999999999999988763 36899999999999999999999998 99999999999999776
Q ss_pred --cEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH
Q 020102 175 --RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 175 --~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~ 252 (331)
.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||..... .
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~ 253 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND--------Q 253 (504)
T ss_dssp CSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred CccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence 69999999998665432 2334569999999999875 689999999999999999999999964311 0
Q ss_pred HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .......+.... ... .....+..+.+|+.+||+.||.+|||++|+++.
T Consensus 254 ~-~~~~i~~~~~~~--~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 254 D-IIKKVEKGKYYF--DFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp H-HHHHHHHCCCCC--CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H-HHHHHHcCCCCC--Ccc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 111111111100 000 012245679999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=319.44 Aligned_cols=229 Identities=25% Similarity=0.336 Sum_probs=186.6
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCccee
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
..++|++.+.||+|+||+||+|.+. +++.|||| .||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999984 78999999 38899999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe---CCCCcEEEeeccC
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGT 183 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~ 183 (331)
||||+.+++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999998865 246899999999999999999999998 9999999999999 4678999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
+....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||..... .. .......+.
T Consensus 176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~-~~~~i~~~~ 243 (484)
T 3nyv_A 176 STHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YD-ILKKVEKGK 243 (484)
T ss_dssp HHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHCC
T ss_pred eEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HH-HHHHHHcCC
Confidence 98654332 2233569999999999877 689999999999999999999999964311 01 111111111
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
... ..+.....+..+.+|+.+||+.+|++|||+.|+++.
T Consensus 244 ~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 244 YTF------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCC------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 110 001123445679999999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=298.45 Aligned_cols=226 Identities=23% Similarity=0.368 Sum_probs=179.3
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc----CCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE----TEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~----~~~~~ 105 (331)
..|.+.+.||+|+||+||+|.+ .++..||+| .||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4578889999999999999988 468889988 38899999998765 45689
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEeeccCc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTS 184 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a 184 (331)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+++|+||||+||+++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999999763 36899999999999999999999975 4599999999999998 7899999999999
Q ss_pred ccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 185 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... . .......+..
T Consensus 180 ~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~-~~~~~~~~~~ 247 (290)
T 1t4h_A 180 TLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------Q-IYRRVTSGVK 247 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------H-HHHHHTTTCC
T ss_pred cccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-------H-HHHHHhccCC
Confidence 754332 2234568999999998875 58999999999999999999999996432110 1 1111111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. ...+...+..+.+++.+||+.||++|||++|+++
T Consensus 248 ~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 P--------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp C--------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 0111223356899999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.59 Aligned_cols=235 Identities=22% Similarity=0.330 Sum_probs=164.8
Q ss_pred HhcCCccCc-eecCCCCeEEEEEEec-CCcEEEEc-------------------ccccchhhhccccc----CCcceeEe
Q 020102 54 ATNHFNVNR-ILGQGGQGTVYKGMRE-DGRIIAVK-------------------KSKNAVKLLGCCLE----TEVPLLVY 108 (331)
Q Consensus 54 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK-------------------~~~niv~~~~~~~~----~~~~~lv~ 108 (331)
..++|.+.+ .||+|+||+||+|.+. +++.|||| .|||++++++++.. +...++||
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 356788854 6999999999999985 69999999 37899999999876 45589999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEeeccCcc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSK 185 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~ 185 (331)
||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++.
T Consensus 106 e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 106 ECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp ECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999998752 2347999999999999999999999998 999999999999986 4559999999997
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... .........
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~~~~~-- 249 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-----MKRRIRLGQ-- 249 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-----HHHhhhccc--
Confidence 55422 22335689999999999988899999999999999999999999964322111000 000000000
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
...+.......+..+.+|+.+||+.||++|||++|+++.
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 250 ----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000111123456679999999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=303.31 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=178.3
Q ss_pred ChHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------ccccchhhhcccccCCc
Q 020102 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 47 ~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------~~~niv~~~~~~~~~~~ 103 (331)
...+.....++|.+.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.....
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3456677789999999999999999999998 468999999 48999999999865433
Q ss_pred -------ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEEccCCCCCEEeCC-C
Q 020102 104 -------PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH--SAASSPIYHRDIKSTNILLDE-R 173 (331)
Q Consensus 104 -------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~i~H~dikp~Nill~~-~ 173 (331)
.++||||+++ +|...+..... ....+++..+..++.|++.||.||| +.+ |+||||||+||+++. +
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCC
Confidence 7899999985 66665554332 3457899999999999999999999 877 999999999999996 8
Q ss_pred CcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH
Q 020102 174 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~ 252 (331)
+.+||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ...
T Consensus 169 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~ 242 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG----QLH 242 (360)
T ss_dssp TEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH
T ss_pred CcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH----HHH
Confidence 999999999998665332 223456899999999887654 8999999999999999999999996432110 000
Q ss_pred HHHH----------HHhhc-Ccccc------ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 253 AYFV----------HSMRK-NRLYD------ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 253 ~~~~----------~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... ..... ..... ..............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00000 00000 000111111222356789999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=297.94 Aligned_cols=235 Identities=26% Similarity=0.395 Sum_probs=186.5
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| +||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356899999999999999999985 68899998 388999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC----cEEEee
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY----RAKVAD 180 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~----~~kl~D 180 (331)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999998752 36899999999999999999999998 99999999999999877 799999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... . .... ...
T Consensus 156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~------~~~~-~~~ 224 (283)
T 3bhy_A 156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--Q------ETLT-NIS 224 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--H------HHHH-HHH
T ss_pred cccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--H------HHHH-HhH
Confidence 99997654322 22334689999999999999999999999999999999999999864311 0 0111 111
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIRG 314 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~~ 314 (331)
.... . ..... ....+..+.+++.+||+.||++|||+.|+++. ++.++.
T Consensus 225 ~~~~-~-~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 225 AVNY-D-FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp TTCC-C-CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred hccc-C-Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1110 0 01111 12234578999999999999999999999873 555544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=309.19 Aligned_cols=238 Identities=26% Similarity=0.418 Sum_probs=182.6
Q ss_pred ChHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhccccc--
Q 020102 47 SSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLE-- 100 (331)
Q Consensus 47 ~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~-- 100 (331)
+..++....++|++.+.||+|+||.||+|.+ .+++.||+| .||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3344455678899999999999999999998 578999999 38899999999976
Q ss_pred ----CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 101 ----TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 101 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46789999999999999998763 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCCceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccch
Q 020102 177 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL 251 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~ 251 (331)
+|+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||..... .
T Consensus 169 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~----- 240 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--M----- 240 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--H-----
T ss_pred EEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--H-----
Confidence 999999987654322 1223356899999999987 56688999999999999999999999854311 0
Q ss_pred HHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 252 AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
... .......... ......+..+.+++.+||+.||++|||+.++++.
T Consensus 241 -~~~-~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 -RAL-FLIPRNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -HHH-HHHHHSCCCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHH-HHhhcCcccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001 1111111111 1122345679999999999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=304.05 Aligned_cols=236 Identities=26% Similarity=0.338 Sum_probs=168.5
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
..++|++.+.||+|+||.||+|.+ .+++.|||| .||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 347899999999999999999998 478999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|||++ ++|.+.+..........+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++..
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99998 5888877654444456799999999999999999999998 8 99999999999999999999999999976
Q ss_pred ccCCCceeeeeccccCCccChhhh----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYH----QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
..... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........... ....+
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------~~~~~ 245 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT--------QVVKG 245 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C--------CCCCS
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH--------HHhcC
Confidence 54322 22234689999999998 456789999999999999999999999964321100000 00000
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. ...........+..+.+|+.+||+.||++|||+.++++.
T Consensus 246 ~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 246 DP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00 001111122345679999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=300.18 Aligned_cols=232 Identities=26% Similarity=0.381 Sum_probs=183.1
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc---------------------ccccchhhhcccccCCcceeEeec
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK---------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK---------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
...++|++.+.||+|+||+||+|.+. +++.||+| .|||++++++++...+..++||||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 34578999999999999999999984 58999999 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 106 CGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred CCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999988642 347899999999999999999999998 999999999999999999999999999765433
Q ss_pred CceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.. ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...... ... ...........
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~-~~~~~~~~~~~--- 245 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAI-FMIPTNPPPTF--- 245 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHH-HHHHHSCCCCC---
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHH-HHHhcCCCccc---
Confidence 22 223356899999999999999999999999999999999999998643110 001 11111111111
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122345679999999999999999999999763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.46 Aligned_cols=239 Identities=26% Similarity=0.399 Sum_probs=188.6
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEec----CCcEEEEc------------------------ccccchhhhcccccCC
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMRE----DGRIIAVK------------------------KSKNAVKLLGCCLETE 102 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK------------------------~~~niv~~~~~~~~~~ 102 (331)
.....++|++.+.||+|+||+||+|.+. .+..||+| .||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3344577899999999999999999873 25678998 3899999999985 45
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 689999999999999988752 346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .. .......
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~-~~~~i~~ 607 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------ND-VIGRIEN 607 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH-HHHHHHH
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HH-HHHHHHc
Confidence 998765443333334457789999999999999999999999999999997 8889854311 01 1111111
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
+.. ...+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 608 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 608 GER---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC---------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111 112334556799999999999999999999999999998653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=305.64 Aligned_cols=245 Identities=22% Similarity=0.267 Sum_probs=181.5
Q ss_pred hHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------------------ccccchh
Q 020102 48 SKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------------------KSKNAVK 93 (331)
Q Consensus 48 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------------------~~~niv~ 93 (331)
.+++....++|.+.+.||+|+||.||+|.+.++..|||| .||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 457788889999999999999999999999889999999 3789999
Q ss_pred hhccccc-----CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCE
Q 020102 94 LLGCCLE-----TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNI 168 (331)
Q Consensus 94 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Ni 168 (331)
+++++.. ....++||||++ ++|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999843 345799999998 688887764 2447999999999999999999999998 99999999999
Q ss_pred EeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 020102 169 LLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQE 247 (331)
Q Consensus 169 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~ 247 (331)
+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99999999999999997543322 2334568999999998877 678999999999999999999999996432100
Q ss_pred ccchHHHHHHHhhcC-------------------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 248 NVSLAAYFVHSMRKN-------------------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 248 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
............ ........ ......+..+..+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 ---QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR-AWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp ---HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC-CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh-hHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000000000 00000000 0011122345678999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.05 Aligned_cols=235 Identities=24% Similarity=0.361 Sum_probs=189.5
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccccCCcceeEee
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
..++|.+.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467899999999999999999984 78999999 48899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe---CCCCcEEEeeccCccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKF 186 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~ 186 (331)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++..
T Consensus 87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 87 LVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred cCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999988753 36899999999999999999999998 9999999999999 7888999999999875
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .. .......+...
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~-~~~~i~~~~~~- 225 (304)
T 2jam_A 159 EQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SK-LFEKIKEGYYE- 225 (304)
T ss_dssp CCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HH-HHHHHHHCCCC-
T ss_pred cCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HH-HHHHHHcCCCC-
Confidence 4322 12234689999999999999999999999999999999999999864311 01 11111111110
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIRG 314 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~~ 314 (331)
. ........+..+.+++.+||+.||++|||++|+++. +++...
T Consensus 226 ~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 226 F-----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp C-----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred C-----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 0 011123345679999999999999999999999873 444433
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=299.78 Aligned_cols=229 Identities=24% Similarity=0.340 Sum_probs=180.8
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------------ccccchhhhcccccC
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------------KSKNAVKLLGCCLET 101 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------------~~~niv~~~~~~~~~ 101 (331)
..++|.+.+.||+|+||.||+|.+ .+++.|||| .||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 456799999999999999999998 458899999 278999999998765
Q ss_pred CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc---EEE
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR---AKV 178 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~---~kl 178 (331)
+ .++||||+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence 5 8999999999999988764 347899999999999999999999998 999999999999987654 999
Q ss_pred eeccCcccccCCCceeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 020102 179 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYF 255 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 255 (331)
+|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||........ ..
T Consensus 159 ~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~--- 229 (322)
T 2ycf_A 159 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LK--- 229 (322)
T ss_dssp CCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC----HH---
T ss_pred ccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH----HH---
Confidence 999999865432 1223356899999999874 56788999999999999999999999965432211 11
Q ss_pred HHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 256 VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.....+... . .+.. ....+..+.+++.+||+.||++|||+.++++
T Consensus 230 -~~~~~~~~~-~-~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 230 -DQITSGKYN-F-IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHHHHTCCC-C-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHhCccc-c-Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111111110 0 0110 1223567899999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=311.00 Aligned_cols=241 Identities=24% Similarity=0.313 Sum_probs=179.7
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------ccccchhhhcccccC------CcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------KSKNAVKLLGCCLET------EVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------~~~niv~~~~~~~~~------~~~~lv~e 109 (331)
.+|.+.+.||+|+||+||+|.+. +++.|||| +||||+++++++... ...++|||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 46899999999999999999984 68999999 389999999988542 23679999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~ 188 (331)
|++ +++.+.+..... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 134 ~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 134 YVP-ETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp CCC-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ccc-ccHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 998 467666654322 3457999999999999999999999988 9999999999999955 568999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc------
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK------ 261 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 261 (331)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.. ....+..
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~----~l~~-i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVE-IIKVLGTPTREQI 281 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH-HHHHHCSCCHHHH
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHH-HHHHhCCCCHHHH
Confidence 3322 2335689999999998765 78999999999999999999999996432110 0000 1110000
Q ss_pred ----Cc-----cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 ----NR-----LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ----~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. +................+..+.+|+.+||+.||++|||+.|+++.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 000000001111223345689999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.80 Aligned_cols=242 Identities=23% Similarity=0.325 Sum_probs=186.7
Q ss_pred HHhcCCccCceecCCCCeEEEEEEe--cCCcEEEEc----------------------------ccccchhhhcccc---
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMR--EDGRIIAVK----------------------------KSKNAVKLLGCCL--- 99 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK----------------------------~~~niv~~~~~~~--- 99 (331)
...++|++.+.||+|+||+||+|.+ .+++.||+| .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999998 468889999 3889999999987
Q ss_pred --cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEE
Q 020102 100 --ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAK 177 (331)
Q Consensus 100 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~k 177 (331)
.....++||||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEE
Confidence 5667899999998 6999988762 2335899999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 020102 178 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVH 257 (331)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 257 (331)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 161 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~ 233 (326)
T 1blx_A 161 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILD 233 (326)
T ss_dssp ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred EecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHH
Confidence 99999997654322 223356899999999999999999999999999999999999998643211 00011111
Q ss_pred HhhcC---cccccc----------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 258 SMRKN---RLYDIL----------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 258 ~~~~~---~~~~~~----------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... .+.... ............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11000 000000 0000011223456678999999999999999999999853
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.71 Aligned_cols=226 Identities=27% Similarity=0.381 Sum_probs=180.2
Q ss_pred ceecCCCCeEEEEEEe---cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMR---EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~---~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|.+ ..++.|||| +||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 346789999 38899999999864 558899999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999965 246899999999999999999999998 999999999999999999999999999866443321
Q ss_pred --eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 194 --VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+..+..
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---------~~~~~~i~~~~~------ 590 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLEKGER------ 590 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHHTTCC------
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCCC------
Confidence 2223456788999999999999999999999999999998 9999964321 011112222211
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
...+...+..+.+|+..||+.||++|||+.+|++.|+.+..
T Consensus 591 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 ---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11233455689999999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=303.79 Aligned_cols=240 Identities=22% Similarity=0.296 Sum_probs=181.9
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccC-----Cc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLET-----EV 103 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~-----~~ 103 (331)
..++|++.+.||+|+||.||+|.+ .++..|||| .||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 356899999999999999999997 468889999 388999999998654 36
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||+. ++|.+.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcc
Confidence 899999997 689888865 36899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCcee--eeeccccCCccChhhhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 184 SKFIAMDQTHV--TTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 184 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
+.......... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||......... ........
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~i~~~~~ 249 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-----NHILGILG 249 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH-----HHHHHHHC
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH-----HHHHHHhC
Confidence 98654322211 23457999999999765 455899999999999999999999999643211110 00100000
Q ss_pred cCc---cccccchH--------------hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 261 KNR---LYDILDDQ--------------VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 261 ~~~---~~~~~~~~--------------~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
... +....... .........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000 0000112345678999999999999999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=295.13 Aligned_cols=225 Identities=25% Similarity=0.387 Sum_probs=178.2
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|.+.+.||+|+||.||+|.+. +++.||+| .||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999985 78999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999998763 36899999999999999999999998 999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... ......+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||..... .. ..........
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~-~~~~~~~~~~-- 228 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PT-LFKKIRGGVF-- 228 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHCCC--
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HH-HHHHhhcCcc--
Confidence 4322 2233468999999999988765 5799999999999999999999854210 01 1111111110
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 229 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 --------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122334578899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=296.00 Aligned_cols=238 Identities=21% Similarity=0.336 Sum_probs=184.4
Q ss_pred hcCCccCceecCCCCeEEEEEEe--cCCcEEEEcc----------------------------cccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR--EDGRIIAVKK----------------------------SKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~----------------------------~~niv~~~~~~~~~~~~ 104 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+|. +++++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999987 3688999993 22588999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC------------
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE------------ 172 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~------------ 172 (331)
++||||+ +++|.+.+... ...++++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999 79999988762 2346899999999999999999999998 999999999999987
Q ss_pred -------CCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc
Q 020102 173 -------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245 (331)
Q Consensus 173 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~ 245 (331)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999754322 233568999999999999999999999999999999999999996432111
Q ss_pred ccccchHHHHHHHhhc--------Cc-----------ccccc----------c-hHhhccCCHHHHHHHHHHHHHhhccC
Q 020102 246 QENVSLAAYFVHSMRK--------NR-----------LYDIL----------D-DQVMKLGKKNQIMAFANLAERCLDLN 295 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~--------~~-----------~~~~~----------~-~~~~~~~~~~~~~~~~~li~~cL~~~ 295 (331)
........... .. +.... . ...........+..+.+|+.+||+.|
T Consensus 242 -----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 242 -----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp -----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred -----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 00001000000 00 00000 0 00001123456788999999999999
Q ss_pred CCCCCCHHHHHHH
Q 020102 296 GKKRPTMEEVSME 308 (331)
Q Consensus 296 p~~RPs~~evl~~ 308 (331)
|++|||+.|+++.
T Consensus 317 P~~Rpt~~ell~h 329 (339)
T 1z57_A 317 PAKRITLREALKH 329 (339)
T ss_dssp TTTSCCHHHHTTS
T ss_pred cccccCHHHHhcC
Confidence 9999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=297.74 Aligned_cols=229 Identities=27% Similarity=0.401 Sum_probs=180.3
Q ss_pred CccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 58 FNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
|.....||+|+||+||+|.+ .++..||+| .||||+++++++...+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 44455899999999999997 568899999 388999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEeeccCcccccCCCc
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~ 192 (331)
++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+|||++.......
T Consensus 104 ~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 104 GSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp EEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 9999998763 22345778999999999999999999998 999999999999987 8999999999997654322
Q ss_pred eeeeeccccCCccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ........ ..
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~-~~------- 243 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA------AMFKVGMF-KV------- 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH------HHHHHHHH-CC-------
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH------HHHhhccc-cc-------
Confidence 1223456899999999987654 78899999999999999999999964321110 00000000 00
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....+...+..+.+++.+||+.||++|||+.++++.
T Consensus 244 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 --HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011223445678999999999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=304.15 Aligned_cols=241 Identities=20% Similarity=0.266 Sum_probs=183.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------------------cccchhhhccccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------------------SKNAVKLLGCCLE 100 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------------------~~niv~~~~~~~~ 100 (331)
.++|.+.+.||+|+||+||+|.+ .+++.||||. |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 36799999999999999999997 5789999992 6799999999876
Q ss_pred CC----cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeC----
Q 020102 101 TE----VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLD---- 171 (331)
Q Consensus 101 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~---- 171 (331)
.+ ..++||||+ +++|.+.+... ....+++..+..++.||+.||.|||+. + |+||||||+||+++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 54 789999999 89999988763 234689999999999999999999997 8 99999999999994
Q ss_pred --CCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc-
Q 020102 172 --ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN- 248 (331)
Q Consensus 172 --~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~- 248 (331)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999765432 223468999999999999999999999999999999999999996442211100
Q ss_pred cchHHHHHHHhhcCcccc--------------------cc--------ch--HhhccCCHHHHHHHHHHHHHhhccCCCC
Q 020102 249 VSLAAYFVHSMRKNRLYD--------------------IL--------DD--QVMKLGKKNQIMAFANLAERCLDLNGKK 298 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~--------------------~~--------~~--~~~~~~~~~~~~~~~~li~~cL~~~p~~ 298 (331)
........... +.+.. .+ .. ......+...+..+.+|+.+||+.||++
T Consensus 247 ~~~~~~~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 247 DDHIAQIIELL--GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp HHHHHHHHHHH--CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred HHHHHHHHHhc--CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 00000000000 00000 00 00 0111235677889999999999999999
Q ss_pred CCCHHHHHHH
Q 020102 299 RPTMEEVSME 308 (331)
Q Consensus 299 RPs~~evl~~ 308 (331)
|||++|+++.
T Consensus 325 Rpt~~ell~h 334 (373)
T 1q8y_A 325 RADAGGLVNH 334 (373)
T ss_dssp CBCHHHHHTC
T ss_pred cCCHHHHhhC
Confidence 9999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=303.38 Aligned_cols=180 Identities=26% Similarity=0.371 Sum_probs=154.2
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEcc-----------------------cc-----cchhhhcccccC
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVKK-----------------------SK-----NAVKLLGCCLET 101 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~-----------------------~~-----niv~~~~~~~~~ 101 (331)
.....++|++.+.||+|+||+||+|.+. +++.||||. |+ +++++++++...
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 3444678999999999999999999974 688999993 22 488888999999
Q ss_pred CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCCeEEccCCCCCEEeC--CCCcEE
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS--AASSPIYHRDIKSTNILLD--ERYRAK 177 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~i~H~dikp~Nill~--~~~~~k 177 (331)
+..++||||++ ++|.+.+... ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred CceEEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 99999999996 6999988763 22468999999999999999999995 45 99999999999995 578899
Q ss_pred EeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 020102 178 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSA 241 (331)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~ 241 (331)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999865432 23356899999999999999999999999999999999999999643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=305.65 Aligned_cols=235 Identities=24% Similarity=0.305 Sum_probs=164.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC------C
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET------E 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~------~ 102 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| +||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999997 568999999 378999999998654 5
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++|+|++ +++|.+.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 6888887753 36999999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~l~~i~~~~g~ 248 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-----QLKLILRLVGT 248 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCS
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCC
Confidence 99764322 234578999999999877 678999999999999999999999996432110 00001111000
Q ss_pred C---ccccccchHh-------h-------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 N---RLYDILDDQV-------M-------KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~---~~~~~~~~~~-------~-------~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .+..+..... . .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000000000 0 00011234678999999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=293.18 Aligned_cols=229 Identities=23% Similarity=0.297 Sum_probs=179.7
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhccc--ccCCc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCC--LETEV 103 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~--~~~~~ 103 (331)
..++|.+.+.||+|+||.||+|.+ .+++.||+| +||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999998 468899998 388999999998 44567
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||++++ |.+.+... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999866 76766542 3457999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCC-ceeeeeccccCCccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 184 SKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 184 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
+....... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ..... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~-~~i~ 226 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLF-ENIG 226 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHH-HHHH
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHH-HHHh
Confidence 97654322 22233456899999999988754 3779999999999999999999986421 01111 1111
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... ..+...+..+.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 KGSY----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HCCC----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCCC----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 1122345678899999999999999999999865
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=299.09 Aligned_cols=230 Identities=24% Similarity=0.352 Sum_probs=182.1
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.++|++.+.||+|+||.||+|.+. ++..||+| .||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467999999999999999999985 58899999 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 98 CPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred CCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999887652 246899999999999999999999998 999999999999999999999999987533211
Q ss_pred CceeeeeccccCCccChhhh-----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 191 QTHVTTKIQGTFGYLDPEYH-----QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
. .......||+.|+|||++ .+..++.++|||||||++|+|++|..||..... ......... ....
T Consensus 171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~ 240 (302)
T 2j7t_A 171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAK-SDPP 240 (302)
T ss_dssp H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH-SCCC
T ss_pred c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhc-cCCc
Confidence 1 112234689999999987 466789999999999999999999999864321 011111111 1111
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 241 ~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 TL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 1123445679999999999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=293.53 Aligned_cols=231 Identities=26% Similarity=0.429 Sum_probs=174.9
Q ss_pred HhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------ccccchhhhccccc----------
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------KSKNAVKLLGCCLE---------- 100 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------~~~niv~~~~~~~~---------- 100 (331)
..++|++.+.||+|+||+||+|.+ .+++.||+| .|||++++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 346789999999999999999997 478999999 38899999988754
Q ss_pred ---CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEE
Q 020102 101 ---TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAK 177 (331)
Q Consensus 101 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~k 177 (331)
....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 45679999999999999998752 336788999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccccCCC-------------ceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 020102 178 VADFGTSKFIAMDQ-------------THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGN 243 (331)
Q Consensus 178 l~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~ 243 (331)
|+|||++....... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999997654221 1122335689999999998865 68999999999999999998 553210
Q ss_pred CcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 244 TSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. .. .......... ..+.......+..+.+++.+||+.||++|||+.++++.
T Consensus 233 ---~~---~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ---ER---VN-ILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---HH---HH-HHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---hH---HH-HHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 00 1111111100 01111233445678999999999999999999999763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=290.98 Aligned_cols=229 Identities=24% Similarity=0.362 Sum_probs=186.3
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc---------------------------------ccccchhhhcccc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK---------------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK---------------------------------~~~niv~~~~~~~ 99 (331)
..++|++.+.||+|+||.||+|.+. +++.|||| .||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999984 68899999 2899999999999
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEe
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~ 179 (331)
.+...++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999998762 36899999999999999999999998 9999999999999999999999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ------SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA 253 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~ 253 (331)
|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||..... ..
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~ 236 (298)
T 1phk_A 167 DFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------ML 236 (298)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH
T ss_pred cccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------HH
Confidence 999997654332 223356899999999875 45688899999999999999999999854311 01
Q ss_pred HHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
... ........ . ........+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~-~~~~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 237 MLR-MIMSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-HHHHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHH-HHhcCCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 11111110 0 00112345667999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=303.42 Aligned_cols=234 Identities=24% Similarity=0.327 Sum_probs=177.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcc----
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVP---- 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~---- 104 (331)
.++|.+.+.||+|+||+||+|.+ .+++.|||| +||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 57899999999999999999997 468999999 388999999999887665
Q ss_pred --eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 105 --LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 105 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
++||||+. ++|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 677766532 5899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .... .......
T Consensus 190 ~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~-i~~~~~~ 260 (371)
T 4exu_A 190 LARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLTQ-ILKVTGV 260 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH-HHHHHCC
T ss_pred ccccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHH-HHHHhCC
Confidence 9975432 2234568999999999887 678999999999999999999999996432110 0000 0000000
Q ss_pred C--ccccccch--------Hh-------hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 N--RLYDILDD--------QV-------MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~--~~~~~~~~--------~~-------~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .....+.. .. .....+..+..+.+|+.+||+.||++|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 00000000 00 000112346689999999999999999999999765
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.26 Aligned_cols=233 Identities=23% Similarity=0.323 Sum_probs=179.6
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEcc---------------------------cccchhhhcccccCC
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK---------------------------SKNAVKLLGCCLETE 102 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~---------------------------~~niv~~~~~~~~~~ 102 (331)
.+....++|.+.+.||+|+||.||+|.+.+++.||+|. |+|++++++++...+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 34445678999999999999999999998899999992 489999999999999
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++ +.+||+|||
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred EEEEEEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 9999999 567899998876 237899999999999999999999998 999999999999965 799999999
Q ss_pred CcccccCCCce-eeeeccccCCccChhhhcC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc
Q 020102 183 TSKFIAMDQTH-VTTKIQGTFGYLDPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS 250 (331)
Q Consensus 183 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~ 250 (331)
++......... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------ 245 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ 245 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------
Confidence 99865433221 2233568999999999876 46788999999999999999999999643211
Q ss_pred hHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 251 LAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
............ ....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 246 -~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 -ISKLHAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHhccc---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 011111111111 011112224578999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=306.74 Aligned_cols=239 Identities=21% Similarity=0.348 Sum_probs=185.9
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------------------------ccccchhh
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------------------------KSKNAVKL 94 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------------------------~~~niv~~ 94 (331)
.++|.+.+.||+|+||.||+|.+ +++.||+| +|||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 89999998 27899999
Q ss_pred hcccccCCcceeEeecccCCCHHHHHhhh--h-cCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEe
Q 020102 95 LGCCLETEVPLLVYEFISNGTLYQHLHDR--L-QNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILL 170 (331)
Q Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill 170 (331)
++++.+.+..++||||+++++|.+++... . ......+++..++.++.|++.||.|||+ .+ ++|+||+|+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 99999999999999999999998873211 0 1224579999999999999999999999 88 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCC-CCCC-cchHHHHHHHHHHHHhCCCCCCCCCCCcccc
Q 020102 171 DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTD-KSDVYSFGVVLVELLTGKKPIFSAGNTSQEN 248 (331)
Q Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~el~~g~~p~~~~~~~~~~~ 248 (331)
+.++.++|+|||++...... ......||+.|+|||.+.+. .++. ++|||||||++|+|++|..||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---
Confidence 99999999999999865432 33445689999999999887 6666 9999999999999999999996542211
Q ss_pred cchHHHHHHHhhcCcccccc---------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 249 VSLAAYFVHSMRKNRLYDIL---------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .............. ............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ----~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ----E-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ----H-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ----H-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 11111111110000 0000001113456689999999999999999999999773
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=295.38 Aligned_cols=239 Identities=21% Similarity=0.290 Sum_probs=180.1
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc------------------------ccccchhhhcccccC-----Ccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK------------------------KSKNAVKLLGCCLET-----EVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK------------------------~~~niv~~~~~~~~~-----~~~ 104 (331)
.++|.+.+.||+|+||+||+|.+. +++.|||| +||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999984 68899999 388999999987654 678
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
++||||+. ++|.+.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 90 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 99999997 689888765 36899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCce---------eeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 020102 185 KFIAMDQTH---------VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 185 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 254 (331)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~-~~ 234 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH----QL-LL 234 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HH-HH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HH-HH
Confidence 865432211 1123468999999998754 678999999999999999999999986432100 00 00
Q ss_pred HHHHhhcC----ccccccchH--------------hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 255 FVHSMRKN----RLYDILDDQ--------------VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 255 ~~~~~~~~----~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........ ......... ......+..+..+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000000000 0000112445678999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=295.97 Aligned_cols=228 Identities=28% Similarity=0.456 Sum_probs=184.0
Q ss_pred ccChHHHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------------cccch
Q 020102 45 LFSSKELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------------SKNAV 92 (331)
Q Consensus 45 ~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------------~~niv 92 (331)
.....+.....++|++.+.||+|+||+||+|.+ .+++.||||. |+|++
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 334456666778999999999999999999987 5688999992 58999
Q ss_pred hhhcccccCCcceeEeecccC-CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 020102 93 KLLGCCLETEVPLLVYEFISN-GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171 (331)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~ 171 (331)
++++++...+..++|+|++.+ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 183 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEe
Confidence 999999999999999999976 8999988762 46899999999999999999999998 99999999999999
Q ss_pred -CCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc
Q 020102 172 -ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV 249 (331)
Q Consensus 172 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~ 249 (331)
+++.+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------- 253 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------- 253 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred CCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------
Confidence 78999999999998654322 233568999999999887765 678999999999999999999985320
Q ss_pred chHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 250 SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... ... ..+...+..+.+++.+||+.||++|||++|+++.
T Consensus 254 -------~~~~-~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 -------EIIR-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -------HHHH-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------hhhc-ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 100 0122344578999999999999999999999763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=309.43 Aligned_cols=234 Identities=26% Similarity=0.345 Sum_probs=172.2
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc---------------------ccccchhhhcccccCCcceeEeecccCC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------KSKNAVKLLGCCLETEVPLLVYEFISNG 114 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------------~~~niv~~~~~~~~~~~~~lv~e~~~~~ 114 (331)
+.|.+.+.||+|+||+||.+...+|+.|||| .||||+++++++.+++..++||||++ |
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 4456678899999999987767789999999 38999999999999999999999996 6
Q ss_pred CHHHHHhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-------------CcEEEe
Q 020102 115 TLYQHLHDRLQNQE--FPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER-------------YRAKVA 179 (331)
Q Consensus 115 ~L~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~-------------~~~kl~ 179 (331)
+|.+++........ ...++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 99998875311111 01133346789999999999999998 9999999999999754 479999
Q ss_pred eccCcccccCCCce---eeeeccccCCccChhhhcC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccc
Q 020102 180 DFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQEN 248 (331)
Q Consensus 180 Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~ 248 (331)
|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--- 247 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--- 247 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---
Confidence 99999876543322 1234579999999999876 568999999999999999999 899985431110
Q ss_pred cchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 249 VSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..... +.. . .+..........+..+.+++.+||+.||++|||+.|+++
T Consensus 248 -------~~i~~-~~~-~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -------SNIIR-GIF-S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -------HHHHH-TCC-C--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHhc-CCC-C--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00111 100 0 001112234567788999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.78 Aligned_cols=223 Identities=27% Similarity=0.425 Sum_probs=176.3
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------------------ccccchhhh
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------------------KSKNAVKLL 95 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------------~~~niv~~~ 95 (331)
+.....++|++.+.||+|+||.||+|.+ .+++.||+| .|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4455678899999999999999999987 568899999 388999999
Q ss_pred cccccCCcceeEeec-ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CC
Q 020102 96 GCCLETEVPLLVYEF-ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ER 173 (331)
Q Consensus 96 ~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~ 173 (331)
+++...+..++|+|+ +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++ .+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 999999999999999 7899999998762 36899999999999999999999998 99999999999999 88
Q ss_pred CcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH
Q 020102 174 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~ 252 (331)
+.++|+|||++....... .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||....
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------- 243 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------- 243 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------
Confidence 999999999998664332 2335689999999998877664 48999999999999999999985320
Q ss_pred HHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 253 AYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.... .. ...+...+..+.+++.+||+.||++|||++|+++.
T Consensus 244 ----~~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ----EILE-AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----HHHH-TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----HHhh-hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00 01123345578999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=292.64 Aligned_cols=238 Identities=22% Similarity=0.313 Sum_probs=180.5
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CC-cEEEEcc----------------------ccc------chhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DG-RIIAVKK----------------------SKN------AVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~----------------------~~n------iv~~~~~~~~~~~~ 104 (331)
.++|++.+.||+|+||+||+|.+. ++ ..||+|. |++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999974 34 6899993 223 77888888888999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe--------------
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL-------------- 170 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill-------------- 170 (331)
++||||+ ++++.+.+... ....+++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 98 ~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999 57777777652 2346899999999999999999999998 9999999999999
Q ss_pred -----CCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc
Q 020102 171 -----DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245 (331)
Q Consensus 171 -----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~ 245 (331)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999754322 233568999999999999999999999999999999999999996432110
Q ss_pred ccccchHHHHHHHhhc--------Cccccc-------cc---------------hHhhccCCHHHHHHHHHHHHHhhccC
Q 020102 246 QENVSLAAYFVHSMRK--------NRLYDI-------LD---------------DQVMKLGKKNQIMAFANLAERCLDLN 295 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~--------~~~~~~-------~~---------------~~~~~~~~~~~~~~~~~li~~cL~~~ 295 (331)
........... ...... +. ...........+..+.+|+.+||+.|
T Consensus 247 -----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 247 -----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp -----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred -----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 00000000000 000000 00 00001123345678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 020102 296 GKKRPTMEEVSME 308 (331)
Q Consensus 296 p~~RPs~~evl~~ 308 (331)
|++|||+.|+++.
T Consensus 322 P~~Rpt~~e~l~h 334 (355)
T 2eu9_A 322 PAQRITLAEALLH 334 (355)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.95 Aligned_cols=230 Identities=25% Similarity=0.358 Sum_probs=184.6
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcce
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
....++|++.+.||+|+||+||+|.+. +++.||+| .||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999984 68899999 3789999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC---CcEEEeecc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER---YRAKVADFG 182 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg 182 (331)
+|+||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ +.+||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999888753 36899999999999999999999998 9999999999999754 469999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
++....... ......+|+.|+|||.+.+. ++.++||||||+++|+|++|..||..... .. .......+
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~-~~~~~~~~ 237 (287)
T 2wei_A 170 LSTCFQQNT--KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE--------YD-ILKRVETG 237 (287)
T ss_dssp GGGTBCCCS--SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHC
T ss_pred cceeecCCC--ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHcC
Confidence 987654332 22234589999999998764 88999999999999999999999864311 01 11111111
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 238 KYAFD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCC------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11100 0011234567899999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.00 Aligned_cols=233 Identities=23% Similarity=0.319 Sum_probs=176.5
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCc-----
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEV----- 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~----- 103 (331)
.++|.+.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46789999999999999999997 468999999 38899999999987654
Q ss_pred -ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 104 -PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 104 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
.++||||+. ++|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 67766543 25899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .. .........
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~-~~i~~~~~~ 242 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QL-TQILKVTGV 242 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH----HH-HHHHHHHCB
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH-HHHHHHhCC
Confidence 99754322 233568999999998887 678999999999999999999999996432110 00 000000000
Q ss_pred C------------------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 N------------------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. .+....... ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCC-TTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCcc-HHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000000000 001123456789999999999999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=290.65 Aligned_cols=230 Identities=25% Similarity=0.389 Sum_probs=166.6
Q ss_pred HhcCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
..++|++.+.||+|+||+||+|.+. +++.|||| .||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3567899999999999999999984 68999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
|||+ ++.+....... ...+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++..
T Consensus 103 ~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp ECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred Eecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999 45554444321 34789999999999999999999995 8 99999999999999999999999999976
Q ss_pred ccCCCceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...... .........
T Consensus 175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~- 244 (318)
T 2dyl_A 175 LVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQ- 244 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHH-
T ss_pred ccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhc-
Confidence 54322 223346899999999984 456888999999999999999999998643211 011111111
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
....... .....+..+.+++.+||+.||.+|||++|+++.
T Consensus 245 ~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 245 EEPPLLP-------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SCCCCCC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCCCCC-------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111100 112345578999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=289.88 Aligned_cols=236 Identities=22% Similarity=0.291 Sum_probs=172.8
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc-----------------------ccccchhhhcccc-----------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-----------------------KSKNAVKLLGCCL----------- 99 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-----------------------~~~niv~~~~~~~----------- 99 (331)
.++|++.+.||+|+||+||+|.+. +++.||+| .|||++++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999985 58999999 3889999988763
Q ss_pred ---cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCc
Q 020102 100 ---ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYR 175 (331)
Q Consensus 100 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~ 175 (331)
+....++||||++ ++|.+.+.. .++++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence 4467899999998 699887753 46899999999999999999999998 99999999999997 5679
Q ss_pred EEEeeccCcccccCCCc--eeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchH
Q 020102 176 AKVADFGTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLA 252 (331)
Q Consensus 176 ~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~ 252 (331)
+||+|||++........ .......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------- 232 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE------- 232 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-------
Confidence 99999999986543211 12233457999999998765 678999999999999999999999996432100
Q ss_pred HHHHHHhhcCc-------------cccccchHhh------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 253 AYFVHSMRKNR-------------LYDILDDQVM------KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 253 ~~~~~~~~~~~-------------~~~~~~~~~~------~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......... +......... .......+..+.+++.+||+.||++|||++|+++.
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 233 -QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp -HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000000000 0000000000 00112346689999999999999999999999763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=304.13 Aligned_cols=229 Identities=24% Similarity=0.363 Sum_probs=171.4
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc---------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
..+|.+.+.||+|+||+|+.....+++.|||| .||||+++++++.+....++||||+.
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 35688899999999999765556689999999 38999999999999999999999997
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-----CCcEEEeeccCccccc
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-----RYRAKVADFGTSKFIA 188 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-----~~~~kl~Dfg~a~~~~ 188 (331)
|+|.+++... ....++..+..++.||+.||.|||+.+ |+||||||+||+++. ...+||+|||++....
T Consensus 102 g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 102 ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 6999888752 234455566789999999999999998 999999999999953 3358899999998665
Q ss_pred CCCc--eeeeeccccCCccChhhhc---CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 189 MDQT--HVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 189 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
.... .......||+.|+|||++. +..++.++|||||||++|||++ |..||...... .........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~~~~~~ 245 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANILLGAC 245 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHHHTTCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHHHhccC
Confidence 3321 2233467999999999987 4567889999999999999999 88888432110 000111111
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
.. .. .......+..+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SL-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CC-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11 00 0112344566889999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=311.50 Aligned_cols=254 Identities=24% Similarity=0.302 Sum_probs=186.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhccccc------CCc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLE------TEV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~------~~~ 103 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999987 568999999 38899999998765 677
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc---EEEee
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR---AKVAD 180 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~---~kl~D 180 (331)
.++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. ++|+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcc
Confidence 89999999999999998763 22346889999999999999999999998 999999999999997665 89999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHH-HHHHHh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA-YFVHSM 259 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 259 (331)
||++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||........-...... ......
T Consensus 168 FG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 168 LGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred ccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 99998664332 233457999999999999999999999999999999999999999643111000000000 000000
Q ss_pred hcCcccc---c-cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHhhhhc
Q 020102 260 RKNRLYD---I-LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE-----VSMELNGIRGS 315 (331)
Q Consensus 260 ~~~~~~~---~-~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~e-----vl~~L~~l~~~ 315 (331)
....... . .....+.......+..+.+++..||+.||++|||+.| +.+.++.+...
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0000000 0 0001112234457788999999999999999999988 56666666553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.22 Aligned_cols=212 Identities=24% Similarity=0.352 Sum_probs=165.6
Q ss_pred hcCCccC-ceecCCCCeEEEEEEe-cCCcEEEEc-------------------ccccchhhhccccc----CCcceeEee
Q 020102 55 TNHFNVN-RILGQGGQGTVYKGMR-EDGRIIAVK-------------------KSKNAVKLLGCCLE----TEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK-------------------~~~niv~~~~~~~~----~~~~~lv~e 109 (331)
.++|.+. +.||+|+||.||+|.+ .+++.||+| .||||+++++++.. ....++|||
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 3567776 7899999999999998 578999999 48999999999876 677899999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEeeccCccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKF 186 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~ 186 (331)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++..
T Consensus 96 ~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 96 CLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp CCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 99999999998762 2346999999999999999999999998 999999999999997 78899999999864
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.. +..++.++|||||||++|+|++|+.||.......... .....
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------------~~~~~ 213 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------------GMKTR 213 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------------CSCCS
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------------HHHHH
Confidence 32 1345679999999999999999999996432111000 00000
Q ss_pred ccchH--hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQ--VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~--~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... .+.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 0000012345679999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=277.79 Aligned_cols=212 Identities=14% Similarity=0.101 Sum_probs=166.3
Q ss_pred hcCCccCceecCCCCeEEEEEEec-CCcEEEEc--------------------------ccccchhhhcccccCCcceeE
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
.++|++.+.||+|+||+||+|.+. +++.|||| .||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999984 58999999 388999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||++|++|.+++.. ......+..++.|++.||.|||+.+ |+||||||+||+++.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999998853 2355678889999999999999998 9999999999999999999998443
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
|++ .++.++|||||||++|||++|+.||............. ......
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----------~~~~~~ 221 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----------RDTAGQ 221 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----------BCTTSC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----------HHhccC
Confidence 333 25789999999999999999999997543211100000 000000
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
.. .........+..+.+++.+||+.||++| |+.|+++.|+.+.....
T Consensus 222 ~~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 222 PI--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp BC--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CC--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00 0001122345678999999999999999 99999999999876544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.54 Aligned_cols=216 Identities=25% Similarity=0.371 Sum_probs=175.3
Q ss_pred hcCCccCceecCCCCeEEEEEEec--CCcEEEEc------------------------ccccchhhhcccccCCc-----
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE--DGRIIAVK------------------------KSKNAVKLLGCCLETEV----- 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK------------------------~~~niv~~~~~~~~~~~----- 103 (331)
.++|++.+.||+|+||+||+|.+. +++.|||| .||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999984 68999999 38999999999987665
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||++|++|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ .+||+|||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999876542 6899999999999999999999998 9999999999999986 899999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
+...... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||...... .
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~ 283 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------G 283 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------S
T ss_pred chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------c
Confidence 9865432 3356999999999987764 88999999999999999998887532100 0
Q ss_pred cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhh
Q 020102 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-TMEEVSMELNGI 312 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-s~~evl~~L~~l 312 (331)
+. . .......+..+.+++.+||+.||++|| +++++...|.++
T Consensus 284 ~~---~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 284 LP---E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CC---T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cc---c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0 000112345788999999999999999 566677777654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=291.22 Aligned_cols=220 Identities=18% Similarity=0.172 Sum_probs=162.0
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEcccc---------------------------cchhhhcc----------
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKKSK---------------------------NAVKLLGC---------- 97 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~---------------------------niv~~~~~---------- 97 (331)
..|...+.||+|+||+||+|.+ .+++.||||... |...+..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577889999999999999997 579999999432 11111111
Q ss_pred -----------ccc-----CCcceeEeecccCCCHHHHHhhhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 020102 98 -----------CLE-----TEVPLLVYEFISNGTLYQHLHDRL--QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIY 159 (331)
Q Consensus 98 -----------~~~-----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~ 159 (331)
+.. ....+++|+++ +++|.+++.... ......+++..+..++.||+.||.|||+.+ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 12345666665 589988875321 122345788899999999999999999998 99
Q ss_pred EccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhh----------cCCCCCCcchHHHHHHHHH
Q 020102 160 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH----------QSSQLTDKSDVYSFGVVLV 229 (331)
Q Consensus 160 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il~ 229 (331)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998754322 344567 999999998 5556888999999999999
Q ss_pred HHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 230 ELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 230 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
||++|+.||........ ...... .....+..+.+|+.+||+.||++|||+.++++
T Consensus 309 elltg~~Pf~~~~~~~~-----------------~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG-----------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC-----------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh-----------------HHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999964321100 000000 01123467999999999999999999887754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.74 Aligned_cols=219 Identities=15% Similarity=0.147 Sum_probs=169.1
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEcc-----------------------------------------------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK----------------------------------------------- 87 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~----------------------------------------------- 87 (331)
.++|++.+.||+|+||+||+|.+ +++.||||.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999988 689999992
Q ss_pred ----------cccchhhhccccc-------------CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHH
Q 020102 88 ----------SKNAVKLLGCCLE-------------TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVA 144 (331)
Q Consensus 88 ----------~~niv~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~ 144 (331)
||||+++++++.+ ....++||||+++|++.+.+.+ ..+++..+..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 5778888888776 7889999999999977666632 3689999999999999
Q ss_pred HHHHHHH-hcCCCCeEEccCCCCCEEeCCCC--------------------cEEEeeccCcccccCCCceeeeeccccCC
Q 020102 145 GALAYLH-SAASSPIYHRDIKSTNILLDERY--------------------RAKVADFGTSKFIAMDQTHVTTKIQGTFG 203 (331)
Q Consensus 145 ~~l~~lH-~~~~~~i~H~dikp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~ 203 (331)
.||.||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 888 99999999999999887 8999999999865432 2469999
Q ss_pred ccChhhhcCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhhccCCHHHHH
Q 020102 204 YLDPEYHQSSQLTDKSDVYSFGVV-LVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIM 282 (331)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwslG~i-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (331)
|+|||++.+.. +.++||||+|++ .+++++|..||... ................... .........+.
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~ 310 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQMTFKTK----CNTPAMKQIKR 310 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHTCCCSSC----CCSHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhhhccCcc----cchhhhhhcCH
Confidence 99999998877 889999998777 77788898887320 0000000011111111100 01112346788
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHH
Q 020102 283 AFANLAERCLDLNGKKRPTMEEVS 306 (331)
Q Consensus 283 ~~~~li~~cL~~~p~~RPs~~evl 306 (331)
.+.+|+.+||+.| |++|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 8999999999976 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-30 Score=247.69 Aligned_cols=138 Identities=20% Similarity=0.173 Sum_probs=102.6
Q ss_pred cccchhhhcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCC
Q 020102 88 SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTN 167 (331)
Q Consensus 88 ~~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~N 167 (331)
|+||+++++++.+++..||||||++|++|.+.|.. .++++.. .|+.||+.||.|+|++| |+||||||+|
T Consensus 301 ~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeN 369 (569)
T 4azs_A 301 GFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWN 369 (569)
T ss_dssp TCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGG
T ss_pred CCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHh
Confidence 77999999999999999999999999999999975 3466654 47899999999999999 9999999999
Q ss_pred EEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 020102 168 ILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 238 (331)
Q Consensus 168 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~ 238 (331)
||++.+|.+||+|||+|+....+. ....+.+||+.|+|||++.+. +..++|+||+|++++++.++..|+
T Consensus 370 ILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 370 VMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp EEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred EEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 999999999999999998665432 223446799999999998864 567899999999988876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=220.11 Aligned_cols=161 Identities=15% Similarity=0.222 Sum_probs=127.1
Q ss_pred ccCceecCCCCeEEEEEEecCCcEEEEc-------------------------------ccccchhhhcccccCCcceeE
Q 020102 59 NVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
...+.||+|+||+||+|.. .+..+++| +||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999944 56777777 378999666666677888999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999988764 4579999999999999998 999999999999999 9999999999876
Q ss_pred cCCCcee------eeeccccCCccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCC
Q 020102 188 AMDQTHV------TTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPI 238 (331)
Q Consensus 188 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~p~ 238 (331)
....... .....||+.|+|||++.+ ..|+..+|+||...-..+-+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5432211 234679999999999987 56788899999999999888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-23 Score=183.58 Aligned_cols=129 Identities=18% Similarity=0.165 Sum_probs=104.9
Q ss_pred HHHhcCCccCceecCCCCeEEEEEEecCCcEEEEcccc---------------------------------------cch
Q 020102 52 DKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK---------------------------------------NAV 92 (331)
Q Consensus 52 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~---------------------------------------niv 92 (331)
......|.+.+.||+|+||.||+|.+.+++.||+|.++ | +
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-~ 164 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-L 164 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-S
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-C
Confidence 34455677779999999999999999779999999753 4 5
Q ss_pred hhhcccccCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC
Q 020102 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE 172 (331)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~ 172 (331)
++.+++ +.+..++||||++|++|.+ +.. .....++.|++.||.|||+.+ |+||||||+||+++
T Consensus 165 ~v~~~~-~~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~- 227 (282)
T 1zar_A 165 AVPKVY-AWEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS- 227 (282)
T ss_dssp SSCCEE-EEETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred CcCeEE-eccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence 566654 3456799999999999977 421 123469999999999999998 99999999999999
Q ss_pred CCcEEEeeccCcccccCCCceeeeeccccCCccChhhhcC
Q 020102 173 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212 (331)
Q Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 212 (331)
++.+||+|||+|. .+..+.|||++..
T Consensus 228 ~~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 228 EEGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 9999999999986 2345788997754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.2e-18 Score=147.67 Aligned_cols=119 Identities=20% Similarity=0.212 Sum_probs=88.3
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcE--EEEccccc---------------------------------------chh
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRI--IAVKKSKN---------------------------------------AVK 93 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~n---------------------------------------iv~ 93 (331)
.-|.+.+.||+|+||.||+|.+ .+|+. ||||.++. +..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999998 68888 99995210 000
Q ss_pred hhcc------cccCCcceeEeecccC-C----CHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEc
Q 020102 94 LLGC------CLETEVPLLVYEFISN-G----TLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH-SAASSPIYHR 161 (331)
Q Consensus 94 ~~~~------~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~i~H~ 161 (331)
+... .......++||||+.+ | +|.+.... .++..+..++.|++.|+.||| +.+ |+||
T Consensus 127 l~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 127 AKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HHHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred HHhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 1000 0011345799999952 4 56554322 224466789999999999999 888 9999
Q ss_pred cCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 162 DIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 162 dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 8999999999744
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.8e-18 Score=154.50 Aligned_cols=119 Identities=14% Similarity=0.164 Sum_probs=92.7
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEcc-------------------------------------cccchhhhcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVKK-------------------------------------SKNAVKLLGC 97 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~-------------------------------------~~niv~~~~~ 97 (331)
..-|.+.+.||+|++|.||+|.+.+|+.||||. |+|+.+++..
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 345899999999999999999999999999994 2355555544
Q ss_pred cccCC------cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 020102 98 CLETE------VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD 171 (331)
Q Consensus 98 ~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~ 171 (331)
..... ..+|||||++|++|..... . .....++.|++.+|.+||+.| |+||||||.|||++
T Consensus 174 gv~vp~p~~~~~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 174 GFPVPEPIAQSRHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp TCSCCCEEEEETTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCCeeeeccCceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 33222 2369999999888754211 1 123567899999999999998 99999999999998
Q ss_pred CCC----------cEEEeeccCcccc
Q 020102 172 ERY----------RAKVADFGTSKFI 187 (331)
Q Consensus 172 ~~~----------~~kl~Dfg~a~~~ 187 (331)
++| .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=1.6e-10 Score=99.70 Aligned_cols=124 Identities=18% Similarity=0.153 Sum_probs=93.1
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEcccc------------------------cchhhhcccccCCccee
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK------------------------NAVKLLGCCLETEVPLL 106 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~------------------------niv~~~~~~~~~~~~~l 106 (331)
+......|.+...++.|+.+.||++... +..+++|..+ .++++++++.+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3444567888888999999999999754 6788899532 45567777777778899
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA-------------------------------- 154 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------------------------------- 154 (331)
||||++|.++.+.+.. ......++.+++.++..||+..
T Consensus 88 v~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 9999999988764211 1123467889999999999811
Q ss_pred ------------------------CCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 155 ------------------------SSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 155 ------------------------~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876556799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.89 E-value=1.5e-09 Score=93.25 Aligned_cols=117 Identities=15% Similarity=0.133 Sum_probs=81.7
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEcccc----------------------cchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK----------------------NAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~----------------------niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
..+.+..+.+.|..+.||+....+|..+++|..+ .+.+++++...++..++||||++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 3444433334566699999977777889999422 145566766666778999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA--------------------------------------- 154 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------- 154 (331)
.++. .. ..+. ..++.+++..+..||+..
T Consensus 100 ~~l~--~~--------~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 100 QDLL--SS--------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp EETT--TS--------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cccC--cC--------cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 8773 21 1111 245677777777777643
Q ss_pred ----------------CCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 155 ----------------SSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 155 ----------------~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=2e-09 Score=95.08 Aligned_cols=163 Identities=20% Similarity=0.210 Sum_probs=103.6
Q ss_pred CceecCCCCeEEEEEEecCCcEEEEcccc------------------------cchhhhcccccCC---cceeEeecccC
Q 020102 61 NRILGQGGQGTVYKGMREDGRIIAVKKSK------------------------NAVKLLGCCLETE---VPLLVYEFISN 113 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~------------------------niv~~~~~~~~~~---~~~lv~e~~~~ 113 (331)
.+.++.|....||+.. ..+++|..+ .+.+++......+ ..++||++++|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 3568999999999862 456777422 1222333322222 35889999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA--------------------------------------- 154 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------- 154 (331)
.++.+.... .++......++.+++..++.||+..
T Consensus 101 ~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 888654332 4677777888888888888888621
Q ss_pred ----------------CCCeEEccCCCCCEEeCC--CCcEEEeeccCcccccCCCceeeeeccccCCc---cChhhh---
Q 020102 155 ----------------SSPIYHRDIKSTNILLDE--RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY---LDPEYH--- 210 (331)
Q Consensus 155 ----------------~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y---~aPE~~--- 210 (331)
...++|+|++|.||++++ .+.+.|+||+.+.... +.... .....+ ..|+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~-~~~Dl----~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD-PDNDF----ISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC-TTHHH----HTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC-hHHHH----HHHHhhccccCHHHHHHH
Confidence 124799999999999998 4567899999876421 11000 001111 233311
Q ss_pred -cCC-CC---------CCcchHHHHHHHHHHHHhCCCCCC
Q 020102 211 -QSS-QL---------TDKSDVYSFGVVLVELLTGKKPIF 239 (331)
Q Consensus 211 -~~~-~~---------~~~~DiwslG~il~el~~g~~p~~ 239 (331)
... .. ....+.|+++.+++.+.+|..+|.
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 11 112589999999999999988864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=6.8e-09 Score=93.78 Aligned_cols=119 Identities=17% Similarity=0.263 Sum_probs=87.4
Q ss_pred cCceecCCCCeEEEEEEecCCcEEEEcccc----------------------------cchhhhcccccC---CcceeEe
Q 020102 60 VNRILGQGGQGTVYKGMREDGRIIAVKKSK----------------------------NAVKLLGCCLET---EVPLLVY 108 (331)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~----------------------------niv~~~~~~~~~---~~~~lv~ 108 (331)
..+.|+.|.++.||+....+ ..+++|+.+ .+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34678999999999987654 566677543 244555555554 3478999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA---------------------------------- 154 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---------------------------------- 154 (331)
||++|..+.+.. ...++......++.+++.+|+.||+..
T Consensus 121 e~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 121 EFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp ECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999987764311 124678888889999999999999831
Q ss_pred ---------------------CCCeEEccCCCCCEEeCCCCc--EEEeeccCccc
Q 020102 155 ---------------------SSPIYHRDIKSTNILLDERYR--AKVADFGTSKF 186 (331)
Q Consensus 155 ---------------------~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~~ 186 (331)
...++|+|++|.||+++.++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134899999999999997753 68999998863
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.1e-05 Score=69.43 Aligned_cols=114 Identities=22% Similarity=0.219 Sum_probs=80.3
Q ss_pred eecCCCCe-EEEEEEec-CCcEEEEcccc---------------------cchhhhcccccCCcceeEeecccCCCHHHH
Q 020102 63 ILGQGGQG-TVYKGMRE-DGRIIAVKKSK---------------------NAVKLLGCCLETEVPLLVYEFISNGTLYQH 119 (331)
Q Consensus 63 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~---------------------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 119 (331)
.+..|..+ .||+.... ++..+++|..| .+.++++++.+.+..++|||+++|.++.+.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 34555554 68987653 46678888543 356777888888889999999999887665
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 020102 120 LHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA--------------------------------------------- 154 (331)
Q Consensus 120 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------------- 154 (331)
.... ......+..+++..+.-||+..
T Consensus 111 ~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 111 LEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 4321 1222345666777777777532
Q ss_pred ----------CCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 155 ----------SSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 155 ----------~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0137999999999999987777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=1.4e-05 Score=70.39 Aligned_cols=113 Identities=17% Similarity=0.170 Sum_probs=72.7
Q ss_pred ceecCCCCeEEEEEEecCCcEEEEcccc------------------------cchhhhcccc-cCCcceeEeecccCCCH
Q 020102 62 RILGQGGQGTVYKGMREDGRIIAVKKSK------------------------NAVKLLGCCL-ETEVPLLVYEFISNGTL 116 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~vavK~~~------------------------niv~~~~~~~-~~~~~~lv~e~~~~~~L 116 (331)
+.++.|....||+. +..+++|..+ .+.+.+.++. ..+..++|||+++|.++
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 56788888899988 4556777421 1333344442 34457899999999888
Q ss_pred HHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 020102 117 YQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA------------------------------------------ 154 (331)
Q Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------------------------------------------ 154 (331)
.+.... .++......++.++...|..||+..
T Consensus 101 ~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 101 GEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp HHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred chhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 653221 2344444445555555555555421
Q ss_pred ---------------CCCeEEccCCCCCEEeCC---CCcE-EEeeccCcc
Q 020102 155 ---------------SSPIYHRDIKSTNILLDE---RYRA-KVADFGTSK 185 (331)
Q Consensus 155 ---------------~~~i~H~dikp~Nill~~---~~~~-kl~Dfg~a~ 185 (331)
...++|+|++|.||+++. ++.+ .|+||+.+.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 224699999999999997 4554 899999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00031 Score=57.74 Aligned_cols=103 Identities=16% Similarity=0.096 Sum_probs=66.8
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
.+|.+.|..+ +.+++++++|.++.|.+.+|.-+-... . -..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc--------
Confidence 4677888764 569999999999999999887662211 1 11334457899999999888764 1110
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCC
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 237 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 237 (331)
.....+.|||... ...+.+.-|||||+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122356887653 3446788999999999998875554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00025 Score=62.85 Aligned_cols=30 Identities=30% Similarity=0.371 Sum_probs=26.8
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 459999999999999888889999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=8.4e-05 Score=66.59 Aligned_cols=30 Identities=17% Similarity=0.213 Sum_probs=25.3
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.|.||+++++..+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 448999999999999964457899999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0012 Score=60.67 Aligned_cols=30 Identities=17% Similarity=0.344 Sum_probs=26.4
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
..++|+|++|.||+++.++ +.++||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 4499999999999999876 99999998863
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0011 Score=60.34 Aligned_cols=29 Identities=24% Similarity=0.332 Sum_probs=24.9
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.|.||+++.+ .+.+.||..+.
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 349999999999999876 48999998775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0011 Score=58.22 Aligned_cols=55 Identities=15% Similarity=0.132 Sum_probs=41.2
Q ss_pred CceecCCCCeEEEEEEecCCcEEEEcccc-----------------------cchhhhcccccCCcceeEeecccCCCH
Q 020102 61 NRILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~-----------------------niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
.+.|+.|....+|+... ++..+++|..+ .+++++.++...+..++||||++|..+
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 36789999999999876 46678888532 345556666666778999999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0039 Score=55.10 Aligned_cols=31 Identities=32% Similarity=0.449 Sum_probs=26.6
Q ss_pred CCeEEccCCCCCEEeCCC----CcEEEeeccCccc
Q 020102 156 SPIYHRDIKSTNILLDER----YRAKVADFGTSKF 186 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~~ 186 (331)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 359999999999999874 6789999998763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0027 Score=54.93 Aligned_cols=34 Identities=18% Similarity=0.141 Sum_probs=28.3
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEcccc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK 89 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~ 89 (331)
....-.+.+|.|..+.||+....+|+.|.+|..|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~ 48 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALP 48 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECC
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeC
Confidence 3445567899999999999999999999999744
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.018 Score=50.39 Aligned_cols=43 Identities=16% Similarity=0.244 Sum_probs=30.9
Q ss_pred HHHHHHHHHhc----CCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 143 VAGALAYLHSA----ASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 143 i~~~l~~lH~~----~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+...+..+++. ....++|+|+.+.||++++++.+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 34445555432 12348999999999999987656899999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.09 E-value=0.024 Score=49.11 Aligned_cols=28 Identities=29% Similarity=0.274 Sum_probs=24.1
Q ss_pred CeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
.++|+|+.|.||+ ..++.+.++||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 4899999999999 556678999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.70 E-value=0.26 Score=42.86 Aligned_cols=28 Identities=21% Similarity=0.272 Sum_probs=24.4
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+++.||+++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 3479999999999999 4 89999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.67 E-value=0.21 Score=44.10 Aligned_cols=30 Identities=20% Similarity=0.352 Sum_probs=26.6
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 348999999999999988889999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.21 E-value=0.15 Score=45.36 Aligned_cols=28 Identities=25% Similarity=0.453 Sum_probs=23.8
Q ss_pred CeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
.++|+|+.+.||++++++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 489999999999998664 8999998775
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.17 E-value=0.62 Score=38.18 Aligned_cols=103 Identities=11% Similarity=0.104 Sum_probs=68.3
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA-YLHSAASSPIYHRDIKSTNILLDERYRAKV 178 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~-~lH~~~~~~i~H~dikp~Nill~~~~~~kl 178 (331)
+++.+.+.++.-+++.-...+. .++...++.++.+|+.... +++. -+|--+.|+|++++.++.+++
T Consensus 59 ~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i 125 (219)
T 4ano_A 59 SEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFF 125 (219)
T ss_dssp CSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEE
T ss_pred eCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEE
Confidence 3444555555543333334443 4788899999999988766 5554 689999999999999999999
Q ss_pred eeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchH-HHHHHHHHHHHhCCCCCC
Q 020102 179 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV-YSFGVVLVELLTGKKPIF 239 (331)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~el~~g~~p~~ 239 (331)
.-.|+-..+ +|. ..+ ..|. -.+=|++..++.++..|.
T Consensus 126 ~hRGi~~~l------------------pP~-----e~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 126 LHVGVKESL------------------PPD-----EWD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp SCCEETTTB------------------SSC-----SCC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEcCCcccC------------------CCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 888864322 221 111 1232 366778888888877763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=87.88 E-value=0.23 Score=45.84 Aligned_cols=26 Identities=12% Similarity=0.073 Sum_probs=18.3
Q ss_pred ceecCCCCeEEEEEEecC-CcEEEEcc
Q 020102 62 RILGQGGQGTVYKGMRED-GRIIAVKK 87 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~-~~~vavK~ 87 (331)
+.|+.|-...+|+....+ +..+++|.
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi 140 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRL 140 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEE
Confidence 567888889999987754 46788885
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=87.54 E-value=0.18 Score=46.20 Aligned_cols=28 Identities=4% Similarity=-0.002 Sum_probs=21.1
Q ss_pred CceecCCCCeEEEEEEecC--------CcEEEEccc
Q 020102 61 NRILGQGGQGTVYKGMRED--------GRIIAVKKS 88 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~ 88 (331)
.+.|+.|....+|+....+ +..+++|..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~ 113 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVY 113 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEe
Confidence 3567888889999997642 477888865
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=86.35 E-value=0.28 Score=44.07 Aligned_cols=29 Identities=34% Similarity=0.395 Sum_probs=25.8
Q ss_pred CeEEccCCCCCEEeCCC----CcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDER----YRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~----~~~kl~Dfg~a~ 185 (331)
.++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 48999999999999876 789999999875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.82 E-value=0.56 Score=38.31 Aligned_cols=81 Identities=10% Similarity=0.172 Sum_probs=59.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCceeeeeccccCCccChhh
Q 020102 130 PLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209 (331)
Q Consensus 130 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~ 209 (331)
..+...++.++.+|+....+++. -+|--+.|+|++++.++.+++.--|+...+ +|.
T Consensus 77 ~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~~~~~p~i~~RGik~~l------------------~P~- 132 (215)
T 4ann_A 77 SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFTRDGLPIAKTRGLQNVV------------------DPL- 132 (215)
T ss_dssp GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEECTTSCEEESCCEETTTB------------------SCC-
T ss_pred hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEcCCCCEEEEEccCccCC------------------CCC-
Confidence 46788999999999988866654 579999999999999999999887764322 111
Q ss_pred hcCCCCCCcch-HHHHHHHHHHHHhCCCCCC
Q 020102 210 HQSSQLTDKSD-VYSFGVVLVELLTGKKPIF 239 (331)
Q Consensus 210 ~~~~~~~~~~D-iwslG~il~el~~g~~p~~ 239 (331)
..+ ..| .-.+=|++..+++++.+|.
T Consensus 133 ----~~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 133 ----PVS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ----CCC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 111 123 3367788888999988874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.29 E-value=0.59 Score=42.18 Aligned_cols=28 Identities=36% Similarity=0.528 Sum_probs=24.0
Q ss_pred eEEccCCCCCEEe------CCCCcEEEeeccCcc
Q 020102 158 IYHRDIKSTNILL------DERYRAKVADFGTSK 185 (331)
Q Consensus 158 i~H~dikp~Nill------~~~~~~kl~Dfg~a~ 185 (331)
++|+|+.+.||++ +++..+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456679999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 331 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-58
Identities = 67/287 (23%), Positives = 109/287 (37%), Gaps = 48/287 (16%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-----------------------NAV 92
V + +G G GTVYKG + + N +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
+G ++ +V ++ +LY HLH E + IA + A + YLH+
Sbjct: 68 LFMGYSTAPQL-AIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLDPEY-- 209
I HRD+KS NI L E K+ DFG + + +H ++ G+ ++ PE
Sbjct: 123 K---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 210 -HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
+ + +SDVY+FG+VL EL+TG+ P + N Q + + + L L
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIFMVGRGYLSPDL 231
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
K A L CL +RP ++ + + S
Sbjct: 232 SKVRSNCPK-----AMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-57
Identities = 56/283 (19%), Positives = 101/283 (35%), Gaps = 46/283 (16%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK----------------------NAVK 93
+ LG G G V+ G +AVK K V+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
L + + ++ E++ NG+L L LT L +A ++A +A++
Sbjct: 73 LYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
HRD+++ NIL+ + K+ADFG ++ I ++ + + PE
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
T KSDV+SFG++L E++T + + + V + + D
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPDNCP 236
Query: 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
+ L C + RPT + + L ++
Sbjct: 237 E--------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-55
Identities = 64/306 (20%), Positives = 113/306 (36%), Gaps = 62/306 (20%)
Query: 51 LDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK---------------------- 87
++ + F LG G G V+K + G ++A K
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 88 --SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
S V G + E + G+L Q L + ++ +++ V
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIK 115
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
L YL I HRD+K +NIL++ R K+ DFG S + + GT Y+
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYM 170
Query: 206 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ------------------- 246
PE Q + + +SD++S G+ LVE+ G+ P + +
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP-IPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 247 ---ENVSLAAYFVHSMRKNRLYDILDDQVM----KLGKKNQIMAFANLAERCLDLNGKKR 299
L++Y + S ++++LD V KL + F + +CL N +R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289
Query: 300 PTMEEV 305
++++
Sbjct: 290 ADLKQL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-55
Identities = 64/280 (22%), Positives = 113/280 (40%), Gaps = 50/280 (17%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK---------------------NAVKL 94
+ + +G+G G V G G +AVK K N V+L
Sbjct: 7 KELKLLQTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 95 LGCCLETEVPL-LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
LG +E + L +V E+++ G+L +L R L + L+ + +V A+ YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG- 121
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
+ HRD+ + N+L+ E AKV+DFG +K + Q + + PE +
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREK 175
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
+ + KSDV+SFG++L E+ + + + V + K D D
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAPDGCPP 227
Query: 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
+ + + C L+ RP+ ++ +L I+
Sbjct: 228 AV---------YEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-55
Identities = 62/282 (21%), Positives = 107/282 (37%), Gaps = 46/282 (16%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKK----------------------SKNAVK 93
+ + +G G G V+ G + +A+K V+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
L G CLE LV+EF+ +G L +L Q E L + +V +AYL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEE- 119
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
+ + HRD+ + N L+ E KV+DFG ++F+ DQ +T + + PE S
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
+ + KSDV+SFGV++ E+ + K + + S+ + + +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----------------VVEDISTGFR 220
Query: 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315
+ + C + RP + +L I S
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 2e-53
Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 48/286 (16%)
Query: 50 ELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK--------------------- 87
E+++ + LG G G VY+G+ ++ +AVK
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 70
Query: 88 -SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGA 146
N V+LLG C ++ EF++ G L +L + ++ + L +AT+++ A
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSA 127
Query: 147 LAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+ YL HRD+ + N L+ E + KVADFG S+ + D + +
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266
PE ++ + KSDV++FGV+L E+ T + + SQ +Y+
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYE 227
Query: 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
+L+ + L C N RP+ E+ +
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-53
Identities = 60/276 (21%), Positives = 102/276 (36%), Gaps = 46/276 (16%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK----------------------NAVK 93
+ LGQG G V+ G +A+K K V+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
L E + +V E++S G+L L L + +A ++A +AY+
Sbjct: 77 LYAVVSEEPI-YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER- 131
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
HRD+++ NIL+ E KVADFG ++ I ++ + + PE
Sbjct: 132 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
+ T KSDV+SFG++L EL T + + + V + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCPPECP 240
Query: 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309
+ + +L +C ++RPT E + L
Sbjct: 241 E--------SLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 6e-53
Identities = 68/314 (21%), Positives = 113/314 (35%), Gaps = 70/314 (22%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYKGM------REDGRIIAVKKSK------------- 89
L+ N+ R +G+G G V++ E ++AVK K
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 90 -----------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDR--------------- 123
N VKLLG C + L++E+++ G L + L
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 124 ----LQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179
PL+ +L IA +VA +AYL HRD+ + N L+ E K+A
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182
Query: 180 DFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 238
DFG S+ I D ++ PE ++ T +SDV+++GVVL E+ +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 239 FSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKK 298
+ + +Y + D ++ +N + NL C
Sbjct: 243 YYGMAHEE----------------VIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPAD 285
Query: 299 RPTMEEVSMELNGI 312
RP+ + L +
Sbjct: 286 RPSFCSIHRILQRM 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-52
Identities = 55/272 (20%), Positives = 104/272 (38%), Gaps = 46/272 (16%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK----------------------NAVK 93
+ LG G G V G +A+K K V+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 94 LLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSA 153
L G C + ++ E+++NG L +L + + L + +V A+ YL S
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES- 118
Query: 154 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 213
HRD+ + N L++++ KV+DFG S+++ D+ + + + PE S
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 214 QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273
+ + KSD+++FGV++ E+ + K + S+ A + +R R + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIAQGLRLYRPHLASEK--- 229
Query: 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ C +RPT + +
Sbjct: 230 ----------VYTIMYSCWHEKADERPTFKIL 251
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 4e-52
Identities = 67/322 (20%), Positives = 116/322 (36%), Gaps = 64/322 (19%)
Query: 40 IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGM------REDGRIIAVKKSK---- 89
ID +L + + N + + LG G G V + + +AVK K
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 90 ---------------------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDR----- 123
N V LLG C L++ E+ G L L +
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 124 --------LQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYR 175
+++ E L E L + +VA +A+L S HRD+ + NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183
Query: 176 AKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG 234
K+ DFG ++ I D + V + ++ PE + T +SDV+S+G+ L EL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 235 KKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDL 294
+ + Y ++ + L ++ ++ + C D
Sbjct: 244 GSSPYPGMPVDSK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287
Query: 295 NGKKRPTMEEVSMELNGIRGSS 316
+ KRPT +++ + S
Sbjct: 288 DPLKRPTFKQIVQLIEKQISES 309
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-51
Identities = 60/278 (21%), Positives = 102/278 (36%), Gaps = 50/278 (17%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVKK-------------------------SKNA 91
+ V +G G G K + DG+I+ K+ N
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 92 VKLLGCCLETE--VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
V+ ++ +V E+ G L + + ++ L E LR+ T++ AL
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKE 124
Query: 150 LH--SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
H S + HRD+K N+ LD + K+ DFG ++ + D + GT Y+ P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267
E +KSD++S G +L EL P F +K I
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPP-----------------FTAFSQKELAGKI 226
Query: 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + ++ + R L+L RP++EE+
Sbjct: 227 REGKFRRI-PYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-51
Identities = 59/295 (20%), Positives = 106/295 (35%), Gaps = 50/295 (16%)
Query: 62 RILGQGGQGTVYKGMREDGRIIAVKK----------------------SKNAVKLLGCCL 99
+G+G G V++G + G +AVK +N + +
Sbjct: 9 ESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 100 ETE----VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA- 154
+ LV ++ +G+L+ +L+ +T E +++A A LA+LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 155 ----SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLDP 207
I HRD+KS NIL+ + +AD G + + GT Y+ P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 208 EYHQSS------QLTDKSDVYSFGVVLVELLTGKKP--IFSAGNTSQENVSLAAYFVHSM 259
E S + ++D+Y+ G+V E+ I ++ + V M
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 260 RKNRLYDILDDQVMKLGKKNQIM-AFANLAERCLDLNGKKRPTMEEVSMELNGIR 313
RK L + + + + A + C NG R T + L+ +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 3e-50
Identities = 56/308 (18%), Positives = 110/308 (35%), Gaps = 65/308 (21%)
Query: 46 FSSKELDKATNHFN---------VNRILGQGGQGTVYKGMR----EDGRIIAVKKSK--- 89
F+ ++ ++A F + +++G G G V G + +A+K K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 90 ---------------------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQE 128
N + L G ++ +++ EF+ NG+L L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123
Query: 129 FPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188
T + + +A + YL HRD+ + NIL++ KV+DFG S+F+
Sbjct: 124 -QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 189 MDQTHVTTK----IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244
D + T + + PE Q + T SDV+S+G+V+ E+++ + +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 245 SQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ + ++ + A L C + RP +
Sbjct: 240 QD-----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 305 VSMELNGI 312
+ L+ +
Sbjct: 283 IVNTLDKM 290
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-50
Identities = 71/277 (25%), Positives = 105/277 (37%), Gaps = 57/277 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK--------------------------S 88
F + R LG+G G VY ++ I+A+K
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
N ++L G + L+ E+ GT+Y+ L + + TE+A AL+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALS 120
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
Y HS + HRDIK N+LL K+ADFG S + + GT YL PE
Sbjct: 121 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPE 174
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
+ +K D++S GV+ E L GK P F A + Y S + D +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQE------TYKRISRVEFTFPDFV 227
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ +L R L N +RP + EV
Sbjct: 228 TEG------------ARDLISRLLKHNPSQRPMLREV 252
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 1e-49
Identities = 72/295 (24%), Positives = 107/295 (36%), Gaps = 63/295 (21%)
Query: 41 DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK------------ 87
D +LF + +K F+ R +G G G VY + ++A+KK
Sbjct: 3 DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 88 --------------SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTW 133
N ++ GC L LV E+ + PL
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQE 114
Query: 134 EMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193
+ LAYLHS + HRD+K+ NILL E K+ DFG++ +A +
Sbjct: 115 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 171
Query: 194 VTTKIQGTFGYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS 250
V GT ++ PE Q K DV+S G+ +EL K P+F+ S
Sbjct: 172 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---- 222
Query: 251 LAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
LY I ++ L + F N + CL + RPT E +
Sbjct: 223 -------------LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-49
Identities = 57/305 (18%), Positives = 100/305 (32%), Gaps = 69/305 (22%)
Query: 56 NHFNVNRILGQGGQGTVYKGMRED------GRIIAVKKSK-------------------- 89
+ ++LG G G V +AVK K
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 90 -----NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQN------------------ 126
N V LLG C + L++E+ G L +L + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 127 QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186
LT+E L A +VA + +L HRD+ + N+L+ K+ DFG ++
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 187 IAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245
I D +V + ++ PE T KSDV+S+G++L E+ + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
Y ++ + + + C + +KRP+ +
Sbjct: 274 AN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 306 SMELN 310
+ L
Sbjct: 318 TSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 6e-49
Identities = 57/296 (19%), Positives = 116/296 (39%), Gaps = 57/296 (19%)
Query: 48 SKELDKATNHFNVNRILGQGGQGTVYKGMREDG-----RIIAVKKSK------------- 89
+ E+ + +++G G G VYKGM + +A+K K
Sbjct: 1 TTEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 58
Query: 90 -----------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLR 138
N ++L G + + +++ E++ NG L + L ++ + + +
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVG 114
Query: 139 IATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTT 196
+ +A + YL + HRD+ + NIL++ KV+DFG S+ + D T+ T+
Sbjct: 115 MLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256
+ + PE + T SDV+SFG+V+ E++T + +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------------- 214
Query: 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
+ + + ++D + A L +C +RP ++ L+ +
Sbjct: 215 WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 8e-49
Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 52/287 (18%)
Query: 44 KLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK--------------- 87
KL S + + +GQG GTVY M G+ +A+++
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 88 --------SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRI 139
+ N V L L + +V E+++ G+L + + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAV 121
Query: 140 ATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 199
E AL +LHS + HRDIKS NILL K+ DFG I +Q+ +T +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177
Query: 200 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259
GT ++ PE K D++S G++ +E++ G+ P + N +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-YLNENPLRA------------ 224
Query: 260 RKNRLYDILDDQVMKLGKKNQI-MAFANLAERCLDLNGKKRPTMEEV 305
LY I + +L ++ F + RCLD++ +KR + +E+
Sbjct: 225 ----LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 9e-49
Identities = 52/280 (18%), Positives = 104/280 (37%), Gaps = 59/280 (21%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------NA 91
+ +G+G TVYKG+ E +A + + N
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 92 VKLLGCCLET----EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
V+ T + +LV E +++GTL +L + ++ ++ L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGL 125
Query: 148 AYLHSAASSPIYHRDIKSTNILL-DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 206
+LH+ + PI HRD+K NI + K+ D G + + + GT ++
Sbjct: 126 QFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMA 181
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266
PE ++ + + DVY+FG+ ++E+ T + P + ++Y
Sbjct: 182 PEMYE-EKYDESVDVYAFGMCMLEMATSEYP-----------------YSECQNAAQIYR 223
Query: 267 -ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ K I + E C+ N +R +++++
Sbjct: 224 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 9e-49
Identities = 70/296 (23%), Positives = 117/296 (39%), Gaps = 56/296 (18%)
Query: 59 NVNRILGQGGQGTVYKGMRED----GRIIAVKK------------------------SKN 90
+ N ++G+G G VY G D AVK N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 91 AVKLLGCCLETE-VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
+ LLG CL +E PL+V ++ +G L + + T + + +VA + +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKF 145
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTFGYLD 206
L S HRD+ + N +LDE++ KVADFG ++ + D H T + ++
Sbjct: 146 LA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 207 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266
E Q+ + T KSDV+SFGV+L EL+T P + NT + Y + R +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRLLQPEY 258
Query: 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAM 322
D + +C + RP+ E+ ++ I + + +
Sbjct: 259 CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-48
Identities = 61/280 (21%), Positives = 106/280 (37%), Gaps = 56/280 (20%)
Query: 61 NRILGQGGQGTVYKGMRED---GRIIAVKKSK-------------------------NAV 92
++ LG G GTV KG + + +AVK K V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
+++G C E E +LV E G L ++L + + + + +V+ + YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE- 124
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ--GTFGYLDPEYH 210
S HRD+ + N+LL ++ AK++DFG SK + D+ + + + PE
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 211 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270
+ + KSDV+SFGV++ E + + + S+ + A R +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGERMGCPAGCPRE 238
Query: 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310
+L C + + RP V + L
Sbjct: 239 -------------MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 62/277 (22%), Positives = 105/277 (37%), Gaps = 51/277 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK------------------------SKN 90
+++ + LG+G G V + R +AVK +N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
VK G E + L E+ S G L+ + + R ++ + YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYL 119
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEY 209
H I HRDIK N+LLDER K++DFG + ++ + K+ GT Y+ PE
Sbjct: 120 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 210 HQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
+ + + DV+S G+VL +L G+ P ++ QE ++ + Y
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------YSDWKEKKTYLNP 228
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
++ L + L N R T+ ++
Sbjct: 229 WKKIDSAPL--------ALLHKILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-48
Identities = 64/315 (20%), Positives = 114/315 (36%), Gaps = 63/315 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDG---RIIAVKKSK----------------------- 89
N ++G+G G V K + A+K+ K
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 90 --NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFP-----------LTWEMR 136
N + LLG C L E+ +G L L + P L+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 137 LRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 196
L A +VA + YL HRD+ + NIL+ E Y AK+ADFG S+ + T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKT 184
Query: 197 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256
+ ++ E S T SDV+S+GV+L E+++ + ++ L
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP 240
Query: 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316
R + + D+ +L +C +RP+ ++ + LN +
Sbjct: 241 QGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLNRML--E 285
Query: 317 RKKRAMFSKIIKRLS 331
+K + + + ++ +
Sbjct: 286 ERKTYVNTTLYEKFT 300
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-48
Identities = 61/301 (20%), Positives = 112/301 (37%), Gaps = 55/301 (18%)
Query: 49 KELDKATNHFNV-NRILGQGGQGTVYKGM---REDGRIIAVKKSK--------------- 89
K+L ++ + + LG G G+V +G+ R+ +A+K K
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 90 ---------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIA 140
V+L+G C + E +LV E G L++ L + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELL 115
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--I 198
+V+ + YL HRD+ + N+LL R+ AK++DFG SK + D ++ T +
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 199 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258
+ + PE + + +SDV+S+GV + E L+ + + + + A+
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAFIEQG 228
Query: 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRK 318
R + + L C + RP V + S
Sbjct: 229 KRMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
Query: 319 K 319
K
Sbjct: 276 K 276
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 5e-48
Identities = 66/288 (22%), Positives = 106/288 (36%), Gaps = 56/288 (19%)
Query: 48 SKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK-------------------- 86
+++L+ + + + LG G G VYK +E + A K
Sbjct: 5 TRDLN-PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 87 ---KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEV 143
N VKLL ++ EF + G + + + E PLT + +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQT 119
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
AL YLH I HRD+K+ NIL K+ADFG S + I GT
Sbjct: 120 LDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175
Query: 204 YLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHS 258
++ PE D K+DV+S G+ L+E+ + P N +
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRV----------- 223
Query: 259 MRKNRLYDILDDQVMKLGKKNQI-MAFANLAERCLDLNGKKRPTMEEV 305
L I + L + ++ F + ++CL+ N R T ++
Sbjct: 224 -----LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (405), Expect = 5e-47
Identities = 58/301 (19%), Positives = 109/301 (36%), Gaps = 54/301 (17%)
Query: 35 YDGSVIDRCKLFSSKEL----DKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK-- 87
YD V D K + + + D +H++++ LG G G V++ R G A K
Sbjct: 1 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 60
Query: 88 ---------------------SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQN 126
V L + +++YEF+S G L++ + D
Sbjct: 61 TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN- 119
Query: 127 QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL--DERYRAKVADFGTS 184
++ + + +V L ++H H D+K NI+ K+ DFG +
Sbjct: 120 ---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
Query: 185 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNT 244
+ Q+ T GT + PE + + +D++S GV+ LL+G P F N
Sbjct: 174 AHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-FGGEND 230
Query: 245 SQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
+ K+ +++ D + + + + L + R T+ +
Sbjct: 231 DE---------TLRNVKSCDWNMDDSAFSGISE-----DGKDFIRKLLLADPNTRMTIHQ 276
Query: 305 V 305
Sbjct: 277 A 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-46
Identities = 59/285 (20%), Positives = 106/285 (37%), Gaps = 53/285 (18%)
Query: 56 NHFNVNRILGQGGQGTVYKGM----REDGRIIAVKKSK---------------------- 89
+ R +G+G G V++G+ +A+K K
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 90 --NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
+ VKL+G E V ++ E + G L L R ++ L + A +++ AL
Sbjct: 67 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTAL 121
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
AYL S HRDI + N+L+ K+ DFG S+++ + +K + ++ P
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267
E + T SDV+ FGV + E+L F + + + + +
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIENGERLPMPPN 233
Query: 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
+L +C + +RP E+ +L+ I
Sbjct: 234 CPPT------------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-45
Identities = 55/295 (18%), Positives = 111/295 (37%), Gaps = 55/295 (18%)
Query: 58 FNVNRILGQGGQGTVYKGM-----REDGRIIAVKKSK----------------------- 89
F ++LG G GTVYKG+ + +A+K+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 90 -NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
+ +LLG CL + V L+ + + G L ++ + N + L ++A +
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMN 125
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDP 207
YL + HRD+ + N+L+ K+ DFG +K + ++ + + ++
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267
E T +SDV+S+GV + EL+T + S+ + I
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISSI 225
Query: 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAM 322
L+ + + +C ++ RP E+ +E + + ++ +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-45
Identities = 66/301 (21%), Positives = 108/301 (35%), Gaps = 63/301 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKGM------REDGRIIAVKKSK-------------------- 89
+ + + LG+G G V + R +AVK K
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 90 -----NAVKLLGCCLETEVPL-LVYEFISNGTLYQHLHDRLQN-----------QEFPLT 132
N V LLG C + PL ++ EF G L +L + + LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 133 WEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192
E + + +VA + +L S HRD+ + NILL E+ K+ DFG ++ I D
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 193 HV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSL 251
+V + ++ PE T +SDV+SFGV+L E+ + + +E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 245
Query: 252 AAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNG 311
F +++ D ++ C +RPT E+ L
Sbjct: 246 ---FCRRLKEGTRMRAPDYTTPEM---------YQTMLDCWHGEPSQRPTFSELVEHLGN 293
Query: 312 I 312
+
Sbjct: 294 L 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-44
Identities = 66/293 (22%), Positives = 113/293 (38%), Gaps = 56/293 (19%)
Query: 56 NHFNVNRILGQGGQGTVYKGM------REDGRIIAVKKSK-------------------- 89
++R LGQG G VY+G+ E +A+K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 90 ----NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEF-----PLTWEMRLRIA 140
+ V+LLG + + L++ E ++ G L +L P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 141 TEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQ 199
E+A +AYL++ + HRD+ + N ++ E + K+ DFG ++ I D K
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 200 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259
++ PE + T SDV+SFGVVL E+ T + + + Q + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VLRFV 248
Query: 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312
+ L D D+ L L C N K RP+ E+ +
Sbjct: 249 MEGGLLDKPDNCPDML---------FELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 7e-44
Identities = 64/302 (21%), Positives = 108/302 (35%), Gaps = 65/302 (21%)
Query: 56 NHFNVNRILGQGGQGTVYKGM--------REDGRIIAVKKSK------------------ 89
+ + + LG+G G V +AVK K
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 90 -------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDR-----------LQNQEFPL 131
N + LLG C + ++ E+ S G L ++L R N E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 132 TWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191
+ + + A +VA + YL S HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 192 THVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS 250
+ T + ++ PE T +SDV+SFGV+L E+ T + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 251 LAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310
L+ +L + N + C +RPT +++ +L+
Sbjct: 246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 311 GI 312
I
Sbjct: 293 RI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-43
Identities = 64/281 (22%), Positives = 96/281 (34%), Gaps = 55/281 (19%)
Query: 53 KATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK------------------------ 87
K F +ILG+G TV R A+K
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 88 --SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
VKL + E + NG L +++ E+
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVS 119
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD-QTHVTTKIQGTFGY 204
AL YLH I HRD+K NILL+E ++ DFGT+K ++ + + GT Y
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 205 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264
+ PE SD+++ G ++ +L+ G P F AGN +
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYL---------IFQKIIKLE 226
Query: 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
YD + +L E+ L L+ KR EE+
Sbjct: 227 YDFPEK---------FFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (374), Expect = 3e-43
Identities = 61/289 (21%), Positives = 100/289 (34%), Gaps = 65/289 (22%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------- 89
++ ILG+G V + + + + AVK
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 90 -------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATE 142
N ++L LV++ + G L+ +L ++ L+ + +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRA 118
Query: 143 VAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 202
+ + LH I HRD+K NILLD+ K+ DFG S + D ++ GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTP 173
Query: 203 GYLDPEYHQSSQL------TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256
YL PE + S + D++S GV++ LL G P F +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQML---------M 223
Query: 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
M + Y + +L R L + +KR T EE
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSD-----TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-43
Identities = 59/286 (20%), Positives = 97/286 (33%), Gaps = 56/286 (19%)
Query: 56 NHFNVNRILGQGGQGTVYKGMRE----DGRIIAVKK------------------------ 87
+ LG G G V +G + +AVK
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 88 --SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
+N ++L G L + +V E G+L L + R A +VA
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAE 122
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--VTTKIQGTFG 203
+ YL S HRD+ + N+LL R K+ DFG + + + H + + F
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263
+ PE ++ + SD + FGV L E+ T + + N SQ
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---------------- 223
Query: 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMEL 309
L+ I + ++ N+ +C + RPT + L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (376), Expect = 1e-42
Identities = 54/304 (17%), Positives = 112/304 (36%), Gaps = 54/304 (17%)
Query: 32 LNSYDGSVIDRCKLFSSKELDKAT----NHFNVNRILGQGGQGTVYKGM-REDGRIIAVK 86
+N YD D K + + ++ +++++ LG G G V++ + + GR+ K
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60
Query: 87 K-----------------------SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDR 123
+ L + +L+ EF+S G L+ DR
Sbjct: 61 FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF----DR 116
Query: 124 LQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADF 181
+ +++ ++ + + L ++H I H DIK NI+ + + K+ DF
Sbjct: 117 IAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDF 173
Query: 182 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSA 241
G + + D+ T T + PE + +D+++ GV+ LL+G P F+
Sbjct: 174 GLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-FAG 230
Query: 242 GNTSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT 301
+ + K ++ +D + + + L +KR T
Sbjct: 231 EDDLE---------TLQNVKRCDWEFDEDAFSSVSP-----EAKDFIKNLLQKEPRKRLT 276
Query: 302 MEEV 305
+ +
Sbjct: 277 VHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-42
Identities = 57/282 (20%), Positives = 99/282 (35%), Gaps = 52/282 (18%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK------------------ 89
KEL + + LG+G G V++ + + K K
Sbjct: 1 KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNI 57
Query: 90 ----NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
N + L E ++++EFIS +++ ++ F L + +V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCE 113
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
AL +LHS I H DI+ NI+ K+ +FG ++ +
Sbjct: 114 ALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPE 168
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263
Y PE HQ ++ +D++S G ++ LL+G P F A Q + N
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-FLAETNQQ---------IIENIMNA 218
Query: 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
Y ++ ++ + +R L K R T E
Sbjct: 219 EYTFDEEAFKEISI-----EAMDFVDRLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (360), Expect = 4e-41
Identities = 66/295 (22%), Positives = 110/295 (37%), Gaps = 61/295 (20%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK-------------------------- 87
++ + + ILG GG V+ R +AVK
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 88 SKNAVKLLGCCLETE----VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEV 143
V + +P +V E++ TL +H E P+T + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 120
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGT 201
AL + H I HRD+K NI++ KV DFG ++ IA V T + GT
Sbjct: 121 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
YL PE + + +SDVYS G VL E+LTG+ P F+ +
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSV-------------- 222
Query: 262 NRLYDILDDQVMKLGKKNQIM--AFANLAERCLDLNGKKRP-TMEEVSMELNGIR 313
Y + + + +++ + + + L N + R T E+ +L +
Sbjct: 223 --AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 5e-41
Identities = 55/307 (17%), Positives = 106/307 (34%), Gaps = 48/307 (15%)
Query: 49 KELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK--------------------- 86
K+ + + ++ +LG G V + +++A+K
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 87 ---KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEV 143
K N V L L+ + +S G L+ + ++ T R+ +V
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQV 116
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
A+ YLH + LDE + ++DFG SK D V + GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPG 174
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263
Y+ PE + D +S GV+ LL G P F N ++ +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-FYDENDAK---------LFEQILKA 224
Query: 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRAMF 323
Y+ + + + ++ + +KR T E+ ++ I G + + +
Sbjct: 225 EYEFDSPYWDDISD-----SAKDFIRHLMEKDPEKRFTCEQA-LQHPWIAGDTALDKNIH 278
Query: 324 SKIIKRL 330
+ +++
Sbjct: 279 QSVSEQI 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-40
Identities = 54/293 (18%), Positives = 100/293 (34%), Gaps = 46/293 (15%)
Query: 53 KATNHFNVNRILGQGGQGTVYKG--MREDGRIIAVKKSK--------------------- 89
+A + +G+G G V+K ++ GR +A+K+ +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 90 -------NAVKLLGCCLETEVPLLVYEFISNGTLYQ-HLHDRLQNQEFPLTWEMRLRIAT 141
N V+L C + + + Q + E + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 201
++ L +LHS + HRD+K NIL+ + K+ADFG ++ + + T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VT 178
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
Y PE S D++S G + E+ KP+F + + + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 262 NRLYDILDDQVMKLGKKNQIM---------AFANLAERCLDLNGKKRPTMEEV 305
+ D+ + K Q + +L +CL N KR +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-39
Identities = 57/277 (20%), Positives = 94/277 (33%), Gaps = 56/277 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK--------------------------- 87
F ++++LG+G G V+ ++ + A+K
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 88 SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGAL 147
+ E V E+++ G L H+ A E+ L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 116
Query: 148 AYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 207
+LHS I +RD+K NILLD+ K+ADFG K + T GT Y+ P
Sbjct: 117 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAP 172
Query: 208 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267
E + D +SFGV+L E+L G+ P F + + + M
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEE------LFHSIRMDNPFYPRW 225
Query: 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
L+ + +L + +KR +
Sbjct: 226 LEKE------------AKDLLVKLFVREPEKRLGVRG 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-38
Identities = 54/273 (19%), Positives = 97/273 (35%), Gaps = 46/273 (16%)
Query: 60 VNRILGQGGQGTVYKGM-REDGRIIAVKK-------------------SKNAVKLLGCC- 98
+++LG G G V + + A+K + V+++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 99 ---LETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS 155
+ L+V E + G L+ + DR T I + A+ YLHS
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHS--- 129
Query: 156 SPIYHRDIKSTNILLDERY---RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
I HRD+K N+L + K+ DFG +K + T T Y+ PE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187
Query: 213 SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272
+ D++S GV++ LL G P +S + + + + + Y+ + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYS------NHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
++ + L L +R T+ E
Sbjct: 242 SEVSE-----EVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 136 bits (344), Expect = 4e-38
Identities = 57/284 (20%), Positives = 100/284 (35%), Gaps = 58/284 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK--------------------------- 87
N F+V+RI+G+GG G VY + G++ A+K
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 88 --SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAG 145
V + + + + ++ G L+ HL + A E+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 118
Query: 146 ALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 205
L ++H+ + +RD+K NILLDE +++D G + + + H + GT GY+
Sbjct: 119 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 172
Query: 206 DPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264
PE Q D +D +S G +L +LL G P + + + L
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVEL 228
Query: 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308
D + +L E L + +R +
Sbjct: 229 PDSFSPE------------LRSLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-37
Identities = 59/285 (20%), Positives = 97/285 (34%), Gaps = 43/285 (15%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVKK-------------------SKNAVKLLGC 97
+ +++G G G VY+ + G ++A+KK N V+L
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 98 CLETEVP------LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
+ LV +++ H Q L ++ +LAY+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRSLAYIH 139
Query: 152 SAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 210
S I HRDIK N+LLD + K+ DFG++K + + +V+ I +
Sbjct: 140 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIF 195
Query: 211 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ----------ENVSLAAYFVHSMR 260
++ T DV+S G VL ELL G+ Q +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + I K+ + L R L+ R T E
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-37
Identities = 55/291 (18%), Positives = 106/291 (36%), Gaps = 45/291 (15%)
Query: 55 TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK------------------------SK 89
+ +G+G G V + +A+KK +
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N + + + + ++ + L+ L+ Q L+ + ++ L Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKY 124
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT--TKIQGTFGYLDP 207
+HSA + HRD+K +N+LL+ K+ DFG ++ D H T+ T Y P
Sbjct: 125 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 208 EYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQEN--VSLAAYFVHSMRKNRL 264
E +S+ KS D++S G +L E+L+ + Q N + + +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 265 YDILDDQVMKLGKKNQIM----------AFANLAERCLDLNGKKRPTMEEV 305
+ ++ L KN++ +L ++ L N KR +E+
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 130 bits (327), Expect = 3e-36
Identities = 53/285 (18%), Positives = 96/285 (33%), Gaps = 43/285 (15%)
Query: 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK-------------------------N 90
++ +G+G G VYK G A+KK + N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
VKL + +LV+E L Q L L E L ++ +AY
Sbjct: 62 IVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 210
H + HRD+K N+L++ K+ADFG ++ + T +I +
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 211 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ----------ENVSLAAYFVHSMR 260
S + + D++S G + E++ G Q N +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + + + K + +L + L L+ +R T ++
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-36
Identities = 62/284 (21%), Positives = 100/284 (35%), Gaps = 69/284 (24%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK------------------------- 89
+ + V +LG GG G+VY G+ D +A+K +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 90 ------NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEV 143
++LL + +L+ E + L E+ +V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQV 119
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 202
A+ + H + + HRDIK NIL+D R K+ DFG+ + + V T GT
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 173
Query: 203 GYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
Y PE+ + + +S V+S G++L +++ G P F H
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----------------FEHDEEI 216
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
R +V +L CL L RPT EE+
Sbjct: 217 IRGQVFFRQRVSS--------ECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-36
Identities = 57/283 (20%), Positives = 90/283 (31%), Gaps = 48/283 (16%)
Query: 62 RILGQGGQGTVYKGM-REDGRIIAVKK----------------------------SKNAV 92
LG+G TVYK + +I+A+KK N +
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
LL LV++F+ + LT L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH- 117
Query: 153 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 212
I HRD+K N+LLDE K+ADFG +K T ++ T Y PE
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFG 174
Query: 213 SQLTD-KSDVYSFGVVLVELLTGKKPIFSAGNTSQ-ENVSLAAYFVHSMRKNRLYDILDD 270
+++ D+++ G +L ELL + + Q + + + + D
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 271 QVMKLGKKNQIM--------AFANLAERCLDLNGKKRPTMEEV 305
K + +L + N R T +
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (327), Expect = 6e-36
Identities = 62/280 (22%), Positives = 101/280 (36%), Gaps = 58/280 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK--------------------------S 88
F + R LG G G V+ R +GR A+K
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
+++ G + + ++ ++I G L+ L + A EV AL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALE 118
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
YLHS I +RD+K NILLD+ K+ DFG +K++ + GT Y+ PE
Sbjct: 119 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPE 171
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
+ D +SFG+++ E+L G P F NT + Y + R
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMK------TYEKILNAELRFPPFF 224
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308
++ +L R + + +R + E
Sbjct: 225 NED------------VKDLLSRLITRDLSQRLGNLQNGTE 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (324), Expect = 8e-36
Identities = 47/287 (16%), Positives = 86/287 (29%), Gaps = 51/287 (17%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK----------------------NAV 92
N + + R +G G G +Y G G +A+K
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
+ C E + ++V E + + + L +A ++ + Y+HS
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS 121
Query: 153 AASSPIYHRDIKSTNIL---LDERYRAKVADFGTSKFIAMDQTHV------TTKIQGTFG 203
HRD+K N L + + DFG +K +TH + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 204 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR 263
Y H + + + D+ S G VL+ G P ++ + + +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK------RQKYERISEKK 232
Query: 264 LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310
+ ++ FA C L +P +
Sbjct: 233 MSTPIEVLCKGYPS-----EFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-35
Identities = 51/287 (17%), Positives = 97/287 (33%), Gaps = 47/287 (16%)
Query: 57 HFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK-------------------------N 90
+F +G+G G VYK + G ++A+KK + N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 91 AVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYL 150
VKLL LV+EF+ + + + ++ LA+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQD----LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 151 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 210
HS + HRD+K N+L++ K+ADFG ++ + T ++ +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 211 QSSQLTDKSDVYSFGVVLVELLTGKKP------------IFSAGNTSQENVSLAAYFVHS 258
+ D++S G + E++T + IF T E V +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 259 MRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + D + ++ +L + L + KR + +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDE--DGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-35
Identities = 47/287 (16%), Positives = 95/287 (33%), Gaps = 45/287 (15%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK-------------------------SK 89
+ +G+G GTV+K RE I+A+K+ K
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 90 NAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAY 149
N V+L + LV+EF E+ ++ L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGF 116
Query: 150 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 209
HS + HRD+K N+L++ K+A+FG ++ + + ++ +
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 210 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ--ENVSLAAYFVHSMRKNRLYDI 267
+ + D++S G + EL +P+F + + + + + +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 268 LDDQVMKLGKKNQIM---------AFANLAERCLDLNGKKRPTMEEV 305
D + + + +L + L N +R + EE
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-35
Identities = 65/295 (22%), Positives = 108/295 (36%), Gaps = 62/295 (21%)
Query: 45 LFSSKELDKATNHFNVNRILGQGGQGTVYKGM-REDGRIIAVK----------------- 86
+F + +D ++++ LG G V K + G A K
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 87 ------------KSKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWE 134
+ N + L +L+ E ++ G L+ L ++ LT E
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEE 113
Query: 135 MRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAMD 190
++ + YLHS I H D+K NI+L +R R K+ DFG + I D
Sbjct: 114 EATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 168
Query: 191 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS 250
+ I GT ++ PE L ++D++S GV+ LL+G P G+T QE
Sbjct: 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQE--- 223
Query: 251 LAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ Y+ D+ + R L + KKR T+++
Sbjct: 224 -----TLANVSAVNYEFEDEYFSNTSA-----LAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (311), Expect = 7e-34
Identities = 48/309 (15%), Positives = 93/309 (30%), Gaps = 67/309 (21%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK----------------------NAV 92
H+ V R +G+G G +++G + + +A+K
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 93 KLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS 152
+ E +LV + + D L + + A ++ + +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSL-----EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 153 AASSPIYHRDIKSTNILLDERYR-----AKVADFGTSKFIAMDQTHV------TTKIQGT 201
+ +RDIK N L+ V DFG KF T + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 202 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
Y+ H + + + D+ + G V + L G P + + + K
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ-----GLKAATNKQKYERIGEK 231
Query: 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSRKKRA 321
+ + + F +L P + + +
Sbjct: 232 KQSTPLREL------CAGFPEEFYKYMHYARNLAFDATPDYDYL--------------QG 271
Query: 322 MFSKIIKRL 330
+FSK+++RL
Sbjct: 272 LFSKVLERL 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-34
Identities = 57/302 (18%), Positives = 105/302 (34%), Gaps = 49/302 (16%)
Query: 46 FSSKELDKAT----NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK------------- 87
F +E+ K + + +G G G V + G +A+KK
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 88 ------------SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEM 135
+N + LL E +F +L E L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDR 122
Query: 136 RLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 195
+ ++ L Y+H+A I HRD+K N+ ++E K+ DFG ++ + +T
Sbjct: 123 IQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMT 176
Query: 196 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN------V 249
+ + + T D++S G ++ E++TGK + + Q
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 250 SLAAYFVHSMRKNRLYDILDDQVMKLGK------KNQIMAFANLAERCLDLNGKKRPTME 303
+ A FV ++ + + + K N NL E+ L L+ ++R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 304 EV 305
E
Sbjct: 297 EA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-32
Identities = 62/280 (22%), Positives = 98/280 (35%), Gaps = 55/280 (19%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVK--------------------------KS 88
N F+ ++LG+G G V + GR A+K +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
L + V E+ + G L+ HL +E T E E+ AL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALE 119
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
YLHS + +RDIK N++LD+ K+ DFG K D GT YL PE
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPE 175
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
+ + D + GVV+ E++ G+ P F + + + + M + R L
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHER------LFELILMEEIRFPRTL 228
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308
+ +L L + K+R +
Sbjct: 229 SPE------------AKSLLAGLLKKDPKQRLGGGPSDAK 256
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (301), Expect = 4e-32
Identities = 54/295 (18%), Positives = 102/295 (34%), Gaps = 58/295 (19%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSK---------------------NAVK 93
+ + + R LG+G V++ + + + VK K N +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 94 LLGCCLE--TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
L + + P LV+E ++N Q LT E+ AL Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH 146
Query: 152 SAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 210
S I HRD+K N+++D E + ++ D+G ++F Q + + + PE
Sbjct: 147 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELL 201
Query: 211 QSSQLTD-KSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYF-------------- 255
Q+ D D++S G +L ++ K+P F + + V +A
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 256 -----VHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEV 305
+ + + V + + ++ L + + R T E
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-32
Identities = 55/301 (18%), Positives = 101/301 (33%), Gaps = 59/301 (19%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK-------------------------SK 89
+ + +GQG G V+K R+ G+ +A+KK +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 90 NAVKLLGCCLETEVP--------LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIAT 141
N V L+ C P LV++F + + T R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQ 124
Query: 142 EVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---HVTTKI 198
+ L Y+H + I HRD+K+ N+L+ K+ADFG ++ ++ + + T
Sbjct: 125 MLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 199 QGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKP------------IFSAGNTS 245
T Y PE + D++ G ++ E+ T I +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 246 QENVSLAAYFVHSMRKNRLYDILDDQVM-KLGKKNQIMAFANLAERCLDLNGKKRPTMEE 304
V K L +V +L + +L ++ L L+ +R ++
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 305 V 305
Sbjct: 302 A 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (282), Expect = 2e-29
Identities = 56/280 (20%), Positives = 92/280 (32%), Gaps = 58/280 (20%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK--------------------------S 88
+ F+ + LG G G V +E G A+K
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 89 KNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALA 148
VKL + +V E+++ G ++ HL + A ++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155
Query: 149 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 208
YLHS + +RD+K N+L+D++ +V DFG +K + + GT L PE
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPE 208
Query: 209 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268
S D ++ GV++ E+ G P F A Q Y K R
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP-FFADQPIQ------IYEKIVSGKVRFPSHF 261
Query: 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308
+L L ++ KR + +
Sbjct: 262 SSD------------LKDLLRNLLQVDLTKRFGNLKNGVN 289
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-28
Identities = 68/289 (23%), Positives = 99/289 (34%), Gaps = 61/289 (21%)
Query: 56 NHFNVNRILGQGGQGTVYKGM----REDGRIIAVKK------------------------ 87
+F + ++LG G G V+ + G++ A+K
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 88 ----SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEV 143
S V L L+ ++I+ G L+ HL R T E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEI 138
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 203
AL +LH I +RDIK NILLD + DFG SK D+T GT
Sbjct: 139 VLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 204 YLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261
Y+ P+ + D +S GV++ ELLTG P F K
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-----------------FTVDGEK 238
Query: 262 NRLYDILDDQVMKLGKKNQIM--AFANLAERCLDLNGKKRPTMEEVSME 308
N +I + Q M +L +R L + KKR +
Sbjct: 239 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-27
Identities = 55/302 (18%), Positives = 102/302 (33%), Gaps = 49/302 (16%)
Query: 46 FSSKELDKA----TNHFNVNRILGQGGQGTVYKGM-REDGRIIAVKK------------- 87
F +EL+K + +G G G+V + G +AVKK
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 88 ------------SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEM 135
+N + LL + L + + + LT +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDH 122
Query: 136 RLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 195
+ ++ L Y+HSA I HRD+K +N+ ++E K+ DFG ++ +T
Sbjct: 123 VQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMT 176
Query: 196 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN--VSLAA 253
+ + D++S G ++ ELLTG+ + Q + L
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 254 YFVHSMRKNRLYDILDDQVMKLGKKNQIM----------AFANLAERCLDLNGKKRPTME 303
+ K + + + L + ++ +L E+ L L+ KR T
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 304 EV 305
+
Sbjct: 297 QA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 6e-26
Identities = 50/297 (16%), Positives = 100/297 (33%), Gaps = 52/297 (17%)
Query: 56 NHFNVNRILGQGGQGTVYKGM-REDGRIIAVKKSKNA-------------VKLLGCCLET 101
+ + +G G QG V R +A+KK + L+ C
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 102 EVPLLVYEFISNGTLYQHLH----------DRLQNQEFPLTWEMRLRIATEVAGALAYLH 151
+ L+ F TL + + Q + L E + ++ + +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 152 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 211
S + I HRD+K +NI++ K+ DFG ++ + + T T Y PE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 212 SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQ-----------------ENVSLAAY 254
+ D++S G ++ E++ K Q +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 255 FVHSMRK---NRLYDILDDQVMKLGKKNQIMA---FANLAERCLDLNGKKRPTMEEV 305
+V + K + D + ++ + +L + L ++ KR ++++
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.3 bits (238), Expect = 4e-23
Identities = 46/317 (14%), Positives = 98/317 (30%), Gaps = 75/317 (23%)
Query: 58 FNVNRILGQGGQGTVYKGM-REDGRIIAVKK----------------------------- 87
+ + R LG G TV+ + +A+K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 88 ----SKNAVKLLGCCLETEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEV 143
+ + +KLL + + L + + + +I+ ++
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 144 AGALAYLHSAASSPIYHRDIKSTNILLDER------YRAKVADFGTSKFIAMDQTHVTTK 197
L Y+H I H DIK N+L++ + K+AD G + + T+
Sbjct: 135 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--- 189
Query: 198 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI--FSAGNTSQENVSLA--- 252
T Y PE + +D++S ++ EL+TG + ++++ +A
Sbjct: 190 -IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 253 -------AYFVHSMRKNRLYDILDDQVMKLGKKNQIM-----------------AFANLA 288
+Y + + + R + + + K ++
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 289 ERCLDLNGKKRPTMEEV 305
L L+ +KR +
Sbjct: 309 SPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.2 bits (158), Expect = 3e-13
Identities = 24/179 (13%), Positives = 51/179 (28%), Gaps = 38/179 (21%)
Query: 60 VNRILGQGGQGTVYKGMREDGRIIAVK---KSKNAVKLLGCCLETEVPLLVYEFISNGTL 116
+ +++G+G + V+ E VK + K + + I +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 117 YQHLHDRLQ----------------------NQEFPLTWEMRLRIATEVAGALAYLHSAA 154
+LQ + + + E + + +A +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR- 122
Query: 155 SSPIYHRDIKSTNILLDERYRAKVADFGTSK---------FIAMDQTHVTTKIQGTFGY 204
I H D+ N+L+ E + DF S + D ++ T T+
Sbjct: 123 --GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRT 178
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.87 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=375.92 Aligned_cols=235 Identities=27% Similarity=0.403 Sum_probs=184.7
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
++|++.+.||+|+||+||+|.+.+++.|||| +||||+++++++..++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 5788999999999999999999888899999 499999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 85 g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 85 GCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999998765 2346899999999999999999999998 999999999999999999999999999876554444
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHhh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQVM 273 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
......||+.|+|||++.+..++.++|||||||++|||+|+..|++...... . .......+. .
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-------~-~~~~i~~~~---------~ 220 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------E-VVEDISTGF---------R 220 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-------H-HHHHHHHTC---------C
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-------H-HHHHHHhcC---------C
Confidence 4444678999999999999999999999999999999999666654332110 1 111111111 1
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 274 KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 274 ~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
...+...+.++.+|+.+||+.||++|||++||+++|+.+..
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11233345678999999999999999999999999998854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-54 Score=379.11 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=201.8
Q ss_pred HHhcCCccCceecCCCCeEEEEEEec-CCcEEEEc----------------------ccccchhhhcccccCCcceeEee
Q 020102 53 KATNHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 53 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
...++|++.+.||+|+||+||+|.+. +++.|||| +|||||++++++.+++..++|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 34567899999999999999999984 58899999 49999999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++|+|.+.+.. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 94 ~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 94 FMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred cccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999998875 23457999999999999999999999998 99999999999999999999999999987765
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
..........||+.|+|||++.+..++.++|||||||++|||++|..|++...... ........+.
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--------~~~~~i~~~~------ 233 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDY------ 233 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHTTC------
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--------HHHHHHhcCC------
Confidence 55444455568999999999999999999999999999999999888875432211 1111111111
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
....+...+..+.+|+.+||+.||++|||++||++.|+.+.....
T Consensus 234 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~ 278 (287)
T d1opja_ 234 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278 (287)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred ---CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence 112234456689999999999999999999999999998866543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=371.70 Aligned_cols=228 Identities=28% Similarity=0.435 Sum_probs=187.8
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||+|+||+||+|.+ .+++.|||| +||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5689999999999999999998 568999999 489999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 85 CSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999988754 347999999999999999999999998 999999999999999999999999999876543
Q ss_pred Cc-eeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 191 QT-HVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 191 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||......... .........
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------~~~~~~~~~----- 224 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKT----- 224 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-------HHHHHTTCT-----
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-------HHHHhcCCC-----
Confidence 32 22345679999999999988876 56899999999999999999999654322111 111111110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
........+.++.+|+.+||+.||++|||++|+++
T Consensus 225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112334567889999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-54 Score=375.26 Aligned_cols=237 Identities=23% Similarity=0.389 Sum_probs=194.3
Q ss_pred HhcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 54 ATNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 54 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
..++|++.+.||+|+||+||+|..+++..|||| +|||||++++++.+ +..++||||+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 346789999999999999999999888999999 49999999998865 5679999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++|+|.+.+.... ..++++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999998775432 235899999999999999999999988 9999999999999999999999999998776544
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
........||+.|+|||++.+..++.++|||||||++|||+||..|++...... . ....+..+.
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-------~-~~~~i~~~~-------- 227 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------E-VIQNLERGY-------- 227 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------H-HHHHHHTTC--------
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHhcC--------
Confidence 444445678999999999999999999999999999999999777765432211 1 111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
....+...+.++.+|+.+||+.||++|||++||++.|+.+..
T Consensus 228 -~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 228 -RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 111233455679999999999999999999999999988643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=366.47 Aligned_cols=222 Identities=30% Similarity=0.444 Sum_probs=188.1
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+ .+++.||+| +||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4689999999999999999998 468999999 4899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|....
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999998763 36999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ...... ......
T Consensus 158 ~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~------~~~~~~-i~~~~~---- 221 (263)
T d2j4za1 158 SS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--Y------QETYKR-ISRVEF---- 221 (263)
T ss_dssp CC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--H------HHHHHH-HHTTCC----
T ss_pred CC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--H------HHHHHH-HHcCCC----
Confidence 32 2334679999999999999999999999999999999999999995421 1 111111 111111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 222 ------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112335567999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=370.45 Aligned_cols=232 Identities=25% Similarity=0.401 Sum_probs=178.0
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc--CCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE--TEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~--~~~~~lv 107 (331)
++|++.+.||+|+||+||+|.+ .+|+.||+| +||||+++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5689999999999999999997 568999999 48999999999865 4568999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA--SSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
|||+++|+|.+++...... ...+++..++.++.||+.||.|||+.+ .++|+||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999988764322 347999999999999999999999965 2459999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.+..+. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .. .......+...
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~-~~~~i~~~~~~ 232 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KE-LAGKIREGKFR 232 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HH-HHHHHHHTCCC
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HH-HHHHHHcCCCC
Confidence 765432 233456799999999999999999999999999999999999999954211 01 11112222221
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 233 ---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 123345668999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=368.53 Aligned_cols=226 Identities=27% Similarity=0.427 Sum_probs=188.8
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
++|++.+.||+|+||+||+|.+ .+|+.|||| +||||+++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999997 569999999 4999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
+||+|.+.+.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 100 ~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999987754 26899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchH
Q 020102 192 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQ 271 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .......... ...
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~~~~~~-~~~----- 235 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNG-TPE----- 235 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHC-SCC-----
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCC-CCC-----
Confidence 2334457999999999999999999999999999999999999999643110 1111111111 111
Q ss_pred hhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 272 VMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+...+..+.+|+.+||+.||++|||++|+++
T Consensus 236 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123345668999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=366.47 Aligned_cols=238 Identities=29% Similarity=0.454 Sum_probs=186.1
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||+||+|..+ ..|||| +|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999764 359999 48999999998764 56899999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999998865 2347999999999999999999999988 99999999999999999999999999986643
Q ss_pred CC-ceeeeeccccCCccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 190 DQ-THVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 190 ~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.. ........||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ........+...
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--------~~~~~~~~~~~~ 228 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--------QIIFMVGRGYLS 228 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------HHHHHHHHTSCC
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--------HHHHHHhcCCCC
Confidence 32 2233456799999999998653 57899999999999999999999996432111 111111111110
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
. .....+...++.+.+|+.+||+.||++|||++||++.|+.++.+
T Consensus 229 p-----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 P-----DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp C-----CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C-----cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0 01122334566899999999999999999999999999988753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=375.39 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=194.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| +|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46799999999999999999997 568999999 48999999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
|++||+|.+++.+. ..+++..+..++.|++.||.|||+ ++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 85 y~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999998763 368999999999999999999997 47 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHH---HHHh------
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYF---VHSM------ 259 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~------ 259 (331)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||................. ....
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 32 22346799999999999999999999999999999999999999975432211100000000 0000
Q ss_pred ---------hc---CccccccchHh----hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhccccchh
Q 020102 260 ---------RK---NRLYDILDDQV----MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIRGSSRKKRA 321 (331)
Q Consensus 260 ---------~~---~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~~~~~~~~~ 321 (331)
.. ........... +.......+.++.+|+.+||+.||++|||++|+++. ++.....+-.-..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d~~~ 313 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAG 313 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccccHHH
Confidence 00 00000000000 000111245679999999999999999999999884 6655443333333
Q ss_pred hHH
Q 020102 322 MFS 324 (331)
Q Consensus 322 ~~~ 324 (331)
.+.
T Consensus 314 ~~~ 316 (322)
T d1s9ja_ 314 WLC 316 (322)
T ss_dssp HHH
T ss_pred HHH
Confidence 333
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-52 Score=369.99 Aligned_cols=235 Identities=24% Similarity=0.428 Sum_probs=181.9
Q ss_pred cCCccCceecCCCCeEEEEEEec-CC---cEEEEc------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DG---RIIAVK------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|++.+.||+|+||+||+|.+. ++ ..|||| +|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56788899999999999999874 22 358888 499999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 106 ~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999987764 2347999999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCcee----eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 188 AMDQTHV----TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 188 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
....... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... . . .......+
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~------~-~~~~i~~~ 249 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--Q------D-VINAIEQD 249 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H------H-HHHHHHTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--H------H-HHHHHHcC
Confidence 5433221 122457899999999999999999999999999999998 8999864311 0 1 11111111
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
. ....+...+..+.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus 250 ~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 Y---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1 1122344567899999999999999999999999999987654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=362.59 Aligned_cols=232 Identities=23% Similarity=0.379 Sum_probs=194.9
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
++|++.+.||+|+||+||+|..++++.|||| +||||+++++++.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 6789999999999999999999888899999 489999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|+|..++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 84 g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 84 GCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9998887652 346899999999999999999999988 999999999999999999999999999876554444
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... . . ....+..+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~------~-~~~~i~~~~--------- 218 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--S------E-TAEHIAQGL--------- 218 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--H------H-HHHHHHTTC---------
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--H------H-HHHHHHhCC---------
Confidence 4445678999999999999999999999999999999998 7888854311 1 1 111111111
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
+...+...++.+.+|+.+||+.||++|||+++|++.|.+|
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1122334456799999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=370.99 Aligned_cols=236 Identities=25% Similarity=0.380 Sum_probs=190.3
Q ss_pred hcCCccCceecCCCCeEEEEEEecC------CcEEEEc-------------------------ccccchhhhcccccCCc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRED------GRIIAVK-------------------------KSKNAVKLLGCCLETEV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK-------------------------~~~niv~~~~~~~~~~~ 103 (331)
.++|++.+.||+|+||+||+|.+.. ...||+| .|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678999999999999999998632 2368888 38999999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhc------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQ------------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp 165 (331)
.++||||+++|+|.+++..... .....+++..+..++.||+.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999975321 11235899999999999999999999998 99999999
Q ss_pred CCEEeCCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCC
Q 020102 166 TNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGN 243 (331)
Q Consensus 166 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~ 243 (331)
+||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999866544332 2334568999999999999999999999999999999998 8999864321
Q ss_pred CcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 020102 244 TSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELN 310 (331)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~ 310 (331)
.. ........+. +...+...+..+.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~--------~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA--------NFYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH--------HHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--------HHHHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11 1111121111 11223445668999999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=361.63 Aligned_cols=236 Identities=22% Similarity=0.374 Sum_probs=185.8
Q ss_pred cCCccCceecCCCCeEEEEEEecCC-----cEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDG-----RIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
++|+..++||+|+||+||+|...+. ..|||| +|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688889999999999999986432 468999 48999999999999999999
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+.++++.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999998877652 347999999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCCce--eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
....... ......||+.|+|||++.+..++.++|||||||++|||++|..|+....... . ....+..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-------~-~~~~i~~~-- 229 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------E-VMKAINDG-- 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H-HHHHHHTT--
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-------H-HHHHHhcc--
Confidence 6543322 2223468999999999999999999999999999999999777765432111 1 11112111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
.+...+...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 230 -------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11222334556799999999999999999999999999988664
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=361.68 Aligned_cols=229 Identities=26% Similarity=0.350 Sum_probs=186.8
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
+.|++.+.||+|+||+||+|.+ .+++.||+| +|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999998 568999999 4899999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++|+|.+++... ..++++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|.......
T Consensus 92 ~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999987653 347999999999999999999999998 9999999999999999999999999997543221
Q ss_pred ceeeeeccccCCccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 192 THVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||....... ...... .+....
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~-~~~~~~ 234 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIA-KSEPPT 234 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHH-HSCCCC
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHH-cCCCCC
Confidence 1223457999999999884 4568899999999999999999999996432111 111111 111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ..+...+.++.+|+.+||+.||++|||++|+++.
T Consensus 235 ~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 L-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp C-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1123456689999999999999999999999763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=364.64 Aligned_cols=225 Identities=26% Similarity=0.370 Sum_probs=186.0
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4699999999999999999998 578999999 4899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||++||+|.+++... +.+++..+..++.|++.||.|||+.+ |+||||||+||+++++|.+||+|||+|+.+.
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999988763 47999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCC-ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 189 MDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 189 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ....
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~-~~~~--- 227 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKII-KLEY--- 227 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-TTCC---
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHH-cCCC---
Confidence 432 2233446799999999999999999999999999999999999999964310 01111111 1111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..+...+.++.+||.+||+.||++|||++|+++
T Consensus 228 -------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112344567899999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-51 Score=364.06 Aligned_cols=229 Identities=24% Similarity=0.343 Sum_probs=178.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCcceeEee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.+.|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46799999999999999999998 468999999 48999999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC---CCCcEEEeeccCccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKF 186 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~ 186 (331)
|++||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||++. +++.+||+|||+|+.
T Consensus 88 ~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 88 LVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999865 347999999999999999999999998 99999999999995 578999999999986
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ....
T Consensus 160 ~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~-~~~~- 227 (307)
T d1a06a_ 160 EDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILK-AEYE- 227 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHT-TCCC-
T ss_pred ccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-cCCC-
Confidence 54322 23346799999999999999999999999999999999999999964211 011111111 1110
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.........++++.+|+.+||+.||++|||++|+++.
T Consensus 228 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 -----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111223456689999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=360.12 Aligned_cols=233 Identities=24% Similarity=0.368 Sum_probs=188.4
Q ss_pred cCCccCce-ecCCCCeEEEEEEec---CCcEEEEc------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRI-LGQGGQGTVYKGMRE---DGRIIAVK------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|.+... ||+|+||+||+|... ++..|||| +|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34566664 999999999999763 45579999 48999999999865 468999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+|+.+
T Consensus 87 mE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999988754 2347999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCcee--eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 188 AMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 188 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... . ....+..+..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~-~~~~i~~~~~ 230 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------E-VMAFIEQGKR 230 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------H-HHHHHHTTCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------H-HHHHHHcCCC
Confidence 5433322 223468999999999999999999999999999999998 89998643211 1 1112222221
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
...+...+.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 231 ---------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12234456689999999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=361.82 Aligned_cols=238 Identities=25% Similarity=0.368 Sum_probs=188.8
Q ss_pred hcCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCCcceeEeeccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFIS 112 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~~ 112 (331)
.++|++.+.||+|+||+||+|.++++..|||| +|||||++++++.+ +..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 46799999999999999999999888889999 48999999999865 56899999999
Q ss_pred CCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCc
Q 020102 113 NGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 192 (331)
Q Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 192 (331)
+|+|...+.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 95 ~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 95 KGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999998876532 236899999999999999999999998 99999999999999999999999999987654443
Q ss_pred eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 193 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
.......||+.|+|||.+.+..++.++|||||||++|||++|..|+....... . ....+..+.
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-------~-~~~~i~~~~--------- 231 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------E-VLDQVERGY--------- 231 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------H-HHHHHHTTC---------
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHhcC---------
Confidence 34444678999999999999999999999999999999999877776532211 1 111111111
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSS 316 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~ 316 (331)
..+.+...++.+.+++.+||+.||++|||+++|+++|+....+.
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11223445568999999999999999999999999999876543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=355.47 Aligned_cols=224 Identities=22% Similarity=0.366 Sum_probs=179.0
Q ss_pred CccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhccccc----CCcceeE
Q 020102 58 FNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLE----TEVPLLV 107 (331)
Q Consensus 58 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~----~~~~~lv 107 (331)
|++.+.||+|+||+||+|.+. +++.||+| +|||||++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999984 68899999 48999999999864 4567999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEeeccCccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKF 186 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~ 186 (331)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||+|+.
T Consensus 91 mE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999998763 36899999999999999999999875 4599999999999997 578999999999975
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... . .......+...
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~-~~~~i~~~~~~- 231 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------Q-IYRRVTSGVKP- 231 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------H-HHHHHTTTCCC-
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------H-HHHHHHcCCCC-
Confidence 4322 2345679999999999876 59999999999999999999999996432111 1 11111111111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+...++++.+|+.+||+.||++|||++|+++
T Consensus 232 -------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112223456899999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=357.32 Aligned_cols=225 Identities=27% Similarity=0.388 Sum_probs=183.2
Q ss_pred ceecCCCCeEEEEEEec---CCcEEEEc-------------------------ccccchhhhcccccCCcceeEeecccC
Q 020102 62 RILGQGGQGTVYKGMRE---DGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEFISN 113 (331)
Q Consensus 62 ~~lg~G~~g~V~~~~~~---~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~~~~ 113 (331)
+.||+|+||+||+|... .++.|||| +|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999853 35689999 48999999999865 457899999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999998875 347999999999999999999999988 999999999999999999999999999876544333
Q ss_pred ee--eeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccch
Q 020102 194 VT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDD 270 (331)
Q Consensus 194 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
.. ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+..+..
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---------~~~~~~i~~~~~------ 228 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLEKGER------ 228 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHHTTCC------
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---------HHHHHHHHcCCC------
Confidence 22 23568999999999999999999999999999999998 8999864311 011122222211
Q ss_pred HhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 271 QVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
...+...+..+.+|+.+||+.||++|||+++|++.|+...
T Consensus 229 ---~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 ---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1223345668999999999999999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-51 Score=365.45 Aligned_cols=221 Identities=29% Similarity=0.427 Sum_probs=182.8
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEee
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
.|+..+.||+|+||+||+|.+ .+++.|||| +|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488999999999999999997 578899999 48999999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
||.+|++...+.. ..++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999988765544 347999999999999999999999998 99999999999999999999999999986432
Q ss_pred CCceeeeeccccCCccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........ .....
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~-~~~~~- 232 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIA-QNESP- 232 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH-HSCCC-
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-hCCCC-
Confidence 223569999999999864 4589999999999999999999999964311 01111111 11111
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...+...++.+.+|+.+||+.||++|||++|+++
T Consensus 233 -------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 -------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1122345668999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=356.83 Aligned_cols=235 Identities=25% Similarity=0.400 Sum_probs=180.1
Q ss_pred hcCCccCceecCCCCeEEEEEEecC----CcEEEEc------------------------ccccchhhhcccccCCccee
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRED----GRIIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.++|++.+.||+|+||+||+|.+.. +..|||| +||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578999999999999999998632 4568888 4999999999986 467899
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
||||+++|+|.+++.. ...++++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999987765 2347899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLY 265 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
.............||+.|+|||++.+..++.++|||||||++|||++ |..||...... .. . .....+..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----~~---~-~~i~~~~~- 227 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DV---I-GRIENGER- 227 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GH---H-HHHHTTCC-
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----HH---H-HHHHcCCC-
Confidence 65544444455678999999999999999999999999999999998 78887543211 01 1 11111211
Q ss_pred cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 266 DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
...++..+..+.+|+.+||+.||++|||++||++.|+.+...
T Consensus 228 --------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 228 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 122344567899999999999999999999999999987643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=360.96 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=186.7
Q ss_pred HHHHHhcCCccCceecCCCCeEEEEEEec------CCcEEEEcc-------------------------cccchhhhccc
Q 020102 50 ELDKATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVKK-------------------------SKNAVKLLGCC 98 (331)
Q Consensus 50 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~-------------------------~~niv~~~~~~ 98 (331)
+++...++|++.+.||+|+||.||+|.+. +++.||||+ |+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33334468999999999999999999862 356899992 77999999987
Q ss_pred cc-CCcceeEeecccCCCHHHHHhhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 020102 99 LE-TEVPLLVYEFISNGTLYQHLHDRLQN-----------QEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKST 166 (331)
Q Consensus 99 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~ 166 (331)
.. +...++||||+++|+|.+++...... ....+++..+..++.||+.||.|||+++ |+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 65 45689999999999999999753211 1235899999999999999999999998 999999999
Q ss_pred CEEeCCCCcEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCCC
Q 020102 167 NILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKK-PIFSAGNT 244 (331)
Q Consensus 167 Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~-p~~~~~~~ 244 (331)
|||+++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||.. ||.....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~- 242 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI- 242 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999986544332 22334679999999999999999999999999999999999755 5543211
Q ss_pred cccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 245 SQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.. .+...+..+... ..+...+.++.+++.+||+.||++|||++||+++|+.+..
T Consensus 243 ~~-------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 243 DE-------EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SH-------HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-------HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 112222222211 1233445679999999999999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-50 Score=363.10 Aligned_cols=230 Identities=20% Similarity=0.311 Sum_probs=189.5
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
-++|++.+.||+|+||+||+|.+ .+|+.|||| +|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999997 579999999 499999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC--CCCcEEEeeccCccccc
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIA 188 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~--~~~~~kl~Dfg~a~~~~ 188 (331)
++||+|.+.+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 105 ~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999998854 2347999999999999999999999998 99999999999996 46789999999998765
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ ..... .
T Consensus 178 ~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~-~~~~~-~- 244 (350)
T d1koaa2 178 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVK-SCDWN-M- 244 (350)
T ss_dssp TTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HTCCC-S-
T ss_pred ccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCCCC-C-
Confidence 433 33446799999999999999999999999999999999999999954311 11111111 11110 0
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
........++++.+|+.+||+.||++|||++|+++.
T Consensus 245 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 ----DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011123345679999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=358.54 Aligned_cols=224 Identities=27% Similarity=0.350 Sum_probs=189.0
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||.||+|.+ .+++.|||| .||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5699999999999999999997 579999999 3899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||++||+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999988763 47899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..... ....+..
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~-~i~~~~~---- 222 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFE-LILMEEI---- 222 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHCCC----
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHH-HHhcCCC----
Confidence 332 233456799999999999999999999999999999999999999965321 11111 1111111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSM 307 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~ 307 (331)
..+...+.++.+||.+||+.||++||+ ++|+++
T Consensus 223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 123345667899999999999999995 777765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.5e-50 Score=362.46 Aligned_cols=230 Identities=19% Similarity=0.313 Sum_probs=190.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------ccccchhhhcccccCCcceeEeec
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
.+.|++.+.||+|+||+||+|.+ .+|+.|||| +||||+++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999998 579999999 489999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC--CCCcEEEeeccCccccc
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIA 188 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~--~~~~~kl~Dfg~a~~~~ 188 (331)
|+||+|.+.+.. ...++++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|..+.
T Consensus 108 ~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 108 LSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecC
Confidence 999999887654 2447999999999999999999999998 99999999999998 67899999999998765
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||..... . .... ........
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~------~~~~-~i~~~~~~--- 246 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--L------ETLQ-NVKRCDWE--- 246 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--H------HHHH-HHHHCCCC---
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--H------HHHH-HHHhCCCC---
Confidence 433 33445799999999999999999999999999999999999999964311 0 1111 11111110
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.+.......+.++.+|+.+||+.||++|||++|+++.
T Consensus 247 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 ---FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111223456679999999999999999999999774
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=353.72 Aligned_cols=228 Identities=26% Similarity=0.364 Sum_probs=187.9
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.++|++.+.||+|+||+||+|.+ .+|+.|||| +|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999998 579999999 389999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC----cEEEee
Q 020102 105 LLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY----RAKVAD 180 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~----~~kl~D 180 (331)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence 9999999999999998763 37999999999999999999999998 99999999999998776 499999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
||+|....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... . ..... ..
T Consensus 161 fG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~------~~~~~-i~ 229 (293)
T d1jksa_ 161 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--Q------ETLAN-VS 229 (293)
T ss_dssp CTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H------HHHHH-HH
T ss_pred hhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--H------HHHHH-HH
Confidence 99998664332 23345789999999999999999999999999999999999999964311 0 11111 11
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..... .... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 230 AVNYE--FEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TTCCC--CCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcCCC--CCch----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110 0011 11234567899999999999999999999976
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-49 Score=360.39 Aligned_cols=225 Identities=24% Similarity=0.337 Sum_probs=186.0
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-----------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-----------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-----------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
++|++.+.||+|+||+||+|.+ .+|+.|||| .||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999998 469999999 2899999999999999999
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||++||+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999998763 46889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 186 FIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 186 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
...... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......... . ........
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~-~~~~~~~~-- 224 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----E-IDRMTLTM-- 224 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-----H-HHHHSSSC--
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-----H-HHHhcccC--
Confidence 665332 234579999999999865 56899999999999999999999999654322110 0 11110000
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSM 307 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~ 307 (331)
....+...+..+.+||.+||+.||++||| ++|+++
T Consensus 225 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01112345567999999999999999999 677765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-49 Score=352.37 Aligned_cols=222 Identities=27% Similarity=0.406 Sum_probs=187.0
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+ .+|+.|||| +||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4689999999999999999998 569999999 4899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+.||+|...+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999888876 346889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... +..
T Consensus 156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~-~~~---- 218 (316)
T d1fota_ 156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILN-AEL---- 218 (316)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-CCC----
T ss_pred cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHc-CCC----
Confidence 32 2346799999999999999999999999999999999999999964311 111111111 111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSME 308 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~~ 308 (331)
..+...+.++.+++.+||+.||.+|| |++++++.
T Consensus 219 ------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11233456799999999999999996 89998763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=353.21 Aligned_cols=240 Identities=28% Similarity=0.372 Sum_probs=189.6
Q ss_pred hcCCccCceecCCCCeEEEEEEecC--------CcEEEEc-------------------------ccccchhhhcccccC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRED--------GRIIAVK-------------------------KSKNAVKLLGCCLET 101 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK-------------------------~~~niv~~~~~~~~~ 101 (331)
.++|++.+.||+|+||.||+|.... +..|||| +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678999999999999999998522 3479999 389999999999999
Q ss_pred CcceeEeecccCCCHHHHHhhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQ-----------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL 170 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill 170 (331)
+..++||||+++|+|.+++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975421 12346899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCCce-eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccc
Q 020102 171 DERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQEN 248 (331)
Q Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~ 248 (331)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--~~-- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VE-- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HH--
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC--HH--
Confidence 99999999999999876543322 2334568999999999999999999999999999999998 577764321 10
Q ss_pred cchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 249 VSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
. ....+..+.. ...+...+..+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 245 ----~-~~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 ----E-LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ----H-HHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----H-HHHHHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1 1112222211 122334556799999999999999999999999999988664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=357.93 Aligned_cols=235 Identities=23% Similarity=0.326 Sum_probs=185.8
Q ss_pred hcCCccCc-eecCCCCeEEEEEEe-cCCcEEEEc-------------------ccccchhhhccccc----CCcceeEee
Q 020102 55 TNHFNVNR-ILGQGGQGTVYKGMR-EDGRIIAVK-------------------KSKNAVKLLGCCLE----TEVPLLVYE 109 (331)
Q Consensus 55 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK-------------------~~~niv~~~~~~~~----~~~~~lv~e 109 (331)
.++|.+.+ .||+|+||+||+|.+ .+++.|||| .||||+++++++.+ +...++|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 35788765 699999999999998 578999999 48999999999865 567899999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEeeccCccc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKF 186 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~ 186 (331)
||+||+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 90 y~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 90 CLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp CCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeee
Confidence 9999999999975 22347999999999999999999999998 999999999999985 56799999999986
Q ss_pred ccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccc
Q 020102 187 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYD 266 (331)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
..... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........... ..........
T Consensus 164 ~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-----~~~~i~~~~~-- 234 (335)
T d2ozaa1 164 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKTRIRMGQY-- 234 (335)
T ss_dssp CCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSCSS--
T ss_pred ccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-----HHHHHhcCCC--
Confidence 65432 23345799999999999999999999999999999999999999964322111000 0000000000
Q ss_pred ccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 267 ILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..+.......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 235 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 ----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00111123456789999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=345.72 Aligned_cols=230 Identities=27% Similarity=0.411 Sum_probs=181.3
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc---------------------ccccchhhhccccc-CCcceeEeecccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK---------------------KSKNAVKLLGCCLE-TEVPLLVYEFISN 113 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK---------------------~~~niv~~~~~~~~-~~~~~lv~e~~~~ 113 (331)
++|++.+.||+|+||.||+|.. .+..|||| +||||+++++++.+ .+..++||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 4678889999999999999988 47789999 49999999999865 4568999999999
Q ss_pred CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCCce
Q 020102 114 GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 193 (331)
Q Consensus 114 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 193 (331)
|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 86 GSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp EEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999987532 125899999999999999999999988 999999999999999999999999999854322
Q ss_pred eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCccccccchHh
Q 020102 194 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILDDQV 272 (331)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... . . .......+.
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~---~----~~~~i~~~~--------- 217 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--K---D----VVPRVEKGY--------- 217 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--G---G----HHHHHTTTC---------
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--H---H----HHHHHHcCC---------
Confidence 223457899999999999999999999999999999998 5666643211 1 0 111111111
Q ss_pred hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 273 MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 273 ~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
....+...+..+.+|+.+||+.||++|||+.+++++|+.++.
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 112233455678999999999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.2e-49 Score=344.51 Aligned_cols=236 Identities=27% Similarity=0.404 Sum_probs=185.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCc----
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEV---- 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~---- 103 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999997 579999999 48899999999876543
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||++|++|.+.+... +++++..+..++.||+.||.|||+.+ |+||||||+||+++.++..+|+|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhh
Confidence 78999999999999888663 47999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCC--ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 184 SKFIAMDQ--THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 184 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
+....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~~ 229 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVRE 229 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHC
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHHhc
Confidence 87553322 2233446799999999999999999999999999999999999999954211 1111122222
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhh
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-TMEEVSMELNGIR 313 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-s~~evl~~L~~l~ 313 (331)
.... +.......++.+.+++.+||+.||++|| |++++++.|.+++
T Consensus 230 ~~~~-------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 230 DPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCC-------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCC-------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111 1112234556899999999999999999 8999999998875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=352.70 Aligned_cols=238 Identities=27% Similarity=0.401 Sum_probs=190.8
Q ss_pred hcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhhcccccCCcc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLLGCCLETEVP 104 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~~~~~~~~~~ 104 (331)
.++|++.+.||+|+||+||+|... +++.|||| +|||++++++++...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 467999999999999999999863 45789999 389999999999999999
Q ss_pred eeEeecccCCCHHHHHhhhh-------------------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCC
Q 020102 105 LLVYEFISNGTLYQHLHDRL-------------------QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKS 165 (331)
Q Consensus 105 ~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp 165 (331)
+++|||+++|+|.+++.... ......+++..+..++.|++.||+|||+.+ ++||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999886521 111235899999999999999999999998 99999999
Q ss_pred CCEEeCCCCcEEEeeccCcccccCCC-ceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCC
Q 020102 166 TNILLDERYRAKVADFGTSKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKK-PIFSAGN 243 (331)
Q Consensus 166 ~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~-p~~~~~~ 243 (331)
+|||++.++.+||+|||+|+...... ........||+.|+|||.+.+..++.++|||||||++|||++|.. ||... .
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-A 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-C
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-C
Confidence 99999999999999999998654332 223334568999999999999999999999999999999999865 45322 1
Q ss_pred CcccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 020102 244 TSQENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIR 313 (331)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~ 313 (331)
.. ........+... ..+...+.++.+|+.+||+.+|++|||+.||+++|+.+.
T Consensus 248 ~~--------e~~~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HE--------EVIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH--------HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH--------HHHHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 111222222221 123344567999999999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=346.05 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=191.4
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc----------------------ccccchhhhcccccCC----cceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK----------------------KSKNAVKLLGCCLETE----VPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK----------------------~~~niv~~~~~~~~~~----~~~lv~e 109 (331)
.+|.+.+.||+|+||+||+|.. +|+.|||| +||||+++++++.+.+ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4577889999999999999986 68899999 4899999999998654 5789999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEccCCCCCEEeCCCCcEEEeeccCc
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAA-----SSPIYHRDIKSTNILLDERYRAKVADFGTS 184 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 184 (331)
|+++|+|.+++.+ ..+++..++.++.|++.||+|+|+.+ .++|+||||||+||||+.++.+||+|||++
T Consensus 82 y~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 82 YHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999976 26899999999999999999999741 234999999999999999999999999999
Q ss_pred ccccCCCce---eeeeccccCCccChhhhcCCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc------c
Q 020102 185 KFIAMDQTH---VTTKIQGTFGYLDPEYHQSSQ------LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN------V 249 (331)
Q Consensus 185 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~------~ 249 (331)
......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+.......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876543322 223467999999999987653 5678999999999999999988875322111110 0
Q ss_pred chHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 250 SLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
.................-+. ......+....+.+|+.+||+.||++|||+.||++.|+.+...++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCC---GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhccccCCCCC---cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 11111222221111110000 011133456679999999999999999999999999999987654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=354.37 Aligned_cols=224 Identities=26% Similarity=0.399 Sum_probs=187.9
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5789999999999999999998 469999999 489999999999999999999
Q ss_pred eecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccc
Q 020102 108 YEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 187 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 187 (331)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999998763 36899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccc
Q 020102 188 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDI 267 (331)
Q Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ... .....+..
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~------~~~-~~i~~~~~--- 220 (320)
T d1xjda_ 154 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--E------ELF-HSIRMDNP--- 220 (320)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H------HHH-HHHHHCCC---
T ss_pred cccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--H------HHH-HHHHcCCC---
Confidence 4332 233446799999999999999999999999999999999999999964311 0 111 11111111
Q ss_pred cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 020102 268 LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTME-EVSM 307 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~-evl~ 307 (331)
..+...+.++.+|+.+||+.||++|||+. |+++
T Consensus 221 -------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11233456799999999999999999996 6753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=353.03 Aligned_cols=233 Identities=24% Similarity=0.430 Sum_probs=184.0
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCc----EEEEc------------------------ccccchhhhcccccCCccee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGR----IIAVK------------------------KSKNAVKLLGCCLETEVPLL 106 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK------------------------~~~niv~~~~~~~~~~~~~l 106 (331)
.+|++.+.||+|+||+||+|.+. +|+ .||+| +|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999873 343 58888 499999999999865 5678
Q ss_pred EeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccc
Q 020102 107 VYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 186 (331)
Q Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 186 (331)
++||+.+++|.+.+.. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence 8899999999988765 2457999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcCcc
Q 020102 187 IAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKNRL 264 (331)
Q Consensus 187 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
........ .....||+.|+|||++.+..++.++|||||||++|||+| |..||..... . .. ...+..+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~---~~----~~~i~~~~- 230 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--S---EI----SSILEKGE- 230 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--G---GH----HHHHHHTC-
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--H---HH----HHHHHcCC-
Confidence 65433322 233568999999999999999999999999999999999 6777753211 1 01 11111111
Q ss_pred ccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 265 YDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
+...+...+..+.+|+.+||+.||++|||+.||++.|..+..
T Consensus 231 --------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 112234455679999999999999999999999999887643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-49 Score=353.75 Aligned_cols=221 Identities=24% Similarity=0.323 Sum_probs=187.2
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc--------------------------ccccchhhhcccccCCcceeEe
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK--------------------------KSKNAVKLLGCCLETEVPLLVY 108 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK--------------------------~~~niv~~~~~~~~~~~~~lv~ 108 (331)
++|++.+.||+|+||+||+|.+ .+|+.|||| .||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999998 579999999 4899999999999999999999
Q ss_pred ecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCccccc
Q 020102 109 EFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 188 (331)
Q Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 188 (331)
||+.+|+|...+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999988763 36999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 189 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||.... . ........ ....
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~------~~~~~~i~-~~~~---- 255 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--P------IQIYEKIV-SGKV---- 255 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--H------HHHHHHHH-HCCC----
T ss_pred cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--H------HHHHHHHh-cCCC----
Confidence 32 234579999999999999999999999999999999999999996421 0 11111111 1111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRP-----TMEEVSM 307 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RP-----s~~evl~ 307 (331)
..+...+.++.+|+.+||+.||++|+ |++++++
T Consensus 256 ------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11234556799999999999999994 8999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=350.22 Aligned_cols=238 Identities=26% Similarity=0.368 Sum_probs=190.0
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCc--EEEEc-------------------------ccccchhhhcccccCCcceeE
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGR--IIAVK-------------------------KSKNAVKLLGCCLETEVPLLV 107 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK-------------------------~~~niv~~~~~~~~~~~~~lv 107 (331)
++|++.+.||+|+||+||+|.+. ++. .|||| +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67889999999999999999874 444 46777 389999999999999999999
Q ss_pred eecccCCCHHHHHhhhh-----------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 020102 108 YEFISNGTLYQHLHDRL-----------QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRA 176 (331)
Q Consensus 108 ~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~ 176 (331)
|||+++|+|.+++.... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999986531 123457999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 020102 177 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|..|++...+. .. ..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-------~~-~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AE-LY 236 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-------HH-HH
Confidence 999999997543222 222346899999999999999999999999999999999987654332111 11 11
Q ss_pred HHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 257 HSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
..+..+. +...+...+..+.+||.+||+.||++|||++||++.|+.+...
T Consensus 237 ~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111 1122334566899999999999999999999999999988653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-48 Score=339.18 Aligned_cols=228 Identities=25% Similarity=0.365 Sum_probs=187.6
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------------------cccchhhhccccc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------------------SKNAVKLLGCCLE 100 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------------------~~niv~~~~~~~~ 100 (331)
.++|++.+.||+|+||+||+|.+ .+++.||||. ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36799999999999999999997 5789999992 8899999999999
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
++..++||||+++|+|.+++... .++++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEcc
Confidence 99999999999999999999752 47999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAY 254 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 254 (331)
||+++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...
T Consensus 154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~ 223 (277)
T d1phka_ 154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLM 223 (277)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH
T ss_pred chheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHH
Confidence 99998765432 2344679999999998753 3468899999999999999999999964311 011
Q ss_pred HHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 255 FVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
..... .+... .+.......++++.+|+.+||+.||++|||++||++
T Consensus 224 ~~~i~-~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 224 LRMIM-SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHH-HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHH-hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 11111 011123345678999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=349.75 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=196.5
Q ss_pred HHHHhcCCccCceecCCCCeEEEEEEe------cCCcEEEEc-------------------------ccccchhhhcccc
Q 020102 51 LDKATNHFNVNRILGQGGQGTVYKGMR------EDGRIIAVK-------------------------KSKNAVKLLGCCL 99 (331)
Q Consensus 51 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK-------------------------~~~niv~~~~~~~ 99 (331)
++...++|++.+.||+|+||.||+|.. .+++.|||| .|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 334457889999999999999999975 346789999 3899999999999
Q ss_pred cCCcceeEeecccCCCHHHHHhhhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 020102 100 ETEVPLLVYEFISNGTLYQHLHDRLQ-------------NQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKST 166 (331)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~ 166 (331)
+.+..++||||+++|+|.+++..... .....+++..+..++.||+.|++|||+++ ++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 99999999999999999999876321 12346899999999999999999999998 999999999
Q ss_pred CEEeCCCCcEEEeeccCcccccCCCc-eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc
Q 020102 167 NILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTS 245 (331)
Q Consensus 167 Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~ 245 (331)
||+++.++.++++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+..|++......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433 33344678999999999999999999999999999999999666654332221
Q ss_pred ccccchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 246 QENVSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.. +......+ .+...+...+..+.+||.+||+.||++|||++||+++|+++..
T Consensus 255 ~~-------~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 255 SK-------FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HH-------HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-------HHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 11 11111111 1122233455679999999999999999999999999986543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=345.12 Aligned_cols=230 Identities=23% Similarity=0.364 Sum_probs=188.2
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc----------------------ccccchhhhcccccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK----------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
.++|++.+.||+|+||+||+|.+ .+++.||+| +||||+++++++.+++..++|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 46799999999999999999998 468899999 4999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC--CCcEEEeeccCcccccC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE--RYRAKVADFGTSKFIAM 189 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~ 189 (331)
+||+|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||++.....
T Consensus 84 ~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 84 SGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999998864 2347999999999999999999999998 999999999999984 45799999999986643
Q ss_pred CCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCccccccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDILD 269 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
. .......+|+.|+|||.+.+..++.++||||+||++|+|++|..||..... ......... .... ..
T Consensus 157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~-~~~~--~~ 223 (321)
T d1tkia_ 157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMN-AEYT--FD 223 (321)
T ss_dssp T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-TCCC--CC
T ss_pred C--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCCC--CC
Confidence 3 233445789999999999999999999999999999999999999964321 111111111 1110 01
Q ss_pred hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 270 DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. .....+.++.+|+.+||+.||++|||++|+++.
T Consensus 224 ~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 EE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hh----hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 111245678999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=343.63 Aligned_cols=232 Identities=24% Similarity=0.371 Sum_probs=181.0
Q ss_pred cCCccCceecCCCCeEEEEEEec--C--CcEEEEc--------------------------ccccchhhhcccccCCcce
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE--D--GRIIAVK--------------------------KSKNAVKLLGCCLETEVPL 105 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~--~--~~~vavK--------------------------~~~niv~~~~~~~~~~~~~ 105 (331)
++|++.+.||+|+||+||+|... + ...|||| +||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999852 2 3468998 48999999999965 5678
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
+||||+++|++.+.+... ..++++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999887653 236999999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCcee--eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 186 FIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 186 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
......... .....|++.|+|||.+.+..++.++|||||||++|||+| |..||..... ..........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHHhCC
Confidence 765443222 223457889999999999999999999999999999998 8999853211 11111222221
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGI 312 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l 312 (331)
.. .+.+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 232 ~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 112334456799999999999999999999999998865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-49 Score=342.53 Aligned_cols=218 Identities=28% Similarity=0.466 Sum_probs=180.9
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc-------------------------------cccchhhhcccccCC
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK-------------------------------SKNAVKLLGCCLETE 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-------------------------------~~niv~~~~~~~~~~ 102 (331)
.++|++.+.||+|+||+||+|.+ .+++.||||. ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46799999999999999999998 5789999991 789999999999999
Q ss_pred cceeEeecccC-CCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEee
Q 020102 103 VPLLVYEFISN-GTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-RYRAKVAD 180 (331)
Q Consensus 103 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-~~~~kl~D 180 (331)
..++||||+.+ +++.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence 99999999976 5777777652 47999999999999999999999998 999999999999985 57899999
Q ss_pred ccCcccccCCCceeeeeccccCCccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 181 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
||+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ...
T Consensus 155 FG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~ 217 (273)
T d1xwsa_ 155 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EII 217 (273)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHH
T ss_pred cccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHh
Confidence 9999865432 2334679999999999987765 567899999999999999999985320 011
Q ss_pred hcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 260 RKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ... ..+...+.++.+|+.+||+.||++|||++|+++.
T Consensus 218 ~-~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 R-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp H-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h-ccc----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 111 1122345679999999999999999999999764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=342.32 Aligned_cols=231 Identities=29% Similarity=0.444 Sum_probs=184.2
Q ss_pred CceecCCCCeEEEEEEecC----CcEEEEc------------------------ccccchhhhccccc-CCcceeEeecc
Q 020102 61 NRILGQGGQGTVYKGMRED----GRIIAVK------------------------KSKNAVKLLGCCLE-TEVPLLVYEFI 111 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~----~~~vavK------------------------~~~niv~~~~~~~~-~~~~~lv~e~~ 111 (331)
.++||+|+||+||+|.+.+ ...|||| +||||+++++++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998743 2358889 49999999999875 45789999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
++++|.+++.. .....++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999998765 2346788899999999999999999998 9999999999999999999999999998664432
Q ss_pred ce---eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc
Q 020102 192 TH---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL 268 (331)
Q Consensus 192 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ .. .....+..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~----~~i~~g~~---- 252 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----IT----VYLLQGRR---- 252 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CH----HHHHTTCC----
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HH----HHHHcCCC----
Confidence 21 22235689999999999999999999999999999999998888764322111 11 11111111
Q ss_pred chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 020102 269 DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 315 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~ 315 (331)
...+...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 253 -----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 112233456799999999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=344.56 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=196.7
Q ss_pred cChHHHHHHhcCCccCceecCCCCeEEEEEEec------CCcEEEEc------------------------ccccchhhh
Q 020102 46 FSSKELDKATNHFNVNRILGQGGQGTVYKGMRE------DGRIIAVK------------------------KSKNAVKLL 95 (331)
Q Consensus 46 ~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK------------------------~~~niv~~~ 95 (331)
+..++++...++|++.+.||+|+||+||+|.+. ++..|||| .||||++++
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 444445555678999999999999999999863 35789999 389999999
Q ss_pred cccccCCcceeEeecccCCCHHHHHhhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe
Q 020102 96 GCCLETEVPLLVYEFISNGTLYQHLHDRL-----QNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILL 170 (331)
Q Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill 170 (331)
+++..++..++||||+++|+|.+++.... ......+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence 99999999999999999999999876431 122245799999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCCcee-eeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCcccc
Q 020102 171 DERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK-KPIFSAGNTSQEN 248 (331)
Q Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~-~p~~~~~~~~~~~ 248 (331)
++++++||+|||+|+......... .....||+.|+|||.+.+..++.++|||||||++|||+||. .||... +.
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~---- 241 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SN---- 241 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CH----
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-CH----
Confidence 999999999999998665433322 23346899999999999999999999999999999999986 455321 11
Q ss_pred cchHHHHHHHhhcCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 249 VSLAAYFVHSMRKNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
..... ....+.. ...+...+..+.+++.+||+.+|++|||++||+++|+....
T Consensus 242 ---~~~~~-~i~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 242 ---EQVLR-FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---HHHHH-HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---HHHHH-HHHhCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 1112211 11233455679999999999999999999999999987643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=339.82 Aligned_cols=234 Identities=23% Similarity=0.226 Sum_probs=178.2
Q ss_pred CceecCCCCeEEEEEEe-cCCcEEEEc----------------------------ccccchhhhcccccCCcceeEeecc
Q 020102 61 NRILGQGGQGTVYKGMR-EDGRIIAVK----------------------------KSKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 61 ~~~lg~G~~g~V~~~~~-~~~~~vavK----------------------------~~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
+++||+|+||+||+|.+ .+++.|||| .|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999997 568999999 3889999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 191 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 191 (331)
.++++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9876654433 2457899999999999999999999998 9999999999999999999999999998655433
Q ss_pred ceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC---ccccc
Q 020102 192 THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN---RLYDI 267 (331)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 267 (331)
. ......||+.|+|||++.+. .++.++|||||||++|||++|..||..... .+ ............ .+...
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~---~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LD---QLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHHHHCCCCTTTSSST
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HH---HHHHHHHhcCCCChhhccch
Confidence 2 22345799999999988655 579999999999999999999998854321 10 000011111000 00000
Q ss_pred cc-----------hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 268 LD-----------DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 268 ~~-----------~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.. ...........++++.+|+.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 000000112345679999999999999999999999763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=336.92 Aligned_cols=244 Identities=22% Similarity=0.308 Sum_probs=184.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cC-CcEEEEc----------------------------ccccchhhhccccc----
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-ED-GRIIAVK----------------------------KSKNAVKLLGCCLE---- 100 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK----------------------------~~~niv~~~~~~~~---- 100 (331)
.++|++.+.||+|+||+||+|.+ .+ ++.|||| .||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999997 34 6779999 28999999999853
Q ss_pred -CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEe
Q 020102 101 -TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVA 179 (331)
Q Consensus 101 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~ 179 (331)
....+++|||+.++++..... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence 346899999998776644332 23457899999999999999999999998 9999999999999999999999
Q ss_pred eccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 020102 180 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSM 259 (331)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
|||++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .. .+ .......
T Consensus 159 dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~--~~-~~i~~~~ 231 (305)
T d1blxa_ 159 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VD--QL-GKILDVI 231 (305)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH--HH-HHHHHHH
T ss_pred chhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HH--HH-HHHHHhh
Confidence 99998755432 233446799999999999999999999999999999999999999964321 10 00 0111111
Q ss_pred hcC---ccccc----------cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 020102 260 RKN---RLYDI----------LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGI 312 (331)
Q Consensus 260 ~~~---~~~~~----------~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l 312 (331)
... .+... .............++.+.+|+.+||+.||++|||++|+++. ++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 000 00000 00000111123345678999999999999999999999764 4444
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=334.96 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=185.1
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4789999999999999999998 578999999 48999999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
|+.+ ++.+.+.. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~-~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC
Confidence 9975 44454433 23457999999999999999999999998 99999999999999999999999999986643
Q ss_pred CCceeeeeccccCCccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC--cccc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN--RLYD 266 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 266 (331)
.. .......||+.|+|||++.... ++.++||||+||++|+|++|+.||...... . ............. ....
T Consensus 155 ~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~--~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 155 PV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--D--QLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp CS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H--HHHHHHHHHCCCCTTTSTT
T ss_pred Cc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--H--HHHHHHHhcCCCchhhccc
Confidence 32 2233457999999999877766 478999999999999999999999643210 0 0000000000000 0000
Q ss_pred cc---c---------hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 020102 267 IL---D---------DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGI 312 (331)
Q Consensus 267 ~~---~---------~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l 312 (331)
.. + ...........+.++.+|+.+||+.||++|||++|+++. ++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00 0 000000112345678999999999999999999999875 4443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-46 Score=331.32 Aligned_cols=238 Identities=21% Similarity=0.263 Sum_probs=180.8
Q ss_pred cCCccCceecCCCCeEEEEEEecCCcEEEEc-------------------------ccccchhhhcccccCCcceeEeec
Q 020102 56 NHFNVNRILGQGGQGTVYKGMREDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYEF 110 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e~ 110 (331)
++|++.+.||+|+||+||+|.+++++.|||| .||||+++++++.+++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999999999999 388999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccCC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 190 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 190 (331)
+.++.+...... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 987655544432 357999999999999999999999988 999999999999999999999999999866443
Q ss_pred CceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCcccccc-
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNRLYDIL- 268 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 268 (331)
.. ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||...... + .... ..............
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~--~~~~-i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--D--QLMR-IFRILGTPNSKNWPN 227 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H--HHHH-HHHHHCCCCTTTSTT
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--H--HHHH-HHHhhCCCChhhccc
Confidence 22 23334689999999988765 5689999999999999999999999643211 0 0000 00111000000000
Q ss_pred --------------chHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 269 --------------DDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 269 --------------~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
............+..+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001122334567899999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-46 Score=327.83 Aligned_cols=244 Identities=20% Similarity=0.293 Sum_probs=184.8
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------ccc-chhhhcccccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------SKN-AVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------~~n-iv~~~~~~~~~~~~~lv~e~~ 111 (331)
+++|++.+.||+|+||+||+|.+ .+++.||||. |+| ++.+..++.+++..++||||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 46799999999999999999997 5689999992 444 555566667788889999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEeeccCccccc
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKFIA 188 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~ 188 (331)
+ +++...+.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++. +..++|+|||+|+.+.
T Consensus 86 ~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 86 G-PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred C-Cchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 5 666665543 2347999999999999999999999999 999999999999863 4579999999998765
Q ss_pred CCCce------eeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 189 MDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 189 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... .......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~~~~~~~~~~-~ 235 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMS-T 235 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-S
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-HHHhhcccCC-C
Confidence 43321 22345799999999999999999999999999999999999999965432211111 0000000000 0
Q ss_pred ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccc
Q 020102 263 RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSSR 317 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~~~~ 317 (331)
. .+ ......+.++.+++..||+.+|++||+++++.+.|+.+....+
T Consensus 236 ~-----~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 236 P-----IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp C-----HH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred C-----hh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 0 00 0122345678999999999999999999999999988755433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-45 Score=323.10 Aligned_cols=241 Identities=18% Similarity=0.239 Sum_probs=190.3
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEcc----------------------cccchhhhcccccCCcceeEeecc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK----------------------SKNAVKLLGCCLETEVPLLVYEFI 111 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~----------------------~~niv~~~~~~~~~~~~~lv~e~~ 111 (331)
+++|++.+.||+|+||+||+|.+ .+++.||||. ++|++++++++..+...++||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 57899999999999999999997 4689999992 479999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-----CCcEEEeeccCccc
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDE-----RYRAKVADFGTSKF 186 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~-----~~~~kl~Dfg~a~~ 186 (331)
+++|.+.+... ...+++..+..++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||+|+.
T Consensus 84 -~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 84 -GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred -CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 68998877652 347899999999999999999999999 999999999999974 57899999999987
Q ss_pred ccCCCc------eeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 020102 187 IAMDQT------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMR 260 (331)
Q Consensus 187 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~--~~~i~~~~~ 233 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--YERIGEKKQ 233 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH--HHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH--HHHHHhccC
Confidence 643221 123346799999999999999999999999999999999999999964322211110 000000000
Q ss_pred cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 020102 261 KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSMELNGIRG 314 (331)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~L~~l~~ 314 (331)
.... +.+ ....++++.+++..|++.+|++||+++.+.+.|+.+..
T Consensus 234 ~~~~-----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 234 STPL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HSCH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCh-----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0000 111 12234578999999999999999999999998887654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=336.13 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=181.9
Q ss_pred CCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------ccccchhhhccccc------CCcceeEeec
Q 020102 57 HFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------KSKNAVKLLGCCLE------TEVPLLVYEF 110 (331)
Q Consensus 57 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------~~~niv~~~~~~~~------~~~~~lv~e~ 110 (331)
.|...++||+|+||+||+|.+ .+++.|||| +||||+++++++.. ..+.++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 578889999999999999998 469999999 48999999999854 2346899999
Q ss_pred ccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEeeccCcccccC
Q 020102 111 ISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAM 189 (331)
Q Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~ 189 (331)
++++ +...+.... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 101 ~~~~-~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 101 VPET-VYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp CSEE-HHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred cCCc-cHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9855 444444322 23457999999999999999999999988 99999999999999775 899999999986644
Q ss_pred CCceeeeeccccCCccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCccccc-------chHHHHHHHhh-
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENV-------SLAAYFVHSMR- 260 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~- 260 (331)
.. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........... ...........
T Consensus 176 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 176 GE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp TS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred Cc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 32 2334579999999998765 4689999999999999999999999964321110000 00000000000
Q ss_pred --cCccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 020102 261 --KNRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIR 313 (331)
Q Consensus 261 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~ 313 (331)
....................+.++.+|+.+||+.||++|||+.|+++. ++.++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 001111111111112233456689999999999999999999999864 45543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=327.70 Aligned_cols=229 Identities=28% Similarity=0.381 Sum_probs=185.5
Q ss_pred cCCccCceecCCCCeEEEEEEe----cCCcEEEEcc---------------------------c-ccchhhhcccccCCc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR----EDGRIIAVKK---------------------------S-KNAVKLLGCCLETEV 103 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~---------------------------~-~niv~~~~~~~~~~~ 103 (331)
++|++.+.||+|+||+||+|.+ .+|+.||||. | |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999986 2588999992 4 799999999999999
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.+++|||+.+|+|.+.+... ..+++..+..++.||+.||.|+|+.+ |+||||||+||+++.+|.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999998763 36788999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
++.+............|++.|+|||.+.+. .++.++|||||||++|+|++|+.||......... .........
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~- 250 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILK- 250 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHH-
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhccc-
Confidence 987655444445556799999999988765 4678999999999999999999999654322211 111111111
Q ss_pred CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 020102 262 NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPT-----MEEVSM 307 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs-----~~evl~ 307 (331)
.. ...+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 251 ~~----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 SE----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 10 1123345678999999999999999995 778765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=331.12 Aligned_cols=239 Identities=21% Similarity=0.286 Sum_probs=176.9
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc------------------------ccccchhhhcccccCCc----ce
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK------------------------KSKNAVKLLGCCLETEV----PL 105 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK------------------------~~~niv~~~~~~~~~~~----~~ 105 (331)
+.+|++.+.||+|+||+||+|.+ .+++.|||| .|||++++++++..... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999987 579999999 38899999999876542 34
Q ss_pred eEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 106 LVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
++++|+.+|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|.
T Consensus 87 ~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence 55667779999998865 26899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCce--eeeeccccCCccChhhhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 186 FIAMDQTH--VTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 186 ~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
........ ......||+.|+|||++. +..++.++||||+||++|+|++|+.||........ ...........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-----~~~~~~~~~~~ 232 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-----LNHILGILGSP 232 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHHCSC
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-----HHHHhhhccCC
Confidence 65432221 223456999999999874 45678899999999999999999999964321100 00000000000
Q ss_pred c------------------cccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 R------------------LYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 ~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
. ........ .....+..+.++.+|+.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCC-HHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCC-HHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000 000112234578999999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=325.36 Aligned_cols=241 Identities=21% Similarity=0.279 Sum_probs=176.7
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhccccc--------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLE-------- 100 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~-------- 100 (331)
.++|++.+.||+|+||+||+|.+ .+|+.|||| +|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999998 579999999 38899999988754
Q ss_pred CCcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEee
Q 020102 101 TEVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 180 (331)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~D 180 (331)
....++||||+.++.+..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeee
Confidence 345789999998665543322 3457899999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCCce---eeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 020102 181 FGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFV 256 (331)
Q Consensus 181 fg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 256 (331)
||++......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ... ......
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~---~~~~i~ 235 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQH---QLALIS 235 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHH---HHHHHH
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHH---HHHHHH
Confidence 9999765532221 22235699999999998765 68999999999999999999999985421 111 000111
Q ss_pred HHhhc---CccccccchH--------------h-hccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 257 HSMRK---NRLYDILDDQ--------------V-MKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 257 ~~~~~---~~~~~~~~~~--------------~-~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
..... .......... . ........+..+++|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11100 0000000000 0 000011124467899999999999999999999753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=323.18 Aligned_cols=239 Identities=21% Similarity=0.267 Sum_probs=186.2
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCCcceeEee
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETEVPLLVYE 109 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~~~~lv~e 109 (331)
++|++.+.||+|+||+||+|.+ .+++.|||| +||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999998 578999999 38899999999999999999999
Q ss_pred cccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccCcccccC
Q 020102 110 FISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 189 (331)
Q Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 189 (331)
++.++++...+.. .+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+.....
T Consensus 82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccC
Confidence 9998888776653 347899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCceeeeeccccCCccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcCc---cc
Q 020102 190 DQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKNR---LY 265 (331)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 265 (331)
... ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||+...+.... ............ +.
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ----LKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH----HHHHHHHHCCCCTTTCT
T ss_pred CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH----HHHHHhhcCCCChhhhh
Confidence 332 223345788899999887765 689999999999999999999998754322111 011111111000 00
Q ss_pred ------------cccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 266 ------------DILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 266 ------------~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
...............++.+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000111122344567899999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=325.44 Aligned_cols=239 Identities=23% Similarity=0.316 Sum_probs=177.0
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccCC------
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLETE------ 102 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~~------ 102 (331)
.++|++.+.||+|+||+||+|.+ .+++.|||| +|||+|+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999998 569999999 4889999999987655
Q ss_pred cceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeecc
Q 020102 103 VPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 182 (331)
Q Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 182 (331)
..++||||+ +.+|...... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence 469999999 5677665543 36999999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 020102 183 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRK 261 (331)
Q Consensus 183 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
+|...... .+...||+.|+|||++.+. .++.++||||+||++|+|++|+.||........ +.... .....
T Consensus 167 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~----~~~~~-~~~~~ 237 (346)
T d1cm8a_ 167 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ----LKEIM-KVTGT 237 (346)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHH-HHHCC
T ss_pred ceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH----HHHHH-hccCC
Confidence 99865432 2345699999999988764 568999999999999999999999964321100 00000 00000
Q ss_pred ------------------CccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 020102 262 ------------------NRLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME--LNGIR 313 (331)
Q Consensus 262 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~--L~~l~ 313 (331)
.......... ........+..+.+|+.+||+.||++|||++|+++. ++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccc-hHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000000 011122345678999999999999999999999875 55543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.6e-45 Score=327.00 Aligned_cols=239 Identities=22% Similarity=0.312 Sum_probs=180.2
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEc---------------------ccccchhhhccccc--CCcceeEeecc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK---------------------KSKNAVKLLGCCLE--TEVPLLVYEFI 111 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK---------------------~~~niv~~~~~~~~--~~~~~lv~e~~ 111 (331)
++|++.+.||+|+||+||+|.+ .+++.|||| .||||+++++++.. ....++||||+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 5799999999999999999998 579999999 28999999999874 45689999999
Q ss_pred cCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEeeccCcccccCC
Q 020102 112 SNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMD 190 (331)
Q Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~ 190 (331)
.+++|.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|......
T Consensus 115 ~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 115 NNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred CCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999986532 26899999999999999999999999 99999999999998655 5899999999865433
Q ss_pred CceeeeeccccCCccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHH-----HHHHHhhcCcc
Q 020102 191 QTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAA-----YFVHSMRKNRL 264 (331)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 264 (331)
. ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||............... ...........
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 23345689999999987765 4799999999999999999999999754322111100000 00000000000
Q ss_pred c---c---c--------cchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 020102 265 Y---D---I--------LDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSM 307 (331)
Q Consensus 265 ~---~---~--------~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~ 307 (331)
. . . .............+.++.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 0 0000111122335667999999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=320.76 Aligned_cols=240 Identities=22% Similarity=0.288 Sum_probs=171.6
Q ss_pred cCCccCceecCCCCeEEEEEEec-CCcEEEEc-------------------------ccccchhhhccccc------CCc
Q 020102 56 NHFNVNRILGQGGQGTVYKGMRE-DGRIIAVK-------------------------KSKNAVKLLGCCLE------TEV 103 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK-------------------------~~~niv~~~~~~~~------~~~ 103 (331)
++|++.+.||+|+||+||+|.+. +|+.|||| +||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999984 69999999 48899999999864 357
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.++||||+.++ +.+.+.. .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++++|||+
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccchH-HHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 89999999754 4444432 5899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccc-------------
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVS------------- 250 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~------------- 250 (331)
+...... .......+|+.|+|||++.+..++.++||||+||++++|++|+.||............
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8755432 2334457899999999999999999999999999999999999998643211000000
Q ss_pred -hHHHHHHHhhcC-ccc-----cccchHhh---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 251 -LAAYFVHSMRKN-RLY-----DILDDQVM---KLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 251 -~~~~~~~~~~~~-~~~-----~~~~~~~~---~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
............ ... ........ .......+.++.+|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 000 00000000 01123457789999999999999999999999755
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=319.14 Aligned_cols=235 Identities=23% Similarity=0.276 Sum_probs=175.5
Q ss_pred hcCCccCceecCCCCeEEEEEEe-cCCcEEEEc-------------------------ccccchhhhcccccC-----Cc
Q 020102 55 TNHFNVNRILGQGGQGTVYKGMR-EDGRIIAVK-------------------------KSKNAVKLLGCCLET-----EV 103 (331)
Q Consensus 55 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK-------------------------~~~niv~~~~~~~~~-----~~ 103 (331)
.++|++.+.||+|+||+||+|.+ .+|+.|||| +|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999997 579999999 388999999998643 34
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeeccC
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 183 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 183 (331)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence 4677788889999988753 36999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcC
Q 020102 184 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQENVSLAAYFVHSMRKN 262 (331)
Q Consensus 184 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
+..... ......||+.|+|||...+.. ++.++||||+||++|+|++|+.||........ ...........
T Consensus 168 a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-----~~~i~~~~~~~ 238 (348)
T d2gfsa1 168 ARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-----LKLILRLVGTP 238 (348)
T ss_dssp --CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHHCCC
T ss_pred hcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcCCC
Confidence 875432 223356899999999877654 68899999999999999999999964321100 00000000000
Q ss_pred ------------------ccccccchHhhccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 020102 263 ------------------RLYDILDDQVMKLGKKNQIMAFANLAERCLDLNGKKRPTMEEVSME 308 (331)
Q Consensus 263 ------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~~evl~~ 308 (331)
.......... .......+..+.+|+.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000 00012345678999999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-39 Score=295.39 Aligned_cols=243 Identities=20% Similarity=0.227 Sum_probs=174.1
Q ss_pred cCCccCceecCCCCeEEEEEEe-cCCcEEEEcc---------------------------------cccchhhhcccccC
Q 020102 56 NHFNVNRILGQGGQGTVYKGMR-EDGRIIAVKK---------------------------------SKNAVKLLGCCLET 101 (331)
Q Consensus 56 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~---------------------------------~~niv~~~~~~~~~ 101 (331)
++|++.+.||+|+||+||+|.+ .+|+.||||+ |+|++++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4599999999999999999998 5799999993 46788888887653
Q ss_pred --CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCCEEeCCCCc---
Q 020102 102 --EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHS-AASSPIYHRDIKSTNILLDERYR--- 175 (331)
Q Consensus 102 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dikp~Nill~~~~~--- 175 (331)
...+++++++..+........ ......+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred cccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 345666666655544333333 2334578999999999999999999998 77 999999999999986553
Q ss_pred ---EEEeeccCcccccCCCceeeeeccccCCccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCcccc--cc
Q 020102 176 ---AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSAGNTSQEN--VS 250 (331)
Q Consensus 176 ---~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p~~~~~~~~~~~--~~ 250 (331)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||.......... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999998754322 234569999999999999999999999999999999999999986432211110 00
Q ss_pred hHHHHHHHhhc--------C----------cccccc--------c--hHhhccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 020102 251 LAAYFVHSMRK--------N----------RLYDIL--------D--DQVMKLGKKNQIMAFANLAERCLDLNGKKRPTM 302 (331)
Q Consensus 251 ~~~~~~~~~~~--------~----------~~~~~~--------~--~~~~~~~~~~~~~~~~~li~~cL~~~p~~RPs~ 302 (331)
.... ...+.. . ...... . ...........+..+.+|+.+||+.||++|||+
T Consensus 244 ~~~~-~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 244 IAQI-IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHH-HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHH-HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 0000 000000 0 000000 0 001122345678899999999999999999999
Q ss_pred HHHHHH
Q 020102 303 EEVSME 308 (331)
Q Consensus 303 ~evl~~ 308 (331)
+|+++.
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2e-23 Score=171.06 Aligned_cols=144 Identities=22% Similarity=0.258 Sum_probs=101.0
Q ss_pred ccCceecCCCCeEEEEEEecCCcEEEEcccc---------------------------------cchhhhccccc----C
Q 020102 59 NVNRILGQGGQGTVYKGMREDGRIIAVKKSK---------------------------------NAVKLLGCCLE----T 101 (331)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~---------------------------------niv~~~~~~~~----~ 101 (331)
.+.+.||+|+||+||+|.+.+|+.||||.++ ++.++.+.... .
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999999889999999421 22222222111 1
Q ss_pred CcceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEeec
Q 020102 102 EVPLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 181 (331)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 181 (331)
...+++|||+++..+. .++...+..++.|++.++.|||+++ |+||||||+|||++++ .++|+||
T Consensus 83 ~~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EGNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ETTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred cCCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 2347899999876442 1334455678999999999999998 9999999999999976 4899999
Q ss_pred cCcccccCCCceeeeeccccCCccCh------hhhcCCCCCCcchHHHHHHHH
Q 020102 182 GTSKFIAMDQTHVTTKIQGTFGYLDP------EYHQSSQLTDKSDVYSFGVVL 228 (331)
Q Consensus 182 g~a~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwslG~il 228 (331)
|+|.....+... .|... +.+ ...|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 998755432211 11111 111 24567889999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.19 E-value=1.9e-06 Score=71.75 Aligned_cols=127 Identities=18% Similarity=0.165 Sum_probs=85.3
Q ss_pred hHHHHHHhcCCccCceecCCCCeEEEEEEecCCcEEEEcccc------------------------cchhhhcccccCCc
Q 020102 48 SKELDKATNHFNVNRILGQGGQGTVYKGMREDGRIIAVKKSK------------------------NAVKLLGCCLETEV 103 (331)
Q Consensus 48 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~------------------------niv~~~~~~~~~~~ 103 (331)
.+|+......|++.+..+-++.+.||+... ++..+++|..+ -+.+++.+..+++.
T Consensus 6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp CHHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred CHHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 467777778888776655455578998854 45556777432 23455666666778
Q ss_pred ceeEeecccCCCHHHHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----------------------------
Q 020102 104 PLLVYEFISNGTLYQHLHDRLQNQEFPLTWEMRLRIATEVAGALAYLHSAAS---------------------------- 155 (331)
Q Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---------------------------- 155 (331)
.++||++++|.++.+.... ... ...++.+++..++.||+...
T Consensus 85 ~~lv~~~l~G~~~~~~~~~-------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED-------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT-------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred eEEEEEecccccccccccc-------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 8999999998877553321 111 22245556666666664320
Q ss_pred ----------------------------CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 ----------------------------SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ----------------------------~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.|.||++++++...|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 137899999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.69 E-value=1.9e-05 Score=65.15 Aligned_cols=54 Identities=15% Similarity=0.155 Sum_probs=39.6
Q ss_pred eecCCCC-eEEEEEEecCCcEEEEcccc----------------------cchhhhcccccCCcceeEeecccCCCH
Q 020102 63 ILGQGGQ-GTVYKGMREDGRIIAVKKSK----------------------NAVKLLGCCLETEVPLLVYEFISNGTL 116 (331)
Q Consensus 63 ~lg~G~~-g~V~~~~~~~~~~vavK~~~----------------------niv~~~~~~~~~~~~~lv~e~~~~~~L 116 (331)
.+..|.. +.||+....++..+++|..+ .+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455554 68999988778888888432 356667777777888999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00029 Score=61.96 Aligned_cols=28 Identities=25% Similarity=0.305 Sum_probs=24.8
Q ss_pred CeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 157 PIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 157 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
.++|+|+.|.||++++++ ++|.||..|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 489999999999999774 8999998875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.73 E-value=0.039 Score=46.41 Aligned_cols=28 Identities=21% Similarity=0.308 Sum_probs=23.2
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
..++|+|+.|.||+++++ ..+.||+.+.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 458999999999999743 4589999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.31 E-value=0.076 Score=45.79 Aligned_cols=16 Identities=38% Similarity=0.638 Sum_probs=13.4
Q ss_pred eEEccCCCCCEEeCCC
Q 020102 158 IYHRDIKSTNILLDER 173 (331)
Q Consensus 158 i~H~dikp~Nill~~~ 173 (331)
+||+|+.+.||++.+.
T Consensus 220 ~CHnDL~~~NiL~~~~ 235 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPKA 235 (395)
T ss_dssp EECSCCCGGGEEEEC-
T ss_pred EEecCCCcccEeeccc
Confidence 5899999999999654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.87 E-value=0.012 Score=49.24 Aligned_cols=30 Identities=17% Similarity=0.195 Sum_probs=26.5
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEeeccCcc
Q 020102 156 SPIYHRDIKSTNILLDERYRAKVADFGTSK 185 (331)
Q Consensus 156 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 185 (331)
.++||+|+.++||+++++...-+.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 359999999999999988777899999875
|